Clustering O 0 0.10100672394037247
of O 0 0.00483396602794528
missense O 1 0.9996963739395142
mutations O 1 0.9987932443618774
in O 0 0.001800025231204927
the O 0 0.006851816549897194
ataxia B-Disease 1 1.0
- I-Disease 1 0.9994310736656189
telangiectasia I-Disease 1 1.0
gene O 1 0.9978880286216736
in O 0 0.0020385617390275
a O 0 0.008776022121310234
sporadic B-Disease 1 0.9884238839149475
T I-Disease 1 0.999988317489624
- I-Disease 1 0.7434796094894409
cell I-Disease 1 0.9503389596939087
leukaemia I-Disease 1 0.9999998807907104
. O 0 0.009157937951385975

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9966604709625244
telangiectasia I-Disease 1 1.0
( O 0 0.009393534623086452
A B-Disease 1 0.9930487871170044
- I-Disease 1 0.9447263479232788
T I-Disease 1 0.9999980926513672
) O 0 0.002460251795127988
is O 0 0.0023416525218635798
a O 0 0.01177128404378891
recessive B-Disease 1 1.0
multi I-Disease 1 0.9991746544837952
- I-Disease 1 0.6007852554321289
system I-Disease 1 0.8753166794776917
disorder I-Disease 1 1.0
caused O 1 0.999991774559021
by O 0 0.0056234318763017654
mutations O 1 0.999908447265625
in O 0 0.00112779694609344
the O 0 0.003359032329171896
ATM O 1 0.994550883769989
gene O 1 0.9791082739830017
at O 0 0.00986829400062561
11q22 O 1 0.9994077682495117
- O 0 0.05815456062555313
q23 O 1 0.9995369911193848
( O 0 0.013107762672007084
ref O 1 0.9979148507118225
. O 0 0.004605220165103674
3 O 0 0.013930895365774632
) O 0 0.004249663092195988
. O 0 0.004677174147218466

The O 0 0.007847104221582413
risk O 1 0.9643412828445435
of O 0 0.004794434178620577
cancer B-Disease 1 1.0
, O 0 0.002654740586876869
especially O 0 0.011766443960368633
lymphoid B-Disease 1 0.9999996423721313
neoplasias I-Disease 1 0.9999123811721802
, O 0 0.0016407943330705166
is O 0 0.0022114610765129328
substantially O 0 0.025740869343280792
elevated O 1 0.990097165107727
in O 0 0.0018943974282592535
A B-Disease 1 0.9981775283813477
- I-Disease 1 0.9990594983100891
T I-Disease 1 1.0
patients O 1 0.9999985694885254
and O 0 0.0014871993334963918
has O 0 0.003063662676140666
long O 0 0.006186219863593578
been O 0 0.003603683551773429
associated O 0 0.008866426534950733
with O 0 0.004488176200538874
chromosomal O 1 0.9999998807907104
instability O 1 0.9999817609786987
. O 0 0.006317033898085356

By O 0 0.010214023292064667
analysing O 0 0.15263338387012482
tumour B-Disease 1 1.0
DNA O 0 0.07289642840623856
from O 0 0.006314969155937433
patients O 1 0.9998149275779724
with O 0 0.002413444686681032
sporadic B-Disease 1 0.991248607635498
T I-Disease 1 0.9999872446060181
- I-Disease 0 0.16799424588680267
cell I-Disease 1 0.8109564185142517
prolymphocytic I-Disease 1 0.9999912977218628
leukaemia I-Disease 1 1.0
( O 0 0.024831708520650864
T B-Disease 1 0.9999126195907593
- I-Disease 0 0.0856316089630127
PLL I-Disease 1 0.9999871253967285
) O 0 0.005028459709137678
, O 0 0.001188357942737639
a O 0 0.006742587313055992
rare O 0 0.07429516315460205
clonal B-Disease 1 0.9999011754989624
malignancy I-Disease 1 0.9999986886978149
with O 0 0.0019397662254050374
similarities O 0 0.007668298669159412
to O 0 0.0011437577195465565
a O 0 0.008397961966693401
mature B-Disease 1 0.797418475151062
T I-Disease 1 0.9999934434890747
- I-Disease 0 0.05733722820878029
cell I-Disease 1 0.6890183091163635
leukaemia I-Disease 1 0.9999998807907104
seen O 0 0.012912957929074764
in O 0 0.0022777519188821316
A B-Disease 1 0.9936002492904663
- I-Disease 1 0.918781042098999
T I-Disease 1 0.9999995231628418
, O 0 0.0014564256416633725
we O 0 0.0008955858065746725
demonstrate O 0 0.0038288754876703024
a O 0 0.003789597423747182
high O 0 0.005008124280720949
frequency O 0 0.020432936027646065
of O 0 0.0021901109721511602
ATM O 1 0.9997686743736267
mutations O 1 0.999981164932251
in O 0 0.005440590437501669
T B-Disease 1 0.9998972415924072
- I-Disease 0 0.09129782766103745
PLL I-Disease 1 0.9999624490737915
. O 0 0.007829634472727776

In O 0 0.004314656835049391
marked O 0 0.015210011973977089
contrast O 0 0.005487306974828243
to O 0 0.0009558083256706595
the O 0 0.0033274113666266203
ATM O 1 0.9952983260154724
mutation O 1 0.9999325275421143
pattern O 0 0.025950146839022636
in O 0 0.002507670084014535
A B-Disease 1 0.9152493476867676
- I-Disease 0 0.48321983218193054
T I-Disease 1 0.9999955892562866
, O 0 0.0015220793429762125
the O 0 0.0016183725092560053
most O 0 0.0028289170004427433
frequent O 0 0.03678380697965622
nucleotide O 0 0.09567224979400635
changes O 0 0.006030045449733734
in O 0 0.0011398764327168465
this O 0 0.003858842421323061
leukaemia B-Disease 1 1.0
were O 0 0.008029719814658165
missense O 1 0.9999127388000488
mutations O 1 0.999570906162262
. O 0 0.007635191082954407

These O 0 0.0027873353101313114
clustered O 0 0.02564745396375656
in O 0 0.0014484311686828732
the O 0 0.0018152593402191997
region O 0 0.0077995844185352325
corresponding O 0 0.0062495749443769455
to O 0 0.0012689981376752257
the O 0 0.005071389488875866
kinase O 1 0.9999146461486816
domain O 0 0.03392498567700386
, O 0 0.0012475786497816443
which O 0 0.0013643268030136824
is O 0 0.0025724531151354313
highly O 0 0.011418227106332779
conserved O 0 0.03146439790725708
in O 0 0.0037605694960802794
ATM O 0 0.3019654452800751
- O 0 0.03385857120156288
related O 0 0.014463708736002445
proteins O 0 0.026409000158309937
in O 0 0.004148061387240887
mouse O 1 0.9994702935218811
, O 0 0.004153842572122812
yeast O 1 0.8599244952201843
and O 0 0.003439994528889656
Drosophila O 1 0.950307309627533
. O 0 0.0058773537166416645

The O 0 0.0069130766205489635
resulting O 0 0.05688584968447685
amino O 0 0.09539167582988739
- O 0 0.03887093812227249
acid O 0 0.15198345482349396
substitutions O 0 0.03340979292988777
are O 0 0.001211369875818491
predicted O 0 0.010064898990094662
to O 0 0.0015416500391438603
interfere O 0 0.0196490827947855
with O 0 0.0027461617719382048
ATP O 1 0.9915071129798889
binding O 0 0.031160254031419754
or O 0 0.0070721847005188465
substrate O 0 0.08370069414377213
recognition O 0 0.024662064388394356
. O 0 0.005174300167709589

Two O 0 0.0019929385744035244
of O 0 0.0015063744504004717
seventeen O 0 0.06302890926599503
mutated O 1 0.9999977350234985
T B-Disease 1 0.9999605417251587
- I-Disease 0 0.0712006464600563
PLL I-Disease 1 0.9998195767402649
samples O 0 0.016714276745915413
had O 0 0.0034719721879810095
a O 0 0.004342208616435528
previously O 0 0.005417248234152794
reported O 0 0.01656581088900566
A B-Disease 0 0.23455552756786346
- I-Disease 1 0.7012707591056824
T I-Disease 1 0.9999961853027344
allele O 1 0.9999215602874756
. O 0 0.008220559917390347

In O 0 0.003547414904460311
contrast O 0 0.008855235762894154
, O 0 0.001483023981563747
no O 0 0.00398158747702837
mutations O 1 0.999908447265625
were O 0 0.002067842287942767
detected O 0 0.044445913285017014
in O 0 0.0012777328956872225
the O 0 0.004816986620426178
p53 O 1 0.9999961853027344
gene O 1 0.9984384179115295
, O 0 0.0021070593502372503
suggesting O 0 0.008558100089430809
that O 0 0.0012597566237673163
this O 0 0.006126841995865107
tumour B-Disease 1 1.0
suppressor O 1 0.9999998807907104
is O 0 0.004280376248061657
not O 0 0.0012602799106389284
frequently O 0 0.007949150167405605
altered O 0 0.021205317229032516
in O 0 0.0015734941698610783
this O 0 0.005298711825162172
leukaemia B-Disease 1 1.0
. O 0 0.007879069074988365

Occasional O 0 0.11246106028556824
missense O 1 0.9997653365135193
mutations O 1 0.9995511174201965
in O 0 0.0028520566411316395
ATM O 1 0.594153106212616
were O 0 0.0014142482541501522
also O 0 0.0012979765888303518
found O 0 0.004096710588783026
in O 0 0.004022921435534954
tumour B-Disease 1 1.0
DNA O 0 0.05721081420779228
from O 0 0.004984941799193621
patients O 1 0.9999343156814575
with O 0 0.0024365228600800037
B B-Disease 1 0.9983131885528564
- I-Disease 0 0.02827518992125988
cell I-Disease 0 0.048468708992004395
non I-Disease 0 0.024021124467253685
- I-Disease 1 0.9979985356330872
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.9999998807907104
( O 0 0.015452378429472446
B B-Disease 1 0.9987201690673828
- I-Disease 0 0.03549526259303093
NHL I-Disease 0 0.22317612171173096
) O 0 0.0027262617368251085
and O 0 0.000943334714975208
a O 0 0.008879064582288265
B B-Disease 1 0.9987829327583313
- I-Disease 0 0.04284672811627388
NHL I-Disease 1 0.784311056137085
cell O 0 0.056952476501464844
line O 0 0.012197688221931458
. O 0 0.005473270080983639

The O 0 0.0029833721928298473
evidence O 0 0.0015473857056349516
of O 0 0.0008558178669773042
a O 0 0.003888264764100313
significant O 0 0.006665172521024942
proportion O 0 0.010783168487250805
of O 0 0.0017146276077255607
loss O 0 0.4584105610847473
- O 0 0.013561294414103031
of O 0 0.0019190895836800337
- O 0 0.03161938115954399
function O 0 0.03630240634083748
mutations O 1 0.9997548460960388
and O 0 0.0012460935395210981
a O 0 0.004219068679958582
complete O 0 0.004761174786835909
absence O 0 0.010900101624429226
of O 0 0.0009680049843154848
the O 0 0.0022255564108490944
normal O 0 0.015999820083379745
copy O 0 0.010985429398715496
of O 0 0.001534123090095818
ATM O 0 0.22896316647529602
in O 0 0.001092157675884664
the O 0 0.0019019977189600468
majority O 0 0.007430232595652342
of O 0 0.003708972129970789
mutated O 1 1.0
tumours B-Disease 1 1.0
establishes O 1 0.886671245098114
somatic O 1 0.9989835619926453
inactivation O 1 0.9994361996650696
of O 0 0.0015894905664026737
this O 0 0.002543974667787552
gene O 1 0.939172089099884
in O 0 0.0013092439621686935
the O 0 0.003489765804260969
pathogenesis O 1 0.9999901056289673
of O 0 0.0036087415646761656
sporadic B-Disease 1 0.9994926452636719
T I-Disease 1 0.999983549118042
- I-Disease 0 0.48006144165992737
PLL I-Disease 1 0.999993085861206
and O 0 0.002278692787513137
suggests O 0 0.010791508480906487
that O 0 0.0016738604754209518
ATM O 0 0.3180913031101227
acts O 0 0.007445750292390585
as O 0 0.0027200202457606792
a O 0 0.026496069505810738
tumour B-Disease 1 1.0
suppressor O 1 0.9999990463256836
. O 0 0.010662571527063847

As O 0 0.004644525703042746
constitutional O 0 0.012412849813699722
DNA O 0 0.036545444279909134
was O 0 0.0048099420964717865
not O 0 0.0008314666920341551
available O 0 0.0011096224188804626
, O 0 0.0007537108613178134
a O 0 0.00534377247095108
putative O 1 0.9997126460075378
hereditary O 1 1.0
predisposition O 1 0.9999998807907104
to O 0 0.008172567002475262
T B-Disease 1 0.999988317489624
- I-Disease 0 0.3013923764228821
PLL I-Disease 1 0.9999912977218628
will O 0 0.0028031880501657724
require O 0 0.0056593394838273525
further O 0 0.003480492625385523
investigation O 0 0.010799385607242584
. O 0 0.0024934050161391497
. O 0 0.003879074240103364

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 1 0.9775247573852539
kinase O 1 0.9997796416282654
is O 0 0.004040210507810116
involved O 0 0.0043335361406207085
in O 0 0.0008822401869110763
the O 0 0.0024488435592502356
modulation O 0 0.09328777343034744
of O 0 0.0015366172883659601
the O 0 0.006284619681537151
Ca2 O 1 0.999944806098938
+ O 0 0.3245603144168854
homeostasis O 1 0.9973457455635071
in O 0 0.0073920260183513165
skeletal O 1 0.9999947547912598
muscle O 1 0.9999982118606567
cells O 0 0.09615062177181244
. O 0 0.005875553470104933

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.4187081456184387
DM B-Disease 1 1.0
) O 0 0.0037328582257032394
, O 0 0.0007094698376022279
the O 0 0.0016306535108014941
most O 0 0.0049462090246379375
prevalent O 1 0.9999991655349731
muscular B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 0.00499070156365633
adults O 1 0.975064754486084
, O 0 0.0016354183899238706
is O 0 0.004311253782361746
caused O 1 0.9992515444755554
by O 0 0.005749136675149202
( O 0 0.009524499997496605
CTG O 1 0.9997102618217468
) O 0 0.0069052958860993385
n O 0 0.03407503664493561
- O 0 0.019716940820217133
repeat O 0 0.04682920128107071
expansion O 0 0.008976881392300129
in O 0 0.0013359044678509235
a O 0 0.00900381151586771
gene O 1 0.7133095860481262
encoding O 0 0.053260207176208496
a O 0 0.01172404084354639
protein O 0 0.09813138097524643
kinase O 1 0.9984902143478394
( O 0 0.020969290286302567
DM B-Disease 1 0.9999998807907104
protein O 0 0.4597699046134949
kinase O 1 0.999481737613678
; O 0 0.011604700237512589
DMPK O 1 0.9999258518218994
) O 0 0.003220680635422468
and O 0 0.0009995725704357028
involves O 0 0.013621963560581207
changes O 0 0.005444585811346769
in O 0 0.002494467655196786
cytoarchitecture O 1 0.9991787075996399
and O 0 0.00420877942815423
ion O 0 0.4909166991710663
homeostasis O 1 0.9995396137237549
. O 0 0.008526801131665707

To O 0 0.0024956141132861376
obtain O 0 0.004283924121409655
clues O 0 0.009339631535112858
to O 0 0.0009772112825885415
the O 0 0.0019338523270562291
normal O 0 0.014092272147536278
biological O 0 0.007666716352105141
role O 0 0.006557598244398832
of O 0 0.0021919673308730125
DMPK O 1 0.9999442100524902
in O 0 0.00462350994348526
cellular O 0 0.14202308654785156
ion O 1 0.5995442271232605
homeostasis O 1 0.9997614026069641
, O 0 0.0022021112963557243
we O 0 0.001218403340317309
have O 0 0.0013448341051116586
compared O 0 0.007899810560047626
the O 0 0.003987825009971857
resting O 1 0.9954949617385864
[ O 0 0.08168257027864456
Ca2 O 1 0.999397873878479
+ O 0 0.131630077958107
] O 0 0.044445402920246124
i O 0 0.0057955048978328705
, O 0 0.0011223226319998503
the O 0 0.002395137446001172
amplitude O 0 0.06070476770401001
and O 0 0.0014735282165929675
shape O 0 0.015580800361931324
of O 0 0.00296404049731791
depolarization O 1 0.9999955892562866
- O 1 0.8702958822250366
induced O 1 0.9999966621398926
Ca2 O 1 0.9999101161956787
+ O 0 0.19065771996974945
transients O 1 0.9917224049568176
, O 0 0.002358535770326853
and O 0 0.0009397675166837871
the O 0 0.0017037724610418081
content O 0 0.003931563813239336
of O 0 0.002067721216008067
ATP O 1 0.9936269521713257
- O 0 0.03238769993185997
driven O 0 0.04646383225917816
ion O 0 0.11208690702915192
pumps O 0 0.07647598534822464
in O 0 0.005038286093622446
cultured O 1 0.8553433418273926
skeletal O 1 0.9999911785125732
muscle O 1 0.9999855756759644
cells O 0 0.05155012384057045
of O 0 0.0020504584535956383
wild O 0 0.02672215737402439
- O 0 0.02426215261220932
type O 0 0.0356467179954052
and O 0 0.0028821276500821114
DMPK O 1 0.9999934434890747
[ O 0 0.05185219645500183
- O 0 0.042498573660850525
/ O 1 0.6773923635482788
- O 0 0.04288885369896889
] O 0 0.08689196407794952
knockout O 1 0.9995743632316589
mice O 1 0.9988172054290771
. O 0 0.0066452911123633385

In O 0 0.005945275072008371
vitro O 0 0.11083412170410156
- O 0 0.0473606251180172
differentiated O 1 0.9564194679260254
DMPK O 1 0.9999785423278809
[ O 0 0.06690692156553268
- O 0 0.042405202984809875
/ O 0 0.3160766065120697
- O 0 0.0420704260468483
] O 0 0.0673556998372078
myotubes O 1 0.9863767027854919
exhibit O 0 0.015394766815006733
a O 0 0.005700891371816397
higher O 0 0.01107604056596756
resting O 1 0.988224983215332
[ O 0 0.09110401570796967
Ca2 O 1 0.9998927116394043
+ O 0 0.11347013711929321
] O 0 0.04137178137898445
i O 0 0.0055243270471692085
than O 0 0.002107123611494899
do O 0 0.003936695400625467
wild O 0 0.030307641252875328
- O 0 0.035829659551382065
type O 0 0.29684099555015564
myotubes O 1 0.9994138479232788
because O 0 0.004645843990147114
of O 0 0.0009556926670484245
an O 0 0.0020536379888653755
altered O 0 0.03189963474869728
open O 0 0.006897171959280968
probability O 0 0.008158124051988125
of O 0 0.0014860752271488309
voltage O 0 0.05776724964380264
- O 0 0.03152430057525635
dependent O 0 0.04937770590186119
l O 0 0.12529343366622925
- O 0 0.051601946353912354
type O 0 0.34897324442863464
Ca2 O 1 0.9987218976020813
+ O 0 0.09021598845720291
and O 0 0.0047151995822787285
Na O 1 0.9862105250358582
+ O 0 0.08172259479761124
channels O 0 0.02252073399722576
. O 0 0.005410537123680115

The O 0 0.012202918529510498
mutant O 1 0.9987741112709045
myotubes O 1 0.9919082522392273
exhibit O 0 0.02287755161523819
smaller O 0 0.007489263080060482
and O 0 0.0018211239948868752
slower O 0 0.0530865415930748
Ca2 O 1 0.9982465505599976
+ O 0 0.0866122916340828
responses O 0 0.029230408370494843
upon O 0 0.00858142040669918
triggering O 1 0.967133104801178
by O 0 0.008136976510286331
acetylcholine O 1 0.9950551986694336
or O 0 0.004689293913543224
high O 0 0.00807826779782772
external O 0 0.018162377178668976
K O 0 0.17325136065483093
+ O 0 0.08124534040689468
. O 0 0.00636806758120656

In O 0 0.00322824832983315
addition O 0 0.0033588120713829994
, O 0 0.0012137630255892873
we O 0 0.0013103921664878726
observed O 0 0.00871388427913189
that O 0 0.0011020698584616184
these O 0 0.002373453928157687
Ca2 O 1 0.99986732006073
+ O 0 0.3750905692577362
transients O 1 0.9987829327583313
partially O 0 0.08484356850385666
result O 0 0.010857186280190945
from O 0 0.0016495410818606615
an O 0 0.0020224498584866524
influx O 0 0.037410058081150055
of O 0 0.002925335196778178
extracellular O 1 0.78041011095047
Ca2 O 1 0.9988521337509155
+ O 0 0.05897326394915581
through O 0 0.0042062923312187195
the O 0 0.005096471402794123
l O 0 0.3969652056694031
- O 0 0.05059631168842316
type O 0 0.19512587785720825
Ca2 O 1 0.9962504506111145
+ O 0 0.11514140665531158
channel O 0 0.04966408759355545
. O 0 0.007351841311901808

Neither O 0 0.014503497630357742
the O 0 0.002332706470042467
content O 0 0.004786340985447168
nor O 0 0.005437180865556002
the O 0 0.0019649879541248083
activity O 0 0.007258961908519268
of O 0 0.0027474232483655214
Na O 1 0.9991075396537781
+ O 0 0.14180946350097656
/ O 0 0.09279966354370117
K O 0 0.15038983523845673
+ O 0 0.12049371004104614
ATPase O 1 0.9506142735481262
and O 0 0.010522749274969101
sarcoplasmic O 1 0.9999823570251465
reticulum O 1 0.9993683695793152
Ca2 O 1 0.9979469180107117
+ O 0 0.14284391701221466
- O 0 0.05872073397040367
ATPase O 1 0.9684191942214966
are O 0 0.0026841263752430677
affected O 0 0.03765150532126427
by O 0 0.006480006035417318
DMPK O 1 0.9999483823776245
absence O 0 0.042068738490343094
. O 0 0.005160692147910595

In O 0 0.002902162726968527
conclusion O 0 0.006170538254082203
, O 0 0.0009414891246706247
our O 0 0.001140481443144381
data O 0 0.0017288553062826395
suggest O 0 0.0054976860992610455
that O 0 0.002046772511675954
DMPK O 1 0.9999507665634155
is O 0 0.003982646390795708
involved O 0 0.006483335047960281
in O 0 0.0027885364834219217
modulating O 1 0.9947373270988464
the O 0 0.0028319626580923796
initial O 0 0.013209767639636993
events O 0 0.0037449225783348083
of O 0 0.0021209397818893194
excitation O 1 0.9919145107269287
- O 0 0.048869334161281586
contraction O 1 0.9963326454162598
coupling O 0 0.12526781857013702
in O 0 0.0063007185235619545
skeletal O 1 0.9999977350234985
muscle O 1 0.9999912977218628
. O 0 0.00373365287669003
. O 0 0.004267685115337372

Constitutional O 0 0.06483224034309387
RB1 O 1 0.999998927116394
- O 1 0.54047691822052
gene O 1 0.999933123588562
mutations O 1 0.9999212026596069
in O 0 0.00442917924374342
patients O 1 0.9999946355819702
with O 0 0.0027271772269159555
isolated O 1 0.9982379674911499
unilateral B-Disease 1 0.999536395072937
retinoblastoma I-Disease 1 0.9999992847442627
. O 0 0.008122565224766731

In O 0 0.0034652340691536665
most O 0 0.005873546004295349
patients O 1 0.999935507774353
with O 0 0.0025776878464967012
isolated O 1 0.995735764503479
unilateral B-Disease 1 0.9993650317192078
retinoblastoma I-Disease 1 0.9999998807907104
, O 0 0.007712904363870621
tumor B-Disease 1 0.9999998807907104
development O 0 0.004276171792298555
is O 0 0.002707654144614935
initiated O 0 0.026667248457670212
by O 0 0.004904151428490877
somatic O 1 0.9912534356117249
inactivation O 1 0.9975994229316711
of O 0 0.001810871995985508
both O 0 0.0027064166497439146
alleles O 1 0.9993299245834351
of O 0 0.0023365160450339317
the O 0 0.008772811852395535
RB1 O 1 1.0
gene O 1 0.998883068561554
. O 0 0.007271687500178814

However O 0 0.006265925243496895
, O 0 0.000990511616691947
some O 0 0.0007461555069312453
of O 0 0.0010272788349539042
these O 0 0.001911447267048061
patients O 1 0.9999983310699463
can O 0 0.005429203622043133
transmit O 1 0.9954303503036499
retinoblastoma B-Disease 1 1.0
predisposition O 1 0.9999985694885254
to O 0 0.0020177296828478575
their O 0 0.0025071180425584316
offspring O 1 0.8545893430709839
. O 0 0.00557282380759716

To O 0 0.0030094890389591455
determine O 0 0.004663511179387569
the O 0 0.00252031022682786
frequency O 0 0.023163411766290665
and O 0 0.0009247040143236518
nature O 0 0.0028213891200721264
of O 0 0.0012759409146383405
constitutional O 0 0.030553780496120453
RB1 O 1 1.0
- O 1 0.958936870098114
gene O 1 0.9999210834503174
mutations O 1 0.9999351501464844
in O 0 0.004763351287692785
patients O 1 0.999992847442627
with O 0 0.002995890798047185
isolated O 1 0.9843750596046448
unilateral B-Disease 1 0.9996179342269897
retinoblastoma I-Disease 1 0.9999996423721313
, O 0 0.0015751505270600319
we O 0 0.0009915572591125965
analyzed O 0 0.012831628322601318
DNA O 0 0.031197600066661835
from O 0 0.004928696900606155
peripheral O 1 0.9999983310699463
blood O 1 0.9983041286468506
and O 0 0.002316211350262165
from O 0 0.008703188970685005
tumor B-Disease 1 1.0
tissue O 1 0.9999574422836304
. O 0 0.006366755347698927

The O 0 0.0041252379305660725
analysis O 0 0.0049009546637535095
of O 0 0.00455706100910902
tumors B-Disease 1 0.9999998807907104
from O 0 0.004662590101361275
54 O 0 0.034716542810201645
( O 0 0.005504160653799772
71 O 0 0.04502163827419281
% O 0 0.004793521482497454
) O 0 0.0019517320906743407
of O 0 0.0014888296136632562
76 O 1 0.8403458595275879
informative O 0 0.04994475468993187
patients O 1 0.9999731779098511
showed O 0 0.013894308358430862
loss O 0 0.022288626059889793
of O 0 0.0017213538521900773
constitutional O 0 0.022948503494262695
heterozygosity O 1 0.9999966621398926
( O 0 0.014306792989373207
LOH O 1 0.9999995231628418
) O 0 0.005537041462957859
at O 0 0.008244888857007027
intragenic O 1 0.9990284442901611
loci O 1 0.9982991814613342
. O 0 0.008732691407203674

Three O 0 0.003128373995423317
of O 0 0.0017099149990826845
13 O 0 0.020289644598960876
uninformative O 1 0.9999493360519409
patients O 1 0.9999887943267822
had O 0 0.006958060897886753
constitutional O 0 0.017513412982225418
deletions O 1 0.9856570959091187
. O 0 0.005728714633733034

For O 0 0.004504991229623556
39 O 0 0.023505883291363716
randomly O 0 0.03799252584576607
selected O 0 0.019429055973887444
tumors B-Disease 1 0.9999997615814209
, O 0 0.004701502155512571
SSCP O 1 0.9999961853027344
, O 0 0.006199599709361792
hetero O 1 0.9995496869087219
- O 0 0.04770698770880699
duplex O 0 0.48703640699386597
analysis O 0 0.00690389983355999
, O 0 0.0021642292849719524
sequencing O 0 0.055936943739652634
, O 0 0.0012279592920094728
and O 0 0.0010360685409978032
Southern O 0 0.016861196607351303
blot O 1 0.9990653395652771
analysis O 0 0.004733995534479618
were O 0 0.0008168376516550779
used O 0 0.0012821300188079476
to O 0 0.0017727854428812861
identify O 0 0.024385372176766396
mutations O 1 0.9986417889595032
. O 0 0.006635772995650768

Mutations O 1 0.9988222718238831
were O 0 0.004204169847071171
detected O 0 0.07113517820835114
in O 0 0.002378719625994563
21 O 0 0.01601283624768257
( O 0 0.0051704333163797855
91 O 0 0.054531898349523544
% O 0 0.00512479105964303
) O 0 0.0022753640078008175
of O 0 0.0017703131306916475
23 O 0 0.08341091126203537
tumors B-Disease 1 1.0
with O 0 0.006602725945413113
LOH O 1 0.9999990463256836
. O 0 0.009814385324716568

In O 0 0.006624818779528141
6 O 0 0.01941368170082569
( O 0 0.006114212796092033
38 O 0 0.02288944460451603
% O 0 0.004104984924197197
) O 0 0.0021476480178534985
of O 0 0.0017360711935907602
16 O 0 0.0365731380879879
tumors B-Disease 1 1.0
without O 0 0.0125805102288723
LOH O 1 0.9999980926513672
, O 0 0.002168074483051896
one O 0 0.0059480005875229836
mutation O 1 0.9999971389770508
was O 0 0.012773755937814713
detected O 0 0.30719831585884094
, O 0 0.0011114553781226277
and O 0 0.0008146363543346524
in O 0 0.0017396118491888046
9 O 0 0.015427754260599613
( O 0 0.00441179471090436
56 O 0 0.024933217093348503
% O 0 0.004188472405076027
) O 0 0.0014822882367298007
of O 0 0.0010185693390667439
the O 0 0.0063761500641703606
tumors B-Disease 1 1.0
without O 0 0.012568575330078602
LOH O 1 0.9999997615814209
, O 0 0.002546749310567975
both O 0 0.003985149320214987
mutations O 1 0.9999346733093262
were O 0 0.0025425374042242765
found O 0 0.006058334372937679
. O 0 0.004685539286583662

Thus O 0 0.010649214498698711
, O 0 0.0012617926113307476
a O 0 0.003053335240110755
total O 0 0.0023289076052606106
of O 0 0.0013904751976951957
45 O 0 0.017103489488363266
mutations O 1 0.9999258518218994
were O 0 0.0021661713253706694
identified O 0 0.011677161790430546
in O 0 0.0037811838556081057
tumors B-Disease 1 0.9999994039535522
of O 0 0.00302199088037014
36 O 0 0.100580595433712
patients O 1 0.9999960660934448
. O 0 0.004903013352304697

Thirty O 0 0.045149534940719604
- O 0 0.01523167546838522
nine O 0 0.0035752265248447657
of O 0 0.0011806682450696826
the O 0 0.0057275439612567425
mutations O 1 0.9999679327011108
- O 0 0.020530452951788902
including O 0 0.002859504660591483
34 O 0 0.021552154794335365
small O 0 0.010733358561992645
mutations O 1 0.9999825954437256
, O 0 0.0020205785986036062
2 O 0 0.006320339627563953
large O 0 0.00501621188595891
structural O 0 0.051404811441898346
alterations O 0 0.09044825285673141
, O 0 0.0012520087184384465
and O 0 0.0016289737541228533
hypermethylation O 1 0.999998927116394
in O 0 0.0039328900165855885
3 O 0 0.03833875432610512
tumors O 1 0.9999998807907104
- O 0 0.017848452553153038
were O 0 0.0015008477494120598
not O 0 0.001489528687670827
detected O 0 0.037826623767614365
in O 0 0.0009266465785913169
the O 0 0.0018266488332301378
corresponding O 0 0.019964037463068962
peripheral O 1 0.9999980926513672
blood O 1 0.9996028542518616
DNA O 0 0.05840776488184929
. O 0 0.005066644866019487

In O 0 0.0068159704096615314
6 O 0 0.02107382006943226
( O 0 0.005942861083894968
17 O 0 0.014459359459578991
% O 0 0.004524375312030315
) O 0 0.0014567626640200615
of O 0 0.0007814416894689202
the O 0 0.003344358876347542
36 O 0 0.042264558374881744
patients O 1 0.9999964237213135
, O 0 0.0018878746777772903
a O 0 0.01081046462059021
mutation O 1 0.9999922513961792
was O 0 0.010177758522331715
detected O 0 0.0587909109890461
in O 0 0.0015908894129097462
constitutional O 0 0.012297987937927246
DNA O 0 0.03671947121620178
, O 0 0.0012444769963622093
and O 0 0.0007853758870624006
1 O 0 0.0046112569980323315
of O 0 0.0009020963334478438
these O 0 0.0020765371154993773
mutations O 1 0.999984860420227
is O 0 0.003449491923674941
known O 0 0.0051382798701524734
to O 0 0.0008789334096945822
be O 0 0.001410071854479611
associated O 0 0.005210393574088812
with O 0 0.00169853784609586
reduced O 0 0.0671149492263794
expressivity O 1 0.9996978044509888
. O 0 0.009067710489034653

The O 0 0.005165681708604097
presence O 0 0.006397431716322899
of O 0 0.0009141454356722534
a O 0 0.0057747215032577515
constitutional O 0 0.021081672981381416
mutation O 1 0.9999979734420776
was O 0 0.0074978177435696125
not O 0 0.0015241694636642933
associated O 0 0.004936366342008114
with O 0 0.0008593822713010013
an O 0 0.0017952669877558947
early O 0 0.00719908531755209
age O 0 0.010797419585287571
at O 0 0.007658645510673523
treatment O 1 0.9995057582855225
. O 0 0.005980102811008692

In O 0 0.005264941602945328
1 O 0 0.02131773717701435
patient O 1 0.9997531771659851
, O 0 0.004368131048977375
somatic O 1 0.9984011054039001
mosaicism O 1 0.9999911785125732
was O 0 0.007988009601831436
demonstrated O 0 0.008776113390922546
by O 0 0.0025122195947915316
molecular O 0 0.016805166378617287
analysis O 0 0.0025980521459132433
of O 0 0.001090492238290608
DNA O 0 0.02826916053891182
and O 0 0.0019978361669927835
RNA O 0 0.11402233690023422
from O 0 0.008956524543464184
peripheral O 1 0.9999958276748657
blood O 1 0.9962343573570251
. O 0 0.00596565892919898

In O 0 0.005487035494297743
2 O 0 0.01694401353597641
patients O 1 0.9995244741439819
without O 0 0.003914480097591877
a O 0 0.008853691630065441
detectable O 1 0.9982894062995911
mutation O 1 0.9999607801437378
in O 0 0.004496607463806868
peripheral O 1 0.999998927116394
blood O 1 0.9994947910308838
, O 0 0.0055335694923996925
mosaicism O 1 0.9999967813491821
was O 0 0.009001213125884533
suggested O 0 0.006250226870179176
because O 0 0.003069629892706871
1 O 0 0.003965208772569895
of O 0 0.0007885796367190778
the O 0 0.004293442238122225
patients O 1 0.9999998807907104
showed O 1 0.9199215173721313
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 0.0013898396864533424
the O 0 0.0013449793914332986
other O 0 0.000686965708155185
later O 0 0.003686192212626338
developed O 0 0.014200286008417606
bilateral B-Disease 0 0.01305305678397417
retinoblastoma I-Disease 1 0.9999845027923584
. O 0 0.00797725934535265

In O 0 0.004635045304894447
conclusion O 0 0.007728959899395704
, O 0 0.0012342287227511406
our O 0 0.001852442161180079
results O 0 0.005345427896827459
emphasize O 0 0.008486350066959858
that O 0 0.0009063886827789247
the O 0 0.0024355375207960606
manifestation O 1 0.9928522706031799
and O 0 0.0025781546719372272
transmissibility O 1 0.9999186992645264
of O 0 0.0051756082102656364
retinoblastoma B-Disease 1 0.9999984502792358
depend O 0 0.008379478938877583
on O 0 0.001198075944557786
the O 0 0.001454630633816123
nature O 0 0.0032427944242954254
of O 0 0.0007441501948051155
the O 0 0.0021961943712085485
first O 0 0.007801753934472799
mutation O 1 0.9999995231628418
, O 0 0.0015929820947349072
its O 0 0.0017015095800161362
time O 0 0.002264919923618436
in O 0 0.0011637150309979916
development O 0 0.002438921947032213
, O 0 0.0009304889244958758
and O 0 0.0005916364607401192
the O 0 0.0014561392599716783
number O 0 0.001699597341939807
and O 0 0.000982348108664155
types O 0 0.006507659796625376
of O 0 0.001593219581991434
cells O 0 0.09919436275959015
that O 0 0.001299042021855712
are O 0 0.0012338509550318122
affected O 0 0.39234232902526855
. O 0 0.0020140516571700573
. O 0 0.003739487612619996

Hereditary B-Disease 1 0.9999995231628418
deficiency I-Disease 1 0.9999998807907104
of I-Disease 0 0.0021244152449071407
the I-Disease 0 0.00247503025457263
fifth I-Disease 0 0.019377587363123894
component I-Disease 0 0.019900640472769737
of I-Disease 0 0.0014533443609252572
complement I-Disease 0 0.018489399924874306
in O 0 0.0019954019226133823
man O 0 0.020951295271515846
. O 0 0.004834242630749941

I O 0 0.029358122497797012
. O 0 0.006729800254106522

Clinical O 1 0.99433833360672
, O 0 0.005440415348857641
immunochemical O 1 0.9999051094055176
, O 0 0.001682507456280291
and O 0 0.0012479049619287252
family O 0 0.010330462828278542
studies O 0 0.006049336865544319
. O 0 0.0042609828524291515

The O 0 0.004085517954081297
first O 0 0.004187744576483965
recognized O 0 0.011756372638046741
human O 0 0.011114793829619884
kindred O 1 0.9999760389328003
with O 0 0.00491258455440402
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 0 0.0015037902630865574
the I-Disease 0 0.0022370803635567427
fifth I-Disease 0 0.02081579901278019
component I-Disease 0 0.022085053846240044
of I-Disease 0 0.001912491861730814
complement I-Disease 0 0.03485838696360588
( O 0 0.010952647775411606
C5 O 1 0.9999963045120239
) O 0 0.004607522394508123
is O 0 0.0038385523948818445
described O 0 0.01297833677381277
. O 0 0.0038005004171282053

The O 0 0.009634475223720074
proband O 1 0.9863795638084412
, O 0 0.0019954191520810127
a O 0 0.0051154084503650665
20 O 0 0.006225804798305035
- O 0 0.013450882397592068
year O 0 0.006522127892822027
- O 0 0.01841682568192482
old O 0 0.014712506905198097
black O 0 0.022803954780101776
female O 0 0.025252165272831917
with O 0 0.015479503199458122
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 0 0.14974094927310944
age O 0 0.014478962868452072
11 O 0 0.006509383674710989
, O 0 0.0018234191229566932
lacked O 0 0.35771632194519043
serum O 1 0.999982476234436
hemolytic O 1 1.0
complement O 0 0.04173140972852707
activity O 0 0.010266338475048542
, O 0 0.0012273886241018772
even O 0 0.0032371999695897102
during O 0 0.01536314096301794
remission O 1 0.9999899864196777
. O 0 0.0074156238697469234

C5 O 1 0.9998787641525269
was O 0 0.01810234971344471
undetectable O 1 0.752632737159729
in O 0 0.002057274803519249
her O 0 0.007613373454660177
serum O 1 0.995230495929718
by O 0 0.002571350894868374
both O 0 0.0025741446297615767
immunodiffusion O 1 0.9998289346694946
and O 0 0.007706250064074993
hemolytic O 1 1.0
assays O 0 0.2240183800458908
. O 0 0.005945257376879454

Other O 0 0.002344793640077114
complement O 0 0.01527553889900446
components O 0 0.00507545517757535
were O 0 0.0015198072651401162
normal O 0 0.014872177504003048
during O 0 0.012153614312410355
remission O 1 0.9999964237213135
of O 0 0.009583516046404839
lupus O 1 1.0
, O 0 0.003747485112398863
but O 0 0.004581181798130274
C1 O 1 0.9999998807907104
, O 0 0.005255525466054678
C4 O 1 0.999765932559967
, O 0 0.005595648195594549
C2 O 1 0.9999966621398926
, O 0 0.0021688579581677914
and O 0 0.0020298694726079702
C3 O 1 0.9999935626983643
levels O 0 0.027339350432157516
fell O 0 0.050585318356752396
during O 0 0.022403908893465996
exacerbations O 1 0.9999979734420776
. O 0 0.007741238456219435

A O 0 0.033721260726451874
younger O 0 0.04928799718618393
half O 0 0.013443606905639172
- O 0 0.03347614035010338
sister O 0 0.45058056712150574
, O 0 0.0016118029598146677
who O 0 0.0022062717471271753
had O 0 0.0034614866599440575
no O 0 0.003578771837055683
underlying O 1 0.9998435974121094
disease O 1 1.0
, O 0 0.0021344947163015604
was O 0 0.004210235085338354
also O 0 0.00110372353810817
found O 0 0.0027651898562908173
to O 0 0.0014700839528813958
lack O 0 0.01882762461900711
immunochemically O 1 0.9998977184295654
detectable O 1 0.9998070597648621
C5 O 1 0.9999324083328247
. O 0 0.008902467787265778

By O 0 0.02953980676829815
hemolytic O 1 1.0
assay O 1 0.8333442211151123
, O 0 0.0027475643437355757
she O 0 0.004579823464155197
exhibited O 0 0.020039362832903862
1 O 0 0.01632990688085556
- O 0 0.016565974801778793
2 O 0 0.00710982596501708
% O 0 0.0020437943749129772
of O 0 0.0008287476957775652
the O 0 0.0032456086482852697
normal O 0 0.045427948236465454
serum O 1 0.9996588230133057
C5 O 1 0.999924898147583
level O 0 0.005799930077046156
and O 0 0.0015154876746237278
normal O 0 0.020940793678164482
concentrations O 0 0.02479194477200508
of O 0 0.000865100184455514
other O 0 0.000959408120252192
complement O 0 0.02006872184574604
components O 0 0.009886770509183407
. O 0 0.0047092619352042675

C5 O 1 0.9990518689155579
levels O 0 0.019749296829104424
of O 0 0.001589478342793882
other O 0 0.0012019266141578555
family O 0 0.00834407564252615
members O 0 0.0017181547591462731
were O 0 0.0015247035771608353
either O 0 0.004911488853394985
normal O 0 0.016993043944239616
or O 0 0.0031551476567983627
approximately O 0 0.005759372841566801
half O 0 0.009070475585758686
- O 0 0.024883773177862167
normal O 0 0.019719241186976433
, O 0 0.0014717801241204143
consistent O 0 0.010404626838862896
with O 0 0.004171131178736687
autosomal O 1 1.0
codominant O 1 0.99981290102005
inheritance O 0 0.12475059181451797
of O 0 0.0013923421502113342
the O 0 0.003948008641600609
gene O 1 0.9998910427093506
determining O 0 0.06245609000325203
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.009288308210670948

Normal O 1 0.8990479111671448
hemolytic O 1 1.0
titers O 1 0.9986405968666077
were O 0 0.0025338621344417334
restored O 0 0.011752383783459663
to O 0 0.0009758663363754749
both O 0 0.0032040865626186132
homozygous O 1 0.9999867677688599
C5 B-Disease 1 0.9999994039535522
- I-Disease 0 0.26579704880714417
deficient I-Disease 1 0.9999854564666748
( O 0 0.016378602012991905
C5D B-Disease 1 0.9999997615814209
) O 0 0.005257900804281235
sera O 0 0.05107996240258217
by O 0 0.002133699832484126
addition O 0 0.0024527350906282663
of O 0 0.0013013904681429267
highly O 0 0.016502700746059418
purified O 0 0.3405514657497406
human O 0 0.02654069848358631
C5 O 1 0.9997220635414124
. O 0 0.008892923593521118

In O 0 0.0037082708440721035
specific O 0 0.011475183069705963
C5 O 1 0.9999966621398926
titrations O 1 0.9999734163284302
, O 0 0.0028221565298736095
however O 0 0.0033126238267868757
, O 0 0.001006386592052877
it O 0 0.0014591403305530548
was O 0 0.0050369733944535255
noted O 0 0.0029277296271175146
that O 0 0.0010415873257443309
when O 0 0.0040973792783916
limited O 0 0.005534414667636156
amounts O 0 0.0071649192832410336
of O 0 0.0030824800487607718
C5 O 1 0.9998725652694702
were O 0 0.0028220650274306536
assayed O 0 0.10898534953594208
in O 0 0.001233810791745782
the O 0 0.0016851117834448814
presence O 0 0.0068206461146473885
of O 0 0.001932356390170753
low O 0 0.03331412002444267
dilutions O 1 0.9958096742630005
of O 0 0.00274640996940434
either O 0 0.013864814303815365
C5D B-Disease 1 0.9999997615814209
serum O 1 0.9988486766815186
, O 0 0.0035509360022842884
curving O 0 0.05537155643105507
rather O 0 0.003977478016167879
than O 0 0.004301637876778841
linear O 0 0.05284504592418671
dose O 1 0.9952583909034729
- O 0 0.034057870507240295
response O 0 0.020763246342539787
plots O 0 0.015004320070147514
were O 0 0.0015228724805638194
consistently O 0 0.008567288517951965
obtained O 0 0.003251863643527031
, O 0 0.0011588791385293007
suggesting O 0 0.011884156614542007
some O 0 0.003482924308627844
inhibitory O 1 0.9492464661598206
effect O 0 0.02584562636911869
. O 0 0.006019357591867447

Further O 0 0.007790304720401764
studies O 0 0.004398097284138203
suggested O 0 0.004681395832449198
that O 0 0.0013729444472119212
low O 0 0.026619337499141693
dilutions O 1 0.9905189871788025
of O 0 0.007001112215220928
C5D B-Disease 1 0.9999998807907104
serum O 1 0.9965284466743469
contain O 0 0.014408646151423454
a O 0 0.009731659665703773
factor O 0 0.05274172127246857
( O 0 0.0051454417407512665
or O 0 0.004456824157387018
factors O 0 0.015605518594384193
) O 0 0.0038390227127820253
interfering O 0 0.026213429868221283
at O 0 0.0029807721730321646
some O 0 0.0016082772053778172
step O 0 0.00991511158645153
in O 0 0.0018043889431282878
the O 0 0.008469442836940289
hemolytic O 1 1.0
assay O 0 0.2418815940618515
of O 0 0.004250229336321354
C5 O 1 0.9999943971633911
, O 0 0.001467814901843667
rather O 0 0.0016116972547024488
than O 0 0.001454652170650661
a O 0 0.005216630641371012
true O 0 0.017508598044514656
C5 O 1 0.9999936819076538
inhibitor O 1 0.9999196529388428
or O 0 0.012609128840267658
inactivator O 1 0.9985601305961609
. O 0 0.007678228430449963

Of O 0 0.004649953916668892
clinical O 1 0.8262816667556763
interest O 0 0.0034856742713600397
are O 0 0.0012232407461851835
( O 0 0.002960992744192481
a O 0 0.004773620516061783
) O 0 0.0014998747501522303
the O 0 0.0014068022137507796
documentation O 0 0.00789201445877552
of O 0 0.0036950113717466593
membranous O 1 1.0
glomerulonephritis B-Disease 1 1.0
, O 0 0.013921132311224937
vasculitis B-Disease 1 1.0
, O 0 0.003576053772121668
and O 0 0.007494744844734669
arthritis B-Disease 1 1.0
in O 0 0.0023492644540965557
an O 0 0.002041249070316553
individual O 0 0.004859916400164366
lacking O 1 0.8496736884117126
C5 O 1 0.9999938011169434
( O 0 0.003880585078150034
and O 0 0.0009535226854495704
its O 0 0.0043449182994663715
biologic O 1 0.9982081651687622
functions O 0 0.010127896443009377
) O 0 0.0028991687577217817
, O 0 0.001323280157521367
and O 0 0.0015347922453656793
( O 0 0.005638875532895327
b O 0 0.0778340995311737
) O 0 0.002149380976334214
a O 0 0.004186361096799374
remarkable O 0 0.01401862595230341
propensity O 1 0.9818283915519714
to O 0 0.010684589855372906
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 0.002196972956880927
the O 0 0.004169014748185873
proband O 1 0.9999821186065674
, O 0 0.0017442320240661502
even O 0 0.002123028738424182
during O 0 0.004904798697680235
periods O 0 0.007797400001436472
of O 0 0.001736674690619111
low O 0 0.030866065993905067
- O 0 0.04133618250489235
dose O 1 0.9980792999267578
or O 0 0.004433630034327507
alternate O 0 0.010014799423515797
- O 0 0.023221377283334732
day O 0 0.024767955765128136
corticosteroid O 1 0.9999991655349731
therapy O 1 0.9998914003372192
. O 0 0.006646620109677315

Other O 0 0.0019151294836774468
observations O 0 0.005207176320254803
indicate O 0 0.005938518326729536
that O 0 0.0010418457677587867
the O 0 0.0045684222131967545
C5D B-Disease 1 0.9999991655349731
state O 0 0.002576397033408284
is O 0 0.0025481171905994415
compatible O 0 0.013170982711017132
with O 0 0.0021193991415202618
normal O 0 0.03605305030941963
coagulation O 1 0.9999330043792725
function O 0 0.017468513920903206
and O 0 0.0007375807035714388
the O 0 0.001216268166899681
capacity O 0 0.0030916195828467607
to O 0 0.001129738288000226
mount O 0 0.026050133630633354
a O 0 0.018840301781892776
neutrophilic O 1 0.9999996423721313
leukocytosis O 1 0.9999988079071045
during O 1 0.5841919779777527
pyogenic B-Disease 1 1.0
infection I-Disease 1 1.0
. O 0 0.0044056749902665615
. O 0 0.004370402544736862

Susceptibility O 1 0.9999620914459229
to O 0 0.01812756434082985
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 0.0064850798808038235
twins O 1 0.9800753593444824
: O 0 0.0019220956601202488
the O 0 0.0013243587454780936
role O 0 0.005785998422652483
of O 0 0.0019279287662357092
genes O 1 0.9965521097183228
, O 0 0.005479560233652592
HLA O 1 0.9999998807907104
, O 0 0.001739072846248746
and O 0 0.0007764986366964877
the O 0 0.0020639069844037294
environment O 0 0.009649496525526047
. O 0 0.004582488909363747

OBJECTIVE O 0 0.02251286432147026
To O 0 0.001917583984322846
determine O 0 0.004249047487974167
the O 0 0.0024760824162513018
relative O 0 0.015668177977204323
effects O 0 0.032645657658576965
of O 0 0.0021233258303254843
genetic O 0 0.4560662806034088
and O 0 0.0012671025469899178
environmental O 0 0.00740772532299161
factors O 0 0.007268466055393219
in O 0 0.003052832093089819
susceptibility O 1 0.999998927116394
to O 0 0.012735496275126934
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 0.013541966676712036
AS B-Disease 0 0.04633147642016411
) O 0 0.0029693138785660267
. O 0 0.003419419750571251

METHODS O 0 0.03403099626302719
Twins O 0 0.3019566237926483
with O 0 0.002182569820433855
AS B-Disease 0 0.007627357728779316
were O 0 0.0013488426338881254
identified O 0 0.00782216340303421
from O 0 0.0011313261929899454
the O 0 0.0016892616404220462
Royal O 0 0.017771698534488678
National O 0 0.015983672812581062
Hospital O 1 1.0
for O 0 0.016005242243409157
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 0 0.04063922539353371
. O 0 0.005770906340330839

Clinical O 1 0.8882482647895813
and O 0 0.0029816958121955395
radiographic O 1 0.9937639832496643
examinations O 0 0.0293259359896183
were O 0 0.0011830092407763004
performed O 0 0.005822591949254274
to O 0 0.001111023360863328
establish O 0 0.010506297461688519
diagnoses O 1 0.9999982118606567
, O 0 0.002503041410818696
and O 0 0.003560562850907445
disease O 1 1.0
severity O 1 0.9999994039535522
was O 0 0.006812233477830887
assessed O 0 0.018776170909404755
using O 0 0.002318670740351081
a O 0 0.0051049161702394485
combination O 0 0.020292576402425766
of O 0 0.0014464276609942317
validated O 0 0.03343404829502106
scoring O 0 0.012434314005076885
systems O 0 0.014445951208472252
. O 0 0.005208308342844248

HLA O 1 0.9998372793197632
typing O 0 0.14506419003009796
for O 0 0.008369025774300098
HLA O 1 0.9999971389770508
- O 0 0.0546756274998188
B27 O 1 0.9976758360862732
, O 0 0.008454169146716595
HLA O 1 0.9999997615814209
- O 0 0.058550991117954254
B60 O 1 0.999316930770874
, O 0 0.0021957806311547756
and O 0 0.0034899485763162374
HLA O 1 0.9999998807907104
- O 0 0.3071333169937134
DR1 O 1 0.9999454021453857
was O 0 0.010745355859398842
performed O 0 0.012423509731888771
by O 0 0.005842738784849644
polymerase O 1 0.923186719417572
chain O 0 0.1446944922208786
reaction O 0 0.02670401893556118
with O 0 0.0019806118216365576
sequence O 0 0.02332315221428871
- O 0 0.017476161941885948
specific O 0 0.005544582847505808
primers O 0 0.07551772147417068
, O 0 0.0014316331362351775
and O 0 0.0017970026237890124
zygosity O 1 0.9997797608375549
was O 0 0.007569829002022743
assessed O 0 0.022996822372078896
using O 0 0.006545635871589184
microsatellite O 1 0.9799011945724487
markers O 0 0.06386150419712067
. O 0 0.006300070323050022

Genetic O 0 0.14096775650978088
and O 0 0.0025553058367222548
environmental O 0 0.01250520534813404
variance O 0 0.02986706979572773
components O 0 0.005723027046769857
were O 0 0.0015299259684979916
assessed O 0 0.015374354086816311
with O 0 0.0009741273242980242
the O 0 0.0026354538276791573
program O 0 0.01858779974281788
Mx O 1 0.9998087286949158
, O 0 0.0015932362293824553
using O 0 0.0016338907880708575
data O 0 0.001548629836179316
from O 0 0.001470769289880991
this O 0 0.001139132771641016
and O 0 0.0009312485926784575
previous O 0 0.004246881231665611
studies O 0 0.0038054846227169037
of O 0 0.0018859878182411194
twins O 1 0.8689683079719543
with O 0 0.0019687095191329718
AS B-Disease 0 0.012595084495842457
. O 0 0.004969907458871603

RESULTS O 0 0.023334117606282234
Six O 0 0.004454977810382843
of O 0 0.0020388083066791296
8 O 0 0.025158559903502464
monozygotic O 1 0.999433696269989
( O 0 0.015380889177322388
MZ O 1 0.9999991655349731
) O 0 0.008809039369225502
twin O 1 0.897208034992218
pairs O 0 0.017151065170764923
were O 0 0.004973535891622305
disease O 1 1.0
concordant O 1 0.9990487694740295
, O 0 0.002320542698726058
compared O 0 0.006977576296776533
with O 0 0.0010921277571469545
4 O 0 0.006344940047711134
of O 0 0.0015408400213345885
15 O 0 0.012160898186266422
B27 O 1 0.999738872051239
- O 0 0.034871529787778854
positive O 0 0.03307373449206352
dizygotic O 1 0.9995993971824646
( O 0 0.01330584567040205
DZ O 1 0.9999979734420776
) O 0 0.008947594091296196
twin O 1 0.8662751317024231
pairs O 0 0.02435699664056301
( O 0 0.006824387703090906
27 O 0 0.017925318330526352
% O 0 0.006353938020765781
) O 0 0.002826591022312641
and O 0 0.0010467666434124112
4 O 0 0.0059535629115998745
of O 0 0.0016577201895415783
32 O 0 0.035294059664011
DZ O 1 0.9999780654907227
twin O 1 0.8864060044288635
pairs O 0 0.026959823444485664
overall O 0 0.01926031894981861
( O 0 0.005608961917459965
12 O 0 0.008773102425038815
. O 0 0.0024165448267012835
5 O 0 0.00875046569854021
% O 0 0.005323769990354776
) O 0 0.003360958071425557
. O 0 0.004138539079576731

Nonsignificant O 1 0.9983610510826111
increases O 0 0.027680054306983948
in O 0 0.0018314222106710076
similarity O 0 0.018512526527047157
with O 0 0.0009300248930230737
regard O 0 0.004178175237029791
to O 0 0.001621831557713449
age O 0 0.01392081193625927
at O 0 0.01814359612762928
disease O 1 1.0
onset O 1 1.0
and O 0 0.0009012552327476442
all O 0 0.00048424978740513325
of O 0 0.0009342511184513569
the O 0 0.007066099438816309
disease O 1 1.0
severity O 1 0.999995231628418
scores O 0 0.016760583966970444
assessed O 0 0.020853737369179726
were O 0 0.0012519719311967492
noted O 0 0.0029345625080168247
in O 0 0.0034468243829905987
disease O 1 1.0
- O 0 0.3916804790496826
concordant O 1 0.9999322891235352
MZ O 1 0.9999994039535522
twins O 1 0.9930151700973511
compared O 0 0.014296871609985828
with O 0 0.003697269828990102
concordant O 1 0.9989327788352966
DZ O 1 0.999997615814209
twins O 1 0.9807568788528442
. O 0 0.008435945026576519

HLA O 1 0.9999958276748657
- O 0 0.07977235317230225
B27 O 1 0.9992826581001282
and O 0 0.003864685073494911
B60 O 1 0.9994426369667053
were O 0 0.0018862140132114291
associated O 0 0.00474043283611536
with O 0 0.0011101342970505357
the O 0 0.005493589676916599
disease O 1 1.0
in O 0 0.004187384620308876
probands O 1 0.9999936819076538
, O 0 0.0014562987489625812
and O 0 0.0006103101186454296
the O 0 0.0016323095187544823
rate O 0 0.009695812128484249
of O 0 0.004411610774695873
disease O 1 1.0
concordance O 1 0.9163981676101685
was O 0 0.008418221026659012
significantly O 0 0.022497450932860374
increased O 0 0.012436836957931519
among O 0 0.008585456758737564
DZ O 1 0.9999971389770508
twin O 1 0.9852958917617798
pairs O 0 0.014007306657731533
in O 0 0.001186071545816958
which O 0 0.0012998017482459545
the O 0 0.00336904707364738
co O 0 0.05171482264995575
- O 0 0.0326787531375885
twin O 1 0.9108979105949402
was O 0 0.0074481964111328125
positive O 0 0.009770202450454235
for O 0 0.0013875304721295834
both O 0 0.002541526686400175
B27 O 1 0.999847412109375
and O 0 0.0049531226977705956
DR1 O 1 0.9999854564666748
. O 0 0.008058049716055393

Additive O 1 0.6304205656051636
genetic O 1 0.5132648944854736
effects O 0 0.050123248249292374
were O 0 0.0016620677197352052
estimated O 0 0.005950843449681997
to O 0 0.0014982796274125576
contribute O 0 0.013655640184879303
97 O 0 0.04102541133761406
% O 0 0.0034219035878777504
of O 0 0.001054207794368267
the O 0 0.0032274629920721054
population O 0 0.009993367828428745
variance O 0 0.04611452296376228
. O 0 0.005465253256261349

CONCLUSION O 0 0.07031332701444626
Susceptibility O 1 0.9998761415481567
to O 0 0.0032341135665774345
AS B-Disease 0 0.009492965415120125
is O 0 0.0031337945256382227
largely O 0 0.009825572371482849
genetically O 0 0.11979414522647858
determined O 0 0.011358319781720638
, O 0 0.00096772366669029
and O 0 0.0005407834541983902
the O 0 0.0016518608899787068
environmental O 0 0.01197256613522768
trigger O 1 0.9985016584396362
for O 0 0.0019899304024875164
the O 0 0.0056831748224794865
disease O 1 1.0
is O 0 0.004430809058248997
probably O 0 0.017897821962833405
ubiquitous O 1 0.5179994702339172
. O 0 0.0051335827447474

HLA O 1 0.9999936819076538
- O 0 0.0749988853931427
B27 O 1 0.9799373745918274
accounts O 0 0.004346263594925404
for O 0 0.0011112733045592904
a O 0 0.004549384582787752
minority O 0 0.010172990150749683
of O 0 0.0010759567376226187
the O 0 0.0024036886170506477
overall O 0 0.020350007340312004
genetic O 1 0.9946011304855347
susceptibility O 1 0.9999970197677612
to O 0 0.0026207950431853533
AS B-Disease 0 0.009843059815466404
. O 0 0.003705168142914772

Cell O 0 0.10632747411727905
cycle O 0 0.08485978096723557
- O 0 0.03335597738623619
dependent O 0 0.037129417061805725
colocalization O 1 0.975373387336731
of O 0 0.003903727512806654
BARD1 O 1 0.9999969005584717
and O 0 0.007143415044993162
BRCA1 O 1 1.0
proteins O 0 0.029998769983649254
in O 0 0.0016567640705034137
discrete O 0 0.024261221289634705
nuclear O 0 0.005555410403758287
domains O 0 0.04107365384697914
. O 0 0.00507416483014822

Germ O 1 0.9939326643943787
- O 0 0.03374740481376648
line O 0 0.017921866849064827
mutations O 1 0.9962928891181946
of O 0 0.0015478645218536258
the O 0 0.007913907058537006
BRCA1 O 1 1.0
gene O 1 0.999946117401123
predispose O 1 0.999975323677063
women O 0 0.005521176382899284
to O 0 0.0010677463142201304
early O 0 0.010027851909399033
- O 1 0.9930917024612427
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.6676705479621887
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 0.0027405989822000265
compromising O 0 0.021837344393134117
the O 0 0.0035548373125493526
genes O 1 0.9950940608978271
presumptive O 1 0.9999979734420776
function O 0 0.013036487624049187
as O 0 0.002423984697088599
a O 0 0.01806510239839554
tumor B-Disease 1 1.0
suppressor O 1 0.9999988079071045
. O 0 0.009304776787757874

Although O 0 0.006690280977636576
the O 0 0.0033309271093457937
biochemical O 0 0.044872358441352844
properties O 0 0.01122431643307209
of O 0 0.005030941218137741
BRCA1 O 1 1.0
polypeptides O 1 0.9751431941986084
are O 0 0.0012882910668849945
not O 0 0.0013025524094700813
understood O 0 0.011076072230935097
, O 0 0.0010331047233194113
their O 0 0.0015339055098593235
expression O 0 0.02606465294957161
pattern O 0 0.022245356813073158
and O 0 0.0015929944347590208
subcellular O 0 0.10054107755422592
localization O 0 0.0687137171626091
suggest O 0 0.007197520695626736
a O 0 0.003656454151496291
role O 0 0.006224934011697769
in O 0 0.0020335016306489706
cell O 0 0.0500560887157917
- O 0 0.030842401087284088
cycle O 0 0.07963793724775314
regulation O 0 0.02885139361023903
. O 0 0.005355759523808956

When O 0 0.019724437966942787
resting O 1 0.9965935349464417
cells O 0 0.05708147957921028
are O 0 0.0029203142039477825
induced O 1 0.9998084902763367
to O 0 0.00365269323810935
proliferate O 0 0.0566275380551815
, O 0 0.0013185032876208425
the O 0 0.0021437671966850758
steady O 0 0.025102585554122925
- O 0 0.012731635011732578
state O 0 0.00187241833191365
levels O 0 0.010995514690876007
of O 0 0.00420746486634016
BRCA1 O 1 1.0
increase O 0 0.011239668354392052
in O 0 0.0022633173502981663
late O 0 0.020967919379472733
G1 O 1 0.999707043170929
and O 0 0.0020879057701677084
reach O 0 0.006069686263799667
a O 0 0.005740729160606861
maximum O 0 0.01531682163476944
during O 0 0.0128976134583354
S O 0 0.37538671493530273
phase O 0 0.05260568857192993
. O 0 0.0078440485522151

Moreover O 0 0.018701810389757156
, O 0 0.001331234467215836
in O 0 0.00215684506110847
S O 1 0.997190535068512
phase O 0 0.059926487505435944
cells O 0 0.060164257884025574
, O 0 0.006975613534450531
BRCA1 O 1 1.0
polypeptides O 1 0.5471070408821106
are O 0 0.003027454949915409
hyperphosphorylated O 1 0.9906052947044373
and O 0 0.002285806694999337
accumulate O 0 0.04442932829260826
into O 0 0.0045654247514903545
discrete O 0 0.0400594025850296
subnuclear O 1 0.9982526898384094
foci O 1 0.9864205121994019
termed O 0 0.10753889381885529
" O 0 0.018405023962259293
BRCA1 O 1 1.0
nuclear O 0 0.015178275294601917
dots O 0 0.07103396952152252
. O 0 0.006360908504575491

" O 0 0.02932133711874485
BRCA1 O 1 1.0
associates O 0 0.031215980648994446
in O 0 0.002305582631379366
vivo O 0 0.06080534681677818
with O 0 0.0017856777412816882
a O 0 0.009072866290807724
structurally O 1 0.7186271548271179
related O 0 0.02046053484082222
protein O 0 0.1148088276386261
termed O 0 0.1924045830965042
BARD1 O 1 0.9998142123222351
. O 0 0.008979396894574165

Here O 0 0.0034183913376182318
we O 0 0.0015402714489027858
show O 0 0.003382455324754119
that O 0 0.0008010573801584542
the O 0 0.0019017868908122182
steady O 0 0.025725016370415688
- O 0 0.013470625504851341
state O 0 0.0020136204548180103
levels O 0 0.009789966978132725
of O 0 0.0025756226386874914
BARD1 O 1 0.9999995231628418
, O 0 0.0017588557675480843
unlike O 0 0.006493564695119858
those O 0 0.001287805731408298
of O 0 0.0032431166619062424
BRCA1 O 1 1.0
, O 0 0.0020767259411513805
remain O 0 0.003970753401517868
relatively O 0 0.0074510881677269936
constant O 0 0.019692320376634598
during O 0 0.010609698481857777
cell O 0 0.05775050073862076
cycle O 0 0.11649466305971146
progression O 1 0.9956117272377014
. O 0 0.007595219183713198

However O 0 0.007648359518498182
, O 0 0.003677572123706341
immunostaining O 1 0.998884379863739
revealed O 0 0.018957801163196564
that O 0 0.002862325869500637
BARD1 O 1 0.9999287128448486
resides O 0 0.036892715841531754
within O 0 0.009916726499795914
BRCA1 O 1 0.9999995231628418
nuclear O 0 0.01566455140709877
dots O 0 0.06536948680877686
during O 0 0.013278215192258358
S O 0 0.21672528982162476
phase O 0 0.026170626282691956
of O 0 0.001190433744341135
the O 0 0.0038772285915911198
cell O 0 0.061181504279375076
cycle O 0 0.06120891124010086
, O 0 0.0015492861857637763
but O 0 0.0012842357391491532
not O 0 0.00100311532150954
during O 0 0.005089273676276207
the O 0 0.005763855297118425
G1 O 1 0.9998949766159058
phase O 0 0.06758065521717072
. O 0 0.005883603356778622

Nevertheless O 0 0.02980199083685875
, O 0 0.005386822856962681
BARD1 O 1 0.9999775886535645
polypeptides O 0 0.22739388048648834
are O 0 0.0015474993269890547
found O 0 0.003912299405783415
exclusively O 0 0.003957557026296854
in O 0 0.0008960048435255885
the O 0 0.0013985311379656196
nuclear O 0 0.002912537893280387
fractions O 0 0.0144559470936656
of O 0 0.0010055393213406205
both O 0 0.0036534653045237064
G1 O 1 0.999993085861206
- O 0 0.026932017877697945
and O 0 0.002920487429946661
S O 1 0.978849470615387
- O 0 0.03990775719285011
phase O 0 0.06423873454332352
cells O 0 0.07999449968338013
. O 0 0.006500379182398319

Therefore O 0 0.0103922663256526
, O 0 0.002969147637486458
progression O 1 0.9990800619125366
to O 0 0.004176413640379906
S O 1 0.617361843585968
phase O 0 0.035514988005161285
is O 0 0.003232122166082263
accompanied O 0 0.008740007877349854
by O 0 0.0017695212736725807
the O 0 0.0025527572724968195
aggregation O 0 0.06896211951971054
of O 0 0.001661232323385775
nuclear O 0 0.009281438775360584
BARD1 O 1 0.99934321641922
polypeptides O 0 0.1513121873140335
into O 0 0.0232868455350399
BRCA1 O 1 0.9999995231628418
nuclear O 0 0.018014006316661835
dots O 0 0.07160893827676773
. O 0 0.005814670119434595

This O 0 0.007228108588606119
cell O 0 0.05743638053536415
cycle O 0 0.07854373008012772
- O 0 0.03725182265043259
dependent O 0 0.04357527568936348
colocalization O 1 0.949413537979126
of O 0 0.0033734303433448076
BARD1 O 1 0.9999974966049194
and O 0 0.006722365040332079
BRCA1 O 1 1.0
indicates O 0 0.018550721928477287
a O 0 0.0044526089914143085
role O 0 0.006160323973745108
for O 0 0.0023212269879877567
BARD1 O 1 0.9999814033508301
in O 0 0.008758584037423134
BRCA1 O 1 1.0
- O 1 0.9930992126464844
mediated O 1 0.9999276399612427
tumor B-Disease 1 0.9999998807907104
suppression O 1 0.9367212057113647
. O 0 0.005636924412101507

Ethnic O 0 0.01000546757131815
differences O 0 0.004437372088432312
in O 0 0.0011767385294660926
the O 0 0.0051829619333148
HFE O 1 0.9999995231628418
codon O 1 0.9603675603866577
282 O 0 0.38640764355659485
( O 0 0.01676291972398758
Cys O 1 0.9998447895050049
/ O 1 0.9556241035461426
Tyr O 1 0.9997825026512146
) O 0 0.010148799046874046
polymorphism O 0 0.43498748540878296
. O 0 0.006834160536527634

Recent O 0 0.014964436180889606
studies O 0 0.003981256391853094
have O 0 0.0014478560769930482
shown O 0 0.005604560021311045
that O 0 0.004034891724586487
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 0.04666640982031822
HH B-Disease 1 1.0
) O 0 0.004957599099725485
is O 0 0.0025784270837903023
likely O 0 0.005788428708910942
to O 0 0.0008320425404235721
be O 0 0.001722300541587174
caused O 1 0.9882645606994629
by O 0 0.004205184057354927
homozygosity O 1 0.9827120304107666
for O 0 0.002105505671352148
a O 0 0.009930312633514404
Cys282Tyr O 1 0.9999780654907227
mutation O 1 0.9999628067016602
in O 0 0.002504348987713456
the O 0 0.007538341451436281
HFE O 1 0.9999996423721313
gene O 1 0.9988399147987366
located O 0 0.018521947786211967
4 O 0 0.012783837504684925
. O 0 0.0048553249798715115

5 O 0 0.03250052034854889
Mb O 1 0.9801819920539856
telomeric O 1 0.9952321648597717
to O 0 0.01059874240309
HLA O 1 0.9999983310699463
- O 0 0.037045612931251526
A O 0 0.01962832175195217
. O 0 0.005311298184096813

Population O 0 0.014164361171424389
studies O 0 0.0031532146967947483
of O 0 0.0009386689634993672
this O 0 0.0026518888771533966
polymorphism O 1 0.8964188694953918
are O 0 0.0010851722909137607
facilitated O 0 0.02262716367840767
by O 0 0.0018586383666843176
the O 0 0.0012680556392297149
fact O 0 0.0019638389348983765
that O 0 0.0008242397452704608
the O 0 0.0035351149272173643
Cys282Tyr O 1 0.9999984502792358
mutation O 1 0.9999955892562866
creates O 0 0.03176102787256241
a O 0 0.015368890948593616
Rsal O 1 0.9994257688522339
restriction O 0 0.04986388981342316
site O 0 0.012747539207339287
. O 0 0.005302221979945898

We O 0 0.0030512039083987474
have O 0 0.0015544660855084658
studied O 0 0.0036573659162968397
the O 0 0.0039729769341647625
codon O 1 0.6804667711257935
282 O 0 0.16681009531021118
( O 0 0.015634004026651382
Cys O 1 0.9999792575836182
/ O 1 0.9824969172477722
Tyr O 1 0.9999756813049316
) O 0 0.008209049701690674
polymorphism O 1 0.554236650466919
in O 0 0.0011882534017786384
different O 0 0.0010301175061613321
ethnic O 0 0.0053878650069236755
groups O 0 0.0041490779258310795
. O 0 0.004842645954340696

In O 0 0.0022573652677237988
agreement O 0 0.0024501674342900515
with O 0 0.0010388290975242853
previous O 0 0.0037258535157889128
observations O 0 0.00536696333438158
the O 0 0.006173896603286266
Tyr O 1 0.9999990463256836
allele O 1 0.9999934434890747
appeared O 0 0.013192743062973022
to O 0 0.0011712918058037758
be O 0 0.0020027372520416975
rare O 0 0.01543793361634016
or O 0 0.004518552683293819
absent O 0 0.05357636138796806
in O 0 0.003502308391034603
Asiatic O 1 0.9999678134918213
( O 0 0.005385584197938442
Indian O 0 0.007946514524519444
, O 0 0.0013163634575903416
Chinese O 0 0.0036583009641617537
) O 0 0.0041885399259626865
populations O 0 0.028093624860048294
. O 0 0.004477587062865496

The O 0 0.007083759177476168
highest O 0 0.033945463597774506
allele O 1 0.999809205532074
frequency O 0 0.07966272532939911
( O 0 0.006750678177922964
7 O 0 0.012016290798783302
. O 0 0.002108577871695161
5 O 0 0.00933066662400961
% O 0 0.005176227539777756
) O 0 0.003000488970428705
was O 0 0.005874848924577236
found O 0 0.003960170783102512
in O 0 0.001796446624211967
Swedes O 0 0.4479597210884094
. O 0 0.00657698605209589

Saamis O 1 0.9990795850753784
( O 0 0.010126891545951366
2 O 0 0.010654345154762268
% O 0 0.005024231504648924
) O 0 0.0026952901389449835
and O 0 0.0024450866039842367
Mordvinians O 1 0.9999773502349854
( O 0 0.007817394100129604
1 O 0 0.012838407419621944
. O 0 0.00259745167568326
8 O 0 0.013015680015087128
% O 0 0.005683160852640867
) O 0 0.003014463232830167
had O 0 0.005898887291550636
significantly O 0 0.027823714539408684
lower O 0 0.013987281359732151
frequencies O 0 0.015418658033013344
of O 0 0.0012940018204972148
the O 0 0.006309004966169596
Tyr O 1 0.9999990463256836
allele O 1 0.999964714050293
. O 0 0.008823886513710022

Comparisons O 0 0.022494109347462654
with O 0 0.004931303206831217
allele O 1 0.9994294047355652
frequencies O 0 0.02529921382665634
based O 0 0.002367217093706131
on O 0 0.002758756745606661
prevalence O 1 0.9986536502838135
estimates O 0 0.009088416583836079
of O 0 0.004384967032819986
HH B-Disease 1 0.9999998807907104
showed O 0 0.012364204041659832
some O 0 0.0023504202254116535
disagreements O 0 0.013507709838449955
with O 0 0.0011941252741962671
the O 0 0.004785886965692043
RFLP O 1 0.9997046589851379
data O 0 0.004402407445013523
, O 0 0.00187153450679034
particularly O 0 0.006012976169586182
in O 0 0.002389622386544943
Finns O 1 0.5635566115379333
. O 0 0.005517865065485239

The O 0 0.005760035943239927
newly O 0 0.019551731646060944
described O 0 0.02815333940088749
HFE O 1 0.9999923706054688
marker O 0 0.10330946743488312
provides O 0 0.0051867226138710976
a O 0 0.003824401879683137
new O 0 0.0018115832936018705
approach O 0 0.005459492094814777
to O 0 0.0011115485103800893
the O 0 0.002695285016670823
screening O 0 0.053332339972257614
of O 0 0.004062247462570667
HH B-Disease 1 0.9999998807907104
as O 0 0.0029714296106249094
well O 0 0.0015076976269483566
as O 0 0.0013442679774016142
studies O 0 0.001969891367480159
of O 0 0.0005800123908556998
the O 0 0.0015400624834001064
relationship O 0 0.0059628719463944435
between O 0 0.0015207307878881693
the O 0 0.0053413608111441135
HFE O 1 1.0
Tyr O 1 0.9999996423721313
allele O 1 0.9999833106994629
and O 0 0.002156750997528434
different O 0 0.003357966197654605
disorders O 1 1.0
including O 0 0.009519184939563274
cancer B-Disease 1 1.0

Autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 0.9998785257339478
neurohypophyseal I-Disease 1 0.9999997615814209
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
associated O 0 0.010541840456426144
with O 0 0.0013117071939632297
a O 0 0.008863945491611958
missense O 1 0.9998593330383301
mutation O 1 0.999772846698761
encoding O 0 0.10336609184741974
Gly23 O 1 0.9985993504524231
- O 0 0.04594877362251282
- O 0 0.04876910522580147
> O 1 0.9972295165061951
Val O 1 0.9999493360519409
in O 0 0.005115947686135769
neurophysin O 1 0.999931812286377
II O 1 0.9990528225898743
. O 0 0.006877335254102945

Autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 0.9994174242019653
neurohypophyseal I-Disease 1 0.9999997615814209
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 0.01919827051460743
ADNDI B-Disease 1 0.9999862909317017
) O 0 0.003286294173449278
is O 0 0.002536652609705925
an O 0 0.004962772596627474
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 0.9999973773956299
by O 0 0.005413827486336231
progressive O 1 0.9999890327453613
degeneration O 1 1.0
of O 0 0.0018938836874440312
the O 0 0.0044656977988779545
magnocellular O 1 0.9999514818191528
neurons O 1 0.607589066028595
of O 0 0.0013155776541680098
the O 0 0.0038493943866342306
hypothalamus O 1 0.9999436140060425
leading O 0 0.010729992762207985
to O 0 0.0023656622506678104
decreased O 0 0.1622784435749054
ability O 0 0.0073585291393101215
to O 0 0.0010454411385580897
produce O 0 0.004562807269394398
the O 0 0.005766637623310089
hormone O 1 0.999627947807312
arginine O 1 0.948685348033905
vasopressin O 1 0.9994589686393738
( O 0 0.017112597823143005
AVP O 1 0.9999914169311523
) O 0 0.006761352531611919
. O 0 0.004737643990665674

Affected O 0 0.2510589063167572
individuals O 0 0.006089042406529188
are O 0 0.001078727305866778
not O 0 0.002958251629024744
symptomatic O 1 0.9999998807907104
at O 0 0.006566083990037441
birth O 0 0.4593445658683777
, O 0 0.0009582662023603916
but O 0 0.0013235780643299222
usually O 0 0.007408552337437868
develop O 0 0.2567986845970154
diabetes B-Disease 1 1.0
insipidus I-Disease 1 1.0
at O 0 0.009021456353366375
1 O 0 0.015609313733875751
- O 0 0.024012861773371696
6 O 0 0.022046057507395744
yr O 1 0.9982550740242004
of O 0 0.002847089432179928
age O 0 0.013321449048817158
. O 0 0.004822961054742336

The O 0 0.007801887113600969
genetic O 0 0.1007918268442154
locus O 1 0.9993232488632202
of O 0 0.002432173816487193
the O 0 0.007141118869185448
disease O 1 1.0
is O 0 0.0025536485482007265
the O 0 0.003797950455918908
AVP O 1 0.9999996423721313
- O 0 0.12468298524618149
neurophysin O 1 0.99989914894104
II O 1 0.9998737573623657
( O 0 0.010240117087960243
NPII O 1 0.9999895095825195
) O 0 0.007835770957171917
gene O 1 0.998024582862854
, O 0 0.001634277286939323
and O 0 0.0016249516047537327
mutations O 1 0.9999192953109741
that O 0 0.003146006027236581
cause O 1 0.999942421913147
ADNDI B-Disease 1 0.9999958276748657
have O 0 0.0027705426327884197
been O 0 0.00339314853772521
found O 0 0.0028712842613458633
in O 0 0.0007804760825820267
both O 0 0.0008347728289663792
the O 0 0.0026540702674537897
signal O 0 0.033190980553627014
peptide O 0 0.0918244794011116
of O 0 0.0012596024898812175
the O 0 0.004017825238406658
prepro O 1 0.999874472618103
- O 0 0.1801348626613617
AVP O 1 0.9999885559082031
- O 0 0.08131124079227448
NPII O 1 0.9999723434448242
precursor O 0 0.07598185539245605
and O 0 0.0020857667550444603
within O 0 0.00586472125723958
NPII O 1 0.9997755885124207
itself O 0 0.017483040690422058
. O 0 0.00530574657022953

An O 0 0.008721272461116314
affected O 1 0.6806207299232483
girl O 1 0.9729874134063721
who O 0 0.004581664688885212
presented O 0 0.004745339043438435
at O 0 0.004295178689062595
9 O 0 0.010415693745017052
months O 0 0.0066462354734539986
of O 0 0.0012586783850565553
age O 0 0.00783976074308157
and O 0 0.0012092809192836285
her O 0 0.0058082896284759045
similarly O 0 0.04946838691830635
affected O 1 0.9949681162834167
younger O 1 0.9276244640350342
brother O 0 0.4467064440250397
and O 0 0.0016123595414683223
father O 0 0.01622699946165085
were O 0 0.0010890440316870809
all O 0 0.0007498429040424526
found O 0 0.002843573223799467
to O 0 0.0008096220553852618
have O 0 0.0010356574784964323
a O 0 0.005143591668456793
novel O 0 0.039776112884283066
missense O 1 0.9998469352722168
mutation O 1 0.9999581575393677
( O 0 0.010960414074361324
G1758 O 1 0.9997157454490662
- O 0 0.04999211058020592
- O 0 0.06437233090400696
> O 1 0.9987555742263794
T O 1 0.9989927411079407
) O 0 0.003592281136661768
encoding O 0 0.027683893218636513
the O 0 0.003083731746301055
amino O 0 0.061640821397304535
acid O 0 0.12724778056144714
substitution O 0 0.07979319244623184
Gly23 O 1 0.9953072667121887
- O 0 0.04800194501876831
- O 0 0.05509458854794502
> O 1 0.9924571514129639
Val O 1 0.9999479055404663
within O 0 0.0121541079133749
NPII O 1 0.9999469518661499
. O 0 0.007763731759041548

The O 0 0.010651947930455208
mutation O 1 0.9999873638153076
was O 0 0.01051149982959032
confirmed O 0 0.015830110758543015
by O 0 0.0039551518857479095
restriction O 0 0.06969115883111954
endonuclease O 1 0.998996913433075
analysis O 0 0.011087332852184772
. O 0 0.005194894969463348

A O 0 0.05263880640268326
T1 O 1 0.9960248470306396
- O 0 0.03364007920026779
weighted O 0 0.04811152443289757
magnetic O 0 0.0270125363022089
resonance O 0 0.06312209367752075
imaging O 0 0.047309599816799164
of O 0 0.0011631310917437077
the O 0 0.003099683439359069
fathers O 1 0.5021212100982666
pituitary O 1 0.999997615814209
gland O 1 0.9999574422836304
demonstrates O 0 0.03373555466532707
an O 0 0.007740356959402561
attenuated O 1 0.999935507774353
posterior O 1 0.9999916553497314
pituitary O 1 0.9999951124191284
bright O 0 0.054025884717702866
spot O 0 0.035779066383838654
. O 0 0.0049629113636910915

This O 0 0.009900078177452087
mutation O 1 0.9999936819076538
may O 0 0.009159239009022713
be O 0 0.0013883805368095636
valuable O 0 0.004597814287990332
for O 0 0.0011828516144305468
developing O 0 0.008132551796734333
models O 0 0.0061363959684967995
of O 0 0.0031898042652755976
dominantly B-Disease 1 0.9999995231628418
inherited I-Disease 1 0.9999997615814209
neurodegeneration I-Disease 1 1.0
, O 0 0.0022618931252509356
as O 0 0.0011871667811647058
the O 0 0.0017215522238984704
early O 0 0.006493416614830494
age O 0 0.009288008324801922
of O 0 0.0029515656642615795
onset O 1 1.0
of O 0 0.007636027876287699
symptoms O 1 1.0
suggests O 0 0.011997675523161888
that O 0 0.0012113722041249275
this O 0 0.003681391477584839
mutation O 1 0.9999997615814209
may O 0 0.009373788721859455
be O 0 0.0017852570163086057
particularly O 0 0.009338109754025936
deleterious O 1 0.9997386336326599
to O 0 0.0018469758797436953
the O 0 0.005593674257397652
magnocellular O 1 0.9999680519104004
neuron O 1 0.9998904466629028
. O 0 0.0037983939982950687
. O 0 0.0043780324049293995

Frequent O 0 0.08986592292785645
inactivation O 1 0.9996203184127808
of O 0 0.005726224277168512
PTEN O 1 1.0
/ O 1 0.9973879456520081
MMAC1 O 1 0.9999960660934448
in O 0 0.006176711991429329
primary O 1 0.9999337196350098
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.009914826601743698

Sporadic B-Disease 1 0.9999850988388062
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.004792093299329281
the O 0 0.0017252085963264108
most O 0 0.002855762606486678
common O 0 0.034954674541950226
male B-Disease 1 0.9988289475440979
cancer I-Disease 1 1.0
in O 0 0.001618406386114657
the O 0 0.002027661306783557
Western O 0 0.005541250109672546
world O 0 0.0038130551110953093
, O 0 0.001017412985675037
yet O 0 0.0023543413262814283
many O 0 0.0006414200179278851
of O 0 0.0007494953460991383
the O 0 0.002159695839509368
major O 0 0.01582617312669754
genetic O 0 0.24617885053157806
events O 0 0.004825690295547247
involved O 0 0.004975588992238045
in O 0 0.000946143118198961
the O 0 0.003416165243834257
progression O 1 0.9989702701568604
of O 0 0.0011703126365318894
this O 0 0.0023304750211536884
often O 0 0.016623573377728462
fatal O 1 1.0
cancer B-Disease 1 1.0
remain O 0 0.004880395717918873
to O 0 0.0011873957701027393
be O 0 0.0023303329944610596
elucidated O 1 0.9736411571502686
. O 0 0.005172255914658308

Numerous O 0 0.023718073964118958
cytogenetic O 1 0.9928102493286133
and O 0 0.004919292870908976
allelotype O 1 0.9960660338401794
studies O 0 0.005240991711616516
have O 0 0.001778886653482914
reported O 0 0.013409777544438839
frequent O 0 0.032246943563222885
loss O 0 0.027150319889187813
of O 0 0.002476426074281335
heterozygosity O 1 0.9999637603759766
on O 0 0.006535486783832312
chromosomal O 1 0.9999964237213135
arm O 1 0.9985742568969727
10q O 1 0.9990053772926331
in O 0 0.007458065636456013
sporadic B-Disease 1 0.9999901056289673
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.008701516315340996

Deletion O 1 0.9679191708564758
mapping O 0 0.03335133194923401
studies O 0 0.004433028399944305
have O 0 0.0021504221949726343
unambiguously O 0 0.04551718011498451
identified O 0 0.010113383643329144
a O 0 0.004346828907728195
region O 0 0.00696997344493866
of O 0 0.003491673618555069
chromosome O 1 0.9999982118606567
10q23 O 1 0.9997647404670715
to O 0 0.0014037148794159293
be O 0 0.000945916457567364
the O 0 0.002009038580581546
minimal O 0 0.027363590896129608
area O 0 0.006515940185636282
of O 0 0.0019744141027331352
loss O 1 0.9366631507873535
. O 0 0.005584849044680595

A O 0 0.018054097890853882
new O 0 0.011360911652445793
tumor B-Disease 1 1.0
suppressor O 1 0.9999997615814209
gene O 1 0.9997196793556213
, O 0 0.008215309120714664
PTEN O 1 0.9999996423721313
/ O 1 0.9933028221130371
MMAC1 O 1 0.9999735355377197
, O 0 0.0031179164070636034
was O 0 0.008496459573507309
isolated O 0 0.05815587937831879
recently O 0 0.010766660794615746
at O 0 0.0021911824587732553
this O 0 0.0014048730954527855
region O 0 0.007452660705894232
of O 0 0.0037485873326659203
chromosome O 1 0.9999984502792358
10q23 O 1 0.9998220801353455
and O 0 0.0017289441311731935
found O 0 0.0026621290016919374
to O 0 0.0006714157061651349
be O 0 0.002006042515859008
inactivated O 1 0.9987418055534363
by O 0 0.0038345614448189735
mutation O 1 0.9998939037322998
in O 0 0.002808208344504237
three O 0 0.014034328050911427
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 0.4561328887939453
lines O 0 0.013105017133057117
. O 0 0.004605983383953571

We O 0 0.007293557748198509
screened O 0 0.18628184497356415
80 O 0 0.24496540427207947
prostate B-Disease 1 1.0
tumors I-Disease 1 0.9999997615814209
by O 0 0.008093110285699368
microsatellite O 1 0.9026346206665039
analysis O 0 0.006639639846980572
and O 0 0.0014366747345775366
found O 0 0.012674512341618538
chromosome O 1 0.9999871253967285
10q23 O 1 0.9926300048828125
to O 0 0.0019703053403645754
be O 0 0.0020924778655171394
deleted O 0 0.04612253978848457
in O 0 0.0020600901916623116
23 O 0 0.015173620544373989
cases O 0 0.013187205418944359
. O 0 0.004426744766533375

We O 0 0.0034482725895941257
then O 0 0.003570331260561943
proceeded O 0 0.009973343461751938
with O 0 0.0015442254953086376
sequence O 0 0.013809592463076115
analysis O 0 0.002598878927528858
of O 0 0.0006919601000845432
the O 0 0.002256398554891348
entire O 0 0.04893749952316284
PTEN O 1 1.0
/ O 1 0.9963451027870178
MMAC1 O 1 0.9999699592590332
coding O 0 0.11863445490598679
region O 0 0.009600384160876274
and O 0 0.0015688930870965123
tested O 0 0.0267101489007473
for O 0 0.003557104617357254
homozygous O 1 0.9998718500137329
deletion O 1 0.995306670665741
with O 0 0.002176400739699602
new O 0 0.00522959791123867
intragenic O 1 0.9998884201049805
markers O 0 0.033378537744283676
in O 0 0.001379642402753234
these O 0 0.0009948015213012695
23 O 0 0.012021851725876331
cases O 0 0.00746245589107275
with O 0 0.002327662892639637
10q23 O 1 0.9998206496238708
loss O 0 0.12275013327598572
of O 0 0.004271794110536575
heterozygosity O 1 0.9998041987419128
. O 0 0.00892757810652256

The O 0 0.004409891087561846
identification O 0 0.007028371095657349
of O 0 0.0009872418595477939
the O 0 0.0026372168213129044
second O 0 0.018147774040699005
mutational O 1 0.9998726844787598
event O 0 0.021078286692500114
in O 0 0.0021174135617911816
10 O 0 0.0067111290991306305
( O 0 0.005555414129048586
43 O 0 0.02303433232009411
% O 0 0.008020521141588688
) O 0 0.010189827531576157
tumors B-Disease 1 0.9999998807907104
establishes O 1 0.993606686592102
PTEN O 1 0.9999998807907104
/ O 1 0.9416325688362122
MMAC1 O 1 0.9997298121452332
as O 0 0.0032181632705032825
a O 0 0.004628114402294159
main O 0 0.011064869351685047
inactivation O 1 0.9998058676719666
target O 0 0.011184362694621086
of O 0 0.0019928470719605684
10q O 1 0.9999357461929321
loss O 1 0.8166519999504089
in O 0 0.005185286048799753
sporadic B-Disease 1 0.9999922513961792
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.004046185873448849
. O 0 0.003978500608354807

Risk O 1 0.9933605790138245
reversals O 0 0.1446467489004135
in O 0 0.002357735065743327
predictive O 0 0.11067382991313934
testing O 0 0.028750641271471977
for O 0 0.0076015405356884
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.006522711832076311

The O 0 0.003081779694184661
first O 0 0.004293855279684067
predictive O 0 0.10672494024038315
testing O 0 0.02889515645802021
for O 0 0.008213646709918976
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.013546529226005077
HD B-Disease 1 0.9997392296791077
) O 0 0.003321668365970254
was O 0 0.0037977411411702633
based O 0 0.0014196294359862804
on O 0 0.0010040834313258529
analysis O 0 0.00264564948156476
of O 0 0.0017584555316716433
linked O 1 0.6958009004592896
polymorphic O 1 0.9999521970748901
DNA O 0 0.06118717044591904
markers O 0 0.025317974388599396
to O 0 0.0009656372130848467
estimate O 0 0.00440061604604125
the O 0 0.002040914027020335
likelihood O 0 0.028072331100702286
of O 0 0.0025225086137652397
inheriting O 1 0.9992222785949707
the O 0 0.00863345805555582
mutation O 1 0.9999823570251465
for O 0 0.004967646207660437
HD B-Disease 1 0.9960365891456604
. O 0 0.006563403178006411

Limits O 0 0.009231813251972198
to O 0 0.0013589320005849004
accuracy O 0 0.005709094926714897
included O 0 0.003900405950844288
recombination O 0 0.10299693048000336
between O 0 0.002077251672744751
the O 0 0.0028270669281482697
DNA O 0 0.041091084480285645
markers O 0 0.02353547513484955
and O 0 0.0010978883365169168
the O 0 0.0046603181399405
mutation O 1 0.9999994039535522
, O 0 0.0036207593511790037
pedigree O 1 0.9800218939781189
structure O 0 0.00811913050711155
, O 0 0.0010338254505768418
and O 0 0.0007939451606944203
whether O 0 0.003625452285632491
DNA O 0 0.03747833892703056
samples O 0 0.012258965522050858
were O 0 0.00135306257288903
available O 0 0.0019416947616264224
from O 0 0.0027681721840053797
family O 0 0.012331145815551281
members O 0 0.003926494158804417
. O 0 0.004492426291108131

With O 0 0.003069062251597643
direct O 0 0.006302909925580025
tests O 0 0.007344835437834263
for O 0 0.001008962863124907
the O 0 0.005164444912225008
HD B-Disease 1 0.9999669790267944
mutation O 1 0.9999845027923584
, O 0 0.0020175480749458075
we O 0 0.0009545907378196716
have O 0 0.0011205908376723528
assessed O 0 0.014054988510906696
the O 0 0.0015638020122423768
accuracy O 0 0.003958609886467457
of O 0 0.00102321058511734
results O 0 0.005676194094121456
obtained O 0 0.0025135930627584457
by O 0 0.0031103682704269886
linkage O 0 0.0874013602733612
approaches O 0 0.026912765577435493
when O 0 0.005829162430018187
requested O 0 0.005861002020537853
to O 0 0.001312096370384097
do O 0 0.0017801648937165737
so O 0 0.0018646332900971174
by O 0 0.0015503473114222288
the O 0 0.0021563032642006874
test O 0 0.012755115516483784
individuals O 0 0.005530513357371092
. O 0 0.004162095952779055

For O 0 0.0032420747447758913
six O 0 0.0031474707648158073
such O 0 0.001176783349364996
individuals O 0 0.0036701264325529337
, O 0 0.0012701499508693814
there O 0 0.0013386026257649064
was O 0 0.005532131530344486
significant O 0 0.007651697378605604
disparity O 0 0.03884084150195122
between O 0 0.0017351856222376227
the O 0 0.002700360491871834
tests O 0 0.01492605172097683
. O 0 0.003897343296557665

Three O 0 0.0036999331787228584
went O 0 0.006383612286299467
from O 0 0.00224410742521286
a O 0 0.008287603966891766
decreased O 1 0.9986304044723511
risk O 1 0.8558587431907654
to O 0 0.0013037004973739386
an O 0 0.002454566303640604
increased O 0 0.019834619015455246
risk O 1 0.9992437362670898
, O 0 0.0013664826983585954
while O 0 0.001415660372003913
in O 0 0.001002498553134501
another O 0 0.004721787292510271
three O 0 0.0013636213261634111
the O 0 0.0029010865837335587
risk O 1 0.9999816417694092
was O 0 0.010709892027080059
decreased O 1 0.8910099267959595
. O 0 0.005315640475600958

Knowledge O 0 0.005506426561623812
of O 0 0.0010601691901683807
the O 0 0.002898068865761161
potential O 0 0.011814461089670658
reasons O 0 0.004671317059546709
for O 0 0.0008142677252180874
these O 0 0.0007811181712895632
changes O 0 0.0039004578720778227
in O 0 0.0011076254304498434
results O 0 0.004973098635673523
and O 0 0.0009177693864330649
impact O 0 0.010720532387495041
of O 0 0.0008679272141307592
these O 0 0.0015951412497088313
risk O 1 0.9996999502182007
reversals O 1 0.9835800528526306
on O 0 0.0023931297473609447
both O 0 0.003269726876169443
patients O 1 0.9999969005584717
and O 0 0.0011385622201487422
the O 0 0.0036472738720476627
counseling O 1 0.9963638186454773
team O 0 0.006286943331360817
can O 0 0.002466500736773014
assist O 0 0.01020259503275156
in O 0 0.0010059188352897763
the O 0 0.0013070355635136366
development O 0 0.001987589756026864
of O 0 0.0011837199563160539
strategies O 0 0.013080974109470844
for O 0 0.001368058379739523
the O 0 0.004015427548438311
prevention O 1 0.9999643564224243
and O 0 0.0014597023837268353
, O 0 0.0012305116979405284
where O 0 0.0019832123070955276
necessary O 0 0.002882952569052577
, O 0 0.0012392675271257758
management O 0 0.006768426392227411
of O 0 0.0010468632681295276
a O 0 0.009986992925405502
risk O 1 0.9999408721923828
reversal O 0 0.0857611894607544
in O 0 0.0014090359909459949
any O 0 0.0033808350563049316
predictive O 0 0.12698566913604736
testing O 0 0.02864369936287403
program O 0 0.008522250689566135
. O 0 0.002139852847903967
. O 0 0.0034993106964975595

A O 0 0.02183333970606327
novel O 0 0.02455904521048069
common O 0 0.024367718026041985
missense O 1 0.9999158382415771
mutation O 1 0.999980092048645
G301C O 1 0.9753853678703308
in O 0 0.0020706357900053263
the O 0 0.0033742415253072977
N O 0 0.08011795580387115
- O 0 0.04229823499917984
acetylgalactosamine O 1 0.9978949427604675
- O 0 0.038317546248435974
6 O 0 0.02477855794131756
- O 0 0.05829907953739166
sulfate O 1 0.9982330799102783
sulfatase O 1 0.9999836683273315
gene O 1 0.9742271304130554
in O 0 0.006300616543740034
mucopolysaccharidosis B-Disease 1 0.999822199344635
IVA I-Disease 1 0.9999899864196777
. O 0 0.008480999618768692

Mucopolysaccharidosis B-Disease 1 0.9997451901435852
IVA I-Disease 1 0.999997615814209
( O 0 0.014920955523848534
MPS B-Disease 1 0.9998331069946289
IVA I-Disease 1 0.9999998807907104
) O 0 0.00384856597520411
is O 0 0.0021534059196710587
an O 0 0.005343402270227671
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 0.9999998807907104
storage I-Disease 1 0.9922612309455872
disorder I-Disease 1 1.0
caused O 1 0.9998377561569214
by O 0 0.0027442583814263344
a O 0 0.009223964996635914
genetic B-Disease 1 0.9994845390319824
defect I-Disease 1 0.9999715089797974
in O 0 0.0026137176901102066
N O 0 0.1165936216711998
- O 0 0.03473591059446335
acetylgalactosamine O 1 0.9998558759689331
- O 0 0.031064821407198906
6 O 0 0.023323893547058105
- O 0 0.056820813566446304
sulfate O 1 0.9995563626289368
sulfatase O 1 0.9999669790267944
( O 0 0.018881527706980705
GALNS O 1 0.9999312162399292
) O 0 0.006524625234305859
. O 0 0.004691823851317167

In O 0 0.0032525393180549145
previous O 0 0.0061138770543038845
studies O 0 0.0048765698447823524
, O 0 0.0010572326136752963
we O 0 0.0007599478703923523
have O 0 0.0014057691441848874
found O 0 0.003549381159245968
two O 0 0.0018129486124962568
common O 0 0.018110327422618866
mutations O 1 0.9999719858169556
in O 0 0.003908404614776373
Caucasians O 1 0.9991421699523926
and O 0 0.001830112305469811
Japanese O 0 0.0071796546690166
, O 0 0.0016055239830166101
respectively O 0 0.00783509574830532
. O 0 0.00478872936218977

To O 0 0.0050035277381539345
characterize O 0 0.05082494020462036
the O 0 0.007456351537257433
mutational O 1 0.9998365640640259
spectrum O 0 0.048991501331329346
in O 0 0.0015720946248620749
various O 0 0.0009306787396781147
ethnic O 0 0.004756900016218424
groups O 0 0.0037746315356343985
, O 0 0.0029573121573776007
mutations O 1 0.9993494153022766
in O 0 0.0017459464725106955
the O 0 0.004794450011104345
GALNS O 1 0.9999929666519165
gene O 1 0.9882566332817078
in O 0 0.002798828762024641
Colombian O 0 0.44486647844314575
MPS B-Disease 1 0.999934196472168
IVA I-Disease 1 1.0
patients O 1 0.9999991655349731
were O 0 0.0024268515408039093
investigated O 0 0.023884780704975128
, O 0 0.001451632590033114
and O 0 0.001564154983498156
genetic O 0 0.057847172021865845
backgrounds O 0 0.005618704482913017
were O 0 0.00121872138697654
extensively O 0 0.007950188592076302
analyzed O 0 0.010841680690646172
to O 0 0.0015821198467165232
identify O 0 0.009612583555281162
racial O 0 0.013344702310860157
origin O 0 0.007153144106268883
, O 0 0.0011945046717301011
based O 0 0.0018103041220456362
on O 0 0.0029265983030200005
mitochondrial O 1 0.756194531917572
DNA O 0 0.06378360837697983
( O 0 0.009006709791719913
mtDNA O 0 0.17938996851444244
) O 0 0.00816985685378313
lineages O 0 0.13488836586475372
. O 0 0.005592689849436283

Three O 0 0.006478778552263975
novel O 0 0.05643593892455101
missense O 1 0.9999688863754272
mutations O 1 0.9999754428863525
never O 0 0.01328638382256031
identified O 0 0.01230759546160698
previously O 0 0.003997359424829483
in O 0 0.0012785979779437184
other O 0 0.0010429313406348228
populations O 0 0.02456551231443882
and O 0 0.001162830158136785
found O 0 0.0037173228338360786
in O 0 0.0011862535029649734
16 O 0 0.004821194335818291
out O 0 0.0017137578688561916
of O 0 0.0011245248606428504
19 O 0 0.015039902180433273
Colombian O 0 0.19586233794689178
MPS B-Disease 1 0.9990943670272827
IVA I-Disease 1 0.9999997615814209
unrelated O 0 0.23558689653873444
alleles O 1 0.9995414018630981
account O 0 0.004812743980437517
for O 0 0.00244405516423285
84 O 0 0.045960310846567154
. O 0 0.005361930001527071

2 O 0 0.01558625791221857
% O 0 0.003338997717946768
of O 0 0.001126104616560042
the O 0 0.004839159548282623
alleles O 1 0.9999678134918213
in O 0 0.0019311492796987295
this O 0 0.001557157258503139
study O 0 0.005043042358011007
. O 0 0.004550187382847071

The O 0 0.0068234894424676895
G301C O 1 0.9992383718490601
and O 0 0.004463194869458675
S162F O 1 0.9998168349266052
mutations O 1 0.9989421963691711
account O 0 0.00510028749704361
for O 0 0.0022762310691177845
68 O 0 0.04053395241498947
. O 0 0.004723291378468275

4 O 0 0.02280507981777191
% O 0 0.004848194308578968
and O 0 0.0012990252580493689
10 O 0 0.005999579094350338
. O 0 0.004386312328279018

5 O 0 0.016618050634860992
% O 0 0.005051991902291775
of O 0 0.0033107511699199677
mutations O 1 0.9999971389770508
, O 0 0.002501365728676319
respectively O 0 0.0067302207462489605
, O 0 0.0013759308494627476
whereas O 0 0.00772230327129364
the O 0 0.0021213465370237827
remaining O 0 0.010762892663478851
F69V O 1 0.999996542930603
is O 0 0.00323334033600986
limited O 0 0.0036454410292208195
to O 0 0.0009672300657257438
a O 0 0.0063422382809221745
single O 0 0.031474657356739044
allele O 1 0.9998117089271545
. O 0 0.0071429042145609856

The O 0 0.008363775908946991
skewed O 0 0.12464366853237152
prevalence O 1 0.9935451745986938
of O 0 0.003903742413967848
G301C O 1 0.9992690682411194
in O 0 0.002032581716775894
only O 0 0.003054071217775345
Colombian O 1 0.6900572776794434
patients O 1 0.9999724626541138
and O 0 0.0023878272622823715
haplotype O 1 0.9977660179138184
analysis O 0 0.005599204450845718
by O 0 0.0032773141283541918
restriction O 0 0.04476416856050491
fragment O 0 0.08271243423223495
length O 0 0.015317180193960667
polymorphisms O 0 0.25148805975914
in O 0 0.0015235984465107322
the O 0 0.0050188894383609295
GALNS O 1 0.9999980926513672
gene O 1 0.9988576173782349
suggest O 0 0.010396470315754414
that O 0 0.00252830283716321
G301C O 1 0.9892565011978149
originated O 0 0.01947113126516342
from O 0 0.0020574999507516623
a O 0 0.006899246480315924
common O 0 0.014460275880992413
ancestor O 1 0.5219981670379639
. O 0 0.0073772696778178215

Investigation O 0 0.014512277208268642
of O 0 0.001123991678468883
the O 0 0.0026863764505833387
genetic O 0 0.09504599869251251
background O 0 0.00477105937898159
by O 0 0.0015725939301773906
means O 0 0.003083731746301055
of O 0 0.002042521722614765
mtDNA O 1 0.6331415176391602
lineages O 0 0.47380152344703674
indicate O 0 0.0074590048752725124
that O 0 0.0007306536426767707
all O 0 0.0007966350531205535
our O 0 0.006292224396020174
patients O 1 0.9999985694885254
are O 0 0.001106445793993771
probably O 0 0.006958992686122656
of O 0 0.0012241015210747719
native O 0 0.006198057439178228
American O 0 0.009685371071100235
descent O 0 0.09943143278360367

Low O 0 0.040026139467954636
frequency O 0 0.03673925995826721
of O 0 0.006601199973374605
BRCA1 O 1 1.0
germline O 1 0.9999611377716064
mutations O 1 0.9980165958404541
in O 0 0.00211917026899755
45 O 0 0.010643931105732918
German O 1 0.921759307384491
breast B-Disease 1 1.0
/ I-Disease 1 0.9999995231628418
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.015523150563240051
. O 0 0.00458995345979929

In O 0 0.0028185781557112932
this O 0 0.001334715518169105
study O 0 0.0024334671907126904
we O 0 0.0012523367768153548
investigated O 0 0.018090182915329933
45 O 0 0.011330641806125641
German O 0 0.20749913156032562
breast B-Disease 1 1.0
/ I-Disease 1 0.9999997615814209
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.01120135560631752
for O 0 0.0037324579898267984
germline O 1 0.9999853372573853
mutations O 1 0.9999030828475952
in O 0 0.00206346926279366
the O 0 0.009244614280760288
BRCA1 O 1 1.0
gene O 1 0.9997738003730774
. O 0 0.007029573433101177

We O 0 0.0035747336223721504
identified O 0 0.012102528475224972
four O 0 0.005856375675648451
germline O 1 0.9998832941055298
mutations O 1 0.9986164569854736
in O 0 0.0031597488559782505
three O 0 0.009722624905407429
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.005517284385859966
and O 0 0.0005800375365652144
in O 0 0.0009934755507856607
one O 0 0.018353980034589767
breast B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.24387606978416443
. O 0 0.0010263723088428378
among O 0 0.001443203305825591
these O 0 0.0004135904018767178
were O 0 0.0008600372239015996
one O 0 0.005244751926511526
frameshift O 1 0.9999997615814209
mutation O 1 0.999998927116394
, O 0 0.0015557403676211834
one O 0 0.0033372603356838226
nonsense O 1 0.9862613081932068
mutation O 1 0.9999940395355225
, O 0 0.0013120127841830254
one O 0 0.0021128414664417505
novel O 0 0.023667600005865097
splice O 1 0.9948049187660217
site O 0 0.024560362100601196
mutation O 1 0.9999935626983643
, O 0 0.0011138130212202668
and O 0 0.0009221291402354836
one O 0 0.005463151726871729
missense O 1 0.999997615814209
mutation O 1 0.9999866485595703
. O 0 0.006325534079223871

The O 0 0.011684784665703773
missense O 1 0.9998531341552734
mutation O 1 0.9999761581420898
was O 0 0.008873938582837582
also O 0 0.0015396680682897568
found O 0 0.004077413585036993
in O 0 0.0018638453911989927
2 O 0 0.009927181527018547
. O 0 0.003726896597072482

8 O 0 0.02187429927289486
% O 0 0.003149357857182622
of O 0 0.001000626478344202
the O 0 0.002198508009314537
general O 0 0.005885341204702854
population O 0 0.006484443787485361
, O 0 0.0013358714058995247
suggesting O 0 0.009544160217046738
that O 0 0.0008534379885531962
it O 0 0.0010877900058403611
is O 0 0.002652453724294901
not O 0 0.005008606240153313
disease O 1 1.0
associated O 0 0.01736760511994362
. O 0 0.004221218638122082

The O 0 0.0052466681227087975
average O 0 0.010569615289568901
age O 0 0.011203627102077007
of O 0 0.005613032728433609
disease O 1 1.0
onset O 1 1.0
in O 0 0.0020812377333641052
those O 0 0.0016605090349912643
families O 0 0.010339012369513512
harbouring O 1 0.9999817609786987
causative O 1 0.9999867677688599
mutations O 1 0.9999332427978516
was O 0 0.00816312525421381
between O 0 0.0023854293394833803
32 O 0 0.016681356355547905
. O 0 0.00436534034088254

3 O 0 0.019313307479023933
and O 0 0.002283300505951047
37 O 0 0.02730076014995575
. O 0 0.00520672183483839

4 O 0 0.02144106663763523
years O 0 0.004594641737639904
, O 0 0.00145160558167845
whereas O 0 0.00824833009392023
the O 0 0.0022713374346494675
family O 0 0.015978537499904633
harbouring O 1 0.9981616139411926
the O 0 0.009966250509023666
missense O 1 0.9999724626541138
mutation O 1 0.9999752044677734
had O 0 0.005939413793385029
an O 0 0.002088195877149701
average O 0 0.00919776875525713
age O 0 0.010214364156126976
of O 0 0.003590487642213702
onset O 1 0.9999994039535522
of O 0 0.00311068631708622
51 O 0 0.0401843897998333
. O 0 0.004956776276230812

2 O 0 0.022007044404745102
years O 0 0.006074481178075075
. O 0 0.005547717213630676

These O 0 0.0020601311698555946
findings O 0 0.008637342602014542
show O 0 0.006881557404994965
that O 0 0.0043769595213234425
BRCA1 O 1 1.0
is O 0 0.006267338991165161
implicated O 1 0.7389922142028809
in O 0 0.001198336249217391
a O 0 0.0034183571115136147
small O 0 0.0030359842348843813
fraction O 0 0.020764824002981186
of O 0 0.007425838615745306
breast B-Disease 1 1.0
/ I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.011753288097679615
suggesting O 0 0.01032462902367115
the O 0 0.0016336775152012706
involvement O 0 0.011417284607887268
of O 0 0.0015655882889404893
another O 0 0.033453404903411865
susceptibility O 1 0.9999998807907104
gene O 1 0.9999134540557861
( O 0 0.009131213650107384
s O 0 0.09313482791185379
) O 0 0.00907811988145113

Paternal O 1 0.9959706664085388
transmission O 1 0.8782773613929749
of O 0 0.010810373350977898
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.011864815838634968

We O 0 0.002973476890474558
report O 0 0.0023286209907382727
a O 0 0.005500216037034988
rare O 0 0.013230625540018082
case O 0 0.005116485990583897
of O 0 0.002508171135559678
paternally O 1 0.9999986886978149
transmitted O 1 0.9999998807907104
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.8979502320289612
DM B-Disease 1 1.0
) O 0 0.008219071663916111
. O 0 0.0046621812507510185

The O 0 0.008984164334833622
proband O 1 0.9964267611503601
is O 0 0.004865833092480898
a O 0 0.0069082994014024734
23 O 0 0.009888731874525547
year O 0 0.0043643442913889885
old O 0 0.011751997284591198
, O 0 0.003489074530079961
mentally B-Disease 1 0.9999994039535522
retarded I-Disease 1 0.9999953508377075
male O 1 0.7678736448287964
who O 1 0.7141191959381104
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 0.9999985694885254
. O 0 0.007015415467321873

He O 0 0.004048381000757217
presented O 0 0.0049668289721012115
with O 0 0.004620959050953388
respiratory O 1 1.0
and O 0 0.002309905830770731
feeding O 1 0.9982770681381226
difficulties O 0 0.13578253984451294
at O 0 0.007190236821770668
birth O 1 0.609231173992157
. O 0 0.005072176922112703

His O 0 0.005682273767888546
two O 0 0.003845633240416646
sibs O 1 0.999998927116394
suffer O 1 0.9999920129776001
from O 0 0.009717690758407116
childhood O 1 0.999993085861206
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 0.010606816969811916

Their O 0 0.004098498262465
late O 0 0.013472342863678932
father O 0 0.014048619195818901
had O 0 0.0034993060398846865
the O 0 0.0029270851518958807
adult O 0 0.04751250147819519
type O 0 0.04195991903543472
of O 0 0.0047724987380206585
DM B-Disease 1 1.0
, O 0 0.003065090626478195
with O 0 0.0036356789059937
onset O 1 1.0
around O 0 0.006882792804390192
30 O 0 0.007469687610864639
years O 0 0.004312508273869753
. O 0 0.004058449063450098

Only O 0 0.002830668818205595
six O 0 0.0030013681389391422
other O 0 0.0008785101817920804
cases O 0 0.005518278572708368
of O 0 0.0017960671102628112
paternal O 1 0.9999219179153442
transmission O 1 0.9827085137367249
of O 0 0.010235932655632496
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.004997558891773224
been O 0 0.004901766311377287
reported O 0 0.01360388658940792
recently O 0 0.016504529863595963
. O 0 0.004589788615703583

We O 0 0.0025484119541943073
review O 0 0.0050412556156516075
the O 0 0.002583551686257124
sex O 0 0.015138667076826096
related O 0 0.0077632577158510685
effects O 0 0.028606006875634193
on O 0 0.0021695669274777174
transmission O 1 0.566893994808197
of O 0 0.009405829012393951
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.010610970668494701

Decreased O 0 0.45893871784210205
fertility O 0 0.1384316235780716
of O 0 0.002609566319733858
males O 0 0.03648800030350685
with O 0 0.0034630876034498215
adult O 1 0.9945461750030518
onset O 1 1.0
DM B-Disease 1 1.0
and O 0 0.00452514598146081
contraction O 1 0.632103443145752
of O 0 0.0012656461913138628
the O 0 0.00251878728158772
repeat O 0 0.25770774483680725
upon O 0 0.0070319161750376225
male O 0 0.028849484398961067
transmission O 0 0.17429202795028687
contribute O 0 0.008425676263868809
to O 0 0.000795986910816282
the O 0 0.0017902001272886992
almost O 0 0.006846367847174406
absent O 0 0.04568726569414139
occurrence O 0 0.06297027319669724
of O 0 0.0018975783605128527
paternal O 1 0.9998492002487183
transmission O 1 0.9973176121711731
of O 0 0.007977097295224667
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.009427986107766628

Also O 0 0.002647236455231905
the O 0 0.002009287942200899
fathers O 0 0.016023380681872368
of O 0 0.001133532845415175
the O 0 0.003586024511605501
reported O 0 0.03783537819981575
congenitally O 1 0.999991774559021
affected O 1 0.9806870818138123
children O 0 0.01341291330754757
showed O 0 0.008458790369331837
, O 0 0.001061230548657477
on O 0 0.0015311838360503316
average O 0 0.007098434027284384
, O 0 0.0020173387601971626
shorter O 0 0.04100656509399414
CTG O 1 0.9996529817581177
repeat O 0 0.09402491897344589
lengths O 0 0.026376837864518166
and O 0 0.0014397632330656052
hence O 0 0.013437151908874512
less O 0 0.013229786418378353
severe O 1 1.0
clinical O 1 0.999990701675415
symptoms O 1 1.0
than O 0 0.0022966531105339527
the O 0 0.0025125087704509497
mothers O 0 0.19524139165878296
of O 0 0.0013924004742875695
children O 0 0.024525754153728485
with O 0 0.01060011237859726
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.011705083772540092

We O 0 0.002592337317764759
conclude O 0 0.012504028156399727
that O 0 0.0019809354562312365
paternal O 1 0.994378387928009
transmission O 1 0.8231704235076904
of O 0 0.007563283666968346
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 0.006448914762586355
rare O 0 0.021499216556549072
and O 0 0.0013983206590637565
preferentially O 1 0.9264705181121826
occurs O 0 0.034271374344825745
with O 0 0.003111030673608184
onset O 1 0.9999998807907104
of O 0 0.008679136633872986
DM B-Disease 1 1.0
past O 0 0.012287394143640995
30 O 0 0.007001563906669617
years O 0 0.0022289359476417303
in O 0 0.0011216780403628945
the O 0 0.0029367120005190372
father O 0 0.058100104331970215
. O 0 0.0021215402521193027
. O 0 0.004394989460706711

The O 0 0.015846505761146545
RB1 O 1 0.9999992847442627
gene O 1 0.9997288584709167
mutation O 1 0.9999030828475952
in O 0 0.0019117010524496436
a O 0 0.0060671670362353325
child O 0 0.025688841938972473
with O 0 0.006843178067356348
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 0.999998927116394
. O 0 0.009702000766992569

The O 0 0.018131263554096222
RB1 O 1 0.9999994039535522
gene O 1 0.9998891353607178
mutation O 1 0.9999855756759644
was O 0 0.009890730492770672
investigated O 0 0.016634825617074966
in O 0 0.001049888669513166
a O 0 0.00575277442112565
child O 0 0.028432698920369148
with O 0 0.005824386607855558
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 0.9999904632568359
using O 0 0.00569418678060174
DNA O 0 0.025522436946630478
obtained O 0 0.0022419674787670374
from O 0 0.0012597530148923397
both O 0 0.0011217507999390364
the O 0 0.00418923981487751
pineal B-Disease 1 0.9999457597732544
and I-Disease 0 0.008020274341106415
retinal I-Disease 1 1.0
tumours I-Disease 1 1.0
of O 0 0.002441337099298835
the O 0 0.0047678267583251
patient O 1 0.9999629259109497
. O 0 0.005943034775555134

A O 0 0.026745539158582687
nonsense O 0 0.10907161235809326
mutation O 1 0.9997052550315857
in O 0 0.00472984416410327
exon O 1 0.9975503087043762
17 O 0 0.022516105324029922
( O 0 0.008364229463040829
codon O 1 0.7630624771118164
556 O 0 0.44195473194122314
) O 0 0.003047062549740076
of O 0 0.0010981177911162376
the O 0 0.007195340935140848
RB1 O 1 0.9999998807907104
gene O 1 0.9994389414787292
was O 0 0.007406529504805803
found O 0 0.0035096053034067154
to O 0 0.000786709482781589
be O 0 0.0011068517342209816
present O 0 0.0032885826658457518
homozygously O 1 0.9989342093467712
in O 0 0.0012512030079960823
both O 0 0.001021767035126686
the O 0 0.004439498297870159
retinal B-Disease 1 0.9999995231628418
and I-Disease 0 0.0019891737028956413
the I-Disease 0 0.0067788176238536835
pineal I-Disease 1 0.9999996423721313
tumours I-Disease 1 1.0
. O 0 0.010422330349683762

The O 0 0.005014978814870119
same O 0 0.00882900133728981
mutation O 1 0.9999891519546509
was O 0 0.007654326967895031
present O 0 0.004864951130002737
heterozygously O 1 0.998757004737854
in O 0 0.0014350010314956307
the O 0 0.002443011151626706
DNA O 0 0.027944345027208328
from O 0 0.001343087526038289
the O 0 0.001710200565867126
constitutional O 0 0.011309582740068436
cells O 0 0.02729180082678795
of O 0 0.0009545816574245691
the O 0 0.004936619196087122
patient O 1 0.9999992847442627
, O 0 0.0019231024198234081
proving O 0 0.018680673092603683
it O 0 0.001030423678457737
to O 0 0.0007546209963038564
be O 0 0.0011676701251417398
of O 0 0.002462471602484584
germline O 1 0.9996508359909058
origin O 0 0.014138542115688324
. O 0 0.00472409650683403

The O 0 0.00651953648775816
initial O 0 0.049635812640190125
mutation O 1 0.9999812841415405
was O 0 0.007831968367099762
shown O 0 0.004534456878900528
to O 0 0.0007900568307377398
have O 0 0.001393428654409945
occurred O 0 0.012579428032040596
in O 0 0.0010497085750102997
the O 0 0.003736731596291065
paternally O 1 0.999461829662323
derived O 0 0.05692630261182785
RB1 O 1 0.9999996423721313
allele O 1 0.9999648332595825
. O 0 0.008619552478194237

The O 0 0.015847131609916687
mutation O 1 0.9999939203262329
is O 0 0.003476498881354928
in O 0 0.0010429760441184044
an O 0 0.0014767542015761137
area O 0 0.0043557328172028065
of O 0 0.0009259290527552366
the O 0 0.0039094798266887665
gene O 1 0.9987242817878723
that O 0 0.001972155412659049
encodes O 0 0.09199564903974533
the O 0 0.0044531505554914474
protein O 0 0.07667262107133865
- O 0 0.020652150735259056
binding O 0 0.018405182287096977
region O 0 0.010310460813343525
known O 0 0.007708322256803513
as O 0 0.0017524041468277574
the O 0 0.00320055871270597
pocket O 1 0.9791107773780823
region O 0 0.009862853214144707
and O 0 0.0010868085082620382
has O 0 0.0031842796597629786
been O 0 0.0050146146677434444
detected O 0 0.07085759937763214
in O 0 0.0009585716761648655
other O 0 0.0007615097565576434
cases O 0 0.008000052534043789
of O 0 0.003858113195747137
retinoblastoma B-Disease 1 0.9999998807907104
. O 0 0.003675231710076332
. O 0 0.003928786609321833

Low O 0 0.03842201456427574
levels O 0 0.013048659078776836
of O 0 0.0024716942571103573
beta O 0 0.09555011987686157
hexosaminidase O 1 0.9982801675796509
A O 0 0.01222321204841137
in O 0 0.0021285689435899258
healthy O 1 0.7635635137557983
individuals O 0 0.00429700268432498
with O 0 0.002778703114017844
apparent O 1 0.9998584985733032
deficiency O 1 1.0
of O 0 0.001997701358050108
this O 0 0.003436669474467635
enzyme O 1 0.8814056515693665
. O 0 0.0059617976658046246

Appreciable O 0 0.22270838916301727
beta O 0 0.14377176761627197
hexosaminidase O 1 0.9945656061172485
A O 0 0.02021251991391182
( O 0 0.005568457301706076
hex O 1 0.725596010684967
A O 0 0.016905304044485092
) O 0 0.002730817534029484
activity O 0 0.006199132651090622
has O 0 0.0026339327450841665
been O 0 0.004253104329109192
detected O 0 0.0481199286878109
in O 0 0.002867087721824646
cultured O 1 0.9978347420692444
skin O 1 1.0
fibroblasts O 1 0.9999967813491821
and O 0 0.011930030770599842
melanoma B-Disease 1 1.0
tissue O 1 0.9999988079071045
from O 0 0.00508622033521533
healthy O 1 0.9848225116729736
individuals O 0 0.003657145192846656
previously O 0 0.004090827889740467
reported O 0 0.008485615253448486
as O 0 0.0021324828267097473
having O 0 0.026315126568078995
deficiency B-Disease 1 1.0
of I-Disease 0 0.0021414044313132763
hex I-Disease 1 0.9654626846313477
A I-Disease 0 0.011892755515873432
activity O 0 0.010604244656860828
indistinguishable O 0 0.03954086825251579
from O 0 0.0011891111498698592
that O 0 0.0005981446010991931
of O 0 0.0013212064513936639
patients O 1 0.9999991655349731
with O 0 0.006509305909276009
Tay B-Disease 1 1.0
- I-Disease 1 0.9999889135360718
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.024214988574385643
TSD B-Disease 1 1.0
) O 0 0.006769462488591671
. O 0 0.00446312315762043

Identification O 0 0.02220105566084385
and O 0 0.002330674324184656
quantitation O 1 0.7850977778434753
of O 0 0.0032965384889394045
hex O 0 0.47733402252197266
A O 0 0.0154352355748415
, O 0 0.002129683271050453
amounting O 0 0.029469218105077744
to O 0 0.002482001669704914
3 O 0 0.011857366189360619
. O 0 0.004234880208969116

5 O 0 0.025205422192811966
% O 0 0.009105079807341099
- O 0 0.026342129334807396
6 O 0 0.018803777173161507
. O 0 0.005438622552901506

9 O 0 0.02037203498184681
% O 0 0.0033970046788454056
of O 0 0.0011737645836547017
total O 0 0.007055485155433416
beta O 0 0.13308437168598175
hexosaminidase O 1 0.998714804649353
activity O 0 0.018179070204496384
, O 0 0.0015176746528595686
has O 0 0.0022740880958735943
been O 0 0.0028337498661130667
obtained O 0 0.0031613262835890055
by O 0 0.004952114541083574
cellulose O 0 0.14166617393493652
acetate O 0 0.1779744029045105
gel O 1 0.9243865013122559
electrophoresis O 0 0.20722955465316772
, O 0 0.0059521496295928955
DEAE O 1 0.9998006224632263
- O 0 0.05322021245956421
cellulose O 0 0.15924277901649475
ion O 0 0.12358580529689789
- O 0 0.023149767890572548
exchange O 0 0.010109766386449337
chromatography O 0 0.07299795001745224
, O 0 0.0050431955605745316
radial O 1 0.998630940914154
immunodiffusion O 1 0.9998064637184143
, O 0 0.0020738246385008097
and O 0 0.0022083751391619444
radioimmunoassay O 1 0.9997896552085876
. O 0 0.006812043488025665

Previous O 0 0.017627133056521416
family O 0 0.01521201804280281
studies O 0 0.005283589009195566
suggested O 0 0.0051184287294745445
that O 0 0.0008520050905644894
these O 0 0.00081786816008389
individuals O 0 0.004046343732625246
may O 0 0.006737314164638519
be O 0 0.002377924509346485
compound O 0 0.0347321480512619
heterozygotes O 1 0.9889270067214966
for O 0 0.0018905767938122153
the O 0 0.003316415473818779
common O 0 0.0227148849517107
mutant O 1 0.9999686479568481
TSD B-Disease 1 0.9999984502792358
gene O 1 0.9991527795791626
and O 0 0.0021825109142810106
a O 0 0.007719738874584436
rare O 0 0.02878698520362377
( O 0 0.007772166281938553
allelic O 1 0.9998434782028198
) O 0 0.011363261379301548
mutant O 1 0.9999306201934814
gene O 1 0.9967369437217712
. O 0 0.007489050272852182

Thus O 0 0.010028509423136711
, O 0 0.0013151104794815183
the O 0 0.002602997934445739
postulated O 0 0.10032214969396591
rate O 0 0.028139356523752213
mutant O 1 0.9996936321258545
gene O 1 0.9979204535484314
appears O 0 0.019042273983359337
to O 0 0.0013315958203747869
code O 0 0.005028249230235815
for O 0 0.0008072158670984209
the O 0 0.0017626389162614942
expression O 0 0.015434026718139648
of O 0 0.0012090039672330022
low O 0 0.013777211308479309
amounts O 0 0.006023019086569548
of O 0 0.0018882083240896463
hex O 1 0.5629041194915771
A O 0 0.020070381462574005
. O 0 0.006067886017262936

Heterozygotes O 1 0.9897835850715637
for O 0 0.0026786825619637966
the O 0 0.003531527239829302
rare O 0 0.057340677827596664
mutant O 1 0.9999806880950928
may O 0 0.009552432224154472
be O 0 0.002457704395055771
indistinguishable O 0 0.04466180503368378
from O 0 0.004841017536818981
heterozygotes O 1 0.9990597367286682
for O 0 0.0013471144484356046
the O 0 0.0031758600380271673
common O 0 0.027086200192570686
TSD B-Disease 1 0.9999995231628418
mutant O 1 0.9999520778656006
. O 0 0.007049745414406061

However O 0 0.006201447919011116
, O 0 0.0012686917325481772
direct O 0 0.0064856261014938354
visualization O 0 0.03651518374681473
and O 0 0.0020073861815035343
quantitation O 1 0.9810786247253418
of O 0 0.002227082848548889
hex O 1 0.7152965068817139
A O 0 0.009595467709004879
by O 0 0.0016130058793351054
the O 0 0.0016068759141489863
methods O 0 0.004355187062174082
described O 0 0.009589822962880135
may O 0 0.008007281459867954
prevent O 0 0.021129511296749115
false O 0 0.00781905185431242
- O 0 0.026465024799108505
positive O 0 0.04377099126577377
prenatal O 1 0.9999947547912598
diagnosis O 1 0.9999909400939941
of O 0 0.005121782422065735
TSD B-Disease 1 0.9999996423721313
in O 0 0.0048270635306835175
fetuses O 1 0.9999390840530396
having O 0 0.004973399452865124
the O 0 0.002230982296168804
incomplete O 0 0.01629495620727539
hex B-Disease 1 0.9669394493103027
A I-Disease 0 0.10274948179721832
deficiency I-Disease 1 1.0
of O 0 0.001773180440068245
the O 0 0.0036013589706271887
type O 0 0.07987367361783981
described O 0 0.006511677987873554
in O 0 0.000874241057317704
the O 0 0.0017888646107167006
four O 0 0.003821984864771366
healthy O 1 0.885076642036438
individuals O 0 0.01697499491274357

The O 0 0.016408326104283333
tumor B-Disease 1 1.0
suppressor O 1 0.9999998807907104
gene O 1 0.9999030828475952
Smad4 O 1 0.9999486207962036
/ O 1 0.9906368851661682
Dpc4 O 1 0.9997736811637878
is O 0 0.003425050061196089
required O 0 0.0029272078536450863
for O 0 0.0023850572761148214
gastrulation O 1 0.9984411597251892
and O 0 0.0019301542779430747
later O 0 0.004472643602639437
for O 0 0.00287961820140481
anterior O 1 0.9999797344207764
development O 0 0.0025783716700971127
of O 0 0.0013638318050652742
the O 0 0.005852409638464451
mouse O 1 0.9999904632568359
embryo O 1 0.9815375804901123
. O 0 0.006429269444197416

Mutations O 1 0.9936890602111816
in O 0 0.001929457182995975
the O 0 0.004262825008481741
SMAD4 O 1 0.9999991655349731
/ O 1 0.9987321496009827
DPC4 O 1 0.9999998807907104
tumor B-Disease 1 1.0
suppressor O 1 0.9999997615814209
gene O 1 0.9983545541763306
, O 0 0.0015038822311908007
a O 0 0.003741239430382848
key O 0 0.007498334627598524
signal O 0 0.03785630688071251
transducer O 0 0.26268208026885986
in O 0 0.002221522619947791
most O 0 0.004907631315290928
TGFbeta O 1 0.9999501705169678
- O 0 0.0356682650744915
related O 0 0.015921177342534065
pathways O 1 0.7450920343399048
, O 0 0.001630608574487269
are O 0 0.0007351295789703727
involved O 0 0.00555994501337409
in O 0 0.001338488538749516
50 O 0 0.005919626913964748
% O 0 0.004230076912790537
of O 0 0.005302566569298506
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.007990598678588867

Homozygous O 1 0.9997827410697937
Smad4 O 1 0.9999275207519531
mutant O 1 0.999969482421875
mice O 1 0.9999799728393555
die O 1 0.993969202041626
before O 0 0.005628332495689392
day O 0 0.007797908969223499
7 O 0 0.016463996842503548
. O 0 0.004418166354298592

5 O 0 0.015119434334337711
of O 0 0.004163190722465515
embryogenesis O 1 0.9763895869255066
. O 0 0.007962371222674847

Mutant O 1 0.9987258315086365
embryos O 0 0.03983358293771744
have O 0 0.0035915523767471313
reduced O 0 0.022855566814541817
size O 0 0.00658102473244071
, O 0 0.001746089430525899
fail O 0 0.029381217435002327
to O 0 0.002640816383063793
gastrulate O 1 0.9994279742240906
or O 0 0.0051887379959225655
express O 0 0.01923634298145771
a O 0 0.011301705613732338
mesodermal O 1 0.9974798560142517
marker O 0 0.11089153587818146
, O 0 0.0016158418729901314
and O 0 0.001164877787232399
show O 0 0.011707008816301823
abnormal O 1 0.9992998838424683
visceral O 1 0.9993539452552795
endoderm O 1 0.9913254380226135
development O 0 0.007384361699223518
. O 0 0.004672215785831213

Growth B-Disease 0 0.06616498529911041
retardation I-Disease 1 0.9999923706054688
of O 0 0.0014967821771278977
the O 0 0.004110389854758978
Smad4 O 1 0.999996542930603
- O 0 0.3307900130748749
deficient O 1 0.9998107552528381
embryos O 0 0.026037953794002533
results O 0 0.006623525638133287
from O 0 0.0027574782725423574
reduced O 0 0.029674025252461433
cell O 0 0.047673121094703674
proliferation O 0 0.024536870419979095
rather O 0 0.0026795759331434965
than O 0 0.0027934096287935972
increased O 0 0.0257998276501894
apoptosis O 1 0.9990436434745789
. O 0 0.006523738615214825

Aggregation O 0 0.10670215636491776
of O 0 0.0041566998697817326
mutant O 1 0.9993588328361511
Smad4 O 1 0.9998356103897095
ES O 1 0.9990612864494324
cells O 0 0.05219395086169243
with O 0 0.0024535285774618387
wild O 0 0.028598720207810402
- O 0 0.03357371687889099
type O 0 0.13874082267284393
tetraploid O 1 0.9960145950317383
morulae O 1 0.9967831373214722
rescues O 1 0.9071096181869507
the O 0 0.012340633198618889
gastrulation B-Disease 1 0.9999374151229858
defect I-Disease 1 0.9998337030410767
. O 0 0.007309044245630503

These O 0 0.00234913919121027
results O 0 0.007424080278724432
indicate O 0 0.009553915821015835
that O 0 0.0021576557774096727
Smad4 O 1 0.9993557333946228
is O 0 0.003925382625311613
initially O 0 0.007676099427044392
required O 0 0.0023161505814641714
for O 0 0.0008271572878584266
the O 0 0.002275007776916027
differentiation O 0 0.053487565368413925
of O 0 0.00111896893940866
the O 0 0.0046013533137738705
visceral O 1 0.9999933242797852
endoderm O 1 0.9992557168006897
and O 0 0.001158631988801062
that O 0 0.001025563571602106
the O 0 0.004580995533615351
gastrulation B-Disease 1 0.9999406337738037
defect I-Disease 1 0.9982737302780151
in O 0 0.002126747742295265
the O 0 0.004786455072462559
epiblast O 1 0.9999107122421265
is O 0 0.0051197633147239685
secondary O 0 0.0248996764421463
and O 0 0.0013780106091871858
non O 0 0.011782760731875896
- O 0 0.0251290425658226
cell O 0 0.04656495153903961
autonomous O 0 0.012938766740262508
. O 0 0.004571042489260435

Rescued O 1 0.8604335784912109
embryos O 0 0.05361558496952057
show O 0 0.028114134445786476
severe O 1 0.9999992847442627
anterior O 1 0.9999982118606567
truncations O 1 0.9995877146720886
, O 0 0.0027727223932743073
indicating O 0 0.012814155779778957
a O 0 0.0035832736175507307
second O 0 0.00478727463632822
important O 0 0.002160902600735426
role O 0 0.006669247057288885
for O 0 0.0024423457216471434
Smad4 O 1 0.9998086094856262
in O 0 0.007818426005542278
anterior O 1 0.9999915361404419
patterning O 1 0.9976577758789062
during O 0 0.025520799681544304
embryogenesis O 1 0.992024302482605
. O 0 0.006354245822876692

Prevalence O 1 0.9967027306556702
of O 0 0.004778727423399687
p16 O 1 0.9999017715454102
and O 0 0.005239072721451521
CDK4 O 1 0.9999990463256836
germline O 1 0.9999933242797852
mutations O 1 0.9997009038925171
in O 0 0.004001275636255741
48 O 1 0.5720622539520264
melanoma B-Disease 1 1.0
- O 1 0.7759004235267639
prone O 1 0.9998903274536133
families O 0 0.0075467657297849655
in O 0 0.0016978000057861209
France O 0 0.017905760556459427
. O 0 0.004967208486050367

The O 0 0.009987921454012394
French O 1 0.9589047431945801
Familial B-Disease 1 1.0
Melanoma I-Disease 1 1.0
Study O 0 0.01545950397849083
Group O 0 0.009862272068858147
. O 0 0.004858904518187046

Germline O 1 0.9997350573539734
mutations O 1 0.9981959462165833
in O 0 0.002464698161929846
the O 0 0.004518380854278803
p16 O 1 0.9998078942298889
and O 0 0.004871840123087168
CDK4 O 1 0.9999966621398926
genes O 1 0.6109330654144287
have O 0 0.0022503789514303207
been O 0 0.003252398455515504
reported O 0 0.007924397476017475
in O 0 0.001015379442833364
a O 0 0.005134264472872019
subset O 0 0.05043620616197586
of O 0 0.005453150253742933
melanoma B-Disease 1 1.0
pedigrees O 1 0.9995618462562561
, O 0 0.0019516475731506944
but O 0 0.001406288705766201
their O 0 0.002258286578580737
prevalence O 1 0.999858021736145
is O 0 0.0029636570252478123
not O 0 0.0010841562179848552
well O 0 0.0020451496820896864
known O 0 0.00956924632191658
. O 0 0.003988624084740877

We O 0 0.003450790187343955
searched O 0 0.013214267790317535
for O 0 0.0012394092045724392
such O 0 0.0026715619023889303
germline O 1 0.9999076128005981
mutations O 1 0.9993029832839966
in O 0 0.002367396140471101
48 O 0 0.020670713856816292
French O 1 0.9966513514518738
melanoma B-Disease 1 1.0
- O 1 0.9041169881820679
prone O 1 0.9997774958610535
families O 0 0.008213697001338005
selected O 0 0.004229691345244646
according O 0 0.0011439331574365497
to O 0 0.0006964221247471869
two O 0 0.0010625943541526794
major O 0 0.008367501199245453
criteria O 0 0.008443267084658146
families O 0 0.0050861043855547905
with O 0 0.0012192043941468
at O 0 0.0031427955254912376
least O 0 0.005593717563897371
three O 0 0.002476308261975646
affected O 0 0.08788085728883743
members O 0 0.004180008079856634
( O 0 0.007402579765766859
n O 0 0.05720451846718788
= O 0 0.04605013504624367
20 O 0 0.009492107667028904
) O 0 0.0034161489456892014
or O 0 0.002806838368996978
families O 0 0.004549714736640453
with O 0 0.001247511012479663
two O 0 0.002092232694849372
affected O 1 0.5654311180114746
members O 0 0.002428875071927905
, O 0 0.0011935350485146046
one O 0 0.0015111558604985476
of O 0 0.0010549436556175351
them O 0 0.001883713761344552
affected O 0 0.04917221888899803
before O 0 0.003203971078619361
the O 0 0.0024063177406787872
age O 0 0.00827563926577568
of O 0 0.001734292134642601
50 O 0 0.010739066638052464
( O 0 0.006854257546365261
n O 0 0.05715765431523323
= O 0 0.048185840249061584
28 O 0 0.018233396112918854
) O 0 0.0027113184332847595
, O 0 0.0008469812455587089
and O 0 0.000656822812743485
one O 0 0.0019544032402336597
additional O 0 0.004944679327309132
minor O 1 0.9001354575157166
criterion O 0 0.0540301613509655
. O 0 0.004359609913080931

Sixteen O 0 0.037008900195360184
different O 0 0.0058479090221226215
p16 O 1 0.9999706745147705
germline O 1 0.999961256980896
mutations O 1 0.9998144507408142
were O 0 0.0029528725426644087
found O 0 0.004036539699882269
in O 0 0.0015521359164267778
21 O 0 0.011196593753993511
families O 0 0.005045753438025713
, O 0 0.0010705827735364437
while O 0 0.0023715610150247812
one O 0 0.006893972400575876
germline O 1 0.9999959468841553
mutation O 1 0.9999990463256836
, O 0 0.0035621265415102243
Arg24His O 1 0.9999635219573975
, O 0 0.0021472941152751446
was O 0 0.00754307396709919
detected O 0 0.0451962873339653
in O 0 0.0014281109906733036
the O 0 0.005419569555670023
CDK4 O 1 0.9999988079071045
gene O 1 0.999248206615448
. O 0 0.0072081866674125195

The O 0 0.005341565702110529
frequency O 0 0.027814311906695366
of O 0 0.004231105092912912
p16 O 1 0.9999353885650635
gene O 1 0.9997000694274902
mutation O 1 0.9998286962509155
in O 0 0.0020420104265213013
our O 0 0.003312146756798029
sample O 0 0.01655813679099083
( O 0 0.006325587630271912
44 O 0 0.0195136871188879
% O 0 0.005925384350121021
) O 0 0.0025027296505868435
is O 0 0.002002317225560546
among O 0 0.0020675843115895987
the O 0 0.002093303482979536
highest O 0 0.012934576719999313
rates O 0 0.016346583142876625
yet O 0 0.0056505766697227955
reported O 0 0.008322671055793762
and O 0 0.0011115389643236995
the O 0 0.0049302782863378525
CDK4 O 1 0.999996542930603
mutation O 1 0.9999338388442993
is O 0 0.00317232683300972
the O 0 0.001973753562197089
second O 0 0.01697356253862381
mutation O 1 0.9999816417694092
detected O 0 0.09558422863483429
in O 0 0.0017783289076760411
this O 0 0.004199824295938015
gene O 1 0.9953216910362244
worldwide O 0 0.03461684659123421
. O 0 0.006043467670679092

In O 0 0.0049387202598154545
summary O 0 0.018317045643925667
, O 0 0.0013707809848710895
our O 0 0.002246168674901128
results O 0 0.007663126103579998
show O 0 0.007728949189186096
frequent O 0 0.027868827804923058
involvement O 0 0.0157176461070776
of O 0 0.0011417934438213706
the O 0 0.005688420031219721
p16 O 1 0.9999949932098389
gene O 1 0.9998593330383301
in O 0 0.007380790542811155
familial B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 0 0.002336143748834729
confirm O 0 0.006002400536090136
the O 0 0.0014443465042859316
role O 0 0.004053959157317877
of O 0 0.0008289313409477472
the O 0 0.00412222184240818
CDK4 O 1 0.9999992847442627
gene O 1 0.9971948862075806
as O 0 0.0029023669194430113
a O 0 0.017365198582410812
melanoma B-Disease 1 1.0
- O 1 0.9861674904823303
predisposing O 1 0.9999982118606567
gene O 1 0.9996065497398376
. O 0 0.0030280668288469315
. O 0 0.003658695612102747

Progression O 1 0.9220474362373352
of O 0 0.006585533730685711
somatic O 1 0.9880802631378174
CTG O 1 0.9975416660308838
repeat O 0 0.08967909961938858
length O 0 0.016645409166812897
heterogeneity O 0 0.09073497354984283
in O 0 0.0015710957814007998
the O 0 0.003518882440403104
blood O 1 0.9975919723510742
cells O 0 0.06404393166303635
of O 0 0.009264922700822353
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 1.0
. O 0 0.008206269703805447

The O 0 0.006567589472979307
genetic O 0 0.0477977953851223
basis O 0 0.0032012443989515305
of O 0 0.006940258201211691
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.5552488565444946
DM B-Disease 1 1.0
) O 0 0.005102513357996941
is O 0 0.0017450024606660008
the O 0 0.0015176357701420784
expansion O 0 0.005984503775835037
of O 0 0.0010140718659386039
an O 0 0.0041941567324101925
unstable O 1 0.9997302889823914
CTG O 1 0.9998059868812561
repeat O 0 0.06370280683040619
in O 0 0.0016435525612905622
the O 0 0.0025649359449744225
34 O 0 0.01985982432961464
UTR O 0 0.2526617646217346
of O 0 0.0017270490061491728
the O 0 0.007825887762010098
DM B-Disease 1 1.0
protein O 0 0.3737184405326843
kinase O 1 0.9997581839561462
gene O 1 0.9645054936408997
on O 0 0.00611600698903203
chromosome O 1 0.999715268611908
19 O 0 0.023023027926683426
. O 0 0.004555026069283485

One O 0 0.0036080998834222555
of O 0 0.0010192920453846455
the O 0 0.001894907676614821
principal O 0 0.006427825428545475
features O 0 0.003163620363920927
of O 0 0.0010618637315928936
the O 0 0.009458855725824833
DM B-Disease 1 1.0
mutation O 1 0.9999982118606567
is O 0 0.0035417459439486265
an O 0 0.0023093114141374826
extraordinarily O 0 0.25925472378730774
high O 0 0.005200476851314306
level O 0 0.0036488547921180725
of O 0 0.003065565600991249
somatic O 1 0.9994776844978333
mosaicism O 1 0.999988317489624
, O 0 0.003276887582615018
due O 0 0.009140257723629475
to O 0 0.0011556200915947556
an O 0 0.002252335660159588
extremely O 0 0.016931889578700066
high O 0 0.005367042031139135
degree O 0 0.004015696235001087
of O 0 0.0024646429810673
somatic O 1 0.9995915293693542
instability O 1 0.9955476522445679
both O 0 0.0017583902226760983
within O 0 0.0018444026354700327
and O 0 0.0008408384746871889
between O 0 0.00216629053466022
different O 0 0.0027528153732419014
tissues O 1 0.9996044039726257
. O 0 0.006820142734795809

This O 0 0.006371940020471811
instability O 1 0.9944804906845093
appears O 0 0.018106449395418167
to O 0 0.001291719963774085
be O 0 0.0018972414545714855
biased O 0 0.0170284416526556
towards O 0 0.004653144162148237
further O 0 0.002920069731771946
expansion O 0 0.006954703480005264
and O 0 0.001254724687896669
continuous O 0 0.021062657237052917
throughout O 0 0.00390856945887208
the O 0 0.0019878677558153868
life O 0 0.004377118311822414
of O 0 0.0010849765967577696
an O 0 0.0018580828327685595
individual O 0 0.0034797927364706993
, O 0 0.0014802219811826944
features O 0 0.0037455435376614332
that O 0 0.0009387285099364817
could O 0 0.002443281002342701
be O 0 0.001455712947063148
associated O 0 0.004993681330233812
with O 0 0.0008891043835319579
the O 0 0.00212256726808846
progressive O 1 0.9907020330429077
nature O 0 0.004229089245200157
of O 0 0.0011191490339115262
the O 0 0.011602407321333885
disease O 1 1.0
. O 0 0.006329854018986225

Although O 0 0.009185323491692543
increasing O 0 0.013875648379325867
measured O 0 0.029812470078468323
allele O 1 0.9977808594703674
size O 0 0.012817038223147392
between O 0 0.0062968675047159195
patients O 1 0.9999759197235107
clearly O 0 0.009321401827037334
correlates O 0 0.07025324553251266
with O 0 0.0011632130481302738
an O 0 0.0019208394223824143
increased O 0 0.015490909107029438
severity O 1 0.9999059438705444
of O 0 0.005663910880684853
symptoms O 1 1.0
and O 0 0.0010397041914984584
an O 0 0.001529568457044661
earlier O 0 0.004370356909930706
age O 0 0.008145746774971485
of O 0 0.003137454856187105
onset O 1 1.0
, O 0 0.0021772212348878384
this O 0 0.001711969613097608
correlation O 0 0.02758491039276123
is O 0 0.001858887611888349
not O 0 0.0008901774999685585
precise O 0 0.004346364643424749
and O 0 0.0011010722955688834
measured O 0 0.025961708277463913
allele O 1 0.999922513961792
length O 0 0.01578531786799431
cannot O 0 0.003937764558941126
be O 0 0.0012660884531214833
used O 0 0.0013228843454271555
as O 0 0.0010301274014636874
an O 0 0.0013665661681443453
accurate O 0 0.007962740957736969
predictor O 1 0.9927661418914795
of O 0 0.0019318819977343082
age O 0 0.009214140474796295
of O 0 0.004509285558015108
onset O 1 1.0
. O 0 0.007771015167236328

In O 0 0.0023089302703738213
order O 0 0.0021672556176781654
to O 0 0.0009924537735059857
further O 0 0.003134646452963352
characterize O 0 0.02817719802260399
the O 0 0.0026410785503685474
dynamics O 0 0.025284284725785255
of O 0 0.005515733268111944
DM B-Disease 1 1.0
CTG O 1 0.9999698400497437
repeat O 1 0.9781903028488159
somatic O 1 0.9972279667854309
instability O 1 0.9897868633270264
, O 0 0.0017563701840117574
we O 0 0.0009905078914016485
have O 0 0.001295835361815989
studied O 0 0.005156755447387695
repeat O 0 0.05669363960623741
length O 0 0.008238467387855053
changes O 0 0.0036398773081600666
over O 0 0.001558623625896871
time O 0 0.0024786556605249643
in O 0 0.0035489914007484913
111 O 1 0.9997554421424866
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999996423721313
with O 0 0.0025913857389241457
varying O 0 0.010665207169950008
clinical O 1 0.9998836517333984
severity O 1 0.9999936819076538
and O 0 0.00363742932677269
CTG O 1 0.9999632835388184
repeat O 0 0.06728491187095642
size O 0 0.006507811136543751
over O 0 0.002356158569455147
time O 0 0.0031550456769764423
intervals O 0 0.015499129891395569
of O 0 0.0020980052649974823
1 O 0 0.017693502828478813
- O 0 0.02420169673860073
7 O 0 0.015635155141353607
years O 0 0.0046490952372550964
. O 0 0.0044204662553966045

We O 0 0.002747919876128435
have O 0 0.0015801979461684823
found O 0 0.0036971396766602993
a O 0 0.005187690258026123
direct O 0 0.011693240143358707
progression O 1 0.995194137096405
of O 0 0.0010885446099564433
the O 0 0.002114409115165472
size O 0 0.009435278363525867
heterogeneity O 1 0.7224496006965637
over O 0 0.002310153329744935
time O 0 0.0024859041441231966
related O 0 0.00497726583853364
to O 0 0.001879437710158527
initial O 0 0.031017666682600975
CTG O 1 0.9995883107185364
repeat O 0 0.07400685548782349
size O 0 0.006717794109135866
and O 0 0.0007305223844014108
the O 0 0.001834274735301733
time O 0 0.0040470510721206665
interval O 0 0.03040299005806446
and O 0 0.001251352485269308
always O 0 0.004757080227136612
biased O 0 0.02010229043662548
towards O 0 0.004327485803514719
further O 0 0.0035154467914253473
expansion O 0 0.013230476528406143
. O 0 0.004825488664209843

Attempts O 0 0.019115906208753586
to O 0 0.002310217125341296
mathematically O 0 0.027870751917362213
model O 0 0.006854682229459286
the O 0 0.0024371868930757046
dynamics O 0 0.022873155772686005
have O 0 0.0023219790309667587
proved O 0 0.014450697228312492
only O 0 0.003021209267899394
partially O 0 0.05302760750055313
successful O 0 0.01842426508665085
suggesting O 0 0.011980476789176464
that O 0 0.000938334153033793
individual O 0 0.0026192774530500174
specific O 0 0.0054472931660711765
genetic O 0 0.19195957481861115
and O 0 0.0027707074768841267
/ O 1 0.6212365627288818
or O 0 0.003361361101269722
environmental O 0 0.00865060742944479
factors O 0 0.008258051238954067
also O 0 0.0012172196293249726
play O 0 0.002176893875002861
a O 0 0.003933873027563095
role O 0 0.007784163113683462
in O 0 0.004074538592249155
somatic O 1 0.9992281198501587
mosaicism O 1 0.9999411106109619
. O 0 0.0040277098305523396
. O 0 0.003706784686073661

Aspartylglucosaminuria B-Disease 1 0.9998842477798462
among O 0 0.009385245852172375
Palestinian O 0 0.020695393905043602
Arabs O 0 0.027910921722650528
. O 0 0.007150279823690653

Aspartylglucosaminuria B-Disease 1 0.9999850988388062
( O 0 0.029006605967879295
AGU B-Disease 1 0.9999998807907104
) O 0 0.004790013190358877
is O 0 0.0030637765303254128
a O 0 0.007666291669011116
rare O 0 0.17974942922592163
disorder B-Disease 1 0.9999998807907104
of I-Disease 0 0.005285569000989199
glycoprotein I-Disease 1 0.9999867677688599
metabolism I-Disease 1 0.9999290704727173
caused O 1 0.9950868487358093
by O 0 0.0030544837936758995
the O 0 0.004173503257334232
deficiency B-Disease 1 1.0
of I-Disease 0 0.0015945762861520052
the I-Disease 0 0.005160217173397541
lysosomal I-Disease 1 0.9999991655349731
enzyme I-Disease 1 0.9983186721801758
aspartylglucosaminidase I-Disease 1 0.9998427629470825
( O 0 0.012983040884137154
AGA O 1 0.9994962215423584
) O 0 0.006681868806481361
. O 0 0.004948504269123077

AGU B-Disease 1 0.9999990463256836
is O 0 0.011880556121468544
inherited O 1 0.999660849571228
as O 0 0.0019997861236333847
an O 0 0.006841431837528944
autosomal O 1 1.0
recessive O 1 1.0
trait O 1 0.9999972581863403
and O 0 0.0018686826806515455
occurs O 0 0.030701447278261185
with O 0 0.000825658964458853
a O 0 0.003961299080401659
high O 0 0.005375494249165058
frequency O 0 0.02556517720222473
in O 0 0.0015087135834619403
Finland O 0 0.010887395590543747
because O 0 0.003051776671782136
of O 0 0.0012894485844299197
a O 0 0.00828921515494585
founder O 0 0.07462094724178314
effect O 0 0.024747416377067566
. O 0 0.0046830978244543076

While O 0 0.00530504435300827
very O 0 0.0039362916722893715
few O 0 0.006252477876842022
patients O 1 0.9999841451644897
with O 0 0.006163819693028927
AGU B-Disease 1 1.0
have O 0 0.003416955703869462
been O 0 0.003780544036999345
reported O 0 0.010082640685141087
from O 0 0.002798462752252817
non O 0 0.011621085926890373
- O 0 0.01915745623409748
Finnish O 0 0.029030732810497284
origin O 0 0.006556893233209848
, O 0 0.001609943457879126
we O 0 0.004294141195714474
diagnosed O 1 1.0
the O 0 0.011113815009593964
disorder O 1 1.0
in O 0 0.0033560870215296745
8 O 0 0.04085461050271988
patients O 1 0.9999964237213135
originating O 0 0.030301418155431747
from O 0 0.00414237892255187
3 O 0 0.014747155830264091
unrelated O 0 0.03403061255812645
families O 0 0.006535579450428486
, O 0 0.00111765053588897
all O 0 0.0009414922678843141
Palestinian O 0 0.011602374725043774
Arabs O 0 0.014208847656846046
from O 0 0.002037723083049059
the O 0 0.0022407672367990017
region O 0 0.007575541734695435
of O 0 0.0015842017019167542
Jerusalem O 0 0.01749792881309986
. O 0 0.005161042790859938

The O 0 0.00915490835905075
clinical O 1 0.9995232820510864
diagnosis O 1 0.9999978542327881
of O 0 0.007758139166980982
AGU B-Disease 1 1.0
is O 0 0.007504778448492289
often O 0 0.004230581223964691
difficult O 0 0.005940455012023449
, O 0 0.0009458717540837824
in O 0 0.0009432003134861588
particular O 0 0.004367517307400703
early O 0 0.003972033970057964
in O 0 0.0009131690603680909
the O 0 0.0016858893213793635
course O 0 0.007228142581880093
of O 0 0.0014097945531830192
the O 0 0.00994843989610672
disease O 1 1.0
, O 0 0.0015476098051294684
and O 0 0.0006389584741555154
most O 0 0.0013510403223335743
of O 0 0.0010127781424671412
the O 0 0.006547304801642895
patients O 1 1.0
are O 0 0.005166530143469572
diagnosed O 1 1.0
after O 0 0.010841849260032177
the O 0 0.002642788691446185
age O 0 0.007938298396766186
of O 0 0.0015058295102789998
5 O 0 0.010196293704211712
years O 0 0.004716566763818264
. O 0 0.004150650463998318

However O 0 0.00646888418123126
, O 0 0.0013630513567477465
since O 0 0.005439822096377611
these O 0 0.0025915757287293673
patients O 1 0.999994158744812
excrete O 1 0.9991554021835327
early O 0 0.009274156764149666
large O 0 0.0031819376163184643
amounts O 0 0.0057412972673773766
of O 0 0.0021064418833702803
aspartylglucosamine O 1 0.9996449947357178
in O 0 0.003316814312711358
urine O 1 0.8607804775238037
, O 0 0.0030852642375975847
biochemical O 0 0.07128432393074036
screening O 0 0.051156628876924515
is O 0 0.0028993533924221992
easy O 0 0.006315609440207481
by O 0 0.004805319476872683
urine O 1 0.6413219571113586
chromatography O 0 0.06796229630708694
. O 0 0.0032729189842939377
. O 0 0.0041694738902151585

Detection O 0 0.05749746412038803
of O 0 0.003856874769553542
heterozygous O 1 0.9999228715896606
carriers O 0 0.05779222398996353
of O 0 0.0013074526796117425
the O 0 0.006602947600185871
ataxia B-Disease 1 1.0
- I-Disease 1 0.9992337226867676
telangiectasia I-Disease 1 1.0
( O 0 0.010298055596649647
ATM O 1 0.9858916401863098
) O 0 0.005451994016766548
gene O 1 0.9936779141426086
by O 0 0.0058924173936247826
G2 O 1 0.9999629259109497
phase O 0 0.08620421588420868
chromosomal O 1 0.9999079704284668
radiosensitivity O 1 0.9983322024345398
of O 0 0.005195158533751965
peripheral O 1 0.9999998807907104
blood O 1 0.9999977350234985
lymphocytes O 1 0.9999923706054688
. O 0 0.00869582500308752

In O 0 0.010904671624302864
ataxia B-Disease 1 1.0
- I-Disease 1 0.984653651714325
telangiectasia I-Disease 1 1.0
( O 0 0.010798112489283085
A B-Disease 1 0.9989266991615295
- I-Disease 1 0.9973466396331787
T I-Disease 1 0.9999998807907104
) O 0 0.01091378927230835
patients O 1 0.9999974966049194
, O 0 0.003229009686037898
mutations O 1 0.9998524188995361
in O 0 0.0009798798710107803
a O 0 0.005980372428894043
single O 0 0.02209911122918129
gene O 1 0.999461829662323
, O 0 0.002977452240884304
ATM O 1 0.8923680782318115
, O 0 0.0014532197965309024
result O 0 0.005407004617154598
in O 0 0.0012665764661505818
an O 0 0.011724615469574928
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 0.0033398515079170465
embraces O 0 0.1642213761806488
a O 0 0.003816940588876605
variety O 0 0.0030879739206284285
of O 0 0.0013409823877736926
clinical O 1 0.9951058626174927
features O 0 0.004509566351771355
and O 0 0.0016828911611810327
manifests O 1 0.9973437190055847
extreme O 1 0.9421249628067017
radiosensitivity O 1 0.9997844099998474
and O 0 0.001411022269167006
a O 0 0.004527956712990999
strong O 0 0.007691929582506418
pre O 0 0.052490681409835815
- O 0 0.03336673974990845
disposition O 1 0.8811637759208679
to O 0 0.005478409584611654
malignancy B-Disease 1 0.9999972581863403
. O 0 0.007160489447414875

Heterozygotes O 1 0.9872057437896729
for O 0 0.0022395444102585316
the O 0 0.004389514215290546
ATM O 1 0.992852509021759
gene O 1 0.9960983991622925
have O 0 0.002106268424540758
no O 0 0.0025212166365236044
clinical O 0 0.2631698548793793
expression O 0 0.0127967344596982
of O 0 0.0014572858344763517
A B-Disease 1 0.9980474710464478
- I-Disease 1 0.966891884803772
T I-Disease 1 0.9999986886978149
but O 0 0.003066957462579012
may O 0 0.009745136834681034
be O 0 0.006305843126028776
cancer B-Disease 1 1.0
prone O 1 0.9999392032623291
with O 0 0.0019038536120206118
a O 0 0.006051378324627876
moderate O 0 0.024661948904395103
increase O 0 0.004907594062387943
in O 0 0.0013569359434768558
in O 0 0.0031559139024466276
vitro O 1 0.8295401930809021
radiosensitivity O 1 0.9992609620094299
. O 0 0.005562890786677599

We O 0 0.004173734690994024
performed O 0 0.011007526889443398
a O 0 0.009330873377621174
blind O 1 0.9937352538108826
chromosomal O 1 0.9975680708885193
analysis O 0 0.0072440640069544315
on O 0 0.0038757959846407175
G2 O 1 0.9999659061431885
- O 0 0.04715139418840408
phase O 0 0.07995764911174774
lymphocytes O 1 0.9955638647079468
from O 0 0.004831124562770128
7 O 0 0.012917176820337772
unrelated O 0 0.0360974445939064
A B-Disease 1 0.9882192611694336
- I-Disease 1 0.9967554211616516
T I-Disease 1 0.9999998807907104
patients O 1 0.9999942779541016
, O 0 0.0016318951966241002
13 O 0 0.008488846011459827
obligate O 1 0.9956939220428467
A B-Disease 1 0.9952340722084045
- I-Disease 1 0.9914634823799133
T I-Disease 1 0.9999997615814209
heterozygotes O 1 0.9999871253967285
( O 0 0.006002605427056551
parents O 0 0.00928118359297514
of O 0 0.001301260432228446
the O 0 0.007216408383101225
patients O 1 0.9999996423721313
) O 0 0.003122393973171711
, O 0 0.0008342220680788159
and O 0 0.0008344331872649491
14 O 0 0.007729764562100172
normal O 0 0.01730354130268097
controls O 0 0.02219039760529995
following O 0 0.01605481281876564
X O 1 0.9921687245368958
- O 0 0.03150937706232071
irradiation O 1 0.7419501543045044
with O 0 0.002655718009918928
1 O 0 0.016696326434612274
Gy O 1 0.9904595613479614
in O 0 0.0019292046781629324
order O 0 0.002443021861836314
to O 0 0.001385380164720118
evaluate O 0 0.018907977268099785
this O 0 0.0040009887889027596
cytogenetic O 1 0.9858971238136292
method O 0 0.008667496033012867
as O 0 0.0016860178438946605
a O 0 0.003947892226278782
tool O 0 0.012168553657829762
for O 0 0.0017550920601934195
detection O 0 0.041783012449741364
of O 0 0.0029807621613144875
ATM O 1 0.9990460276603699
carriers O 0 0.49383988976478577
. O 0 0.006863371469080448

Both O 0 0.004436820279806852
A B-Disease 1 0.5769398808479309
- I-Disease 1 0.8946097493171692
T I-Disease 1 0.9999988079071045
homozygotes O 1 0.999931812286377
and O 0 0.0037313569337129593
heterozygotes O 1 0.9998551607131958
showed O 0 0.012906942516565323
significantly O 0 0.020213967189192772
increased O 0 0.008534245193004608
levels O 0 0.008742867037653923
of O 0 0.002074827440083027
radiation O 1 0.9989976286888123
- O 0 0.12937664985656738
induced O 1 0.9999821186065674
chromatid O 1 0.9999879598617554
damage O 1 0.938373327255249
relative O 0 0.01054833922535181
to O 0 0.0008914524223655462
that O 0 0.0005970417405478656
of O 0 0.0010353708639740944
normal O 0 0.02298804372549057
controls O 0 0.028356315568089485
. O 0 0.005539641249924898

These O 0 0.00199956726282835
results O 0 0.005560944322496653
show O 0 0.004031759686768055
that O 0 0.00087117770453915
the O 0 0.004548146855086088
G2 O 1 0.999993085861206
- O 0 0.05194813385605812
phase O 0 0.08965681493282318
chromosomal O 1 0.9999797344207764
radiosensitivity O 1 0.9996501207351685
assay O 0 0.18810884654521942
can O 0 0.0027433878276497126
be O 0 0.0009338336531072855
used O 0 0.000769604230299592
for O 0 0.0006498117581941187
the O 0 0.0014917232329025865
detection O 0 0.02677197940647602
of O 0 0.0017233513062819839
A B-Disease 1 0.9987823367118835
- I-Disease 1 0.995975911617279
T I-Disease 1 0.9999974966049194
heterozygotes O 1 0.9997240900993347
. O 0 0.008290030062198639

In O 0 0.004736919887363911
combination O 0 0.029647815972566605
with O 0 0.0026519340462982655
molecular O 0 0.039679866284132004
genetic O 0 0.08740461617708206
analyses O 0 0.00835904199630022
, O 0 0.0010483304504305124
this O 0 0.0015063595492392778
test O 0 0.011747672222554684
may O 0 0.005703597329556942
be O 0 0.0008749651606194675
of O 0 0.0006792765343561769
value O 0 0.0017956593073904514
in O 0 0.000896118872333318
studies O 0 0.002860774751752615
of O 0 0.002230691723525524
familial B-Disease 1 0.9999998807907104
and I-Disease 0 0.004385598003864288
sporadic I-Disease 1 0.9998621940612793
cancers I-Disease 1 0.9999998807907104
aimed O 0 0.01074538566172123
at O 0 0.0031359985005110502
determination O 0 0.008337272331118584
of O 0 0.0007115720654837787
the O 0 0.0013416344299912453
potential O 0 0.00873471237719059
involvement O 0 0.016918163746595383
of O 0 0.0024417778477072716
ATM O 1 0.9999040365219116
mutations O 1 0.9999960660934448
in O 0 0.00812991987913847
tumor B-Disease 1 1.0
risk O 1 0.9994375109672546
or O 0 0.0036426554434001446
development O 0 0.0026535361539572477
. O 0 0.001889836392365396
. O 0 0.003952704835683107

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9823696613311768
telangiectasia I-Disease 1 0.9999998807907104
: O 0 0.006718882825225592
identification O 0 0.009740973822772503
and O 0 0.0011627337662503123
detection O 0 0.025972673669457436
of O 0 0.0013801796594634652
founder O 0 0.1717539131641388
- O 0 0.029073510318994522
effect O 0 0.031129127368330956
mutations O 1 0.99899822473526
in O 0 0.001843862235546112
the O 0 0.004454046953469515
ATM O 1 0.9987959861755371
gene O 1 0.976811945438385
in O 0 0.002499593421816826
ethnic O 0 0.009802150540053844
populations O 0 0.043491385877132416
. O 0 0.004809725098311901

To O 0 0.002719525946304202
facilitate O 0 0.006330793257802725
the O 0 0.0016286944737657905
evaluation O 0 0.01376686803996563
of O 0 0.0020504137501120567
ATM O 1 0.9983610510826111
heterozygotes O 1 0.9998186230659485
for O 0 0.004507092293351889
susceptibility O 1 0.999992847442627
to O 0 0.00211091386154294
other O 0 0.0028176361229270697
diseases O 1 1.0
, O 0 0.001178521546535194
such O 0 0.0013150481972843409
as O 0 0.021930428221821785
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.0017849912401288748
we O 0 0.0009568799287080765
have O 0 0.001119254040531814
attempted O 0 0.009264507330954075
to O 0 0.001169250113889575
define O 0 0.006619636435061693
the O 0 0.0021092542447149754
most O 0 0.0031087067909538746
common O 0 0.01839209720492363
mutations O 1 0.999954104423523
and O 0 0.000890421390067786
their O 0 0.0011220312444493175
frequencies O 0 0.021176299080252647
in O 0 0.004805196542292833
ataxia B-Disease 1 1.0
- I-Disease 1 0.9985626339912415
telangiectasia I-Disease 1 1.0
( O 0 0.010214654728770256
A B-Disease 1 0.9986131191253662
- I-Disease 1 0.9850083589553833
T I-Disease 1 0.9999982118606567
) O 0 0.008118761703372002
homozygotes O 1 0.9999029636383057
from O 0 0.003528184723109007
10 O 0 0.006772410124540329
ethnic O 0 0.011858300305902958
populations O 0 0.04976697638630867
. O 0 0.007004057057201862

Both O 0 0.010084081441164017
genomic O 1 0.914929211139679
mutations O 1 0.9996007084846497
and O 0 0.0014679372543469071
their O 0 0.001661299611441791
effects O 0 0.03269769623875618
on O 0 0.0024266010150313377
cDNA O 0 0.11483334749937057
were O 0 0.004044649191200733
characterized O 0 0.05627170577645302
. O 0 0.005350874271243811

Protein O 0 0.16149812936782837
- O 0 0.050798606127500534
truncation O 1 0.9639558792114258
testing O 0 0.017232106998562813
of O 0 0.0010696438839659095
the O 0 0.002308664610609412
entire O 0 0.027513092383742332
ATM O 0 0.4445725679397583
cDNA O 0 0.21867232024669647
detected O 0 0.13321180641651154
92 O 0 0.08535221219062805
( O 0 0.007195941172540188
66 O 0 0.03709578141570091
% O 0 0.006983472034335136
) O 0 0.005832004360854626
truncating O 1 0.997256338596344
mutations O 1 0.9975787997245789
in O 0 0.0025185393169522285
140 O 0 0.0383036844432354
mutant O 1 0.999859094619751
alleles O 1 0.999816358089447
screened O 0 0.1062757819890976
. O 0 0.006081936415284872

The O 0 0.007774000987410545
haplotyping O 1 0.9979689717292786
of O 0 0.0036400845274329185
patients O 1 0.9999974966049194
with O 0 0.0023826381657272577
identical O 0 0.026565201580524445
mutations O 1 0.9999982118606567
indicates O 0 0.014179709367454052
that O 0 0.0011241715401411057
almost O 0 0.0029691713862121105
all O 0 0.0006911391974426806
of O 0 0.0005918149836361408
these O 0 0.000675265328027308
represent O 0 0.0033983669709414244
common O 0 0.009540965780615807
ancestry O 0 0.033374905586242676
and O 0 0.0007629984756931663
that O 0 0.0007782821194268763
very O 0 0.002515393076464534
few O 0 0.0035205665044486523
spontaneously O 1 0.9983338713645935
recurring O 1 0.9999808073043823
ATM O 1 0.9995858073234558
mutations O 1 0.9998071789741516
exist O 0 0.006522947456687689
. O 0 0.004135837312787771

Assays O 0 0.1438659429550171
requiring O 0 0.02547868713736534
minimal O 0 0.028356725350022316
amounts O 0 0.008680945262312889
of O 0 0.002177146729081869
genomic O 1 0.949702262878418
DNA O 0 0.037133362144231796
were O 0 0.0014237466966733336
designed O 0 0.003296096809208393
to O 0 0.0012065735645592213
allow O 0 0.004363270942121744
rapid O 0 0.03829341009259224
screening O 0 0.04059459641575813
for O 0 0.001760386861860752
common O 0 0.009774562902748585
ethnic O 0 0.015659870579838753
mutations O 1 0.9999587535858154
. O 0 0.007303292863070965

These O 0 0.0031734127551317215
rapid O 0 0.05454205349087715
assays O 0 0.15613634884357452
detected O 0 0.34276795387268066
mutations O 1 0.9991222023963928
in O 0 0.002869178308174014
76 O 0 0.04012078419327736
% O 0 0.004239897709339857
of O 0 0.001894504064694047
Costa O 0 0.06011104956269264
Rican O 1 0.9914714694023132
patients O 1 0.9999934434890747
( O 0 0.007360994815826416
3 O 0 0.012907015159726143
) O 0 0.0023759896866977215
, O 0 0.001164248213171959
50 O 0 0.004961818922311068
% O 0 0.002614676021039486
of O 0 0.0018243055092170835
Norwegian O 0 0.05064686760306358
patients O 1 0.9999935626983643
( O 0 0.007681622635573149
1 O 0 0.016288572922348976
) O 0 0.002774206455796957
, O 0 0.00130177428945899
25 O 0 0.005765284411609173
% O 0 0.003026871010661125
of O 0 0.0023407547269016504
Polish O 1 0.9776777625083923
patients O 1 0.9999995231628418
( O 0 0.009110839106142521
4 O 0 0.014037150889635086
) O 0 0.0029050465673208237
, O 0 0.0009666837868280709
and O 0 0.0009693427127785981
14 O 0 0.007553011644631624
% O 0 0.0028648448642343283
of O 0 0.00217052293010056
Italian O 1 0.7937836647033691
patients O 1 0.9999990463256836
( O 0 0.008174694143235683
1 O 0 0.01658060774207115
) O 0 0.002699622418731451
, O 0 0.0008181437151506543
as O 0 0.0011821177322417498
well O 0 0.0011459733359515667
as O 0 0.0016133461613208055
in O 0 0.002513835672289133
patients O 1 0.9999586343765259
of O 0 0.0030301318038254976
Amish O 1 0.9922428727149963
/ O 1 0.8747060894966125
Mennonite O 0 0.08149710297584534
and O 0 0.0018542609177529812
Irish O 0 0.02714822255074978
English O 0 0.008638184517621994
backgrounds O 0 0.011155868880450726
. O 0 0.004552237689495087

Additional O 0 0.0264702457934618
mutations O 1 0.9990413784980774
were O 0 0.0028080481570214033
observed O 0 0.009980818256735802
in O 0 0.0018098095897585154
Japanese O 0 0.008460458368062973
, O 0 0.0019439973402768373
Utah O 0 0.025723803788423538
Mormon O 0 0.03087620437145233
, O 0 0.0014511661138385534
and O 0 0.001183755462989211
African O 0 0.018445413559675217
American O 0 0.023487655445933342
patients O 1 0.9999978542327881
. O 0 0.005965794902294874

These O 0 0.003076172899454832
assays O 0 0.05488692969083786
should O 0 0.0019293460063636303
facilitate O 0 0.008401593193411827
screening O 0 0.03559746593236923
for O 0 0.0023036364000290632
A B-Disease 1 0.5767667293548584
- I-Disease 1 0.7364441156387329
T I-Disease 1 0.9999938011169434
heterozygotes O 1 0.9991402626037598
in O 0 0.0018504769541323185
the O 0 0.0033608193043619394
populations O 0 0.03165202960371971
studied O 0 0.006721199955791235
. O 0 0.0023615628015249968
. O 0 0.0041005718521773815

The O 0 0.008886902593076229
von B-Disease 1 0.9574438333511353
Hippel I-Disease 1 0.9999921321868896
- I-Disease 1 0.9658687710762024
Lindau I-Disease 1 0.9999996423721313
tumor I-Disease 1 1.0
suppressor O 1 0.9999998807907104
gene O 1 0.9990078806877136
is O 0 0.002664721803739667
required O 0 0.0018381595145910978
for O 0 0.0016039516776800156
cell O 0 0.04184342920780182
cycle O 0 0.06218891963362694
exit O 0 0.055090516805648804
upon O 0 0.011492558754980564
serum O 1 0.9975085258483887
withdrawal O 0 0.07032962143421173
. O 0 0.007782981265336275

The O 0 0.008641055785119534
inactivation O 1 0.9990240335464478
of O 0 0.0018025829922407866
the O 0 0.004257262218743563
von B-Disease 1 0.9989176988601685
Hippel I-Disease 1 0.9999716281890869
- I-Disease 0 0.16208814084529877
Lindau I-Disease 1 0.9999691247940063
( I-Disease 0 0.017539629712700844
VHL I-Disease 1 0.9999997615814209
) I-Disease 0 0.01922623999416828
tumor I-Disease 1 1.0
suppressor O 1 0.9999998807907104
gene O 1 0.9999164342880249
predisposes O 1 0.9999814033508301
affected O 0 0.1443515419960022
individuals O 0 0.0022972780279815197
to O 0 0.00069414236349985
the O 0 0.0029770229011774063
human O 1 0.556795597076416
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.001865107100456953
is O 0 0.0020733647979795933
associated O 0 0.004691419657319784
with O 0 0.002096394542604685
sporadic B-Disease 1 0.9997881054878235
renal I-Disease 1 1.0
cell I-Disease 1 0.99989914894104
carcinomas I-Disease 1 1.0
( O 0 0.014756858348846436
RCC B-Disease 1 0.9999990463256836
) O 0 0.005053434055298567
and O 0 0.0033389420714229345
brain B-Disease 1 0.9999998807907104
hemangioblastomas I-Disease 1 0.9998944997787476
. O 0 0.006251686718314886

VHL O 1 0.9999648332595825
- O 0 0.0656401589512825
negative O 0 0.08215375244617462
786 O 1 0.9991292357444763
- O 0 0.0589851438999176
0 O 0 0.06808027625083923
RCC B-Disease 1 0.9999966621398926
cells O 0 0.059129584580659866
are O 0 0.002059483202174306
tumorigenic O 1 0.9954124093055725
in O 0 0.0032265796326100826
nude O 0 0.3250523507595062
mice O 1 0.9983289837837219
which O 0 0.0023375367745757103
is O 0 0.0037166269030421972
suppressed O 0 0.06067837029695511
by O 0 0.002345079556107521
the O 0 0.0031068394891917706
reintroduction O 1 0.9700750112533569
of O 0 0.00689455633983016
VHL B-Disease 1 0.9999992847442627
. O 0 0.00901123508810997

Remarkably O 0 0.07088422030210495
, O 0 0.002278525847941637
this O 0 0.0026696191634982824
occurs O 0 0.0304990503937006
without O 0 0.0042873527854681015
affecting O 0 0.0419006310403347
the O 0 0.002443277509883046
growth O 0 0.007816665805876255
rate O 0 0.00916911568492651
and O 0 0.002386984648182988
cell O 0 0.05460815876722336
cycle O 0 0.07143405824899673
profile O 0 0.03397584706544876
of O 0 0.0015548082301393151
these O 0 0.0018585763173177838
cells O 0 0.03667977452278137
in O 0 0.002210064325481653
culture O 0 0.008423772640526295
. O 0 0.005373360589146614

The O 0 0.012031687423586845
786 O 1 0.9988389611244202
- O 0 0.052884239703416824
0 O 0 0.04162614420056343
cell O 0 0.04033144935965538
line O 0 0.007768026553094387
, O 0 0.0015806065639480948
like O 0 0.004750382620841265
many O 0 0.006772284861654043
cancer B-Disease 1 1.0
cells O 0 0.29367026686668396
, O 0 0.0022924926597625017
fails O 0 0.0280576441437006
to O 0 0.0015321464743465185
exit O 0 0.032624758780002594
the O 0 0.0035675649996846914
cell O 0 0.0454368032515049
cycle O 0 0.0588182769715786
upon O 0 0.013899031095206738
serum O 1 0.9951865077018738
withdrawal O 0 0.07474395632743835
. O 0 0.007504654116928577

Here O 0 0.004359679762274027
, O 0 0.0014023749390617013
it O 0 0.001524613588117063
is O 0 0.0023115144576877356
shown O 0 0.005068563390523195
that O 0 0.0016594856278970838
reintroduction O 0 0.2583346962928772
of O 0 0.0009860843420028687
the O 0 0.0023253541439771652
wild O 0 0.032828401774168015
- O 0 0.04226908087730408
type O 1 0.98506760597229
VHL B-Disease 1 0.9999991655349731
gene O 1 0.9973094463348389
restores O 0 0.07879281044006348
the O 0 0.0027975994162261486
ability O 0 0.00765707204118371
of O 0 0.0032411750871688128
VHL O 1 0.9999998807907104
- O 0 0.4523732662200928
negative O 1 0.9809373021125793
RCC B-Disease 1 1.0
cancer I-Disease 1 1.0
cells O 0 0.05745675414800644
to O 0 0.002229454228654504
exit O 0 0.028002848848700523
the O 0 0.0033514949027448893
cell O 0 0.03647678345441818
cycle O 0 0.04289907589554787
and O 0 0.0021627992391586304
enter O 0 0.027056848630309105
G0 O 1 0.9999924898147583
/ O 1 0.6244649887084961
quiescence O 1 0.9973104000091553
in O 0 0.004630423150956631
low O 0 0.04459923878312111
serum O 1 0.8559989333152771
. O 0 0.008533282205462456

Both O 0 0.012962818145751953
VHL O 1 0.9999951124191284
- O 0 0.03319917246699333
positive O 0 0.01714392937719822
and O 0 0.004184306133538485
VHL O 1 0.9999994039535522
- O 0 0.05839571729302406
negative O 0 0.07983218878507614
RCC B-Disease 1 0.9999806880950928
cells O 0 0.07562658190727234
exit O 0 0.03246641159057617
the O 0 0.0037248285952955484
cell O 0 0.03626842424273491
cycle O 0 0.04486813023686409
by O 0 0.005102838389575481
contact O 0 0.03056023269891739
inhibition O 1 0.9910489320755005
. O 0 0.0071001420728862286

The O 0 0.015041688457131386
cyclin O 1 0.9972526431083679
- O 0 0.050246573984622955
dependent O 0 0.06946057826280594
kinase O 1 0.9999469518661499
inhibitor O 1 0.9999672174453735
, O 0 0.006492044776678085
p27 O 1 0.9998962879180908
, O 0 0.004345074761658907
accumulates O 1 0.6286216974258423
upon O 0 0.010025806725025177
serum O 1 0.998849630355835
withdrawal O 0 0.06635953485965729
, O 0 0.0012442221632227302
only O 0 0.0009739663219079375
in O 0 0.00078113644849509
the O 0 0.0019887867383658886
presence O 0 0.008594590239226818
of O 0 0.0036256725434213877
VHL B-Disease 1 1.0
, O 0 0.0023658110294491053
as O 0 0.0019290412310510874
a O 0 0.005077131558209658
result O 0 0.0072777969762682915
of O 0 0.0010852576233446598
the O 0 0.0022822741884738207
stabilization O 0 0.04594354331493378
of O 0 0.0015868541086092591
the O 0 0.0037675302010029554
protein O 0 0.07986117899417877
. O 0 0.004649002570658922

We O 0 0.0036927827168256044
propose O 0 0.013848485425114632
that O 0 0.0009148037061095238
the O 0 0.0021451744250953197
loss O 0 0.023944847285747528
of O 0 0.0018739186925813556
wild O 0 0.09894341975450516
- O 0 0.1315372884273529
type O 1 0.9993183612823486
VHL B-Disease 1 0.9999998807907104
gene O 1 0.9995111227035522
results O 0 0.006567119620740414
in O 0 0.0009574416908435524
a O 0 0.003964587114751339
specific O 0 0.00521736778318882
cellular O 0 0.280996710062027
defect O 1 0.9990882873535156
in O 0 0.004749104380607605
serum O 1 0.9949334263801575
- O 0 0.03659940883517265
dependent O 0 0.029209917411208153
growth O 0 0.013081148266792297
control O 0 0.018953805789351463
, O 0 0.0012981296749785542
which O 0 0.0018503394676372409
may O 0 0.0125492624938488
initiate O 1 0.981507420539856
tumor B-Disease 1 0.9999998807907104
formation O 0 0.048785313963890076
. O 0 0.004858957137912512

This O 0 0.004026598762720823
is O 0 0.003886875696480274
corrected O 0 0.04827486351132393
by O 0 0.0017561634304001927
the O 0 0.002608922775834799
reintroduction O 1 0.9625265002250671
of O 0 0.0023424187675118446
wild O 0 0.034737177193164825
- O 0 0.04036621376872063
type O 1 0.9898987412452698
VHL B-Disease 1 0.9999995231628418
, O 0 0.005821366794407368
implicating O 1 0.9235184192657471
VHL B-Disease 1 0.9999992847442627
as O 0 0.002990136621519923
the O 0 0.0026107083540409803
first O 0 0.014326381497085094
tumor B-Disease 1 1.0
suppressor O 1 0.9999959468841553
involved O 0 0.010328400880098343
in O 0 0.001219309982843697
the O 0 0.0020153739023953676
regulation O 0 0.015722455456852913
of O 0 0.002338464604690671
cell O 0 0.08096320927143097
cycle O 0 0.10128203779459
exit O 0 0.058232348412275314
, O 0 0.0018022173317149282
which O 0 0.0013835099525749683
is O 0 0.0021203726064413786
consistent O 0 0.007073712069541216
with O 0 0.0011109239421784878
its O 0 0.004412833601236343
gatekeeper O 1 0.9999822378158569
function O 0 0.01586310565471649
in O 0 0.0016493737930431962
the O 0 0.007831708528101444
kidney O 1 1.0
. O 0 0.003491856623440981
. O 0 0.0042451899498701096

Piebaldism B-Disease 1 0.9999749660491943
with O 0 0.013898267410695553
deafness B-Disease 1 1.0
: O 0 0.006154079921543598
molecular O 0 0.01891591213643551
evidence O 0 0.0013375787530094385
for O 0 0.0008786847465671599
an O 0 0.003027499420568347
expanded O 0 0.08004563301801682
syndrome O 1 1.0
. O 0 0.00815786886960268

In O 0 0.0034731801133602858
a O 0 0.005884069018065929
South O 0 0.005943576339632273
African O 0 0.016546983271837234
girl O 0 0.06527610868215561
of O 0 0.0023166786413639784
Xhosa O 1 0.999984622001648
stock O 0 0.05862060561776161
with O 0 0.0033587277866899967
severe O 1 1.0
piebaldism B-Disease 1 0.9999958276748657
and O 0 0.0031872750259935856
profound O 1 0.9999994039535522
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 0.0027053244411945343
identified O 0 0.010096623562276363
a O 0 0.005366045981645584
novel O 0 0.031103035435080528
missense O 1 0.9990247488021851
substitution O 0 0.043310049921274185
at O 0 0.0034423295874148607
a O 0 0.005082500632852316
highly O 0 0.01171085424721241
conserved O 0 0.04035653546452522
residue O 0 0.05871696397662163
in O 0 0.0011909508612006903
the O 0 0.0035682027228176594
intracellular O 1 0.9963801503181458
kinase O 1 0.9960536956787109
domain O 0 0.02093220315873623
of O 0 0.001208548666909337
the O 0 0.0038363211788237095
KIT O 1 0.9998311996459961
proto O 1 0.9999444484710693
- O 0 0.30788832902908325
oncogene O 1 0.9999988079071045
, O 0 0.00661238469183445
R796G O 1 0.9995797276496887
. O 0 0.006760411895811558

Though O 0 0.02283897064626217
auditory B-Disease 1 0.9972442388534546
anomalies I-Disease 1 0.9914719462394714
have O 0 0.0021908485796302557
been O 0 0.0037565503735095263
observed O 0 0.009128388017416
in O 0 0.00217464123852551
mice O 1 0.9991055130958557
with O 0 0.0029017915949225426
dominant O 1 0.6338633298873901
white O 0 0.02179306373000145
spotting O 1 0.9989822506904602
( O 0 0.013113369233906269
W O 1 0.9993663430213928
) O 0 0.003534313989803195
due O 0 0.008126476779580116
to O 0 0.002220289548859
KIT O 1 0.9999631643295288
mutations O 1 0.9999996423721313
, O 0 0.007503283675760031
deafness B-Disease 1 1.0
is O 0 0.0030448399484157562
not O 0 0.0011162395821884274
typical O 0 0.01355808600783348
in O 0 0.0017847158014774323
human O 0 0.013651889748871326
piebaldism B-Disease 1 0.9998992681503296
. O 0 0.004842674359679222

Thus O 0 0.009534290060400963
, O 0 0.0012579041067510843
the O 0 0.0020822472870349884
occurrence O 1 0.7186521291732788
of O 0 0.006312462035566568
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 0.002246859250590205
this O 0 0.0026078522205352783
patient O 1 0.9999459981918335
extends O 0 0.03380328789353371
considerably O 0 0.023961922153830528
the O 0 0.004362659528851509
phenotypic O 1 0.9912211894989014
range O 0 0.004843078553676605
of O 0 0.0021440796554088593
piebaldism B-Disease 1 0.9997581839561462
due O 0 0.011990286409854889
to O 0 0.0029628074262291193
KIT O 1 0.9997144341468811
gene O 1 0.9997875094413757
mutation O 1 0.999941349029541
in O 0 0.0027551136445254087
humans O 0 0.024784186854958534
and O 0 0.0017743852222338319
tightens O 1 0.9999934434890747
the O 0 0.004507134668529034
clinical O 1 0.9883352518081665
similarity O 0 0.02650272101163864
between O 0 0.003114767139777541
piebaldism B-Disease 1 0.9997153878211975
and O 0 0.000947122520301491
the O 0 0.0010078680934384465
various O 0 0.0007762079476378858
forms O 0 0.0061562382616102695
of O 0 0.00686639454215765
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.004328948445618153
. O 0 0.004557186737656593

Cycloheximide O 1 0.9913175106048584
facilitates O 0 0.04962252080440521
the O 0 0.0028213285841047764
identification O 0 0.009079488925635815
of O 0 0.002038555918261409
aberrant O 1 0.9935256242752075
transcripts O 0 0.014148250222206116
resulting O 0 0.025333618745207787
from O 0 0.0022000407334417105
a O 0 0.006281157955527306
novel O 0 0.030081618577241898
splice O 1 0.9944369792938232
- O 0 0.030124414712190628
site O 0 0.016667837277054787
mutation O 1 0.9997602105140686
in O 0 0.0031575087923556566
COL17A1 O 1 0.999963641166687
in O 0 0.0016011075349524617
a O 0 0.007899794727563858
patient O 1 0.9996613264083862
with O 0 0.004555979743599892
generalized O 1 0.9999985694885254
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999998807907104
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999995231628418
. O 0 0.012579410336911678

Patients O 1 0.9999955892562866
with O 0 0.006154353730380535
generalized O 1 0.9999984502792358
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999998807907104
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999998807907104
often O 0 0.00947465468198061
show O 0 0.007770129945129156
decreased O 0 0.05618423596024513
expression O 0 0.016688985750079155
of O 0 0.0023113240022212267
type O 1 0.9993630051612854
XVII O 1 1.0
collagen O 1 0.9999991655349731
, O 0 0.0024833264760673046
a O 0 0.009672563523054123
transmembrane O 1 0.9974997639656067
hemidesmosomal O 1 0.9977039694786072
protein O 0 0.08050065487623215
encoded O 0 0.03800516575574875
by O 0 0.007290872745215893
COL17A1 O 1 0.9992190599441528
. O 0 0.008163013495504856

This O 0 0.003086400916799903
report O 0 0.002471219515427947
documents O 0 0.0011019437806680799
a O 0 0.005841807462275028
novel O 0 0.03184890002012253
splice O 1 0.9925345182418823
- O 0 0.034464042633771896
site O 0 0.0208112895488739
mutation O 1 0.9998077750205994
in O 0 0.003205040004104376
COL17A1 O 1 0.9999338388442993
in O 0 0.0019218606175854802
a O 0 0.008073210716247559
patient O 1 0.9999780654907227
with O 0 0.004789577331393957
generalized O 1 0.9999978542327881
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999998807907104
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999997615814209
, O 0 0.0037425586488097906
and O 0 0.0015506269410252571
applies O 0 0.008559159934520721
a O 0 0.004135597962886095
new O 0 0.0022858232259750366
methodology O 0 0.00972951389849186
to O 0 0.0011153107043355703
define O 0 0.00657870527356863
and O 0 0.0010665769223123789
characterize O 0 0.03133270516991615
the O 0 0.003044557524845004
resulting O 0 0.04774549975991249
mRNA O 0 0.11313005536794662
splice O 1 0.9548175930976868
variants O 0 0.09901154786348343
. O 0 0.005413917824625969

Mutational O 1 0.9835079908370972
analysis O 0 0.008800932206213474
of O 0 0.0025792510714381933
COL17A1 O 1 0.9999173879623413
identified O 0 0.019761858507990837
a O 0 0.013270551338791847
maternally O 1 0.9990824460983276
inherited O 1 0.9999719858169556
G O 1 0.9996662139892578
- O 0 0.02097604051232338
to O 0 0.0033048021141439676
- O 0 0.0560586079955101
T O 1 0.9998130202293396
transversion O 1 0.9980524778366089
at O 0 0.004667038097977638
the O 0 0.0030672375578433275
- O 0 0.016929548233747482
1 O 0 0.00916131678968668
position O 0 0.005040287040174007
of O 0 0.003163945162668824
exon O 1 0.9979845285415649
32 O 0 0.03169625625014305
. O 0 0.005738989915698767

This O 0 0.007951658219099045
acceptor O 1 0.9480522274971008
splice O 1 0.9903532266616821
- O 0 0.03600205108523369
site O 0 0.020346511155366898
mutation O 1 0.9994106292724609
led O 0 0.01019651535898447
to O 0 0.0012183053186163306
the O 0 0.002280548680573702
formation O 0 0.018695887178182602
of O 0 0.002097449265420437
aberrant O 1 0.9714859127998352
transcripts O 0 0.011263609863817692
present O 0 0.0026118040550500154
at O 0 0.0036179982125759125
extremely O 0 0.02426959201693535
low O 0 0.0273133534938097
levels O 0 0.018441539257764816
. O 0 0.005160901229828596

Based O 0 0.0038955258205533028
on O 0 0.001073340536095202
our O 0 0.0017331880517303944
recent O 0 0.004430394619703293
finding O 0 0.00564237404614687
that O 0 0.002393142320215702
cycloheximide O 1 0.99993896484375
stabilized O 1 0.9997594952583313
mutant O 1 0.9984151124954224
COL17A1 O 1 0.9989161491394043
transcripts O 0 0.0140657564625144
in O 0 0.00334482011385262
keratinocytes O 1 0.9992038607597351
homozygous O 1 0.9969017505645752
for O 0 0.002602590946480632
a O 0 0.015413565561175346
frameshift O 1 0.999998927116394
mutation O 1 0.999975323677063
, O 0 0.0014678945299237967
the O 0 0.002251950092613697
effects O 0 0.020926110446453094
of O 0 0.0008934966754168272
the O 0 0.003510327311232686
splice O 1 0.9983744621276855
- O 0 0.0327649787068367
site O 0 0.020272061228752136
mutation O 1 0.9983949065208435
on O 0 0.0038813946302980185
splicing O 0 0.10118159651756287
of O 0 0.004063436295837164
COL17A1 O 1 0.9986217021942139
transcripts O 0 0.01602863520383835
were O 0 0.001407191506586969
determined O 0 0.007541546132415533
using O 0 0.004135082941502333
reverse O 0 0.08113227039575577
transcriptase O 1 0.9967803955078125
polymerase O 1 0.8204768896102905
chain O 0 0.11505688726902008
reaction O 0 0.01942249946296215
of O 0 0.001528507680632174
total O 0 0.007852143608033657
RNA O 0 0.13686712086200714
from O 0 0.007146462332457304
keratinocytes O 1 0.9626136422157288
incubated O 0 0.08672232180833817
for O 0 0.0030609744135290384
2 O 0 0.010685371235013008
. O 0 0.004690431524068117

5 O 0 0.031837694346904755
h O 0 0.07937522232532501
in O 0 0.0014365646056830883
the O 0 0.002523983595892787
presence O 0 0.010020063258707523
or O 0 0.003101205686107278
absence O 0 0.013544642366468906
of O 0 0.001548298168927431
10 O 0 0.010344580747187138
microg O 1 0.9996880292892456
cycloheximide O 1 0.9987066984176636
per O 0 0.014187228865921497
ml O 1 0.9969326257705688
. O 0 0.006861784961074591

Using O 0 0.005540229845792055
this O 0 0.0020561187993735075
approach O 0 0.008076708763837814
, O 0 0.001484904671087861
an O 0 0.0035630047786980867
abnormally O 1 0.9972936511039734
spliced O 0 0.4294145107269287
transcript O 0 0.03989126533269882
was O 0 0.008194154128432274
identified O 0 0.008650987409055233
that O 0 0.0009363113204017282
contains O 0 0.0024195380974560976
an O 0 0.0016964952228590846
extra O 0 0.011716132052242756
264 O 0 0.07219085097312927
bases O 0 0.015503116883337498
upstream O 0 0.04822510480880737
from O 0 0.0064238072372972965
exon O 1 0.9992159605026245
32 O 0 0.01908847689628601
, O 0 0.0018448723712936044
resulting O 0 0.01659870520234108
in O 0 0.001306216698139906
a O 0 0.010745452716946602
premature O 1 0.9999061822891235
termination O 1 0.9911774396896362
codon O 1 0.8593365550041199
27 O 0 0.02546611800789833
bp O 0 0.06529569625854492
downstream O 0 0.039573002606630325
from O 0 0.0024163706693798304
the O 0 0.004138902761042118
cryptic O 1 0.9309118986129761
splice O 1 0.979425847530365
site O 0 0.018024781718850136
. O 0 0.005603727884590626

Three O 0 0.0035982225090265274
other O 0 0.0024879148695617914
splice O 1 0.9937573671340942
variants O 0 0.06644190102815628
, O 0 0.0015046255430206656
including O 0 0.001081550377421081
one O 0 0.0022748562041670084
derived O 0 0.007052145432680845
from O 0 0.001425788039341569
the O 0 0.00206875242292881
skipping O 0 0.05528315529227257
of O 0 0.0031024061609059572
exon O 1 0.9998412132263184
32 O 0 0.023250414058566093
, O 0 0.0014289048267528415
were O 0 0.0012546422658488154
also O 0 0.002139715477824211
identified O 0 0.01578642800450325
. O 0 0.004643820226192474

These O 0 0.002443946897983551
results O 0 0.007337972521781921
indicate O 0 0.007108950987458229
the O 0 0.002317514270544052
usefulness O 0 0.04296490177512169
of O 0 0.0031020010355859995
cycloheximide O 1 0.9999810457229614
treatment O 1 0.9433048367500305
in O 0 0.0015015718527138233
evaluating O 0 0.01749417372047901
the O 0 0.004349068738520145
abnormal O 1 0.8726756572723389
processing O 0 0.0064254445023834705
of O 0 0.001395059167407453
mRNA O 0 0.049296703189611435
due O 0 0.011529959738254547
to O 0 0.0029206962790340185
splice O 1 0.9718220829963684
- O 0 0.04122437164187431
site O 0 0.02271774783730507
mutations O 1 0.9995632767677307
, O 0 0.002796176355332136
because O 0 0.006738418713212013
( O 0 0.004676599521189928
i O 0 0.007939741015434265
) O 0 0.005029180087149143
aberrant O 1 0.9891497492790222
splicing O 0 0.14108245074748993
often O 0 0.005073740612715483
generates O 0 0.026174426078796387
a O 0 0.013113745488226414
premature O 1 0.9986743927001953
termination O 1 0.9972859621047974
codon O 1 0.8952751159667969
, O 0 0.0036717900075018406
( O 0 0.005495924036949873
ii O 0 0.36793190240859985
) O 0 0.0030328379943966866
transcripts O 0 0.007723845075815916
with O 0 0.003579030279070139
premature O 1 0.9999035596847534
termination O 1 0.9980746507644653
codons O 1 0.9551268815994263
can O 0 0.004549169912934303
occur O 0 0.014451267197728157
at O 0 0.0037454222328960896
low O 0 0.020690472796559334
or O 0 0.007951328530907631
undetectable O 1 0.9970760345458984
levels O 0 0.020025478675961494
due O 0 0.008600069209933281
to O 0 0.0019144134130328894
nonsense O 0 0.0495985746383667
- O 0 0.02809566631913185
mediated O 0 0.20401009917259216
mRNA O 0 0.09786121547222137
decay O 0 0.08525967597961426
, O 0 0.0024001910351216793
and O 0 0.0016886749072000384
( O 0 0.006452374625951052
iii O 1 0.5616450309753418
) O 0 0.0020665645133703947
the O 0 0.0017561742570251226
levels O 0 0.007976938970386982
of O 0 0.0008476315997540951
these O 0 0.0008087718742899597
transcripts O 0 0.007401143200695515
can O 0 0.0022956249304115772
be O 0 0.0015387814491987228
increased O 0 0.00826071947813034
by O 0 0.005281766876578331
cycloheximide O 1 0.9991551637649536
. O 0 0.006877087522298098

A O 0 0.047067321836948395
deletion O 1 0.9988952279090881
mutation O 1 0.9998689889907837
in O 0 0.005683629307895899
COL17A1 O 1 0.9998334646224976
in O 0 0.0023885471746325493
five O 0 0.003079538932070136
Austrian O 0 0.03588816896080971
families O 0 0.006087109912186861
with O 0 0.003556601470336318
generalized O 1 0.9999996423721313
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999998807907104
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999994039535522
represents O 0 0.027586907148361206
propagation O 0 0.041134756058454514
of O 0 0.0013948146952316165
an O 0 0.0039831604808568954
ancestral O 0 0.12025522440671921
allele O 1 0.9999423027038574
. O 0 0.009486546739935875

Patients O 1 0.9999784231185913
with O 0 0.0055717583745718
generalized O 1 0.999992847442627
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999998807907104
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999998807907104
, O 0 0.002662213984876871
a O 0 0.005450874101370573
usually O 0 0.006508517079055309
nonlethal O 0 0.05934623256325722
form O 0 0.005985593423247337
of O 0 0.004713170230388641
junctional B-Disease 1 0.9999985694885254
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999998807907104
, O 0 0.003348220605403185
have O 0 0.0030806094873696566
generalized O 1 0.9997522234916687
blistering B-Disease 1 0.9998136162757874
, O 0 0.006206528749316931
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.00719293300062418
patchy B-Disease 1 0.9999969005584717
alopecia I-Disease 1 1.0
, O 0 0.00291804363951087
and O 0 0.0035170589108020067
dental B-Disease 1 0.9999998807907104
abnormalities I-Disease 1 0.9999998807907104
. O 0 0.007077101618051529

Skin B-Disease 1 0.9999997615814209
fragility I-Disease 1 0.9996259212493896
in O 0 0.0023130872286856174
most O 0 0.00334188062697649
cases O 0 0.00823848508298397
is O 0 0.003012311877682805
due O 0 0.008715774863958359
to O 0 0.001980544999241829
mutations O 1 0.9985490441322327
in O 0 0.0013371173990890384
the O 0 0.0034328221809118986
gene O 1 0.998941957950592
encoding O 0 0.10971075296401978
type O 1 0.9772401452064514
XVII O 1 0.9999998807907104
collagen O 1 0.9999998807907104
( O 0 0.01421673595905304
COL17A1 O 1 0.9999949932098389
) O 0 0.005293371621519327
. O 0 0.003567936597391963

Recently O 0 0.027503157034516335
, O 0 0.0016510431887581944
we O 0 0.0012360293185338378
reported O 0 0.00806406605988741
five O 0 0.0027881357818841934
Austrian O 0 0.0364709347486496
families O 0 0.00786743313074112
with O 0 0.004493162035942078
generalized O 1 0.9999924898147583
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999998807907104
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999998807907104
who O 0 0.005695738829672337
share O 0 0.004626353271305561
the O 0 0.001983228139579296
same O 0 0.007248091511428356
COL17A1 O 1 0.9999978542327881
mutation O 1 0.9999935626983643
. O 0 0.0074369702488183975

Affected O 0 0.15783348679542542
individuals O 0 0.0044884998351335526
in O 0 0.001323910430073738
three O 0 0.0016895198496058583
families O 0 0.006141997408121824
are O 0 0.002555581508204341
homozygous O 1 0.9998892545700073
for O 0 0.00424323882907629
4003delTC O 1 0.9999516010284424
, O 0 0.0028337619733065367
whereas O 0 0.010616878047585487
those O 0 0.000798543100245297
in O 0 0.0008018069784156978
two O 0 0.0009387844474986196
others O 0 0.003239594865590334
are O 0 0.0015571631956845522
compound O 0 0.04941406473517418
heterozygotes O 1 0.9997113347053528
. O 0 0.008441530168056488

To O 0 0.002951113972812891
determine O 0 0.005747703369706869
if O 0 0.0023370475973933935
the O 0 0.0029375175945460796
occurrence O 0 0.05983448401093483
of O 0 0.002716447226703167
4003delTC O 1 0.9997873902320862
in O 0 0.0015889903297647834
these O 0 0.0010345575865358114
unrelated O 0 0.024052264168858528
families O 0 0.008398863486945629
signifies O 0 0.06262195110321045
propagation O 0 0.03269655629992485
of O 0 0.0012103365734219551
an O 0 0.0025732729118317366
ancestral O 0 0.10542082041501999
allele O 1 0.9999703168869019
or O 0 0.0038236735854297876
a O 0 0.011591650545597076
mutational O 1 0.9999735355377197
hot O 0 0.2366192787885666
spot O 0 0.030389880761504173
, O 0 0.0026931660249829292
haplotypes O 1 0.9736602902412415
were O 0 0.0016337158158421516
determined O 0 0.00816148892045021
for O 0 0.0019478887552395463
polymorphisms O 1 0.9967124462127686
both O 0 0.001162425964139402
within O 0 0.0016250265762209892
and O 0 0.002072214847430587
flanking O 1 0.9995837807655334
COL17A1 O 1 0.9999834299087524
. O 0 0.007882768288254738

Five O 0 0.01804749108850956
intragenic O 1 0.9985436201095581
polymorphisms O 1 0.964580774307251
were O 0 0.002188689075410366
chosen O 0 0.004046163056045771
based O 0 0.0016300599090754986
on O 0 0.001225855783559382
their O 0 0.00328609230928123
informativeness O 1 0.9988179802894592
. O 0 0.006909270770847797

One O 0 0.004438558593392372
of O 0 0.0010756656993180513
these O 0 0.0007905572419986129
, O 0 0.0009395714150741696
not O 0 0.0010654741199687123
previously O 0 0.00467541441321373
reported O 0 0.008848926983773708
, O 0 0.0013122938107699156
was O 0 0.007731436286121607
2988 O 1 0.9998888969421387
A O 0 0.015477105975151062
or O 0 0.0050379009917378426
C O 0 0.11201900988817215
that O 0 0.0018584559438750148
introduces O 0 0.028801320120692253
a O 0 0.004939635284245014
new O 0 0.003491103183478117
restriction O 0 0.027534861117601395
site O 0 0.007045700680464506
for O 0 0.0031428434886038303
Eco0109 O 1 0.9998999834060669
I O 0 0.022982358932495117
. O 0 0.004900952335447073

All O 0 0.002766404766589403
the O 0 0.005127598065882921
4003delTC O 1 0.9999163150787354
alleles O 1 0.9998685121536255
showed O 0 0.009703388437628746
the O 0 0.0020722465123981237
same O 0 0.004929766058921814
haplotype O 1 0.998222291469574
for O 0 0.001267878687940538
these O 0 0.001013797940686345
five O 0 0.005911903455853462
polymorphic O 1 0.9994668364524841
markers O 0 0.07058768719434738
. O 0 0.00626498693600297

Fourteen O 0 0.08212700486183167
microsatellite O 1 0.9936164617538452
polymorphisms O 1 0.9199076890945435
were O 0 0.0027113198302686214
selected O 0 0.004003842361271381
based O 0 0.001494667842052877
on O 0 0.0010472025023773313
their O 0 0.001340535469353199
high O 0 0.009321529418230057
heterozygosity O 1 0.9986897110939026
and O 0 0.0010563115356490016
their O 0 0.0009088411461561918
location O 0 0.0042658597230911255
within O 0 0.00378235150128603
10q23 O 1 0.9997532963752747
- O 0 0.05597027763724327
q25 O 1 0.9994524121284485
near O 0 0.042369112372398376
COL17A1 O 1 0.9998583793640137
. O 0 0.007752293720841408

Three O 0 0.004113871604204178
families O 0 0.007467016577720642
shared O 0 0.021692117676138878
microsatellite O 1 0.9981993436813354
polymorphisms O 1 0.9939917922019958
covering O 0 0.017730893567204475
at O 0 0.004844345152378082
most O 0 0.004383889026939869
19 O 0 0.023549120873212814
cM O 0 0.05401792749762535
, O 0 0.0015307617140933871
whereas O 0 0.00961667113006115
the O 0 0.0017315518343821168
others O 0 0.0027027386240661144
shared O 0 0.005879209376871586
smaller O 0 0.007613312918692827
regions O 0 0.008333610370755196
consistent O 0 0.009128172881901264
with O 0 0.0017181653529405594
cross O 0 0.014353939332067966
- O 0 0.014346333220601082
over O 0 0.0028210242744535208
events O 0 0.00496424688026309
during O 0 0.006370958872139454
passage O 0 0.008744106628000736
of O 0 0.001337234629318118
this O 0 0.0038341933395713568
mutation O 1 0.9999511241912842
through O 0 0.004858860746026039
several O 0 0.002491517225280404
generations O 0 0.022284969687461853
. O 0 0.006196883041411638

These O 0 0.002318033715710044
results O 0 0.0060133072547614574
indicate O 0 0.0068042888306081295
that O 0 0.0020324045326560736
4003delTC O 1 0.9997068047523499
occurs O 0 0.02535403147339821
on O 0 0.0011644174810498953
a O 0 0.004578200168907642
single O 0 0.01660139672458172
ancestral O 0 0.0868825688958168
allele O 1 0.9999617338180542
. O 0 0.0045055304653942585
. O 0 0.004370817448943853

The O 0 0.01021223608404398
haptoglobin O 1 0.9990076422691345
- O 0 0.07762182503938675
gene O 1 0.9962260723114014
deletion O 1 0.995836615562439
responsible O 0 0.0198972187936306
for O 0 0.003692693542689085
anhaptoglobinemia B-Disease 1 0.9996092915534973
. O 0 0.0063896458595991135

We O 0 0.0029210944194346666
have O 0 0.0013221619883552194
found O 0 0.00336711504496634
an O 0 0.0032150903716683388
allelic O 1 0.9981282353401184
deletion O 1 0.9833917617797852
of O 0 0.0019769929349422455
the O 0 0.005969975143671036
haptoglobin O 1 0.999365508556366
( O 0 0.011341096833348274
Hp O 1 0.6997853517532349
) O 0 0.00733913341537118
gene O 1 0.982780933380127
from O 0 0.002446140628308058
an O 0 0.001668652635999024
individual O 0 0.0026906735729426146
with O 0 0.002948784502223134
anhaptoglobinemia B-Disease 1 0.9996318817138672
. O 0 0.006975848227739334

The O 0 0.010760282166302204
Hp O 1 0.9307769536972046
gene O 1 0.9910665154457092
cluster O 0 0.05461897328495979
consists O 0 0.006005064584314823
of O 0 0.0017222873866558075
coding O 0 0.08645346015691757
regions O 0 0.006523794028908014
of O 0 0.0009797459933906794
the O 0 0.004036762285977602
alpha O 0 0.45832741260528564
chain O 0 0.1441439390182495
and O 0 0.0028577239718288183
beta O 0 0.07693710923194885
chain O 0 0.044716861099004745
of O 0 0.0013350967783480883
the O 0 0.005136920139193535
haptoglobin O 1 0.9998596906661987
gene O 1 0.9991284012794495
( O 0 0.00857583899050951
Hp O 1 0.5227252244949341
) O 0 0.0020464493427425623
and O 0 0.0005319853080436587
of O 0 0.0007046772516332567
the O 0 0.003978007938712835
alpha O 0 0.48472824692726135
chain O 0 0.1465901881456375
and O 0 0.002160327974706888
beta O 0 0.0725121945142746
chain O 0 0.039819587022066116
of O 0 0.0013196560321375728
the O 0 0.004744204226881266
haptoglobin O 1 0.9996076226234436
- O 0 0.04357120767235756
related O 0 0.026547424495220184
gene O 1 0.9982036352157593
( O 0 0.013684958219528198
Hpr O 1 0.9999223947525024
) O 0 0.0045950100757181644
, O 0 0.0011203261092305183
in O 0 0.0016325729666277766
tandem O 0 0.0443807877600193
from O 0 0.0024593204725533724
the O 0 0.0030315681360661983
5 O 0 0.01113363541662693
side O 0 0.011962376534938812
. O 0 0.004142554011195898

Southern O 0 0.04476979747414589
blot O 1 0.9881133437156677
and O 0 0.004800132475793362
PCR O 1 0.8573189377784729
analyses O 0 0.011344539001584053
have O 0 0.0018989325035363436
indicated O 0 0.006913796998560429
that O 0 0.0009058688883669674
the O 0 0.0014970045303925872
individual O 0 0.0022784587927162647
with O 0 0.001893842127174139
anhaptoglobinemia B-Disease 1 0.9998942613601685
was O 0 0.010512303560972214
homozygous O 1 0.9991624355316162
for O 0 0.0014199215220287442
the O 0 0.004735355265438557
gene O 1 0.9998660087585449
deletion O 1 0.9995744824409485
and O 0 0.0012761760735884309
that O 0 0.0008156065596267581
the O 0 0.004116181284189224
gene O 1 0.9969454407691956
deletion O 1 0.9991132616996765
was O 0 0.006722480058670044
included O 0 0.002039618557319045
at O 0 0.002735086716711521
least O 0 0.004739802330732346
from O 0 0.00199138349853456
the O 0 0.003366287564858794
promoter O 1 0.9985285997390747
region O 0 0.00906021986156702
of O 0 0.0017681487370282412
Hp O 1 0.870603621006012
to O 0 0.00498175946995616
Hpr O 1 0.9999790191650391
alpha O 0 0.11808691173791885
but O 0 0.0019647099543362856
not O 0 0.0013728680787608027
to O 0 0.003636192297562957
Hpr O 1 0.9996113181114197
beta O 0 0.1617167741060257
( O 0 0.011113285087049007
Hpdel O 1 0.9986164569854736
) O 0 0.005900542717427015
. O 0 0.00451688002794981

In O 0 0.0039003249257802963
addition O 0 0.0046060942113399506
, O 0 0.0014872992178425193
we O 0 0.0012888973578810692
found O 0 0.003930950537323952
seven O 0 0.0022759854327887297
individuals O 0 0.0038324925117194653
with O 0 0.0024400276597589254
hypohaptoglobinemia B-Disease 1 0.9998825788497925
in O 0 0.0016601122915744781
three O 0 0.0017908121226355433
families O 0 0.005598208401352167
, O 0 0.00123060611076653
and O 0 0.0008626648341305554
the O 0 0.0033577526919543743
genotypes O 1 0.9999644756317139
of O 0 0.0012144556967541575
six O 0 0.0019791205413639545
of O 0 0.000820543325971812
the O 0 0.0018834529910236597
seven O 0 0.0030199771281331778
individuals O 0 0.0030419076792895794
were O 0 0.000992021756246686
found O 0 0.003022965043783188
to O 0 0.0010967160342261195
be O 0 0.0033439667895436287
Hp2 O 1 0.9999831914901733
/ O 1 0.9509469270706177
Hpdel O 1 0.9998019337654114
. O 0 0.007302507758140564

The O 0 0.010568697936832905
phenotypes O 1 0.999595582485199
and O 0 0.0030610745307058096
genotypes O 1 0.9999059438705444
in O 0 0.0014185294276103377
one O 0 0.001389133743941784
of O 0 0.0006786853191442788
these O 0 0.0007279095007106662
three O 0 0.001622639480046928
families O 0 0.00614105723798275
showed O 0 0.006825906690210104
the O 0 0.0021948697976768017
father O 0 0.01296142116189003
to O 0 0.0013965677935630083
be O 0 0.0035241066943854094
hypohaptoglobinemic B-Disease 1 0.9999394416809082
( O 0 0.009575942531228065
Hp2 O 1 0.9996728897094727
) O 0 0.003934153355658054
and O 0 0.002278690692037344
Hp2 O 1 0.9999761581420898
/ O 1 0.9736195802688599
Hpdel O 1 0.9995540976524353
, O 0 0.0015836820239201188
the O 0 0.0018464571330696344
mother O 0 0.024696627631783485
to O 0 0.0014574523083865643
be O 0 0.0028266997542232275
Hp2 O 1 0.9996826648712158
- O 0 0.024745089933276176
1 O 0 0.012408431619405746
and O 0 0.0031590687576681376
Hp1 O 1 0.9999485015869141
/ O 1 0.9819689393043518
Hp2 O 1 0.9997071623802185
, O 0 0.0016041945200413465
one O 0 0.0011838636128231883
of O 0 0.0006694640032947063
the O 0 0.0014186813496053219
two O 0 0.0012510980013757944
children O 0 0.006566021591424942
to O 0 0.001231153029948473
be O 0 0.0029835605528205633
hypohaptoglobinemic B-Disease 1 0.9998509883880615
( O 0 0.008931693620979786
Hp2 O 1 0.9999253749847412
) O 0 0.0033638637978583574
and O 0 0.002305180998519063
Hp2 O 1 0.999992847442627
/ O 1 0.9912374019622803
Hpdel O 1 0.999961256980896
, O 0 0.0017450159648433328
and O 0 0.0006793499342165887
the O 0 0.0012260321527719498
other O 0 0.0008527007303200662
child O 0 0.01636355184018612
to O 0 0.0011304989457130432
be O 0 0.0022154145408421755
Hp1 O 1 0.9995220899581909
and O 0 0.0037416131235659122
Hp1 O 1 0.9999912977218628
/ O 1 0.9761142730712891
Hpdel O 1 0.999669075012207
, O 0 0.0023361716885119677
showing O 0 0.008386638015508652
an O 0 0.003761895466595888
anomalous O 1 0.5173629522323608
inheritance O 0 0.21385924518108368
of O 0 0.0034753542859107256
Hp O 1 0.9982920289039612
phenotypes O 1 0.9995344877243042
in O 0 0.0016536404145881534
the O 0 0.0024016473907977343
child O 0 0.04330700635910034
with O 0 0.003504037857055664
Hp1 O 1 0.9999126195907593
. O 0 0.0075989472679793835

The O 0 0.014602559618651867
Hp2 O 1 0.9998464584350586
/ O 1 0.9727894067764282
Hpdel O 1 0.9998923540115356
individuals O 0 0.006368568167090416
had O 0 0.0033927145414054394
an O 0 0.0019555923063308
extremely O 0 0.019403506070375443
low O 0 0.016425056383013725
level O 0 0.003569489810615778
of O 0 0.0017555583035573363
Hp O 1 0.9790412783622742
( O 0 0.005810327362269163
mean O 0 0.019769718870520592
+ O 0 0.09530531615018845
/ O 0 0.0931742936372757
- O 0 0.05632083863019943
SD O 1 0.9998292922973633
= O 0 0.06156604737043381
0 O 0 0.029818056151270866
. O 0 0.00555277056992054
049 O 1 0.9994387030601501
+ O 0 0.129689022898674
/ O 0 0.09196857362985611
- O 0 0.032557304948568344
0 O 0 0.03291165083646774
. O 0 0.005877651274204254
043 O 1 0.9986180067062378
mg O 1 0.9996942281723022
/ O 0 0.24851825833320618
ml O 1 0.9895983934402466
; O 0 0.007799528073519468
n O 0 0.05356718972325325
= O 0 0.054042115807533264
6 O 0 0.018270067870616913
) O 0 0.003062534611672163
, O 0 0.001234533847309649
compared O 0 0.00698084756731987
with O 0 0.0008885868592187762
the O 0 0.0020795362070202827
level O 0 0.006149141117930412
( O 0 0.004679476376622915
1 O 0 0.009885333478450775
. O 0 0.002172312466427684
64 O 0 0.03531520813703537
+ O 0 0.10077035427093506
/ O 0 0.07086143642663956
- O 0 0.021768342703580856
1 O 0 0.013940750621259212
. O 0 0.004547337535768747
07 O 1 0.9990139007568359
mg O 1 0.9999444484710693
/ O 1 0.918242871761322
ml O 1 0.9915655851364136
) O 0 0.003551509929820895
obtained O 0 0.0027777727227658033
from O 0 0.0027747205458581448
52 O 0 0.032206274569034576
healthy O 1 0.6877759695053101
volunteers O 0 0.03431330993771553
having O 0 0.02932889573276043
phenotype O 1 0.999998927116394
Hp2 O 1 0.9999086856842041
, O 0 0.003107145195826888
whereas O 0 0.011299899779260159
the O 0 0.004425656516104937
serum O 1 0.988201916217804
Hp O 0 0.07560831308364868
level O 0 0.004633890464901924
of O 0 0.0010129507863894105
an O 0 0.0015690678264945745
individual O 0 0.002783579984679818
with O 0 0.00291771930642426
Hp1 O 1 0.9999985694885254
/ O 1 0.993125319480896
Hpdel O 1 0.9998593330383301
was O 0 0.016501596197485924
0 O 0 0.03149843588471413
. O 0 0.004389157984405756

50 O 0 0.03465517610311508
mg O 1 0.999933123588562
/ O 1 0.9812078475952148
ml O 1 0.9998186230659485
, O 0 0.0018929787911474705
which O 0 0.001628258847631514
was O 0 0.005435237195342779
approximately O 0 0.004742363002151251
half O 0 0.004009146708995104
the O 0 0.0016087000258266926
level O 0 0.0033158084843307734
of O 0 0.001405983348377049
Hp O 0 0.1833743453025818
in O 0 0.0019218707457184792
control O 0 0.021473761647939682
sera O 0 0.05857099965214729
from O 0 0.0023549485486000776
the O 0 0.005354565102607012
Hp1 O 1 0.9999970197677612
phenotype O 1 0.9999992847442627
( O 0 0.008181978948414326
1 O 0 0.010118111036717892
. O 0 0.0022372195962816477
26 O 0 0.020121442154049873
+ O 0 0.08663584291934967
/ O 0 0.0727061778306961
- O 0 0.028871679678559303
0 O 0 0.025778457522392273
. O 0 0.0024566794745624065
33 O 0 0.035946473479270935
mg O 1 0.9997623562812805
/ O 0 0.3506162464618683
ml O 1 0.9851164221763611
; O 0 0.007412873674184084
n O 0 0.05275611951947212
= O 0 0.05007309839129448
9 O 0 0.015957584604620934
) O 0 0.0022117262706160545
, O 0 0.001003734301775694
showing O 0 0.009588466957211494
a O 0 0.013273438438773155
gene O 1 0.9994908571243286
- O 0 0.06717923283576965
dosage O 1 0.9982993006706238
effect O 0 0.027046557515859604
. O 0 0.005623165983706713

The O 0 0.005203788634389639
other O 0 0.0031458239536732435
allele O 1 0.9999933242797852
( O 0 0.012982502579689026
Hp2 O 1 0.999466598033905
) O 0 0.0027924200985580683
of O 0 0.0009940293384715915
individuals O 0 0.003827636828646064
with O 0 0.0032115792855620384
Hp2 O 1 0.9999977350234985
/ O 1 0.9837239980697632
Hpdel O 1 0.9999125003814697
was O 0 0.010648153722286224
found O 0 0.0048027620650827885
to O 0 0.0011387364938855171
have O 0 0.0011787236435338855
, O 0 0.0009707480203360319
in O 0 0.0008713207789696753
all O 0 0.0016741411527618766
exons O 1 0.9901212453842163
, O 0 0.0021109087392687798
no O 0 0.00454691844061017
mutation O 1 0.9999550580978394
, O 0 0.001995248021557927
by O 0 0.003936362452805042
DNA O 0 0.05828668922185898
sequencing O 0 0.0813947394490242
. O 0 0.006616189144551754

On O 0 0.003014853224158287
the O 0 0.0015570140676572919
basis O 0 0.0012712464667856693
of O 0 0.0007733628735877573
the O 0 0.0018176586600020528
present O 0 0.002698979340493679
study O 0 0.0030462516006082296
, O 0 0.0008644854533486068
the O 0 0.001609503524377942
mechanism O 0 0.018532870337367058
of O 0 0.0029044870752841234
anhaptoglobinemia B-Disease 1 0.9999097585678101
and O 0 0.0012726112036034465
the O 0 0.0018104187911376357
mechanism O 0 0.017003871500492096
of O 0 0.002735017566010356
anomalous O 1 0.9305760264396667
inheritance O 0 0.19871677458286285
of O 0 0.0028541607316583395
Hp O 1 0.9966225624084473
phenotypes O 1 0.9997909665107727
were O 0 0.0020812132861465216
well O 0 0.001811184803955257
explained O 0 0.009969107806682587
. O 0 0.004376566968858242

However O 0 0.006258571986109018
, O 0 0.0010649891337379813
the O 0 0.0018565329955890775
mechanism O 0 0.017002858221530914
of O 0 0.0023535217624157667
hypohaptoglobinemia B-Disease 1 0.9999501705169678
remains O 0 0.02163425274193287
unknown O 0 0.043055836111307144

ATM O 1 0.9856350421905518
mutations O 1 0.997657299041748
and O 0 0.004168280865997076
phenotypes O 1 0.9993653893470764
in O 0 0.008047818206250668
ataxia B-Disease 1 1.0
- I-Disease 1 0.9996451139450073
telangiectasia I-Disease 1 1.0
families O 0 0.008198046125471592
in O 0 0.001487316912971437
the O 0 0.002666183514520526
British O 0 0.024340685456991196
Isles O 1 0.9991421699523926
: O 0 0.0034714392386376858
expression O 0 0.016820520162582397
of O 0 0.0022113537415862083
mutant O 1 0.9998965263366699
ATM O 1 0.6148286461830139
and O 0 0.0011061992263421416
the O 0 0.002221339847892523
risk O 1 0.9987371563911438
of O 0 0.00501603540033102
leukemia B-Disease 1 1.0
, O 1 0.8202840685844421
lymphoma B-Disease 1 1.0
, O 0 0.003341078758239746
and O 0 0.03145796060562134
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.007797518279403448

We O 0 0.002176160691305995
report O 0 0.002242583315819502
the O 0 0.0018492389936000109
spectrum O 0 0.024715492501854897
of O 0 0.0017230368684977293
59 O 0 0.0642930194735527
ATM O 1 0.9973841309547424
mutations O 1 0.9999531507492065
observed O 0 0.015003815293312073
in O 0 0.0041493987664580345
ataxia B-Disease 1 1.0
- I-Disease 1 0.9971436858177185
telangiectasia I-Disease 1 1.0
( O 0 0.010665152221918106
A B-Disease 1 0.9989778995513916
- I-Disease 1 0.9906272888183594
T I-Disease 1 0.9999995231628418
) O 0 0.010222109965980053
patients O 1 0.9998762607574463
in O 0 0.0011333194561302662
the O 0 0.0023386066313833
British O 0 0.026229264214634895
Isles O 1 0.9987775683403015
. O 0 0.0054810624569654465

Of O 0 0.0046706837601959705
51 O 0 0.05700540542602539
ATM O 1 0.9975797533988953
mutations O 1 0.9999387264251709
identified O 0 0.01655399426817894
in O 0 0.001917542889714241
families O 0 0.005646894220262766
native O 0 0.004483866039663553
to O 0 0.0012703611282631755
the O 0 0.0023597627878189087
British O 0 0.018279289826750755
Isles O 1 0.9994743466377258
, O 0 0.0018362427363172174
11 O 0 0.006147751118987799
were O 0 0.001890474115498364
founder O 1 0.9482188820838928
mutations O 1 0.9999969005584717
, O 0 0.0017638053977862
and O 0 0.0009629407431930304
2 O 0 0.005083986558020115
of O 0 0.0008176686242222786
these O 0 0.0009551584371365607
11 O 0 0.007399650756269693
conferred O 0 0.024777861312031746
a O 0 0.013084225356578827
milder O 1 0.99998939037323
clinical O 1 0.9999127388000488
phenotype O 1 0.9999986886978149
with O 0 0.0014458155492320657
respect O 0 0.001880123047158122
to O 0 0.0010450298432260752
both O 0 0.004927614238113165
cerebellar B-Disease 1 0.9999996423721313
degeneration I-Disease 1 1.0
and O 0 0.003469613380730152
cellular O 0 0.17953220009803772
features O 0 0.008741668425500393
. O 0 0.004805917385965586

We O 0 0.002758766058832407
report O 0 0.0022466699592769146
, O 0 0.0008841276285238564
in O 0 0.0008752015419304371
two O 0 0.0015724741388112307
A B-Disease 1 0.9444841742515564
- I-Disease 1 0.8692734837532043
T I-Disease 1 0.9999972581863403
families O 0 0.0074632177129387856
, O 0 0.0013836463913321495
an O 0 0.004192233085632324
ATM O 1 0.9984983205795288
mutation O 1 0.9999730587005615
( O 0 0.00926833227276802
7271T O 1 0.9995982050895691
- O 0 0.048795126378536224
- O 0 0.0684083104133606
> O 1 0.9985748529434204
G O 1 0.9997197985649109
) O 0 0.003494643373414874
that O 0 0.0012154728174209595
may O 0 0.005473452620208263
be O 0 0.0012396239908412099
associated O 0 0.0035915300250053406
with O 0 0.0006519907619804144
an O 0 0.0017548572504892945
increased O 0 0.01506149023771286
risk O 1 0.9955145716667175
of O 0 0.008323992602527142
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.0018491791561245918
both O 0 0.00253169029019773
homozygotes O 1 0.9999978542327881
and O 0 0.0034095807932317257
heterozygotes O 1 0.9999841451644897
( O 0 0.0055034044198691845
relative O 0 0.019432954490184784
risk O 1 0.9921257495880127
12 O 0 0.009033280424773693
. O 0 0.002381599275395274
7 O 0 0.01391130406409502
; O 0 0.006081803701817989
P O 1 0.9991791844367981
= O 0 0.05570807307958603
. O 0 0.006321962457150221
0025 O 1 0.9999121427536011
) O 0 0.004984734114259481
, O 0 0.0011782442452386022
although O 0 0.0021356751676648855
there O 0 0.0010310758370906115
is O 0 0.0016259333351626992
a O 0 0.004513943567872047
less O 0 0.007689112797379494
severe O 1 0.9999998807907104
A B-Disease 1 0.9997504353523254
- I-Disease 1 0.9994532465934753
T I-Disease 1 0.9999997615814209
phenotype O 1 0.9999839067459106
in O 0 0.00175102346111089
terms O 0 0.0014950679615139961
of O 0 0.0005911319749429822
the O 0 0.001497172866947949
degree O 0 0.0048689693212509155
of O 0 0.003725607180967927
cerebellar B-Disease 1 0.9999998807907104
degeneration I-Disease 1 1.0
. O 0 0.00866000633686781

This O 0 0.009553820826113224
mutation O 1 0.9999220371246338
( O 0 0.01081936713308096
7271T O 1 0.9982557892799377
- O 0 0.054022349417209625
- O 0 0.06949781626462936
> O 1 0.9980649352073669
G O 1 0.9988287091255188
) O 0 0.0033592798281461
also O 0 0.0015106636565178633
allows O 0 0.004617941565811634
expression O 0 0.011454668827354908
of O 0 0.0010339681757614017
full O 0 0.005081119015812874
- O 0 0.02043531835079193
length O 0 0.015954822301864624
ATM O 1 0.7189974784851074
protein O 0 0.05442080274224281
at O 0 0.002804634626954794
a O 0 0.004610311705619097
level O 0 0.00447119353339076
comparable O 0 0.010085891000926495
with O 0 0.0008471346227452159
that O 0 0.0009761350811459124
in O 0 0.002164543140679598
unaffected O 1 0.9999113082885742
individuals O 0 0.007046895567327738
. O 0 0.004874018486589193

In O 0 0.003188478061929345
addition O 0 0.003441138891503215
, O 0 0.0010121723171323538
we O 0 0.0008043395355343819
have O 0 0.001059136469848454
studied O 0 0.003797524841502309
18 O 0 0.007637647911906242
A B-Disease 1 0.9943722486495972
- I-Disease 1 0.9992503523826599
T I-Disease 1 0.9999998807907104
patients O 1 0.9999980926513672
, O 0 0.0018599620088934898
in O 0 0.0013177319196984172
15 O 0 0.005236434284597635
families O 0 0.004487412981688976
, O 0 0.001434188219718635
who O 0 0.0057401275262236595
developed O 1 0.9942851662635803
leukemia B-Disease 1 1.0
, O 0 0.12296907603740692
lymphoma B-Disease 1 1.0
, O 0 0.00651938933879137
preleukemic O 1 0.9999990463256836
T O 1 0.9999951124191284
- O 0 0.03990186005830765
cell O 0 0.051605451852083206
proliferation O 0 0.03365440294146538
, O 0 0.003602172015234828
or O 0 0.30600637197494507
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 0.0037943387869745493
mostly O 0 0.00317057385109365
in O 0 0.0026345818769186735
childhood O 1 0.9997561573982239
. O 0 0.0056635295040905476

A O 0 0.02166900970041752
wide O 0 0.009449492208659649
variety O 0 0.003442676505073905
of O 0 0.0018342616967856884
ATM O 1 0.9996650218963623
mutation O 1 0.9999972581863403
types O 0 0.010680977255105972
, O 0 0.0011834792094305158
including O 0 0.003529770765453577
missense O 1 0.9999779462814331
mutations O 1 0.999980092048645
and O 0 0.001455162651836872
in O 0 0.001694551669061184
- O 0 0.0202904362231493
frame O 0 0.02857792377471924
deletions O 1 0.8586280345916748
, O 0 0.001540723373182118
were O 0 0.001042208750732243
seen O 0 0.005353519693017006
in O 0 0.0010863489005714655
these O 0 0.001993689453229308
patients O 1 0.9999958276748657
. O 0 0.005777695681899786

We O 0 0.002960129640996456
also O 0 0.001407387899234891
show O 0 0.004206264391541481
that O 0 0.0009542088373564184
25 O 0 0.003968854434788227
% O 0 0.001819949015043676
of O 0 0.0006821049028076231
all O 0 0.0014044020790606737
A B-Disease 1 0.9976139068603516
- I-Disease 1 0.9991450309753418
T I-Disease 1 0.9999996423721313
patients O 1 0.9999493360519409
carried O 0 0.007372215390205383
in O 0 0.0017962346319109201
- O 0 0.019312944263219833
frame O 0 0.02544143609702587
deletions O 1 0.9356597661972046
or O 0 0.012590442784130573
missense O 1 0.9999805688858032
mutations O 1 0.9999480247497559
, O 0 0.0017237901920452714
many O 0 0.0008237481815740466
of O 0 0.0007869037799537182
which O 0 0.0014646099880337715
were O 0 0.0009729040320962667
also O 0 0.001469108392484486
associated O 0 0.0049872128292918205
with O 0 0.0010467866668477654
expression O 0 0.016006939113140106
of O 0 0.0025953613221645355
mutant O 1 0.999971866607666
ATM O 1 0.9796023368835449
protein O 0 0.09339141845703125
. O 0 0.00592817971482873

The O 0 0.011037108488380909
DMPK O 1 0.9999253749847412
gene O 1 0.9872991442680359
of O 0 0.004678016062825918
severely O 1 0.9999992847442627
affected O 1 0.9999943971633911
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999998807907104
is O 0 0.011154122650623322
hypermethylated O 1 0.9999954700469971
proximal O 1 0.9999939203262329
to O 0 0.0015523525653406978
the O 0 0.0017737823072820902
largely O 0 0.007878386415541172
expanded O 0 0.01694905012845993
CTG O 1 0.9996711015701294
repeat O 0 0.10569602251052856
. O 0 0.007314689457416534

Using O 0 0.011006083339452744
methylation O 0 0.11995073407888412
- O 0 0.033752236515283585
sensitive O 0 0.027085496112704277
restriction O 0 0.05055910348892212
enzymes O 0 0.06341016292572021
, O 0 0.0016757955309003592
we O 0 0.0018318798393011093
characterized O 0 0.028744639828801155
the O 0 0.0039996071718633175
methylation O 0 0.0925271287560463
pattern O 0 0.019110633060336113
on O 0 0.0013676871312782168
the O 0 0.002531074918806553
5 O 0 0.007419451605528593
side O 0 0.005473394878208637
of O 0 0.001007602084428072
the O 0 0.0033462352585047483
CTG O 1 0.9998173117637634
repeat O 0 0.049867890775203705
in O 0 0.0014310627011582255
the O 0 0.0035773878917098045
DMPK O 1 0.999998927116394
gene O 1 0.996726393699646
of O 0 0.0019578684587031603
normal O 0 0.017620667815208435
individuals O 0 0.0023567471653223038
and O 0 0.000759561953600496
of O 0 0.002035218058153987
patients O 1 0.9999997615814209
affected O 1 0.997878909111023
with O 0 0.0119237769395113
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.003740596352145076
showing O 0 0.010201049037277699
expansions O 0 0.02325141429901123
of O 0 0.0011133378138765693
the O 0 0.004467829130589962
repetitive O 1 0.9980518817901611
sequence O 0 0.03292795270681381
. O 0 0.005375884007662535

The O 0 0.01659717783331871
gene O 1 0.9404675960540771
segment O 0 0.061214376240968704
analyzed O 0 0.02243981882929802
corresponds O 0 0.013124296441674232
to O 0 0.0011225418420508504
the O 0 0.0035076059866696596
genomic O 1 0.7460821866989136
SacI O 1 0.9930456280708313
- O 0 0.05706287920475006
HindIII O 1 0.9911165237426758
fragment O 0 0.10359551012516022
carrying O 0 0.020748594775795937
exons O 0 0.44886478781700134
11 O 0 0.018839756026864052
- O 0 0.02500533126294613
15 O 0 0.011693840846419334
. O 0 0.004780187737196684

There O 0 0.005262174643576145
is O 0 0.005339544266462326
constitutive O 0 0.1347324103116989
methylation O 0 0.09242041409015656
in O 0 0.004033492878079414
intron O 1 0.9981743097305298
12 O 0 0.011838479898869991
at O 0 0.003834717907011509
restriction O 0 0.018618810921907425
sites O 0 0.0026828604750335217
of O 0 0.0018163301283493638
SacII O 1 0.9999395608901978
and O 0 0.004031134303659201
HhaI O 1 0.9999181032180786
, O 0 0.004578888416290283
localized O 1 0.998066246509552
1 O 0 0.013513828627765179
, O 0 0.0023566586896777153
159 O 0 0.09040127694606781
- O 0 0.02324238419532776
1 O 0 0.012237763963639736
, O 0 0.002499035093933344
232 O 0 0.08162403851747513
bp O 0 0.060836032032966614
upstream O 0 0.02854367531836033
of O 0 0.001355228596366942
the O 0 0.0045678322203457355
CTG O 1 0.9999644756317139
repeat O 1 0.7362650632858276
, O 0 0.0025842043105512857
whereas O 0 0.014071119017899036
most O 0 0.0026023334357887506
, O 0 0.0013794045662507415
if O 0 0.0020410313736647367
not O 0 0.000683396530803293
all O 0 0.0005123536102473736
, O 0 0.0006922902539372444
of O 0 0.0006383631261996925
the O 0 0.00122095737606287
other O 0 0.0006494526751339436
sites O 0 0.0024217257741838694
of O 0 0.0020403484813869
SacII O 1 0.9999959468841553
, O 0 0.005685914307832718
HhaI O 1 0.999962329864502
, O 0 0.0020098609384149313
and O 0 0.0019075992750003934
HpaII O 1 0.9998428821563721
in O 0 0.0017087528249248862
this O 0 0.001714454498142004
region O 0 0.008612453006207943
are O 0 0.002020482439547777
unmethylated O 1 0.9981337189674377
, O 0 0.0016628465382382274
in O 0 0.0017281469190493226
normal O 0 0.016451053321361542
individuals O 0 0.002774352440610528
and O 0 0.0008316474268212914
most O 0 0.0014647702919319272
of O 0 0.001173571334220469
the O 0 0.006158934440463781
patients O 1 0.9999971389770508
. O 0 0.005651750601828098

In O 0 0.002746469806879759
a O 0 0.004261387977749109
number O 0 0.0014435219345614314
of O 0 0.0012672552838921547
young O 0 0.015519237145781517
and O 0 0.003956175409257412
severely O 1 0.9999996423721313
affected O 1 0.9999539852142334
patients O 1 0.9999994039535522
, O 0 0.0016330701764672995
however O 0 0.002146845916286111
, O 0 0.0009236116893589497
complete O 0 0.0055687520653009415
methylation O 0 0.05094252526760101
of O 0 0.0010003276402130723
these O 0 0.0009801151463761926
restriction O 0 0.026339132338762283
sites O 0 0.004124920349568129
was O 0 0.004445998463779688
found O 0 0.003026427235454321
in O 0 0.0013087489642202854
the O 0 0.0062532066367566586
mutated O 1 0.9999735355377197
allele O 1 0.9996800422668457
. O 0 0.009314117021858692

In O 0 0.0029328789096325636
most O 0 0.0017265945207327604
of O 0 0.001029138918966055
these O 0 0.0018998347222805023
patients O 1 0.9999967813491821
, O 0 0.0013016879092901945
the O 0 0.0033868122845888138
onset O 1 0.9999996423721313
of O 0 0.001780209830030799
the O 0 0.01975373923778534
disease O 1 1.0
was O 1 0.9997037053108215
congenital O 1 1.0
. O 0 0.006757098250091076

Preliminary O 0 0.010406075976788998
in O 0 0.003733997466042638
vivo O 0 0.16317777335643768
footprinting O 1 0.9830963611602783
data O 0 0.00470510870218277
gave O 0 0.00478556752204895
evidence O 0 0.0014266247162595391
for O 0 0.0022500331979244947
protein O 0 0.0758269876241684
- O 0 0.026668963953852654
DNA O 0 0.04746565595269203
contact O 0 0.01433023251593113
in O 0 0.002092901151627302
normal O 0 0.0254009161144495
genes O 0 0.09523969888687134
at O 0 0.004059821832925081
an O 0 0.004063775762915611
Sp1 O 1 0.9998764991760254
consensus O 0 0.013784774579107761
binding O 0 0.01564807817339897
site O 0 0.0074436296708881855
upstream O 0 0.022863896563649178
of O 0 0.0011957205133512616
the O 0 0.0048042479902505875
CTG O 1 0.999901294708252
repeat O 0 0.08888772875070572
and O 0 0.0010181241668760777
for O 0 0.0010653685312718153
a O 0 0.0048635113053023815
significant O 0 0.006543782074004412
reduction O 0 0.014662746340036392
of O 0 0.0008941958658397198
this O 0 0.001252521644346416
interaction O 0 0.007117352914065123
in O 0 0.0018140864558517933
cells O 0 0.031125159934163094
with O 0 0.0016789943911135197
a O 0 0.011330465786159039
hypermethylated O 1 0.9999852180480957
DMPK O 1 0.9999985694885254
gene O 1 0.9995834231376648
. O 0 0.004042943939566612
. O 0 0.004666320979595184

The O 0 0.025077063590288162
hemochromatosis B-Disease 1 1.0
gene O 1 0.9993854761123657
product O 0 0.0177959855645895
complexes O 0 0.025309141725301743
with O 0 0.00126476283185184
the O 0 0.005045090802013874
transferrin O 1 0.9998561143875122
receptor O 1 0.9871522784233093
and O 0 0.0035846938844770193
lowers O 1 0.9816190004348755
its O 0 0.005070947110652924
affinity O 0 0.04607132449746132
for O 0 0.0035438938066363335
ligand O 0 0.13651785254478455
binding O 0 0.030982013791799545
. O 0 0.006574172526597977

We O 0 0.0046804980374872684
recently O 0 0.012332921847701073
reported O 0 0.010453072376549244
the O 0 0.0029104813002049923
positional O 0 0.07640229910612106
cloning O 0 0.027841608971357346
of O 0 0.001032605185173452
a O 0 0.005717920605093241
candidate O 0 0.02407991886138916
gene O 1 0.9990099668502808
for O 0 0.008165891282260418
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 0 0.35422128438949585
HFE O 1 0.9999990463256836
. O 0 0.009991114027798176

The O 0 0.013046164996922016
gene O 1 0.9928393363952637
product O 0 0.009031316265463829
, O 0 0.0010082493536174297
a O 0 0.003197879297658801
member O 0 0.002526842290535569
of O 0 0.0007439888431690633
the O 0 0.0028642727993428707
major O 0 0.04923638701438904
histocompatibility O 1 0.9999997615814209
complex O 0 0.024520326405763626
class O 0 0.027375705540180206
I O 0 0.02698933333158493
- O 0 0.021385036408901215
like O 0 0.007388581521809101
family O 0 0.013438712805509567
, O 0 0.0014919418608769774
was O 0 0.0049155340529978275
found O 0 0.0031260373070836067
to O 0 0.0007864973740652204
have O 0 0.001430133474059403
a O 0 0.008752760477364063
mutation O 1 0.9998582601547241
, O 0 0.0053426604717969894
Cys O 1 0.999875545501709
- O 0 0.048551544547080994
282 O 0 0.3398522436618805
- O 0 0.056836776435375214
- O 0 0.06830006837844849
> O 1 0.9969130754470825
Tyr O 1 0.9998786449432373
( O 0 0.016982929781079292
C282Y O 1 0.9953545331954956
) O 0 0.004289882257580757
, O 0 0.0012241085059940815
in O 0 0.001836129929870367
85 O 0 0.0242233294993639
% O 0 0.003345762612298131
of O 0 0.0026673641987144947
patient O 1 0.9999905824661255
chromosomes O 1 0.5272051692008972
. O 0 0.006166539154946804

This O 0 0.009621966630220413
mutation O 1 0.9999203681945801
eliminates O 0 0.07088086009025574
the O 0 0.002488776808604598
ability O 0 0.007458942476660013
of O 0 0.0029658644925802946
HFE O 1 0.9999992847442627
to O 0 0.002504432573914528
associate O 0 0.009910007007420063
with O 0 0.0024902026634663343
beta2 O 1 0.9998512268066406
- O 0 0.07530403882265091
microglobulin O 1 0.9999507665634155
( O 0 0.009985078126192093
beta2m O 1 0.9998387098312378
) O 0 0.0029876611661165953
and O 0 0.0018115555867552757
prevents O 1 0.8516917824745178
cell O 0 0.06575336307287216
- O 0 0.03024047426879406
surface O 0 0.019482772797346115
expression O 0 0.03172783553600311
. O 0 0.005317993462085724

A O 0 0.025153758004307747
second O 0 0.023515626788139343
mutation O 1 0.9999630451202393
that O 0 0.0020974702201783657
has O 0 0.0027196656446903944
no O 0 0.0022203477565199137
effect O 0 0.012770346365869045
on O 0 0.003712825709953904
beta2m O 1 0.9997817873954773
association O 0 0.020072754472494125
, O 0 0.003671315498650074
H63D O 1 0.9999982118606567
, O 0 0.002113303868100047
was O 0 0.004482603631913662
found O 0 0.0029721357859671116
in O 0 0.000664564489852637
eight O 0 0.0016771656228229403
out O 0 0.0018054679967463017
of O 0 0.001321344985626638
nine O 0 0.012075466103851795
patients O 1 0.999992847442627
heterozygous O 1 0.9995263814926147
for O 0 0.001922153402119875
the O 0 0.004674446769058704
C282Y O 1 0.9998830556869507
mutant O 1 0.9990718364715576
. O 0 0.00839286670088768

In O 0 0.0032781586050987244
this O 0 0.001789132016710937
report O 0 0.002701745368540287
, O 0 0.0009557792800478637
we O 0 0.0007655829540453851
demonstrate O 0 0.0038534209597855806
in O 0 0.002010760363191366
cultured O 0 0.1466369330883026
293 O 1 0.979900062084198
cells O 0 0.10292646288871765
overexpressing O 1 0.9997947812080383
wild O 0 0.04856587573885918
- O 0 0.03247619420289993
type O 0 0.06332135945558548
or O 0 0.008604045957326889
mutant O 1 0.9999712705612183
HFE O 1 0.9999935626983643
proteins O 0 0.02835729718208313
that O 0 0.0008682158659212291
both O 0 0.0008148657507263124
the O 0 0.0023839238565415144
wild O 0 0.0321180485188961
- O 0 0.023452937602996826
type O 0 0.040949128568172455
and O 0 0.0034166392870247364
H63D O 1 0.9999992847442627
HFE O 1 0.9999990463256836
proteins O 0 0.04885470122098923
form O 0 0.010156864300370216
stable O 0 0.039817385375499725
complexes O 0 0.02506210096180439
with O 0 0.0015388604952022433
the O 0 0.006253798957914114
transferrin O 1 0.9998087286949158
receptor O 1 0.9991388320922852
( O 0 0.013113054446876049
TfR O 1 0.9999569654464722
) O 0 0.005085915792733431
. O 0 0.003929671365767717

The O 0 0.010895886458456516
C282Y O 1 0.9996151924133301
mutation O 1 0.9999464750289917
nearly O 0 0.02336711809039116
completely O 0 0.022646935656666756
prevents O 0 0.04839767888188362
the O 0 0.0024959298316389322
association O 0 0.006537171080708504
of O 0 0.0009992679115384817
the O 0 0.0061408099718391895
mutant O 1 0.9999754428863525
HFE O 1 0.9999954700469971
protein O 0 0.06887352466583252
with O 0 0.0016684111906215549
the O 0 0.0055565242655575275
TfR O 1 0.9997815489768982
. O 0 0.006327500566840172

Studies O 0 0.009293357841670513
on O 0 0.003787666093558073
cell O 0 0.05322073772549629
- O 0 0.028112336993217468
associated O 0 0.016635458916425705
transferrin O 1 0.9748451709747314
at O 0 0.005744997877627611
37 O 0 0.02015090174973011
degrees O 0 0.010107447393238544
C O 0 0.07145959138870239
suggest O 0 0.004924061708152294
that O 0 0.0007736210827715695
the O 0 0.003454409772530198
overexpressed O 1 0.9996128678321838
wild O 0 0.04757282882928848
- O 0 0.04213789477944374
type O 1 0.6651436686515808
HFE O 1 0.9999901056289673
protein O 0 0.12346133589744568
decreases O 0 0.047069892287254333
the O 0 0.002599532948806882
affinity O 0 0.03304082527756691
of O 0 0.0011463516857475042
the O 0 0.004567915573716164
TfR O 1 0.999948263168335
for O 0 0.005710843950510025
transferrin O 1 0.9932878613471985
. O 0 0.006595111917704344

The O 0 0.014514345675706863
overexpressed O 1 0.9995367527008057
H63D O 1 0.9999741315841675
protein O 0 0.09556280076503754
does O 0 0.00395888602361083
not O 0 0.0012679204810410738
have O 0 0.0013108710991218686
this O 0 0.0017511083278805017
effect O 0 0.012133221141994
, O 0 0.0009396765963174403
providing O 0 0.0025294071529060602
the O 0 0.001502324128523469
first O 0 0.0025057338643819094
direct O 0 0.004714908078312874
evidence O 0 0.0015133993001654744
for O 0 0.0011682648910209537
a O 0 0.006013175472617149
functional O 0 0.030054474249482155
consequence O 0 0.03303445875644684
of O 0 0.0015115905553102493
the O 0 0.005871783941984177
H63D O 1 0.9999998807907104
mutation O 1 0.9999902248382568
. O 0 0.007341303862631321

Addition O 0 0.005411263555288315
of O 0 0.0019630463793873787
soluble O 0 0.2062562257051468
wild O 0 0.03774615004658699
- O 0 0.03948065638542175
type O 1 0.9260200262069702
HFE O 1 0.9999990463256836
/ O 1 0.9828470945358276
beta2m O 1 0.9998483657836914
heterodimers O 1 0.9984177350997925
to O 0 0.00476409075781703
cultured O 0 0.19055558741092682
cells O 0 0.05055003985762596
also O 0 0.002601150656118989
decreased O 0 0.05671486631035805
the O 0 0.0034871436655521393
apparent O 0 0.046052560210227966
affinity O 0 0.03352102264761925
of O 0 0.0013160613598302007
the O 0 0.0038747191429138184
TfR O 1 0.999896764755249
for O 0 0.002210428239777684
its O 0 0.0036569545045495033
ligand O 0 0.08087445050477982
under O 0 0.004804353229701519
steady O 0 0.029390914365649223
- O 0 0.01893424056470394
state O 0 0.002696377458050847
conditions O 0 0.008326863870024681
, O 0 0.0011606286279857159
both O 0 0.0014285388169810176
in O 0 0.0024238519836217165
293 O 1 0.9933039546012878
cells O 0 0.05188892036676407
and O 0 0.0016813571564853191
in O 0 0.0038065838161855936
HeLa O 1 0.9999974966049194
cells O 0 0.11107203364372253
. O 0 0.006350396201014519

Furthermore O 0 0.030155595391988754
, O 0 0.0020354019943624735
at O 0 0.003687094198539853
4 O 0 0.01004732958972454
degrees O 0 0.011967280879616737
C O 0 0.13192327320575714
, O 0 0.0013974406756460667
the O 0 0.001813305076211691
added O 0 0.005595589987933636
soluble O 0 0.09294386208057404
complex O 0 0.010018880479037762
of O 0 0.004294359125196934
HFE O 1 0.9999998807907104
/ O 1 0.9923572540283203
beta2m O 1 0.9994031190872192
inhibited O 1 0.97622150182724
binding O 0 0.015089279972016811
of O 0 0.002150626853108406
transferrin O 1 0.9935374855995178
to O 0 0.005591457709670067
HeLa O 1 0.999157190322876
cell O 0 0.08759598433971405
TfR O 1 0.9899320602416992
in O 0 0.0025736133102327585
a O 0 0.008334845304489136
concentration O 0 0.051440536975860596
- O 0 0.02793641947209835
dependent O 0 0.03170653060078621
manner O 0 0.011603408493101597
. O 0 0.004308158066123724

Scatchard O 0 0.20072586834430695
plots O 0 0.0199411753565073
of O 0 0.0011693654814735055
these O 0 0.0007808699738234282
data O 0 0.0018138645682483912
indicate O 0 0.004378789104521275
that O 0 0.000733668974135071
the O 0 0.001760244369506836
added O 0 0.006928847171366215
heterodimer O 1 0.99973064661026
substantially O 0 0.05098491162061691
reduced O 0 0.021251730620861053
the O 0 0.0031289285980165005
affinity O 0 0.040528830140829086
of O 0 0.0033916523680090904
TfR O 1 0.999549925327301
for O 0 0.004387416411191225
transferrin O 1 0.9959142804145813
. O 0 0.006167360581457615

These O 0 0.001946316915564239
results O 0 0.004780754912644625
establish O 0 0.005115365143865347
a O 0 0.007662190590053797
molecular O 0 0.0345030203461647
link O 0 0.024193117395043373
between O 0 0.006289937533438206
HFE O 1 0.999988317489624
and O 0 0.001765024964697659
a O 0 0.006381362676620483
key O 0 0.01095021516084671
protein O 0 0.056504037231206894
involved O 0 0.006277331616729498
in O 0 0.0016153452452272177
iron O 0 0.05854158475995064
transport O 0 0.009081505239009857
, O 0 0.001306185033172369
the O 0 0.0045255632139742374
TfR O 1 0.9999979734420776
, O 0 0.0016763932071626186
and O 0 0.0008151030633598566
raise O 0 0.006507231388241053
the O 0 0.0019832048565149307
possibility O 0 0.008283290080726147
that O 0 0.0014107493916526437
alterations O 0 0.02891450561583042
in O 0 0.0010106604313477874
this O 0 0.0018837739480659366
regulatory O 0 0.03404388949275017
mechanism O 0 0.02916785143315792
may O 0 0.006707439664751291
play O 0 0.002190010854974389
a O 0 0.0031183017417788506
role O 0 0.005060351453721523
in O 0 0.0011469356250017881
the O 0 0.0037834669928997755
pathogenesis O 1 0.9999994039535522
of O 0 0.0097200907766819
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.006165335886180401
. O 0 0.0050285737961530685

Genomic O 0 0.1567162424325943
organization O 0 0.00576501339673996
of O 0 0.0010282975854352117
the O 0 0.005380307789891958
UBE3A O 1 0.9999998807907104
/ O 1 0.9778273701667786
E6 O 1 0.9999297857284546
- O 0 0.05652821809053421
AP O 0 0.09294112026691437
gene O 1 0.9508013129234314
and O 0 0.0031053100246936083
related O 0 0.018796976655721664
pseudogenes O 1 0.9968451261520386
. O 0 0.0071022966876626015

The O 0 0.016103470697999
UBE3A O 1 0.9999945163726807
gene O 1 0.9942620992660522
encodes O 0 0.11189225316047668
the O 0 0.005782800260931253
E6 O 1 0.9995213747024536
- O 0 0.04336158558726311
AP O 0 0.07125458866357803
ubiquitin O 0 0.2999036908149719
- O 0 0.04496615752577782
protein O 0 0.08766477555036545
ligase O 0 0.060042694211006165
and O 0 0.0016296005342155695
has O 0 0.003410019911825657
recently O 0 0.011010791175067425
been O 0 0.00275910971686244
shown O 0 0.00361696002073586
to O 0 0.0009658060153014958
be O 0 0.002808710327371955
mutated O 1 0.999994158744812
in O 0 0.016292501240968704
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 1.0
who O 0 0.005730162840336561
lack O 0 0.019264252856373787
15q11 O 1 0.9999371767044067
- O 0 0.0595187172293663
q13 O 1 0.9999328851699829
deletions O 1 0.961427628993988
or O 0 0.009775632061064243
chromosome O 1 0.9999524354934692
15 O 0 0.02225111424922943
paternal O 1 0.9994218349456787
uniparental B-Disease 1 0.9999994039535522
disomy I-Disease 1 0.9990543723106384
. O 0 0.00930494349449873

Previous O 0 0.0353558212518692
UBE3A O 1 0.9997598528862
cDNA O 0 0.18881087005138397
analysis O 0 0.008514554239809513
has O 0 0.003602254204452038
shown O 0 0.005975643172860146
a O 0 0.007566297892481089
coding O 0 0.08721085637807846
region O 0 0.008768294006586075
of O 0 0.001598298898898065
approximately O 0 0.008019979111850262
2 O 0 0.013081460259854794
. O 0 0.00499795563519001

6 O 0 0.032511044293642044
kb O 1 0.8042157292366028
and O 0 0.0015512265963479877
a O 0 0.0067700170911848545
3 O 0 0.014746061526238918
- O 0 0.029878534376621246
untranslated O 1 0.5942118167877197
region O 0 0.018487980589270592
( O 0 0.007855120114982128
UTR O 1 0.9932839870452881
) O 0 0.004509343300014734
of O 0 0.0030274782329797745
< O 1 0.9588807225227356
50 O 0 0.014058557339012623
bp O 0 0.0582304410636425
, O 0 0.0023908163420856
whereas O 0 0.013026324100792408
Northern O 0 0.011826504953205585
analysis O 0 0.005515698809176683
has O 0 0.004090502858161926
indicated O 0 0.015057670883834362
mRNA O 0 0.04558492824435234
sizes O 0 0.008569124154746532
of O 0 0.0014626550255343318
5 O 0 0.012150180526077747
- O 0 0.023223476484417915
8 O 0 0.02149967849254608
kb O 1 0.7311414480209351
. O 0 0.007207006681710482

We O 0 0.0030277282930910587
have O 0 0.0018913488602265716
analyzed O 0 0.013356893323361874
additional O 0 0.008224347606301308
cDNA O 0 0.16831322014331818
clones O 0 0.3296496570110321
and O 0 0.0014510494656860828
provide O 0 0.0016478662146255374
evidence O 0 0.0012743741972371936
for O 0 0.0011554027441889048
an O 0 0.0019409724045544863
additional O 0 0.005936755798757076
0 O 0 0.028780758380889893
. O 0 0.00500201340764761

5 O 0 0.022847997024655342
kb O 0 0.13741996884346008
of O 0 0.0024669384583830833
5 O 0 0.014382855966687202
- O 0 0.030795827507972717
UTR O 1 0.9866661429405212
and O 0 0.004466110374778509
> O 1 0.7527834177017212
2 O 0 0.012734745629131794
kb O 0 0.12639234960079193
of O 0 0.002442419994622469
3 O 0 0.016493164002895355
- O 0 0.04576687887310982
UTR O 1 0.9322015047073364
. O 0 0.009393805637955666

We O 0 0.003037133486941457
have O 0 0.0015508125070482492
established O 0 0.004766397178173065
the O 0 0.0036038679536432028
genomic O 0 0.19259251654148102
organization O 0 0.006681156810373068
of O 0 0.0026702997274696827
UBE3A O 1 0.9999969005584717
and O 0 0.0011471824254840612
the O 0 0.0019281180575489998
sequence O 0 0.015967044979333878
of O 0 0.003259144024923444
intron O 1 0.999935507774353
- O 0 0.07163967192173004
exon O 1 0.9944579601287842
borders O 0 0.02040434628725052
. O 0 0.005561331752687693

We O 0 0.0032603058498352766
have O 0 0.0016011853003874421
also O 0 0.0018623698269948363
mapped O 0 0.024166518822312355
two O 0 0.002226099604740739
highly O 0 0.020569216459989548
homologous O 0 0.17197003960609436
processed O 0 0.03769923001527786
pseudogenes O 1 0.9937376976013184
, O 0 0.00583166116848588
UBE3AP1 O 1 0.9999572038650513
and O 0 0.005104209296405315
UBE3AP2 O 1 0.9999921321868896
, O 0 0.0020431505981832743
to O 0 0.002710124710574746
chromosomes O 0 0.09620444476604462
2 O 0 0.010102453641593456
and O 0 0.0015641726786270738
21 O 0 0.010821225121617317
, O 0 0.0014563272707164288
respectively O 0 0.006214335560798645
, O 0 0.001158444443717599
and O 0 0.000808963377494365
determined O 0 0.008281061425805092
their O 0 0.002716320799663663
genomic O 0 0.25686681270599365
organization O 0 0.01020166464149952
. O 0 0.004389794543385506

These O 0 0.0028382388409227133
results O 0 0.005726998206228018
will O 0 0.0014398276107385755
form O 0 0.0037271829787641764
the O 0 0.0014054190833121538
basis O 0 0.001358731067739427
for O 0 0.0010186824947595596
studies O 0 0.0028394388500601053
of O 0 0.0021676940377801657
mutation O 1 0.9999955892562866
and O 0 0.0026905930135399103
imprinting O 1 0.9998475313186646
of O 0 0.006249125115573406
UBE3A O 1 0.9999983310699463
. O 0 0.009878852404654026

Mutation O 1 0.9999300241470337
spectrum O 0 0.07471194118261337
and O 0 0.004918559920042753
genotype O 1 0.9999942779541016
- O 0 0.09084217250347137
phenotype O 1 0.9999880790710449
analyses O 0 0.013624814338982105
in O 0 0.0046596769243478775
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 0.003902611555531621
Bannayan B-Disease 1 0.9999994039535522
- I-Disease 1 0.9997465014457703
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.0027991549577564
two O 0 0.004843597766011953
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
with O 0 0.011431236751377583
germline O 1 0.9999990463256836
PTEN O 1 1.0
mutation O 1 0.999997615814209
. O 0 0.0075959921814501286

The O 0 0.02097216062247753
tumour B-Disease 1 1.0
suppressor O 1 1.0
gene O 1 0.9999958276748657
PTEN O 1 0.9999998807907104
, O 0 0.002052241237834096
which O 0 0.0009755117353051901
maps O 0 0.0034709065221250057
to O 0 0.002352355280891061
10q23 O 1 0.9970433115959167
. O 0 0.007707191631197929

3 O 0 0.014596597291529179
and O 0 0.0019139269134029746
encodes O 0 0.09015189111232758
a O 0 0.00895950198173523
403 O 0 0.0978209525346756
amino O 0 0.08072517067193985
acid O 0 0.11652600765228271
dual O 0 0.0406377948820591
specificity O 0 0.09138546139001846
phosphatase O 1 0.9997753500938416
( O 0 0.010979204438626766
protein O 0 0.11663965880870819
tyrosine O 1 0.9951062202453613
phosphatase O 1 0.9985344409942627
; O 0 0.011219507083296776
PTPase O 1 0.9996824264526367
) O 0 0.004726381041109562
, O 0 0.001420175889506936
was O 0 0.005907402373850346
shown O 0 0.00692699383944273
recently O 0 0.0073442617431283
to O 0 0.0009919885778799653
play O 0 0.0022038856986910105
a O 0 0.0055429525673389435
broad O 0 0.02052907831966877
role O 0 0.009907910600304604
in O 0 0.0028293689247220755
human O 0 0.021338853985071182
malignancy B-Disease 1 0.9999997615814209
. O 0 0.006555560044944286

Somatic O 1 0.9980546236038208
PTEN O 1 0.9999984502792358
deletions O 1 0.9815752506256104
and O 0 0.004542500711977482
mutations O 1 0.9989915490150452
were O 0 0.0014310578117147088
observed O 0 0.007083015516400337
in O 0 0.0018499608850106597
sporadic B-Disease 1 0.9978787899017334
breast I-Disease 1 1.0
, I-Disease 0 0.006805185228586197
brain I-Disease 1 1.0
, I-Disease 0 0.009250965900719166
prostate I-Disease 1 1.0
and I-Disease 0 0.40398895740509033
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.7189086675643921
lines O 0 0.007594266906380653
and O 0 0.0006629835697822273
in O 0 0.0007050201529636979
several O 0 0.0019120495999231935
primary O 0 0.33360254764556885
tumours B-Disease 1 1.0
such O 0 0.002064597327262163
as O 0 0.006168334279209375
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 0.9254263639450073
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.8434723019599915
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 0.007252223789691925

In O 0 0.0034994620364159346
addition O 0 0.004807865247130394
, O 0 0.0038334010168910027
PTEN O 1 0.9999997615814209
was O 0 0.009882379323244095
identified O 0 0.008768973872065544
as O 0 0.0011588720371946692
the O 0 0.003924566321074963
susceptibility O 1 0.9999991655349731
gene O 1 0.9900107979774475
for O 0 0.0019793540704995394
two O 0 0.006765427067875862
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.011055944487452507
CD B-Disease 0 0.07985930889844894
; O 0 0.007835584692656994
MIM O 1 0.9999992847442627
158350 O 1 0.9985061287879944
) O 0 0.003598629031330347
and O 0 0.0023916419595479965
Bannayan B-Disease 1 0.9997661709785461
- I-Disease 0 0.08264653384685516
Zonana I-Disease 1 0.9999587535858154
( I-Disease 0 0.011907103471457958
BZS I-Disease 1 0.9977596998214722
) I-Disease 0 0.003883079858496785
or I-Disease 0 0.005350219551473856
Ruvalcaba I-Disease 1 0.9999611377716064
- I-Disease 0 0.048714958131313324
Riley I-Disease 1 0.9996994733810425
- I-Disease 1 0.8203668594360352
Smith I-Disease 1 0.9997960925102234
syndrome I-Disease 1 1.0
( O 0 0.023534022271633148
MIM O 1 0.9999998807907104
153480 O 1 0.9999198913574219
) O 0 0.006075955927371979
. O 0 0.003973830491304398

Constitutive O 0 0.2683643102645874
DNA O 0 0.059786975383758545
from O 0 0.004377458710223436
37 O 0 0.02756386622786522
CD B-Disease 0 0.032463815063238144
families O 0 0.005757346749305725
and O 0 0.0014131158823147416
seven O 0 0.006916682701557875
BZS B-Disease 1 0.9996084570884705
families O 0 0.010972915217280388
was O 0 0.009199758991599083
screened O 0 0.05130848288536072
for O 0 0.0059657106176018715
germline O 1 0.9999676942825317
PTEN O 1 0.9999998807907104
mutations O 1 0.9998214840888977
. O 0 0.010249501094222069

PTEN O 1 0.9999998807907104
mutations O 1 0.9999170303344727
were O 0 0.003257154021412134
identified O 0 0.00966253038495779
in O 0 0.0011652647517621517
30 O 0 0.005759484600275755
of O 0 0.0019438082817941904
37 O 0 0.030196791514754295
( O 0 0.007652131840586662
81 O 0 0.057259440422058105
% O 0 0.005446169059723616
) O 0 0.0029107430018484592
CD B-Disease 0 0.030269967392086983
families O 0 0.006053819786757231
, O 0 0.0010579116642475128
including O 0 0.0029089374002069235
missense O 1 0.9998852014541626
and O 0 0.002161511220037937
nonsense O 0 0.04502151906490326
point O 0 0.012262210249900818
mutations O 1 0.9999287128448486
, O 0 0.00307771866209805
deletions O 1 0.5065777897834778
, O 0 0.0026104466523975134
insertions O 0 0.4606005549430847
, O 0 0.0019098685588687658
a O 0 0.010277250781655312
deletion O 1 0.9997838139533997
/ O 0 0.3470928966999054
insertion O 1 0.6444379091262817
and O 0 0.0025172599125653505
splice O 1 0.9975104331970215
site O 0 0.029411958530545235
mutations O 1 0.9995575547218323
. O 0 0.006628918927162886

These O 0 0.0072956569492816925
mutations O 1 0.9974812865257263
were O 0 0.0019119884818792343
scattered O 0 0.005874880123883486
over O 0 0.0013460854534059763
the O 0 0.0018172173295170069
entire O 0 0.01396852545440197
length O 0 0.009838988073170185
of O 0 0.0033401341643184423
PTEN O 1 1.0
, O 0 0.0018411822384223342
with O 0 0.0009187055402435362
the O 0 0.0016970185097306967
exception O 0 0.007401283830404282
of O 0 0.0008128553163260221
the O 0 0.0018159964820370078
first O 0 0.002681202255189419
, O 0 0.0013340335572138429
fourth O 0 0.009568251669406891
and O 0 0.0013827814254909754
last O 0 0.0122764203697443
exons O 1 0.9782047867774963
. O 0 0.008992835879325867

A O 0 0.02712089568376541
hot O 0 0.05566110834479332
spot O 0 0.03210476040840149
for O 0 0.006418155040591955
PTEN O 1 0.9999998807907104
mutation O 1 0.9998750686645508
in O 0 0.003622685093432665
CD B-Disease 0 0.027657529339194298
was O 0 0.006577278021723032
identified O 0 0.01102751400321722
in O 0 0.002750987187027931
exon O 1 0.9984984397888184
5 O 0 0.008627496659755707
that O 0 0.001051860861480236
contains O 0 0.0026009699795395136
the O 0 0.002870995784178376
PTPase O 1 0.9998670816421509
core O 0 0.02617616392672062
motif O 0 0.09165903180837631
, O 0 0.0016349987126886845
with O 0 0.001179164508357644
13 O 0 0.006204466335475445
of O 0 0.0017216448904946446
30 O 0 0.009798957966268063
( O 0 0.005216482561081648
43 O 0 0.022609444335103035
% O 0 0.005315491929650307
) O 0 0.00435003312304616
CD B-Disease 0 0.06928330659866333
mutations O 1 0.9994681477546692
identified O 0 0.015008965507149696
in O 0 0.0013493563747033477
this O 0 0.0038558815140277147
exon O 1 0.9969678521156311
. O 0 0.0062753986567258835

Seven O 0 0.007658724673092365
of O 0 0.002253015525639057
30 O 0 0.012296505272388458
( O 0 0.00614531384781003
23 O 0 0.014995062723755836
% O 0 0.005317463539540768
) O 0 0.0024752391036599874
were O 0 0.0009645544923841953
within O 0 0.0019720764830708504
the O 0 0.002460860414430499
core O 0 0.0208848025649786
motif O 0 0.08655816316604614
, O 0 0.001656841253861785
the O 0 0.0026921494863927364
majority O 0 0.011326860636472702
( O 0 0.003075858112424612
five O 0 0.0016366926720365882
of O 0 0.0009406113531440496
seven O 0 0.002911087591201067
) O 0 0.0015789588214829564
of O 0 0.0007403161143884063
which O 0 0.001446044072508812
were O 0 0.003587733954191208
missense O 1 0.9999982118606567
mutations O 1 0.9999953508377075
, O 0 0.0027279553469270468
possibly O 0 0.012926092371344566
pointing O 0 0.009187310934066772
to O 0 0.0010317163541913033
the O 0 0.002171250991523266
functional O 0 0.019456228241324425
significance O 0 0.004106289241462946
of O 0 0.0008214210392907262
this O 0 0.0018565329955890775
region O 0 0.010728423483669758
. O 0 0.004936567973345518

Germline O 1 0.9999692440032959
PTEN O 1 0.9999998807907104
mutations O 1 0.999940037727356
were O 0 0.002811128506436944
identified O 0 0.008761503733694553
in O 0 0.0009877203265205026
four O 0 0.0015200631460174918
of O 0 0.0011538469698280096
seven O 0 0.0049685281701385975
( O 0 0.005856911186128855
57 O 0 0.035767972469329834
% O 0 0.007827072404325008
) O 0 0.00740562891587615
BZS B-Disease 1 0.9990297555923462
families O 0 0.014535919763147831
studied O 0 0.009278307668864727
. O 0 0.004789740778505802

Interestingly O 0 0.10846631228923798
, O 0 0.0016207711305469275
none O 0 0.0031940387561917305
of O 0 0.0009930685628205538
these O 0 0.002581105101853609
mutations O 1 0.9999215602874756
was O 0 0.0067993467673659325
observed O 0 0.007219771854579449
in O 0 0.0008996156975626945
the O 0 0.0030945325270295143
PTPase O 1 0.9996901750564575
core O 0 0.02703355811536312
motif O 0 0.12089069932699203
. O 0 0.0064879246056079865

It O 0 0.004248736891895533
is O 0 0.002291447017341852
also O 0 0.0015434985980391502
worthy O 0 0.018687918782234192
of O 0 0.0011933902278542519
note O 0 0.007720645517110825
that O 0 0.0006847215699963272
a O 0 0.003438324434682727
single O 0 0.010522759519517422
nonsense O 0 0.041131481528282166
point O 0 0.011496556922793388
mutation O 1 0.9999964237213135
, O 0 0.0037857634015381336
R233X O 1 0.999873161315918
, O 0 0.0021546254865825176
was O 0 0.006048224400728941
observed O 0 0.008601312525570393
in O 0 0.0015249227872118354
the O 0 0.004794084466993809
germline O 1 0.9999208450317383
DNA O 0 0.04639723151922226
from O 0 0.002288481453433633
two O 0 0.0015055583789944649
unrelated O 0 0.03335968032479286
CD B-Disease 0 0.03142435848712921
families O 0 0.0067410580813884735
and O 0 0.0016426092479377985
one O 0 0.007229744456708431
BZS B-Disease 1 0.9999098777770996
family O 0 0.027479762211441994
. O 0 0.00667682895436883

Genotype O 1 0.999996542930603
- O 1 0.6635660529136658
phenotype O 1 0.9999935626983643
studies O 0 0.006062999367713928
were O 0 0.0012342650443315506
not O 0 0.0012425404274836183
performed O 0 0.005763138644397259
on O 0 0.001163911772891879
this O 0 0.0014106506714597344
small O 0 0.0037891599349677563
group O 0 0.00575998704880476
of O 0 0.0037834979593753815
BZS B-Disease 1 0.9995192289352417
families O 0 0.0174273569136858
. O 0 0.006051149219274521

However O 0 0.008030949160456657
, O 0 0.004843326285481453
genotype O 1 0.9999911785125732
- O 0 0.13873061537742615
phenotype O 1 0.9999877214431763
analysis O 0 0.013377824798226357
inthe O 1 0.9848259091377258
group O 0 0.007490737829357386
of O 0 0.001784247811883688
CD B-Disease 0 0.038136743009090424
families O 0 0.007521188352257013
revealed O 0 0.0129605857655406
two O 0 0.001484196400269866
possible O 0 0.004675795789808035
associations O 0 0.010831831954419613
worthy O 0 0.02583165466785431
of O 0 0.0017651391681283712
follow O 0 0.008339970372617245
- O 0 0.012892480939626694
up O 0 0.0028622823301702738
in O 0 0.0013541082153096795
independent O 0 0.004284302704036236
analyses O 0 0.012812115252017975
. O 0 0.004632091615349054

The O 0 0.004869796801358461
first O 0 0.004103429149836302
was O 0 0.006199878640472889
an O 0 0.0024806573055684566
association O 0 0.010694332420825958
noted O 0 0.0031138139311224222
in O 0 0.0008073123171925545
the O 0 0.0015098785515874624
group O 0 0.0028665626887232065
of O 0 0.0010766602354124188
CD B-Disease 0 0.04787730798125267
families O 0 0.008690179325640202
with O 0 0.011916441842913628
breast B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.00743612227961421

A O 0 0.024514738470315933
correlation O 0 0.04105370119214058
was O 0 0.009422383271157742
observed O 0 0.010066219605505466
between O 0 0.0014120020205155015
the O 0 0.0021722232922911644
presence O 0 0.013227569870650768
/ O 0 0.07526897639036179
absence O 0 0.014837530441582203
of O 0 0.0014038539957255125
a O 0 0.021470926702022552
PTEN O 1 1.0
mutation O 1 0.9999828338623047
and O 0 0.0014645784394815564
the O 0 0.0022939022164791822
type O 0 0.06951086223125458
of O 0 0.004143301397562027
breast O 1 1.0
involvement O 0 0.07730378955602646
( O 0 0.007706805132329464
unaffected O 1 0.9999234676361084
versus O 1 0.9802553653717041
benign O 1 0.9999982118606567
versus O 1 0.9994018077850342
malignant O 1 1.0
) O 0 0.005946562625467777
. O 0 0.004152911715209484

Specifically O 0 0.011512712575495243
and O 0 0.0011970954947173595
more O 0 0.0012541242176666856
directly O 0 0.004149107728153467
, O 0 0.0013017841847613454
an O 0 0.002488356316462159
association O 0 0.012989231385290623
was O 0 0.004577849991619587
also O 0 0.0016855732537806034
observed O 0 0.006529359612613916
between O 0 0.0010849429527297616
the O 0 0.0015439962735399604
presence O 0 0.005051097832620144
of O 0 0.0011804034002125263
a O 0 0.01718129776418209
PTEN O 1 1.0
mutation O 1 0.9999998807907104
and O 0 0.15142707526683807
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.008477061986923218

Secondly O 1 0.8018476963043213
, O 0 0.0022040000185370445
there O 0 0.0015407621394842863
appeared O 0 0.005766930058598518
to O 0 0.0009591879206709564
be O 0 0.0013299387646839023
an O 0 0.0031869085505604744
interdependent O 1 0.6826369166374207
association O 0 0.01714646816253662
between O 0 0.00660389568656683
mutations O 1 0.9998536109924316
upstream O 0 0.04041097313165665
and O 0 0.001037638750858605
within O 0 0.0019299568375572562
the O 0 0.003919281531125307
PTPase O 1 0.9997856020927429
core O 0 0.03034532070159912
motif O 0 0.08908741921186447
, O 0 0.001365377102047205
the O 0 0.0019365416374057531
core O 0 0.013504195027053356
motif O 0 0.05717960372567177
containing O 0 0.005270618479698896
the O 0 0.001657205051742494
majority O 0 0.007095964625477791
of O 0 0.0035292543470859528
missense O 1 0.9999996423721313
mutations O 1 0.9999961853027344
, O 0 0.001685075811110437
and O 0 0.0006259119254536927
the O 0 0.0016782807651907206
involvement O 0 0.012035996653139591
of O 0 0.0007829398382455111
all O 0 0.001184138935059309
major O 0 0.012327533215284348
organ O 1 0.9941310286521912
systems O 0 0.01155502162873745
( O 0 0.0033649506513029337
central O 0 0.005939200054854155
nervous O 1 0.9999979734420776
system O 0 0.011776422150433064
, O 0 0.004689102992415428
thyroid O 1 1.0
, O 0 0.012165206484496593
breast O 1 1.0
, O 0 0.0075181168504059315
skin O 1 1.0
and O 0 0.021328460425138474
gastrointestinal O 1 1.0
tract O 1 1.0
) O 0 0.005361492745578289
. O 0 0.003538647433742881

However O 0 0.0073436531238257885
, O 0 0.0010634864447638392
these O 0 0.0006107113440521061
observations O 0 0.004130716901272535
would O 0 0.0014642173191532493
need O 0 0.0026728787925094366
to O 0 0.0010487670078873634
be O 0 0.0015659895725548267
confirmed O 0 0.010805907659232616
by O 0 0.0019527708645910025
studying O 0 0.003529889741912484
a O 0 0.005399022717028856
larger O 0 0.005925134290009737
number O 0 0.002370788250118494
of O 0 0.0018193204887211323
CD B-Disease 0 0.04226290434598923
families O 0 0.011331812478601933
. O 0 0.004761658143252134

Molecular O 0 0.1567402333021164
defects O 1 0.9999845027923584
leading O 0 0.009038681164383888
to O 0 0.0012193216243758798
human O 0 0.006619825027883053
complement B-Disease 0 0.03193419426679611
component I-Disease 1 0.9921873807907104
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.0022284407168626785
an O 0 0.0024468828924000263
African O 0 0.01860835961997509
- O 0 0.026214709505438805
American O 0 0.011188254691660404
family O 0 0.016998769715428352
. O 0 0.005859574768692255

Complement B-Disease 0 0.07705079764127731
component I-Disease 1 0.6636613607406616
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 0.019194982945919037
C6D B-Disease 1 0.9999986886978149
) O 0 0.006427635904401541
was O 0 0.04039032384753227
diagnosed O 1 1.0
in O 0 0.0018966456409543753
a O 0 0.00572546711191535
16 O 0 0.010064997710287571
- O 0 0.014345159754157066
year O 0 0.0065703620202839375
- O 0 0.017519362270832062
old O 0 0.014579234644770622
African O 0 0.019062157720327377
- O 0 0.01949625089764595
American O 0 0.009660963900387287
male O 0 0.033975739032030106
with O 0 0.010423325002193451
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 0.011100087314844131

The O 0 0.01647253893315792
patients O 1 0.9999973773956299
father O 0 0.021222634240984917
and O 0 0.0011463980190455914
two O 0 0.001478860154747963
brothers O 0 0.02831059694290161
also O 0 0.002821957925334573
had O 0 0.009925836697220802
C6D B-Disease 1 0.9999866485595703
, O 0 0.001970760291442275
but O 0 0.0014022612012922764
gave O 0 0.003554624505341053
no O 0 0.001237531192600727
history O 0 0.0027243539225310087
of O 0 0.0045532770454883575
meningitis B-Disease 1 1.0
or O 0 0.005538055673241615
other O 0 0.0028070760890841484
neisserial B-Disease 1 0.9999994039535522
infection I-Disease 1 1.0
. O 0 0.006951786112040281

By O 0 0.0046553839929401875
using O 0 0.006407526321709156
exon O 1 0.9852308034896851
- O 0 0.02486589550971985
specific O 0 0.009921076707541943
polymerase O 1 0.9307841062545776
chain O 1 0.5210907459259033
reaction O 0 0.053403615951538086
( O 0 0.012309798039495945
PCR O 1 0.8985463976860046
) O 0 0.008279768750071526
/ O 0 0.04954921454191208
single O 0 0.02020195871591568
- O 0 0.03864672780036926
strand O 0 0.15279944241046906
conformation O 0 0.4186322093009949
polymorphism O 0 0.2036459743976593
as O 0 0.003590246895328164
a O 0 0.007458942476660013
screening O 0 0.04922650754451752
step O 0 0.011749964207410812
and O 0 0.0018370189936831594
nucleotide O 0 0.09508224576711655
sequencing O 0 0.038074348121881485
of O 0 0.0017556470120325685
target O 0 0.020367324352264404
exons O 1 0.9693156480789185
, O 0 0.001521697617135942
we O 0 0.0011770697310566902
determined O 0 0.007743994239717722
that O 0 0.0010564075782895088
the O 0 0.003242308972403407
proband O 1 0.9956529140472412
was O 0 0.00755656510591507
a O 0 0.007506931200623512
compound O 0 0.028564797714352608
heterozygote O 1 0.9929651021957397
for O 0 0.0023047709837555885
two O 0 0.004423606209456921
C6 O 1 0.9999994039535522
gene O 1 0.9997128844261169
mutations O 1 0.9995715022087097
. O 0 0.007738690357655287

The O 0 0.005136812571436167
first O 0 0.004409361630678177
, O 0 0.002982359379529953
1195delC O 1 0.9989539384841919
located O 0 0.010086729191243649
in O 0 0.0029738217126578093
exon O 1 0.9994069337844849
7 O 0 0.014473308809101582
, O 0 0.0010977513156831264
is O 0 0.00206065084785223
a O 0 0.006407241802662611
novel O 0 0.05549023300409317
mutation O 1 0.9999845027923584
, O 0 0.0017409843858331442
while O 0 0.001564724836498499
the O 0 0.0018384018912911415
second O 0 0.006860875524580479
, O 0 0.002151238964870572
1936delG O 1 0.9992244243621826
in O 0 0.004395166877657175
exon O 1 0.9998573064804077
12 O 0 0.01044552493840456
, O 0 0.0014744049403816462
has O 0 0.0026621646247804165
been O 0 0.003583478042855859
described O 0 0.006913135759532452
before O 0 0.0022115642204880714
to O 0 0.0021414346992969513
cause O 1 0.9985822439193726
C6D B-Disease 1 0.9999736547470093
in O 0 0.0019004676723852754
an O 0 0.0030546654015779495
unrelated O 0 0.03735079616308212
African O 0 0.0262726042419672
- O 0 0.023749960586428642
American O 0 0.00898150634020567
individual O 0 0.005922806449234486
. O 0 0.005186400376260281

Both O 0 0.00949156191200018
mutations O 1 0.999737560749054
result O 0 0.01117757335305214
in O 0 0.0026889070868492126
premature O 1 0.9999788999557495
termination O 1 0.9980623126029968
codons O 1 0.7559372186660767
and O 0 0.004753706511110067
C6 O 1 0.9999971389770508
null O 1 0.8888090252876282
alleles O 1 0.9998608827590942
. O 0 0.00725373812019825

Allele O 1 0.9997186064720154
- O 0 0.04302883893251419
specific O 0 0.009760772809386253
PCR O 1 0.580437421798706
indicated O 0 0.012591622769832611
that O 0 0.0010302842129021883
the O 0 0.003101811744272709
probands O 1 0.9989494681358337
two O 0 0.0026506558060646057
brothers O 0 0.02435888908803463
also O 0 0.003119516419246793
inherited O 1 0.9997230172157288
the O 0 0.006706429645419121
1195delC O 1 0.9999865293502808
mutation O 1 0.9999850988388062
from O 0 0.002927968977019191
their O 0 0.003025446552783251
heterozygous O 1 0.9999542236328125
mother O 0 0.030541352927684784
and O 0 0.001084511517547071
the O 0 0.003997672349214554
1936delG O 1 0.9999691247940063
mutation O 1 0.9999790191650391
from O 0 0.003676277818158269
their O 0 0.003214129013940692
homozygous O 1 0.9999974966049194
father O 0 0.04416276514530182
. O 0 0.002510916208848357
. O 0 0.0037878176663070917

PAX6 O 1 0.9999862909317017
mutations O 1 0.9997825026512146
reviewed O 0 0.024894243106245995
. O 0 0.00584410410374403

Mutations O 1 0.9997689127922058
in O 0 0.007271226495504379
PAX6 O 1 0.9999984502792358
are O 0 0.0020718954037874937
responsible O 0 0.011013943701982498
for O 0 0.002290714532136917
human O 0 0.01799347996711731
aniridia B-Disease 1 0.9999964237213135
and O 0 0.0015262534143403172
have O 0 0.001270744833163917
also O 0 0.0011925663566216826
been O 0 0.002905012108385563
found O 0 0.0040206159465014935
in O 0 0.0022086126264184713
patients O 1 0.9999955892562866
with O 0 0.0023016994819045067
Peters B-Disease 1 0.9999977350234985
anomaly I-Disease 1 0.9999791383743286
, O 0 0.0020988001488149166
with O 0 0.005892352666705847
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 0.0024839371908456087
with O 0 0.00459182308986783
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999985694885254
keratitis I-Disease 1 1.0
, O 0 0.002026016591116786
and O 0 0.000911656825337559
with O 0 0.0021594935096800327
isolated B-Disease 1 0.9967742562294006
foveal I-Disease 1 0.9999996423721313
hypoplasia I-Disease 1 0.9999998807907104
. O 0 0.009782985784113407

No O 0 0.011433711275458336
locus O 1 0.9980613589286804
other O 0 0.0020647321362048388
than O 0 0.007040491793304682
chromosome O 1 0.9999854564666748
11p13 O 1 0.9997668862342834
has O 0 0.0047896974720060825
been O 0 0.0044255368411540985
implicated O 1 0.9117483496665955
in O 0 0.004495453089475632
aniridia B-Disease 1 0.999998927116394
, O 0 0.0023663996253162622
and O 0 0.0024843427818268538
PAX6 O 1 0.9999996423721313
is O 0 0.003642710857093334
clearly O 0 0.004333822056651115
the O 0 0.0018851460190489888
major O 0 0.008060108870267868
, O 0 0.0011811694130301476
if O 0 0.001650882768444717
not O 0 0.0009148772805929184
only O 0 0.0016679728869348764
, O 0 0.0027336538769304752
gene O 1 0.9980465173721313
responsible O 0 0.02100203186273575
. O 0 0.0053836326114833355

Twenty O 0 0.03431767597794533
- O 0 0.015134964138269424
eight O 0 0.003387910546734929
percent O 0 0.0046179029159247875
of O 0 0.0017323599895462394
identified O 0 0.03363339975476265
PAX6 O 1 0.9999996423721313
mutations O 1 0.9999651908874512
are O 0 0.0037502169143408537
C O 1 0.9937900900840759
- O 0 0.07532694935798645
T O 1 0.9993065595626831
changes O 0 0.011343684047460556
at O 0 0.009595236741006374
CpG O 1 0.9978463649749756
dinucleotides O 1 0.9982815980911255
, O 0 0.0024695058818906546
20 O 0 0.004736915230751038
% O 0 0.0033177239820361137
are O 0 0.0015976818976923823
splicing O 0 0.4710875451564789
errors O 0 0.026380324736237526
, O 0 0.0013838132144883275
and O 0 0.0007290439098142087
more O 0 0.0010864980285987258
than O 0 0.0019499562913551927
30 O 0 0.006396816577762365
% O 0 0.00347158289514482
are O 0 0.002159362891688943
deletion O 1 0.9995673298835754
or O 0 0.008907434530556202
insertion O 1 0.8257349133491516
events O 0 0.009867330081760883
. O 0 0.004939906299114227

There O 0 0.003347994526848197
is O 0 0.002748331520706415
a O 0 0.007492517586797476
noticeably O 1 0.9892945289611816
elevated O 1 0.9934529066085815
level O 0 0.004061541520059109
of O 0 0.002536472864449024
mutation O 1 0.9999892711639404
in O 0 0.0015469850040972233
the O 0 0.0026701497845351696
paired O 0 0.055778149515390396
domain O 0 0.02697720192372799
compared O 0 0.008876627311110497
with O 0 0.0009609094122424722
the O 0 0.0017990198684856296
rest O 0 0.0047078519128263
of O 0 0.001469928422011435
the O 0 0.00673083309084177
gene O 1 0.9997749924659729
. O 0 0.006359495688229799

Increased O 0 0.05134090781211853
mutation O 1 0.9985620379447937
in O 0 0.0021503076422959566
the O 0 0.0044402992352843285
homeodomain O 1 0.9971670508384705
is O 0 0.0038378830067813396
accounted O 0 0.01363730151206255
for O 0 0.0010806305799633265
by O 0 0.0018351314356550574
the O 0 0.0051219891756772995
hypermutable O 1 0.9998867511749268
CpG O 1 0.987403392791748
dinucleotide O 1 0.8669129610061646
in O 0 0.005731681361794472
codon O 0 0.252240389585495
240 O 0 0.04878947511315346
. O 0 0.006143377162516117

Very O 0 0.00806253682821989
nearly O 0 0.010043996386229992
all O 0 0.0022855873685330153
mutations O 1 0.9999477863311768
appear O 0 0.008312939666211605
to O 0 0.0019222761038690805
cause O 1 0.9930428266525269
loss O 0 0.02517816238105297
of O 0 0.001292312634177506
function O 0 0.007440005429089069
of O 0 0.0009825947927311063
the O 0 0.004233223386108875
mutant O 1 0.999993085861206
allele O 1 0.9999834299087524
, O 0 0.002269942779093981
and O 0 0.000730297586414963
more O 0 0.0010129207512363791
than O 0 0.002127967309206724
80 O 0 0.010782597586512566
% O 0 0.0033209689427167177
of O 0 0.0021158272866159678
exonic O 1 0.9998823404312134
substitutions O 0 0.04004548117518425
result O 0 0.010205894708633423
in O 0 0.002404505154117942
nonsense O 0 0.0771714448928833
codons O 1 0.7996736168861389
. O 0 0.007021539844572544

In O 0 0.0042236302979290485
a O 0 0.013869835995137691
gene O 1 0.9893310070037842
with O 0 0.002269965363666415
such O 0 0.0019068968249484897
extraordinarily O 0 0.06420791149139404
high O 0 0.009406015276908875
sequence O 0 0.020578067749738693
conservation O 0 0.010751885361969471
throughout O 0 0.0035574561916291714
evolution O 0 0.012197514995932579
, O 0 0.0009798364480957389
there O 0 0.0009978143498301506
are O 0 0.00111472443677485
presumed O 0 0.17457814514636993
undiscovered O 1 0.9963208436965942
missense O 1 0.9999556541442871
mutations O 1 0.9999817609786987
, O 0 0.0016062150243669748
these O 0 0.0006269143777899444
are O 0 0.0008032344048842788
hypothesized O 1 0.5002554655075073
to O 0 0.0012592441635206342
exist O 0 0.0019561974331736565
in O 0 0.0012918567517772317
as O 0 0.002473448868840933
- O 0 0.018728263676166534
yet O 0 0.009319297038018703
unidentified O 0 0.06051136925816536
phenotypes O 1 0.9976625442504883
. O 0 0.0034376252442598343
. O 0 0.0046913824044167995

Genetic O 0 0.1698887199163437
heterogeneity O 0 0.25422072410583496
and O 0 0.002627859590575099
penetrance O 1 0.9951086640357971
analysis O 0 0.0037218641955405474
of O 0 0.000825161172542721
the O 0 0.005033538676798344
BRCA1 O 1 1.0
and O 0 0.0082918182015419
BRCA2 O 1 1.0
genes O 1 0.9969369173049927
in O 0 0.014878961257636547
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.012476656585931778
. O 0 0.0047808182425796986

The O 0 0.05168868973851204
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9788620471954346
Consortium O 0 0.04803318530321121
. O 0 0.005877690855413675

The O 0 0.0030743656679987907
contribution O 0 0.0074137295596301556
of O 0 0.0030141626484692097
BRCA1 O 1 1.0
and O 0 0.005156632978469133
BRCA2 O 1 1.0
to O 0 0.009874474257230759
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 0.008559714071452618
assessed O 0 0.018934858962893486
by O 0 0.0027826575096696615
linkage O 0 0.06654741615056992
and O 0 0.0033639883622527122
mutation O 1 0.9998999834060669
analysis O 0 0.0070050726644694805
in O 0 0.0028884601779282093
237 O 0 0.41852232813835144
families O 0 0.007327501196414232
, O 0 0.0010832734405994415
each O 0 0.001161686610430479
with O 0 0.0008535684901289642
at O 0 0.0025178841315209866
least O 0 0.005126700270920992
four O 0 0.0022734571248292923
cases O 0 0.009444517083466053
of O 0 0.00687042810022831
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.001375064835883677
collected O 0 0.001791186979971826
by O 0 0.0024663624353706837
the O 0 0.019307775422930717
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9780142307281494
Consortium O 0 0.05146867781877518
. O 0 0.0059607126750051975

Families O 0 0.01265785563737154
were O 0 0.0017322510248050094
included O 0 0.0018406863091513515
without O 0 0.0020345430821180344
regard O 0 0.003548652632161975
to O 0 0.0008655573474243283
the O 0 0.0022548846900463104
occurrence O 1 0.821861743927002
of O 0 0.006546237971633673
ovarian B-Disease 1 1.0
or I-Disease 0 0.006510876584798098
other I-Disease 0 0.0038486667908728123
cancers I-Disease 1 0.9999998807907104
. O 0 0.006593037862330675

Overall O 0 0.030543874949216843
, O 0 0.00610525393858552
disease O 1 1.0
was O 0 0.0116876270622015
linked O 0 0.05799365043640137
to O 0 0.005040633492171764
BRCA1 O 1 1.0
in O 0 0.0024928024504333735
an O 0 0.0020882077515125275
estimated O 0 0.013623179867863655
52 O 0 0.025772204622626305
% O 0 0.003757005324587226
of O 0 0.0012399842962622643
families O 0 0.005343668628484011
, O 0 0.001987745985388756
to O 0 0.004446352832019329
BRCA2 O 1 0.9999998807907104
in O 0 0.004239652305841446
32 O 0 0.01746876910328865
% O 0 0.0031363500747829676
of O 0 0.0012731894385069609
families O 0 0.0058359308168292046
, O 0 0.0011044723214581609
and O 0 0.0007256554090417922
to O 0 0.0014641510788351297
neither O 0 0.013883272185921669
gene O 1 0.9963274598121643
in O 0 0.002425089245662093
16 O 0 0.008433784358203411
% O 0 0.004538931418210268
( O 0 0.003318438306450844
95 O 0 0.015234929509460926
% O 0 0.003893522545695305
confidence O 0 0.01787640154361725
interval O 0 0.05812421068549156
[ O 0 0.05994856730103493
CI O 1 0.999729573726654
] O 0 0.0577545166015625
6 O 0 0.017516743391752243
% O 0 0.0066038332879543304
- O 0 0.02617572620511055
28 O 0 0.019373057410120964
% O 0 0.006016066297888756
) O 0 0.0023661847226321697
, O 0 0.001478393329307437
suggesting O 0 0.013223305344581604
other O 0 0.003125532064586878
predisposition O 1 0.9999994039535522
genes O 1 0.9386559724807739
. O 0 0.005508374888449907

The O 0 0.00773930549621582
majority O 0 0.017155101522803307
( O 0 0.007030991371721029
81 O 0 0.04159178584814072
% O 0 0.0038071158342063427
) O 0 0.001336986431851983
of O 0 0.0009892459493130445
the O 0 0.01025035697966814
breast B-Disease 1 1.0
- I-Disease 1 0.9999988079071045
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.010955030098557472
were O 0 0.0018217545002698898
due O 0 0.010907897725701332
to O 0 0.0042939861305058
BRCA1 O 1 1.0
, O 0 0.0018802628619596362
with O 0 0.001042422722093761
most O 0 0.0027654210571199656
others O 0 0.004550167825073004
( O 0 0.003696596948429942
14 O 0 0.008863619528710842
% O 0 0.00407901918515563
) O 0 0.002494135405868292
due O 0 0.009041108191013336
to O 0 0.004448890686035156
BRCA2 O 1 1.0
. O 0 0.008642371743917465

Conversely O 0 0.10150553286075592
, O 0 0.0017552232602611184
the O 0 0.0019840714521706104
majority O 0 0.006698641926050186
of O 0 0.001041916897520423
families O 0 0.004546049050986767
with O 0 0.0018669422715902328
male B-Disease 0 0.02507823146879673
and I-Disease 0 0.0026280058082193136
female I-Disease 1 0.9998112320899963
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.0024051961954683065
due O 0 0.010540195740759373
to O 0 0.005043338984251022
BRCA2 O 1 1.0
( O 0 0.012142794206738472
76 O 0 0.08120138943195343
% O 0 0.007520382292568684
) O 0 0.003640818176791072
. O 0 0.004383960273116827

The O 0 0.006868170574307442
largest O 0 0.021726151928305626
proportion O 0 0.03028021566569805
( O 0 0.00673840893432498
67 O 0 0.033921364694833755
% O 0 0.004703724756836891
) O 0 0.0017788383411243558
of O 0 0.0011564349988475442
families O 0 0.007411052472889423
due O 0 0.009876301512122154
to O 0 0.001192305120639503
other O 0 0.0012379874242469668
genes O 1 0.6414030194282532
was O 0 0.007411498576402664
found O 0 0.004619371145963669
in O 0 0.001192046096548438
families O 0 0.003960603382438421
with O 0 0.0009631660068407655
four O 0 0.0016544987447559834
or O 0 0.0021803188137710094
five O 0 0.0019657108932733536
cases O 0 0.006740680895745754
of O 0 0.0027085307519882917
female O 1 0.9999465942382812
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
only O 0 0.003890783991664648
. O 0 0.0044510033912956715

These O 0 0.002386151347309351
estimates O 0 0.005867925006896257
were O 0 0.0014292722335085273
not O 0 0.001725185546092689
substantially O 0 0.03305691480636597
affected O 0 0.035837650299072266
either O 0 0.003565097926184535
by O 0 0.0019502651412039995
changing O 0 0.00511547876521945
the O 0 0.0025972072035074234
assumed O 0 0.04741477593779564
penetrance O 1 0.9985264539718628
model O 0 0.014303888194262981
for O 0 0.005052060820162296
BRCA1 O 1 1.0
or O 0 0.003740997752174735
by O 0 0.0015972263645380735
including O 0 0.001335641136392951
or O 0 0.0034191308077424765
excluding O 0 0.033580146729946136
BRCA1 O 1 1.0
mutation O 1 0.9998277425765991
data O 0 0.006163603626191616
. O 0 0.004095803946256638

Among O 0 0.006494462955743074
those O 0 0.0017098889220505953
families O 0 0.006830982863903046
with O 0 0.004999119788408279
disease O 1 1.0
due O 0 0.02141903154551983
to O 0 0.004795590415596962
BRCA1 O 1 1.0
that O 0 0.001679528970271349
were O 0 0.001446796813979745
tested O 0 0.022621186450123787
by O 0 0.001511606271378696
one O 0 0.001133010839112103
of O 0 0.0007364983321167529
the O 0 0.0021266017574816942
standard O 0 0.01311433780938387
screening O 0 0.04890790209174156
methods O 0 0.005395053420215845
, O 0 0.0024447538889944553
mutations O 1 0.9999551773071289
were O 0 0.002402009442448616
detected O 0 0.04170661419630051
in O 0 0.000982464523985982
the O 0 0.0029080563690513372
coding O 0 0.1033460795879364
sequence O 0 0.024957511574029922
or O 0 0.005449364893138409
splice O 1 0.5043767094612122
sites O 0 0.004117656033486128
in O 0 0.0012730039888992906
an O 0 0.0023716501891613007
estimated O 0 0.015366942621767521
63 O 0 0.036413438618183136
% O 0 0.005914673674851656
( O 0 0.0036701508797705173
95 O 0 0.020480133593082428
% O 0 0.008599681779742241
CI O 1 0.9998739957809448
51 O 0 0.043479252606630325
% O 0 0.007951968349516392
- O 0 0.026491304859519005
77 O 0 0.05586051940917969
% O 0 0.007920227013528347
) O 0 0.003912406973540783
. O 0 0.004074825439602137

The O 0 0.006285194307565689
estimated O 0 0.015270962379872799
sensitivity O 0 0.04083327203989029
was O 0 0.006312127690762281
identical O 0 0.006449978332966566
for O 0 0.001268518390133977
direct O 0 0.007201700005680323
sequencing O 0 0.055382199585437775
and O 0 0.0014210937079042196
other O 0 0.0010144853731617332
techniques O 0 0.007799370214343071
. O 0 0.005168159957975149

The O 0 0.009418514557182789
penetrance O 1 0.9978705644607544
of O 0 0.008265181444585323
BRCA2 O 1 1.0
was O 0 0.010603643953800201
estimated O 0 0.007841781713068485
by O 0 0.0025108151603490114
maximizing O 0 0.037074971944093704
the O 0 0.00466541713103652
LOD O 1 0.998674750328064
score O 0 0.007553543895483017
in O 0 0.004856290761381388
BRCA2 O 1 1.0
- O 1 0.8707489967346191
mutation O 1 0.9999912977218628
families O 0 0.008760389871895313
, O 0 0.0008341024513356388
over O 0 0.0015350510366261005
all O 0 0.0010024928487837315
possible O 0 0.009088888764381409
penetrance O 1 0.9997584223747253
functions O 0 0.011547645553946495
. O 0 0.005157278850674629

The O 0 0.005121459253132343
estimated O 0 0.016144372522830963
cumulative O 0 0.09706884622573853
risk O 1 0.9405724406242371
of O 0 0.007982805371284485
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
reached O 0 0.015724383294582367
28 O 0 0.01572887785732746
% O 0 0.005173058714717627
( O 0 0.004522758070379496
95 O 0 0.02125290408730507
% O 0 0.009907123632729053
CI O 1 0.9996309280395508
9 O 0 0.019342083483934402
% O 0 0.0068275039084255695
- O 0 0.020709974691271782
44 O 0 0.020624259486794472
% O 0 0.006129865068942308
) O 0 0.0026719484012573957
by O 0 0.002878687111660838
age O 0 0.012083456851541996
50 O 0 0.007243975531309843
years O 0 0.0036461183335632086
and O 0 0.0015307829016819596
84 O 0 0.03996756300330162
% O 0 0.006086364854127169
( O 0 0.004485055338591337
95 O 0 0.022114036604762077
% O 0 0.008746827021241188
CI O 1 0.9989878535270691
43 O 0 0.033424291759729385
% O 0 0.007608039770275354
- O 0 0.020428383722901344
95 O 0 0.025593161582946777
% O 0 0.006119407247751951
) O 0 0.0030274665914475918
by O 0 0.0030274088494479656
age O 0 0.012796914204955101
70 O 0 0.01368745043873787
years O 0 0.004408796783536673
. O 0 0.005330296233296394

The O 0 0.0104650454595685
corresponding O 0 0.40233099460601807
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.9944374561309814
were O 0 0.003596878843382001
0 O 0 0.026063142344355583
. O 0 0.004379670135676861

4 O 0 0.023922398686408997
% O 0 0.0068671684712171555
( O 0 0.004756495822221041
95 O 0 0.02089313045144081
% O 0 0.009913965128362179
CI O 1 0.9997361302375793
0 O 0 0.03929798677563667
% O 0 0.007356605958193541
- O 0 0.018703287467360497
1 O 0 0.01392251905053854
% O 0 0.005253147333860397
) O 0 0.0026987933088093996
by O 0 0.0035131555050611496
age O 0 0.012630834244191647
50 O 0 0.00846031028777361
years O 0 0.0037999190390110016
and O 0 0.001680354354903102
27 O 0 0.018522728234529495
% O 0 0.005867430008947849
( O 0 0.005198052618652582
95 O 0 0.024922076612710953
% O 0 0.010381056927144527
CI O 1 0.9997715353965759
0 O 0 0.04234613478183746
% O 0 0.007003254257142544
- O 0 0.02335505746304989
47 O 0 0.029814980924129486
% O 0 0.005908970255404711
) O 0 0.003144128480926156
by O 0 0.002997241448611021
age O 0 0.014134337194263935
70 O 0 0.01469513215124607
years O 0 0.005603459198027849
. O 0 0.005543247330933809

The O 0 0.007291634567081928
lifetime O 0 0.21961359679698944
risk O 1 0.9974121451377869
of O 0 0.010627583600580692
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
appears O 0 0.019735246896743774
similar O 0 0.0027738381177186966
to O 0 0.000658028875477612
the O 0 0.0020243022590875626
risk O 1 0.9984349608421326
in O 0 0.007862257771193981
BRCA1 O 1 1.0
carriers O 1 0.9994113445281982
, O 0 0.0018661088543012738
but O 0 0.001339036738499999
there O 0 0.0011806183028966188
was O 0 0.0035396721214056015
some O 0 0.0011614724062383175
suggestion O 0 0.009451817721128464
of O 0 0.0010190168395638466
a O 0 0.006169135216623545
lower O 0 0.02208094298839569
risk O 1 0.997826874256134
in O 0 0.0072876522317528725
BRCA2 O 1 1.0
carriers O 1 0.9988682270050049
< O 1 0.9918197393417358
50 O 0 0.011254307813942432
years O 0 0.0034676422365009785
of O 0 0.0018804650753736496
age O 0 0.01601751707494259
. O 0 0.005173097364604473

Eye B-Disease 1 0.9998749494552612
movement I-Disease 0 0.042478010058403015
abnormalities I-Disease 1 0.9999661445617676
correlate O 0 0.04944967105984688
with O 0 0.0027793741319328547
genotype O 1 0.9999961853027344
in O 0 0.007616051007062197
autosomal O 1 1.0
dominant O 1 0.9997722506523132
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 0.9999376535415649
I I-Disease 0 0.15772975981235504
. O 0 0.004607022274285555

We O 0 0.0038868263363838196
compared O 0 0.0180838480591774
horizontal O 1 0.8387842774391174
eye O 1 0.9999247789382935
movements O 0 0.013853233307600021
( O 0 0.005158178973942995
visually O 0 0.049081623554229736
guided O 0 0.037550706416368484
saccades O 1 0.9999613761901855
, O 0 0.005596481263637543
antisaccades O 1 0.9992801547050476
, O 0 0.001889463048428297
and O 0 0.0016150020528584719
smooth O 0 0.038000646978616714
pursuit O 0 0.04295123741030693
) O 0 0.002940116450190544
in O 0 0.0015421940479427576
control O 0 0.02170611545443535
subjects O 0 0.012462111189961433
( O 0 0.007132306229323149
n O 0 0.050829026848077774
= O 0 0.03783470019698143
14 O 0 0.009817545302212238
) O 0 0.002875642152503133
and O 0 0.0018480248982086778
patients O 1 0.9999898672103882
with O 0 0.0009516729041934013
three O 0 0.0010976556222885847
forms O 0 0.0037208443973213434
of O 0 0.0030106708873063326
autosomal O 1 1.0
dominant O 1 0.9997915625572205
cerebellar B-Disease 1 0.9999990463256836
ataxias I-Disease 1 0.9999899864196777
type I-Disease 1 0.9897632598876953
I I-Disease 1 0.8923975825309753
spinocerebellar B-Disease 1 0.9999997615814209
ataxias I-Disease 1 0.9997954964637756
1 I-Disease 0 0.019465824589133263
and I-Disease 0 0.0018553378758952022
2 I-Disease 0 0.010557993315160275
( O 0 0.006890459917485714
SCA1 B-Disease 1 0.9999938011169434
, O 0 0.004519876092672348
n O 0 0.04850929230451584
= O 0 0.036587487906217575
11 O 0 0.01275074016302824
; O 0 0.00563697749748826
SCA2 B-Disease 1 0.9996170997619629
, O 0 0.005038847681134939
n O 0 0.05337383225560188
= O 0 0.04042875021696091
10 O 0 0.006449309177696705
) O 0 0.002849008422344923
and O 0 0.002574533922597766
SCA3 B-Disease 1 0.9999997615814209
/ O 1 0.853236973285675
Machado B-Disease 1 0.9963153004646301
- I-Disease 0 0.16156725585460663
Joseph I-Disease 1 0.9995686411857605
disease I-Disease 1 1.0
( O 0 0.01654660329222679
MJD B-Disease 1 0.9999997615814209
) O 0 0.006075387354940176
( O 0 0.005669566337019205
n O 0 0.05010669305920601
= O 0 0.046052269637584686
16 O 0 0.012839960865676403
) O 0 0.003421235363930464
. O 0 0.003912816289812326

In O 0 0.008832999505102634
SCA1 B-Disease 1 0.9998897314071655
, O 0 0.006135466042906046
saccade O 1 0.9972395896911621
amplitude O 0 0.11748136579990387
was O 0 0.010480533353984356
significantly O 0 0.022565051913261414
increased O 0 0.009298685938119888
, O 0 0.001621715840883553
resulting O 0 0.02508270926773548
in O 0 0.003365982323884964
hypermetria B-Disease 1 0.9997949004173279
. O 0 0.008070942014455795

The O 0 0.006362789310514927
smooth O 0 0.03422940894961357
pursuit O 0 0.030381128191947937
gain O 0 0.015404931269586086
was O 0 0.012773972004652023
decreased O 1 0.6435901522636414
. O 0 0.005865051876753569

In O 0 0.008428103290498257
SCA2 B-Disease 1 0.9996616840362549
, O 0 0.006381066516041756
saccade O 1 0.9886559247970581
velocity O 0 0.051649391651153564
was O 0 0.012293430976569653
markedly O 0 0.23992463946342468
decreased O 0 0.13609226047992706
. O 0 0.006501182448118925

The O 0 0.005081232637166977
percentage O 0 0.008582815527915955
of O 0 0.0015266414266079664
errors O 0 0.019686857238411903
in O 0 0.0030020198319107294
antisaccades O 1 0.9998762607574463
was O 0 0.009931241162121296
greatly O 0 0.01906578615307808
increased O 0 0.008340565487742424
and O 0 0.0011260997271165252
was O 0 0.006544049363583326
significantly O 0 0.029139449819922447
correlated O 0 0.05390946567058563
with O 0 0.0018164737848564982
age O 0 0.014891902916133404
at O 0 0.024593885987997055
disease O 1 1.0
onset O 1 1.0
. O 0 0.00798457209020853

In O 0 0.0037749847397208214
addition O 0 0.0036444314755499363
, O 0 0.0011248666560277343
a O 0 0.005868119187653065
correlation O 0 0.029296647757291794
between O 0 0.0032812170684337616
smooth O 0 0.03325515612959862
pursuit O 0 0.03281554579734802
gain O 0 0.010079623199999332
and O 0 0.0009400365524925292
the O 0 0.0016028312966227531
number O 0 0.0017961295088753104
of O 0 0.002752193482592702
trinucleotide O 1 0.9999954700469971
repeats O 0 0.1257476508617401
was O 0 0.008402515202760696
found O 0 0.0070286644622683525
. O 0 0.0037093281280249357

In O 0 0.008617250248789787
SCA3 B-Disease 1 0.9999980926513672
, O 0 0.004629526752978563
gaze B-Disease 1 0.9675061106681824
- I-Disease 0 0.0709305927157402
evoked I-Disease 1 0.9987035989761353
nystagmus I-Disease 1 0.9999988079071045
was O 0 0.008681416511535645
often O 0 0.002594294957816601
present O 0 0.001648084376938641
as O 0 0.0015066872583702207
was O 0 0.009278514422476292
saccade O 1 0.9999172687530518
hypometria O 1 0.9974238872528076
and O 0 0.0018688623094931245
smooth O 0 0.030308382585644722
pursuit O 0 0.03130701929330826
gain O 0 0.014717028476297855
was O 0 0.01088071707636118
markedly O 1 0.6251944899559021
decreased O 0 0.19047050178050995
. O 0 0.006476819980889559

Three O 0 0.004835587926208973
major O 0 0.010041944682598114
criteria O 0 0.008615422062575817
, O 0 0.0036854129284620285
saccade O 1 0.9950082302093506
amplitude O 0 0.12252990156412125
, O 0 0.005597766023129225
saccade O 1 0.9922277331352234
velocity O 0 0.037584736943244934
, O 0 0.0013074277667328715
and O 0 0.0007638008682988584
presence O 0 0.005380855407565832
of O 0 0.0017802082002162933
gaze B-Disease 1 0.999129593372345
- I-Disease 0 0.06540623307228088
evoked I-Disease 1 0.998267650604248
nystagmus I-Disease 1 0.9999996423721313
, O 0 0.002640129067003727
permitted O 0 0.004194309469312429
the O 0 0.0027041463181376457
correct O 0 0.02395450696349144
assignment O 0 0.029787447303533554
of O 0 0.00175931875128299
90 O 0 0.011493236757814884
% O 0 0.0027962387539446354
of O 0 0.001140947570092976
the O 0 0.004720313474535942
SCA1 B-Disease 1 0.9999933242797852
, O 0 0.002684662351384759
90 O 0 0.011212088167667389
% O 0 0.002674422226846218
of O 0 0.0009817722020670772
the O 0 0.00479270052164793
SCA2 B-Disease 1 0.9999982118606567
, O 0 0.002226558281108737
and O 0 0.0013844893546774983
93 O 0 0.024192363023757935
% O 0 0.002134643029421568
of O 0 0.0009662951924838126
the O 0 0.004367299843579531
patients O 1 0.9999994039535522
with O 0 0.0031284186989068985
SCA3 B-Disease 1 0.9999998807907104
to O 0 0.0017020717496052384
their O 0 0.0021417844109237194
genetically O 0 0.3521929979324341
confirmed O 0 0.05334245041012764
patient O 1 0.9999551773071289
group O 0 0.007774810306727886
and O 0 0.0011299531906843185
, O 0 0.0010643191635608673
therefore O 0 0.0034397749695926905
, O 0 0.0014148987829685211
may O 0 0.005667563993483782
help O 0 0.005897802300751209
orient O 0 0.05041993409395218
diagnoses O 1 0.9998469352722168
of O 0 0.0047376505099236965
SCA1 B-Disease 1 0.9999988079071045
, O 0 0.006355667021125555
SCA2 B-Disease 1 0.9999971389770508
, O 0 0.0026563408318907022
and O 0 0.00266078719869256
SCA3 B-Disease 1 0.9999997615814209
at O 0 0.00502239353954792
early O 0 0.010361251421272755
clinical O 1 0.6817721724510193
stages O 0 0.017191600054502487
of O 0 0.001328728860244155
the O 0 0.00653415871784091
diseases O 1 1.0
. O 0 0.003069693688303232
. O 0 0.004252042155712843

Genetic O 0 0.07101009786128998
basis O 0 0.0024527779314666986
and O 0 0.0013680844567716122
molecular O 0 0.022232448682188988
mechanism O 0 0.026046955958008766
for O 0 0.00989725161343813
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 0 0.013897203840315342

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 1.0
causes O 1 0.9998049139976501
more O 0 0.0022641767282038927
than O 0 0.002342619700357318
300 O 0 0.009102542884647846
, O 0 0.002397298812866211
000 O 0 0.051618121564388275
sudden O 1 0.9999616146087646
deaths O 1 0.8721815347671509
each O 0 0.0022474697325378656
year O 0 0.0041556754149496555
in O 0 0.001362859271466732
the O 0 0.0033263901714235544
USA O 0 0.05837476998567581
alone O 0 0.014017650857567787
. O 0 0.005520160309970379

In O 0 0.005373228341341019
approximately O 0 0.010213551111519337
5 O 0 0.015625176951289177
- O 0 0.018094884231686592
12 O 0 0.008060420863330364
% O 0 0.002976656425744295
of O 0 0.0009814841905608773
these O 0 0.0012273319298401475
cases O 0 0.008474265225231647
, O 0 0.000920752645470202
there O 0 0.0009275480406358838
are O 0 0.0005435849889181554
no O 0 0.0028911528643220663
demonstrable O 1 0.9999942779541016
cardiac O 1 1.0
or O 0 0.004775036592036486
non O 0 0.018220553174614906
- O 1 0.9994625449180603
cardiac O 1 1.0
causes O 1 0.9999454021453857
to O 0 0.00128832773771137
account O 0 0.0024246869143098593
for O 0 0.0010634389473125339
the O 0 0.0027975381817668676
episode O 0 0.1953130066394806
, O 0 0.0012245650868862867
which O 0 0.0010642173001542687
is O 0 0.0018558148294687271
therefore O 0 0.003083215793594718
classified O 0 0.009198111481964588
as O 0 0.007286725100129843
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 0 0.036543261259794235
IVF B-Disease 1 0.9999988079071045
) O 0 0.00636326614767313
. O 0 0.004046847578138113

A O 0 0.02061448246240616
distinct O 0 0.012805930338799953
group O 0 0.005326520185917616
of O 0 0.004150788765400648
IVF B-Disease 1 1.0
patients O 1 0.9999996423721313
has O 0 0.004245891235768795
been O 0 0.003262691432610154
found O 0 0.0030624864157289267
to O 0 0.0006483783945441246
present O 0 0.0015688115963712335
with O 0 0.0010726556647568941
a O 0 0.008692463859915733
characteristic O 0 0.23382508754730225
electrocardiographic O 1 0.999799907207489
pattern O 0 0.05683358013629913
. O 0 0.005839340388774872

Because O 0 0.00646746251732111
of O 0 0.000960649864282459
the O 0 0.0021238611079752445
small O 0 0.004083163104951382
size O 0 0.005693981423974037
of O 0 0.0011728728422895074
most O 0 0.0033978826832026243
pedigrees O 0 0.34338197112083435
and O 0 0.001237531192600727
the O 0 0.0021552590187639
high O 0 0.009994236752390862
incidence O 1 0.999956488609314
of O 0 0.003329409519210458
sudden B-Disease 1 0.9999994039535522
death I-Disease 1 0.99930739402771
, O 0 0.001829834538511932
however O 0 0.0029268052894622087
, O 0 0.0018404076108708978
molecular O 0 0.028628062456846237
genetic O 0 0.05365128070116043
studies O 0 0.005123884882777929
of O 0 0.002955362666398287
IVF B-Disease 1 0.9999994039535522
have O 0 0.0028552573639899492
not O 0 0.0013858802849426866
yet O 0 0.0034925099462270737
been O 0 0.004023159854114056
done O 0 0.006493743043392897
. O 0 0.003788324538618326

Because O 0 0.02853352203965187
IVF B-Disease 1 0.9999997615814209
causes O 1 0.9999990463256836
cardiac O 1 1.0
rhythm O 1 0.9997217059135437
disturbance O 1 0.9999319314956665
, O 0 0.001532098394818604
we O 0 0.0011898352531716228
investigated O 0 0.019643664360046387
whether O 0 0.005346635356545448
malfunction O 1 0.9957582354545593
of O 0 0.0030549487564712763
ion O 0 0.09287529438734055
channels O 0 0.016573837026953697
could O 0 0.005208700895309448
cause O 1 0.9575075507164001
the O 0 0.006962367799133062
disorder O 1 1.0
by O 0 0.0035451101139187813
studying O 0 0.007433405611664057
mutations O 1 0.9990160465240479
in O 0 0.001467935275286436
the O 0 0.0051068589091300964
cardiac O 1 1.0
sodium O 1 0.9933146834373474
channel O 0 0.07788565009832382
gene O 1 0.9966685175895691
SCN5A O 1 0.9997201561927795
. O 0 0.008774500340223312

We O 0 0.0029749220702797174
have O 0 0.0014783679507672787
now O 0 0.0030548369977623224
identified O 0 0.010033590719103813
a O 0 0.009290927089750767
missense O 1 0.9999535083770752
mutation O 1 0.9999544620513916
, O 0 0.0021453327499330044
a O 0 0.008148428983986378
splice O 1 0.9997175335884094
- O 0 0.06586042791604996
donor O 1 0.9963000416755676
mutation O 1 0.9999784231185913
, O 0 0.0017227893695235252
and O 0 0.000983735197223723
a O 0 0.012715965509414673
frameshift O 1 0.9999967813491821
mutation O 1 0.9997238516807556
in O 0 0.0015894571552053094
the O 0 0.002541871275752783
coding O 0 0.06883583962917328
region O 0 0.006875935010612011
of O 0 0.0022161018569022417
SCN5A O 1 0.9999927282333374
in O 0 0.002895848359912634
three O 0 0.005058349575847387
IVF B-Disease 1 0.9999988079071045
families O 0 0.018155302852392197
. O 0 0.006774026434868574

We O 0 0.003190151182934642
show O 0 0.006279333028942347
that O 0 0.0023353449068963528
sodium O 0 0.1126910150051117
channels O 0 0.00892049353569746
with O 0 0.0010491497814655304
the O 0 0.0044552902691066265
missense O 1 0.999984860420227
mutation O 1 0.9999924898147583
recover O 1 0.9567947387695312
from O 0 0.005544939544051886
inactivation O 1 0.9999555349349976
more O 0 0.003474720288068056
rapidly O 0 0.022146649658679962
than O 0 0.002748170867562294
normal O 0 0.011442186310887337
and O 0 0.00072946009458974
that O 0 0.0008169910870492458
the O 0 0.004803434479981661
frameshift O 1 0.9999992847442627
mutation O 1 0.9999979734420776
causes O 1 0.9989455342292786
the O 0 0.005800133571028709
sodium O 1 0.5454529523849487
channel O 0 0.020055728033185005
to O 0 0.0011189309880137444
be O 0 0.0018592081032693386
non O 0 0.01070190779864788
- O 0 0.027241205796599388
functional O 0 0.04397823289036751
. O 0 0.005442505236715078

Our O 0 0.005947211757302284
results O 0 0.00790624413639307
indicate O 0 0.006679056212306023
that O 0 0.0023251816164702177
mutations O 1 0.9997219443321228
in O 0 0.00642048753798008
cardiac O 1 0.9999998807907104
ion O 0 0.17913244664669037
- O 0 0.034895531833171844
channel O 0 0.04944702237844467
genes O 0 0.08562423288822174
contribute O 0 0.011033127084374428
to O 0 0.0012633674778044224
the O 0 0.002780678914859891
risk O 1 0.9519924521446228
of O 0 0.0025301615241914988
developing O 0 0.031945567578077316
IVF B-Disease 1 0.9999990463256836
. O 0 0.004194948822259903
. O 0 0.004475143272429705

Molecular O 0 0.08606554567813873
heterogeneity O 0 0.13286565244197845
in O 0 0.006092514842748642
mucopolysaccharidosis B-Disease 1 0.9999089241027832
IVA I-Disease 1 0.9999861717224121
in O 0 0.00235918490216136
Australia O 0 0.004718714393675327
and O 0 0.0010535853216424584
Northern O 0 0.009487021714448929
Ireland O 0 0.013252376578748226
: O 0 0.0029680875595659018
nine O 0 0.005264166742563248
novel O 0 0.04325689375400543
mutations O 1 0.9999337196350098
including O 0 0.00409211590886116
T312S O 1 0.9994767308235168
, O 0 0.0016123142559081316
a O 0 0.004724051803350449
common O 0 0.014596466906368732
allele O 1 0.9999818801879883
that O 0 0.0027654198929667473
confers O 1 0.9721792340278625
a O 0 0.017428817227482796
mild O 1 0.9999974966049194
phenotype O 1 0.9999998807907104
. O 0 0.007019003387540579

Mucopolysaccharidosis B-Disease 1 0.9996811151504517
IVA I-Disease 1 0.999993085861206
( O 0 0.013613021932542324
MPS B-Disease 1 0.998872697353363
IVA I-Disease 1 0.9999996423721313
) O 0 0.004288175143301487
is O 0 0.003304840298369527
an O 0 0.006244282238185406
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 0.9999998807907104
storage I-Disease 1 0.9648296236991882
disorder I-Disease 1 1.0
caused O 1 0.9998897314071655
by O 0 0.002691635861992836
a O 0 0.010201376862823963
genetic B-Disease 1 0.9998558759689331
defect I-Disease 1 0.9999887943267822
in O 0 0.003922890406101942
N O 0 0.06783126294612885
- O 0 0.03930877521634102
acetylgalactosamine O 1 0.999640703201294
- O 0 0.034693993628025055
6 O 0 0.02191128022968769
- O 0 0.05358194187283516
sulfate O 1 0.9988877177238464
sulfatase O 1 0.9999951124191284
( O 0 0.016789589077234268
GALNS O 1 0.999982476234436
) O 0 0.00578726502135396
. O 0 0.004658953752368689

Previous O 0 0.012827165424823761
studies O 0 0.004833335056900978
of O 0 0.0026798928156495094
patients O 1 0.9999064207077026
from O 0 0.0024787182919681072
a O 0 0.005816238466650248
British O 0 0.02136441506445408
- O 0 0.01942768692970276
Irish O 0 0.03422298654913902
population O 0 0.008488818071782589
showed O 0 0.006165017373859882
that O 0 0.0009152030688710511
the O 0 0.0038710306398570538
I113F O 1 0.9999849796295166
mutation O 1 0.999963641166687
is O 0 0.002848802600055933
the O 0 0.001315233064815402
most O 0 0.0019146529957652092
common O 0 0.007293402217328548
single O 0 0.022436002269387245
mutation O 1 0.9999986886978149
among O 0 0.010434593074023724
MPS B-Disease 1 0.999943733215332
IVA I-Disease 1 1.0
patients O 1 0.999998927116394
and O 0 0.0014575079549103975
produces O 0 0.019745728000998497
a O 0 0.016567977145314217
severe O 1 1.0
clinical O 1 0.9999970197677612
phenotype O 1 0.9999996423721313
. O 0 0.007104314398020506

We O 0 0.003299265867099166
studied O 0 0.00894992146641016
mutations O 1 0.9929828643798828
in O 0 0.001935934298671782
the O 0 0.005279840901494026
GALNS O 1 0.9999920129776001
gene O 1 0.9963244795799255
from O 0 0.0033600018359720707
23 O 0 0.011023345403373241
additional O 0 0.008542739786207676
MPS B-Disease 1 0.9995749592781067
IVA I-Disease 1 1.0
patients O 1 0.9999984502792358
( O 0 0.006902981549501419
15 O 0 0.005587757099419832
from O 0 0.0024903847370296717
Australia O 0 0.006641433574259281
, O 0 0.0018951009260490537
8 O 0 0.008686162531375885
from O 0 0.002863594563677907
Northern O 0 0.012917681597173214
Ireland O 0 0.021049557253718376
) O 0 0.0032369690015912056
, O 0 0.0009332261397503316
with O 0 0.0008673729025758803
various O 0 0.0021807856392115355
clinical O 1 0.9997333884239197
phenotypes O 1 0.9999938011169434
( O 0 0.01898416504263878
severe O 1 1.0
, O 0 0.002240617759525776
16 O 0 0.009796889498829842
cases O 0 0.009746458381414413
; O 0 0.0029930921737104654
intermediate O 0 0.02545887604355812
, O 0 0.002116420539095998
4 O 0 0.01584508828818798
cases O 0 0.013612791895866394
; O 0 0.00605805916711688
mild O 1 0.9999967813491821
, O 0 0.002598277060315013
3 O 0 0.01307609397917986
cases O 0 0.011483478359878063
) O 0 0.0033650402911007404
. O 0 0.003786912187933922

We O 0 0.0029939175583422184
found O 0 0.005044087767601013
two O 0 0.0018754140473902225
common O 0 0.017915936186909676
mutations O 1 0.9998847246170044
that O 0 0.0013977887574583292
together O 0 0.0015392870409414172
accounted O 0 0.01494440995156765
for O 0 0.0019048269605264068
32 O 0 0.012744001112878323
% O 0 0.002297722501680255
of O 0 0.0008928608731366694
the O 0 0.002943722065538168
44 O 0 0.021506721153855324
unrelated O 0 0.3156323730945587
alleles O 1 0.9999432563781738
in O 0 0.003081743372604251
these O 0 0.002574994694441557
patients O 1 0.999971866607666
. O 0 0.0060873981565237045

One O 0 0.0050179180689156055
is O 0 0.002724063815549016
the O 0 0.004561718087643385
T312S O 1 0.9999667406082153
mutation O 1 0.9999921321868896
, O 0 0.001954104984179139
a O 0 0.006814401596784592
novel O 0 0.03993581235408783
mutation O 1 0.9999855756759644
found O 0 0.006125201471149921
exclusively O 0 0.005015871953219175
in O 0 0.004526925273239613
milder O 1 0.9999963045120239
patients O 1 0.999998927116394
. O 0 0.005627049133181572

The O 0 0.004339158535003662
other O 0 0.0010072950972244143
is O 0 0.0018811883637681603
the O 0 0.001803891034796834
previously O 0 0.006817116402089596
described O 0 0.013277440331876278
I113F O 1 0.9945249557495117
that O 0 0.002287044655531645
produces O 0 0.02269892953336239
a O 0 0.022338058799505234
severe O 1 1.0
phenotype O 1 0.9999997615814209
. O 0 0.009086024947464466

The O 0 0.01008106954395771
I113F O 1 0.9943022727966309
and O 0 0.004579516593366861
T312S O 1 0.9999455213546753
mutations O 1 0.9998512268066406
accounted O 0 0.024266792461276054
for O 0 0.002329351846128702
8 O 0 0.014457753859460354
( O 0 0.004803737625479698
18 O 0 0.008435426279902458
% O 0 0.004975986201316118
) O 0 0.0027851490303874016
and O 0 0.0014070689212530851
6 O 0 0.014831376262009144
( O 0 0.004354872740805149
14 O 0 0.009053084999322891
% O 0 0.0036553647369146347
) O 0 0.001771998475305736
of O 0 0.0012049507349729538
44 O 0 0.022933639585971832
unrelated O 0 0.26374199986457825
alleles O 1 0.9999686479568481
, O 0 0.002984393388032913
respectively O 0 0.009949659928679466
. O 0 0.004761870484799147

The O 0 0.004969634115695953
relatively O 0 0.010806459002196789
high O 0 0.011013742536306381
residual O 1 0.9731565117835999
GALNS O 1 0.9998224377632141
activity O 0 0.015843968838453293
seen O 0 0.0077665746212005615
when O 0 0.003471365198493004
the O 0 0.00371455866843462
T312S O 1 0.9994511008262634
mutant O 1 0.9978039860725403
cDNA O 0 0.15112386643886566
is O 0 0.009195839986205101
overexpressed O 1 0.894990086555481
in O 0 0.005477222613990307
mutant O 1 0.9998394250869751
cells O 0 0.04862479120492935
provides O 0 0.004264610353857279
an O 0 0.0012583103962242603
explanation O 0 0.006586688570678234
for O 0 0.001102027832530439
the O 0 0.004576735198497772
mild O 1 0.9999996423721313
phenotype O 1 0.9999998807907104
in O 0 0.00518248975276947
patients O 1 0.9999943971633911
with O 0 0.0014884085394442081
this O 0 0.003942891024053097
mutation O 1 0.9999961853027344
. O 0 0.005180292297154665

The O 0 0.0045060268603265285
distribution O 0 0.006216724403202534
and O 0 0.0015114040579646826
relative O 0 0.011219363659620285
frequencies O 0 0.014305144548416138
of O 0 0.001078853732906282
the O 0 0.0042877765372395515
I113F O 1 0.999940037727356
and O 0 0.00515983859077096
T312S O 1 0.9999555349349976
mutations O 1 0.9995059967041016
in O 0 0.002205534838140011
Australia O 0 0.006807280238717794
corresponded O 0 0.025005890056490898
to O 0 0.0014797102194279432
those O 0 0.0015576820587739348
observed O 0 0.00972389243543148
in O 0 0.001630644197575748
Northern O 0 0.012472901493310928
Ireland O 0 0.014375180006027222
and O 0 0.0012634480372071266
are O 0 0.0007549255969934165
unique O 0 0.0028844252228736877
to O 0 0.0008286466472782195
these O 0 0.0006368642207235098
two O 0 0.0013921525096520782
populations O 0 0.032544706016778946
, O 0 0.0019117547199130058
suggesting O 0 0.010924546979367733
that O 0 0.0013107341947034001
both O 0 0.0028369720093905926
mutations O 1 0.9999736547470093
were O 0 0.002006800612434745
probably O 0 0.008128814399242401
introduced O 0 0.005879217758774757
to O 0 0.001116716186515987
Australia O 0 0.0038022268563508987
by O 0 0.002224051160737872
Irish O 0 0.025280484929680824
migrants O 0 0.015287650749087334
during O 0 0.006027711555361748
the O 0 0.0023640142753720284
19th O 0 0.011428995057940483
century O 0 0.007853822782635689
. O 0 0.0051037222146987915

Haplotype O 1 0.9877886176109314
analysis O 0 0.007843133062124252
using O 0 0.004339002072811127
6 O 0 0.01816423423588276
RFLPs O 1 0.9908220767974854
provides O 0 0.0065353442914783955
additional O 0 0.0026919725351035595
data O 0 0.0015075094997882843
that O 0 0.0010117886122316122
the O 0 0.004026908427476883
I113F O 1 0.9999459981918335
mutation O 1 0.9999498128890991
originated O 0 0.02127838134765625
from O 0 0.0026834525633603334
a O 0 0.00717162387445569
common O 0 0.01405251119285822
ancestor O 1 0.5543113946914673
. O 0 0.00559159554541111

The O 0 0.004240328446030617
other O 0 0.001421938999556005
9 O 0 0.015356888994574547
novel O 0 0.04234442487359047
mutations O 1 0.9996745586395264
identified O 0 0.013860069215297699
in O 0 0.0011328543769195676
these O 0 0.0013853665441274643
23 O 0 0.02343118190765381
patients O 1 0.9999808073043823
were O 0 0.001256882562302053
each O 0 0.0013098351191729307
limited O 0 0.003805305575951934
to O 0 0.001212925068102777
a O 0 0.006086305249482393
single O 0 0.01603236049413681
family O 0 0.01728702522814274
. O 0 0.005682651419192553

These O 0 0.0015955314738675952
data O 0 0.001529840868897736
provide O 0 0.0015747128054499626
further O 0 0.0018992545083165169
evidence O 0 0.0015370314940810204
for O 0 0.001361912116408348
extensive O 0 0.022468676790595055
allelic O 1 0.9972177743911743
heterogeneity O 1 0.5113825798034668
in O 0 0.0046310629695653915
MPS B-Disease 1 0.9966121315956116
IVA I-Disease 1 0.9999995231628418
in O 0 0.002699782606214285
British O 0 0.021100958809256554
- O 0 0.07310666143894196
Irish O 1 0.9974727034568787
patients O 1 0.999998927116394
and O 0 0.0009028981439769268
provide O 0 0.001083269831724465
evidence O 0 0.000943127553910017
for O 0 0.0008580473950132728
their O 0 0.001559078460559249
transmission O 0 0.07271421700716019
to O 0 0.0014942701673135161
Australia O 0 0.004575137048959732
by O 0 0.003261925419792533
British O 0 0.019613763317465782
- O 0 0.023743029683828354
Irish O 0 0.03778158873319626
migrants O 0 0.01911887712776661
. O 0 0.002528104465454817
. O 0 0.0037569538690149784

Identification O 0 0.0148248840123415
of O 0 0.0016297169495373964
constitutional O 0 0.03945467621088028
WT1 O 1 0.9999998807907104
mutations O 1 0.9999959468841553
, O 0 0.001421825378201902
in O 0 0.0021183218341320753
patients O 1 0.999985933303833
with O 0 0.0029026013799011707
isolated O 1 0.9997954964637756
diffuse B-Disease 1 0.9999995231628418
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 0.0022056112065911293
and O 0 0.0006563359638676047
analysis O 0 0.0026526316069066525
of O 0 0.0027032436337321997
genotype O 1 0.9999998807907104
/ O 1 0.999560534954071
phenotype O 1 0.9999980926513672
correlations O 0 0.04726675897836685
by O 0 0.0016122544184327126
use O 0 0.0010588271543383598
of O 0 0.0010290654608979821
a O 0 0.008554592728614807
computerized O 1 0.8169233202934265
mutation O 1 0.9999172687530518
database O 0 0.03831695392727852
. O 0 0.006645581219345331

Constitutional O 0 0.03291734308004379
mutations O 1 0.985370397567749
of O 0 0.0017448283033445477
the O 0 0.006678496487438679
WT1 O 1 0.9999992847442627
gene O 1 0.9935634136199951
, O 0 0.0019441369222477078
encoding O 0 0.03697100654244423
a O 0 0.01028615515679121
zinc O 1 0.9946202039718628
- O 0 0.0382608100771904
finger O 1 0.9959805011749268
transcription O 0 0.21421942114830017
factor O 0 0.03974534571170807
involved O 0 0.009906272403895855
in O 0 0.005961684510111809
renal O 1 1.0
and O 0 0.006162581034004688
gonadal O 1 0.9999966621398926
development O 0 0.005412606056779623
, O 0 0.0011668219231069088
are O 0 0.0005428678705357015
found O 0 0.002653208328410983
in O 0 0.0011624508770182729
most O 0 0.004057466052472591
patients O 1 0.999994158744812
with O 0 0.0033076652325689793
Denys B-Disease 1 0.9999997615814209
- I-Disease 1 0.9995439648628235
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.049796998500823975
DDS B-Disease 1 1.0
) O 0 0.003980052191764116
, O 0 0.0014048222219571471
or O 0 0.006506781093776226
diffuse B-Disease 1 0.9999995231628418
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 0.037335291504859924
DMS B-Disease 1 0.9999983310699463
) O 0 0.005029148887842894
associated O 0 0.006549598183482885
with O 0 0.0022361946757882833
pseudohermaphroditism B-Disease 1 0.9999966621398926
and O 0 0.0030446387827396393
/ O 1 0.8843878507614136
or O 0 0.014612250030040741
Wilms B-Disease 1 1.0
tumor I-Disease 1 1.0
( O 0 0.02249292843043804
WT B-Disease 1 0.9999997615814209
) O 0 0.006201006937772036
. O 0 0.004105119500309229

Most O 0 0.014869683422148228
mutations O 1 0.9999799728393555
in O 0 0.0077743688598275185
DDS B-Disease 1 1.0
patients O 1 0.9999994039535522
lie O 0 0.013306260108947754
in O 0 0.0031593332532793283
exon O 1 0.9991100430488586
8 O 0 0.015419426374137402
or O 0 0.005367100238800049
exon O 1 0.9973102807998657
9 O 0 0.013022727333009243
, O 0 0.0021708037238568068
encoding O 0 0.065456323325634
zinc O 1 0.9470524787902832
finger O 1 0.820308268070221
2 O 0 0.012105477042496204
or O 0 0.006331975106149912
zinc O 1 0.9977879524230957
finger O 1 0.9970263838768005
3 O 0 0.011847693473100662
, O 0 0.0013201662804931402
respectively O 0 0.004433045629411936
, O 0 0.0008561462163925171
with O 0 0.0009154933504760265
a O 0 0.008674140088260174
hot O 0 0.16255034506320953
spot O 0 0.047788482159376144
( O 0 0.007758641615509987
R394W O 1 0.9996461868286133
) O 0 0.0039535705000162125
in O 0 0.0030442203860729933
exon O 1 0.9991897940635681
9 O 0 0.0237856637686491
. O 0 0.004791679792106152

We O 0 0.003924227319657803
analyzed O 0 0.012861494906246662
a O 0 0.004206252284348011
series O 0 0.005875977221876383
of O 0 0.0015959911979734898
24 O 0 0.02146868035197258
patients O 1 0.9999958276748657
, O 0 0.0014846734702587128
10 O 0 0.003380880458280444
with O 0 0.002600675681605935
isolated B-Disease 1 0.9955772161483765
DMS I-Disease 1 0.9999996423721313
( O 0 0.018919004127383232
IDMS B-Disease 1 0.9999997615814209
) O 0 0.005135095212608576
, O 0 0.0014697675360366702
10 O 0 0.004974940326064825
with O 0 0.0032839286141097546
DDS B-Disease 1 0.9999998807907104
, O 0 0.0017772727878764272
and O 0 0.001058020512573421
4 O 0 0.007426239084452391
with O 0 0.003295349655672908
urogenital B-Disease 1 1.0
abnormalities I-Disease 1 0.9999998807907104
and O 0 0.003843622747808695
/ O 1 0.9910926222801208
or O 0 0.012366709299385548
WT B-Disease 1 0.9999985694885254
. O 0 0.007940961048007011

We O 0 0.00402009068056941
report O 0 0.009077892638742924
WT1 O 1 0.9999979734420776
heterozygous O 1 0.999947190284729
mutations O 1 0.999925971031189
in O 0 0.004034680780023336
16 O 0 0.020119300112128258
patients O 1 0.9999898672103882
, O 0 0.001930299331434071
4 O 0 0.007199518382549286
of O 0 0.0013830489479005337
whom O 0 0.008579723536968231
presented O 0 0.005183164030313492
with O 0 0.004349830560386181
IDMS B-Disease 1 0.9999996423721313
. O 0 0.007385081611573696

One O 0 0.008714226074516773
male O 0 0.019797878339886665
and O 0 0.0007900063646957278
two O 0 0.001786371343769133
female O 0 0.39260026812553406
IDMS B-Disease 1 1.0
patients O 1 0.9999974966049194
with O 0 0.007421601098030806
WT1 O 1 1.0
mutations O 1 0.9999996423721313
underwent O 1 0.9999988079071045
normal O 0 0.07461392879486084
puberty O 1 0.9994267225265503
. O 0 0.00626230426132679

Two O 0 0.008462334983050823
mutations O 1 0.9999639987945557
associated O 0 0.016020476818084717
with O 0 0.0042739431373775005
IDMS B-Disease 1 0.9999991655349731
are O 0 0.0013175525236874819
different O 0 0.0008378013735637069
from O 0 0.0014870144659653306
those O 0 0.001279463293030858
described O 0 0.01194595918059349
in O 0 0.006732353940606117
DDS B-Disease 1 1.0
patients O 1 0.9999972581863403
. O 0 0.006932320073246956

No O 0 0.01729997992515564
WT1 O 1 0.9999988079071045
mutations O 1 0.9998657703399658
were O 0 0.003024810692295432
detected O 0 0.041150763630867004
in O 0 0.0008246381185017526
the O 0 0.001282618148252368
six O 0 0.0035065459087491035
other O 0 0.003921154420822859
IDMS B-Disease 1 1.0
patients O 1 0.9999991655349731
, O 0 0.002286626724526286
suggesting O 0 0.02142808958888054
genetic O 0 0.09081045538187027
heterogeneity O 1 0.6962625980377197
of O 0 0.0016189912566915154
this O 0 0.006183072458952665
disease O 1 1.0
. O 0 0.006077263504266739

We O 0 0.0054001035168766975
analyzed O 0 0.051516301929950714
genotype O 1 0.9999929666519165
/ O 1 0.9966421127319336
phenotype O 1 0.9999972581863403
correlations O 0 0.055800095200538635
, O 0 0.0012100384337827563
on O 0 0.0006998851895332336
the O 0 0.000893078395165503
basis O 0 0.0010440953774377704
of O 0 0.0008076956146396697
the O 0 0.001544149243272841
constitution O 0 0.00362275424413383
of O 0 0.0012564277276396751
a O 0 0.01806713081896305
WT1 O 1 0.9999995231628418
mutation O 1 0.9997738003730774
database O 0 0.01972438395023346
of O 0 0.0020603802986443043
84 O 0 0.18410322070121765
germ O 1 0.9966737031936646
- O 0 0.040184129029512405
line O 0 0.026807883754372597
mutations O 1 0.9999679327011108
, O 0 0.0015779652167111635
to O 0 0.0011613551760092378
compare O 0 0.009696527384221554
the O 0 0.0016264831647276878
distribution O 0 0.00524172792211175
and O 0 0.0013673946959897876
type O 0 0.051458362489938736
of O 0 0.003042596159502864
mutations O 1 0.9999823570251465
, O 0 0.001211722381412983
according O 0 0.000913368770852685
to O 0 0.0008174512768164277
the O 0 0.0023967705201357603
different O 0 0.003799047553911805
symptoms O 1 1.0
. O 0 0.006836763583123684

This O 0 0.005597489885985851
demonstrated O 0 0.01908174715936184
( O 0 0.005713475868105888
1 O 0 0.011647261679172516
) O 0 0.002362234750762582
the O 0 0.0024629016406834126
association O 0 0.010487769730389118
between O 0 0.0044570062309503555
mutations O 1 0.9998915195465088
in O 0 0.003276725532487035
exons O 1 0.9878312945365906
8 O 0 0.01266323309391737
and O 0 0.001581530086696148
9 O 0 0.01223638653755188
and O 0 0.0035949652083218098
DMS B-Disease 1 0.9999974966049194
; O 0 0.005905338563024998
( O 0 0.004591725300997496
2 O 0 0.010595852509140968
) O 0 0.0037968482356518507
among O 0 0.008677802979946136
patients O 1 0.9999821186065674
with O 0 0.004758373834192753
DMS B-Disease 1 0.9999964237213135
, O 0 0.001726980903185904
a O 0 0.004245546646416187
higher O 0 0.0071502188220620155
frequency O 0 0.023945270106196404
of O 0 0.002728362800553441
exon O 1 0.9995225667953491
8 O 0 0.03262582793831825
mutations O 1 0.9984797835350037
among O 0 0.008360936306416988
46 O 0 0.024407394230365753
, O 0 0.006183447781950235
XY O 1 0.9999992847442627
patients O 1 0.9999896287918091
with O 0 0.004386382643133402
female O 0 0.04469800740480423
phenotype O 1 0.9999985694885254
than O 0 0.004044691566377878
among O 0 0.005177923943847418
46 O 0 0.020673532038927078
, O 0 0.006108066998422146
XY O 1 0.9999998807907104
patients O 1 0.999995231628418
with O 0 0.002344447886571288
sexual O 0 0.013419444672763348
ambiguity O 0 0.02203107438981533
or O 0 0.005496447905898094
male O 1 0.7671361565589905
phenotype O 1 1.0
; O 0 0.004516493529081345
and O 0 0.0015656077302992344
( O 0 0.004503242671489716
3 O 0 0.008925381116569042
) O 0 0.002128628548234701
statistically O 0 0.019246099516749382
significant O 0 0.0038366930093616247
evidence O 0 0.0016165513079613447
that O 0 0.0023030436132103205
mutations O 1 0.9997946619987488
in O 0 0.0035522521939128637
exons O 1 0.9762040376663208
8 O 0 0.011118205264210701
and O 0 0.0012971990508958697
9 O 0 0.015096728689968586
preferentially O 0 0.45658576488494873
affect O 0 0.04458880051970482
amino O 0 0.07522382587194443
acids O 0 0.03921414539217949
with O 0 0.00097040826221928
different O 0 0.0007868782267905772
functions O 0 0.0033895496744662523
. O 0 0.0019276535604149103
. O 0 0.003690404584631324

The O 0 0.012085682712495327
185delAG O 1 0.9999696016311646
BRCA1 O 1 1.0
mutation O 1 0.9999377727508545
originated O 0 0.02471162937581539
before O 0 0.0029944495763629675
the O 0 0.0023819843772798777
dispersion O 0 0.03911649063229561
of O 0 0.0011596593540161848
Jews O 0 0.004236935172230005
in O 0 0.001374748069792986
the O 0 0.002644029213115573
diaspora O 0 0.02214912883937359
and O 0 0.0013133090687915683
is O 0 0.0021802864503115416
not O 0 0.0011726615484803915
limited O 0 0.004982754122465849
to O 0 0.0027075354009866714
Ashkenazim O 1 0.9981672763824463
. O 0 0.007846210151910782

The O 0 0.010439109988510609
185delAG O 1 0.9997815489768982
mutation O 1 0.9999428987503052
in O 0 0.008329280652105808
BRCA1 O 1 1.0
is O 0 0.007474617566913366
detected O 0 0.06701036542654037
in O 0 0.002306041307747364
Ashkenazi O 1 0.9954634308815002
Jews O 0 0.0042356583289802074
both O 0 0.0014330093981698155
in O 0 0.00420374283567071
familial B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9964908957481384
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.001489998190663755
in O 0 0.0008456243667751551
the O 0 0.001733742537908256
general O 0 0.006040687207132578
population O 0 0.010277701541781425
. O 0 0.005372789688408375

All O 0 0.004570175427943468
tested O 0 0.09007579833269119
Ashkenazi O 1 0.9999183416366577
mutation O 1 0.9999929666519165
carriers O 0 0.08626681566238403
share O 0 0.0062690856866538525
the O 0 0.002132150111719966
same O 0 0.005088005680590868
allelic O 1 0.9989840388298035
pattern O 0 0.03165252506732941
at O 0 0.003766916459426284
the O 0 0.008843939751386642
BRCA1 O 1 1.0
locus O 1 0.9999709129333496
. O 0 0.009224322624504566

Our O 0 0.005536826327443123
previous O 0 0.005430019460618496
study O 0 0.004500135313719511
showed O 0 0.0059278872795403
that O 0 0.0009828786132857203
this O 0 0.003330107545480132
Ashkenazi O 1 0.9999592304229736
mutation O 1 0.9999979734420776
also O 0 0.003970657475292683
occurs O 0 0.021397557109594345
in O 0 0.0014290239196270704
Iraqi O 0 0.007063089404255152
Jews O 0 0.004091324284672737
with O 0 0.0011194577673450112
a O 0 0.005339891649782658
similar O 0 0.011969785206019878
allelic O 1 0.9997541308403015
pattern O 0 0.05106275901198387
. O 0 0.00499988766387105

We O 0 0.003181155538186431
extended O 0 0.008416865020990372
our O 0 0.0021853456273674965
analysis O 0 0.003101127687841654
to O 0 0.001022263546474278
other O 0 0.000971035158727318
non O 0 0.013112807646393776
- O 0 0.03727773204445839
Ashkenazi O 1 0.9592528939247131
subsets O 0 0.06817830353975296
354 O 0 0.07111801207065582
of O 0 0.0024243490770459175
Moroccan O 0 0.04472930356860161
origin O 0 0.006789109203964472
, O 0 0.0018718944629654288
200 O 0 0.011053494177758694
Yemenites O 1 0.9931067824363708
and O 0 0.0018227684777230024
150 O 0 0.008832147344946861
Iranian O 0 0.004148110747337341
Jews O 0 0.007216176018118858
. O 0 0.005521718412637711

Heteroduplex O 1 0.8516781330108643
analysis O 0 0.012578042224049568
complemented O 0 0.030762264505028725
by O 0 0.003044441808015108
direct O 0 0.009339891374111176
DNA O 0 0.044787801802158356
sequencing O 0 0.058209363371133804
of O 0 0.004334559198468924
abnormally O 1 0.9996564388275146
migrating O 0 0.07434164732694626
bands O 0 0.018366044387221336
were O 0 0.0018684844253584743
employed O 0 0.010391874238848686
. O 0 0.00432293675839901

Four O 0 0.003744533285498619
of O 0 0.001906677265651524
Moroccan O 0 0.05443020537495613
origin O 0 0.011077282950282097
( O 0 0.004788488149642944
1 O 0 0.01087239570915699
. O 0 0.0020086790900677443
1 O 0 0.01313915103673935
% O 0 0.005053861532360315
) O 0 0.002054141368716955
and O 0 0.0008232797845266759
none O 0 0.0031219725497066975
of O 0 0.000833741738460958
the O 0 0.0037792406510561705
Yemenites O 1 0.999953031539917
or O 0 0.0036128393840044737
Iranians O 0 0.006481566000729799
was O 0 0.004723168443888426
a O 0 0.006208122242242098
carrier O 0 0.1025041788816452
of O 0 0.0015376140363514423
the O 0 0.006055962760001421
185delAG O 1 0.9999892711639404
mutation O 1 0.9999887943267822
. O 0 0.009456966072320938

BRCA1 O 1 0.9999998807907104
allelic O 1 0.9990686774253845
patterns O 0 0.017531966790556908
were O 0 0.001689748140051961
determined O 0 0.006769225466996431
for O 0 0.0008210705127567053
four O 0 0.0011266205692663789
of O 0 0.0010354385012760758
these O 0 0.0010558873182162642
individuals O 0 0.003409512573853135
and O 0 0.0007127152057364583
for O 0 0.0011749874101951718
12 O 0 0.003997433464974165
additional O 0 0.002720531076192856
non O 0 0.011362950317561626
- O 0 0.03766191378235817
Ashkenazi O 1 0.999805748462677
185delAG O 1 0.9999823570251465
mutation O 1 0.9999924898147583
carriers O 1 0.9468241333961487
who O 0 0.00614059716463089
had O 0 0.25893014669418335
breast B-Disease 1 1.0
/ I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.007308621890842915

Six O 0 0.010771936737000942
non O 0 0.01904439553618431
- O 0 0.04603882133960724
Ashkenazi O 1 0.9967778325080872
individuals O 0 0.0038272785022854805
shared O 0 0.004063297528773546
the O 0 0.0025703178253024817
common O 0 0.017396345734596252
Ashkenazi O 1 0.9999939203262329
haplotype O 1 0.9999275207519531
, O 0 0.001917320187203586
four O 0 0.001819005934521556
had O 0 0.0037575445603579283
a O 0 0.0054916380904614925
closely O 0 0.005554710980504751
related O 0 0.009765113703906536
pattern O 0 0.02518167532980442
, O 0 0.001074356958270073
and O 0 0.0007016978343017399
the O 0 0.0020645258482545614
rest O 0 0.010775734670460224
( O 0 0.006809740327298641
n O 0 0.048920173197984695
= O 0 0.04357650503516197
6 O 0 0.014317413792014122
) O 0 0.0020660196896642447
displayed O 0 0.005070752464234829
a O 0 0.007345941383391619
distinct O 0 0.0424228273332119
BRCA1 O 1 1.0
allelic O 1 0.9998648166656494
pattern O 0 0.0678618773818016
. O 0 0.006110942456871271

We O 0 0.0029683217871934175
conclude O 0 0.01013623084872961
that O 0 0.0010933647863566875
the O 0 0.004833761602640152
185delAG O 1 0.9999983310699463
BRCA1 O 1 1.0
mutation O 1 0.9999979734420776
occurs O 0 0.034719426184892654
in O 0 0.0014093697536736727
some O 0 0.0018534510163590312
non O 0 0.015069400891661644
- O 0 0.045459866523742676
Ashkenazi O 1 0.9989606142044067
populations O 0 0.04227567836642265
at O 0 0.004866020288318396
rates O 0 0.01602647639811039
comparable O 0 0.011100337840616703
with O 0 0.0011050300672650337
that O 0 0.0010321179870516062
of O 0 0.0025947452522814274
Ashkenazim O 1 0.9999421834945679
. O 0 0.008602248504757881

The O 0 0.004418449476361275
majority O 0 0.006178579293191433
of O 0 0.0014918752713128924
Jewish O 0 0.02118523232638836
185delAG O 1 0.9999977350234985
mutation O 1 0.9999996423721313
carriers O 1 0.963512659072876
have O 0 0.0017365970415994525
a O 0 0.006072530057281256
common O 0 0.01817302219569683
allelic O 1 0.9997429251670837
pattern O 0 0.03701050952076912
, O 0 0.0015921101439744234
supporting O 0 0.005641702096909285
the O 0 0.0027343141846358776
founder O 0 0.05833372101187706
effect O 0 0.015695109963417053
notion O 0 0.010548245161771774
, O 0 0.001452173339203
but O 0 0.0017653441755101085
dating O 0 0.010122940875589848
the O 0 0.005789184011518955
mutations O 1 0.999241828918457
origin O 0 0.00605352409183979
to O 0 0.0009614969021640718
an O 0 0.0015491069061681628
earlier O 0 0.003682869952172041
date O 0 0.00352386012673378
than O 0 0.002249037614092231
currently O 0 0.0043207560665905476
estimated O 0 0.015303279273211956
. O 0 0.007258501835167408

However O 0 0.006381489802151918
, O 0 0.0009612302528694272
the O 0 0.001612979918718338
different O 0 0.0016259737312793732
allelic O 1 0.9914387464523315
pattern O 0 0.025422237813472748
at O 0 0.003877365030348301
the O 0 0.00798026006668806
BRCA1 O 1 1.0
locus O 1 0.9999935626983643
even O 0 0.0036527870688587427
in O 0 0.0010395844001322985
some O 0 0.0013833215925842524
Jewish O 0 0.0217246413230896
mutation O 1 0.9999994039535522
carriers O 1 0.9904781579971313
, O 0 0.00182250642683357
might O 0 0.004378161393105984
suggest O 0 0.004136619158089161
that O 0 0.0008324009249918163
the O 0 0.004684384912252426
mutation O 1 0.999967098236084
arose O 0 0.02902110666036606
independently O 0 0.0104362228885293
. O 0 0.0022088719997555017
. O 0 0.0034172236919403076

Crystal O 0 0.02986455149948597
structure O 0 0.005442993249744177
of O 0 0.001315687200985849
the O 0 0.00912563782185316
hemochromatosis B-Disease 1 1.0
protein O 1 0.9835029244422913
HFE O 1 0.9999949932098389
and O 0 0.0029626397881656885
characterization O 0 0.019623853266239166
of O 0 0.000914371048565954
its O 0 0.00224549463018775
interaction O 0 0.0101693794131279
with O 0 0.004038737155497074
transferrin O 1 0.9992632269859314
receptor O 1 0.9896466135978699
. O 0 0.009110159240663052

HFE O 1 0.9999549388885498
is O 0 0.008508260361850262
an O 0 0.007414111401885748
MHC O 1 0.9999853372573853
- O 0 0.03110615350306034
related O 0 0.013462269678711891
protein O 0 0.041156310588121414
that O 0 0.0009765284485183656
is O 0 0.003355997847393155
mutated O 1 0.9990841150283813
in O 0 0.0009600010816939175
the O 0 0.002546543488278985
iron B-Disease 1 0.9986683130264282
- I-Disease 1 0.9984692931175232
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.012649409472942352

HFE O 1 0.9999724626541138
binds O 0 0.12478519976139069
to O 0 0.006853925995528698
transferrin O 1 0.9923118948936462
receptor O 1 0.9918198585510254
( O 0 0.013735910877585411
TfR O 1 0.9996705055236816
) O 0 0.0038126171566545963
and O 0 0.0014534923247992992
reduces O 0 0.060315802693367004
its O 0 0.002721629571169615
affinity O 0 0.03612769767642021
for O 0 0.0020850463770329952
iron O 0 0.051837414503097534
- O 0 0.026886405423283577
loaded O 0 0.026421692222356796
transferrin O 1 0.9713236093521118
, O 0 0.00373384659178555
implicating O 0 0.24478107690811157
HFE O 1 0.9999969005584717
in O 0 0.0049218242056667805
iron O 1 0.9280652403831482
metabolism O 1 0.9945287108421326
. O 0 0.008197003044188023

The O 0 0.007699843030422926
2 O 0 0.01322933193296194
. O 0 0.005577554926276207

6 O 0 0.0198862012475729
A O 0 0.016078928485512733
crystal O 0 0.021655423566699028
structure O 0 0.00641703512519598
of O 0 0.0029384251683950424
HFE O 1 0.9999972581863403
reveals O 0 0.03737880289554596
the O 0 0.0020400614012032747
locations O 0 0.005021903198212385
of O 0 0.005948172882199287
hemochromatosis B-Disease 1 1.0
mutations O 1 0.9999938011169434
and O 0 0.0020515595097094774
a O 0 0.009388691745698452
patch O 1 0.9999697208404541
of O 0 0.002889275783672929
histidines O 1 0.9999713897705078
that O 0 0.0015599798643961549
could O 0 0.0023966680746525526
be O 0 0.001156160607933998
involved O 0 0.00536968233063817
in O 0 0.003069218248128891
pH O 1 0.9997511506080627
- O 0 0.03617444261908531
dependent O 0 0.036957934498786926
interactions O 0 0.01593177579343319
. O 0 0.004416249692440033

We O 0 0.0031519620679318905
also O 0 0.0016199859092012048
demonstrate O 0 0.0059884763322770596
that O 0 0.0029419423080980778
soluble O 1 0.8814048171043396
TfR O 1 0.9997343420982361
and O 0 0.008185173384845257
HFE O 1 0.999996542930603
bind O 0 0.09644356369972229
tightly O 0 0.02380923368036747
at O 0 0.002579751890152693
the O 0 0.0014789353590458632
basic O 0 0.007962393574416637
pH O 1 0.992789089679718
of O 0 0.0014551744097843766
the O 0 0.00404801219701767
cell O 0 0.0612264946103096
surface O 0 0.013846324756741524
, O 0 0.0012587879318743944
but O 0 0.0013262495631352067
not O 0 0.0008221407188102603
at O 0 0.0022979050409048796
the O 0 0.004364331252872944
acidic O 1 0.9981075525283813
pH O 1 0.9956670999526978
of O 0 0.004408704116940498
intracellular O 1 0.9934990406036377
vesicles O 1 0.9573562145233154
. O 0 0.008579793386161327

TfR O 1 0.9996845722198486
HFE O 1 0.9999803304672241
stoichiometry O 1 0.7349173426628113
( O 0 0.008246785029768944
2 O 0 0.012518367730081081
1 O 0 0.012592499144375324
) O 0 0.0033145814668387175
differs O 0 0.021875521168112755
from O 0 0.005789430812001228
TfR O 1 0.9999324083328247
transferrin O 1 0.9990407824516296
stoichiometry O 1 0.9269977807998657
( O 0 0.006785591132938862
2 O 0 0.011741286143660545
2 O 0 0.010821026749908924
) O 0 0.003261742414906621
, O 0 0.0016407710500061512
implying O 0 0.02635818161070347
a O 0 0.004156358074396849
different O 0 0.0010737496195361018
mode O 0 0.02372264675796032
of O 0 0.0016876099398359656
binding O 0 0.01618763990700245
for O 0 0.0037537391763180494
HFE O 1 0.9999995231628418
and O 0 0.0038322522304952145
transferrin O 1 0.9971972703933716
to O 0 0.004572379402816296
TfR O 1 0.9998272061347961
, O 0 0.002046610228717327
consistent O 0 0.0072911689057946205
with O 0 0.0007514309254474938
our O 0 0.0018233220325782895
demonstration O 0 0.012859654612839222
that O 0 0.003780655562877655
HFE O 1 0.9999980926513672
, O 0 0.004897281993180513
transferrin O 1 0.9990838766098022
, O 0 0.0018447608454152942
and O 0 0.002170583698898554
TfR O 1 0.9999338388442993
form O 0 0.01106295920908451
a O 0 0.010216351598501205
ternary O 0 0.4784664809703827
complex O 0 0.015067064203321934
. O 0 0.00497967004776001

Identification O 0 0.01504847314208746
of O 0 0.0013946612598374486
three O 0 0.0023394080344587564
novel O 0 0.038122981786727905
mutations O 1 0.9999165534973145
and O 0 0.001056090579368174
a O 0 0.004054388031363487
high O 0 0.005755944177508354
frequency O 0 0.01648116298019886
of O 0 0.001215343363583088
the O 0 0.0046648685820400715
Arg778Leu O 1 0.999997615814209
mutation O 1 0.9999912977218628
in O 0 0.0032253193203359842
Korean O 0 0.028760388493537903
patients O 1 0.9999986886978149
with O 0 0.004824590869247913
Wilson B-Disease 1 0.9999958276748657
disease I-Disease 1 1.0
. O 0 0.00648939423263073

Four O 0 0.01528206653892994
mutations O 1 0.999489426612854
- O 0 0.05550533905625343
- O 0 0.0571066178381443
R778L O 1 0.9963850975036621
, O 0 0.00697215273976326
A874V O 1 0.9994663596153259
, O 0 0.004634898155927658
L1083F O 1 0.999543309211731
, O 0 0.0018251019064337015
and O 0 0.0019772432278841734
2304delC O 1 0.9998750686645508
- O 0 0.024337662383913994
- O 0 0.011394953355193138
in O 0 0.0011033042101189494
the O 0 0.0025686498265713453
copper O 0 0.03872819244861603
- O 0 0.020926497876644135
transporting O 0 0.038322433829307556
enzyme O 0 0.1954522430896759
, O 0 0.004252114798873663
P O 1 0.9830273389816284
- O 0 0.050544384866952896
type O 0 0.43054884672164917
ATPase O 1 0.9990567564964294
( O 0 0.018888888880610466
ATP7B O 1 0.9999762773513794
) O 0 0.004157015588134527
, O 0 0.0009439987479709089
were O 0 0.00093465531244874
identified O 0 0.006650703959167004
in O 0 0.0013928336557000875
Korean O 0 0.027169888839125633
Patients O 1 0.9999984502792358
with O 0 0.0056572952307760715
Wilson B-Disease 1 0.9999961853027344
disease I-Disease 1 1.0
. O 0 0.008050129748880863

Arg778Leu O 1 0.9992129802703857
, O 0 0.001933595514856279
the O 0 0.0017085789004340768
most O 0 0.0027720476500689983
frequently O 0 0.011613600887358189
reported O 0 0.022818293422460556
mutation O 1 0.9998793601989746
of O 0 0.0020271893590688705
this O 0 0.0031443017069250345
enzyme O 1 0.9159190058708191
, O 0 0.001812804490327835
was O 0 0.004646830260753632
found O 0 0.003469107672572136
in O 0 0.0008956471574492753
six O 0 0.002169986953958869
of O 0 0.0011713354615494609
eight O 0 0.007620874792337418
unrelated O 1 0.7790943384170532
patients O 1 0.9999581575393677
studied O 0 0.005510220304131508
, O 0 0.0011778741609305143
an O 0 0.003302494529634714
allele O 1 0.9999581575393677
frequency O 0 0.039601463824510574
of O 0 0.0020119184628129005
37 O 0 0.023558400571346283
. O 0 0.004605830647051334

5 O 0 0.024304887279868126
% O 0 0.004741492681205273
, O 0 0.001487959292717278
which O 0 0.0018741319654509425
is O 0 0.0037219703663140535
considerably O 0 0.026431407779455185
higher O 0 0.006817012559622526
than O 0 0.001593095134012401
those O 0 0.0010525373509153724
in O 0 0.0012277874629944563
other O 0 0.0010649556061252952
Asian O 0 0.02388514205813408
populations O 0 0.04936855658888817
. O 0 0.005286637227982283

The O 0 0.004024467431008816
novel O 0 0.018433140590786934
single O 0 0.023567749187350273
nucleotide O 0 0.20723369717597961
deletion O 1 0.9983443021774292
, O 0 0.004282480105757713
2304delC O 1 0.9998801946640015
, O 0 0.001718901563435793
was O 0 0.004361812490969896
found O 0 0.0033611180260777473
in O 0 0.0014434526674449444
one O 0 0.006305801682174206
patient O 1 0.9998202919960022
. O 0 0.005744060967117548

Since O 0 0.014429680071771145
a O 0 0.013045264407992363
mutation O 1 0.9991944432258606
at O 0 0.01113925501704216
cDNA O 0 0.20425519347190857
nucleotide O 0 0.30450186133384705
2302 O 1 0.9986031651496887
( O 0 0.016308436170220375
2302insC O 1 0.9989835619926453
) O 0 0.004302181303501129
had O 0 0.004345376044511795
been O 0 0.004055616445839405
previously O 0 0.005650033243000507
described O 0 0.008630059659481049
, O 0 0.0009453411330468953
this O 0 0.001024480676278472
region O 0 0.004217422101646662
of O 0 0.0008937188540585339
the O 0 0.004972747527062893
ATP7B O 1 0.9999998807907104
gene O 1 0.9999876022338867
may O 0 0.008435171097517014
be O 0 0.0027541678864508867
susceptible O 1 0.9997182488441467
to O 0 0.003350893035531044
gene O 1 0.9989879727363586
rearrangements O 1 0.9999758005142212
causing O 1 0.9999949932098389
Wilson B-Disease 1 0.9999827146530151
disease I-Disease 1 1.0
. O 0 0.006178234238177538

Disruption O 0 0.12846504151821136
of O 0 0.0035041444934904575
splicing O 0 0.1571771800518036
regulated O 0 0.0287465900182724
by O 0 0.0024988853838294744
a O 0 0.010800887830555439
CUG O 1 0.9999191761016846
- O 0 0.03337947279214859
binding O 0 0.02953885868191719
protein O 0 0.07016905397176743
in O 0 0.010604549199342728
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.012307699769735336

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.22135750949382782
DM B-Disease 1 1.0
) O 0 0.006324311252683401
is O 0 0.00425011245533824
caused O 1 0.9948956370353699
by O 0 0.0028670523315668106
a O 0 0.010152071714401245
CTG O 1 0.9992200136184692
expansion O 0 0.011862948536872864
in O 0 0.0013286491157487035
the O 0 0.002800185000523925
3 O 0 0.011256176978349686
untranslated O 0 0.1602153182029724
region O 0 0.00915848184376955
of O 0 0.0015894585521891713
the O 0 0.009939153678715229
DM B-Disease 1 1.0
gene O 1 0.9999045133590698
. O 0 0.006825686432421207

One O 0 0.006311427336186171
model O 0 0.010892361402511597
of O 0 0.007469242438673973
DM B-Disease 1 1.0
pathogenesis O 1 0.9999984502792358
suggests O 0 0.021846096962690353
that O 0 0.0027802041731774807
RNAs O 0 0.11371913552284241
from O 0 0.001929291058331728
the O 0 0.001892576226964593
expanded O 0 0.012318810448050499
allele O 1 0.9997536540031433
create O 0 0.006870347075164318
a O 0 0.005416835192590952
gain O 0 0.011339186690747738
- O 0 0.01358046941459179
of O 0 0.0024364241398870945
- O 0 0.02783186361193657
function O 0 0.033079616725444794
mutation O 1 0.9999580383300781
by O 0 0.002965521765872836
the O 0 0.0029497980140149593
inappropriate O 0 0.02287088707089424
binding O 0 0.012098293751478195
of O 0 0.001356696244329214
proteins O 0 0.016910726204514503
to O 0 0.0012163171777501702
the O 0 0.004916168283671141
CUG O 1 0.999994158744812
repeats O 0 0.09724585711956024
. O 0 0.005851092282682657

Data O 0 0.005466503091156483
presented O 0 0.0033452888019382954
here O 0 0.0014342537615448236
indicate O 0 0.0050339847803115845
that O 0 0.0008044239366427064
the O 0 0.002051424700766802
conserved O 0 0.046639811247587204
heterogeneous O 0 0.06509163975715637
nuclear O 0 0.01182111632078886
ribonucleoprotein O 1 0.9851213693618774
, O 0 0.0057828533463180065
CUG O 1 0.9998595714569092
- O 0 0.03690256178379059
binding O 0 0.03238493949174881
protein O 0 0.07670570909976959
( O 0 0.009838677942752838
CUG O 1 0.9999719858169556
- O 0 0.04963774234056473
BP O 1 0.6626141667366028
) O 0 0.0046592699363827705
, O 0 0.0017011717427521944
may O 0 0.007034447975456715
mediate O 0 0.05132896080613136
the O 0 0.006607556249946356
trans O 1 0.9178810119628906
- O 0 0.038049839437007904
dominant O 0 0.06450269371271133
effect O 0 0.012320778332650661
of O 0 0.001217270502820611
the O 0 0.004105213098227978
RNA O 0 0.15651702880859375
. O 0 0.005673390347510576

CUG O 1 0.9998194575309753
- O 0 0.06472626328468323
BP O 0 0.30153271555900574
was O 0 0.009174705483019352
found O 0 0.004400958772748709
to O 0 0.0014096241211518645
bind O 0 0.02643980085849762
to O 0 0.0010433269198983908
the O 0 0.002491970080882311
human O 0 0.025627674534916878
cardiac O 1 1.0
troponin O 1 0.9999998807907104
T O 1 0.9999746084213257
( O 0 0.010532052256166935
cTNT O 1 0.9953328967094421
) O 0 0.005000322125852108
pre O 0 0.04933146387338638
- O 0 0.035718321800231934
messenger O 0 0.1270657777786255
RNA O 0 0.12084583193063736
and O 0 0.002598598599433899
regulate O 0 0.025387220084667206
its O 0 0.004629045724868774
alternative O 0 0.022650616243481636
splicing O 0 0.16620247066020966
. O 0 0.006993042305111885

Splicing O 0 0.1578972339630127
of O 0 0.003634480992332101
cTNT O 1 0.9995763897895813
was O 0 0.010703518986701965
disrupted O 1 0.7417443990707397
in O 0 0.008486321195960045
DM B-Disease 1 1.0
striated O 1 0.9999998807907104
muscle O 1 0.999995231628418
and O 0 0.001444889814592898
in O 0 0.0017242019530385733
normal O 0 0.028357621282339096
cells O 0 0.03670070692896843
expressing O 0 0.0161894541233778
transcripts O 0 0.008081707172095776
that O 0 0.0014637684216722846
contain O 0 0.016828252002596855
CUG O 1 0.9999817609786987
repeats O 0 0.09973756968975067
. O 0 0.006041600368916988

Altered O 0 0.06525319814682007
expression O 0 0.022141577675938606
of O 0 0.0025830038357526064
genes O 0 0.15846458077430725
regulated O 0 0.04073391109704971
posttranscriptionally O 1 0.9989970326423645
by O 0 0.008094998076558113
CUG O 1 0.9999856948852539
- O 0 0.043929703533649445
BP O 0 0.2889510691165924
therefore O 0 0.006608389317989349
may O 0 0.006368535105139017
contribute O 0 0.012600025162100792
to O 0 0.008243159390985966
DM B-Disease 1 1.0
pathogenesis O 1 0.9999973773956299
. O 0 0.004700102377682924
. O 0 0.004570617340505123

Identification O 0 0.011765274219214916
of O 0 0.0009933535475283861
a O 0 0.005528352223336697
novel O 0 0.024532409384846687
nonsense O 1 0.9664095640182495
mutation O 1 0.9999943971633911
and O 0 0.001391393132507801
a O 0 0.0069955261424183846
missense O 1 0.99570232629776
substitution O 0 0.039799947291612625
in O 0 0.0017372864531353116
the O 0 0.004884043242782354
vasopressin O 1 0.9999562501907349
- O 0 0.07550988346338272
neurophysin O 1 0.9998863935470581
II O 1 0.9995372295379639
gene O 1 0.9398077130317688
in O 0 0.0016374110709875822
two O 0 0.0014366611139848828
Spanish O 0 0.02201860398054123
kindreds O 1 0.9980934262275696
with O 0 0.008614879101514816
familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 0.9999997615814209
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999996423721313
. O 0 0.013666145503520966

Familial B-Disease 1 0.9999998807907104
neurohypophyseal I-Disease 1 0.9999995231628418
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 0.020411785691976547
FNDI B-Disease 1 0.9999997615814209
) O 0 0.0032420563511550426
is O 0 0.0019220272079110146
an O 0 0.0037993688602000475
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999986886978149
disease I-Disease 1 1.0
caused O 1 0.999998927116394
by O 0 0.008455452509224415
deficiency O 1 1.0
in O 0 0.0016752955270931125
the O 0 0.005978833418339491
antidiuretic O 1 0.9999971389770508
hormone O 1 0.9993938207626343
arginine O 1 0.9825659990310669
vasopressin O 1 0.9987955093383789
( O 0 0.015931664034724236
AVP O 1 0.999962568283081
) O 0 0.004698989912867546
encoded O 0 0.018922947347164154
by O 0 0.002059760969132185
the O 0 0.004680484998971224
AVP O 1 0.9999878406524658
- O 0 0.06029512733221054
neurophysin O 1 0.9999371767044067
II O 1 0.9994339346885681
( O 0 0.010113145224750042
AVP O 1 0.9999933242797852
- O 0 0.07084299623966217
NPII O 1 0.9998822212219238
) O 0 0.008893700316548347
gene O 1 0.9838983416557312
on O 0 0.00617891876026988
chromosome O 1 0.9999514818191528
20p13 O 1 0.9985999464988708
. O 0 0.007331872824579477

In O 0 0.003150851931422949
this O 0 0.0019832784309983253
study O 0 0.0034131533466279507
, O 0 0.0010678479447960854
we O 0 0.0011027787113562226
analyzed O 0 0.009529287926852703
two O 0 0.0012882149312645197
families O 0 0.005439383909106255
with O 0 0.0032788505777716637
FNDI B-Disease 1 0.9999911785125732
using O 0 0.004875290673226118
direct O 0 0.00944547075778246
automated O 0 0.04720579460263252
fluorescent O 0 0.09569671750068665
, O 0 0.0019161734962835908
solid O 0 0.009667102247476578
phase O 0 0.02579575590789318
, O 0 0.001622385228984058
single O 0 0.013300632126629353
- O 0 0.027531687170267105
stranded O 0 0.12850356101989746
DNA O 0 0.04947074130177498
sequencing O 0 0.04693495109677315
of O 0 0.0031472418922930956
PCR O 1 0.7922254204750061
- O 0 0.043466661125421524
amplified O 0 0.39048120379447937
AVP O 1 0.9999804496765137
- O 0 0.08801762759685516
NPII O 1 0.999527096748352
DNA O 0 0.086536705493927
. O 0 0.007602436933666468

In O 0 0.002836019964888692
one O 0 0.0018025306053459644
of O 0 0.0008760643540881574
the O 0 0.0020825467072427273
families O 0 0.0050862557254731655
, O 0 0.0018457340775057673
affected O 0 0.36142697930336
individuals O 0 0.002804042538627982
presented O 0 0.0023033253382891417
a O 0 0.004406264517456293
novel O 0 0.022407153621315956
nonsense O 1 0.7124136686325073
mutation O 1 0.999980092048645
in O 0 0.0042507946491241455
exon O 1 0.9953254461288452
3 O 0 0.008123924024403095
of O 0 0.0010587183060124516
the O 0 0.00477330619469285
gene O 1 0.9988521337509155
, O 0 0.0015735359629616141
consisting O 0 0.00381687399931252
in O 0 0.0016631536418572068
a O 0 0.009791015647351742
G O 1 0.9986281394958496
to O 0 0.005182455759495497
T O 1 0.9930379986763
transition O 0 0.024503782391548157
at O 0 0.0070388419553637505
nucleotide O 0 0.278831422328949
2101 O 1 0.997562050819397
, O 0 0.0022090256679803133
which O 0 0.0018336829962208867
produces O 0 0.014773991890251637
a O 0 0.005881676450371742
stop O 0 0.015379979275166988
signal O 0 0.02434280700981617
in O 0 0.00315810926258564
codon O 1 0.7878648042678833
82 O 0 0.07087907195091248
( O 0 0.012703190557658672
Glu O 1 0.9999668598175049
) O 0 0.004601868335157633
of O 0 0.0036098682321608067
NPII O 1 0.999932050704956
. O 0 0.007214515935629606

The O 0 0.015683380886912346
premature O 1 0.9989312291145325
termination O 1 0.9843071699142456
eliminates O 0 0.10236038267612457
part O 0 0.003881661919876933
of O 0 0.0011357205221429467
the O 0 0.0044752685353159904
C O 1 0.9913745522499084
- O 0 0.03806235268712044
terminal O 1 0.6843840479850769
domain O 0 0.024182941764593124
of O 0 0.0028866478241980076
NPII O 1 0.9999967813491821
, O 0 0.0019489084370434284
including O 0 0.0015977580333128572
a O 0 0.007629068568348885
cysteine O 0 0.11852753907442093
residue O 0 0.08656206727027893
in O 0 0.0021965394262224436
position O 0 0.006909332238137722
85 O 0 0.024882281199097633
, O 0 0.0015218706103041768
which O 0 0.001376941567286849
could O 0 0.002506759949028492
be O 0 0.001125385519117117
involved O 0 0.004018430132418871
in O 0 0.0008649109513498843
the O 0 0.0025379147846251726
correct O 0 0.024872425943613052
folding O 0 0.05381740257143974
of O 0 0.001817836775444448
the O 0 0.005738374777138233
prohormone O 1 0.9998680353164673
. O 0 0.00853728037327528

In O 0 0.002571956254541874
the O 0 0.0025711050257086754
second O 0 0.010980596765875816
family O 0 0.01156608946621418
, O 0 0.0016346477204933763
a O 0 0.008122802712023258
G279A O 1 0.9992645382881165
substitution O 0 0.04682561010122299
at O 0 0.004125813953578472
position O 0 0.007447956129908562
- O 0 0.01473750825971365
1 O 0 0.007500102743506432
of O 0 0.00090614432701841
the O 0 0.0025702102575451136
signal O 0 0.04409150406718254
peptide O 0 0.2018095850944519
was O 0 0.007248708512634039
observed O 0 0.008383235894143581
in O 0 0.0010538152419030666
all O 0 0.0016926650423556566
affected O 0 0.4072481691837311
individuals O 0 0.00685218907892704
. O 0 0.0052665770053863525

This O 0 0.010491487570106983
missense O 1 0.9999091625213623
mutation O 1 0.9999889135360718
, O 0 0.002011213917285204
which O 0 0.002675040625035763
replaces O 1 0.9986562728881836
Ala O 1 0.9999734163284302
with O 0 0.006127489265054464
Thr O 1 0.9999998807907104
, O 0 0.0020520389080047607
is O 0 0.0033638698514550924
frequent O 0 0.04936989024281502
among O 0 0.016010280698537827
FNDI B-Disease 1 1.0
patients O 1 0.9999992847442627
and O 0 0.0015572654083371162
is O 0 0.002560100983828306
thought O 0 0.00678738858550787
to O 0 0.001206608023494482
reduce O 0 0.01212693564593792
the O 0 0.002042749198153615
efficiency O 0 0.009147523902356625
of O 0 0.0026109295431524515
cleavage O 1 0.9963162541389465
by O 0 0.0049647060222923756
signal O 0 0.045138563960790634
peptidases O 1 0.9911447167396545
. O 0 0.003345611970871687
. O 0 0.003682771697640419

Genetic O 0 0.10632310062646866
heterogeneity O 0 0.10043548047542572
of O 0 0.003278273856267333
Saethre B-Disease 1 0.9999986886978149
- I-Disease 1 0.9977476000785828
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.0025064966175705194
due O 0 0.007140547037124634
to O 0 0.0017904054839164019
TWIST O 1 0.9971808195114136
and O 0 0.0036141257733106613
FGFR O 1 0.9999995231628418
mutations O 1 0.9999759197235107
. O 0 0.005881681572645903

Thirty O 0 0.04379649832844734
- O 0 0.021974947303533554
two O 0 0.003219006350263953
unrelated O 0 0.2991124391555786
patients O 1 0.9999200105667114
with O 0 0.0013954484602436423
features O 0 0.0033155253622680902
of O 0 0.002285817638039589
Saethre B-Disease 1 0.9999977350234985
- I-Disease 1 0.9991468191146851
Chotzen I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
, O 0 0.002449437975883484
a O 0 0.005902752745896578
common O 0 0.06754158437252045
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9989193677902222
condition I-Disease 1 0.9875108003616333
of O 0 0.002954710740596056
craniosynostosis B-Disease 1 1.0
and O 0 0.008685172535479069
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9998065829277039
, O 0 0.0013484674273058772
were O 0 0.001441674423404038
screened O 0 0.046346649527549744
for O 0 0.0029383148066699505
mutations O 1 0.999749481678009
in O 0 0.0033069264609366655
TWIST O 1 0.9975345134735107
, O 0 0.0039839292876422405
FGFR2 O 1 0.9999872446060181
, O 0 0.002476861933246255
and O 0 0.0026704100891947746
FGFR3 O 1 0.9999834299087524
. O 0 0.0068337926641106606

Nine O 0 0.012275829911231995
novel O 0 0.01737935282289982
and O 0 0.0011962593998759985
three O 0 0.004259967710822821
recurrent O 1 0.9999988079071045
TWIST O 1 0.9999728202819824
mutations O 1 0.9999752044677734
were O 0 0.002109065419062972
found O 0 0.0034566461108624935
in O 0 0.0015791015466675162
12 O 0 0.008071118965744972
families O 0 0.00714804558083415
. O 0 0.005729097407311201

Seven O 0 0.010276989080011845
families O 0 0.005960970185697079
were O 0 0.0012636658502742648
found O 0 0.0026776508893817663
to O 0 0.0008376349578611553
have O 0 0.0014338803011924028
the O 0 0.005123665556311607
FGFR3 O 1 0.9999994039535522
P250R O 1 0.9999967813491821
mutation O 1 0.9999966621398926
, O 0 0.0018473792588338256
and O 0 0.0008043614216148853
one O 0 0.001970050623640418
individual O 0 0.002209555357694626
was O 0 0.005242058541625738
found O 0 0.0027835366781800985
to O 0 0.0006418074481189251
have O 0 0.0012146384688094258
an O 0 0.0034292093478143215
FGFR2 O 1 0.9999938011169434
VV269 O 1 0.9997722506523132
- O 0 0.04460013657808304
270 O 0 0.09265227615833282
deletion O 1 0.9991775155067444
. O 0 0.006646632216870785

To O 0 0.0030368559528142214
date O 0 0.004793819971382618
, O 0 0.0010435470612719655
our O 0 0.002663867548108101
detection O 0 0.0409482903778553
rate O 0 0.009649001061916351
for O 0 0.0025714391376823187
TWIST O 1 0.9845565557479858
or O 0 0.01244494691491127
FGFR O 1 0.9999983310699463
mutations O 1 0.9999412298202515
is O 0 0.005328536964952946
68 O 0 0.021625161170959473
% O 0 0.0020667158532887697
in O 0 0.0009715529740788043
our O 0 0.004238875117152929
Saethre B-Disease 1 0.9999984502792358
- I-Disease 1 0.9998493194580078
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 1.0
, O 0 0.0012066338676959276
including O 0 0.0008020717650651932
our O 0 0.002106504747644067
five O 0 0.005074925255030394
patients O 1 0.9999985694885254
elsewhere O 0 0.010732300579547882
reported O 0 0.01249044667929411
with O 0 0.002712258603423834
TWIST O 1 0.9996726512908936
mutations O 1 0.9999598264694214
. O 0 0.00691228499636054

More O 0 0.0031123782973736525
than O 0 0.002523955889046192
35 O 0 0.009817694313824177
different O 0 0.0027822130359709263
TWIST O 1 0.9998692274093628
mutations O 1 0.999872088432312
are O 0 0.0018030805513262749
now O 0 0.0037840264849364758
known O 0 0.006866550538688898
in O 0 0.0010868939571082592
the O 0 0.0020086485892534256
literature O 0 0.004915079101920128
. O 0 0.00472273351624608

The O 0 0.004767442122101784
most O 0 0.0036892981734126806
common O 0 0.01580670289695263
phenotypic O 1 0.9998756647109985
features O 0 0.006443853955715895
, O 0 0.001067725825123489
present O 0 0.0015483555616810918
in O 0 0.0007653221837244928
more O 0 0.0007962468080222607
than O 0 0.001020157360471785
a O 0 0.0034410408698022366
third O 0 0.005216768942773342
of O 0 0.0012136977165937424
our O 0 0.005303358659148216
patients O 1 0.9999927282333374
with O 0 0.003237247932702303
TWIST O 1 0.9999892711639404
mutations O 1 0.9999867677688599
, O 0 0.0014239493757486343
are O 0 0.0012028024066239595
coronal B-Disease 1 0.997327446937561
synostosis I-Disease 1 0.9998501539230347
, O 0 0.0031131093855947256
brachycephaly B-Disease 1 0.9999110698699951
, O 0 0.0028574930038303137
low B-Disease 0 0.06774801015853882
frontal I-Disease 1 0.9999997615814209
hairline I-Disease 1 1.0
, O 0 0.00860688928514719
facial B-Disease 1 0.9999997615814209
asymmetry I-Disease 1 0.9999101161956787
, O 0 0.006324781570583582
ptosis B-Disease 1 1.0
, O 0 0.005873879883438349
hypertelorism B-Disease 1 0.9999810457229614
, O 0 0.0026687178760766983
broad B-Disease 0 0.01852107048034668
great I-Disease 0 0.015474903397262096
toes I-Disease 1 0.9999942779541016
, O 0 0.0018297082278877497
and O 0 0.0022809356451034546
clinodactyly B-Disease 1 0.999895453453064
. O 0 0.006093113217502832

Significant O 0 0.023024626076221466
intra O 0 0.23666203022003174
- O 0 0.02580331638455391
and O 0 0.0036002369597554207
interfamilial O 1 0.9998923540115356
phenotypic O 1 0.9994102716445923
variability O 0 0.0784442201256752
is O 0 0.001996624516323209
present O 0 0.0013622038532048464
for O 0 0.0008125107269734144
either O 0 0.005968933925032616
TWIST O 1 0.9998863935470581
mutations O 1 0.9999935626983643
or O 0 0.013551175594329834
FGFR O 1 0.9999985694885254
mutations O 1 0.9998834133148193
. O 0 0.006161521188914776

The O 0 0.006348630413413048
overlap O 0 0.02488255314528942
in O 0 0.002996470546349883
clinical O 1 0.9191330075263977
features O 0 0.004053754732012749
and O 0 0.0008023336413316429
the O 0 0.00202851346693933
presence O 0 0.006688382942229509
, O 0 0.0009477964485995471
in O 0 0.000908693065866828
the O 0 0.001861058408394456
same O 0 0.004333813674747944
genes O 0 0.10320723056793213
, O 0 0.0016649914905428886
of O 0 0.002270386554300785
mutations O 1 0.9998812675476074
for O 0 0.0012514716945588589
more O 0 0.000994916190393269
than O 0 0.0017840382643043995
one O 0 0.005143601447343826
craniosynostotic B-Disease 1 0.99997878074646
condition I-Disease 1 0.9406811594963074
- O 0 0.013271438889205456
such O 0 0.0010194557253271341
as O 0 0.0036201165057718754
Saethre B-Disease 1 0.9997574687004089
- I-Disease 0 0.05876394733786583
Chotzen I-Disease 1 0.9998573064804077
, I-Disease 0 0.004212934989482164
Crouzon I-Disease 1 0.9998584985733032
, I-Disease 0 0.00190596969332546
and I-Disease 0 0.002737164730206132
Pfeiffer I-Disease 1 0.9999997615814209
syndromes I-Disease 1 1.0
- O 0 0.019350379705429077
support O 0 0.0036674493458122015
the O 0 0.002415267052128911
hypothesis O 0 0.03935612738132477
that O 0 0.00209608837030828
TWIST O 1 0.857632577419281
and O 0 0.002876008627936244
FGFRs O 1 0.9994403719902039
are O 0 0.0009370100451633334
components O 0 0.0028005994390696287
of O 0 0.0007009128457866609
the O 0 0.0016877433517947793
same O 0 0.0042387680150568485
molecular O 0 0.03590058162808418
pathway O 0 0.08200182765722275
involved O 0 0.007186819799244404
in O 0 0.0012952607357874513
the O 0 0.0026915220078080893
modulation O 1 0.6431442499160767
of O 0 0.004628792870789766
craniofacial O 1 0.9999998807907104
and O 0 0.005478573031723499
limb O 1 0.9999998807907104
development O 0 0.004674449097365141
in O 0 0.002295674057677388
humans O 0 0.04216315224766731
. O 0 0.0024195655714720488
. O 0 0.003805909538641572

Mutation O 1 0.9987785220146179
analysis O 0 0.006426866631954908
of O 0 0.002999489428475499
UBE3A O 1 0.9999998807907104
in O 0 0.09427516907453537
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 1.0
. O 0 0.007205181289464235

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.012521887198090553
AS B-Disease 0 0.018486985936760902
) O 0 0.0023718667216598988
is O 0 0.0028752346988767385
caused O 1 0.999405026435852
by O 0 0.005979508627206087
chromosome O 1 0.9999768733978271
15q11 O 1 0.9995521903038025
- O 0 0.05064455047249794
q13 O 1 0.9966166615486145
deletions O 0 0.12386497110128403
of O 0 0.002765143755823374
maternal O 1 0.9972636699676514
origin O 0 0.006664692889899015
, O 0 0.001313978573307395
by O 0 0.004671042785048485
paternal O 1 0.9999758005142212
uniparental B-Disease 1 1.0
disomy I-Disease 1 0.9999878406524658
( O 0 0.02187449112534523
UPD B-Disease 1 0.9999994039535522
) O 0 0.005734078586101532
15 O 0 0.005362709052860737
, O 0 0.0013717433903366327
by O 0 0.005167206283658743
imprinting O 1 0.9999984502792358
defects O 1 0.999996542930603
, O 0 0.0015809369506314397
and O 0 0.0009339311509393156
by O 0 0.004393545910716057
mutations O 1 0.9998525381088257
in O 0 0.0019165045814588666
the O 0 0.007306778337806463
UBE3A O 1 0.9999996423721313
gene O 1 0.9992921352386475
. O 0 0.007599807344377041

UBE3A O 1 0.9999085664749146
encodes O 0 0.20800958573818207
a O 0 0.015634560957551003
ubiquitin O 0 0.2931428849697113
- O 0 0.03984749689698219
protein O 0 0.0782659500837326
ligase O 0 0.05149214714765549
and O 0 0.0018443887820467353
shows O 0 0.01411717664450407
brain O 1 0.9999872446060181
- O 0 0.028227802366018295
specific O 0 0.011773793026804924
imprinting O 1 0.999146580696106
. O 0 0.006914936006069183

Here O 0 0.003573684487491846
we O 0 0.002321536187082529
describe O 0 0.02309119887650013
UBE3A O 1 0.9999536275863647
coding O 0 0.3194633722305298
- O 0 0.04214276373386383
region O 0 0.03453267365694046
mutations O 1 0.9999383687973022
detected O 0 0.11645293980836868
by O 0 0.005464224610477686
SSCP O 1 0.9997861981391907
analysis O 0 0.00645944569259882
in O 0 0.001956775551661849
13 O 0 0.0085366265848279
AS B-Disease 0 0.011353869922459126
individuals O 0 0.004653514828532934
or O 0 0.0038382934872061014
families O 0 0.007400232832878828
. O 0 0.005853238981217146

Two O 0 0.003822066355496645
identical O 0 0.013051816262304783
de O 0 0.03389527648687363
novo O 0 0.11559079587459564
5 O 0 0.019169161096215248
- O 0 0.029055478051304817
bp O 0 0.08660124987363815
duplications O 1 0.8473309874534607
in O 0 0.0042067659087479115
exon O 1 0.9966176152229309
16 O 0 0.010321934707462788
were O 0 0.0017763205105438828
found O 0 0.006506466772407293
. O 0 0.004739852622151375

Among O 0 0.006148733664304018
the O 0 0.0020081144757568836
other O 0 0.0009384431759826839
11 O 0 0.007868640124797821
unique O 0 0.01175755262374878
mutations O 1 0.9999357461929321
, O 0 0.0016618667868897319
8 O 0 0.006756138522177935
were O 0 0.0009962976910173893
small O 0 0.004477618727833033
deletions O 1 0.9433819651603699
or O 0 0.0044333902187645435
insertions O 1 0.8880748152732849
predicted O 0 0.019282948225736618
to O 0 0.0027372881304472685
cause O 1 0.9932740926742554
frameshifts O 1 0.9997679591178894
, O 0 0.0022451120894402266
1 O 0 0.008034657686948776
was O 0 0.005522417835891247
a O 0 0.010357187129557133
mutation O 1 0.999957799911499
to O 0 0.00156864442396909
a O 0 0.006160960532724857
stop O 0 0.023739658296108246
codon O 1 0.5385116934776306
, O 0 0.002078802092000842
1 O 0 0.00696666119620204
was O 0 0.005734842270612717
a O 0 0.01327592320740223
missense O 1 0.9999914169311523
mutation O 1 0.9999806880950928
, O 0 0.0021383517887443304
and O 0 0.0010536530753597617
1 O 0 0.007670913822948933
was O 0 0.0058785066939890385
predicted O 0 0.011746084317564964
to O 0 0.00255866558291018
cause O 1 0.620234489440918
insertion O 0 0.17784260213375092
of O 0 0.0013204619754105806
an O 0 0.003518598387017846
isoleucine O 1 0.998837411403656
in O 0 0.0020185161847621202
the O 0 0.004447526764124632
hect O 1 0.9904463291168213
domain O 0 0.025303658097982407
of O 0 0.0017400201177224517
the O 0 0.00826318096369505
UBE3A O 1 0.9999986886978149
protein O 0 0.0835854783654213
, O 0 0.0012991254916414618
which O 0 0.0010901421774178743
functions O 0 0.003951625432819128
in O 0 0.0028784945607185364
E2 O 1 0.9991224408149719
binding O 0 0.021374423056840897
and O 0 0.0021191269624978304
ubiquitin O 0 0.13596732914447784
transfer O 0 0.009514061734080315
. O 0 0.0051904115825891495

Eight O 0 0.0062659853138029575
of O 0 0.0010572437895461917
the O 0 0.002599472412839532
cases O 0 0.01214764453470707
were O 0 0.0037591010332107544
familial O 1 0.9999997615814209
, O 0 0.0014028275618329644
and O 0 0.0006815960514359176
five O 0 0.001796771539375186
were O 0 0.00202575558796525
sporadic O 0 0.17976826429367065
. O 0 0.006338777020573616

In O 0 0.003368504112586379
two O 0 0.003763183718547225
familial O 1 0.9999979734420776
cases O 0 0.011968555860221386
and O 0 0.0010372970718890429
one O 0 0.003512270748615265
sporadic O 0 0.2797505855560303
case O 0 0.0074133011512458324
, O 0 0.002814686391502619
mosaicism O 1 0.999996542930603
for O 0 0.00677233561873436
UBE3A O 1 0.9999998807907104
mutations O 1 0.9999966621398926
was O 0 0.010851308703422546
detected O 0 0.04841994866728783
in O 0 0.001106083276681602
the O 0 0.0020922997500747442
mother O 0 0.0197133868932724
of O 0 0.0009890164947137237
three O 0 0.0019406750798225403
AS B-Disease 0 0.14653612673282623
sons O 1 0.8386120796203613
, O 0 0.0009402036666870117
in O 0 0.00085478276014328
the O 0 0.0029353341087698936
maternal O 1 0.9998383522033691
grandfather O 0 0.37234851717948914
of O 0 0.0012156316079199314
two O 0 0.001413650345057249
AS B-Disease 0 0.011525966227054596
first O 0 0.005905028432607651
cousins O 1 0.9490060210227966
, O 0 0.0011944194557145238
and O 0 0.0005443849950097501
in O 0 0.0008943620487116277
the O 0 0.002165206940844655
mother O 0 0.019466711208224297
of O 0 0.001147303730249405
an O 0 0.0024467853363603354
AS B-Disease 0 0.0874757245182991
daughter O 1 0.9967315196990967
. O 0 0.005054336041212082

The O 0 0.006019600201398134
frequencies O 0 0.017736265435814857
with O 0 0.0009788558818399906
which O 0 0.00142079743091017
we O 0 0.0028720428235828876
detected O 1 0.909392237663269
mutations O 1 0.9995947480201721
were O 0 0.0023989127948880196
5 O 0 0.009122900664806366
( O 0 0.0038547501899302006
14 O 0 0.007995245978236198
% O 0 0.004012429155409336
) O 0 0.0017909849993884563
of O 0 0.0012177472235634923
35 O 0 0.008979461155831814
in O 0 0.0026066675782203674
sporadic O 0 0.2315218299627304
cases O 0 0.011393064633011818
and O 0 0.0019201189279556274
8 O 0 0.014017518609762192
( O 0 0.0045417980290949345
80 O 0 0.01314567681401968
% O 0 0.004526358563452959
) O 0 0.0016696141101419926
of O 0 0.0008301739580929279
10 O 0 0.004448518622666597
in O 0 0.0036123301833868027
familial O 1 1.0
cases O 0 0.020100563764572144
. O 0 0.002178692724555731
. O 0 0.004259360954165459

The O 0 0.023377645760774612
hemochromatosis B-Disease 1 1.0
845 O 1 0.999956488609314
G O 1 0.9995549321174622
- O 0 0.04643319174647331
- O 0 0.03810479864478111
> O 1 0.7456848621368408
A O 0 0.011648552492260933
and O 0 0.001893422333523631
187 O 0 0.08397933840751648
C O 1 0.570984959602356
- O 0 0.03519091755151749
- O 0 0.052075330168008804
> O 1 0.9973825812339783
G O 1 0.9998840093612671
mutations O 1 0.9997937083244324
: O 0 0.007405078038573265
prevalence O 1 0.9987271428108215
in O 0 0.0021956658456474543
non O 0 0.01260487362742424
- O 0 0.03783360868692398
Caucasian O 1 0.9990856647491455
populations O 0 0.05227487534284592
. O 0 0.006116780452430248

Hemochromatosis B-Disease 1 1.0
, O 0 0.0029298600275069475
the O 0 0.0058042206801474094
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 0 0.0039224885404109955
iron I-Disease 1 0.9997822642326355
metabolism I-Disease 1 0.9999836683273315
, O 0 0.0016468592220917344
leads O 0 0.014841817319393158
, O 0 0.0014539069961756468
if O 0 0.004842252004891634
untreated O 1 0.9999992847442627
, O 0 0.0013419220922514796
to O 0 0.0016351178055629134
progressive O 1 0.9996371269226074
iron B-Disease 1 0.9978991746902466
overload I-Disease 1 0.9999581575393677
and O 0 0.00487374747171998
premature B-Disease 1 0.9999691247940063
death I-Disease 1 0.9499713778495789
. O 0 0.005404776893556118

The O 0 0.025960959494113922
hemochromatosis B-Disease 1 1.0
gene O 1 0.9999479055404663
, O 0 0.006038520019501448
HFE O 1 1.0
, O 0 0.003297447459772229
recently O 0 0.012458316050469875
has O 0 0.0031416125129908323
been O 0 0.004003145731985569
identified O 0 0.009573016315698624
, O 0 0.0009917401475831866
and O 0 0.0009222794906236231
characterization O 0 0.020076056942343712
of O 0 0.0013076040195301175
this O 0 0.003603149438276887
gene O 1 0.9999409914016724
has O 0 0.0034864679910242558
shown O 0 0.0042326743714511395
that O 0 0.0005843518301844597
it O 0 0.0009899737779051065
contains O 0 0.0029978000093251467
two O 0 0.0025250196922570467
mutations O 1 0.9999613761901855
that O 0 0.0015196442836895585
result O 0 0.006512659136205912
in O 0 0.0020811674185097218
amino O 0 0.0685356929898262
acid O 0 0.12887871265411377
substitutions O 0 0.04723425954580307
- O 0 0.02976938895881176
cDNA O 0 0.15196940302848816
nucleotides O 0 0.1177961453795433
845 O 1 0.9959496259689331
G O 1 0.9921653270721436
- O 0 0.04244999215006828
- O 0 0.04807565361261368
> O 1 0.9243308305740356
A O 0 0.023582080379128456
( O 0 0.009736201725900173
C282Y O 1 0.9966599941253662
) O 0 0.0035763035994023085
and O 0 0.0019452354172244668
187 O 0 0.07970349490642548
C O 1 0.7665347456932068
- O 0 0.04495042935013771
- O 0 0.06658465415239334
> O 1 0.9978209733963013
G O 1 0.9990329742431641
( O 0 0.013441445305943489
H63D O 1 0.9998884201049805
) O 0 0.006715643685311079
. O 0 0.004877125378698111

Although O 0 0.0333012230694294
hemochromatosis B-Disease 1 1.0
is O 0 0.00669292313978076
common O 0 0.008951599709689617
in O 0 0.0027529029175639153
Caucasians O 1 0.9989523887634277
, O 0 0.004468074534088373
affecting O 1 0.9970796704292297
> O 1 0.9978259205818176
= O 0 0.06499151885509491
1 O 0 0.02339344657957554
/ O 0 0.05359002575278282
300 O 0 0.009456516243517399
individuals O 0 0.003140297019854188
of O 0 0.0013472639257088304
northern O 0 0.008735036477446556
European O 0 0.004819720983505249
origin O 0 0.006884363945573568
, O 0 0.0012757579097524285
it O 0 0.0013233727077022195
has O 0 0.0022955965250730515
not O 0 0.0012032773811370134
been O 0 0.0033970593940466642
recognized O 0 0.00719482684507966
in O 0 0.001244779210537672
other O 0 0.0015014015370979905
populations O 0 0.0354740135371685
. O 0 0.005250150337815285

The O 0 0.004382850602269173
present O 0 0.0027655435260385275
study O 0 0.004011703189462423
used O 0 0.0033872518688440323
PCR O 0 0.4985816478729248
and O 0 0.0026681339368224144
restriction O 0 0.04961499571800232
- O 0 0.04660791903734207
enzyme O 0 0.26052263379096985
digestion O 1 0.8229211568832397
to O 0 0.001874841982498765
analyze O 0 0.00769790867343545
the O 0 0.002101668156683445
frequency O 0 0.017979972064495087
of O 0 0.0011206346098333597
the O 0 0.004728858359158039
845 O 1 0.9999701976776123
G O 1 0.9994155168533325
- O 0 0.03548083081841469
- O 0 0.03988547995686531
> O 1 0.9743510484695435
A O 0 0.01038765162229538
and O 0 0.0016290280036628246
187 O 0 0.07418300956487656
C O 1 0.6650075912475586
- O 0 0.03628407418727875
- O 0 0.05192118510603905
> O 1 0.99850994348526
G O 1 0.9983357787132263
mutations O 1 0.996735155582428
in O 0 0.008029889315366745
HLA O 1 0.9999891519546509
- O 0 0.035002414137125015
typed O 0 0.05729448050260544
samples O 0 0.012234785594046116
from O 0 0.0030648428946733475
non O 0 0.015560418367385864
- O 0 0.04390101507306099
Caucasian O 1 0.9719445109367371
populations O 0 0.03544463962316513
, O 0 0.0015113126719370484
comprising O 0 0.005854485090821981
Australian O 0 0.021740972995758057
Aboriginal O 0 0.042666029185056686
, O 0 0.0013760306173935533
Chinese O 0 0.0018899416318163276
, O 0 0.001064552809111774
and O 0 0.001441407366655767
Pacific O 0 0.0409238375723362
Islanders O 1 0.9842372536659241
. O 0 0.005450967699289322

Results O 0 0.014237756840884686
showed O 0 0.006441489327698946
that O 0 0.0007838554447516799
the O 0 0.0034798423293977976
845 O 1 0.9999088048934937
G O 1 0.9994780421257019
- O 0 0.046400461345911026
- O 0 0.052389588207006454
> O 1 0.997111439704895
A O 0 0.04141552373766899
mutation O 1 0.9999638795852661
was O 0 0.008443410508334637
present O 0 0.002301850588992238
in O 0 0.0013025858206674457
these O 0 0.0014739304315298796
populations O 0 0.037522539496421814
( O 0 0.009083564393222332
allele O 1 0.9998031258583069
frequency O 0 0.0822419673204422
0 O 0 0.03044809401035309
. O 0 0.002320963190868497
32 O 0 0.01648131012916565
% O 0 0.005751366727054119
) O 0 0.0028324215672910213
, O 0 0.0012629114789888263
and O 0 0.001026278012432158
, O 0 0.0016475884476676583
furthermore O 0 0.013490297831594944
, O 0 0.0011824346147477627
it O 0 0.0012540124589577317
was O 0 0.005221222061663866
always O 0 0.0035622953437268734
seen O 0 0.0058129336684942245
in O 0 0.0012230415595695376
conjunction O 0 0.017984963953495026
with O 0 0.004870742093771696
HLA O 1 1.0
haplotypes O 1 0.9992865920066833
common O 0 0.015394138172268867
in O 0 0.00297920242883265
Caucasians O 1 0.9995879530906677
, O 0 0.001989859389141202
suggesting O 0 0.012297144159674644
that O 0 0.002675569849088788
845 O 1 0.9999295473098755
G O 1 0.9997488856315613
- O 0 0.04473194107413292
- O 0 0.053317293524742126
> O 1 0.9982715845108032
A O 0 0.02009676583111286
may O 0 0.007322813384234905
have O 0 0.001560448668897152
been O 0 0.00315879681147635
introduced O 0 0.006480255164206028
into O 0 0.0024077764246612787
these O 0 0.001195266144350171
populations O 0 0.026599403470754623
by O 0 0.006356323137879372
Caucasian O 1 0.9772250056266785
admixture O 1 0.9647358655929565
. O 0 0.009338348172605038

187 O 0 0.15921418368816376
C O 0 0.31383413076400757
- O 0 0.04805039241909981
- O 0 0.06442558020353317
> O 1 0.9970805048942566
G O 1 0.9953446984291077
was O 0 0.007266360800713301
present O 0 0.002691756235435605
at O 0 0.003144992748275399
an O 0 0.0053026797249913216
allele O 1 0.9996097683906555
frequency O 0 0.03966778516769409
of O 0 0.002289229305461049
2 O 0 0.010125601664185524
. O 0 0.004474474582821131

68 O 0 0.06195080280303955
% O 0 0.004434691276401281
in O 0 0.0013201662804931402
the O 0 0.0017066338332369924
two O 0 0.0019509622361510992
populations O 0 0.036339059472084045
analyzed O 0 0.023340092971920967
( O 0 0.004690954927355051
Australian O 0 0.02173118107020855
Aboriginal O 0 0.03039478324353695
and O 0 0.0012692761374637485
Chinese O 0 0.0036166210193187
) O 0 0.003895185422152281
. O 0 0.004200426395982504

In O 0 0.0027038261760026217
the O 0 0.002437430201098323
Australian O 0 0.017668578773736954
Aboriginal O 0 0.03147559240460396
samples O 0 0.013111148960888386
, O 0 0.0023848246783018112
187 O 0 0.08185315877199173
C O 0 0.46228936314582825
- O 0 0.04052358493208885
- O 0 0.05466771498322487
> O 1 0.9985421895980835
G O 1 0.9980879426002502
was O 0 0.006953856907784939
found O 0 0.0033623387571424246
to O 0 0.0008127383189275861
be O 0 0.0013625349383801222
associated O 0 0.006038176827132702
with O 0 0.00411450257524848
HLA O 1 0.9999998807907104
haplotypes O 1 0.998711109161377
common O 0 0.015082299709320068
in O 0 0.002939884550869465
Caucasians O 1 0.9999407529830933
, O 0 0.001793606672435999
suggesting O 0 0.010590179823338985
that O 0 0.0009766242001205683
it O 0 0.0012832735665142536
was O 0 0.005004235543310642
introduced O 0 0.007323145866394043
by O 0 0.0024374662898480892
recent O 0 0.010353555902838707
admixture O 1 0.9751714468002319
. O 0 0.00640964275225997

In O 0 0.0028923300560563803
the O 0 0.0018305914709344506
Chinese O 0 0.0031090870033949614
samples O 0 0.012226372957229614
analyzed O 0 0.015002460218966007
, O 0 0.002402546349912882
187 O 0 0.09389493614435196
C O 1 0.6977269649505615
- O 0 0.0426347590982914
- O 0 0.0613984577357769
> O 1 0.9965401887893677
G O 1 0.9982461929321289
was O 0 0.006648811511695385
present O 0 0.002494372660294175
in O 0 0.0015173547435551882
association O 0 0.008504134602844715
with O 0 0.0010928056435659528
a O 0 0.005086340941488743
wide O 0 0.008339925669133663
variety O 0 0.004716909024864435
of O 0 0.0037962617352604866
HLA O 1 1.0
haplotypes O 1 0.9996457099914551
, O 0 0.0024164668284356594
showing O 0 0.008270812220871449
this O 0 0.0036859367974102497
mutation O 1 0.9999938011169434
to O 0 0.0013004576321691275
be O 0 0.0014654503902420402
widespread O 0 0.025332899764180183
and O 0 0.001309358631260693
likely O 0 0.0077256434597074986
to O 0 0.0015422820579260588
predate O 0 0.07080227881669998
the O 0 0.0025222711265087128
more O 0 0.0026141053531318903
genetically O 0 0.06908975541591644
restricted O 0 0.03190122917294502
845 O 1 0.9996774196624756
G O 1 0.998955249786377
- O 0 0.043650973588228226
- O 0 0.04972546547651291
> O 1 0.9768539071083069
A O 0 0.051992468535900116
mutation O 1 0.999925971031189
. O 0 0.007107107434421778

Genotype O 1 0.9999548196792603
- O 0 0.19423162937164307
phenotype O 1 0.9999792575836182
correlations O 0 0.05959087610244751
in O 0 0.007487335242331028
attenuated B-Disease 1 0.9999994039535522
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 0.01243054959923029

Germ O 1 0.9755247831344604
- O 0 0.037061892449855804
line O 0 0.01894303783774376
mutations O 1 0.9907323122024536
of O 0 0.0018215992022305727
the O 0 0.008364811539649963
tumor B-Disease 1 1.0
suppressor O 1 0.9999998807907104
APC O 1 0.9999876022338867
are O 0 0.002626000437885523
implicated O 1 0.535636305809021
in O 0 0.007321285083889961
attenuated B-Disease 1 0.999998927116394
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 0.0350198969244957
AAPC B-Disease 1 0.9999998807907104
) O 0 0.004278171807527542
, O 0 0.0011738133616745472
a O 0 0.006259189452975988
variant O 1 0.9978012442588806
of O 0 0.007257392629981041
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.5425397753715515
FAP B-Disease 1 1.0
) O 0 0.0068554445169866085
. O 0 0.0038311693351715803

AAPC B-Disease 1 0.9999923706054688
is O 0 0.005855464842170477
recognized O 0 0.007943335920572281
by O 0 0.0014776692260056734
the O 0 0.0025249954778701067
occurrence O 0 0.09518487751483917
of O 0 0.0031966299284249544
< O 1 0.9991330504417419
100 O 0 0.018169479444622993
colonic B-Disease 1 0.999980092048645
adenomas I-Disease 1 0.9999853372573853
and O 0 0.0014291791012510657
a O 0 0.004516371991485357
later O 0 0.007523427251726389
onset O 1 0.9999997615814209
of O 0 0.028828442096710205
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.00873494427651167
age O 0 0.02117987349629402
> O 1 0.999363362789154
40 O 0 0.010801025666296482
years O 0 0.004294622223824263
) O 0 0.0035319689195603132
. O 0 0.003662467934191227

The O 0 0.005152999423444271
aim O 0 0.009651492349803448
of O 0 0.0010557665955275297
this O 0 0.0012835769448429346
study O 0 0.002774584572762251
was O 0 0.003686598502099514
to O 0 0.0017351534916087985
assess O 0 0.041659221053123474
genotype O 1 0.9999830722808838
- O 0 0.17041197419166565
phenotype O 1 0.9999980926513672
correlations O 0 0.07897251844406128
in O 0 0.007004117127507925
AAPC B-Disease 1 0.9999988079071045
families O 0 0.01733396388590336
. O 0 0.0052291168831288815

By O 0 0.010932608507573605
protein O 0 0.08782968670129776
- O 0 0.04491402581334114
truncation O 1 0.9777491688728333
test O 0 0.030282607302069664
( O 0 0.00849755946546793
PTT O 1 0.9958969354629517
) O 0 0.005535797215998173
assay O 0 0.054982688277959824
, O 0 0.0009708427242003381
the O 0 0.0020086083095520735
entire O 0 0.016192058101296425
coding O 0 0.07371827214956284
region O 0 0.006570863071829081
of O 0 0.001149840303696692
the O 0 0.0057008289732038975
APC B-Disease 1 0.9999998807907104
gene O 1 0.9997380375862122
was O 0 0.010350842028856277
screened O 0 0.04248128831386566
in O 0 0.0017657619901001453
affected O 0 0.056292299181222916
individuals O 0 0.0034805284813046455
from O 0 0.003416346851736307
11 O 0 0.027467213571071625
AAPC B-Disease 1 1.0
kindreds O 1 0.9998353719711304
, O 0 0.001720414380542934
and O 0 0.000774403044488281
their O 0 0.0023662555031478405
phenotypic O 1 0.9998952150344849
differences O 0 0.007366265170276165
were O 0 0.0016809416702017188
examined O 0 0.03140023350715637
. O 0 0.0044026561081409454

Five O 0 0.007884368300437927
novel O 0 0.03725738450884819
germ O 1 0.9956731200218201
- O 0 0.03667290136218071
line O 0 0.030496222898364067
APC B-Disease 1 0.999998927116394
mutations O 1 0.9999626874923706
were O 0 0.0019399195443838835
identified O 0 0.007458609528839588
in O 0 0.0013750595971941948
seven O 0 0.006917084567248821
kindreds O 1 0.9992268085479736
. O 0 0.0074524059891700745

Mutations O 1 0.9995991587638855
were O 0 0.00252883555367589
located O 0 0.005851940717548132
in O 0 0.0008297148742713034
three O 0 0.0008972445502877235
different O 0 0.0007472570869140327
regions O 0 0.0058256350457668304
of O 0 0.0013176164356991649
the O 0 0.007051320746541023
APC B-Disease 1 0.9999998807907104
gene O 1 0.9995688796043396
( O 0 0.008954925462603569
1 O 0 0.012872227467596531
) O 0 0.0023226409684866667
at O 0 0.0025611629243940115
the O 0 0.0024850789923220873
5 O 0 0.009561457671225071
end O 0 0.012167791835963726
spanning O 0 0.0363469272851944
exons O 1 0.968882143497467
4 O 0 0.01646958850324154
and O 0 0.001981157809495926
5 O 0 0.010360277257859707
, O 0 0.0022043618373572826
( O 0 0.00425001373514533
2 O 0 0.0083048390224576
) O 0 0.002855757251381874
within O 0 0.005754530429840088
exon O 1 0.9997058510780334
9 O 0 0.0175473652780056
, O 0 0.00188571703620255
and O 0 0.0017549159238114953
( O 0 0.004749737214297056
3 O 0 0.01019281055778265
) O 0 0.002268856391310692
at O 0 0.002406251383945346
the O 0 0.002962135709822178
3 O 0 0.018558744341135025
distal O 1 0.9999819993972778
end O 0 0.010748842731118202
of O 0 0.0017495353240519762
the O 0 0.006580500863492489
gene O 1 0.9984656572341919
. O 0 0.007570420391857624

Variability O 0 0.08812694251537323
in O 0 0.0015330951428040862
the O 0 0.0017660584999248385
number O 0 0.0027288091368973255
of O 0 0.00765452953055501
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 0.008950927294790745
most O 0 0.0027765065897256136
apparent O 0 0.04605593532323837
in O 0 0.0013353003887459636
individuals O 0 0.0031885355710983276
with O 0 0.0026582248974591494
mutations O 1 0.9999924898147583
in O 0 0.0023738243617117405
region O 0 0.008099907077848911
1 O 0 0.007145389914512634
, O 0 0.0010453753639012575
and O 0 0.001654467429034412
upper O 1 0.999941349029541
- O 1 0.9998747110366821
gastrointestinal O 1 1.0
manifestations O 1 0.999782145023346
were O 0 0.0015486431075260043
more O 0 0.0024273584131151438
severe O 1 1.0
in O 0 0.001446652808226645
them O 0 0.001238985569216311
. O 0 0.0039672222919762135

In O 0 0.0031581649091094732
individuals O 0 0.004065399058163166
with O 0 0.0026870700530707836
mutations O 1 0.9999604225158691
in O 0 0.0018642392242327332
either O 0 0.004915548022836447
region O 0 0.010554641485214233
2 O 0 0.009793110191822052
or O 0 0.0031515604350715876
region O 0 0.010427664034068584
3 O 0 0.00698979152366519
, O 0 0.0008540058042854071
the O 0 0.0017138018738478422
average O 0 0.005949416197836399
number O 0 0.0019548325799405575
of O 0 0.0024583754129707813
adenomas B-Disease 1 0.9999997615814209
tended O 0 0.026180723682045937
to O 0 0.001339579583145678
be O 0 0.0016466554952785373
lower O 0 0.011660892516374588
than O 0 0.0017193303210660815
those O 0 0.0012221919605508447
in O 0 0.001507874228991568
individuals O 0 0.004038315732032061
with O 0 0.0035901586525142193
mutations O 1 0.9998254179954529
in O 0 0.002155326772481203
region O 0 0.011390769854187965
1 O 0 0.010743657127022743
, O 0 0.0015478734858334064
although O 0 0.004430394619703293
age O 0 0.01118995901197195
at O 0 0.00895810779184103
diagnosis O 1 0.9999973773956299
was O 0 0.008650137111544609
similar O 0 0.007975919172167778
. O 0 0.004983257967978716

In O 0 0.003302830271422863
all O 0 0.0044432468712329865
AAPC B-Disease 1 0.9999998807907104
kindreds O 1 0.9995970129966736
, O 0 0.002306594979017973
a O 0 0.005274549592286348
predominance O 0 0.09247858822345734
of O 0 0.0016017626039683819
right O 0 0.3166083097457886
- O 1 0.992638111114502
sided O 1 0.999992847442627
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 0 0.012173311784863472
rectal B-Disease 1 1.0
polyp I-Disease 1 1.0
sparing O 1 0.9997732043266296
was O 0 0.011646658182144165
observed O 0 0.017360514029860497
. O 0 0.004374884534627199

No O 0 0.01892240159213543
desmoid B-Disease 1 0.9999943971633911
tumors I-Disease 1 0.9999998807907104
were O 0 0.0027556377463042736
found O 0 0.0042067538015544415
in O 0 0.0011708367383107543
these O 0 0.001923859235830605
kindreds O 1 0.9973675608634949
. O 0 0.007087087724357843

Our O 0 0.004642022307962179
data O 0 0.00262453849427402
suggest O 0 0.0059523070231080055
that O 0 0.001018974930047989
, O 0 0.0013678096001967788
in O 0 0.004941243212670088
AAPC B-Disease 1 1.0
families O 0 0.011137115769088268
, O 0 0.0011140195420011878
the O 0 0.0011818637140095234
location O 0 0.002768192905932665
of O 0 0.0009312339825555682
the O 0 0.005853638518601656
APC B-Disease 1 1.0
mutation O 1 0.999998927116394
may O 0 0.01503570657223463
partially O 0 0.04795790836215019
predict O 0 0.023924212902784348
specific O 0 0.009023932740092278
phenotypic O 1 0.9985126852989197
expression O 0 0.03831863030791283
. O 0 0.004980511497706175

This O 0 0.003592303255572915
should O 0 0.002006895374506712
help O 0 0.0031494745053350925
in O 0 0.0009281212696805596
the O 0 0.0015191662823781371
design O 0 0.003383629024028778
of O 0 0.0013848665403202176
tailored O 0 0.11552534997463226
clinical O 1 0.9992197751998901
- O 0 0.02673381194472313
management O 0 0.013897299766540527
protocols O 0 0.014368060044944286
in O 0 0.0008260930189862847
this O 0 0.0014897555811330676
subset O 0 0.04616258293390274
of O 0 0.006019409280270338
FAP B-Disease 1 1.0
patients O 1 0.9999995231628418
. O 0 0.0031848561484366655
. O 0 0.004041716922074556

Wilms B-Disease 1 0.9999994039535522
' I-Disease 1 0.6944294571876526
tumor I-Disease 1 0.9999984502792358
1 O 0 0.01484767533838749
and O 0 0.002741618314757943
Dax O 1 0.9997058510780334
- O 0 0.03100494295358658
1 O 0 0.018032506108283997
modulate O 1 0.5728577971458435
the O 0 0.006735814735293388
orphan O 1 0.9990098476409912
nuclear O 0 0.025544244796037674
receptor O 1 0.9908259510993958
SF O 1 0.9998748302459717
- O 0 0.03465230390429497
1 O 0 0.011478017084300518
in O 0 0.002262891735881567
sex O 0 0.023579012602567673
- O 0 0.022492052987217903
specific O 0 0.01121264323592186
gene O 1 0.9928144812583923
expression O 0 0.04403247311711311
. O 0 0.006266116164624691

Products O 0 0.01628483086824417
of O 0 0.003928705118596554
steroidogenic O 1 0.9999948740005493
factor O 0 0.07497458904981613
1 O 0 0.024229301139712334
( O 0 0.009619896300137043
SF O 1 0.9999957084655762
- O 0 0.02946169301867485
1 O 0 0.011893629096448421
) O 0 0.0027968334034085274
and O 0 0.004830014891922474
Wilms B-Disease 1 1.0
tumor I-Disease 1 1.0
1 O 0 0.024841265752911568
( O 0 0.010720071382820606
WT1 O 1 0.9999988079071045
) O 0 0.007542727515101433
genes O 0 0.0778619647026062
are O 0 0.0007650254410691559
essential O 0 0.004949281923472881
for O 0 0.002394815208390355
mammalian O 1 0.9976613521575928
gonadogenesis O 1 0.9998247027397156
prior O 0 0.007801739498972893
to O 0 0.0018974781269207597
sexual O 0 0.020920654758810997
differentiation O 0 0.382026344537735
. O 0 0.0058913868851959705

In O 0 0.005752678960561752
males O 0 0.049704160541296005
, O 0 0.0046096378937363625
SF O 1 0.9999988079071045
- O 0 0.03109162673354149
1 O 0 0.016426822170615196
participates O 0 0.03971441835165024
in O 0 0.0023557553067803383
sexual O 0 0.010874862782657146
development O 0 0.002989616245031357
by O 0 0.003347855992615223
regulating O 0 0.03733297064900398
expression O 0 0.01686789281666279
of O 0 0.0010986186098307371
the O 0 0.005295028910040855
polypeptide O 1 0.999931812286377
hormone O 1 0.9989639520645142
Mullerian O 1 0.999750554561615
inhibiting O 1 0.9871798157691956
substance O 0 0.09658980369567871
( O 0 0.015228744596242905
MIS O 1 0.9999878406524658
) O 0 0.006378829944878817
. O 0 0.004823516588658094

Here O 0 0.0033832367043942213
, O 0 0.0010929977288469672
we O 0 0.0011552139185369015
show O 0 0.0046495674178004265
that O 0 0.0030846158042550087
WT1 O 1 0.9999977350234985
- O 0 0.1064130961894989
KTS O 1 0.9999663829803467
isoforms O 0 0.2619265615940094
associate O 0 0.013097741641104221
and O 0 0.002150391461327672
synergize O 1 0.9979484677314758
with O 0 0.006092662923038006
SF O 1 0.9999513626098633
- O 0 0.02618694305419922
1 O 0 0.009832454845309258
to O 0 0.0016936128959059715
promote O 0 0.013373206369578838
MIS O 1 0.99994957447052
expression O 0 0.05388391390442848
. O 0 0.0058091264218091965

In O 0 0.003343593329191208
contrast O 0 0.01023956574499607
, O 0 0.004568914417177439
WT1 O 1 1.0
missense O 1 0.9999933242797852
mutations O 1 0.9999796152114868
, O 0 0.0021477194968611
associated O 0 0.005174359306693077
with O 0 0.0015744323609396815
male B-Disease 0 0.04294884577393532
pseudohermaphroditism I-Disease 1 0.9999951124191284
in O 0 0.005301055032759905
Denys B-Disease 1 0.9999986886978149
- I-Disease 1 0.9992011189460754
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.0032734691631048918
fail O 0 0.08864354342222214
to O 0 0.002637565368786454
synergize O 1 0.9976758360862732
with O 0 0.007888334803283215
SF O 1 0.9999918937683105
- O 0 0.04011866822838783
1 O 0 0.017369868233799934
. O 0 0.0050036050379276276

Additionally O 0 0.025423772633075714
, O 0 0.0016733348602429032
the O 0 0.004246599040925503
X O 1 0.9977128505706787
- O 0 0.03295964375138283
linked O 0 0.04200850799679756
, O 0 0.0021848005708307028
candidate O 0 0.024275001138448715
dosage O 1 0.999321699142456
- O 0 0.02615722082555294
sensitive O 0 0.02075229398906231
sex O 0 0.025436243042349815
- O 0 0.0321955606341362
reversal O 1 0.7314358353614807
gene O 1 0.9988499879837036
, O 0 0.004434370901435614
Dax O 1 0.9994601607322693
- O 0 0.025999417528510094
1 O 0 0.012683931738138199
, O 0 0.00296055618673563
antagonizes O 1 0.9987455606460571
synergy O 0 0.11895492672920227
between O 0 0.008892624638974667
SF O 1 0.9999910593032837
- O 0 0.03379039093852043
1 O 0 0.015684835612773895
and O 0 0.004347947426140308
WT1 O 1 0.9999977350234985
, O 0 0.0029498219955712557
most O 0 0.0026097355876117945
likely O 0 0.006110869813710451
through O 0 0.0026541193947196007
a O 0 0.004110169596970081
direct O 0 0.006832776125520468
interaction O 0 0.011481653898954391
with O 0 0.0052975257858633995
SF O 1 0.99998939037323
- O 0 0.04794243350625038
1 O 0 0.020430175587534904
. O 0 0.0054337987676262856

We O 0 0.0030913548544049263
propose O 0 0.017926963046193123
that O 0 0.0035820037592202425
WT1 O 1 0.9999971389770508
and O 0 0.004859427455812693
Dax O 1 0.9998931884765625
- O 0 0.038784537464380264
1 O 0 0.022342052310705185
functionally O 1 0.9186215996742249
oppose O 0 0.013151233084499836
each O 0 0.0013060655910521746
other O 0 0.0006173500441946089
in O 0 0.0022588036954402924
testis O 1 0.9989832043647766
development O 0 0.004683738108724356
by O 0 0.0058032795786857605
modulating O 1 0.9999281167984009
SF O 1 0.999990701675415
- O 0 0.043853405863046646
1 O 0 0.023195093497633934
- O 0 0.049912579357624054
mediated O 1 0.7958654165267944
transactivation O 1 0.9980233907699585
. O 0 0.0045129987411201
. O 0 0.0046029104851186275

A O 0 0.03010445646941662
mouse O 1 0.965125322341919
model O 0 0.012290703132748604
for O 0 0.004746514838188887
Prader B-Disease 1 1.0
- I-Disease 1 0.9999279975891113
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.9999984502792358
- O 0 0.22926729917526245
centre O 0 0.05781114473938942
mutations O 1 0.9999914169311523
. O 0 0.006218209397047758

Imprinting O 1 0.8696866631507874
in O 0 0.0034666932187974453
the O 0 0.004849872086197138
15q11 O 1 0.9994329810142517
- O 0 0.0522569939494133
q13 O 1 0.9937969446182251
region O 0 0.014113831333816051
involves O 0 0.01930936798453331
an O 0 0.0051194136030972
imprinting O 1 0.9998229146003723
centre O 0 0.03887544572353363
( O 0 0.010938948020339012
IC O 1 0.9999103546142578
) O 0 0.004244885873049498
, O 0 0.0011167629854753613
mapping O 0 0.013139757327735424
in O 0 0.0011039657983928919
part O 0 0.0030780581291764975
to O 0 0.001017818576656282
the O 0 0.0028560557402670383
promoter O 1 0.9994902610778809
and O 0 0.0016538813943043351
first O 0 0.005282421130686998
exon O 1 0.9933383464813232
of O 0 0.004920292645692825
SNRPN O 1 0.9999784231185913
. O 0 0.00909176655113697

Deletion O 1 0.9635046720504761
of O 0 0.002358572091907263
this O 0 0.0038624973967671394
IC O 1 0.9982615113258362
abolishes O 1 0.9983154535293579
local O 0 0.014694716781377792
paternally O 1 0.9906151294708252
derived O 0 0.03730025142431259
gene O 1 0.9940603375434875
expression O 0 0.022484589368104935
and O 0 0.0009395580273121595
results O 0 0.005062418524175882
in O 0 0.0040165032260119915
Prader B-Disease 1 1.0
- I-Disease 1 0.9999860525131226
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.47721099853515625
PWS B-Disease 1 1.0
) O 0 0.009113219566643238
. O 0 0.005273498594760895

We O 0 0.0022644815035164356
have O 0 0.001414940576069057
created O 0 0.005513716954737902
two O 0 0.0032607861794531345
deletion O 1 0.9999372959136963
mutations O 1 0.9999459981918335
in O 0 0.004150254186242819
mice O 1 0.9991917014122009
to O 0 0.003134567756205797
understand O 0 0.022389821708202362
PWS B-Disease 1 1.0
and O 0 0.0016720083076506853
the O 0 0.001727897790260613
mechanism O 0 0.01485415082424879
of O 0 0.0015565176727250218
this O 0 0.004213590640574694
IC O 1 0.9992458820343018
. O 0 0.007253143936395645

Mice O 1 0.9981951117515564
harbouring O 1 0.9504743218421936
an O 0 0.009366786107420921
intragenic O 1 0.9986531734466553
deletion O 1 0.9889118671417236
in O 0 0.004437285475432873
Snrpn O 1 0.9998050332069397
are O 0 0.002940198639407754
phenotypically O 1 0.9997370839118958
normal O 0 0.025161348283290863
, O 0 0.0015744817210361362
suggesting O 0 0.010548667050898075
that O 0 0.0025027270894497633
mutations O 1 0.9994354844093323
of O 0 0.0034370694775134325
SNRPN O 1 0.9999970197677612
are O 0 0.0010917135514318943
not O 0 0.0010593751212581992
sufficient O 0 0.004889213480055332
to O 0 0.004175890237092972
induce O 1 0.9979700446128845
PWS B-Disease 1 0.9999998807907104
. O 0 0.010927916504442692

Mice O 1 0.9934666752815247
with O 0 0.0025985317770391703
a O 0 0.005878214258700609
larger O 0 0.014945082366466522
deletion O 1 0.9979968667030334
involving O 0 0.013643840327858925
both O 0 0.003249242203310132
Snrpn O 1 0.9985871315002441
and O 0 0.0014922714326530695
the O 0 0.004530246835201979
putative O 1 0.9999673366546631
PWS O 1 1.0
- O 0 0.08166629076004028
IC O 1 0.9992139339447021
lack O 0 0.015652719885110855
expression O 0 0.014931962825357914
of O 0 0.001114408951252699
the O 0 0.0042856899090111256
imprinted O 1 0.9999392032623291
genes O 1 0.9851964712142944
Zfp127 O 1 0.9997005462646484
( O 0 0.012950488366186619
mouse O 1 0.9996254444122314
homologue O 1 0.9956455826759338
of O 0 0.007376881781965494
ZNF127 O 1 0.99997878074646
) O 0 0.005788350012153387
, O 0 0.0038511808961629868
Ndn O 1 0.9999053478240967
and O 0 0.005273726303130388
Ipw O 1 0.9994699358940125
, O 0 0.0018322145333513618
and O 0 0.0012046843767166138
manifest O 0 0.040124256163835526
several O 0 0.0029256732668727636
phenotypes O 1 0.9997130036354065
common O 0 0.01493109855800867
to O 0 0.006313850171864033
PWS B-Disease 1 1.0
infants O 1 0.9999932050704956
. O 0 0.008093925192952156

These O 0 0.00184782431460917
data O 0 0.001983574591577053
demonstrate O 0 0.004657248966395855
that O 0 0.0007589369197376072
both O 0 0.0009718857472762465
the O 0 0.0015066055348142982
position O 0 0.0033829279709607363
of O 0 0.001215228228829801
the O 0 0.004172447137534618
IC O 1 0.9995915293693542
and O 0 0.0013128607533872128
its O 0 0.002219507936388254
role O 0 0.005205062218010426
in O 0 0.0007558354991488159
the O 0 0.0015944495098665357
coordinate O 0 0.011292209848761559
expression O 0 0.015207375399768353
of O 0 0.0015817636158317327
genes O 1 0.5212052464485168
is O 0 0.0032218224368989468
conserved O 0 0.028643326833844185
between O 0 0.0035260827280580997
mouse O 1 0.9999526739120483
and O 0 0.0020403845701366663
human O 0 0.006887413095682859
, O 0 0.0009435442625544965
and O 0 0.0007640738622285426
indicate O 0 0.004667538683861494
that O 0 0.0007970830192789435
the O 0 0.003725816495716572
mouse O 1 0.9997201561927795
is O 0 0.0033675101585686207
a O 0 0.005348498933017254
suitable O 0 0.013024510815739632
model O 0 0.008646138943731785
system O 0 0.007092646788805723
in O 0 0.0011240338208153844
which O 0 0.0011764694936573505
to O 0 0.0009084395715035498
investigate O 0 0.009370672516524792
the O 0 0.0023702606558799744
molecular O 0 0.030364349484443665
mechanisms O 0 0.016997724771499634
of O 0 0.0023739549797028303
imprinting O 1 0.9996602535247803
in O 0 0.0014475651551038027
this O 0 0.0013131278101354837
region O 0 0.005060160998255014
of O 0 0.0010105082765221596
the O 0 0.003945599775761366
genome O 1 0.8105403780937195
. O 0 0.0030117330607026815
. O 0 0.004410224035382271

Mutations O 1 0.9939056038856506
of O 0 0.001971573568880558
the O 0 0.004158820491284132
ATM O 1 0.9942730069160461
gene O 1 0.9968532919883728
detected O 0 0.06423301249742508
in O 0 0.0018758365185931325
Japanese O 0 0.025742484256625175
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999538660049438
telangiectasia I-Disease 1 1.0
patients O 1 0.9999998807907104
: O 0 0.0037084699142724276
possible O 0 0.005346797872334719
preponderance O 0 0.05500548705458641
of O 0 0.0008127909386530519
the O 0 0.0015851259231567383
two O 0 0.0018850464839488268
founder O 1 0.9098633527755737
mutations O 1 0.9999963045120239
4612del165 O 1 0.9999024868011475
and O 0 0.003665956435725093
7883del5 O 1 0.9982530474662781
. O 0 0.007631325628608465

The O 0 0.008988689631223679
ATM O 1 0.8309726119041443
( O 0 0.005979995243251324
A O 1 0.709843099117279
- O 1 0.5466151237487793
T O 1 0.9999980926513672
, O 0 0.005680097732692957
mutated O 1 0.9999425411224365
) O 0 0.006572612561285496
gene O 1 0.9963879585266113
on O 0 0.0029096317011862993
human O 0 0.017278512939810753
chromosome O 1 0.9999721050262451
11q22 O 1 0.9986003041267395
. O 0 0.007160418666899204

3 O 0 0.019099712371826172
has O 0 0.003951678052544594
recently O 0 0.01094108261168003
been O 0 0.0034304449800401926
identified O 0 0.007681167684495449
as O 0 0.0014110549818724394
the O 0 0.0029980989638715982
gene O 1 0.9969761371612549
responsible O 0 0.008736955001950264
for O 0 0.0007623473065905273
the O 0 0.002374849747866392
human O 1 0.7146463990211487
recessive B-Disease 1 1.0
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999687671661377
telangiectasia I-Disease 1 1.0
( O 0 0.010004451498389244
A B-Disease 1 0.9997487664222717
- I-Disease 1 0.9983482360839844
T I-Disease 1 0.9999991655349731
) O 0 0.005509370472282171
. O 0 0.004289865959435701

In O 0 0.002494885353371501
order O 0 0.002361763035878539
to O 0 0.0011926003498956561
define O 0 0.005520954262465239
the O 0 0.002049496630206704
types O 0 0.0078074028715491295
of O 0 0.0037296079099178314
disease O 1 1.0
- O 1 0.9647085666656494
causing O 1 0.9999505281448364
ATM O 1 0.9955249428749084
mutations O 1 0.9990724325180054
in O 0 0.0019340245053172112
Japanese O 0 0.011392036452889442
A B-Disease 1 0.9987138509750366
- I-Disease 1 0.9996249675750732
T I-Disease 1 1.0
patients O 1 0.9999986886978149
as O 0 0.002237555803731084
well O 0 0.0011581911239773035
as O 0 0.0009701715316623449
to O 0 0.0007925711688585579
look O 0 0.0033705972600728273
for O 0 0.0011158144334331155
possible O 0 0.011358270421624184
mutational O 1 0.9998828172683716
hotspots O 1 0.9898605942726135
, O 0 0.0032370800618082285
reverse O 0 0.05297354236245155
- O 0 0.03163442015647888
transcribed O 0 0.07815064489841461
RNA O 0 0.10776355117559433
derived O 0 0.011655592359602451
from O 0 0.0026534770149737597
ten O 0 0.010706376284360886
patients O 1 0.9999390840530396
belonging O 0 0.015703899785876274
to O 0 0.0014126470778137445
eight O 0 0.004163103643804789
unrelated O 0 0.026958594098687172
Japanese O 0 0.013729291036725044
A B-Disease 1 0.9597908854484558
- I-Disease 1 0.6204057335853577
T I-Disease 1 0.9999809265136719
families O 0 0.009184750728309155
was O 0 0.005412864964455366
analyzed O 0 0.013581146486103535
for O 0 0.002623579930514097
mutations O 1 0.9965279698371887
by O 0 0.0024858186952769756
the O 0 0.004019878804683685
restriction O 0 0.07210962474346161
endonuclease O 1 0.9983800649642944
fingerprinting O 0 0.06712176650762558
method O 0 0.015237699262797832
. O 0 0.00564030883833766

As O 0 0.005061114206910133
has O 0 0.003175253514200449
been O 0 0.004410252906382084
reported O 0 0.009750132448971272
by O 0 0.002219465561211109
others O 0 0.004100828431546688
, O 0 0.00256942305713892
mutations O 1 0.9999874830245972
that O 0 0.0009108923259191215
lead O 0 0.005598688963800669
to O 0 0.0021876280661672354
exon O 1 0.99964439868927
skipping O 1 0.6267422437667847
or O 0 0.0119635546579957
premature O 1 0.9981358051300049
protein O 0 0.10860925167798996
truncation O 1 0.9881494045257568
were O 0 0.0019281426211819053
also O 0 0.0016971866134554148
predominant O 0 0.029246661812067032
in O 0 0.0015540850581601262
our O 0 0.005016597453504801
mutants O 1 0.9985780715942383
. O 0 0.006822688039392233

Six O 0 0.007805641740560532
different O 0 0.0030062575824558735
mutations O 1 0.99968421459198
were O 0 0.0018593707354739308
identified O 0 0.006996036507189274
on O 0 0.001312033855356276
12 O 0 0.0038054664619266987
of O 0 0.0008281169575639069
the O 0 0.002689362270757556
16 O 0 0.016885440796613693
alleles O 1 0.9999253749847412
examined O 0 0.062140654772520065
. O 0 0.004893231671303511

Four O 0 0.004113977309316397
were O 0 0.0022040032781660557
deletions O 0 0.18381313979625702
involving O 0 0.012548235245049
a O 0 0.007723593153059483
loss O 0 0.02847759798169136
of O 0 0.0011936265509575605
a O 0 0.006402692291885614
single O 0 0.023196514695882797
exon O 1 0.9987396597862244
exon O 1 0.9959456324577332
7 O 0 0.023643342778086662
, O 0 0.0030003078281879425
exon O 1 0.9871542453765869
16 O 0 0.013504029251635075
, O 0 0.0038710213266313076
exon O 1 0.9926643967628479
33 O 0 0.029076697304844856
or O 0 0.008532911539077759
exon O 1 0.9947847723960876
35 O 0 0.021338047459721565
. O 0 0.0059964293614029884

The O 0 0.004845763556659222
others O 0 0.003401509951800108
were O 0 0.0013872450217604637
minute O 0 0.01979743503034115
deletions O 0 0.2395165115594864
, O 0 0.0038777587469667196
4649delA O 1 0.995817244052887
in O 0 0.004091070499271154
exon O 1 0.9967558979988098
33 O 0 0.02548566274344921
and O 0 0.0026230334769934416
7883del5 O 1 0.9953420162200928
in O 0 0.004818284884095192
exon O 1 0.9972819089889526
55 O 0 0.03557238727807999
. O 0 0.005742716137319803

The O 0 0.017561130225658417
mutations O 1 0.999969482421875
4612del165 O 1 0.99906986951828
and O 0 0.0034561865031719208
7883del5 O 1 0.9991480112075806
were O 0 0.002128420863300562
found O 0 0.003331890096887946
in O 0 0.0010462566278874874
more O 0 0.001210121437907219
than O 0 0.0021824443247169256
two O 0 0.002451181411743164
unrelated O 0 0.045352473855018616
families O 0 0.013702752999961376
; O 0 0.005030816420912743
44 O 0 0.017842870205640793
% O 0 0.006591679062694311
( O 0 0.005071471910923719
7 O 0 0.009398679248988628
of O 0 0.0015111399115994573
16 O 0 0.007888688705861568
) O 0 0.001596265472471714
of O 0 0.0008001091191545129
the O 0 0.004524218384176493
mutant O 1 0.9999852180480957
alleles O 1 0.999975323677063
had O 0 0.004731330089271069
one O 0 0.001491437666118145
of O 0 0.0007084722747094929
the O 0 0.002045043744146824
two O 0 0.0038159654941409826
mutations O 1 0.9999715089797974
. O 0 0.006791700143367052

The O 0 0.01074120495468378
4612del165 O 1 0.9999575614929199
mutations O 1 0.9997519850730896
in O 0 0.0017936858348548412
three O 0 0.0014128574403002858
different O 0 0.0009263273677788675
families O 0 0.004306112881749868
were O 0 0.0009209131821990013
all O 0 0.0010944126406684518
ascribed O 0 0.03326980024576187
to O 0 0.0009840852580964565
the O 0 0.00178947439417243
same O 0 0.007047021761536598
T O 1 0.9996987581253052
- O 0 0.039289191365242004
- O 0 0.0405949205160141
> O 1 0.8997412323951721
A O 0 0.014883624389767647
substitution O 0 0.03613542765378952
at O 0 0.002800756599754095
the O 0 0.0034992273431271315
splice O 1 0.9983083009719849
donor O 0 0.06756476312875748
site O 0 0.011235970072448254
in O 0 0.004116588272154331
intron O 1 0.9994028806686401
33 O 0 0.039915673434734344
. O 0 0.005673016421496868

Microsatellite O 1 0.994034469127655
genotyping O 1 0.683067798614502
around O 0 0.004918957594782114
the O 0 0.004530312959104776
ATM O 1 0.9951766729354858
locus O 1 0.9999784231185913
also O 0 0.00331753958016634
indicated O 0 0.006885462906211615
that O 0 0.0010215684305876493
a O 0 0.005138743203133345
common O 0 0.01467209029942751
haplotype O 1 0.998855710029602
was O 0 0.005959108006209135
shared O 0 0.004632263444364071
by O 0 0.0019064004300162196
the O 0 0.004733751527965069
mutant O 1 0.9999556541442871
alleles O 1 0.9994856119155884
in O 0 0.0027295358013361692
both O 0 0.005365835037082434
mutations O 1 0.999970555305481
. O 0 0.005387232173234224

This O 0 0.004335859324783087
suggests O 0 0.009896512143313885
that O 0 0.0009211632423102856
these O 0 0.0006895700935274363
two O 0 0.0020282624755054712
founder O 1 0.9852281808853149
mutations O 1 0.9999974966049194
may O 0 0.008259594440460205
be O 0 0.0015729862498119473
predominant O 0 0.02897319570183754
among O 0 0.003382043680176139
Japanese O 0 0.013428828679025173
ATM O 1 0.9957127571105957
mutant O 1 0.999624490737915
alleles O 1 0.999832034111023
. O 0 0.008770821616053581

W474C O 1 0.9710898399353027
amino O 0 0.1423574537038803
acid O 0 0.2166079580783844
substitution O 0 0.10401446372270584
affects O 0 0.1455213725566864
early O 0 0.00685491319745779
processing O 0 0.004777142312377691
of O 0 0.0009550237446092069
the O 0 0.0037281427066773176
alpha O 0 0.1085202544927597
- O 0 0.03102024458348751
subunit O 0 0.14834068715572357
of O 0 0.0039238580502569675
beta O 0 0.09668823331594467
- O 0 0.043083466589450836
hexosaminidase O 1 0.998823344707489
A O 0 0.013988333754241467
and O 0 0.0010993529576808214
is O 0 0.0030179594177752733
associated O 0 0.00815415009856224
with O 0 0.005087241064757109
subacute O 1 1.0
G B-Disease 1 0.9999440908432007
( I-Disease 0 0.013888010755181313
M2 I-Disease 1 0.997968852519989
) I-Disease 0 0.008990474045276642
gangliosidosis I-Disease 1 0.996677041053772
. O 0 0.007382097188383341

Mutations O 1 0.9959749579429626
in O 0 0.002729753963649273
the O 0 0.008210593834519386
HEXA O 1 0.9999991655349731
gene O 1 0.9948545694351196
, O 0 0.0022959187626838684
encoding O 0 0.030435705557465553
the O 0 0.0031281569972634315
alpha O 0 0.08307293057441711
- O 0 0.029809650033712387
subunit O 0 0.1584610790014267
of O 0 0.0034741603303700686
beta O 0 0.10172247886657715
- O 0 0.04495231434702873
hexosaminidase O 1 0.998537540435791
A O 0 0.021624965593218803
( O 0 0.006989367306232452
Hex O 1 0.8518719673156738
A O 0 0.017051437869668007
) O 0 0.002804954769089818
, O 0 0.0009358252282254398
that O 0 0.0013067424297332764
abolish O 0 0.05691005662083626
Hex O 0 0.11442369967699051
A O 0 0.017851196229457855
enzyme O 0 0.12426675111055374
activity O 0 0.02081754058599472
cause O 1 0.9993366599082947
Tay B-Disease 1 1.0
- I-Disease 1 0.9996216297149658
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.02229802869260311
TSD B-Disease 1 1.0
) O 0 0.0035598387476056814
, O 0 0.0011683894554153085
the O 0 0.004958526697009802
fatal O 1 1.0
infantile B-Disease 1 0.9999998807907104
form I-Disease 0 0.010705573484301567
of I-Disease 0 0.003295190166682005
G I-Disease 1 0.9999922513961792
( I-Disease 0 0.009278238750994205
M2 I-Disease 1 0.9997110962867737
) I-Disease 0 0.006862344220280647
gangliosidosis I-Disease 1 0.9996461868286133
, I-Disease 0 0.003566434606909752
Type I-Disease 0 0.10600188374519348
1 I-Disease 0 0.012203401885926723
. O 0 0.0037067963276058435

Less O 0 0.03484458103775978
severe O 1 0.9999998807907104
, O 0 0.005526724737137556
subacute O 1 1.0
( O 0 0.014739799313247204
juvenile O 1 0.999993085861206
- O 1 0.9873326420783997
onset O 1 1.0
) O 0 0.0049727121368050575
and O 0 0.004298955202102661
chronic O 1 1.0
( O 0 0.010118875652551651
adult O 1 0.90716153383255
- O 1 0.8889318704605103
onset O 1 0.9999998807907104
) O 0 0.006545754615217447
variants O 0 0.04696923866868019
are O 0 0.0010757354320958257
characterized O 0 0.026665249839425087
by O 0 0.0019627364818006754
a O 0 0.005489938426762819
broad O 0 0.02330288104712963
spectrum O 0 0.04230430722236633
of O 0 0.002627926878631115
clinical O 1 0.9998096823692322
manifestations O 1 0.9988075494766235
and O 0 0.0010814052075147629
are O 0 0.0006942366017028689
associated O 0 0.005179678089916706
with O 0 0.0014805094106122851
residual O 0 0.16562078893184662
levels O 0 0.009104275144636631
of O 0 0.0019183728145435452
Hex O 1 0.8905830979347229
A O 0 0.025655457749962807
enzyme O 0 0.2319888472557068
activity O 0 0.016032878309488297
. O 0 0.0042924839071929455

We O 0 0.0041544814594089985
identified O 0 0.015757247805595398
a O 0 0.01404503919184208
1422 O 1 0.9999315738677979
G O 1 0.9991675615310669
- O 0 0.044575516134500504
- O 0 0.04847351089119911
> O 1 0.993606686592102
C O 0 0.35931745171546936
( O 0 0.009190062992274761
amino O 0 0.12814047932624817
acid O 0 0.3931279480457306
W474C O 1 0.9559748768806458
) O 0 0.004605515394359827
substitution O 0 0.02916855551302433
in O 0 0.0009932105895131826
the O 0 0.0011711539700627327
first O 0 0.0019963611848652363
position O 0 0.0035052953753620386
of O 0 0.0020348827820271254
exon O 1 0.9995059967041016
13 O 0 0.010217683389782906
of O 0 0.0032431879080832005
HEXA O 1 0.9999947547912598
of O 0 0.0019615148194134235
a O 0 0.00660817651078105
non O 0 0.010967757552862167
- O 0 0.019490443170070648
Jewish O 0 0.016308879479765892
proband O 1 0.9999587535858154
who O 0 0.006319476757198572
manifested O 1 0.8592045903205872
a O 0 0.02062353678047657
subacute O 1 0.9999998807907104
variant O 1 0.9982434511184692
of O 0 0.004628832917660475
G B-Disease 1 0.9999740123748779
( I-Disease 0 0.008374903351068497
M2 I-Disease 1 0.9990262985229492
) I-Disease 0 0.00861942209303379
gangliosidosis I-Disease 1 0.9987849593162537
. O 0 0.006930018309503794

On O 0 0.0025290788616985083
the O 0 0.002384765539318323
second O 0 0.015163186937570572
maternally O 1 0.9998225569725037
inherited O 1 0.999997615814209
allele O 1 0.9999951124191284
, O 0 0.0012405700981616974
we O 0 0.0009202820947393775
identified O 0 0.006027839612215757
the O 0 0.0023954203352332115
common O 1 0.9018120765686035
infantile O 1 1.0
disease O 1 1.0
- O 1 0.9736921191215515
causing O 1 0.9998857975006104
4 O 0 0.01705385185778141
- O 0 0.027362942695617676
bp O 0 0.10158012807369232
insertion O 1 0.6183880567550659
, O 0 0.00486917095258832
+ O 0 0.1305868774652481
TATC O 1 0.9999595880508423
1278 O 1 0.9996844530105591
, O 0 0.0035040993243455887
in O 0 0.0034908708184957504
exon O 1 0.9982237219810486
11 O 0 0.016497813165187836
. O 0 0.004507332108914852

Pulse O 1 0.8176480531692505
- O 0 0.05033555254340172
chase O 0 0.0788143053650856
analysis O 0 0.007822178304195404
using O 0 0.008885890245437622
proband O 1 0.9996292591094971
fibroblasts O 1 0.9989306330680847
revealed O 0 0.01650511659681797
that O 0 0.0011934612412005663
the O 0 0.0035540657117962837
W474C O 1 0.9941118359565735
- O 0 0.02448563277721405
containing O 0 0.013955422677099705
alpha O 0 0.09760484844446182
- O 0 0.036220651119947433
subunit O 0 0.3297266960144043
precursor O 0 0.07657775282859802
was O 0 0.009177706204354763
normally O 0 0.012843719683587551
synthesized O 0 0.0528782494366169
, O 0 0.001627555233426392
but O 0 0.0018120851600542665
not O 0 0.0025779828429222107
phosphorylated O 1 0.9662230014801025
or O 0 0.008256133645772934
secreted O 0 0.14021582901477814
, O 0 0.0012968272203579545
and O 0 0.0006468730280175805
the O 0 0.0025917075108736753
mature O 0 0.0807514637708664
lysosomal O 1 0.9998960494995117
alpha O 0 0.17780040204524994
- O 0 0.04403889924287796
subunit O 1 0.7969809174537659
was O 0 0.008037695661187172
not O 0 0.0036812240723520517
detected O 0 0.07063396275043488
. O 0 0.006513186730444431

When O 0 0.010005646385252476
the O 0 0.004938151687383652
W474C O 1 0.9881924986839294
- O 0 0.025143545120954514
containing O 0 0.0134372403845191
alpha O 0 0.11328915506601334
- O 0 0.042202167212963104
subunit O 0 0.2363930642604828
was O 0 0.02029048092663288
transiently O 1 0.9940477609634399
co O 0 0.04796776920557022
- O 0 0.0188722126185894
expressed O 0 0.006037433166056871
with O 0 0.0013917627511546016
the O 0 0.0035669871140271425
beta O 0 0.09200996905565262
- O 0 0.029118936508893967
subunit O 0 0.14093203842639923
to O 0 0.0016769079957157373
produce O 0 0.007037778850644827
Hex O 0 0.17560984194278717
A O 0 0.022041883319616318
( O 0 0.008846627548336983
alphabeta O 1 0.9980090260505676
) O 0 0.00404359633103013
in O 0 0.0032001782674342394
COS O 1 0.9999933242797852
- O 0 0.039312396198511124
7 O 0 0.02347034215927124
cells O 0 0.03934720531105995
, O 0 0.0017822860972955823
the O 0 0.004414509981870651
mature O 0 0.07795776426792145
alpha O 0 0.13880282640457153
- O 0 0.03796109929680824
subunit O 1 0.5181123614311218
was O 0 0.008190439082682133
present O 0 0.00306971138343215
, O 0 0.0012002072762697935
but O 0 0.0012877942062914371
its O 0 0.001757073332555592
level O 0 0.0040132272988557816
was O 0 0.005805274937301874
much O 0 0.004342938773334026
lower O 0 0.010771495290100574
than O 0 0.0016835074638947845
that O 0 0.0009715404012240469
from O 0 0.002593639539554715
normal O 0 0.021980950608849525
alpha O 0 0.11467353999614716
- O 0 0.04766540974378586
subunit O 1 0.9328944087028503
transfections O 1 0.9995645880699158
, O 0 0.0018037536647170782
although O 0 0.0021735818590968847
higher O 0 0.003953855484724045
than O 0 0.0014588964404538274
in O 0 0.0010570472804829478
those O 0 0.002049991162493825
cells O 0 0.1864762157201767
transfected O 1 0.9939879179000854
with O 0 0.0015514135593548417
an O 0 0.0033506304025650024
alpha O 0 0.10687533766031265
- O 0 0.0410861074924469
subunit O 0 0.4061177670955658
associated O 0 0.013058695942163467
with O 0 0.007777320221066475
infantile O 1 1.0
TSD B-Disease 1 0.9999964237213135
. O 0 0.011229624971747398

Furthermore O 0 0.02525557018816471
, O 0 0.0014767083339393139
the O 0 0.0023900046944618225
precursor O 0 0.04421968758106232
level O 0 0.0031069519463926554
of O 0 0.0009190675336867571
the O 0 0.0038397882599383593
W474C O 1 0.9994725584983826
alpha O 0 0.17862887680530548
- O 0 0.03387317433953285
subunit O 0 0.21235553920269012
was O 0 0.007451793644577265
found O 0 0.004068592097610235
to O 0 0.0014229509979486465
accumulate O 0 0.037836235016584396
in O 0 0.0014793643495067954
comparison O 0 0.005285426042973995
to O 0 0.0009426308097317815
the O 0 0.002845889190211892
normal O 0 0.030894391238689423
alpha O 0 0.11161507666110992
- O 0 0.04628165066242218
subunit O 0 0.33182016015052795
precursor O 0 0.09660413861274719
levels O 0 0.023325132206082344
. O 0 0.005077016074210405

We O 0 0.003295028815045953
conclude O 0 0.010834483429789543
that O 0 0.0010912118013948202
the O 0 0.004446707665920258
1422 O 1 0.9999873638153076
G O 1 0.9997804760932922
- O 0 0.0441751629114151
- O 0 0.053901489824056625
> O 1 0.9978759288787842
C O 1 0.9711915850639343
mutation O 1 0.9999419450759888
is O 0 0.003164634108543396
the O 0 0.0020431324373930693
cause O 0 0.03878701105713844
of O 0 0.0014772549038752913
Hex B-Disease 1 0.9979591369628906
A I-Disease 0 0.47551679611206055
enzyme I-Disease 1 0.9999788999557495
deficiency I-Disease 1 1.0
in O 0 0.0027097987476736307
the O 0 0.004884443711489439
proband O 1 0.9998406171798706
. O 0 0.007265948224812746

The O 0 0.008492972701787949
resulting O 0 0.06431259214878082
W474C O 1 0.9939576387405396
substitution O 0 0.06836999207735062
clearly O 0 0.015373595990240574
interferes O 0 0.09592954814434052
with O 0 0.004076244309544563
alpha O 0 0.11641041934490204
- O 0 0.04291092976927757
subunit O 0 0.2047860026359558
processing O 0 0.009423195384442806
, O 0 0.0013191777979955077
but O 0 0.0013907941756770015
because O 0 0.0030356780625879765
the O 0 0.0027586573269218206
base O 0 0.01638813689351082
substitution O 0 0.06184060126543045
falls O 0 0.045763902366161346
at O 0 0.003081715200096369
the O 0 0.0017385092796757817
first O 0 0.002398646669462323
position O 0 0.003589827800169587
of O 0 0.0023691446986049414
exon O 1 0.9996854066848755
13 O 0 0.01662224344909191
, O 0 0.0037585264071822166
aberrant O 1 0.9685795903205872
splicing O 0 0.19696880877017975
may O 0 0.008120455779135227
also O 0 0.001373369013890624
contribute O 0 0.007334596943110228
to O 0 0.001840531942434609
Hex B-Disease 1 0.9876135587692261
A I-Disease 0 0.24730248749256134
deficiency I-Disease 1 1.0
in O 0 0.002249284880235791
this O 0 0.0028293500654399395
proband O 1 0.9997884631156921
. O 0 0.00257877423427999
. O 0 0.004061699844896793

Two O 0 0.004940580110996962
frequent O 0 0.06506581604480743
missense O 1 0.9997972846031189
mutations O 1 0.9999374151229858
in O 0 0.010170857422053814
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.01176746841520071

Pendred B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
is O 0 0.008135482668876648
an O 0 0.026547322049736977
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9996837377548218
by O 0 0.00299725285731256
early O 0 0.02152770385146141
childhood O 1 0.9999997615814209
deafness B-Disease 1 1.0
and O 0 0.01084690447896719
goiter B-Disease 1 1.0
. O 0 0.008146795444190502

A O 0 0.017585458233952522
century O 0 0.005479233339428902
after O 0 0.0068564810790121555
its O 0 0.002302059903740883
recognition O 0 0.010171937756240368
as O 0 0.00304122781381011
a O 0 0.2113335132598877
syndrome O 1 1.0
by O 0 0.007523167412728071
Vaughan O 1 0.9998477697372437
Pendred O 1 0.9999039173126221
, O 0 0.002463191980496049
the O 0 0.009898955933749676
disease O 1 1.0
gene O 1 0.9999899864196777
( O 0 0.011405057273805141
PDS O 1 0.9999983310699463
) O 0 0.0035855916794389486
was O 0 0.004857449792325497
mapped O 0 0.028460202738642693
to O 0 0.004676564130932093
chromosome O 1 0.9998400211334229
7q22 O 1 0.9990662932395935
- O 0 0.07233330607414246
q31 O 1 0.9960595369338989
. O 0 0.008185920305550098

1 O 0 0.019389035180211067
and O 0 0.0015515140257775784
, O 0 0.0019109040731564164
recently O 0 0.01197162363678217
, O 0 0.0011593527160584927
found O 0 0.0024955237749964
to O 0 0.0011131798382848501
encode O 0 0.026910731568932533
a O 0 0.012390107847750187
putative O 1 0.9894958138465881
sulfate O 1 0.9992094039916992
transporter O 1 0.9946411848068237
. O 0 0.007394399493932724

We O 0 0.0051452359184622765
performed O 0 0.02322501130402088
mutation O 1 0.9899243712425232
analysis O 0 0.003715080674737692
of O 0 0.0009989766404032707
the O 0 0.005325560458004475
PDS B-Disease 1 0.9999997615814209
gene O 1 0.9999010562896729
in O 0 0.005285228136926889
patients O 1 0.9999814033508301
from O 0 0.0035613614600151777
14 O 0 0.01502478588372469
Pendred B-Disease 1 0.9997891783714294
families O 0 0.011767800897359848
originating O 0 0.024359753355383873
from O 0 0.0024613402783870697
seven O 0 0.0022780727595090866
countries O 0 0.0008930771145969629
and O 0 0.001007210579700768
identified O 0 0.011332842521369457
all O 0 0.0029806627426296473
mutations O 1 0.9998979568481445
. O 0 0.005779904313385487

The O 0 0.012302541173994541
mutations O 1 0.9985260367393494
include O 0 0.0026512129697948694
three O 0 0.0013828665250912309
single O 0 0.011613847687840462
base O 0 0.013278109952807426
deletions O 1 0.619824230670929
, O 0 0.0014396549668163061
one O 0 0.003739168168976903
splice O 1 0.994717538356781
site O 0 0.0203234925866127
mutation O 1 0.9999144077301025
and O 0 0.0017335443990305066
10 O 0 0.009808682836592197
missense O 1 0.9999792575836182
mutations O 1 0.9998495578765869
. O 0 0.006826505530625582

One O 0 0.02155149169266224
missense O 1 0.9998816251754761
mutation O 1 0.9999958276748657
( O 0 0.01712752878665924
L236P O 1 0.9995219707489014
) O 0 0.004049217794090509
was O 0 0.005432979203760624
found O 0 0.003921050112694502
in O 0 0.0011825102847069502
a O 0 0.009354750625789165
homozygous O 1 0.9994958639144897
state O 0 0.0014729242539033294
in O 0 0.0010313022648915648
two O 0 0.0024158223532140255
consanguineous O 1 0.999068558216095
families O 0 0.006851245183497667
and O 0 0.0007781123858876526
in O 0 0.0010794814443215728
a O 0 0.00844822358340025
heterozygous O 1 0.9994022846221924
state O 0 0.0017104001017287374
in O 0 0.0008775488822720945
five O 0 0.0015459498390555382
additional O 0 0.003372154664248228
non O 0 0.016191687434911728
- O 0 0.049051765352487564
consanguineous O 1 0.999139666557312
families O 0 0.016534749418497086
. O 0 0.005652059335261583

Another O 0 0.04821763187646866
missense O 1 0.9998483657836914
mutation O 1 0.9999902248382568
( O 0 0.014903143048286438
T416P O 1 0.9979618787765503
) O 0 0.004015320912003517
was O 0 0.004762729629874229
found O 0 0.0030852388590574265
in O 0 0.0013308858033269644
a O 0 0.010956249199807644
homozygous O 1 0.9989470839500427
state O 0 0.002177943242713809
in O 0 0.0014508498134091496
one O 0 0.0032855491153895855
family O 0 0.00927471462637186
and O 0 0.0008660536259412766
in O 0 0.0015134441200643778
a O 0 0.00995858944952488
heterozygous O 1 0.9997907280921936
state O 0 0.002009008079767227
in O 0 0.0011594330426305532
four O 0 0.0022751952055841684
families O 0 0.008673759177327156
. O 0 0.004958098754286766

Pendred B-Disease 1 0.9999828338623047
patients O 1 0.9999179840087891
in O 0 0.001651450409553945
three O 0 0.001648867386393249
non O 0 0.01361196581274271
- O 0 0.04726674035191536
consanguineous O 1 0.9998283386230469
families O 0 0.008785107173025608
were O 0 0.0013948132982477546
shown O 0 0.004069929011166096
to O 0 0.0009548617526888847
be O 0 0.0019678552635014057
compound O 0 0.03888711705803871
heterozygotes O 1 0.9991933703422546
for O 0 0.0036848159506917
L236P O 1 0.9997711777687073
and O 0 0.0042319027706980705
T416P O 1 0.9996230602264404
. O 0 0.007401303853839636

In O 0 0.003819721518084407
total O 0 0.004481918644160032
, O 0 0.001341980998404324
one O 0 0.002280651591718197
or O 0 0.001921013812534511
both O 0 0.0010754502145573497
of O 0 0.0009271870367228985
these O 0 0.002547207288444042
mutations O 1 0.9999827146530151
were O 0 0.0015861871652305126
found O 0 0.0030858449172228575
in O 0 0.0009095463319681585
nine O 0 0.0024574308190494776
of O 0 0.0010523092932999134
the O 0 0.0028931042179465294
14 O 0 0.010585259646177292
families O 0 0.009256330318748951
analyzed O 0 0.02345513179898262
. O 0 0.005657472647726536

The O 0 0.003803999163210392
identification O 0 0.006971446331590414
of O 0 0.0008167249034158885
two O 0 0.0018382241250947118
frequent O 1 0.9893165826797485
PDS B-Disease 1 1.0
mutations O 1 0.9999566078186035
will O 0 0.0014426934067159891
facilitate O 0 0.00502835912629962
the O 0 0.0032897754572331905
molecular O 0 0.04778779298067093
diagnosis O 1 0.9999985694885254
of O 0 0.007504974491894245
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.008481379598379135

Insertional O 1 0.9999336004257202
mutation O 1 0.999913215637207
by O 0 0.008022218011319637
transposable O 1 0.9710502624511719
element O 0 0.025395045056939125
, O 0 0.003316278103739023
L1 O 1 0.9985694885253906
, O 0 0.0016968328272923827
in O 0 0.0013063031947240233
the O 0 0.008573390543460846
DMD B-Disease 1 1.0
gene O 1 0.9992400407791138
results O 0 0.008929304778575897
in O 0 0.0025376565754413605
X B-Disease 1 0.9985149502754211
- I-Disease 0 0.08351986855268478
linked I-Disease 1 0.9956056475639343
dilated I-Disease 1 0.9999996423721313
cardiomyopathy I-Disease 1 1.0
. O 0 0.01095309667289257

X B-Disease 1 0.9754794239997864
- I-Disease 0 0.07937204837799072
linked I-Disease 1 0.9901989698410034
dilated I-Disease 1 0.9999992847442627
cardiomyopathy I-Disease 1 1.0
( O 0 0.016790006309747696
XLDCM B-Disease 1 0.9999973773956299
) O 0 0.00340110226534307
is O 0 0.0022850404493510723
a O 0 0.008544565178453922
clinical O 1 0.9952310919761658
phenotype O 1 0.9999914169311523
of O 0 0.0034221329260617495
dystrophinopathy B-Disease 1 0.9999908208847046
which O 0 0.0020970888435840607
is O 0 0.002680865814909339
characterized O 0 0.03196301683783531
by O 0 0.004030244890600443
preferential O 1 0.998018741607666
myocardial B-Disease 1 1.0
involvement I-Disease 0 0.03226708620786667
without O 0 0.0028294995427131653
any O 0 0.002651865826919675
overt O 0 0.37124133110046387
clinical O 1 0.9368749856948853
signs O 0 0.021974770352244377
of O 0 0.0069717830047011375
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 0.013241074979305267

To O 0 0.002183381002396345
date O 0 0.003721588058397174
, O 0 0.0008613080717623234
several O 0 0.0018482516752555966
mutations O 1 0.9987322688102722
in O 0 0.0013992551248520613
the O 0 0.009308614768087864
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.9999990463256836
, O 0 0.01014365628361702
DMD O 1 1.0
, O 0 0.002535637002438307
have O 0 0.0011955765075981617
been O 0 0.003133663209155202
identified O 0 0.008646433241665363
in O 0 0.0025370847433805466
patients O 1 0.9999986886978149
with O 0 0.0033838555682450533
XLDCM B-Disease 1 0.9999995231628418
, O 0 0.001625207718461752
but O 0 0.001380694448016584
a O 0 0.007441247813403606
pathogenic O 1 0.9998496770858765
correlation O 0 0.023521631956100464
of O 0 0.0009645259706303477
these O 0 0.0018846848979592323
cardiospecific O 1 0.9999831914901733
mutations O 1 0.999834418296814
in O 0 0.006630368996411562
DMD O 1 1.0
with O 0 0.003274076385423541
the O 0 0.0063011907041072845
XLDCM B-Disease 1 0.9999998807907104
phenotype O 1 0.9999997615814209
has O 0 0.00558472191914916
remained O 0 0.007041648495942354
to O 0 0.0011258057784289122
be O 0 0.002452238230034709
elucidated O 1 0.5403501391410828
. O 0 0.0064802393317222595

We O 0 0.0034092271234840155
report O 0 0.00226138299331069
here O 0 0.0010224271100014448
the O 0 0.0015315009513869882
identification O 0 0.005970343481749296
of O 0 0.0009492721874266863
a O 0 0.004789795260876417
unique O 0 0.006449233274906874
de O 0 0.030348405241966248
novo O 1 0.7957965135574341
L1 O 1 0.9979630708694458
insertion O 0 0.18613827228546143
in O 0 0.0026432385202497244
the O 0 0.006948336958885193
muscle O 1 0.9999922513961792
exon O 1 0.9996383190155029
1 O 0 0.016918830573558807
in O 0 0.005370818078517914
DMD O 1 1.0
in O 0 0.0034319027327001095
three O 0 0.006470502354204655
XLDCM B-Disease 1 0.9999997615814209
patients O 1 0.9999877214431763
from O 0 0.0029910493176430464
two O 0 0.002194763161242008
unrelated O 0 0.030925389379262924
Japanese O 0 0.011617602780461311
families O 0 0.01003353763371706
. O 0 0.006308892276138067

The O 0 0.008394620381295681
insertion O 1 0.8623021245002747
was O 0 0.007549851667135954
a O 0 0.007276945747435093
5 O 0 0.01403533760458231
- O 0 0.027971547096967697
truncated O 0 0.12268758565187454
form O 0 0.00788831152021885
of O 0 0.001907623023726046
human O 0 0.020529532805085182
L1 O 1 0.9995552897453308
inversely O 0 0.11847763508558273
integrated O 0 0.02031099423766136
in O 0 0.0015002940781414509
the O 0 0.002656604629009962
5 O 0 0.01143709011375904
- O 0 0.0243085790425539
untranslated O 0 0.30956220626831055
region O 0 0.009493346326053143
in O 0 0.0015960214659571648
the O 0 0.005886496044695377
muscle O 1 0.999998927116394
exon O 1 0.9999274015426636
1 O 0 0.01436188817024231
, O 0 0.0013556862249970436
which O 0 0.0016027160454541445
affected O 0 0.026712989434599876
the O 0 0.0033000188414007425
transcription O 0 0.21852780878543854
or O 0 0.0018842131830751896
the O 0 0.001190141774713993
stability O 0 0.006730354856699705
of O 0 0.0012654784368351102
the O 0 0.005361427552998066
muscle O 1 0.9999990463256836
form O 0 0.007508814800530672
of O 0 0.0029902334790676832
dystrophin O 1 0.9999966621398926
transcripts O 0 0.017344379797577858
but O 0 0.0017416732152923942
not O 0 0.000773274339735508
that O 0 0.0005616553826257586
of O 0 0.0007076733163557947
the O 0 0.005143371876329184
brain O 1 0.9999997615814209
or O 0 0.01033035572618246
Purkinje O 1 0.9999730587005615
cell O 0 0.06759181618690491
form O 0 0.008120467886328697
, O 0 0.0016591071616858244
probably O 0 0.011011622846126556
due O 0 0.00756305456161499
to O 0 0.0007792710093781352
its O 0 0.0014314872678369284
unique O 0 0.003682771697640419
site O 0 0.0037758275866508484
of O 0 0.0011479794047772884
integration O 0 0.014209206216037273
. O 0 0.0052282982505857944

We O 0 0.004924465902149677
speculate O 0 0.029980579391121864
that O 0 0.001219688798300922
this O 0 0.0021510343067348003
insertion O 0 0.08353828638792038
of O 0 0.0013299556449055672
an O 0 0.0042024217545986176
L1 O 1 0.9991439580917358
sequence O 0 0.03974407538771629
in O 0 0.007586900144815445
DMD O 1 1.0
is O 0 0.006670744623988867
responsible O 0 0.011035568080842495
for O 0 0.0009801310952752829
some O 0 0.0007225539302453399
of O 0 0.0006462380406446755
the O 0 0.0016544735990464687
population O 0 0.005635144654661417
of O 0 0.0015454149106517434
Japanese O 0 0.02413960173726082
patients O 1 0.9999982118606567
with O 0 0.004419832024723291
XLDCM B-Disease 1 0.9999996423721313
. O 0 0.0034731868654489517
. O 0 0.004759358707815409

Severe O 1 0.9999971389770508
early O 0 0.022022465243935585
- O 1 0.9759758114814758
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 0.009936009533703327
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 0.002687319414690137
red O 1 0.9994756579399109
hair O 1 0.9999967813491821
pigmentation O 1 1.0
caused O 1 0.9999743700027466
by O 0 0.009694834239780903
POMC O 1 1.0
mutations O 1 0.9999961853027344
in O 0 0.0036974854301661253
humans O 0 0.040771469473838806
. O 0 0.004741668235510588

Sequential O 0 0.10470864921808243
cleavage O 0 0.44411930441856384
of O 0 0.001382035086862743
the O 0 0.002643871121108532
precursor O 0 0.07565930485725403
protein O 0 0.06125772371888161
pre O 0 0.045148108154535294
- O 0 0.03263254463672638
pro O 0 0.05267510190606117
- O 0 0.049196384847164154
opiomelanocortin O 1 0.9991284012794495
( O 0 0.016180047765374184
POMC O 1 0.9999935626983643
) O 0 0.00525709567591548
generates O 0 0.02504013665020466
the O 0 0.007251214236021042
melanocortin O 1 0.9999674558639526
peptides O 1 0.7805724740028381
adrenocorticotrophin O 1 0.9972124695777893
( O 0 0.01258475985378027
ACTH O 1 0.9998732805252075
) O 0 0.004933093208819628
, O 0 0.0029834855813533068
melanocyte O 1 0.9999265670776367
- O 0 0.056360986083745956
stimulating O 1 0.9859570264816284
hormones O 1 0.998392641544342
( O 0 0.01781066320836544
MSH O 1 0.9999983310699463
) O 0 0.010191366076469421
alpha O 0 0.08777677267789841
, O 0 0.0030506369657814503
beta O 0 0.057992879301309586
and O 0 0.0023069025482982397
gamma O 0 0.0777944028377533
as O 0 0.0018012132495641708
well O 0 0.0012229298008605838
as O 0 0.0015469967620447278
the O 0 0.005048833321779966
opioid O 1 0.9998736381530762
- O 0 0.06488389521837234
receptor O 1 0.9691425561904907
ligand O 0 0.21779821813106537
beta O 0 0.15339551866054535
- O 0 0.08440335094928741
endorphin O 1 0.993883490562439
. O 0 0.012577496469020844

While O 0 0.005031179171055555
a O 0 0.004863088484853506
few O 0 0.0025578492786735296
cases O 0 0.00609023729339242
of O 0 0.002248442964628339
isolated O 1 0.9993267059326172
ACTH B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
have O 0 0.003889387706294656
been O 0 0.005237601697444916
reported O 0 0.020637420937418938
( O 0 0.01098173763602972
OMIM O 1 1.0
201400 O 1 0.9999288320541382
) O 0 0.0033431893680244684
, O 0 0.0010871926788240671
an O 0 0.004174396861344576
inherited O 1 0.9999998807907104
POMC O 1 1.0
defect O 1 0.9999969005584717
has O 0 0.0045470609329640865
not O 0 0.0013978166971355677
been O 0 0.003571087494492531
described O 0 0.008684582076966763
so O 0 0.00274923094548285
far O 0 0.00493020610883832
. O 0 0.004372859839349985

Recent O 0 0.019592594355344772
studies O 0 0.00561907421797514
in O 0 0.0023281765170395374
animal O 0 0.026177098974585533
models O 0 0.010322997346520424
elucidated O 0 0.11113742738962173
a O 0 0.005720838438719511
central O 0 0.004053155891597271
role O 0 0.007109570782631636
of O 0 0.002819889457896352
alpha O 0 0.37393423914909363
- O 0 0.08669494092464447
MSH O 1 0.9999890327453613
in O 0 0.0023959348909556866
the O 0 0.0024624867364764214
regulation O 0 0.01487423200160265
of O 0 0.00148750317748636
food O 0 0.017254158854484558
intake O 0 0.17090240120887756
by O 0 0.0036255139857530594
activation O 0 0.07036121934652328
of O 0 0.001876797410659492
the O 0 0.006801093462854624
brain O 1 0.9999997615814209
melanocortin O 1 0.9999843835830688
- O 0 0.04310710355639458
4 O 0 0.020877771079540253
- O 0 0.047513365745544434
receptor O 1 0.9930597543716431
( O 0 0.01436521764844656
MC4 O 1 0.9999707937240601
- O 0 0.07280664891004562
R O 0 0.26632460951805115
; O 0 0.0069277058355510235
refs O 0 0.4049260914325714
3 O 0 0.018488172441720963
- O 0 0.023676428943872452
5 O 0 0.012261949479579926
) O 0 0.002041435334831476
and O 0 0.0008071097545325756
the O 0 0.0021281568333506584
linkage O 0 0.04594847932457924
of O 0 0.002795657841488719
human O 0 0.02951536327600479
obesity B-Disease 1 1.0
to O 0 0.008725767023861408
chromosome O 1 0.9998726844787598
2 O 0 0.009541590698063374
in O 0 0.0016867314698174596
close O 0 0.006825033575296402
proximity O 0 0.015003327280282974
to O 0 0.0016466844826936722
the O 0 0.00808608066290617
POMC O 1 0.999998927116394
locus O 1 0.9999969005584717
, O 0 0.0031040627509355545
led O 0 0.006405123043805361
to O 0 0.001109544769860804
the O 0 0.0018327048746868968
proposal O 0 0.005903440993279219
of O 0 0.0009471699595451355
an O 0 0.002169301500543952
association O 0 0.010629037395119667
of O 0 0.003156815655529499
POMC O 1 0.9999998807907104
with O 0 0.005580396857112646
human O 0 0.05475277453660965
obesity B-Disease 1 1.0
. O 0 0.00750923715531826

The O 0 0.004656639415770769
dual O 0 0.018176980316638947
role O 0 0.00641526049003005
of O 0 0.002636512042954564
alpha O 0 0.25891733169555664
- O 0 0.06905907392501831
MSH O 1 0.9999879598617554
in O 0 0.00380068295635283
regulating O 0 0.04884476959705353
food O 0 0.022006789222359657
intake O 0 0.2329777330160141
and O 0 0.0026247892528772354
influencing O 0 0.14955660700798035
hair O 1 0.9997276663780212
pigmentation O 1 0.9999994039535522
predicts O 0 0.04484402388334274
that O 0 0.0014663521433249116
the O 0 0.0048674773424863815
phenotype O 1 0.9999980926513672
associated O 0 0.009389440529048443
with O 0 0.0011709650279954076
a O 0 0.007071059662848711
defect O 1 0.9996751546859741
in O 0 0.005050023552030325
POMC O 1 0.9999996423721313
function O 0 0.019012050703167915
would O 0 0.002823767252266407
include O 0 0.0064183613285422325
obesity B-Disease 1 1.0
, O 0 0.0030132471583783627
alteration O 1 0.9976714253425598
in O 0 0.0036211709957569838
pigmentation O 1 0.9999998807907104
and O 0 0.007580931764096022
ACTH B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
. O 0 0.0077093434520065784

The O 0 0.004354207310825586
observation O 0 0.01762652024626732
of O 0 0.001491946168243885
these O 0 0.003144427202641964
symptoms O 1 1.0
in O 0 0.002001628279685974
two O 0 0.0024096278939396143
probands O 1 0.9999392032623291
prompted O 0 0.051561545580625534
us O 0 0.0036940653808414936
to O 0 0.0010397478472441435
search O 0 0.008539057336747646
for O 0 0.003050949890166521
mutations O 1 0.9997350573539734
within O 0 0.0035620620474219322
their O 0 0.005395331885665655
POMC O 1 0.9999957084655762
genes O 1 0.6803897619247437
. O 0 0.006825658027082682

Patient O 1 0.9989713430404663
1 O 0 0.01932429149746895
was O 0 0.007267823442816734
found O 0 0.0031999771017581224
to O 0 0.0007322562742047012
be O 0 0.001066395197995007
a O 0 0.005407074466347694
compound O 0 0.0293248500674963
heterozygote O 1 0.997456967830658
for O 0 0.0020770758856087923
two O 0 0.0027077337726950645
mutations O 1 0.9996515512466431
in O 0 0.004257850348949432
exon O 1 0.9994992017745972
3 O 0 0.020284855738282204
( O 0 0.00727890944108367
G7013T O 1 0.9998307228088379
, O 0 0.00472631212323904
C7133delta O 1 0.99973064661026
) O 0 0.0037173652090132236
which O 0 0.001657757326029241
interfere O 0 0.013557475060224533
with O 0 0.0010669255862012506
appropriate O 0 0.004917038604617119
synthesis O 0 0.023755522444844246
of O 0 0.003486464498564601
ACTH O 1 0.9999467134475708
and O 0 0.004481448791921139
alpha O 0 0.18167142570018768
- O 0 0.10667497664690018
MSH O 1 0.9999947547912598
. O 0 0.012569623067975044

Patient O 1 0.9996711015701294
2 O 0 0.013187360018491745
was O 0 0.010392796248197556
homozygous O 1 0.9961611032485962
for O 0 0.0018169785616919398
a O 0 0.011279125697910786
mutation O 1 0.9997367262840271
in O 0 0.005526056047528982
exon O 1 0.995578944683075
2 O 0 0.01854586973786354
( O 0 0.008473104797303677
C3804A O 1 0.999664306640625
) O 0 0.0033009250182658434
which O 0 0.0042580426670610905
abolishes O 1 0.9998801946640015
POMC O 1 0.9999896287918091
translation O 0 0.02448846772313118
. O 0 0.0052292682230472565

These O 0 0.0018723835237324238
findings O 0 0.005867841187864542
represent O 0 0.002441267715767026
the O 0 0.0014195686671882868
first O 0 0.0018821608973667026
examples O 0 0.0020873029716312885
of O 0 0.0012104063061997294
a O 0 0.00937082152813673
genetic B-Disease 1 0.9998836517333984
defect I-Disease 1 0.9999477863311768
within O 0 0.0044612460769712925
the O 0 0.007846041582524776
POMC O 1 0.9999997615814209
gene O 1 0.987758457660675
and O 0 0.0016145763220265508
define O 0 0.005986223462969065
a O 0 0.005020592827349901
new O 0 0.00896227452903986
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 1 1.0
resulting O 0 0.029926784336566925
in O 0 0.001683622831478715
early O 0 0.011108108796179295
- O 1 0.9988510608673096
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 0.013799374923110008
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 0.005190529860556126
red O 1 0.997925877571106
hair O 1 0.9999711513519287
pigmentation O 1 0.9999998807907104
. O 0 0.003787313587963581
. O 0 0.0036951557267457247

A O 0 0.020316505804657936
European O 0 0.009681821800768375
multicenter O 1 0.9838415384292603
study O 0 0.006706524640321732
of O 0 0.00436714431270957
phenylalanine B-Disease 1 0.9999860525131226
hydroxylase I-Disease 1 0.9999380111694336
deficiency I-Disease 1 1.0
: O 0 0.007665772922337055
classification O 0 0.023538213223218918
of O 0 0.0019149729050695896
105 O 0 0.069707952439785
mutations O 1 0.9999380111694336
and O 0 0.0010931194992735982
a O 0 0.003912108484655619
general O 0 0.003968093544244766
system O 0 0.007142058573663235
for O 0 0.0040337019599974155
genotype O 1 0.9999897480010986
- O 0 0.019448671489953995
based O 0 0.0036335845943540335
prediction O 0 0.02512631006538868
of O 0 0.004079997073858976
metabolic O 1 0.9999990463256836
phenotype O 1 0.9999990463256836
. O 0 0.00774475559592247

Phenylketonuria B-Disease 1 0.9999991655349731
( O 0 0.03238780423998833
PKU B-Disease 1 1.0
) O 0 0.006035447586327791
and O 0 0.0030090913642197847
mild B-Disease 1 0.9999997615814209
hyperphenylalaninemia I-Disease 1 1.0
( O 0 0.019952118396759033
MHP B-Disease 1 1.0
) O 0 0.004568444564938545
are O 0 0.0027744134422391653
allelic B-Disease 1 0.9999988079071045
disorders I-Disease 1 1.0
caused O 1 0.999977707862854
by O 0 0.006156705319881439
mutations O 1 0.9999510049819946
in O 0 0.0014222613535821438
the O 0 0.003636870998889208
gene O 1 0.9967669248580933
encoding O 0 0.10195684432983398
phenylalanine O 1 0.9975989460945129
hydroxylase O 1 0.9987999200820923
( O 0 0.021016959100961685
PAH O 1 0.9999983310699463
) O 0 0.0074247559532523155
. O 0 0.004363233223557472

Previous O 0 0.013337139040231705
studies O 0 0.005125459749251604
have O 0 0.0013517951592803001
suggested O 0 0.003715652972459793
that O 0 0.0005987434997223318
the O 0 0.0017621841980144382
highly O 0 0.015444689430296421
variable O 0 0.09482813626527786
metabolic O 1 0.9998544454574585
phenotypes O 1 0.9979861974716187
of O 0 0.0089450404047966
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 0 0.297704815864563
with O 0 0.008442217484116554
PAH O 1 1.0
genotypes O 1 0.9999849796295166
. O 0 0.008284801617264748

We O 0 0.0033880341798067093
identified O 0 0.011554308235645294
both O 0 0.003808446694165468
causative O 1 0.9999462366104126
mutations O 1 0.9999475479125977
in O 0 0.004877833649516106
686 O 1 0.9999915361404419
patients O 1 0.999981164932251
from O 0 0.0026268784422427416
seven O 0 0.003439183346927166
European O 0 0.005317060276865959
centers O 0 0.014451472088694572
. O 0 0.00473017618060112

On O 0 0.002400400349870324
the O 0 0.0011285351356491446
basis O 0 0.0009039755095727742
of O 0 0.0007430213154293597
the O 0 0.0030140422750264406
phenotypic O 1 0.9998365640640259
characteristics O 0 0.01135298702865839
of O 0 0.002121084136888385
297 O 1 0.9996856451034546
functionally O 1 0.9999531507492065
hemizygous O 1 0.9999985694885254
patients O 1 0.9999943971633911
, O 0 0.0019835219718515873
105 O 0 0.015110228210687637
of O 0 0.0011212026001885533
the O 0 0.004546150099486113
mutations O 1 0.9999916553497314
were O 0 0.001834623166359961
assigned O 0 0.008061205968260765
to O 0 0.0007276862161234021
one O 0 0.0011600290890783072
of O 0 0.0007338811992667615
four O 0 0.0026102543342858553
arbitrary O 0 0.021261803805828094
phenotype O 1 0.9999996423721313
categories O 0 0.012868611142039299
. O 0 0.004299520514905453

We O 0 0.003660980612039566
proposed O 0 0.005133981816470623
and O 0 0.0015588648384436965
tested O 0 0.031052419915795326
a O 0 0.004875269718468189
simple O 0 0.005448233801871538
model O 0 0.006303922273218632
for O 0 0.0015520693268626928
correlation O 0 0.02976725995540619
between O 0 0.0062814257107675076
genotype O 1 0.9998090863227844
and O 0 0.0039777010679244995
phenotypic O 1 0.9998327493667603
outcome O 0 0.02162793278694153
. O 0 0.004910960793495178

The O 0 0.006559303030371666
observed O 0 0.029348749667406082
phenotype O 1 0.9999781847000122
matched O 0 0.025355985388159752
the O 0 0.00383598729968071
predicted O 0 0.0479416586458683
phenotype O 1 0.9999669790267944
in O 0 0.004015198443084955
79 O 0 0.04641824960708618
% O 0 0.0037790469359606504
of O 0 0.0012112995609641075
the O 0 0.0033126871567219496
cases O 0 0.009654195979237556
, O 0 0.0012670995201915503
and O 0 0.0007754527032375336
in O 0 0.0010520120849832892
only O 0 0.001685218419879675
5 O 0 0.006590636447072029
of O 0 0.0023335323203355074
184 O 1 0.9993218183517456
patients O 1 0.9999947547912598
was O 0 0.004589378368109465
the O 0 0.0028246911242604256
observed O 0 0.027828576043248177
phenotype O 1 0.9999980926513672
more O 0 0.001781568629667163
than O 0 0.00155292684212327
one O 0 0.0027189154643565416
category O 0 0.0156635083258152
away O 0 0.004601852968335152
from O 0 0.0017697628354653716
that O 0 0.0011924970895051956
expected O 0 0.004863413516432047
. O 0 0.004156668204814196

Among O 0 0.007141456473618746
the O 0 0.0023229492362588644
seven O 0 0.004466569051146507
contributing O 0 0.02880246751010418
centers O 0 0.011807621456682682
, O 0 0.0011793902376666665
the O 0 0.002046748297289014
proportion O 0 0.014254369772970676
of O 0 0.002588726347312331
patients O 1 0.9999927282333374
for O 0 0.0016571820015087724
whom O 0 0.007066186983138323
the O 0 0.003040082985535264
observed O 0 0.03771039843559265
phenotype O 1 0.9999996423721313
did O 0 0.0030890577472746372
not O 0 0.0009567085653543472
match O 0 0.003887514816597104
the O 0 0.0029974221251904964
predicted O 0 0.04356452450156212
phenotype O 1 0.9999957084655762
was O 0 0.010669439099729061
4 O 0 0.010999888181686401
% O 0 0.0053588589653372765
- O 0 0.01948515884578228
23 O 0 0.015602068975567818
% O 0 0.005552452523261309
( O 0 0.007842320017516613
P O 1 0.999592125415802
< O 1 0.9796321988105774
. O 0 0.009080118499696255
0001 O 1 0.9979786276817322
) O 0 0.004657003562897444
, O 0 0.001363152638077736
suggesting O 0 0.010500207543373108
that O 0 0.001143945730291307
differences O 0 0.003127960255369544
in O 0 0.0007872363785281777
methods O 0 0.0024742630776017904
used O 0 0.001422143541276455
for O 0 0.0025646723806858063
mutation O 1 0.9999977350234985
detection O 0 0.11654887348413467
or O 0 0.008750531822443008
phenotype O 1 0.9999996423721313
classification O 0 0.23719927668571472
may O 0 0.005759042222052813
account O 0 0.0018168108072131872
for O 0 0.000978082069195807
a O 0 0.004332810640335083
considerable O 0 0.011912754736840725
proportion O 0 0.01356816478073597
of O 0 0.0039828200824558735
genotype O 1 0.999997615814209
- O 1 0.9432355761528015
phenotype O 1 0.9999983310699463
inconsistencies O 0 0.04197757691144943
. O 0 0.005923899356275797

Our O 0 0.004670313093811274
data O 0 0.002081074519082904
indicate O 0 0.0047532301396131516
that O 0 0.0011392532614991069
the O 0 0.006309244781732559
PAH O 1 1.0
- O 1 0.9504326581954956
mutation O 1 0.9999986886978149
genotype O 1 0.999945878982544
is O 0 0.002575772115960717
the O 0 0.0015715013723820448
main O 0 0.00682616513222456
determinant O 1 0.9883458614349365
of O 0 0.004356704652309418
metabolic O 1 0.9999997615814209
phenotype O 1 0.9999996423721313
in O 0 0.0021795860957354307
most O 0 0.00433435570448637
patients O 1 0.9999997615814209
with O 0 0.008832965046167374
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.0097929947078228

In O 0 0.0023292398545891047
the O 0 0.0015959386946633458
present O 0 0.002407281892374158
study O 0 0.003054517088457942
, O 0 0.000802391383331269
the O 0 0.0018247169209644198
classification O 0 0.021372666582465172
of O 0 0.003003697143867612
105 O 1 0.9158658981323242
PAH O 1 1.0
mutations O 1 0.9999970197677612
may O 0 0.008319932967424393
allow O 0 0.0019607774447649717
the O 0 0.0015155429719015956
prediction O 0 0.0191872026771307
of O 0 0.0009071139502339065
the O 0 0.003462152788415551
biochemical O 1 0.9513754844665527
phenotype O 1 0.999997615814209
in O 0 0.004802151117473841
> O 1 0.9972550272941589
10 O 0 0.005711731966584921
, O 0 0.002300438703969121
000 O 0 0.05650298297405243
genotypes O 1 0.9999812841415405
, O 0 0.0025179393123835325
which O 0 0.002129150088876486
may O 0 0.005913198459893465
be O 0 0.0011072867782786489
useful O 0 0.00258521712385118
for O 0 0.0007326084305532277
the O 0 0.0019110016291961074
management O 0 0.011708277277648449
of O 0 0.002773777348920703
hyperphenylalaninemia B-Disease 1 0.9999995231628418
in O 0 0.005342844873666763
newborns O 1 0.999972939491272
. O 0 0.006197549402713776

Somatic O 1 0.8641406297683716
instability O 0 0.09477002918720245
of O 0 0.0017269914969801903
the O 0 0.005162922665476799
CTG O 1 0.999795138835907
repeat O 0 0.06756486743688583
in O 0 0.003888881066814065
mice O 1 0.9981460571289062
transgenic O 0 0.05688551440834999
for O 0 0.0023250586818903685
the O 0 0.012098805978894234
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 0.024878880009055138
is O 0 0.005153050180524588
age O 0 0.013242317363619804
dependent O 0 0.018441783264279366
but O 0 0.0016032769344747066
not O 0 0.0016416414873674512
correlated O 0 0.038635823875665665
to O 0 0.0008842422976158559
the O 0 0.001935692154802382
relative O 0 0.0192605908960104
intertissue O 1 0.9995099306106567
transcription O 0 0.11971782147884369
levels O 0 0.017661383375525475
and O 0 0.003829729976132512
proliferative O 1 0.9999960660934448
capacities O 0 0.03587179258465767
. O 0 0.005251583177596331

A O 0 0.033240918070077896
( O 0 0.011314271949231625
CTG O 1 0.9998602867126465
) O 0 0.007905982434749603
nexpansion O 1 0.992493212223053
in O 0 0.0018221177160739899
the O 0 0.002911366755142808
3 O 0 0.014733701013028622
- O 0 0.030487533658742905
untranslated O 1 0.7652570009231567
region O 0 0.018196824938058853
( O 0 0.007188585586845875
UTR O 1 0.9880848526954651
) O 0 0.0021781972609460354
of O 0 0.0011752302525565028
the O 0 0.007923811674118042
DM O 1 1.0
protein O 1 0.7121019959449768
kinase O 1 0.9999290704727173
gene O 1 0.9904493689537048
( O 0 0.011337924748659134
DMPK O 1 0.9999701976776123
) O 0 0.0033872323110699654
is O 0 0.0019100267672911286
responsible O 0 0.00888149905949831
for O 0 0.003718410851433873
causing O 1 0.9999995231628418
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.880325198173523
DM B-Disease 1 1.0
) O 0 0.008288688957691193
. O 0 0.0047547887079417706

Major O 0 0.04016690328717232
instability O 1 0.9954496026039124
, O 0 0.0018127372022718191
with O 0 0.00122896209359169
very O 0 0.002858714899048209
large O 0 0.0048819067887961864
expansions O 0 0.03058099001646042
between O 0 0.0028509923722594976
generations O 0 0.014121304266154766
and O 0 0.0011270897230133414
high O 0 0.004801253322511911
levels O 0 0.009084097109735012
of O 0 0.002965722233057022
somatic O 1 0.9999587535858154
mosaicism O 1 0.9999979734420776
, O 0 0.0024400625843554735
is O 0 0.002971111563965678
observed O 0 0.012978392653167248
in O 0 0.0032293591648340225
patients O 1 0.9999880790710449
. O 0 0.005575292278081179

There O 0 0.0030919720884412527
is O 0 0.002415685448795557
a O 0 0.004454177338629961
good O 0 0.005754184443503618
correlation O 0 0.028974847868084908
between O 0 0.004100834485143423
repeat O 0 0.07161889225244522
size O 0 0.010664347559213638
( O 0 0.0040316274389624596
at O 0 0.003137729363515973
least O 0 0.006977576296776533
in O 0 0.003476314013823867
leucocytes O 1 0.9997512698173523
) O 0 0.0041917115449905396
, O 0 0.0023957504890859127
clinical O 1 0.9981478452682495
severity O 1 0.9999873638153076
and O 0 0.001581471529789269
age O 0 0.00868167169392109
of O 0 0.0040643359534442425
onset O 1 1.0
. O 0 0.007450663950294256

The O 0 0.014047917909920216
trinucleotide O 1 0.9998886585235596
repeat O 0 0.1697131097316742
instability O 1 0.5660091042518616
mechanisms O 0 0.030748363584280014
involved O 0 0.009917841292917728
in O 0 0.00498598488047719
DM B-Disease 1 1.0
and O 0 0.0015339392703026533
other O 0 0.0011478185188025236
human O 0 0.018126163631677628
genetic B-Disease 1 0.9999982118606567
diseases I-Disease 1 1.0
are O 0 0.002296147868037224
unknown O 0 0.016829725354909897
. O 0 0.00390675850212574

We O 0 0.0037487333174794912
studied O 0 0.008606486953794956
somatic O 1 0.8017142415046692
instability O 0 0.10041698813438416
by O 0 0.0037556332536041737
measuring O 0 0.018421247601509094
the O 0 0.005790226627141237
CTG O 1 0.9997090697288513
repeat O 0 0.10613211989402771
length O 0 0.011427067220211029
at O 0 0.003255570540204644
several O 0 0.0022715276572853327
ages O 0 0.010785442776978016
in O 0 0.001162411062978208
various O 0 0.0020801497157663107
tissues O 1 0.9946609139442444
of O 0 0.0033303052186965942
transgenic O 1 0.9770664572715759
mice O 1 0.9970605969429016
carrying O 0 0.014420298859477043
a O 0 0.010025626048445702
( O 0 0.009626111015677452
CTG O 1 0.9993189573287964
) O 0 0.009202267974615097
55expansion O 1 0.9954829216003418
surrounded O 0 0.01989169418811798
by O 0 0.00329386699013412
45 O 0 0.010100550949573517
kb O 0 0.13893814384937286
of O 0 0.0014852426247671247
the O 0 0.0035896641202270985
human O 0 0.02702157013118267
DM B-Disease 1 1.0
region O 0 0.016565609723329544
, O 0 0.0014494259376078844
using O 0 0.003060008166357875
small O 0 0.006510870065540075
- O 0 0.03060832805931568
pool O 0 0.0674487054347992
PCR O 0 0.49886554479599
. O 0 0.00845023151487112

These O 0 0.006480392534285784
mice O 1 0.9997228980064392
have O 0 0.002195540349930525
been O 0 0.0035372385755181313
shown O 0 0.005055129993706942
to O 0 0.0014323674840852618
reproduce O 0 0.027641654014587402
the O 0 0.003955352585762739
intergenerational O 0 0.24663399159908295
and O 0 0.0033894998487085104
somatic O 1 0.9673193693161011
instability O 0 0.25770601630210876
of O 0 0.0013966610422357917
the O 0 0.0028274618089199066
55 O 0 0.03310243412852287
CTG O 1 0.999941349029541
repeat O 0 0.10877194255590439
suggesting O 0 0.01609533652663231
that O 0 0.00141462916508317
surrounding O 0 0.008247658610343933
sequences O 0 0.018860694020986557
and O 0 0.0008285416988655925
the O 0 0.0027077258564531803
chromatin O 0 0.08139956742525101
environment O 0 0.005832144990563393
are O 0 0.0007645579753443599
involved O 0 0.005158124957233667
in O 0 0.00232676905579865
instability O 1 0.9987033605575562
mechanisms O 0 0.04305422306060791
. O 0 0.005985212977975607

As O 0 0.006449349224567413
observed O 0 0.009624066762626171
in O 0 0.0008666347712278366
some O 0 0.0007430950063280761
of O 0 0.0008240834577009082
the O 0 0.003471792209893465
tissues O 1 0.9999822378158569
of O 0 0.008715910837054253
DM B-Disease 1 1.0
patients O 1 1.0
, O 0 0.0017582846339792013
there O 0 0.0012565364595502615
is O 0 0.002008409472182393
a O 0 0.005710161756724119
tendency O 0 0.03621484711766243
for O 0 0.002297965344041586
repeat O 0 0.06305597722530365
length O 0 0.01095319539308548
and O 0 0.00307563878595829
somatic O 1 0.998417854309082
mosaicism O 1 0.999913215637207
to O 0 0.0030703796073794365
increase O 0 0.00435996986925602
with O 0 0.001206635613925755
the O 0 0.0023936680518090725
age O 0 0.0075215864926576614
of O 0 0.0013743116287514567
the O 0 0.006130362395197153
mouse O 1 0.9999518394470215
. O 0 0.0075744083151221275

Furthermore O 0 0.03056131675839424
, O 0 0.0015322178369387984
we O 0 0.001292973174713552
observed O 0 0.009042192250490189
no O 0 0.0021906851325184107
correlation O 0 0.020202776417136192
between O 0 0.0017004141118377447
the O 0 0.004641770850867033
somatic O 1 0.9998524188995361
mutation O 1 0.9999990463256836
rate O 0 0.014342259615659714
and O 0 0.0035818249452859163
tissue O 1 0.9999710321426392
proliferation O 0 0.037086859345436096
capacity O 0 0.007230257149785757
. O 0 0.005251562688499689

The O 0 0.009162161499261856
somatic O 1 0.9996823072433472
mutation O 1 0.9999862909317017
rates O 0 0.016361864283680916
in O 0 0.0015729265287518501
different O 0 0.001793853472918272
tissues O 1 0.9995423555374146
were O 0 0.0013068700209259987
also O 0 0.0010992535389959812
not O 0 0.0012369467876851559
correlated O 0 0.030185434967279434
to O 0 0.0009227712289430201
the O 0 0.0016012843698263168
relative O 0 0.013766097836196423
inter O 0 0.03286096826195717
- O 0 0.057018812745809555
tissue O 1 0.9996534585952759
difference O 0 0.009251110255718231
in O 0 0.00225890357978642
transcriptional O 1 0.6176949739456177
levels O 0 0.007968769408762455
of O 0 0.0006505330093204975
the O 0 0.0015249619027599692
three O 0 0.0031087559182196856
genes O 1 0.9681507349014282
( O 0 0.00874953530728817
DMAHP O 1 0.9999982118606567
, O 0 0.005223858170211315
DMPK O 1 0.9999879598617554
and O 0 0.0029074521735310555
59 O 0 0.030275311321020126
) O 0 0.0030473133083432913
surrounding O 0 0.00785096175968647
the O 0 0.003519789082929492
repeat O 0 0.40164172649383545
. O 0 0.0028186857234686613
. O 0 0.0034000829327851534

A O 0 0.027031954377889633
novel O 0 0.05144204944372177
missense O 1 0.9999788999557495
mutation O 1 0.99998939037323
in O 0 0.005455721169710159
patients O 1 0.9998917579650879
from O 0 0.0029583696741610765
a O 0 0.014389603398740292
retinoblastoma B-Disease 1 0.9999996423721313
pedigree O 1 0.9929817914962769
showing O 0 0.013373243622481823
only O 0 0.003298988100141287
mild O 1 0.9995667338371277
expression O 0 0.015988361090421677
of O 0 0.0011432573664933443
the O 0 0.008443986065685749
tumor B-Disease 1 1.0
phenotype O 1 0.9999997615814209
. O 0 0.007379183545708656

We O 0 0.002426780993118882
have O 0 0.0013085806276649237
used O 0 0.002020041923969984
single O 0 0.017346013337373734
strand O 0 0.13726170361042023
conformation O 0 0.34794777631759644
polymorphism O 0 0.1621791124343872
analysis O 0 0.004257282707840204
to O 0 0.0010316597763448954
study O 0 0.0027760763186961412
the O 0 0.0025928071700036526
27 O 0 0.01661992073059082
exons O 0 0.12700332701206207
of O 0 0.0019193707266822457
the O 0 0.008861247450113297
RB1 O 1 0.9999997615814209
gene O 1 0.9986476302146912
in O 0 0.002480265451595187
individuals O 0 0.0030028661713004112
from O 0 0.0020426022820174694
a O 0 0.005626678001135588
family O 0 0.01463608630001545
showing O 0 0.020049430429935455
mild O 1 0.999982476234436
expression O 0 0.017587589100003242
of O 0 0.0011981985298916698
the O 0 0.007992923259735107
retinoblastoma B-Disease 1 1.0
phenotype O 1 0.9999997615814209
. O 0 0.007826872169971466

In O 0 0.0033031287603080273
this O 0 0.002326146000996232
family O 0 0.014207164756953716
affected O 1 0.8887210488319397
individuals O 0 0.005768321920186281
developed O 0 0.1405504047870636
unilateral B-Disease 1 0.9999873638153076
tumors I-Disease 1 1.0
and O 0 0.0014779063640162349
, O 0 0.000732804590370506
as O 0 0.0010887738317251205
a O 0 0.00360205234028399
result O 0 0.005482658743858337
of O 0 0.0011995432432740927
linkage O 0 0.05721917375922203
analysis O 0 0.0061091091483831406
, O 0 0.0031361680012196302
unaffected O 1 0.9999809265136719
mutation O 1 0.999998927116394
carriers O 1 0.878403902053833
were O 0 0.001249685068614781
also O 0 0.0010715872049331665
identified O 0 0.006416567135602236
within O 0 0.0019726399332284927
the O 0 0.003905797377228737
pedigree O 1 0.9284113645553589
. O 0 0.006959519814699888

A O 0 0.026621153578162193
single O 0 0.018991539254784584
band O 0 0.02555128186941147
shift O 0 0.024722373113036156
using O 0 0.007551107089966536
SSCP O 1 0.9997861981391907
was O 0 0.008221792988479137
identified O 0 0.01149236410856247
in O 0 0.0034357307013124228
exon O 1 0.99893718957901
21 O 0 0.013363916426897049
which O 0 0.0016882360214367509
resulted O 0 0.016039906069636345
in O 0 0.0012843668228015304
a O 0 0.010620309971272945
missense O 1 0.9998620748519897
mutation O 1 0.9996658563613892
converting O 0 0.028328338637948036
a O 0 0.017341163009405136
cys O 1 0.9973199963569641
- O 0 0.05936862900853157
- O 0 0.06480498611927032
> O 1 0.9964344501495361
arg O 1 0.9890700578689575
at O 0 0.0075006852857768536
nucleotide O 0 0.09405539184808731
position O 0 0.00719000119715929
28 O 0 0.008646220900118351
in O 0 0.0010943015804514289
the O 0 0.0046789878979325294
exon O 1 0.9993054866790771
. O 0 0.007296088617295027

The O 0 0.012183833867311478
mutation O 1 0.9999638795852661
destroyed O 0 0.030500683933496475
an O 0 0.005262122489511967
NdeI O 1 0.9996501207351685
restriction O 0 0.08027121424674988
enzyme O 0 0.2146683931350708
site O 0 0.01057620532810688
. O 0 0.004544930998235941

Analysis O 0 0.00717737153172493
of O 0 0.0011806271504610777
all O 0 0.0012319684028625488
family O 0 0.00869833305478096
members O 0 0.0022459658794105053
demonstrated O 0 0.007453337777405977
that O 0 0.0010096528567373753
the O 0 0.004269525408744812
missense O 1 0.9998822212219238
mutation O 1 0.9999936819076538
co O 0 0.04979250580072403
- O 0 0.028056642040610313
segregated O 0 0.06345617771148682
with O 0 0.005256554577499628
patients O 1 0.9999998807907104
with O 0 0.009870391339063644
tumors B-Disease 1 1.0
or O 0 0.004413776099681854
who O 0 0.003239396493881941
, O 0 0.000885007088072598
as O 0 0.001121541834436357
a O 0 0.003444461850449443
result O 0 0.006311720237135887
of O 0 0.0015356737421825528
linkage O 0 0.07481072843074799
analysis O 0 0.005863220430910587
had O 0 0.004123400431126356
been O 0 0.0038822628557682037
predicted O 0 0.009948767721652985
to O 0 0.0010768643114715815
carry O 0 0.005052612163126469
the O 0 0.005792900919914246
predisposing O 1 0.9999682903289795
mutation O 1 0.9999406337738037
. O 0 0.008415468037128448

These O 0 0.002217859262600541
observations O 0 0.004187907557934523
point O 0 0.0028794100508093834
to O 0 0.0010618676897138357
another O 0 0.005596892908215523
region O 0 0.0050907558761537075
of O 0 0.0012274886248633265
the O 0 0.008303683251142502
RB1 O 1 0.9999997615814209
gene O 1 0.9995077848434448
where O 0 0.009542105719447136
mutations O 1 0.9991241097450256
only O 0 0.0024214168079197407
modify O 0 0.022393638268113136
the O 0 0.002166910097002983
function O 0 0.008600898087024689
of O 0 0.0009333871421404183
the O 0 0.0038941274397075176
gene O 1 0.9997846484184265
and O 0 0.0015528263757005334
raise O 0 0.006408844608813524
important O 0 0.0016548880375921726
questions O 0 0.002953024348244071
for O 0 0.0020407612901180983
genetic O 1 0.7894837856292725
counseling O 1 0.8265137672424316
in O 0 0.0019036398734897375
families O 0 0.0051605189219117165
with O 0 0.0012776781804859638
these O 0 0.0017147223697975278
distinctive O 1 0.8152729868888855
phenotypes O 1 0.9999886751174927
. O 0 0.002603343687951565
. O 0 0.003559964010491967

Maternal B-Disease 1 0.9990986585617065
disomy I-Disease 1 0.9980016350746155
and O 0 0.006804694887250662
Prader B-Disease 1 1.0
- I-Disease 1 0.9999605417251587
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 0.018914317712187767
with O 0 0.0031991482246667147
gamete O 1 0.9988678693771362
complementation O 1 0.9999393224716187
in O 0 0.0017681075260043144
a O 0 0.004558979533612728
case O 0 0.006222890689969063
of O 0 0.003928113263100386
familial O 1 0.9999998807907104
translocation O 1 0.9999085664749146
( O 0 0.008580828085541725
3 O 0 0.013469720259308815
; O 0 0.002965371124446392
15 O 0 0.008475259877741337
) O 0 0.003990644123405218
( O 0 0.0068693608045578
p25 O 1 0.9998891353607178
; O 0 0.00812869518995285
q11 O 1 0.9992769360542297
. O 0 0.0031625963747501373
2 O 0 0.010666209273040295
) O 0 0.003899170318618417
. O 0 0.003950668498873711

Maternal B-Disease 1 0.9999169111251831
uniparental I-Disease 1 0.9999994039535522
disomy I-Disease 1 0.9999672174453735
( I-Disease 0 0.0229159127920866
UPD I-Disease 1 0.9999994039535522
) I-Disease 0 0.006353405769914389
for I-Disease 0 0.004101668484508991
chromosome I-Disease 1 0.9998816251754761
15 I-Disease 0 0.010043147951364517
is O 0 0.002752520376816392
responsible O 0 0.00883411429822445
for O 0 0.0012356196530163288
an O 0 0.001975907478481531
estimated O 0 0.008929924108088017
30 O 0 0.00634324736893177
% O 0 0.002089413348585367
of O 0 0.0008598246495239437
cases O 0 0.006558470893651247
of O 0 0.0036711725406348705
Prader B-Disease 1 1.0
- I-Disease 1 0.9999963045120239
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.669630765914917
PWS B-Disease 1 1.0
) O 0 0.0074641820974648
. O 0 0.00470912316814065

We O 0 0.003208896378055215
report O 0 0.0024750421289354563
on O 0 0.0013019925681874156
an O 0 0.0016541334334760904
unusual O 0 0.007184111978858709
case O 0 0.005512765143066645
of O 0 0.002379982965067029
maternal B-Disease 1 0.9999723434448242
disomy I-Disease 1 0.9998842477798462
15 I-Disease 0 0.01179733220487833
in O 0 0.003978362772613764
PWS B-Disease 1 1.0
that O 0 0.0020881432574242353
is O 0 0.0017161546275019646
most O 0 0.0020509466994553804
consistent O 0 0.00841914489865303
with O 0 0.0014720928156748414
adjacent O 0 0.016657697036862373
- O 0 0.018813516944646835
1 O 0 0.013100898824632168
segregation O 0 0.03441834822297096
of O 0 0.0015996904112398624
a O 0 0.014743199571967125
paternal O 1 0.9999896287918091
t O 1 0.9992056488990784
( O 0 0.008526942692697048
3 O 0 0.014721909537911415
; O 0 0.003274919930845499
15 O 0 0.007781953550875187
) O 0 0.0037660435773432255
( O 0 0.007357187569141388
p25 O 1 0.9998364448547363
; O 0 0.008949247188866138
q11 O 1 0.9983859062194824
. O 0 0.0025782748125493526
2 O 0 0.006747117266058922
) O 0 0.0018133828416466713
with O 0 0.0011889513116329908
simultaneous O 0 0.03805023804306984
maternal O 1 0.9997064471244812
meiotic O 1 0.9999934434890747
nondisjunction O 1 0.9997022747993469
for O 0 0.0074202800169587135
chromosome O 1 0.9998382329940796
15 O 0 0.012262938544154167
. O 0 0.004947913344949484

The O 0 0.012658351100981236
patient O 1 0.9999728202819824
( O 0 0.013101083226501942
J O 1 0.9999988079071045
. O 0 0.005397839937359095
B O 1 0.9944381713867188
. O 0 0.0027744383551180363
) O 0 0.0022265298757702112
, O 0 0.000957939017098397
a O 0 0.005228640045970678
17 O 0 0.013853391632437706
- O 0 0.01634844020009041
year O 0 0.008119076490402222
- O 0 0.024593772366642952
old O 0 0.016959408298134804
white O 0 0.013469592668116093
male O 0 0.027741044759750366
with O 0 0.00504817720502615
PWS B-Disease 1 1.0
, O 0 0.002866327064111829
was O 0 0.005687654484063387
found O 0 0.0030228300020098686
to O 0 0.000875846017152071
have O 0 0.00180280942004174
47 O 0 0.021868757903575897
chromosomes O 0 0.0606498159468174
with O 0 0.001431817188858986
a O 0 0.009202633053064346
supernumerary O 1 0.9999701976776123
, O 0 0.00516642676666379
paternal O 1 0.9997237324714661
der O 1 0.9930190443992615
( O 0 0.005579239688813686
15 O 0 0.007678115740418434
) O 0 0.0020840433426201344
consisting O 0 0.0028738477267324924
of O 0 0.0007345259073190391
the O 0 0.0023216665722429752
short O 0 0.011368153616786003
arm O 1 0.9827640056610107
and O 0 0.001379308057948947
the O 0 0.005597632844001055
proximal O 1 0.9999997615814209
long O 0 0.024359285831451416
arm O 1 0.8349829912185669
of O 0 0.0040094018913805485
chromosome O 1 0.9999951124191284
15 O 0 0.007467617280781269
, O 0 0.0013345476472750306
and O 0 0.003889276646077633
distal O 1 1.0
chromosome O 1 0.9999986886978149
arm O 1 0.9996330738067627
3p O 1 0.9966891407966614
. O 0 0.008668307214975357

The O 0 0.017110858112573624
t O 1 0.9944557547569275
( O 0 0.007507950998842716
3 O 0 0.015676146373152733
; O 0 0.0033580383751541376
15 O 0 0.008322195149958134
) O 0 0.0027282265946269035
was O 0 0.004274236969649792
present O 0 0.0016307723708450794
in O 0 0.0009001378202810884
the O 0 0.0015994879649952054
balanced O 0 0.009418273344635963
state O 0 0.0012606699019670486
in O 0 0.0011879870435222983
the O 0 0.004591915290802717
patients O 1 0.9999995231628418
father O 0 0.05502541363239288
and O 0 0.0013325409963726997
a O 0 0.00784327369183302
sister O 1 0.6726846694946289
. O 0 0.005933257285505533

Fluorescent O 0 0.14834819734096527
in O 0 0.006144573446363211
situ O 0 0.16179631650447845
hybridization O 0 0.06928997486829758
analysis O 0 0.006623167544603348
demonstrated O 0 0.008334442041814327
that O 0 0.0013657242525368929
the O 0 0.007125509437173605
PWS B-Disease 1 0.9999996423721313
critical O 0 0.03465768322348595
region O 0 0.013236883096396923
resided O 0 0.028025943785905838
on O 0 0.0017503333510830998
the O 0 0.00442305626347661
derivative O 1 0.9426743388175964
chromosome O 1 0.9999213218688965
3 O 0 0.010841220617294312
and O 0 0.0007767162169329822
that O 0 0.0007452945574186742
there O 0 0.0012763220584020019
was O 0 0.005212514195591211
no O 0 0.0032719450537115335
deletion O 1 0.8492789268493652
of O 0 0.0018223397200927138
the O 0 0.00658139493316412
PWS B-Disease 1 1.0
region O 0 0.01298082247376442
on O 0 0.0013774019898846745
the O 0 0.0026039034128189087
normal O 0 0.018487202003598213
pair O 0 0.0073135471902787685
of O 0 0.0022478450555354357
15s O 1 0.9996755123138428
present O 0 0.004220967646688223
in O 0 0.0041904933750629425
J O 1 0.9999986886978149
. O 0 0.006847995799034834

B O 1 0.8752361536026001
. O 0 0.008436938747763634

Methylation O 0 0.12994958460330963
analysis O 0 0.007342579308897257
at O 0 0.006229514256119728
exon O 1 0.9404119253158569
alpha O 0 0.06316446512937546
of O 0 0.0010561635717749596
the O 0 0.002067944500595331
small O 0 0.0053579495288431644
nuclear O 0 0.009623534977436066
ribonucleoprotein O 1 0.9791086316108704
- O 0 0.04224279522895813
associated O 0 0.0208232831209898
polypeptide O 1 0.9931519031524658
N O 0 0.10260996222496033
( O 0 0.009815668687224388
SNRPN O 1 0.9999068975448608
) O 0 0.006957802921533585
gene O 1 0.9789083003997803
showed O 0 0.009110567159950733
a O 0 0.006517461501061916
pattern O 0 0.025379473343491554
characteristic O 0 0.01732684299349785
of O 0 0.0006587768439203501
only O 0 0.001041544252075255
the O 0 0.0032778005115687847
maternal O 1 0.9999730587005615
chromosome O 1 0.9999972581863403
15 O 0 0.00825272686779499
in O 0 0.0034191079903393984
J O 1 0.9999966621398926
. O 0 0.006052600685507059

B O 1 0.5081983804702759
. O 0 0.009875577874481678

Maternal B-Disease 1 0.9998210072517395
disomy I-Disease 1 0.9997819066047668
was O 0 0.012042591348290443
confirmed O 0 0.017038948833942413
by O 0 0.006225898861885071
polymerase O 1 0.9418866038322449
chain O 0 0.1358773112297058
reaction O 0 0.024241268634796143
analysis O 0 0.004282732494175434
of O 0 0.0025953527074307203
microsatellite O 1 0.9976664781570435
repeats O 0 0.05596291646361351
at O 0 0.0036958190612494946
the O 0 0.0039048106409609318
gamma O 0 0.17134152352809906
- O 0 0.049143221229314804
aminobutyric O 1 0.9983682036399841
acid O 1 0.9038232564926147
receptor O 1 0.9473628401756287
beta3 O 1 0.9812705516815186
subunit O 0 0.4538094401359558
( O 0 0.015591043047606945
GABRB3 O 1 0.9998190999031067
) O 0 0.012131747789680958
locus O 1 0.9997536540031433
. O 0 0.008095396682620049

A O 0 0.0425119623541832
niece O 1 0.9990776777267456
( O 0 0.011690815910696983
B O 1 0.9979002475738525
. O 0 0.005120060406625271
B O 1 0.9770481586456299
. O 0 0.002167829079553485
) O 0 0.002401896519586444
with O 0 0.001529922359623015
45 O 0 0.013353683985769749
chromosomes O 0 0.06941507011651993
and O 0 0.0011645738268271089
the O 0 0.0035706295166164637
derivative O 0 0.08547760546207428
3 O 0 0.00936710461974144
but O 0 0.0015484764007851481
without O 0 0.002684300299733877
the O 0 0.004482784774154425
der O 1 0.9661110639572144
( O 0 0.005487376824021339
15 O 0 0.008557095192372799
) O 0 0.0027158402372151613
demonstrated O 0 0.012474540621042252
a O 0 0.014140230603516102
phenotype O 1 0.9999966621398926
consistent O 0 0.012623142451047897
with O 0 0.001186980283819139
that O 0 0.0011222019093111157
reported O 0 0.009476027451455593
for O 0 0.0023016929626464844
haploinsufficiency O 1 0.9975911378860474
of O 0 0.005934410262852907
distal O 1 0.9999994039535522
3 O 0 0.027574801817536354
p O 0 0.19796407222747803
. O 0 0.005120177287608385

Uniparental B-Disease 1 0.9999997615814209
disomy I-Disease 1 0.999982476234436
associated O 0 0.013805494643747807
with O 0 0.0021958849392831326
unbalanced O 0 0.33589303493499756
segregation O 0 0.04057896509766579
of O 0 0.0014097146922722459
non O 0 0.012643139809370041
- O 0 0.07406262308359146
Robertsonian O 1 0.9999972581863403
translocations O 1 0.9999641180038452
has O 0 0.004767917096614838
been O 0 0.004375721327960491
reported O 0 0.013952232897281647
previously O 0 0.004791573155671358
but O 0 0.0018912984523922205
has O 0 0.00242885435000062
not O 0 0.0010148445144295692
, O 0 0.0006741920951753855
to O 0 0.0007466637762263417
our O 0 0.001601709984242916
knowledge O 0 0.0025023415219038725
, O 0 0.001112582627683878
been O 0 0.0031791075598448515
observed O 0 0.0077261487022042274
in O 0 0.0010445083025842905
a O 0 0.003948375582695007
case O 0 0.005486807320266962
of O 0 0.004250384867191315
PWS B-Disease 1 1.0
. O 0 0.009288975037634373

Furthermore O 0 0.027979157865047455
, O 0 0.0016182962572202086
our O 0 0.0025149816647171974
findings O 0 0.005586697719991207
are O 0 0.0007851255941204727
best O 0 0.003313615918159485
interpreted O 0 0.005585415754467249
as O 0 0.0018298100912943482
true O 0 0.010960185900330544
gamete O 1 0.988698422908783
complementation O 1 0.9999459981918335
resulting O 0 0.04328281059861183
in O 0 0.0038904331158846617
maternal B-Disease 1 0.9999761581420898
UPD I-Disease 1 0.9999998807907104
15 I-Disease 0 0.0178361963480711
and O 0 0.006613170728087425
PWS B-Disease 1 0.9999998807907104

Schwartz B-Disease 1 0.9886009097099304
- I-Disease 1 0.7836615443229675
Jampel I-Disease 1 0.9999973773956299
syndrome I-Disease 1 1.0
type I-Disease 1 0.5073385238647461
2 I-Disease 0 0.0068910992704331875
and O 0 0.002089031506329775
Stuve B-Disease 1 0.9999997615814209
- I-Disease 1 0.999269425868988
Wiedemann I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
: O 0 0.004784931428730488
a O 0 0.00449191452935338
case O 0 0.004307695664465427
for O 0 0.0012302680406719446
" O 0 0.005664007738232613
lumping O 0 0.31164851784706116
" O 0 0.007131259888410568
. O 0 0.004708245396614075

Recent O 0 0.016624128445982933
studies O 0 0.005371877457946539
demonstrated O 0 0.007704296614974737
the O 0 0.0013859932078048587
existence O 0 0.0033482564613223076
of O 0 0.0012141952756792307
a O 0 0.009613278321921825
genetically O 0 0.088615782558918
distinct O 0 0.017150970175862312
, O 0 0.002075578086078167
usually O 0 0.008339997380971909
lethal O 1 0.5280556678771973
form O 0 0.0038754830602556467
of O 0 0.0009133373969234526
the O 0 0.003368292935192585
Schwartz B-Disease 1 0.9999532699584961
- I-Disease 1 0.9988892674446106
Jampel I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
( O 0 0.032851070165634155
SJS B-Disease 1 1.0
) O 0 0.004240763373672962
of O 0 0.0037206565029919147
myotonia B-Disease 1 1.0
and O 0 0.009009442292153835
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 0.0018539768643677235
which O 0 0.001367365475744009
we O 0 0.0017072765622287989
called O 0 0.02353961206972599
SJS B-Disease 1 1.0
type I-Disease 1 0.5449124574661255
2 I-Disease 0 0.014569660648703575
. O 0 0.004853199236094952

This O 0 0.012790067121386528
disorder O 1 0.9999998807907104
is O 0 0.00500683905556798
reminiscent O 0 0.026708154007792473
of O 0 0.0014025751734152436
another O 0 0.012174895964562893
rare O 0 0.08137862384319305
condition O 1 0.985960841178894
, O 0 0.0009548373054713011
the O 0 0.0032146258745342493
Stuve B-Disease 1 0.9999996423721313
- I-Disease 1 0.9990597367286682
Wiedemann I-Disease 1 0.9999996423721313
syndrome I-Disease 1 1.0
( O 0 0.03420701250433922
SWS B-Disease 1 1.0
) O 0 0.004791640676558018
, O 0 0.0010645710863173008
which O 0 0.0015321049140766263
comprises O 0 0.010503493249416351
campomelia B-Disease 1 0.9991742968559265
at O 0 0.00453256955370307
birth O 0 0.09980329126119614
with O 0 0.0044262828305363655
skeletal B-Disease 1 0.9999998807907104
dysplasia I-Disease 1 1.0
, O 0 0.007601958233863115
contractures B-Disease 1 0.9999997615814209
, O 0 0.00167632766533643
and O 0 0.0010467441752552986
early B-Disease 0 0.008717422373592854
death I-Disease 1 0.9145459532737732
. O 0 0.005101991351693869

To O 0 0.003567305626347661
test O 0 0.009148837067186832
for O 0 0.001545599545352161
possible O 0 0.008832172490656376
nosologic O 1 0.9992067217826843
identity O 0 0.014480588026344776
between O 0 0.0030003408901393414
these O 0 0.003237852593883872
disorders O 1 1.0
, O 0 0.0013243852881714702
we O 0 0.0010633142665028572
reviewed O 0 0.007053234614431858
the O 0 0.0016575780464336276
literature O 0 0.0025329827331006527
and O 0 0.0007839500322006643
obtained O 0 0.0022565145045518875
a O 0 0.004129818640649319
follow O 0 0.005983386654406786
- O 0 0.010173488408327103
up O 0 0.0019126010593026876
of O 0 0.0005920372204855084
the O 0 0.0012098858132958412
only O 0 0.0013245706213638186
two O 0 0.0017296957084909081
surviving O 1 0.9973565340042114
patients O 1 0.9999986886978149
, O 0 0.0014807519037276506
one O 0 0.0022138538770377636
with O 0 0.004715512506663799
SJS B-Disease 1 1.0
type I-Disease 1 0.9425579309463501
2 I-Disease 0 0.009943331591784954
at O 0 0.004464695230126381
age O 0 0.00829616840928793
10 O 0 0.003756880294531584
years O 0 0.0019788651261478662
and O 0 0.0008347752736881375
another O 0 0.008387453854084015
with O 0 0.0037636072374880314
SWS B-Disease 1 0.9999998807907104
at O 0 0.007892999798059464
age O 0 0.014007714577019215
7 O 0 0.013135375455021858
years O 0 0.005067385267466307
. O 0 0.004649303387850523

Patients O 1 0.9999628067016602
reported O 0 0.016154825687408447
as O 0 0.001983337802812457
having O 0 0.00931104552000761
either O 0 0.017991842702031136
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 0.021397562697529793
SWS B-Disease 1 0.9999988079071045
presented O 0 0.005614033434540033
a O 0 0.004389061592519283
combination O 0 0.01724410429596901
of O 0 0.0010411553084850311
a O 0 0.010551558807492256
severe O 1 1.0
, O 0 0.004403941333293915
prenatal O 1 0.9999998807907104
- O 1 0.9999221563339233
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 0.009272647090256214
with O 0 0.008224593475461006
congenital B-Disease 1 1.0
joint I-Disease 1 0.9998455047607422
contractures I-Disease 1 1.0
, O 0 0.013035058043897152
respiratory O 1 1.0
and O 0 0.0026270844973623753
feeding O 1 0.999629020690918
difficulties O 1 0.5914192199707031
, O 0 0.001829151762649417
tendency O 0 0.13573522865772247
to O 0 0.004075228236615658
hyperthermia B-Disease 1 0.9999996423721313
, O 0 0.0022150478325784206
and O 0 0.001456258469261229
frequent O 0 0.04638468474149704
death O 1 0.6358187198638916
in O 0 0.003802927676588297
infancy O 1 0.9995840191841125
) O 0 0.0021256792824715376
with O 0 0.000837171683087945
a O 0 0.005780465435236692
distinct O 0 0.022890275344252586
campomelic B-Disease 1 0.9999799728393555
- I-Disease 1 0.758270263671875
metaphyseal I-Disease 1 0.9999973773956299
skeletal I-Disease 1 0.9999982118606567
dysplasia I-Disease 1 1.0
. O 0 0.009859100915491581

The O 0 0.0049097067676484585
similarity O 0 0.01882254146039486
of O 0 0.0010187756270170212
the O 0 0.0034988485276699066
clinical O 1 0.9945499300956726
and O 0 0.002193886088207364
radiographic O 1 0.9993619322776794
findings O 0 0.009357172064483166
is O 0 0.002575599355623126
so O 0 0.0021028779447078705
extensive O 0 0.007909039035439491
that O 0 0.0011895750649273396
these O 0 0.0029085110872983932
disorders O 1 1.0
appear O 0 0.008666890673339367
to O 0 0.001030530664138496
be O 0 0.0014504214050248265
a O 0 0.005374221596866846
single O 0 0.016321297734975815
entity O 0 0.03271016478538513
. O 0 0.007498792838305235

The O 0 0.006055498030036688
follow O 0 0.008464391343295574
- O 0 0.013891615904867649
up O 0 0.0037825237959623337
observation O 0 0.014160984195768833
of O 0 0.0010697555262595415
an O 0 0.002050031442195177
identical O 0 0.007938962429761887
and O 0 0.0008253577980212867
unique O 0 0.004318963270634413
pattern O 0 0.020171474665403366
of O 0 0.0034007744397968054
progressive O 1 0.9999997615814209
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 0.002127627143636346
the O 0 0.00231655640527606
two O 0 0.003427261020988226
patients O 1 0.9999973773956299
( O 0 0.0039022075943648815
one O 0 0.002770255319774151
with O 0 0.004840615671128035
SJS B-Disease 1 1.0
type I-Disease 1 0.9819283485412598
2 I-Disease 0 0.008948071859776974
, O 0 0.0009110560058616102
one O 0 0.0025493281427770853
with O 0 0.003985414747148752
SWS B-Disease 1 0.999998927116394
) O 0 0.006718589924275875
surviving O 0 0.040148377418518066
beyond O 0 0.01632864400744438
infancy O 1 0.9990882873535156
adds O 0 0.017255572602152824
to O 0 0.0011398568749427795
the O 0 0.0014304890064522624
evidence O 0 0.0015263959066942334
in O 0 0.0012801703996956348
favor O 0 0.005460913758724928
of O 0 0.0016111142467707396
identity O 0 0.015254507772624493
. O 0 0.0049751694314181805

The O 0 0.005696028005331755
hypothesis O 0 0.0385788269340992
that O 0 0.0044817547313869
SWS B-Disease 1 0.9999991655349731
and O 0 0.010367217473685741
SJS B-Disease 1 1.0
type I-Disease 0 0.2975732386112213
2 I-Disease 0 0.007185340393334627
are O 0 0.000687704945448786
the O 0 0.0025784210301935673
same O 0 0.008360417559742928
disorder O 1 1.0
should O 0 0.003043504199013114
be O 0 0.0018092170357704163
testable O 0 0.04065670445561409
by O 0 0.0039014937356114388
molecular O 0 0.024724166840314865
methods O 0 0.004576075356453657
. O 0 0.0021510545630007982
. O 0 0.004391679540276527

A O 0 0.027958311140537262
mouse O 1 0.9978466033935547
model O 0 0.010303712449967861
of O 0 0.0030538609717041254
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 0.01282262708991766
defects O 1 0.9999988079071045
in O 0 0.004529848694801331
hemostasis O 1 1.0
and O 0 0.010558431036770344
thrombosis B-Disease 1 1.0
. O 0 0.007818344980478287

von B-Disease 1 0.99896240234375
Willebrand I-Disease 1 1.0
factor I-Disease 0 0.4273122549057007
( I-Disease 0 0.010012814775109291
vWf I-Disease 1 0.9999430179595947
) I-Disease 0 0.016457144170999527
deficiency I-Disease 1 1.0
causes O 1 1.0
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 0.004851543344557285
humans O 0 0.308110773563385
. O 0 0.0043882448226213455

We O 0 0.003917238209396601
generated O 0 0.012484132312238216
a O 0 0.011250377632677555
mouse O 1 0.9843807220458984
model O 0 0.008174518123269081
for O 0 0.0014460226520895958
this O 0 0.004500481765717268
disease O 1 1.0
by O 0 0.003440306754782796
using O 0 0.005793980322778225
gene O 1 0.9963249564170837
targeting O 0 0.03559667989611626
. O 0 0.005518990568816662

vWf B-Disease 1 0.9991633892059326
- I-Disease 1 0.5836744904518127
deficient I-Disease 1 0.9999711513519287
mice O 1 0.9997649788856506
appeared O 0 0.018950864672660828
normal O 0 0.022822437807917595
at O 0 0.006145074963569641
birth O 1 0.6565067768096924
; O 0 0.0021779744420200586
they O 0 0.0009042795281857252
were O 0 0.0016237738309428096
viable O 0 0.03616541251540184
and O 0 0.00290581863373518
fertile O 0 0.08526938408613205
. O 0 0.006498217117041349

Neither O 0 0.043675363063812256
vWf O 1 0.9986807703971863
nor O 0 0.03821524605154991
vWf O 1 0.9996352195739746
propolypeptide O 1 0.9996923208236694
( O 0 0.017153266817331314
von B-Disease 1 0.9995802044868469
Willebrand I-Disease 1 1.0
antigen O 1 0.9999892711639404
II O 1 0.9993645548820496
) O 0 0.003480353392660618
were O 0 0.0019319657003507018
detectable O 0 0.37253275513648987
in O 0 0.002341171493753791
plasma O 0 0.05172450840473175
, O 0 0.0029731348622590303
platelets O 1 0.9999195337295532
, O 0 0.0024053938686847687
or O 0 0.005902039352804422
endothelial O 1 0.9999665021896362
cells O 0 0.029868395999073982
of O 0 0.0012529226951301098
the O 0 0.005350818857550621
homozygous O 1 0.9999874830245972
mutant O 1 0.9999667406082153
mice O 1 0.9997666478157043
. O 0 0.005841712933033705

The O 0 0.01297196839004755
mutant O 1 0.9999003410339355
mice O 1 0.9998589754104614
exhibited O 0 0.1024395078420639
defects O 1 0.9999346733093262
in O 0 0.0031594785396009684
hemostasis O 1 0.9999955892562866
with O 0 0.0017039005178958178
a O 0 0.006451408378779888
highly O 0 0.029896384105086327
prolonged O 1 0.9999995231628418
bleeding O 1 1.0
time O 0 0.005005226004868746
and O 0 0.0025819106958806515
spontaneous O 1 0.999950647354126
bleeding O 1 1.0
events O 0 0.007113325409591198
in O 0 0.0016701322747394443
approximately O 0 0.007204659283161163
10 O 0 0.004750758875161409
% O 0 0.0036269440315663815
of O 0 0.0034398820716887712
neonates O 1 0.9999715089797974
. O 0 0.007165013812482357

As O 0 0.0029529286548495293
in O 0 0.001378617133013904
the O 0 0.0033152131363749504
human O 0 0.11268855631351471
disease O 1 1.0
, O 0 0.0016238309908658266
the O 0 0.003073484404012561
factor O 1 0.8644193410873413
VIII O 1 0.9999953508377075
level O 0 0.004670609720051289
in O 0 0.001239644712768495
these O 0 0.001896976144053042
mice O 1 0.9998688697814941
was O 0 0.008852148428559303
reduced O 0 0.024302583187818527
strongly O 0 0.006301494315266609
as O 0 0.0015824204310774803
a O 0 0.003987400326877832
result O 0 0.005719406064599752
of O 0 0.0008043491397984326
the O 0 0.0017594401724636555
lack O 0 0.006624407600611448
of O 0 0.0012627695687115192
protection O 0 0.011507824994623661
provided O 0 0.00379876047372818
by O 0 0.007832508534193039
vWf O 1 0.9998078942298889
. O 0 0.00788875948637724

Defective O 1 0.9999961853027344
thrombosis B-Disease 1 1.0
in O 0 0.009990539401769638
mutant O 1 0.9999889135360718
mice O 1 0.999954104423523
was O 0 0.006704374216496944
also O 0 0.0015561135951429605
evident O 0 0.011213318444788456
in O 0 0.0008413589675910771
an O 0 0.0011462386464700103
in O 0 0.0015055512776598334
vivo O 0 0.0723193883895874
model O 0 0.008875415660440922
of O 0 0.005112652666866779
vascular B-Disease 1 1.0
injury I-Disease 1 0.9999998807907104
. O 0 0.0066930982284247875

In O 0 0.00299902749247849
this O 0 0.001583187491632998
model O 0 0.005569774191826582
, O 0 0.0011514764046296477
the O 0 0.0038687163032591343
exteriorized O 1 0.9999121427536011
mesentery O 1 0.9998449087142944
was O 0 0.01899867132306099
superfused O 1 0.9980018734931946
with O 0 0.006925265304744244
ferric O 1 0.9998986721038818
chloride O 0 0.12401755154132843
and O 0 0.0011723488569259644
the O 0 0.0022025839425623417
accumulation O 0 0.05588801950216293
of O 0 0.0035246824845671654
fluorescently O 1 0.9999459981918335
labeled O 1 0.8533609509468079
platelets O 1 0.9992297887802124
was O 0 0.010996833443641663
observed O 0 0.01217400562018156
by O 0 0.004944718908518553
intravital O 1 0.9991071820259094
microscopy O 0 0.06960508972406387
. O 0 0.006364502478390932

We O 0 0.003749917494133115
conclude O 0 0.012079084292054176
that O 0 0.001153149758465588
these O 0 0.0015854707453399897
mice O 1 0.9971243739128113
very O 0 0.0039057782851159573
closely O 0 0.008024190552532673
mimic O 1 0.999860405921936
severe O 1 1.0
human O 0 0.1394949108362198
von B-Disease 1 0.9999998807907104
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 0.001876405207440257
will O 0 0.0009544210624881089
be O 0 0.0010141772218048573
very O 0 0.0021584033966064453
useful O 0 0.003168291412293911
for O 0 0.001366422395221889
investigating O 0 0.009405620396137238
the O 0 0.0018032315419986844
role O 0 0.007046510931104422
of O 0 0.0025326034519821405
vWf O 1 0.9993863105773926
in O 0 0.003200701205059886
normal O 0 0.03158761188387871
physiology O 1 0.9881932139396667
and O 0 0.0015195191372185946
in O 0 0.00477979751303792
disease O 1 1.0
models O 0 0.011271604336798191
. O 0 0.0021276057232171297
. O 0 0.0041294340044260025

Oral O 0 0.10653603821992874
contraceptives O 1 0.6602246761322021
and O 0 0.0009655387839302421
the O 0 0.0026935646310448647
risk O 1 0.9916669726371765
of O 0 0.006161559373140335
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.009748240001499653

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.9996311664581299
Study O 0 0.007469411939382553
Group O 0 0.00860427413135767
. O 0 0.00382806733250618

BACKGROUND O 0 0.027685046195983887
Women O 0 0.007870828732848167
with O 0 0.00270042079500854
mutations O 1 0.9996627569198608
in O 0 0.0014148966874927282
either O 0 0.002679083961993456
the O 0 0.00485165836289525
BRCA1 O 1 1.0
or O 0 0.005150934215635061
the O 0 0.007170378230512142
BRCA2 O 1 1.0
gene O 1 0.99967360496521
have O 0 0.001783700194209814
a O 0 0.003755818819627166
high O 0 0.006954180542379618
lifetime O 0 0.33432385325431824
risk O 1 0.9998044371604919
of O 0 0.015702396631240845
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.008399304933845997

Oral O 0 0.3552533984184265
contraceptives O 1 0.9993688464164734
protect O 0 0.1685258448123932
against O 1 0.8475574254989624
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.0025242993142455816
general O 0 0.004801249131560326
, O 0 0.0011303367791697383
but O 0 0.001269631669856608
it O 0 0.0011057098163291812
is O 0 0.0019673898350447416
not O 0 0.0011591126676648855
known O 0 0.006163346115499735
whether O 0 0.0018992831464856863
they O 0 0.0006954557611607015
also O 0 0.0011157314293086529
protect O 0 0.008796191774308681
against O 0 0.005985416937619448
hereditary B-Disease 1 0.9999967813491821
forms I-Disease 0 0.014022711664438248
of I-Disease 0 0.02266596257686615
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.008292688056826591

METHODS O 0 0.01266947016119957
We O 0 0.0028166226111352444
enrolled O 0 0.03367214277386665
207 O 1 0.5067999362945557
women O 0 0.011119905859231949
with O 0 0.007058045361191034
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.0032768938690423965
161 O 0 0.04113595187664032
of O 0 0.001202683662995696
their O 0 0.0017334899166598916
sisters O 0 0.027640707790851593
as O 0 0.0018378812819719315
controls O 0 0.0117950439453125
in O 0 0.0010411265539005399
a O 0 0.005814498756080866
case O 0 0.011029147543013096
- O 0 0.025428395718336105
control O 0 0.02246650867164135
study O 0 0.006901935674250126
. O 0 0.004608078394085169

All O 0 0.002347312867641449
the O 0 0.0047784000635147095
patients O 1 0.99988853931427
carried O 0 0.007894927635788918
a O 0 0.009463207796216011
pathogenic O 1 0.9999630451202393
mutation O 1 0.9999798536300659
in O 0 0.002929868409410119
either O 0 0.014271424151957035
BRCA1 O 1 1.0
( O 0 0.00947924517095089
179 O 0 0.45747455954551697
women O 0 0.009519536048173904
) O 0 0.004714912734925747
or O 0 0.01126930397003889
BRCA2 O 1 1.0
( O 0 0.011979872360825539
28 O 0 0.019348949193954468
women O 0 0.009569386951625347
) O 0 0.00395626574754715
. O 0 0.004086526110768318

The O 0 0.007524481508880854
control O 0 0.028700456023216248
women O 0 0.005961814895272255
were O 0 0.0018170166295021772
enrolled O 0 0.023288758471608162
regardless O 0 0.006461594719439745
of O 0 0.0008874708437360823
whether O 0 0.0021141034085303545
or O 0 0.0018020302522927523
not O 0 0.0007816263823769987
they O 0 0.0008710609981790185
had O 0 0.003803288796916604
either O 0 0.010105433873832226
mutation O 1 0.9999746084213257
. O 0 0.007114183157682419

Lifetime O 0 0.07224295288324356
histories O 0 0.033622197806835175
of O 0 0.0031734926160424948
oral O 0 0.3620440363883972
- O 0 0.049633853137493134
contraceptive O 1 0.9997171759605408
use O 0 0.0024298790376633406
were O 0 0.0010322955204173923
obtained O 0 0.0024007451720535755
by O 0 0.0022785759065300226
interview O 0 0.008808501996099949
or O 0 0.002513403072953224
by O 0 0.002168819308280945
written O 0 0.0028708036988973618
questionnaire O 0 0.02940075844526291
and O 0 0.0009482915047556162
were O 0 0.0014184943865984678
compared O 0 0.010904214344918728
between O 0 0.005542674567550421
patients O 1 0.9999977350234985
and O 0 0.0019158862996846437
control O 0 0.06214418634772301
women O 0 0.006808137986809015
, O 0 0.001734699122607708
after O 0 0.009529300965368748
adjustment O 0 0.02976878173649311
for O 0 0.0011785373790189624
year O 0 0.002739989198744297
of O 0 0.001580079784616828
birth O 0 0.23453880846500397
and O 0 0.0019210284808650613
parity O 0 0.055686503648757935
. O 0 0.004934066906571388

RESULTS O 0 0.021594518795609474
The O 0 0.004260865971446037
adjusted O 0 0.022113610059022903
odds O 0 0.0446203276515007
ratio O 0 0.041533052921295166
for O 0 0.01935655251145363
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 0.009387306869029999
with O 0 0.0010129169095307589
any O 0 0.001467422116547823
past O 0 0.0028148109558969736
use O 0 0.0017888457514345646
of O 0 0.0018319007940590382
oral O 0 0.2493259310722351
contraceptives O 1 0.9989295601844788
was O 0 0.014090628363192081
0 O 0 0.029939481988549232
. O 0 0.004607437178492546

5 O 0 0.02529621683061123
( O 0 0.005589410662651062
95 O 0 0.018900766968727112
percent O 0 0.007857746444642544
confidence O 0 0.01974118873476982
interval O 0 0.05899098888039589
, O 0 0.0028782659210264683
0 O 0 0.02277465909719467
. O 0 0.0020054620690643787
3 O 0 0.0074974666349589825
to O 0 0.0018608635291457176
0 O 0 0.023219073191285133
. O 0 0.002490066224709153
8 O 0 0.015604705549776554
) O 0 0.0037327734753489494
. O 0 0.004304383881390095

The O 0 0.012120071798563004
risk O 1 0.989538848400116
decreased O 0 0.07335808873176575
with O 0 0.0018909942591562867
increasing O 0 0.012625031173229218
duration O 0 0.03259357810020447
of O 0 0.0011014336487278342
use O 0 0.003081987611949444
( O 0 0.0064176470041275024
P O 1 0.9703893065452576
for O 0 0.0023889667354524136
trend O 0 0.03144657611846924
, O 0 0.003977678716182709
< O 1 0.977403998374939
0 O 0 0.035537928342819214
. O 0 0.004064895212650299
001 O 1 0.9690486192703247
) O 0 0.004621877800673246
; O 0 0.0016536044422537088
use O 0 0.0012136629084125161
for O 0 0.0009461399749852717
six O 0 0.0027269097045063972
or O 0 0.002373805968090892
more O 0 0.0014902252005413175
years O 0 0.004102743696421385
was O 0 0.006220314186066389
associated O 0 0.005403605755418539
with O 0 0.0008655833662487566
a O 0 0.005636448971927166
60 O 0 0.01070247869938612
percent O 0 0.010043309070169926
reduction O 0 0.030038950964808464
in O 0 0.004228790290653706
risk O 1 0.9922493696212769
. O 0 0.00568127166479826

Oral O 0 0.10480023175477982
- O 0 0.05206332355737686
contraceptive O 1 0.9990063309669495
use O 0 0.004802543204277754
protected O 0 0.02580670826137066
against O 0 0.3993472158908844
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 0.0018760488601401448
for O 0 0.0013860083417966962
carriers O 0 0.04939388856291771
of O 0 0.0013578623766079545
the O 0 0.008203809149563313
BRCA1 O 1 1.0
mutation O 1 0.9999995231628418
( O 0 0.007036185823380947
odds O 0 0.06124247610569
ratio O 0 0.029069984331727028
, O 0 0.0026068896986544132
0 O 0 0.023933913558721542
. O 0 0.002402624348178506
5 O 0 0.00935401115566492
; O 0 0.002607829635962844
95 O 0 0.01344209536910057
percent O 0 0.006809431128203869
confidence O 0 0.02393755130469799
interval O 0 0.05641678348183632
, O 0 0.003666888689622283
0 O 0 0.024258652701973915
. O 0 0.002058458747342229
3 O 0 0.007662901189178228
to O 0 0.0024093526881188154
0 O 0 0.02359766699373722
. O 0 0.0024414812214672565
9 O 0 0.012677841819822788
) O 0 0.0017829625867307186
and O 0 0.0006346699083223939
for O 0 0.001137358951382339
carriers O 0 0.041715171188116074
of O 0 0.00120792374946177
the O 0 0.00804680585861206
BRCA2 O 1 1.0
mutation O 1 0.9999988079071045
( O 0 0.008638041093945503
odds O 0 0.07007557898759842
ratio O 0 0.028704019263386726
, O 0 0.0024464826565235853
0 O 0 0.02144443430006504
. O 0 0.002425198210403323
4 O 0 0.010614816099405289
; O 0 0.003061989787966013
95 O 0 0.017902785912156105
percent O 0 0.009531335905194283
confidence O 0 0.024897731840610504
interval O 0 0.05021602287888527
, O 0 0.0030208302196115255
0 O 0 0.02323705330491066
. O 0 0.0021037764381617308
2 O 0 0.006646317895501852
to O 0 0.001649299287237227
1 O 0 0.010603143833577633
. O 0 0.002559537533670664
1 O 0 0.01374435517936945
) O 0 0.003911086358129978
. O 0 0.004455819260329008

CONCLUSIONS O 0 0.038781095296144485
Oral O 0 0.09874409437179565
- O 0 0.05582980811595917
contraceptive O 1 0.9999111890792847
use O 0 0.003394829109311104
may O 0 0.005327546037733555
reduce O 0 0.012922181747853756
the O 0 0.003846864914521575
risk O 1 0.9990624785423279
of O 0 0.012571237981319427
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.002245038514956832
women O 0 0.004111407324671745
with O 0 0.0024910198990255594
pathogenic O 1 0.999998927116394
mutations O 1 0.9999808073043823
in O 0 0.0014164032181724906
the O 0 0.005593218374997377
BRCA1 O 1 1.0
or O 0 0.028165306895971298
BRCA2 O 1 1.0
gene O 1 0.9997856020927429

A O 0 0.024424199014902115
Japanese O 0 0.012399925850331783
family O 0 0.014287545345723629
with O 0 0.004269605968147516
adrenoleukodystrophy B-Disease 1 1.0
with O 0 0.0030991178937256336
a O 0 0.011389637365937233
codon O 1 0.9731283783912659
291 O 1 0.913884699344635
deletion O 1 0.9943912625312805
: O 0 0.004045344423502684
a O 0 0.007074636407196522
clinical O 1 0.9968835711479187
, O 0 0.002076432341709733
biochemical O 0 0.07765491306781769
, O 0 0.0022350940853357315
pathological O 1 0.9996863603591919
, O 0 0.00132128712721169
and O 0 0.0016108948038890958
genetic O 1 0.5515956282615662
report O 0 0.004089299123734236
. O 0 0.00368047715164721

We O 0 0.0020889760926365852
report O 0 0.002219798509031534
a O 0 0.004667359869927168
Japanese O 0 0.01025149505585432
family O 0 0.017317239195108414
with O 0 0.008152365684509277
adrenoleukodystrophy B-Disease 1 1.0
( O 0 0.09529490768909454
ALD B-Disease 1 1.0
) O 0 0.0044526900164783
with O 0 0.0010689673945307732
a O 0 0.003873916808515787
three O 0 0.001986871939152479
base O 0 0.012252379208803177
pair O 0 0.021117405965924263
deletion O 1 0.997734546661377
( O 0 0.011450458317995071
delGAG O 1 0.9996446371078491
291 O 1 0.7450916767120361
) O 0 0.0030134418047964573
in O 0 0.0018074543913826346
the O 0 0.009472854435443878
ALD B-Disease 1 1.0
gene O 1 0.999790370464325
. O 0 0.0069043939001858234

A O 0 0.019836416468024254
variety O 0 0.006094874814152718
of O 0 0.0024765285197645426
phenotypes O 1 0.9999486207962036
were O 0 0.002294728299602866
observed O 0 0.010228848084807396
within O 0 0.0018155764555558562
this O 0 0.0018507782369852066
family O 0 0.012873154133558273
. O 0 0.004149070009589195

While O 0 0.005446977447718382
the O 0 0.005751405842602253
proband O 1 0.9998123049736023
( O 0 0.013401603326201439
patient O 1 0.999985933303833
1 O 0 0.01447566319257021
) O 0 0.002651676768437028
was O 0 0.005166598130017519
classified O 0 0.008039668202400208
as O 0 0.0016338224522769451
having O 0 0.0055432310327887535
a O 0 0.0061851441860198975
rare O 0 0.020811058580875397
intermediate O 0 0.030804449692368507
type O 0 0.02683955803513527
of O 0 0.002265429822728038
adult O 1 0.994744062423706
cerebral O 1 1.0
and O 0 0.0040839365683496
cerebello O 1 0.9999992847442627
- O 1 0.9991970658302307
brain O 1 0.9999997615814209
stem O 0 0.4591049253940582
forms O 0 0.006431904621422291
, O 0 0.001195013988763094
his O 0 0.004550865385681391
younger O 1 0.804931640625
brother O 1 0.9179267883300781
( O 0 0.01035020500421524
patient O 1 0.9999910593032837
2 O 0 0.013463898561894894
) O 0 0.0026993746869266033
and O 0 0.0019204783020541072
nephew O 1 0.9999456405639648
( O 0 0.010186168365180492
patient O 1 0.999984860420227
3 O 0 0.010931149125099182
) O 0 0.001962547656148672
had O 0 0.003807847620919347
a O 0 0.014347086660563946
childhood O 1 0.9999940395355225
ALD B-Disease 1 1.0
type O 1 0.8084120154380798
. O 0 0.006694873794913292

Another O 0 0.039787206798791885
nephew O 1 0.9986850619316101
( O 0 0.013133070431649685
patient O 1 0.9998900890350342
4 O 0 0.015107494778931141
) O 0 0.0022181314416229725
of O 0 0.001982396934181452
patient O 1 0.9999754428863525
1 O 0 0.010438011959195137
was O 0 0.0059240893460810184
classified O 0 0.00804060511291027
as O 0 0.0020168889313936234
having O 0 0.006650619208812714
an O 0 0.004713836591690779
adolescent O 1 0.9998563528060913
form O 0 0.015450011938810349
. O 0 0.005028046667575836

The O 0 0.01018642820417881
tau O 1 0.8658426403999329
level O 0 0.004200434777885675
in O 0 0.0013364300830289721
the O 0 0.005197872407734394
cerebrospinal O 1 0.9999992847442627
fluid O 1 0.9960681200027466
( O 0 0.010699968785047531
CSF O 1 0.9999911785125732
) O 0 0.0037663509137928486
in O 0 0.00299080484546721
patient O 1 0.9999814033508301
1 O 0 0.011029443703591824
was O 0 0.004497423302382231
as O 0 0.0012338778469711542
high O 0 0.0032079785596579313
as O 0 0.0009548277594149113
that O 0 0.00068209960591048
of O 0 0.0020502733532339334
patients O 1 1.0
with O 0 0.030500715598464012
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.012413615360856056
AD B-Disease 1 0.9794233441352844
) O 0 0.00495135085657239
. O 0 0.0040970658883452415

His O 0 0.01771475560963154
brain O 1 0.9999752044677734
magnetic O 0 0.03869221359491348
resonance O 0 0.07299897819757462
image O 0 0.04056338965892792
( O 0 0.009755966253578663
MRI O 1 0.9999681711196899
) O 0 0.004865618422627449
showed O 0 0.015185446478426456
abnormalities B-Disease 1 0.9999552965164185
in I-Disease 0 0.0010211358312517405
the I-Disease 0 0.0016459492035210133
bilateral I-Disease 0 0.01042302418500185
cerebellar I-Disease 1 0.9999985694885254
hemispheres I-Disease 1 0.999840497970581
and O 0 0.006727365776896477
brain O 1 1.0
stem O 1 0.9949058294296265
, O 0 0.001376529922708869
but O 0 0.0009573503630235791
not O 0 0.0008159399731084704
in O 0 0.0012282422976568341
the O 0 0.006562794558703899
cerebral O 1 1.0
white O 0 0.015392721630632877
matter O 0 0.0040802122093737125
, O 0 0.0011986764147877693
where O 0 0.0020038464572280645
marked O 0 0.014483937062323093
reductions O 0 0.01467135176062584
of O 0 0.0012302440591156483
the O 0 0.006752705667167902
cerebral O 1 1.0
blood O 1 0.9993226528167725
flow O 0 0.020976116880774498
and O 0 0.0030460951384156942
oxygen O 1 0.6712745428085327
metabolism O 1 0.9790810942649841
were O 0 0.0023023237008601427
clearly O 0 0.005806480534374714
demonstrated O 0 0.00861644372344017
by O 0 0.004900013096630573
positron O 1 0.9981845021247864
emission O 0 0.1278901845216751
tomography O 1 0.9482994675636292
( O 0 0.014496942982077599
PET O 1 0.9999390840530396
) O 0 0.00632579205557704
. O 0 0.004208212718367577

In O 0 0.011178852990269661
patients O 1 0.9999734163284302
2 O 0 0.011396070942282677
and O 0 0.0013938447227701545
3 O 0 0.008056971244513988
, O 0 0.0009937993017956614
the O 0 0.0023468583822250366
autopsy O 1 0.8896512389183044
findings O 0 0.009834789671003819
showed O 0 0.012171001173555851
massive O 0 0.16740015149116516
demyelination B-Disease 1 0.9999992847442627
of I-Disease 0 0.003463225904852152
the I-Disease 0 0.007992076687514782
cerebral I-Disease 1 1.0
white I-Disease 0 0.013558894395828247
matter I-Disease 0 0.0027797850780189037
with O 0 0.0010973676107823849
sparing O 0 0.17504344880580902
of O 0 0.0013779267901554704
the O 0 0.004456752445548773
U O 1 0.9986335635185242
- O 0 0.04536757245659828
fibers O 0 0.16337327659130096
, O 0 0.0018139370949938893
compatible O 0 0.009577751159667969
with O 0 0.0007116502965800464
the O 0 0.0014091862831264734
findings O 0 0.006886010058224201
of O 0 0.0033813558984547853
childhood O 1 0.999997615814209
ALD B-Disease 1 1.0
. O 0 0.011572899296879768

Oleic O 1 0.9769212603569031
and O 0 0.010104290209710598
erucic O 1 0.9987755417823792
acids O 0 0.09818962216377258
( O 0 0.008289864286780357
Lorenzos O 1 0.9958949089050293
Oil O 0 0.01472460012882948
) O 0 0.0025444449856877327
were O 0 0.0013696495443582535
administered O 0 0.08707895874977112
to O 0 0.0043069408275187016
patients O 1 0.9999853372573853
1 O 0 0.011580243706703186
and O 0 0.0015243587549775839
4 O 0 0.008566082455217838
, O 0 0.0009698600042611361
but O 0 0.0013535975012928247
sufficient O 0 0.00773251848295331
effectiveness O 0 0.03814639896154404
was O 0 0.005501958541572094
not O 0 0.0015031698858365417
obtained O 0 0.003379350993782282
. O 0 0.004344497341662645

The O 0 0.005088283680379391
findings O 0 0.008913591504096985
in O 0 0.0013740669237449765
this O 0 0.001964797265827656
family O 0 0.011269611306488514
suggest O 0 0.00804885383695364
that O 0 0.002170926658436656
delGAG291 O 1 0.9990397095680237
is O 0 0.002604037057608366
part O 0 0.0023893178440630436
of O 0 0.0007884172373451293
the O 0 0.002552218036726117
cause O 1 0.9563784599304199
of O 0 0.0020831036381423473
Japanese O 0 0.061563119292259216
ALD B-Disease 1 1.0
with O 0 0.00722535140812397
phenotypic O 1 0.999572217464447
variations O 0 0.02338925190269947
. O 0 0.004053253680467606

Moreover O 0 0.02356242947280407
, O 0 0.0017042825929820538
although O 0 0.002184458775445819
the O 0 0.0013426501536741853
scale O 0 0.00525595573708415
of O 0 0.0008098122198134661
the O 0 0.0021897158585488796
study O 0 0.003692624857649207
is O 0 0.003262992249801755
limited O 0 0.005563339218497276
, O 0 0.0011606320040300488
there O 0 0.001181700499728322
is O 0 0.0021225137170404196
a O 0 0.004441660828888416
possibility O 0 0.011233783327043056
that O 0 0.002082294784486294
PET O 1 0.9998356103897095
can O 0 0.004013200756162405
detect O 0 0.04140041023492813
an O 0 0.0068514361046254635
insidious B-Disease 1 0.9999954700469971
lesion I-Disease 1 0.9999996423721313
which O 0 0.0033915103413164616
is O 0 0.0044470117427408695
undetectable O 1 0.8266273736953735
by O 0 0.00527976593002677
computed O 0 0.09952200949192047
tomogram O 1 0.9978662133216858
( O 0 0.017987698316574097
CT O 1 0.9999969005584717
) O 0 0.00634247250854969
or O 0 0.006172033492475748
MRI O 1 0.9985478520393372
analysis O 0 0.005776611156761646
, O 0 0.0010024966904893517
and O 0 0.0006397746619768441
that O 0 0.0005768706905655563
the O 0 0.0015668924897909164
higher O 0 0.004772557877004147
level O 0 0.00384855130687356
of O 0 0.002366396365687251
tau O 1 0.9993935823440552
reflects O 0 0.008770539425313473
the O 0 0.0013568848371505737
process O 0 0.0029048349242657423
of O 0 0.0032987748272717
neuronal B-Disease 1 0.9999566078186035
degeneration I-Disease 1 1.0
in O 0 0.013409972190856934
ALD B-Disease 1 1.0
. O 0 0.010341564193367958

Lorenzos O 1 0.9971672892570496
Oil O 0 0.013782771304249763
should O 0 0.0024453934747725725
be O 0 0.0011995009845122695
given O 0 0.0022258679382503033
in O 0 0.0009494255646131933
the O 0 0.001881095115095377
early O 0 0.009386301040649414
stage O 0 0.023732829838991165
. O 0 0.00240358361043036
. O 0 0.003787621157243848

Nonsense O 0 0.3402613401412964
mutation O 1 0.9985800981521606
in O 0 0.004909522831439972
exon O 1 0.9892547130584717
4 O 0 0.009902242571115494
of O 0 0.001499996054917574
human O 0 0.011745093390345573
complement O 0 0.0558689720928669
C9 O 1 0.9999903440475464
gene O 1 0.9940500855445862
is O 0 0.002638774923980236
the O 0 0.00201434176415205
major O 0 0.0105627765879035
cause O 0 0.14052368700504303
of O 0 0.0013589521404355764
Japanese O 0 0.012198165990412235
complement B-Disease 0 0.4652622938156128
C9 I-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
. O 0 0.008751966990530491

Deficiency B-Disease 1 0.9999997615814209
of I-Disease 0 0.002372049493715167
the I-Disease 0 0.0025951997376978397
ninth I-Disease 0 0.04162066429853439
component I-Disease 0 0.02285640873014927
of I-Disease 0 0.0016704743029549718
human I-Disease 0 0.010808929800987244
complement I-Disease 0 0.034840017557144165
( O 0 0.01144611369818449
C9 O 1 0.9999982118606567
) O 0 0.003296911483630538
is O 0 0.001805305713787675
the O 0 0.0014482125407084823
most O 0 0.0023844274692237377
common O 0 0.017471378669142723
complement B-Disease 1 0.9993144273757935
deficiency I-Disease 1 1.0
in O 0 0.0028818477876484394
Japan O 0 0.004465700127184391
but O 0 0.002010480035096407
is O 0 0.0027698890771716833
rare O 0 0.014040999114513397
in O 0 0.0010264120064675808
other O 0 0.0007129210862331092
countries O 0 0.0012673868332058191
. O 0 0.003713401034474373

We O 0 0.0030838269740343094
studied O 0 0.0035483387764543295
the O 0 0.0018454213859513402
molecular O 0 0.015327167697250843
basis O 0 0.002075582044199109
of O 0 0.004113242495805025
C9 B-Disease 1 0.9999997615814209
deficiency I-Disease 1 1.0
in O 0 0.002190585946664214
four O 0 0.002590577583760023
Japanese O 0 0.019206224009394646
C9 B-Disease 1 0.9999995231628418
- I-Disease 1 0.9919398427009583
deficient I-Disease 1 0.9999992847442627
patients O 1 0.9999994039535522
who O 0 0.004733899142593145
had O 0 0.010522902943193913
suffered O 1 1.0
from O 0 0.022467512637376785
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 0.010978106409311295

Direct O 0 0.019100651144981384
sequencing O 0 0.05859393626451492
of O 0 0.0037572660949081182
amplified O 0 0.17473094165325165
C9 O 1 0.9997307658195496
cDNA O 0 0.15161587297916412
and O 0 0.003082266077399254
DNA O 0 0.03779751807451248
revealed O 0 0.015800917521119118
a O 0 0.008077981881797314
nonsense O 0 0.05340581387281418
substitution O 0 0.06280593574047089
( O 0 0.007070430554449558
CGA O 0 0.1960001140832901
- O 0 0.052537497133016586
- O 0 0.07118706405162811
> O 1 0.9959889054298401
TGA O 1 0.9999872446060181
) O 0 0.004818463698029518
at O 0 0.0054734935984015465
codon O 0 0.23681393265724182
95 O 0 0.020739611238241196
in O 0 0.002873392542824149
exon O 1 0.9923961758613586
4 O 0 0.008347437717020512
in O 0 0.0010011537233367562
the O 0 0.0017996064852923155
four O 0 0.006748318672180176
C9 B-Disease 1 0.9999947547912598
- I-Disease 1 0.5158147811889648
deficient I-Disease 1 0.999834418296814
individuals O 0 0.007975513115525246
. O 0 0.004909825045615435

An O 0 0.013099553994834423
allele O 1 0.9996827840805054
- O 0 0.0361182726919651
specific O 0 0.010764934122562408
polymerase O 1 0.96468585729599
chain O 0 0.30297356843948364
reaction O 0 0.03257451578974724
system O 0 0.0092306574806571
designed O 0 0.005345902405679226
to O 0 0.0018062706803902984
detect O 0 0.038744259625673294
exclusively O 0 0.004133210517466068
only O 0 0.001228821580298245
one O 0 0.0011244586203247309
of O 0 0.0006853296072222292
the O 0 0.002414779970422387
normal O 0 0.01946774683892727
and O 0 0.0031574175227433443
mutant O 1 0.9999133348464966
alleles O 1 0.9999785423278809
indicated O 0 0.010019206441938877
that O 0 0.0007447467651218176
all O 0 0.0004523328971117735
the O 0 0.0015325024724006653
four O 0 0.003878046292811632
patients O 1 0.9999748468399048
were O 0 0.0029796441085636616
homozygous O 1 0.9998613595962524
for O 0 0.0017331971321254969
the O 0 0.0043731252662837505
mutation O 1 0.9999617338180542
in O 0 0.0038376622833311558
exon O 1 0.9994915723800659
4 O 0 0.011291341856122017
and O 0 0.0008761072531342506
that O 0 0.0007282831356860697
the O 0 0.0016384668415412307
parents O 0 0.009062116965651512
of O 0 0.002507563913241029
patient O 1 0.9999985694885254
2 O 0 0.008552385494112968
were O 0 0.0031650459859520197
heterozygous O 1 0.99982750415802
. O 0 0.005892554298043251

The O 0 0.006136100273579359
common O 0 0.018808791413903236
mutation O 1 0.9999414682388306
at O 0 0.008103306405246258
codon O 1 0.5862412452697754
95 O 0 0.01920282654464245
in O 0 0.0036691119894385338
exon O 1 0.9986308217048645
4 O 0 0.014526259154081345
might O 0 0.005444252863526344
be O 0 0.0014360497007146478
responsible O 0 0.007803403772413731
for O 0 0.0011052750051021576
most O 0 0.003856975119560957
Japanese O 0 0.03386467695236206
C9 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.004428684711456299
. O 0 0.0039245192892849445

BRCA1 O 1 0.9999982118606567
required O 0 0.007135163992643356
for O 0 0.0022364810574799776
transcription O 0 0.18309180438518524
- O 0 0.02928551472723484
coupled O 0 0.0438632033765316
repair O 0 0.4483078122138977
of O 0 0.004657162819057703
oxidative O 1 0.9999074935913086
DNA O 0 0.10421153903007507
damage O 1 0.9250643849372864
. O 0 0.0064308964647352695

The O 0 0.01712164469063282
breast B-Disease 1 1.0
and I-Disease 0 0.35965660214424133
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.9999996423721313
gene O 1 0.9999821186065674
BRCA1 O 1 0.9999998807907104
encodes O 1 0.526242196559906
a O 0 0.016115251928567886
zinc O 1 0.9759830832481384
finger O 1 0.8500005006790161
protein O 0 0.05175759270787239
of O 0 0.0018524754559621215
unknown O 0 0.018702438101172447
function O 0 0.01858655922114849
. O 0 0.004226828459650278

Association O 0 0.015671605244278908
of O 0 0.0017252250108867884
the O 0 0.008905195631086826
BRCA1 O 1 1.0
protein O 0 0.06619634479284286
with O 0 0.0012707386631518602
the O 0 0.0036300611682236195
DNA O 0 0.0777178406715393
repair O 1 0.9933907985687256
protein O 0 0.15045492351055145
Rad51 O 1 0.9998119473457336
and O 0 0.0023595953825861216
changes O 0 0.004189439583569765
in O 0 0.0009544329368509352
the O 0 0.0024564466439187527
phosphorylation O 0 0.06727557629346848
and O 0 0.001996953273192048
cellular O 0 0.051012005656957626
localization O 0 0.04456532374024391
of O 0 0.0009426397737115622
the O 0 0.003153624013066292
protein O 0 0.06404922902584076
after O 0 0.01295367069542408
exposure O 1 0.5797309875488281
to O 0 0.0026863969396799803
DNA O 0 0.05664724111557007
- O 0 0.03617056831717491
damaging O 0 0.11334700882434845
agents O 0 0.009235503152012825
are O 0 0.000848064199090004
consistent O 0 0.0066218385472893715
with O 0 0.0009142616763710976
a O 0 0.004142087418586016
role O 0 0.008698632940649986
for O 0 0.004717753268778324
BRCA1 O 1 1.0
in O 0 0.0037445719353854656
DNA O 0 0.06379126757383347
repair O 1 0.9783907532691956
. O 0 0.006822539027780294

Here O 0 0.003257917007431388
, O 0 0.0009709529113024473
it O 0 0.0009755493956618011
is O 0 0.0017510042525827885
shown O 0 0.00399259477853775
that O 0 0.002261639107018709
mouse O 1 0.9999572038650513
embryonic O 1 0.970867395401001
stem O 1 0.8679450154304504
cells O 0 0.26002237200737
deficient B-Disease 1 0.9998780488967896
in I-Disease 0 0.0062889778055250645
BRCA1 I-Disease 1 1.0
are O 0 0.003318206639960408
defective O 1 0.999244213104248
in O 0 0.001519743469543755
the O 0 0.0016835987335070968
ability O 0 0.005905745085328817
to O 0 0.0009108888916671276
carry O 0 0.004226671997457743
out O 0 0.004046635702252388
transcription O 0 0.11171123385429382
- O 0 0.026007242500782013
coupled O 0 0.041972361505031586
repair O 1 0.795434296131134
of O 0 0.003794372547417879
oxidative O 1 0.9999933242797852
DNA O 0 0.11557693034410477
damage O 1 0.9377264380455017
, O 0 0.0012876633554697037
and O 0 0.0007587861036881804
are O 0 0.001342995441518724
hypersensitive O 1 0.9999840259552002
to O 0 0.004924403037875891
ionizing O 1 0.9982390403747559
radiation O 1 0.8565230965614319
and O 0 0.0024675517342984676
hydrogen O 0 0.04329219087958336
peroxide O 0 0.26417839527130127
. O 0 0.006973573472350836

These O 0 0.00202439958229661
results O 0 0.005496200639754534
suggest O 0 0.006477077957242727
that O 0 0.0035635449457913637
BRCA1 O 1 1.0
participates O 0 0.1618259698152542
, O 0 0.0018137090373784304
directly O 0 0.004300372209399939
or O 0 0.0032843437511473894
indirectly O 0 0.024118943139910698
, O 0 0.0012553168926388025
in O 0 0.0016212124610319734
transcription O 0 0.17172083258628845
- O 0 0.023954808712005615
coupled O 0 0.04508599266409874
repair O 1 0.5778490900993347
of O 0 0.004623220767825842
oxidative O 1 0.9999682903289795
DNA O 0 0.15445595979690552
damage O 1 0.8759421706199646
. O 0 0.002767724683508277
. O 0 0.004366002511233091

Truncation O 1 0.9995623230934143
mutations O 1 0.9975305199623108
in O 0 0.0017141003627330065
the O 0 0.0034238621592521667
transactivation O 1 0.9991974234580994
region O 0 0.012478864751756191
of O 0 0.0033185360953211784
PAX6 O 1 0.9999996423721313
result O 0 0.01583155058324337
in O 0 0.0024911677464842796
dominant O 1 0.9351975321769714
- O 0 0.03844089061021805
negative O 0 0.06595439463853836
mutants O 1 0.9834067225456238
. O 0 0.007291410584002733

PAX6 O 1 0.9998452663421631
is O 0 0.007137663662433624
a O 0 0.010793008841574192
transcription O 0 0.11012717336416245
factor O 0 0.029159070923924446
with O 0 0.0012070356169715524
two O 0 0.0017770148115232587
DNA O 0 0.05046995356678963
- O 0 0.02850569784641266
binding O 0 0.02966916188597679
domains O 0 0.053324177861213684
( O 0 0.006679660174995661
paired O 0 0.045923128724098206
box O 0 0.03252653777599335
and O 0 0.004640903323888779
homeobox O 1 0.9999790191650391
) O 0 0.003607763908803463
and O 0 0.0010926792165264487
a O 0 0.010376781225204468
proline O 1 0.9945770502090454
- O 0 0.04740207642316818
serine O 1 0.9538917541503906
- O 0 0.058928340673446655
threonine O 1 0.976276159286499
( O 0 0.014651202596724033
PST O 1 0.9968709349632263
) O 0 0.007794360630214214
- O 0 0.02837260253727436
rich O 0 0.03749270737171173
transactivation O 1 0.9961637258529663
domain O 0 0.054256621748209
. O 0 0.006785286590456963

PAX6 O 1 0.9999947547912598
regulates O 1 0.9957774877548218
eye O 1 0.9997358918190002
development O 0 0.004278608597815037
in O 0 0.0017185145989060402
animals O 0 0.012478654272854328
ranging O 0 0.006305126007646322
from O 0 0.004368722438812256
jellyfish O 1 0.9956320524215698
to O 0 0.0029664412140846252
Drosophila O 1 0.5042511224746704
to O 0 0.003355340799316764
humans O 0 0.035252079367637634
. O 0 0.005225918255746365

Heterozygous O 1 0.9996967315673828
mutations O 1 0.9969930648803711
in O 0 0.0021475343964993954
the O 0 0.003141717053949833
human O 0 0.026071542873978615
PAX6 O 1 0.9999997615814209
gene O 1 0.9995940327644348
result O 0 0.009720003232359886
in O 0 0.0014027174329385161
various O 0 0.001917671412229538
phenotypes O 1 0.9998183846473694
, O 0 0.0016783549217507243
including O 0 0.002779725706204772
aniridia B-Disease 1 0.9999997615814209
, O 0 0.004064185079187155
Peters B-Disease 1 0.999995231628418
anomaly I-Disease 1 0.9999933242797852
, O 0 0.007201161701232195
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999624490737915
keratitis I-Disease 1 1.0
, O 0 0.002569902455434203
and O 0 0.003164959140121937
familial B-Disease 1 1.0
foveal I-Disease 1 0.9999998807907104
dysplasia I-Disease 1 1.0
. O 0 0.009105785749852657

It O 0 0.003518048208206892
is O 0 0.002540973015129566
believed O 0 0.004718660376966
that O 0 0.0009941864991560578
the O 0 0.004460388328880072
mutated O 1 0.9999842643737793
allele O 1 0.9997729659080505
of O 0 0.005498233716934919
PAX6 O 1 0.9999964237213135
produces O 0 0.03164122626185417
an O 0 0.004796348046511412
inactive O 1 0.7128673791885376
protein O 0 0.058975402265787125
and O 0 0.0029314933344721794
aniridia B-Disease 1 0.9999953508377075
is O 0 0.007316510658711195
caused O 1 0.9995157718658447
due O 0 0.010667531751096249
to O 0 0.0024717224296182394
genetic O 1 0.9878852963447571
haploinsufficiency O 1 0.9998663663864136
. O 0 0.006851128302514553

However O 0 0.006046355701982975
, O 0 0.001382836839184165
several O 0 0.0032554299104958773
truncation O 1 0.9999463558197021
mutations O 1 0.9999805688858032
have O 0 0.0023889769800007343
been O 0 0.0029578646644949913
found O 0 0.002991163171827793
to O 0 0.000998323899693787
occur O 0 0.0091587845236063
in O 0 0.0010369729716330767
the O 0 0.003964403178542852
C O 1 0.956439197063446
- O 0 0.03470906987786293
terminal O 0 0.17075376212596893
half O 0 0.0069497195072472095
of O 0 0.0032631675712764263
PAX6 O 1 0.9999992847442627
in O 0 0.006516072433441877
patients O 1 0.999991774559021
with O 0 0.004472085274755955
Aniridia B-Disease 1 0.9999990463256836
resulting O 0 0.06966294348239899
in O 0 0.0035150055773556232
mutant O 1 0.9996227025985718
proteins O 0 0.025117991492152214
that O 0 0.0013307095505297184
retain O 0 0.013078444637358189
the O 0 0.004046608693897724
DNA O 0 0.058658067137002945
- O 0 0.029099950566887856
binding O 0 0.030706223100423813
domains O 0 0.031244518235325813
but O 0 0.002098498633131385
have O 0 0.0020762248896062374
lost O 0 0.014866757206618786
most O 0 0.0017496495274826884
of O 0 0.001151501084677875
the O 0 0.006121400278061628
transactivation O 1 0.9999393224716187
domain O 0 0.041461288928985596
. O 0 0.0050430018454790115

It O 0 0.004348323214799166
is O 0 0.0028804726898670197
not O 0 0.0012719137594103813
clear O 0 0.0032937228679656982
whether O 0 0.002489200560376048
such O 0 0.0016200876561924815
mutants O 1 0.9986419081687927
really O 0 0.015308508649468422
behave O 0 0.021100105717778206
as O 0 0.0030235855374485254
loss O 0 0.05298854783177376
- O 0 0.013125037774443626
of O 0 0.0021721988450735807
- O 0 0.024279000237584114
function O 0 0.025651080533862114
mutants O 1 0.9980111122131348
as O 0 0.0034955565351992846
predicted O 0 0.01820419169962406
by O 0 0.0069130961783230305
haploinsufficiency O 1 0.9989523887634277
. O 0 0.007271347101777792

Contrary O 0 0.013404497876763344
to O 0 0.001463628956116736
this O 0 0.001439182087779045
theory O 0 0.00390152120962739
, O 0 0.0010086356196552515
our O 0 0.0018211605492979288
data O 0 0.0018059647409245372
showed O 0 0.005976470187306404
that O 0 0.000884520763065666
these O 0 0.0012866698671132326
mutants O 1 0.9625705480575562
are O 0 0.002191774779930711
dominant O 0 0.08515296876430511
- O 0 0.024604158475995064
negative O 0 0.03327445313334465
in O 0 0.0037502828054130077
transient O 1 0.9803786277770996
transfection O 1 0.9975525736808777
assays O 0 0.09051144123077393
when O 0 0.006044711451977491
they O 0 0.0010626288130879402
are O 0 0.0011859145015478134
coexpressed O 1 0.9972301125526428
with O 0 0.002298695733770728
wild O 0 0.039641160517930984
- O 0 0.05156870558857918
type O 1 0.9310585856437683
PAX6 O 1 0.9999915361404419
. O 0 0.009705007076263428

We O 0 0.0031434979755431414
found O 0 0.0032581461127847433
that O 0 0.0007837142911739647
the O 0 0.003041036892682314
dominant O 0 0.44752082228660583
- O 0 0.042725883424282074
negative O 0 0.06285962462425232
effects O 0 0.06265980750322342
result O 0 0.008110234513878822
from O 0 0.001817159354686737
the O 0 0.0027957295533269644
enhanced O 0 0.03811506927013397
DNA O 0 0.052170220762491226
binding O 0 0.017045574262738228
ability O 0 0.0061303796246647835
of O 0 0.0010784135665744543
these O 0 0.001881870673969388
mutants O 1 0.9992314577102661
. O 0 0.006301333196461201

Kinetic O 0 0.04882756248116493
studies O 0 0.004476445727050304
of O 0 0.001724597648717463
binding O 0 0.017640935257077217
and O 0 0.0023514525964856148
dissociation O 1 0.9802912473678589
revealed O 0 0.01254403404891491
that O 0 0.0008025614079087973
various O 0 0.0016496588941663504
truncation O 1 0.9996930360794067
mutants O 1 0.9974094033241272
have O 0 0.0030957753770053387
3 O 0 0.012106348760426044
- O 0 0.020511990413069725
5 O 0 0.014151341281831264
- O 0 0.02219093032181263
fold O 0 0.041978634893894196
higher O 0 0.008641975000500679
affinity O 0 0.031866710633039474
to O 0 0.0013047767570242286
various O 0 0.0013375874841585755
DNA O 0 0.04668485373258591
- O 0 0.02454797737300396
binding O 0 0.016149956732988358
sites O 0 0.004838932305574417
when O 0 0.005368423648178577
compared O 0 0.007008535321801901
with O 0 0.0012780694523826241
the O 0 0.0031360741704702377
wild O 0 0.058768972754478455
- O 0 0.05306297168135643
type O 1 0.9815850257873535
PAX6 O 1 0.9999891519546509
. O 0 0.010884350165724754

These O 0 0.0022316479589790106
results O 0 0.005561656318604946
provide O 0 0.0018741916865110397
a O 0 0.003914447966963053
new O 0 0.001988360658288002
insight O 0 0.014755728654563427
into O 0 0.002226967364549637
the O 0 0.00168030324857682
role O 0 0.006168018095195293
of O 0 0.002436602720990777
mutant O 1 0.9999947547912598
PAX6 O 1 0.9999995231628418
in O 0 0.00800896342843771
causing O 1 0.9999635219573975
aniridia B-Disease 1 0.9999986886978149
. O 0 0.0033956761471927166
. O 0 0.004501954186707735

Reversal O 0 0.10289253294467926
of O 0 0.006876677740365267
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 0.002779213013127446
excellent O 0 0.011414259672164917
neuropsychologic O 1 0.9999390840530396
outcome O 0 0.009714570827782154
in O 0 0.0012667482951655984
very B-Disease 0 0.004154908005148172
- I-Disease 0 0.01872473955154419
long I-Disease 0 0.014024901203811169
- I-Disease 0 0.0351150743663311
chain I-Disease 1 0.9916651844978333
acyl I-Disease 1 0.999152660369873
- I-Disease 0 0.045144375413656235
coenzyme I-Disease 1 0.9993911981582642
A I-Disease 1 0.7022689580917358
dehydrogenase I-Disease 1 0.9999971389770508
deficiency I-Disease 1 1.0
. O 0 0.009769094176590443

Very B-Disease 0 0.014128079637885094
- I-Disease 0 0.026834242045879364
long I-Disease 0 0.015607315115630627
- I-Disease 0 0.04180748760700226
chain I-Disease 1 0.8701260685920715
acyl I-Disease 1 0.9971592426300049
- I-Disease 0 0.04850422590970993
coenzyme I-Disease 1 0.9978463649749756
A I-Disease 0 0.051801931113004684
dehydrogenase I-Disease 1 0.9999538660049438
( I-Disease 0 0.012997452169656754
VLCAD I-Disease 1 0.9999971389770508
) I-Disease 0 0.01312640868127346
deficiency I-Disease 1 1.0
is O 0 0.004825536161661148
a O 0 0.011873322539031506
disorder O 1 1.0
of O 0 0.005292520392686129
fatty O 1 0.9999964237213135
acid O 1 0.9734829664230347
beta O 0 0.11361032724380493
oxidation O 0 0.0755782201886177
that O 0 0.0017677011201158166
reportedly O 0 0.015042290091514587
has O 0 0.002674891846254468
high O 0 0.0049596745520830154
rates O 0 0.011864027008414268
of O 0 0.0031581304501742125
morbidity O 1 0.9999964237213135
and O 0 0.00321295321919024
mortality O 1 0.9990014433860779
. O 0 0.006576755084097385

We O 0 0.0037083446513861418
describe O 0 0.00795285589993
the O 0 0.0016726888716220856
outcome O 0 0.008555733598768711
of O 0 0.0011139126727357507
a O 0 0.006510117091238499
5 O 0 0.009941495023667812
- O 0 0.013494377955794334
year O 0 0.005809214431792498
- O 0 0.0173798818141222
old O 0 0.01724974438548088
girl O 1 0.9711005091667175
with O 0 0.007063691969960928
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 0.0073133809491992
was O 0 0.005779881961643696
first O 0 0.0030914386734366417
seen O 0 0.007902217097580433
at O 0 0.0035267414059489965
5 O 0 0.007541067898273468
months O 0 0.005206371657550335
of O 0 0.000795240979641676
age O 0 0.010258395224809647
with O 0 0.004687819164246321
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 0 0.19018244743347168
hepatomegaly B-Disease 1 1.0
, O 0 0.20255106687545776
encephalopathy B-Disease 1 1.0
, O 0 0.0026558858808130026
and O 0 0.0024820594117045403
hypotonia B-Disease 1 0.999997615814209
. O 0 0.007305104285478592

Biochemical O 0 0.0955285131931305
studies O 0 0.010474035516381264
indicated O 0 0.0362912155687809
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 1 0.9996892213821411
by O 0 0.0029364703223109245
a O 0 0.006853136699646711
stable O 0 0.057545483112335205
yet O 0 0.013860024511814117
inactive O 1 0.8939451575279236
enzyme O 1 0.5171162486076355
. O 0 0.006132747512310743

Molecular O 0 0.06429583579301834
genetic O 0 0.05354516580700874
analysis O 0 0.003522489219903946
of O 0 0.0011737673776224256
her O 0 0.011670409701764584
VLCAD O 1 0.9999994039535522
gene O 1 0.9991270899772644
revealed O 0 0.021281559020280838
a O 0 0.012997439131140709
T1372C O 1 0.9988975524902344
( O 0 0.008488781750202179
F458L O 1 0.9993528723716736
) O 0 0.008543083444237709
missense O 1 0.9997648596763611
mutation O 1 0.9999189376831055
and O 0 0.0018026996403932571
a O 0 0.010056735016405582
1668 O 1 0.9999918937683105
ACAG O 1 0.9999942779541016
1669 O 1 0.9999309778213501
splice O 1 0.9978373646736145
site O 0 0.03342003747820854
mutation O 1 0.999629020690918
. O 0 0.007373056374490261

After O 0 0.023296372964978218
initial O 0 0.034999582916498184
treatment O 1 0.9727427959442139
with O 0 0.0037494816351681948
intravenous O 1 0.9999829530715942
glucose O 1 0.9989767074584961
and O 0 0.0031943286303430796
carnitine O 1 0.9999889135360718
, O 0 0.001984519185498357
the O 0 0.0034331977367401123
patient O 1 0.999982476234436
has O 0 0.004945345222949982
thrived O 0 0.05058682709932327
on O 0 0.0014050510944798589
a O 0 0.006886219140142202
low O 0 0.03483635187149048
- O 0 0.05055967718362808
fat O 1 0.9504402875900269
diet O 0 0.41116324067115784
supplemented O 0 0.029140496626496315
with O 0 0.002117299707606435
medium O 0 0.015839844942092896
- O 0 0.03732655942440033
chain O 1 0.9148126840591431
triglyceride O 1 0.9212928414344788
oil O 0 0.008518424816429615
and O 0 0.003114038845524192
carnitine O 1 0.9996875524520874
and O 0 0.0033689888659864664
avoidance O 1 0.9556286931037903
of O 0 0.003604887519031763
fasting O 1 0.9931829571723938
. O 0 0.005460551008582115

Her O 0 0.12264034152030945
ventricular O 1 1.0
hypertrophy O 1 0.9999994039535522
resolved O 0 0.04372578114271164
significantly O 0 0.03029550611972809
over O 0 0.003397661494091153
1 O 0 0.00929141417145729
year O 0 0.004541141912341118
, O 0 0.001571435364894569
and O 0 0.002470435108989477
cognitively O 1 0.9999746084213257
, O 0 0.002442040480673313
she O 0 0.003646750934422016
is O 0 0.0019035699078813195
in O 0 0.0011699391761794686
the O 0 0.0025036726146936417
superior O 0 0.01565309427678585
range O 0 0.004606886301189661
for O 0 0.0016521817306056619
age O 0 0.014687512069940567
. O 0 0.004985162056982517

Clinical O 1 0.6335135102272034
recognition O 0 0.018948527052998543
of O 0 0.005867102183401585
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.004015845246613026
important O 0 0.0024200119078159332
because O 0 0.0028968523256480694
it O 0 0.0011014158371835947
is O 0 0.0012778984382748604
one O 0 0.0009107699734158814
of O 0 0.0004928882117383182
the O 0 0.0016884271753951907
few O 0 0.003045520279556513
directly O 0 0.013597087934613228
treatable O 1 1.0
causes O 1 0.9999489784240723
of O 0 0.006455578841269016
cardiomyopathy B-Disease 1 1.0
in O 0 0.0036556690465658903
children O 0 0.012768050655722618
. O 0 0.002206267323344946
. O 0 0.0036383247934281826

Cloning O 0 0.0655294880270958
of O 0 0.0018460425781086087
a O 0 0.005712734069675207
novel O 0 0.014302381314337254
member O 0 0.0031759582925587893
of O 0 0.0007787584327161312
the O 0 0.0028209518641233444
low O 0 0.025210460647940636
- O 0 0.03166750818490982
density O 0 0.037943653762340546
lipoprotein O 1 0.9999778270721436
receptor O 1 0.9955329895019531
family O 0 0.02596592903137207
. O 0 0.006091166753321886

A O 0 0.03571546822786331
gene O 1 0.9258798956871033
encoding O 0 0.057757843285799026
a O 0 0.010074784979224205
novel O 0 0.040562596172094345
transmembrane O 1 0.9889906644821167
protein O 0 0.07650627195835114
was O 0 0.00724232941865921
identified O 0 0.009131421335041523
by O 0 0.0024575102142989635
DNA O 0 0.02639838308095932
sequence O 0 0.01182930264621973
analysis O 0 0.002731764456257224
within O 0 0.001309563172981143
the O 0 0.0035176819656044245
insulin B-Disease 1 0.9999955892562866
- I-Disease 1 0.6092784404754639
dependent I-Disease 1 0.9970205426216125
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 0.015575770288705826
IDDM B-Disease 1 0.9999927282333374
) O 0 0.010102692060172558
locus O 1 0.9999936819076538
IDDM4 O 1 0.9999147653579712
on O 0 0.011548897251486778
chromosome O 1 0.9999476671218872
11q13 O 1 0.9986440539360046
. O 0 0.006992158479988575

Based O 0 0.003935285843908787
on O 0 0.001696823164820671
its O 0 0.004328800830990076
chromosomal O 1 0.999946117401123
position O 0 0.007659862283617258
, O 0 0.0013742507435381413
this O 0 0.002730119973421097
gene O 1 0.9991292357444763
is O 0 0.0027447203174233437
a O 0 0.004617823753505945
candidate O 0 0.01037951372563839
for O 0 0.0021284441463649273
conferring O 1 0.763929545879364
susceptibility O 1 0.9999935626983643
to O 0 0.01095306221395731
diabetes B-Disease 1 1.0
. O 0 0.008122795261442661

The O 0 0.010904529131948948
gene O 1 0.9819481372833252
, O 0 0.003117495682090521
termed O 0 0.053698230534791946
low O 0 0.029121100902557373
- O 0 0.027578936889767647
density O 0 0.028918512165546417
lipoprotein O 1 0.9997687935829163
receptor O 1 0.9527555704116821
related O 0 0.023459434509277344
protein O 0 0.07542651891708374
5 O 0 0.01540343463420868
( O 0 0.008246208541095257
LRP5 O 1 0.9999743700027466
) O 0 0.003727608360350132
, O 0 0.0018046003533527255
encodes O 0 0.09326577186584473
a O 0 0.008014638908207417
protein O 0 0.046127259731292725
of O 0 0.002010144293308258
1615 O 1 0.9970421195030212
amino O 0 0.08536984771490097
acids O 0 0.0380144901573658
that O 0 0.0010966041591018438
contains O 0 0.004077626392245293
conserved O 0 0.027936823666095734
modules O 0 0.011604408733546734
which O 0 0.0011496591614559293
are O 0 0.0006575305596925318
characteristic O 0 0.013074463233351707
of O 0 0.000719562463928014
the O 0 0.002335702534765005
low O 0 0.02882346883416176
- O 0 0.026820866391062737
density O 0 0.03511231020092964
lipoprotein O 1 0.9999836683273315
( O 0 0.020597590133547783
LDL O 1 0.9999998807907104
) O 0 0.013159125111997128
receptor O 1 0.9962791800498962
family O 0 0.020384568721055984
. O 0 0.0048299990594387054

These O 0 0.002349703572690487
modules O 0 0.012923738919198513
include O 0 0.0022892022971063852
a O 0 0.008468502201139927
putative O 1 0.6546733379364014
signal O 0 0.05422259494662285
peptide O 0 0.14006319642066956
for O 0 0.0029614767991006374
protein O 0 0.042887259274721146
export O 0 0.004624278750270605
, O 0 0.0014523813733831048
four O 0 0.004384043160825968
epidermal O 1 0.9998775720596313
growth O 0 0.025204507634043694
factor O 0 0.0816427618265152
( O 0 0.011762379668653011
EGF O 1 0.9999812841415405
) O 0 0.0062973336316645145
repeats O 0 0.046026553958654404
with O 0 0.00183531129732728
associated O 0 0.010057110339403152
spacer O 1 0.921265721321106
domains O 0 0.038121405988931656
, O 0 0.0017025757115334272
three O 0 0.005385775584727526
LDL O 1 0.9999997615814209
- O 0 0.10991687327623367
receptor O 1 0.9969434142112732
( O 0 0.01493650209158659
LDLR O 1 0.9999246597290039
) O 0 0.007281187456101179
repeats O 0 0.04377659410238266
, O 0 0.0015481121372431517
a O 0 0.004938870668411255
single O 0 0.018062429502606392
transmembrane O 1 0.9702878594398499
spanning O 0 0.03238224610686302
domain O 0 0.028754061087965965
, O 0 0.001194460317492485
and O 0 0.000983147299848497
a O 0 0.008726486004889011
cytoplasmic O 1 0.5974962115287781
domain O 0 0.04141939803957939
. O 0 0.0059865438379347324

The O 0 0.007608069106936455
encoded O 0 0.05386840179562569
protein O 0 0.04884570091962814
has O 0 0.002822459675371647
a O 0 0.003899587783962488
unique O 0 0.0037977665197104216
organization O 0 0.005023280158638954
of O 0 0.0031628008000552654
EGF O 1 0.9999840259552002
and O 0 0.006632382981479168
LDLR O 1 0.9999936819076538
repeats O 0 0.3652306795120239
; O 0 0.00397436274215579
therefore O 0 0.004976349882781506
, O 0 0.003187290159985423
LRP5 O 1 0.9999915361404419
likely O 0 0.015831179916858673
represents O 0 0.0098465820774436
a O 0 0.004453232977539301
new O 0 0.00244514225050807
category O 0 0.010431211441755295
of O 0 0.0010841024341061711
the O 0 0.00546194426715374
LDLR O 1 0.9999992847442627
family O 0 0.02509891986846924
. O 0 0.005796654149889946

Both O 0 0.004827265627682209
human O 0 0.008039835840463638
and O 0 0.0032122889533638954
mouse O 1 0.9999899864196777
LRP5 O 1 0.9999990463256836
cDNAs O 1 0.9996700286865234
have O 0 0.0036992691457271576
been O 0 0.004808408208191395
isolated O 0 0.032343316823244095
and O 0 0.001121046137996018
the O 0 0.0029141742270439863
encoded O 0 0.059700801968574524
mature O 0 0.06595062464475632
proteins O 0 0.023098688572645187
are O 0 0.0011522169224917889
95 O 0 0.01626772992312908
% O 0 0.004868262447416782
identical O 0 0.011121630668640137
, O 0 0.0018123609479516745
indicating O 0 0.016241522505879402
a O 0 0.005899194628000259
high O 0 0.006290251389145851
degree O 0 0.004161900375038385
of O 0 0.0014732362469658256
evolutionary O 0 0.03407660499215126
conservation O 0 0.015537403523921967
. O 0 0.0022308987099677324
. O 0 0.004122590180486441

The O 0 0.014557390473783016
APC B-Disease 1 0.9999126195907593
variants O 0 0.44393086433410645
I1307K O 1 0.9989724159240723
and O 0 0.002922622486948967
E1317Q O 1 0.9992789626121521
are O 0 0.0014434120384976268
associated O 0 0.00996357761323452
with O 0 0.018255148082971573
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.002376370830461383
but O 0 0.0014012855244800448
not O 0 0.0008843071409501135
always O 0 0.002074280520901084
with O 0 0.0009755298378877342
a O 0 0.005849095992743969
family O 0 0.012693405151367188
history O 0 0.006364526692777872
. O 0 0.005227693356573582

Classical O 0 0.054226234555244446
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 0.1159532219171524
FAP B-Disease 1 1.0
) O 0 0.0032509348820894957
is O 0 0.0015615687007084489
a O 0 0.0038734625559300184
high O 0 0.008248921483755112
- O 0 0.3476100564002991
penetrance O 1 0.9999994039535522
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999986886978149
disease I-Disease 1 1.0
that O 0 0.004719779826700687
predisposes O 1 0.9999963045120239
to O 0 0.0018486246699467301
hundreds O 0 0.005089374724775553
or O 0 0.0025300977285951376
thousands O 0 0.006594184320420027
of O 0 0.007850074209272861
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.024580929428339005
carcinoma I-Disease 1 1.0
and O 0 0.0012040712172165513
that O 0 0.000677660689689219
results O 0 0.0043924953788518906
from O 0 0.0037107609678059816
truncating O 1 0.9998900890350342
mutations O 1 0.999790608882904
in O 0 0.0021554550621658564
the O 0 0.00619948236271739
APC B-Disease 1 0.9999997615814209
gene O 1 0.9997183680534363
. O 0 0.007141385227441788

A O 0 0.030498048290610313
variant O 1 0.9222047924995422
of O 0 0.005524683278053999
FAP B-Disease 1 1.0
is O 0 0.025581717491149902
attenuated B-Disease 1 0.9999997615814209
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 0.0030937923584133387
which O 0 0.001470116782002151
results O 0 0.005417253822088242
from O 0 0.0038948894944041967
germ O 1 0.9981483221054077
- O 0 0.032723478972911835
line O 0 0.023596404120326042
mutations O 1 0.9996917247772217
in O 0 0.001666126772761345
the O 0 0.0022828399669378996
5 O 0 0.0072064814157783985
and O 0 0.0011387369595468044
3 O 0 0.006741737946867943
regions O 0 0.005217527039349079
of O 0 0.001209483714774251
the O 0 0.007939819246530533
APC B-Disease 1 0.9999991655349731
gene O 1 0.9987953901290894
. O 0 0.008209087885916233

Attenuated B-Disease 1 0.9999996423721313
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 1 0.9999997615814209
have O 0 0.002450239611789584
" O 0 0.004270525183528662
multiple O 0 0.022683581337332726
" O 1 0.6867035627365112
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 0.008372829295694828
typically O 0 0.007734538987278938
fewer O 0 0.007336124312132597
than O 0 0.0022240797989070415
100 O 0 0.0058922297321259975
) O 0 0.0022010020911693573
without O 0 0.0025163108948618174
the O 0 0.003998412285000086
florid O 1 0.9994412064552307
phenotype O 1 0.9999918937683105
of O 0 0.003273849142715335
classical O 0 0.013480110093951225
FAP B-Disease 1 0.9999997615814209
. O 0 0.009048668667674065

Another O 0 0.01746225729584694
group O 0 0.005883561447262764
of O 0 0.0026070112362504005
patients O 1 0.9999951124191284
with O 0 0.0022277915850281715
multiple O 0 0.03522152081131935
adenomas B-Disease 1 0.9999997615814209
has O 0 0.004273500293493271
no O 0 0.003660390619188547
mutations O 1 0.9999066591262817
in O 0 0.0014222105965018272
the O 0 0.005398449953645468
APC B-Disease 1 0.9999998807907104
gene O 1 0.9998268485069275
, O 0 0.0012840672861784697
and O 0 0.0008995406096801162
their O 0 0.0032614911906421185
phenotype O 1 0.9999998807907104
probably O 0 0.011776300147175789
results O 0 0.004965273663401604
from O 0 0.001603750977665186
variation O 0 0.018185025081038475
at O 0 0.0030985537450760603
a O 0 0.009404148906469345
locus O 1 0.9999980926513672
, O 0 0.0026503782719373703
or O 0 0.005519587080925703
loci O 1 0.9999843835830688
, O 0 0.0014882433461025357
elsewhere O 0 0.0042663682252168655
in O 0 0.001170754199847579
the O 0 0.004330778494477272
genome O 0 0.4475822150707245
. O 0 0.008144892752170563

Recently O 0 0.0293634794652462
, O 0 0.002119022188708186
however O 0 0.0021124461200088263
, O 0 0.0012307403376325965
a O 0 0.010263703763484955
missense O 1 0.999208390712738
variant O 1 0.989389955997467
of O 0 0.006527577992528677
APC B-Disease 1 0.9999992847442627
( O 0 0.012527991086244583
I1307K O 1 0.9998540878295898
) O 0 0.004427798092365265
was O 0 0.005113612394779921
described O 0 0.0057196724228560925
that O 0 0.0009161295020021498
confers O 0 0.08668568730354309
an O 0 0.0017690092790871859
increased O 0 0.015702655538916588
risk O 1 0.9996558427810669
of O 0 0.016604868695139885
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.0019309555646032095
including O 0 0.002034499542787671
multiple O 0 0.05940548703074455
adenomas B-Disease 1 0.999998927116394
, O 0 0.0020698613952845335
in O 0 0.002719353884458542
Ashkenazim O 1 0.999862790107727
. O 0 0.006679505109786987

We O 0 0.003459797939285636
have O 0 0.0015372897032648325
studied O 0 0.0030836728401482105
a O 0 0.002513868035748601
set O 0 0.0015175561420619488
of O 0 0.0017873598262667656
164 O 1 0.9783154726028442
patients O 1 0.9999955892562866
with O 0 0.00341598829254508
multiple O 1 0.9987468719482422
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.00505419448018074
/ I-Disease 1 0.9988271594047546
or I-Disease 0 0.012930450960993767
carcinoma I-Disease 1 1.0
and O 0 0.0024196896702051163
analyzed O 0 0.02907026745378971
codons O 1 0.8964336514472961
1263 O 1 0.9980552196502686
- O 0 0.06982124596834183
1377 O 1 0.9941078424453735
( O 0 0.017801405861973763
exon O 1 0.9992998838424683
15G O 1 0.9959270358085632
) O 0 0.002610808238387108
of O 0 0.0010180838871747255
the O 0 0.005159779917448759
APC B-Disease 1 0.9999988079071045
gene O 1 0.9937127232551575
for O 0 0.004139727912843227
germ O 1 0.9852296710014343
- O 0 0.030054207891225815
line O 0 0.015460439957678318
variants O 0 0.06676118075847626
. O 0 0.004604833200573921

Three O 0 0.010507413186132908
patients O 1 0.9987742304801941
with O 0 0.001645816839300096
the O 0 0.0046915761195123196
I1307K O 1 0.9999911785125732
allele O 1 0.999987006187439
were O 0 0.003917718306183815
detected O 0 0.06079183891415596
, O 0 0.0011889140587300062
each O 0 0.0014129524352028966
of O 0 0.002764306031167507
Ashkenazi O 1 0.9997648596763611
descent O 0 0.07693708688020706
. O 0 0.006162011995911598

Four O 0 0.012992650270462036
patients O 1 0.9999499320983887
had O 0 0.0054469238966703415
a O 0 0.010299134068191051
germ O 1 0.9892784953117371
- O 0 0.0330294631421566
line O 0 0.020904267206788063
E1317Q O 1 0.9992744326591492
missense O 1 0.9991974234580994
variant O 1 0.9621667861938477
of O 0 0.005787172354757786
APC O 1 0.9999971389770508
that O 0 0.0020022126846015453
was O 0 0.004543348681181669
not O 0 0.001124342903494835
present O 0 0.0018220102647319436
in O 0 0.0015045065665617585
controls O 0 0.02438051998615265
; O 0 0.002162488643079996
one O 0 0.0014619419816881418
of O 0 0.000875823141541332
these O 0 0.0008908130694180727
individuals O 0 0.0037625122349709272
had O 0 0.00304011651314795
an O 0 0.0023560691624879837
unusually O 0 0.032076090574264526
large O 0 0.003230311209335923
number O 0 0.0020741766784340143
of O 0 0.0024123783223330975
metaplastic B-Disease 1 0.9999932050704956
polyps I-Disease 1 0.9999951124191284
of I-Disease 0 0.0020658799912780523
the I-Disease 0 0.00551784411072731
colorectum I-Disease 1 0.9996007084846497
. O 0 0.006529989652335644

There O 0 0.0037504839710891247
is O 0 0.0030048582702875137
increasing O 0 0.006650855299085379
evidence O 0 0.0016268054023385048
that O 0 0.0007626136066392064
there O 0 0.0015592863783240318
exist O 0 0.0048717292957007885
germ O 1 0.9824920892715454
- O 0 0.022733591496944427
line O 0 0.008882842026650906
variants O 0 0.030185842886567116
of O 0 0.0013538243947550654
the O 0 0.006635706871747971
APC B-Disease 1 0.9999996423721313
gene O 1 0.9993651509284973
that O 0 0.0032017300836741924
predispose O 1 0.9969320297241211
to O 0 0.0009208354749716818
the O 0 0.0009371708729304373
development O 0 0.0016667384188622236
of O 0 0.0021083455067127943
multiple O 1 0.9997319579124451
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.03561345860362053
carcinoma I-Disease 1 1.0
, O 0 0.0024293086025863886
but O 0 0.0015814368380233645
without O 0 0.0021976535208523273
the O 0 0.004233076237142086
florid O 1 0.999667763710022
phenotype O 1 0.9999876022338867
of O 0 0.0026629138737916946
classical O 0 0.012575228698551655
FAP B-Disease 1 1.0
, O 0 0.0020758812315762043
and O 0 0.000880932726431638
possibly O 0 0.008126592263579369
with O 0 0.0009073456167243421
importance O 0 0.004266261123120785
for O 0 0.02567322924733162
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.9997120499610901
in O 0 0.0015145621728152037
the O 0 0.0021061934530735016
general O 0 0.006091490853577852
population O 0 0.010237948037683964
. O 0 0.002535749226808548
. O 0 0.004767381586134434

Genomic O 0 0.15680037438869476
structure O 0 0.006508212070912123
of O 0 0.0008379350765608251
the O 0 0.0031410453375428915
human O 1 0.8625592589378357
congenital B-Disease 1 1.0
chloride I-Disease 1 0.9999996423721313
diarrhea I-Disease 1 1.0
( O 0 0.025182943791151047
CLD B-Disease 1 1.0
) O 0 0.012309357523918152
gene O 1 0.9991581439971924
. O 0 0.005767493508756161

Congenital B-Disease 1 1.0
chloride I-Disease 1 0.999990701675415
diarrhea I-Disease 1 1.0
( O 0 0.028184249997138977
CLD B-Disease 1 0.9999998807907104
) O 0 0.004186271224170923
is O 0 0.004010491538792849
caused O 1 0.9993698000907898
by O 0 0.004500729031860828
mutations O 1 0.9999397993087769
in O 0 0.0018492249073460698
a O 0 0.008069919422268867
gene O 1 0.9958744645118713
which O 0 0.0027268389239907265
encodes O 1 0.6060545444488525
an O 0 0.010303796268999577
intestinal O 1 1.0
anion O 1 0.9998631477355957
transporter O 1 0.998537540435791
. O 0 0.0074094077572226524

We O 0 0.0027542910538613796
report O 0 0.0024832426570355892
here O 0 0.0012659921776503325
the O 0 0.0021195525769144297
complete O 0 0.009472250938415527
genomic O 0 0.10260996222496033
organization O 0 0.00445150351151824
of O 0 0.0008629501680843532
the O 0 0.003369162091985345
human O 0 0.024722430855035782
CLD B-Disease 1 0.9999997615814209
gene O 1 0.998414158821106
which O 0 0.004443727899342775
spans O 0 0.042346686124801636
approximately O 0 0.011313999071717262
39kb O 1 0.9998108744621277
, O 0 0.001541182049550116
and O 0 0.0010014026192948222
comprises O 0 0.010588781908154488
21 O 0 0.022167891263961792
exons O 1 0.8973113894462585
. O 0 0.006287644151598215

All O 0 0.006363308522850275
exon O 1 0.9986881613731384
/ O 0 0.18711166083812714
intron O 1 0.9888134598731995
boundaries O 0 0.007996372878551483
conform O 0 0.008685017004609108
to O 0 0.0011602555168792605
the O 0 0.004291752353310585
GT O 1 0.9999958276748657
/ O 1 0.9975454211235046
AG O 1 0.9999862909317017
rule O 0 0.021291866898536682
. O 0 0.0049484907649457455

An O 0 0.004226095508784056
analysis O 0 0.0030558707658201456
of O 0 0.001056276261806488
the O 0 0.004522259812802076
putative O 1 0.9979209303855896
promoter O 1 0.9961168766021729
region O 0 0.014672495424747467
sequence O 0 0.01811223477125168
shows O 0 0.006150036584585905
a O 0 0.009688299149274826
putative O 1 0.9937233328819275
TATA O 1 0.9999405145645142
box O 0 0.03377238288521767
and O 0 0.002097813645377755
predicts O 0 0.03725271672010422
multiple O 0 0.021135393530130386
transcription O 0 0.12355014681816101
factor O 0 0.05589274317026138
binding O 0 0.01870151236653328
sites O 0 0.005696313921362162
. O 0 0.0043205199763178825

The O 0 0.0067267827689647675
genomic O 0 0.19660888612270355
structure O 0 0.009884479455649853
was O 0 0.005288086365908384
determined O 0 0.0076909721828997135
using O 0 0.003355989698320627
DNA O 0 0.029420705512166023
from O 0 0.001904680160805583
several O 0 0.0010507352417334914
sources O 0 0.001569403219036758
including O 0 0.0013237622333690524
multiple O 0 0.012425563298165798
large O 0 0.006984858773648739
- O 0 0.0326990969479084
insert O 1 0.8382776975631714
libaries O 1 0.9936215281486511
and O 0 0.003435902064666152
genomic O 0 0.149562269449234
DNA O 0 0.03468351811170578
from O 0 0.00397782027721405
Finnish O 0 0.2297223061323166
CLD B-Disease 1 0.9999998807907104
patients O 1 0.9999727010726929
and O 0 0.002590239979326725
controls O 0 0.027148155495524406
. O 0 0.004641273524612188

Exon O 1 0.9988627433776855
- O 0 0.036706436425447464
specific O 0 0.008524617180228233
primers O 0 0.10461847484111786
developed O 0 0.010236573405563831
in O 0 0.0008835100452415645
this O 0 0.000942307582590729
study O 0 0.002161088865250349
will O 0 0.001403569127433002
facilitate O 0 0.020481446757912636
mutation O 1 0.9999814033508301
screening O 0 0.05869738757610321
studies O 0 0.0044481223449110985
of O 0 0.0023339344188570976
patients O 1 0.9999797344207764
with O 0 0.001960576046258211
the O 0 0.010056249797344208
disease O 1 1.0
. O 0 0.006680948194116354

Genomic O 0 0.18089140951633453
sequencing O 0 0.04918710142374039
of O 0 0.00225926679559052
a O 0 0.015276835300028324
BAC O 1 0.9999984502792358
clone O 1 0.9998588562011719
H O 1 0.99992835521698
_ O 0 0.02176976576447487
RG364P16 O 1 0.9981535077095032
revealed O 0 0.016195811331272125
the O 0 0.002047167159616947
presence O 0 0.006970726419240236
of O 0 0.0010066397953778505
another O 0 0.007603818085044622
, O 0 0.0021145278587937355
highly O 0 0.022521698847413063
homologous O 1 0.9711822271347046
gene O 1 0.956123948097229
3 O 0 0.008576557040214539
of O 0 0.0012918481370434165
the O 0 0.00781678780913353
CLD B-Disease 1 0.9999998807907104
gene O 1 0.9993202686309814
, O 0 0.0019609848968684673
with O 0 0.001149017596617341
a O 0 0.0051107509061694145
similar O 0 0.006939663551747799
genomic O 0 0.3807595670223236
structure O 0 0.0073255691677331924
, O 0 0.0012544067576527596
recently O 0 0.008554884232580662
identified O 0 0.007151938043534756
as O 0 0.0016677307430654764
the O 0 0.007313429843634367
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 1 0.9999986886978149
( O 0 0.014870408922433853
PDS B-Disease 1 0.9999997615814209
) O 0 0.005253809969872236
. O 0 0.0021187379024922848
. O 0 0.0038035146426409483

The O 0 0.00963728316128254
APCI1307K O 1 0.9999972581863403
allele O 1 0.9999990463256836
and O 0 0.011688281781971455
cancer B-Disease 1 1.0
risk O 1 0.9968469738960266
in O 0 0.0017426934791728854
a O 0 0.00577836437150836
community O 0 0.00870326068252325
- O 0 0.01222701370716095
based O 0 0.0021787062287330627
study O 0 0.003000727156177163
of O 0 0.0022314758971333504
Ashkenazi O 1 0.9997335076332092
Jews O 0 0.011278370395302773
. O 0 0.004359703045338392

Mutations O 1 0.9995688796043396
in O 0 0.004735622555017471
APC O 1 0.9999983310699463
are O 0 0.002532103331759572
classically O 1 0.9997134804725647
associated O 0 0.009264756925404072
with O 0 0.005647044628858566
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 0.3243492841720581
FAP B-Disease 1 1.0
) O 0 0.004018075298517942
, O 0 0.001029673614539206
a O 0 0.0058745043352246284
highly O 0 0.04284706339240074
penetrant O 1 0.9999996423721313
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999964237213135
disorder I-Disease 1 1.0
characterized O 1 0.990854024887085
by O 0 0.005624360870569944
multiple O 1 0.9993502497673035
intestinal O 1 1.0
polyps B-Disease 1 1.0
and O 0 0.0015668977284803987
, O 0 0.0013002414489164948
without O 0 0.005772866308689117
surgical O 1 0.9999979734420776
intervention O 0 0.30190593004226685
, O 0 0.00076338677899912
the O 0 0.0011072709457948804
development O 0 0.00360194593667984
of O 0 0.016660502180457115
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.017263540998101234
CRC B-Disease 1 0.9999898672103882
) O 0 0.005504476837813854
. O 0 0.0036639939062297344

APC B-Disease 1 0.999940037727356
is O 0 0.0055356714874506
a O 0 0.019552497193217278
tumour O 1 1.0
- O 1 0.9906182885169983
suppressor O 1 0.9999998807907104
gene O 1 0.9991821646690369
, O 0 0.0020743149798363447
and O 0 0.0022092796862125397
somatic O 1 0.9988552331924438
loss O 1 0.6585968732833862
occurs O 0 0.04666857793927193
in O 0 0.005298118572682142
tumours B-Disease 1 1.0
. O 0 0.007317556068301201

The O 0 0.017110882326960564
germline O 1 0.9998099207878113
T O 1 0.9989293217658997
- O 0 0.020218536257743835
to O 0 0.0021320872474461794
- O 0 0.01883229985833168
A O 0 0.02171856351196766
transversion O 1 0.9997268319129944
responsible O 0 0.013929631561040878
for O 0 0.001536860247142613
the O 0 0.005148615688085556
APC O 1 0.9999970197677612
I1307K O 1 0.999764621257782
allele O 1 0.9998326301574707
converts O 0 0.02780558541417122
the O 0 0.0033220709301531315
wild O 0 0.027169333770871162
- O 0 0.0231642946600914
type O 0 0.033753447234630585
sequence O 0 0.013307197950780392
to O 0 0.0013014462310820818
a O 0 0.012355899438261986
homopolymer O 1 0.9999942779541016
tract O 1 0.9999996423721313
( O 0 0.013035678304731846
A8 O 1 0.9999974966049194
) O 0 0.0024761115200817585
that O 0 0.0008646913338452578
is O 0 0.003350289538502693
genetically O 1 0.9392409324645996
unstable O 1 0.9991106390953064
and O 0 0.00298231840133667
prone O 1 0.9990012049674988
to O 0 0.005797296762466431
somatic O 1 0.9961232542991638
mutation O 1 0.9998263716697693
. O 0 0.009215050376951694

The O 0 0.013057189993560314
I1307K O 1 0.9993701577186584
allele O 1 0.9995438456535339
was O 0 0.011250903829932213
found O 0 0.005174501333385706
in O 0 0.002341990126296878
6 O 0 0.014205501414835453
. O 0 0.005602027289569378

1 O 0 0.018215497955679893
% O 0 0.0042801508679986
of O 0 0.002128768479451537
unselected O 1 0.9985904097557068
Ashkenazi O 1 0.9986441731452942
Jews O 0 0.007256117183715105
and O 0 0.0012791715562343597
higher O 0 0.009268424473702908
proportions O 0 0.08547968417406082
of O 0 0.003267269115895033
Ashkenazim O 1 0.9998784065246582
with O 0 0.003169931937009096
family O 0 0.01102780643850565
or O 0 0.0026683055330067873
personal O 0 0.0059234946966171265
histories O 0 0.023535452783107758
of O 0 0.003547074506059289
CRC B-Disease 1 0.9999914169311523
( O 0 0.011782909743487835
ref O 1 0.999805748462677
. O 0 0.0036081981379538774
2 O 0 0.010084034875035286
) O 0 0.003630130086094141
. O 0 0.003466986818239093

To O 0 0.0029317024163901806
evaluate O 0 0.01338240783661604
the O 0 0.0017575316596776247
role O 0 0.005639939568936825
of O 0 0.0019746797624975443
I1307K O 1 0.9999886751174927
in O 0 0.005670743994414806
cancer B-Disease 1 1.0
, O 0 0.001672887010499835
we O 0 0.0022308751940727234
genotyped O 1 0.9999244213104248
5 O 0 0.01378096453845501
, O 0 0.0046459985896945
081 O 1 0.9995310306549072
Ashkenazi O 1 0.9940763711929321
volunteers O 0 0.0220915749669075
in O 0 0.001555207185447216
a O 0 0.0051513658836483955
community O 0 0.007229086477309465
survey O 0 0.011849815957248211
. O 0 0.004543287679553032

Risk O 1 0.6065261363983154
of O 0 0.0037568537518382072
developing O 0 0.39343807101249695
colorectal B-Disease 1 1.0
, I-Disease 0 0.010347207076847553
breast I-Disease 1 1.0
and I-Disease 0 0.001827803673222661
other I-Disease 0 0.0024194149300456047
cancers I-Disease 1 1.0
were O 0 0.0016396341379731894
compared O 0 0.007543838117271662
between O 0 0.0038730024825781584
genotyped O 1 0.9999854564666748
I1307K O 1 0.999976634979248
carriers O 1 0.8247941136360168
and O 0 0.0018169587710872293
non O 0 0.013645842671394348
- O 0 0.030918419361114502
carriers O 0 0.1579790860414505
and O 0 0.0009970891987904906
their O 0 0.00131565413903445
first O 0 0.004807997960597277
- O 0 0.019918281584978104
degree O 0 0.009380432777106762
relatives O 0 0.02495635859668255
. O 0 0.005246341228485107

Sperm O 0 0.11281953752040863
DNA O 0 0.03961319848895073
analysis O 0 0.0035563865676522255
in O 0 0.0014775474555790424
a O 0 0.013522190041840076
Friedreich B-Disease 1 0.9999991655349731
ataxia I-Disease 1 1.0
premutation O 1 0.9999814033508301
carrier O 1 0.9988957643508911
suggests O 0 0.015062245540320873
both O 0 0.0030817242804914713
meiotic O 1 0.9998252987861633
and O 0 0.003264734521508217
mitotic O 1 0.6346144676208496
expansion O 0 0.009679006412625313
in O 0 0.0015685644466429949
the O 0 0.00561408931389451
FRDA B-Disease 1 0.9999982118606567
gene O 1 0.9991739392280579
. O 0 0.006534486077725887

Friedreich B-Disease 1 0.9999974966049194
ataxia I-Disease 1 1.0
is O 0 0.008657680824398994
usually O 0 0.008559949696063995
caused O 1 0.988834798336029
by O 0 0.002113070571795106
an O 0 0.0014626301126554608
expansion O 0 0.006280919536948204
of O 0 0.001453564502298832
a O 0 0.009938256815075874
GAA O 1 0.97801274061203
trinucleotide O 1 0.999879002571106
repeat O 0 0.08095136284828186
in O 0 0.004775534849613905
intron O 1 0.9909929633140564
1 O 0 0.009923662059009075
of O 0 0.001457809703424573
the O 0 0.006404015235602856
FRDA B-Disease 1 0.9999977350234985
gene O 1 0.9987175464630127
. O 0 0.007453090976923704

Occasionally O 0 0.022987712174654007
, O 0 0.0015466257464140654
a O 0 0.004743803292512894
fully O 0 0.009047219529747963
expanded O 0 0.014475452713668346
allele O 1 0.999970555305481
has O 0 0.004885187838226557
been O 0 0.003911979962140322
found O 0 0.003767186775803566
to O 0 0.0014600874856114388
arise O 0 0.015795083716511726
from O 0 0.0021016111131757498
a O 0 0.00725005054846406
premutation O 1 0.9693400859832764
of O 0 0.0020642890594899654
100 O 0 0.006871046498417854
or O 0 0.0038831427227705717
less O 0 0.013915039598941803
triplet O 1 0.9975726008415222
repeats O 0 0.10641944408416748
. O 0 0.006942364852875471

We O 0 0.00434526102617383
have O 0 0.002306337235495448
examined O 0 0.021344291046261787
the O 0 0.0037135842721909285
sperm O 0 0.05440831929445267
DNA O 0 0.02807854674756527
of O 0 0.0016914374427869916
a O 0 0.013426441699266434
premutation O 1 0.9998063445091248
carrier O 1 0.9969005584716797
. O 0 0.006336263846606016

This O 0 0.006271412130445242
mans O 0 0.4082470238208771
leucocyte O 1 0.9978647828102112
DNA O 0 0.05139100179076195
showed O 0 0.008779540657997131
one O 0 0.003241326194256544
normal O 0 0.02927197515964508
allele O 1 0.999672532081604
and O 0 0.0016334863612428308
one O 0 0.004964546300470829
allele O 1 0.9987367987632751
of O 0 0.0025817241985350847
approximately O 0 0.006960020866245031
100 O 0 0.010558751411736012
repeats O 0 0.07498783618211746
. O 0 0.005871088244020939

His O 0 0.013550186529755592
sperm O 0 0.06268156319856644
showed O 0 0.008808727376163006
an O 0 0.002597993006929755
expanded O 0 0.014842738397419453
allele O 1 0.9997509121894836
in O 0 0.0022923636715859175
a O 0 0.006659496109932661
tight O 0 0.018200716003775597
range O 0 0.0047868387773633
centering O 0 0.028236722573637962
on O 0 0.0018429268384352326
a O 0 0.0037623813841491938
size O 0 0.004240871872752905
of O 0 0.001347608515061438
approximately O 0 0.011422834359109402
320 O 0 0.3997213840484619
trinucleotide O 1 0.9998291730880737
repeats O 0 0.11508546769618988
. O 0 0.007189422845840454

His O 0 0.011617542244493961
affected O 1 0.9223337769508362
son O 1 0.9491047263145447
has O 0 0.005748910829424858
repeat O 0 0.06303434073925018
sizes O 0 0.011730086989700794
of O 0 0.0030371679458767176
1040 O 1 0.9990836381912231
and O 0 0.003390630939975381
540 O 0 0.1204582154750824
. O 0 0.006775951478630304

These O 0 0.0017049001762643456
data O 0 0.0023496088106185198
suggest O 0 0.005158896557986736
that O 0 0.0013251681812107563
expansion O 0 0.012655116617679596
occurs O 0 0.024948494508862495
in O 0 0.0011705673532560468
two O 0 0.0016462956555187702
stages O 0 0.024282274767756462
, O 0 0.0011128585319966078
the O 0 0.001594440545886755
first O 0 0.003705340437591076
during O 0 0.013425007462501526
meiosis O 1 0.9088305830955505
followed O 0 0.009947560727596283
by O 0 0.0019112572772428393
a O 0 0.005220400169491768
second O 0 0.01411093957722187
mitotic O 1 0.9708707928657532
expansion O 0 0.020414533093571663
. O 0 0.0063418056815862656

We O 0 0.00360616366378963
also O 0 0.001504414831288159
show O 0 0.0037052121479064226
that O 0 0.0007335522095672786
in O 0 0.0007515261531807482
all O 0 0.0009860111167654395
informative O 0 0.027765728533267975
carrier O 1 0.9997339844703674
father O 0 0.02042212337255478
to O 0 0.002499182475730777
affected O 0 0.32895609736442566
child O 0 0.07650033384561539
transmissions O 0 0.09118366241455078
, O 0 0.001216120203025639
with O 0 0.0007900951895862818
the O 0 0.0017622446175664663
notable O 0 0.005387553479522467
exception O 0 0.008794297464191914
of O 0 0.0011554582742974162
the O 0 0.00457902392372489
premutation O 1 0.9999951124191284
carrier O 1 0.9981064796447754
, O 0 0.0013874168507754803
the O 0 0.0018787330482155085
expansion O 0 0.014567238278687
size O 0 0.012366382405161858
decreases O 0 0.08001979440450668
. O 0 0.0026435668114572763
. O 0 0.004157331306487322

The O 0 0.011599438264966011
R496H O 1 0.9988314509391785
mutation O 1 0.9998131394386292
of O 0 0.004011141136288643
arylsulfatase O 1 0.9998605251312256
A O 0 0.01608511433005333
does O 0 0.0030806518625468016
not O 0 0.002240001456812024
cause O 1 0.9998754262924194
metachromatic B-Disease 1 0.9999979734420776
leukodystrophy I-Disease 1 0.9999998807907104
. O 0 0.011909258551895618

Deficiency B-Disease 1 0.9999998807907104
of I-Disease 0 0.005468518007546663
arylsulfatase I-Disease 1 0.9999325275421143
A I-Disease 0 0.02752724289894104
( O 0 0.010221531614661217
ARSA O 1 0.9999916553497314
) O 0 0.00726226856932044
enzyme O 1 0.7869693040847778
activity O 0 0.032879553735256195
causes O 1 0.999951958656311
metachromatic B-Disease 1 0.9999991655349731
leukodystrophy I-Disease 1 1.0
( O 0 0.024591563269495964
MLD B-Disease 1 0.9999994039535522
) O 0 0.007997567765414715
. O 0 0.0047805458307266235

A O 0 0.014189043082296848
number O 0 0.0026447586715221405
of O 0 0.0036502820439636707
ARSA O 1 0.9999991655349731
gene O 1 0.9999555349349976
mutations O 1 0.9999687671661377
responsible O 0 0.015101330354809761
for O 0 0.0032788366079330444
MLD B-Disease 1 0.9999998807907104
have O 0 0.003390309866517782
been O 0 0.004573100246489048
identified O 0 0.015289596281945705
. O 0 0.004116435535252094

Recently O 0 0.019847918301820755
, O 0 0.0018542221514508128
the O 0 0.003651492763310671
R496H O 1 0.9999531507492065
mutation O 1 0.9998393058776855
of O 0 0.005378582049161196
ARSA O 1 0.9999959468841553
was O 0 0.007231777533888817
proposed O 0 0.004356089048087597
to O 0 0.0009138392633758485
be O 0 0.0010661574779078364
a O 0 0.0052589415572583675
cause O 1 0.5880976319313049
of O 0 0.003571168752387166
MLD B-Disease 1 1.0
( O 0 0.013760668225586414
Draghia O 1 0.9998437166213989
et O 0 0.07222731411457062
al O 0 0.026585454121232033
. O 0 0.0025693890638649464
, O 0 0.0020953442435711622
1997 O 0 0.021058805286884308
) O 0 0.004626985639333725
. O 0 0.00463459175080061

We O 0 0.0026894237380474806
have O 0 0.0017036127392202616
investigated O 0 0.016841091215610504
the O 0 0.005137099884450436
R496H O 1 0.9999853372573853
mutation O 1 0.9999940395355225
and O 0 0.0018150717951357365
found O 0 0.003172065829858184
this O 0 0.002745203208178282
mutation O 1 0.9999802112579346
at O 0 0.0031382024753838778
a O 0 0.004656524397432804
relatively O 0 0.008182176388800144
high O 0 0.00712579907849431
frequency O 0 0.02658858895301819
in O 0 0.001531977322883904
an O 0 0.002207017969340086
African O 0 0.014138408936560154
American O 0 0.008963952772319317
population O 0 0.012638724409043789
( O 0 0.009576945565640926
f O 0 0.0876646637916565
= O 0 0.047926679253578186
0 O 0 0.02992192469537258
. O 0 0.0032203637529164553
09 O 1 0.7249149084091187
, O 0 0.0034357565455138683
n O 0 0.045367900282144547
= O 0 0.04795529320836067
61 O 0 0.04021496698260307
subjects O 0 0.012054436840116978
) O 0 0.003284258069470525
. O 0 0.003985170740634203

The O 0 0.01752891018986702
ARSA O 1 0.9999833106994629
enzyme O 0 0.2926104664802551
activity O 0 0.012819511815905571
in O 0 0.0018355000065639615
subjects O 0 0.005207215901464224
with O 0 0.0010541551746428013
and O 0 0.0008271043770946562
without O 0 0.0022576807532459497
the O 0 0.0044454410672187805
R496H O 1 0.9999939203262329
mutation O 1 0.9999967813491821
was O 0 0.009040347300469875
determined O 0 0.008863217197358608
and O 0 0.000983223202638328
found O 0 0.0031593944877386093
to O 0 0.0009656831389293075
be O 0 0.002310845535248518
normal O 0 0.02166922762989998
. O 0 0.004609025549143553

It O 0 0.0038599371910095215
is O 0 0.00273381476290524
therefore O 0 0.0038019379135221243
concluded O 0 0.00869679544121027
that O 0 0.0010079420171678066
the O 0 0.0035081261303275824
R496H O 1 0.9998136162757874
mutation O 1 0.9999551773071289
of O 0 0.00589674012735486
ARSA O 1 0.9999997615814209
does O 0 0.007104853168129921
not O 0 0.0021868108306080103
negatively O 0 0.03721791133284569
influence O 0 0.005212455056607723
the O 0 0.0018015920650213957
activity O 0 0.009205298498272896
of O 0 0.0033480210695415735
ARSA O 1 0.9999991655349731
and O 0 0.001861611264757812
is O 0 0.0018948167562484741
not O 0 0.0010910970158874989
a O 0 0.005338149145245552
cause O 1 0.831501841545105
of O 0 0.0059964521788060665
MLD B-Disease 1 0.9999997615814209

Down O 0 0.03011704795062542
- O 0 0.02104668691754341
regulation O 0 0.01391535997390747
of O 0 0.0025023999623954296
transmembrane O 1 0.9993745684623718
carbonic O 1 0.9999215602874756
anhydrases O 1 0.9998527765274048
in O 0 0.010060884058475494
renal B-Disease 1 1.0
cell I-Disease 1 0.9999628067016602
carcinoma I-Disease 1 1.0
cell O 0 0.12726306915283203
lines O 0 0.007817293517291546
by O 0 0.002874010242521763
wild O 0 0.03410882502794266
- O 0 0.03367508202791214
type O 1 0.8034071922302246
von B-Disease 1 0.9968107342720032
Hippel I-Disease 1 0.999944806098938
- I-Disease 0 0.19176431000232697
Lindau I-Disease 1 0.9999306201934814
transgenes O 1 0.9890729784965515
. O 0 0.008529425598680973

To O 0 0.006271572317928076
discover O 0 0.06550601869821548
genes O 0 0.10126204788684845
involved O 0 0.008534323424100876
in O 0 0.0032951869070529938
von B-Disease 1 0.9934446811676025
Hippel I-Disease 1 0.9999816417694092
- I-Disease 1 0.6639336943626404
Lindau I-Disease 1 0.9999783039093018
( O 0 0.01801581308245659
VHL B-Disease 1 0.9999992847442627
) O 0 0.008237963542342186
- O 0 0.03989652544260025
mediated O 1 0.9951946139335632
carcinogenesis O 1 0.9997885823249817
, O 0 0.0018385287839919329
we O 0 0.001240754616446793
used O 0 0.00719547038897872
renal B-Disease 1 1.0
cell I-Disease 1 0.9998471736907959
carcinoma I-Disease 1 1.0
cell O 0 0.18829192221164703
lines O 0 0.021460801362991333
stably O 1 0.9421960711479187
transfected O 1 0.9867905974388123
with O 0 0.003898128168657422
wild O 0 0.036815304309129715
- O 0 0.04233597591519356
type O 1 0.9662059545516968
VHL O 1 0.9999990463256836
- O 0 0.052414052188396454
expressing O 0 0.05516120046377182
transgenes O 1 0.9746531844139099
. O 0 0.008287020027637482

Large O 0 0.012542304582893848
- O 0 0.0265999473631382
scale O 0 0.024834906682372093
RNA O 0 0.14453618228435516
differential O 0 0.04754792898893356
display O 0 0.005693973507732153
technology O 0 0.003201486775651574
applied O 0 0.003385233925655484
to O 0 0.0009518362348899245
these O 0 0.0011426160344853997
cell O 0 0.03576825186610222
lines O 0 0.01008455827832222
identified O 0 0.009448157623410225
several O 0 0.0022348484490066767
differentially O 1 0.995331346988678
expressed O 0 0.01544886827468872
genes O 0 0.09371805191040039
, O 0 0.0010877562453970313
including O 0 0.0010235049994662404
an O 0 0.0029925440903753042
alpha O 0 0.4976043999195099
carbonic O 1 0.9998061060905457
anhydrase O 1 0.9999328851699829
gene O 1 0.9975511431694031
, O 0 0.005032931920140982
termed O 0 0.33537524938583374
CA12 O 1 0.9998701810836792
. O 0 0.008422326296567917

The O 0 0.006177110597491264
deduced O 0 0.06327462196350098
protein O 0 0.058802224695682526
sequence O 0 0.01694602333009243
was O 0 0.00516460370272398
classified O 0 0.006766036152839661
as O 0 0.0013364088954403996
a O 0 0.004211646970361471
one O 0 0.004192298278212547
- O 0 0.023834850639104843
pass O 0 0.030134961009025574
transmembrane O 1 0.9996283054351807
CA O 0 0.0547042042016983
possessing O 0 0.012797716073691845
an O 0 0.003081174800172448
apparently O 0 0.024248722940683365
intact O 0 0.0531979463994503
catalytic O 0 0.1295035183429718
domain O 0 0.02456551231443882
in O 0 0.001454374403692782
the O 0 0.0030547420028597116
extracellular O 0 0.13802000880241394
CA O 0 0.05605310946702957
module O 0 0.05281185358762741
. O 0 0.005415921099483967

Reintroduced O 1 0.9703907370567322
wild O 0 0.0571417473256588
- O 0 0.046047598123550415
type O 1 0.7788310647010803
VHL B-Disease 1 0.99998939037323
strongly O 0 0.029711363837122917
inhibited O 1 0.9061998724937439
the O 0 0.004902835935354233
overexpression O 1 0.9866952896118164
of O 0 0.0014533899957314134
the O 0 0.004446192644536495
CA12 O 1 0.9999984502792358
gene O 1 0.9953741431236267
in O 0 0.001520584337413311
the O 0 0.004021236207336187
parental O 1 0.9999983310699463
renal B-Disease 1 1.0
cell I-Disease 1 0.9999868869781494
carcinoma I-Disease 1 1.0
cell O 1 0.5469711422920227
lines O 0 0.013537981547415257
. O 0 0.0046189106069505215

Similar O 0 0.0106880534440279
results O 0 0.006267520599067211
were O 0 0.0008746401872485876
obtained O 0 0.0025651005562394857
with O 0 0.00283652450889349
CA9 O 1 0.9999970197677612
, O 0 0.002567443996667862
encoding O 0 0.04914993420243263
another O 0 0.0145118348300457
transmembrane O 1 0.9997426867485046
CA O 0 0.034364622086286545
with O 0 0.0012351925252005458
an O 0 0.002445620484650135
intact O 0 0.053912945091724396
catalytic O 0 0.262992799282074
domain O 0 0.04218588024377823
. O 0 0.005102700088173151

Although O 0 0.006850791163742542
both O 0 0.0020864626858383417
domains O 0 0.020809998735785484
of O 0 0.0014685154892504215
the O 0 0.007692465092986822
VHL B-Disease 1 0.9999997615814209
protein O 0 0.09796562045812607
contribute O 0 0.01065117958933115
to O 0 0.0014377979096025229
regulation O 0 0.014036465436220169
of O 0 0.0032295624259859324
CA12 O 1 0.9999982118606567
expression O 0 0.026248851791024208
, O 0 0.001154920319095254
the O 0 0.0037586370017379522
elongin O 1 0.9995844960212708
binding O 0 0.03040437400341034
domain O 0 0.026807310059666634
alone O 0 0.010386093519628048
could O 0 0.00529904430732131
effectively O 0 0.0363619290292263
regulate O 0 0.11233588308095932
CA9 O 1 0.9999170303344727
expression O 0 0.05429837107658386
. O 0 0.005525893997400999

We O 0 0.0056113689206540585
mapped O 0 0.061482589691877365
CA12 O 1 0.9999287128448486
and O 0 0.007257288787513971
CA9 O 1 0.9999936819076538
loci O 1 0.9993088245391846
to O 0 0.007597729098051786
chromosome O 1 0.9998130202293396
bands O 0 0.044736284762620926
15q22 O 1 0.9880756139755249
and O 0 0.0038033919408917427
17q21 O 1 0.9997319579124451
. O 0 0.0058194054290652275

2 O 0 0.01643024943768978
respectively O 0 0.006563517730683088
, O 0 0.0018583880737423897
regions O 0 0.013871081173419952
prone O 1 0.9993315935134888
to O 0 0.0022142818197607994
amplification O 0 0.1069178581237793
in O 0 0.0014934443170204759
some O 0 0.0029878488276153803
human O 0 0.02117513306438923
cancers B-Disease 1 0.9999997615814209
. O 0 0.005977807566523552

Additional O 0 0.00948583334684372
experiments O 0 0.011133525520563126
are O 0 0.0009324955753982067
needed O 0 0.0038243711460381746
to O 0 0.0009070629603229463
define O 0 0.005816131364554167
the O 0 0.0016597812063992023
role O 0 0.006162797100841999
of O 0 0.0019217125372961164
CA O 1 0.9985185265541077
IX O 1 0.9999997615814209
and O 0 0.0029297862201929092
CA O 1 0.9973524808883667
XII O 1 0.999995231628418
enzymes O 0 0.061928801238536835
in O 0 0.0012481817975640297
the O 0 0.0019720878917723894
regulation O 0 0.016897398978471756
of O 0 0.002586183836683631
pH O 1 0.9978359341621399
in O 0 0.0018148713279515505
the O 0 0.003622878110036254
extracellular O 0 0.17998206615447998
microenvironment O 1 0.9991968274116516
and O 0 0.0013007349334657192
its O 0 0.0017426153644919395
potential O 0 0.009663492441177368
impact O 0 0.020392723381519318
on O 0 0.006025644019246101
cancer B-Disease 1 1.0
cell O 0 0.06834763288497925
growth O 0 0.014796609990298748
. O 0 0.004814475309103727

A O 0 0.038065582513809204
gene O 0 0.47352373600006104
encoding O 0 0.060549672693014145
a O 0 0.01046689786016941
transmembrane O 1 0.9832890629768372
protein O 0 0.05567855387926102
is O 0 0.0055862474255263805
mutated O 1 0.9999752044677734
in O 0 0.0035256475675851107
patients O 1 0.9999991655349731
with O 0 0.01051272451877594
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 0.022721679881215096
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 0 0.292766273021698
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 0.00798812322318554
. O 0 0.005195501260459423

Wolfram B-Disease 1 0.9999996423721313
syndrome I-Disease 1 1.0
( O 0 0.030758650973439217
WFS B-Disease 1 0.9999997615814209
; O 0 0.015764066949486732
OMIM O 1 0.9999997615814209
222300 O 1 0.9997846484184265
) O 0 0.0033244886435568333
is O 0 0.0023379167541861534
an O 0 0.007736998610198498
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 0 0.010722175240516663
by O 0 0.0030085137113928795
young O 0 0.019193409010767937
- O 0 0.29483193159103394
onset O 1 0.9999998807907104
non O 0 0.024664195254445076
- O 1 0.9824566841125488
immune O 1 1.0
insulin B-Disease 1 0.9999996423721313
- I-Disease 1 0.7378574013710022
dependent I-Disease 1 0.9960446357727051
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 0.006632631178945303
progressive O 1 0.9999997615814209
optic B-Disease 1 1.0
atrophy I-Disease 1 0.9999998807907104
. O 0 0.007125779986381531

Linkage O 0 0.09193547070026398
to O 0 0.002918272279202938
markers O 0 0.029318686574697495
on O 0 0.005409562028944492
chromosome O 1 0.9999697208404541
4p O 1 0.9999898672103882
was O 0 0.012397770769894123
confirmed O 0 0.014806163497269154
in O 0 0.0014031468890607357
five O 0 0.0030394066125154495
families O 0 0.008145015686750412
. O 0 0.005349064711481333

On O 0 0.0020291274413466454
the O 0 0.0012748445151373744
basis O 0 0.0014454210177063942
of O 0 0.002498290967196226
meiotic O 1 0.9999988079071045
recombinants O 1 0.9999929666519165
and O 0 0.008809659630060196
disease O 1 1.0
- O 0 0.04590000957250595
associated O 0 0.018170684576034546
haplotypes O 1 0.9956574440002441
, O 0 0.002136240480467677
the O 0 0.005838355980813503
WFS B-Disease 1 0.9999995231628418
gene O 1 0.9993263483047485
was O 0 0.011177746579051018
localized O 1 0.6484132409095764
to O 0 0.001601534546352923
a O 0 0.0135574359446764
BAC O 1 0.9999936819076538
/ O 1 0.9378775954246521
P1 O 1 0.9976683259010315
contig O 1 0.9921457171440125
of O 0 0.0020916357170790434
less O 0 0.0051087490282952785
than O 0 0.002986564999446273
250 O 0 0.022158507257699966
kb O 1 0.9865981340408325
. O 0 0.0067606959491968155

Mutations O 1 0.9959284663200378
in O 0 0.0026965695433318615
a O 0 0.00857293326407671
novel O 0 0.047083254903554916
gene O 1 0.9992247819900513
( O 0 0.009298070333898067
WFS1 O 1 0.999967098236084
) O 0 0.0040290760807693005
encoding O 0 0.03647429868578911
a O 0 0.011045427992939949
putative O 1 0.9921309351921082
transmembrane O 1 0.9906355738639832
protein O 0 0.055212266743183136
were O 0 0.0013765809126198292
found O 0 0.0035861539654433727
in O 0 0.0008803645614534616
all O 0 0.0012782131088897586
affected O 0 0.0804421603679657
individuals O 0 0.0038827022071927786
in O 0 0.0018232265720143914
six O 0 0.009715492837131023
WFS B-Disease 1 0.9999983310699463
families O 0 0.01118986401706934
, O 0 0.001166097936220467
and O 0 0.0007668720791116357
these O 0 0.0015902912709861994
mutations O 1 0.9999856948852539
were O 0 0.0014834969770163298
associated O 0 0.004381138365715742
with O 0 0.0010387616930529475
the O 0 0.009226440452039242
disease O 1 1.0
phenotype O 1 1.0
. O 0 0.008583156391978264

WFS1 O 1 0.9997915625572205
appears O 0 0.02809935249388218
to O 0 0.0018143256893381476
function O 0 0.009639731608331203
in O 0 0.001430888893082738
survival O 0 0.059332702308893204
of O 0 0.0032027834095060825
islet O 1 0.9996834993362427
beta O 1 0.7605801224708557
- O 0 0.05875811725854874
cells O 0 0.05559767410159111
and O 0 0.0035823392681777477
neurons O 1 0.8564314246177673
. O 0 0.00314122112467885
. O 0 0.00428331783041358

Stable O 0 0.05949779599905014
interaction O 0 0.009064258076250553
between O 0 0.0014365118695423007
the O 0 0.0014389017596840858
products O 0 0.003379245288670063
of O 0 0.0009956383146345615
the O 0 0.005393428262323141
BRCA1 O 1 1.0
and O 0 0.011614552699029446
BRCA2 O 1 1.0
tumor B-Disease 1 1.0
suppressor O 1 0.9999997615814209
genes O 0 0.18986444175243378
in O 0 0.0027991721872240305
mitotic O 1 0.9971367120742798
and O 0 0.0044190180487930775
meiotic O 1 0.9999755620956421
cells O 0 0.132280632853508
. O 0 0.006787179969251156

BRCA1 O 1 0.9999998807907104
and O 0 0.008393139578402042
BRCA2 O 1 0.9999998807907104
account O 0 0.0044400752522051334
for O 0 0.0010549260769039392
most O 0 0.0021094169933348894
cases O 0 0.005959763191640377
of O 0 0.002261147368699312
familial O 1 1.0
, O 0 0.0027325437404215336
early O 0 0.036506328731775284
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 0 0.0037390082143247128
/ I-Disease 1 0.9999071359634399
or I-Disease 1 0.8759782910346985
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.002653493545949459
encode O 0 0.03016272559762001
products O 0 0.0049431961961090565
that O 0 0.0007413073326461017
each O 0 0.0018157321028411388
interact O 0 0.014359499327838421
with O 0 0.0027677654288709164
hRAD51 O 1 0.9996095299720764
. O 0 0.0068762535229325294

Results O 0 0.013406655751168728
presented O 0 0.0035340061876922846
here O 0 0.0015321567188948393
show O 0 0.005151461809873581
that O 0 0.0032204966992139816
BRCA1 O 1 1.0
and O 0 0.007977938279509544
BRCA2 O 1 1.0
coexist O 0 0.034263577312231064
in O 0 0.0014904991257935762
a O 0 0.006660448387265205
biochemical O 0 0.04630960896611214
complex O 0 0.008139196783304214
and O 0 0.001805681036785245
colocalize O 1 0.9968194961547852
in O 0 0.004402465652674437
subnuclear O 1 0.999982476234436
foci O 1 0.9943516254425049
in O 0 0.004401018843054771
somatic O 1 0.9978109002113342
cells O 0 0.047389332205057144
and O 0 0.001223255880177021
on O 0 0.0012288580182939768
the O 0 0.0030659723561257124
axial O 1 0.5471638441085815
elements O 0 0.0036646416410803795
of O 0 0.0014691350515931845
developing O 0 0.025074908509850502
synaptonemal O 1 0.9997709393501282
complexes O 0 0.05606129765510559
. O 0 0.005487247370183468

Like O 0 0.03483942151069641
BRCA1 O 1 1.0
and O 0 0.006771088112145662
RAD51 O 1 0.9999970197677612
, O 0 0.010359534062445164
BRCA2 O 1 1.0
relocates O 1 0.9369961619377136
to O 0 0.007127702236175537
PCNA O 1 0.9987694621086121
+ O 0 0.11253917217254639
replication O 0 0.14167140424251556
sites O 0 0.006838914472609758
following O 0 0.01105749886482954
exposure O 0 0.07427238672971725
of O 0 0.0029589927289634943
S O 1 0.9924706220626831
phase O 0 0.051986243575811386
cells O 0 0.047676969319581985
to O 0 0.0049455235712230206
hydroxyurea O 1 0.9999219179153442
or O 0 0.01614963635802269
UV O 1 0.9999955892562866
irradiation O 1 0.9646201729774475
. O 0 0.007408212870359421

Thus O 0 0.01567584089934826
, O 0 0.006563747767359018
BRCA1 O 1 1.0
and O 0 0.00827625673264265
BRCA2 O 1 1.0
participate O 0 0.00860816240310669
, O 0 0.0010967112611979246
together O 0 0.0012835413217544556
, O 0 0.001042516203597188
in O 0 0.0012400958221405745
a O 0 0.008987637236714363
pathway O 1 0.9799403548240662
( O 0 0.008834101259708405
s O 0 0.08504600822925568
) O 0 0.0035110260359942913
associated O 0 0.0046139610931277275
with O 0 0.0008194903493858874
the O 0 0.002562686102464795
activation O 0 0.0971987321972847
of O 0 0.0021549679804593325
double O 0 0.02642691507935524
- O 0 0.03754010051488876
strand O 0 0.12826399505138397
break O 0 0.037738535553216934
repair O 1 0.9259548187255859
and O 0 0.004157106392085552
/ O 0 0.05573583021759987
or O 0 0.007782539818435907
homologous O 1 0.953296959400177
recombination O 0 0.313326895236969
. O 0 0.006428089924156666

Dysfunction O 1 0.9999970197677612
of O 0 0.0025251086335629225
this O 0 0.0033325357362627983
pathway O 1 0.9880698323249817
may O 0 0.007492549251765013
be O 0 0.0012052286183461547
a O 0 0.004611589480191469
general O 0 0.006376194767653942
phenomenon O 0 0.03594836965203285
in O 0 0.0010675020748749375
the O 0 0.0015109010273590684
majority O 0 0.004816314671188593
of O 0 0.0010160567471757531
cases O 0 0.006388142239302397
of O 0 0.0032377936877310276
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 0 0.004335065837949514
/ I-Disease 1 0.9999788999557495
or I-Disease 1 0.9864896535873413
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.004220775328576565
. O 0 0.00417308509349823

A O 0 0.026059800758957863
novel O 0 0.04685072600841522
Arg362Ser O 1 0.9998499155044556
mutation O 1 0.999178946018219
in O 0 0.002286420203745365
the O 0 0.0040883650071918964
sterol O 1 0.9906401634216309
27 O 0 0.03176349774003029
- O 0 0.05650044232606888
hydroxylase O 1 0.9979198575019836
gene O 1 0.997632622718811
( O 0 0.014737307094037533
CYP27 O 1 0.9999008178710938
) O 0 0.0038239203859120607
: O 0 0.0019262166460976005
its O 0 0.0023885881528258324
effects O 0 0.030894117429852486
on O 0 0.0022279624827206135
pre O 0 0.041531432420015335
- O 0 0.0294011402875185
mRNA O 0 0.07874492555856705
splicing O 0 0.13748902082443237
and O 0 0.003692053025588393
enzyme O 0 0.250441312789917
activity O 0 0.017584368586540222
. O 0 0.005266152322292328

A O 0 0.024541711434721947
novel O 0 0.032062940299510956
C O 0 0.07537827640771866
to O 0 0.002014386234804988
A O 0 0.020162049680948257
mutation O 1 0.9998646974563599
in O 0 0.0018607943784445524
the O 0 0.0034106874372810125
sterol O 1 0.9983862638473511
27 O 0 0.0282285176217556
- O 0 0.04833931475877762
hydroxylase O 1 0.9970914125442505
gene O 1 0.998275637626648
( O 0 0.01261941622942686
CYP27 O 1 0.999943733215332
) O 0 0.00425167940557003
was O 0 0.005924886558204889
identified O 0 0.009342437610030174
by O 0 0.003460268024355173
sequencing O 0 0.08568522334098816
amplified O 0 0.18685173988342285
CYP27 O 1 0.999795138835907
gene O 1 0.9822167158126831
products O 0 0.0055881282314658165
from O 0 0.0017343845684081316
a O 0 0.007637069094926119
patient O 1 0.9999517202377319
with O 0 0.005406574346125126
cerebrotendinous B-Disease 1 0.9999997615814209
xanthomatosis I-Disease 1 0.999993085861206
( O 0 0.017938198521733284
CTX B-Disease 1 0.9999997615814209
) O 0 0.00733797624707222
. O 0 0.004528580233454704

The O 0 0.01109287515282631
mutation O 1 0.9996734857559204
changed O 0 0.011615817435085773
the O 0 0.004447096027433872
adrenodoxin O 1 0.9986475110054016
cofactor O 1 0.9876745343208313
binding O 0 0.03756733983755112
residue O 0 0.15778861939907074
362Arg O 1 0.9829603433609009
to O 0 0.003690976183861494
362Ser O 1 0.9977376461029053
( O 0 0.010346855968236923
CGT O 1 0.9999039173126221
362Arg O 1 0.9996558427810669
to O 0 0.012622255831956863
AGT O 1 0.9999997615814209
362Ser O 1 0.9998358488082886
) O 0 0.0054310220293700695
, O 0 0.0011787741677835584
and O 0 0.0010359322186559439
was O 0 0.00603305920958519
responsible O 0 0.015868160873651505
for O 0 0.004919131752103567
deficiency O 1 1.0
in O 0 0.0022218364756554365
the O 0 0.003784299362450838
sterol O 1 0.9991082549095154
27 O 0 0.02912939339876175
- O 0 0.04003038629889488
hydroxylase O 1 0.9872617125511169
activity O 0 0.014645841903984547
, O 0 0.0015212548896670341
as O 0 0.0017924066632986069
confirmed O 0 0.009976626373827457
by O 0 0.0023054303601384163
expression O 0 0.01382583100348711
of O 0 0.0022743716835975647
mutant O 1 0.9984391331672668
cDNA O 0 0.13069148361682892
into O 0 0.014500383287668228
COS O 1 0.9999426603317261
- O 0 0.04428510367870331
1 O 0 0.02629109099507332
cells O 0 0.05863993614912033
. O 0 0.0061288923025131226

Quantitative O 0 0.04049285501241684
analysis O 0 0.0067824628204107285
showed O 0 0.0056743319146335125
that O 0 0.0007370059611275792
the O 0 0.0021603794302791357
expression O 0 0.01890481822192669
of O 0 0.003353526582941413
CYP27 O 1 0.9999948740005493
gene O 1 0.9916833639144897
mRNA O 0 0.04496297240257263
in O 0 0.0016349762445315719
the O 0 0.004740373697131872
patient O 1 0.9998879432678223
represented O 0 0.008996797725558281
52 O 0 0.031677599996328354
. O 0 0.004681960213929415

5 O 0 0.018176566809415817
% O 0 0.0035888163838535547
of O 0 0.001225771731697023
the O 0 0.0031372117809951305
normal O 0 0.021383069455623627
level O 0 0.007685806602239609
. O 0 0.005150447599589825

As O 0 0.004170416854321957
the O 0 0.004811681807041168
mutation O 1 0.9999810457229614
occurred O 0 0.026911716908216476
at O 0 0.0029630837962031364
the O 0 0.002773550571873784
penultimate O 1 0.981550931930542
nucleotide O 0 0.12043166905641556
of O 0 0.004732829984277487
exon O 1 0.9979972243309021
6 O 0 0.02927006222307682
( O 0 0.0067517743445932865
- O 0 0.015289072878658772
2 O 0 0.0061346981674432755
position O 0 0.00394967757165432
of O 0 0.0020850093569606543
exon O 1 0.9984070658683777
6 O 0 0.03051055781543255
- O 0 0.04936050623655319
intron O 1 0.9969256520271301
6 O 0 0.04115614295005798
splice O 1 0.6488445997238159
site O 0 0.012606678530573845
) O 0 0.001781785860657692
of O 0 0.0008925126167014241
the O 0 0.0045556314289569855
gene O 1 0.9999481439590454
, O 0 0.0014240279560908675
we O 0 0.0015557449078187346
hypothesized O 0 0.07956229895353317
that O 0 0.0014305815566331148
the O 0 0.005477395839989185
mutation O 1 0.9999990463256836
may O 0 0.013331160880625248
partially O 0 0.04943886771798134
affect O 0 0.015103863552212715
the O 0 0.002858641091734171
normal O 0 0.019626619294285774
splicing O 0 0.11018246412277222
efficiency O 0 0.012052161619067192
in O 0 0.0028749010525643826
exon O 1 0.999460756778717
6 O 0 0.015528806485235691
and O 0 0.0022633979097008705
cause O 1 0.6704962253570557
alternative O 0 0.02195165678858757
splicing O 0 0.14089149236679077
elsewhere O 0 0.010112300515174866
, O 0 0.0012202790239825845
which O 0 0.0015949406661093235
resulted O 0 0.017193911597132683
in O 0 0.0020514167845249176
decreased O 0 0.42976006865501404
transcript O 0 0.021598638966679573
in O 0 0.0013512212317436934
the O 0 0.004830042831599712
patient O 1 0.9999881982803345
. O 0 0.006307373289018869

Transfection O 0 0.39753401279449463
of O 0 0.0033235156442970037
constructed O 0 0.015389304608106613
minigenes O 1 0.9997627139091492
, O 0 0.0014637390850111842
with O 0 0.0010824739001691341
or O 0 0.0020934687927365303
without O 0 0.0028874329291284084
the O 0 0.005370420403778553
mutation O 1 0.9999933242797852
, O 0 0.002298600971698761
into O 0 0.008693552576005459
COS O 1 0.999948263168335
- O 0 0.03919157758355141
1 O 0 0.02375687099993229
cells O 0 0.04956696555018425
confirmed O 0 0.011474317871034145
that O 0 0.0008889688178896904
the O 0 0.0034523664508014917
mutant O 1 0.9999377727508545
minigene O 1 0.9996789693832397
was O 0 0.008410082198679447
responsible O 0 0.013199814595282078
for O 0 0.0015970530221238732
a O 0 0.009874717332422733
mRNA O 0 0.07873540371656418
species O 0 0.024129293859004974
alternatively O 0 0.04618816077709198
spliced O 0 0.08748070150613785
at O 0 0.00433829752728343
an O 0 0.004632553551346064
activated O 1 0.9977173805236816
cryptic O 1 0.713675320148468
5 O 0 0.020807459950447083
splice O 1 0.7778469324111938
site O 0 0.019234860315918922
88 O 0 0.05527045577764511
bp O 0 0.06663214415311813
upstream O 0 0.03399389609694481
from O 0 0.0025063154753297567
the O 0 0.0023617136757820845
3 O 0 0.008127029985189438
end O 0 0.006995220668613911
of O 0 0.0028320983983576298
exon O 1 0.9998660087585449
6 O 0 0.02406952902674675
. O 0 0.0047419131733477116

Our O 0 0.004475253634154797
data O 0 0.0020157936960458755
suggest O 0 0.0041397083550691605
that O 0 0.0008263425552286208
the O 0 0.002616909332573414
C O 0 0.18540655076503754
to O 0 0.0019809098448604345
A O 0 0.023693883791565895
mutation O 1 0.9994586110115051
at O 0 0.004889380186796188
the O 0 0.0038271346129477024
penultimate O 1 0.9935128092765808
nucleotide O 0 0.11517228931188583
of O 0 0.003368022618815303
exon O 1 0.9933013916015625
6 O 0 0.008979812264442444
of O 0 0.0011524397414177656
the O 0 0.00522238202393055
CYP27 O 1 0.9999996423721313
gene O 1 0.9988465309143066
not O 0 0.001931607024744153
only O 0 0.0029929440934211016
causes O 1 0.9947260022163391
the O 0 0.00783307384699583
deficiency B-Disease 1 1.0
in I-Disease 0 0.0022295108065009117
the I-Disease 0 0.003600103547796607
sterol I-Disease 1 0.9998476505279541
27 I-Disease 0 0.028806641697883606
- I-Disease 0 0.04030643031001091
hydroxylase I-Disease 1 0.9898231625556946
activity I-Disease 0 0.01502787135541439
, O 0 0.0015556479338556528
but O 0 0.0015290231676772237
also O 0 0.0024576003197580576
partially O 0 0.05186384916305542
leads O 0 0.016012510284781456
to O 0 0.0016503313090652227
alternative O 0 0.014346548356115818
pre O 0 0.050447870045900345
- O 0 0.028935668990015984
mRNA O 0 0.07121587544679642
splicing O 0 0.0911535993218422
of O 0 0.0020569320768117905
the O 0 0.006421722937375307
gene O 1 0.9940003156661987
. O 0 0.006917559076100588

To O 0 0.002734394511207938
our O 0 0.0021914958488196135
knowledge O 0 0.003262113081291318
, O 0 0.0010498830815777183
this O 0 0.001152039272710681
is O 0 0.0018542750040069222
the O 0 0.0014758193865418434
first O 0 0.002619529142975807
report O 0 0.0025301508139818907
regarding O 0 0.004221212584525347
effects O 0 0.03484120965003967
on O 0 0.0025727099273353815
pre O 0 0.04653368890285492
- O 0 0.02763672173023224
mRNA O 0 0.0637127235531807
splicing O 0 0.08302793651819229
of O 0 0.0016866734949871898
a O 0 0.011623458005487919
mutation O 1 0.9999790191650391
at O 0 0.005108516197651625
the O 0 0.0034398604184389114
- O 0 0.019542226567864418
2 O 0 0.007000470068305731
position O 0 0.0037585708778351545
of O 0 0.0009721154347062111
a O 0 0.006949364207684994
5 O 0 0.016135945916175842
splice O 1 0.9702394604682922
site O 0 0.014932838268578053
. O 0 0.004280931781977415

ATM O 1 0.9923158884048462
germline O 1 0.9998427629470825
mutations O 1 0.9969658255577087
in O 0 0.002626192755997181
classical O 0 0.014409425668418407
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999452829360962
telangiectasia I-Disease 1 1.0
patients O 1 0.9999990463256836
in O 0 0.00142488197889179
the O 0 0.0024532275274395943
Dutch O 0 0.034280166029930115
population O 0 0.01190645806491375
. O 0 0.003979609813541174

Germline O 1 0.9999098777770996
mutations O 1 0.9992997646331787
in O 0 0.002617977326735854
the O 0 0.004846584517508745
ATM O 1 0.9969082474708557
gene O 1 0.990786075592041
are O 0 0.0009540369501337409
responsible O 0 0.007981940172612667
for O 0 0.0014667893992736936
the O 0 0.009647970087826252
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999933242797852
telangiectasia I-Disease 1 1.0
( O 0 0.014004101045429707
A B-Disease 1 0.9998624324798584
- I-Disease 1 0.997600257396698
T I-Disease 1 0.9999966621398926
) O 0 0.005304842721670866
. O 0 0.00454205647110939

In O 0 0.0034793978556990623
our O 0 0.003524361178278923
study O 0 0.0038323162589222193
, O 0 0.001024032710120082
we O 0 0.0008803135133348405
have O 0 0.0011433264007791877
determined O 0 0.00788887869566679
the O 0 0.003882552497088909
ATM O 1 0.9915071129798889
mutation O 1 0.9999217987060547
spectrum O 0 0.042674411088228226
in O 0 0.0013567776186391711
19 O 0 0.008061830885708332
classical O 0 0.004431290552020073
A B-Disease 1 0.9615179896354675
- I-Disease 1 0.999823272228241
T I-Disease 1 1.0
patients O 1 0.9999988079071045
, O 0 0.0013177769724279642
including O 0 0.001143525238148868
some O 0 0.002221320988610387
immigrant O 0 0.048745397478342056
populations O 0 0.04349273815751076
, O 0 0.001413826597854495
as O 0 0.001314717112109065
well O 0 0.0012555938446894288
as O 0 0.0014326785458251834
12 O 0 0.0036872080527246
of O 0 0.0012409011833369732
Dutch O 0 0.029255829751491547
ethnic O 0 0.008909312076866627
origin O 0 0.010443010367453098
. O 0 0.005589538253843784

Both O 0 0.0032879889477044344
the O 0 0.0031367361079901457
protein O 0 0.08689525723457336
truncation O 1 0.9866494536399841
test O 0 0.03086160123348236
( O 0 0.007600749842822552
PTT O 1 0.9843654632568359
) O 0 0.0025997308548539877
and O 0 0.0006828440818935633
the O 0 0.002414982533082366
restriction O 0 0.07026480883359909
endonuclease O 1 0.9998592138290405
fingerprinting O 0 0.07226232439279556
( O 0 0.01205348875373602
REF O 1 0.9996902942657471
) O 0 0.004609891679137945
method O 0 0.006466445047408342
were O 0 0.001162238302640617
used O 0 0.001620422350242734
and O 0 0.0008882364491000772
compared O 0 0.00568210706114769
for O 0 0.0009583708015270531
their O 0 0.0018965814961120486
detection O 0 0.042370013892650604
efficiency O 0 0.012101292610168457
, O 0 0.0022668668534606695
identifying O 0 0.031203866004943848
76 O 0 0.061440713703632355
% O 0 0.004235712345689535
and O 0 0.0010503247613087296
60 O 0 0.006464153993874788
% O 0 0.002261308953166008
of O 0 0.0011505645234137774
the O 0 0.005605957470834255
mutations O 1 0.9999880790710449
, O 0 0.0025720775593072176
respectively O 0 0.009348209016025066
. O 0 0.004363979212939739

Most O 0 0.01876504346728325
patients O 1 0.9999915361404419
were O 0 0.0014276746660470963
found O 0 0.0026086235884577036
to O 0 0.0010273120133206248
be O 0 0.0023983686696738005
compound O 0 0.047661058604717255
heterozygote O 1 0.9977854490280151
. O 0 0.00898334477096796

Seventeen O 0 0.11615051329135895
mutations O 1 0.9997392296791077
were O 0 0.0021090032532811165
distinct O 0 0.00978111382573843
, O 0 0.000832627119962126
of O 0 0.000772060186136514
which O 0 0.001556146307848394
10 O 0 0.003456143429502845
were O 0 0.0011525304289534688
not O 0 0.0016553221503272653
reported O 0 0.012802819721400738
previously O 0 0.0071068378165364265
. O 0 0.004635362420231104

Mutations O 1 0.9997658133506775
are O 0 0.0021665990352630615
small O 0 0.007140686269849539
deletions O 0 0.3251107335090637
or O 0 0.005032751243561506
point O 0 0.01311798021197319
mutations O 1 0.9992110729217529
frequently O 0 0.024660181254148483
affecting O 0 0.10152829438447952
splice O 1 0.9931086301803589
sites O 0 0.010413880459964275
. O 0 0.004935316741466522

Moreover O 0 0.028694940730929375
, O 0 0.0022088950499892235
a O 0 0.006355100777000189
16 O 0 0.010723809711635113
. O 0 0.004607085138559341

7 O 0 0.02963867038488388
- O 0 0.04673492908477783
kb O 1 0.9549900889396667
genomic O 0 0.3038822412490845
deletion O 1 0.854080319404602
of O 0 0.001655709114857018
the O 0 0.002465115627273917
3 O 0 0.00793636403977871
end O 0 0.005146176088601351
of O 0 0.0010721759172156453
the O 0 0.004559718072414398
gene O 1 0.9999332427978516
, O 0 0.0016604275442659855
most O 0 0.0022404342889785767
likely O 0 0.00873633474111557
a O 0 0.005291586741805077
result O 0 0.007534967735409737
of O 0 0.0020412548910826445
recombination O 0 0.19836407899856567
between O 0 0.0023790523409843445
two O 0 0.0016127671115100384
LINE O 0 0.01322038285434246
elements O 0 0.0047450195997953415
, O 0 0.0015411407221108675
was O 0 0.007798226084560156
identified O 0 0.018415629863739014
. O 0 0.005345407873392105

The O 0 0.004371435847133398
most O 0 0.002985459053888917
frequently O 0 0.009842228144407272
found O 0 0.014530252665281296
mutation O 1 0.9999872446060181
, O 0 0.00247494806535542
identified O 0 0.006805678363889456
in O 0 0.0009066935162991285
three O 0 0.0016145786503329873
unrelated O 0 0.023019274696707726
Turkish O 0 0.020158613100647926
A B-Disease 1 0.9961305856704712
- I-Disease 1 0.9945212602615356
T I-Disease 1 0.9999982118606567
individuals O 0 0.006510919891297817
, O 0 0.001835901872254908
was O 0 0.006594499107450247
previously O 0 0.005891892127692699
described O 0 0.007056243252009153
to O 0 0.0008758573094382882
be O 0 0.0010161870159208775
a O 0 0.004493658896535635
Turkish O 0 0.01647685095667839
A B-Disease 0 0.29635950922966003
- I-Disease 0 0.37682977318763733
T I-Disease 1 0.999996542930603
founder O 1 0.9187737107276917
mutation O 1 0.9999518394470215
. O 0 0.008297830820083618

The O 0 0.004592738579958677
presence O 0 0.0071403649635612965
of O 0 0.0012647246476262808
a O 0 0.009874697774648666
founder O 1 0.8770958781242371
mutation O 1 0.999966025352478
among O 0 0.0068357414565980434
relatively O 0 0.00964069738984108
small O 0 0.0039739166386425495
ethnic O 0 0.006103888154029846
population O 0 0.00720773683860898
groups O 0 0.002102701459079981
in O 0 0.001229919958859682
Western O 0 0.0043989988043904305
Europe O 0 0.005267062224447727
could O 0 0.0026586889289319515
indicate O 0 0.006549051031470299
a O 0 0.005194040481001139
high O 0 0.00999991875141859
carrier O 1 0.9787310361862183
frequency O 0 0.03493067994713783
in O 0 0.0014325262745842338
such O 0 0.0012178033357486129
communities O 0 0.009483975358307362
. O 0 0.004791486542671919

In O 0 0.008328706957399845
patients O 1 0.9993547797203064
of O 0 0.002136604394763708
Dutch O 0 0.026460345834493637
ethnic O 0 0.007033331785351038
origin O 0 0.006496611051261425
, O 0 0.001333286170847714
however O 0 0.002142266370356083
, O 0 0.0009699303773231804
no O 0 0.0016883895732462406
significant O 0 0.007518987637013197
founder O 0 0.03978784382343292
effect O 0 0.014834079891443253
could O 0 0.003065983997657895
be O 0 0.002007826464250684
identified O 0 0.013844143599271774
. O 0 0.004168745595961809

The O 0 0.007381552364677191
observed O 0 0.023792361840605736
genetic O 0 0.098398357629776
heterogeneity O 0 0.15408453345298767
including O 0 0.0014014429179951549
the O 0 0.001739524770528078
relative O 0 0.009389028884470463
high O 0 0.005195264704525471
percentage O 0 0.006950075272470713
of O 0 0.002708860905840993
splice O 1 0.9988433122634888
- O 0 0.029340090230107307
site O 0 0.018184330314397812
mutations O 1 0.9998464584350586
had O 0 0.004253676161170006
no O 0 0.001675968524068594
reflection O 0 0.013528101146221161
on O 0 0.0015422271098941565
the O 0 0.006879501976072788
phenotype O 1 0.9999994039535522
. O 0 0.007996470667421818

All O 0 0.0077745672315359116
patients O 1 0.9999076128005981
manifested O 0 0.32495397329330444
classical O 0 0.00702313520014286
A B-Disease 1 0.6471996307373047
- I-Disease 1 0.9192695021629333
T I-Disease 1 0.9999974966049194
and O 0 0.001693323371000588
increased O 0 0.014127220958471298
cellular O 0 0.1101624071598053
radioresistant O 1 0.9985858201980591
DNA O 0 0.0763835534453392
synthesis O 0 0.04941196367144585
. O 0 0.005518420599400997

Determination O 0 0.021189164370298386
of O 0 0.0012909950455650687
the O 0 0.003068887162953615
genomic O 0 0.12221024185419083
structure O 0 0.004763072822242975
of O 0 0.0008830951410345733
the O 0 0.00479530543088913
COL4A4 O 1 0.9999971389770508
gene O 1 0.9895052313804626
and O 0 0.0010761742014437914
of O 0 0.0011749985860660672
novel O 0 0.3715033531188965
mutations O 1 0.9999997615814209
causing O 1 0.9999991655349731
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.011336471885442734

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 0.0036934108939021826
a O 0 0.008662085048854351
progressive O 1 0.999991774559021
hematuric B-Disease 1 0.9999996423721313
glomerulonephritis I-Disease 1 1.0
characterized O 1 0.9790011048316956
by O 0 0.006819470319896936
glomerular B-Disease 1 0.9999998807907104
basement I-Disease 1 0.9844693541526794
membrane I-Disease 1 0.9868066906929016
abnormalities I-Disease 1 0.9999821186065674
and O 0 0.002550744917243719
associated O 0 0.007722215726971626
with O 0 0.002256758278235793
mutations O 1 0.9996114373207092
in O 0 0.0016023925272747874
either O 0 0.0035327691584825516
the O 0 0.0036236182786524296
COL4A3 O 1 0.9999911785125732
or O 0 0.004784486256539822
the O 0 0.0056510972790420055
COL4A4 O 1 0.9999992847442627
gene O 1 0.9992783665657043
, O 0 0.0015987958759069443
which O 0 0.0014320736518129706
encode O 0 0.023084009066224098
the O 0 0.003940471913665533
alpha3 O 1 0.991046130657196
and O 0 0.003341991687193513
alpha4 O 1 0.9999003410339355
type O 1 0.9962702989578247
IV O 1 0.9999998807907104
collagen O 1 0.9999998807907104
chains O 1 0.8589403629302979
, O 0 0.002377300290390849
respectively O 0 0.008001787588000298
. O 0 0.004213918931782246

To O 0 0.0035516079515218735
date O 0 0.00717698410153389
, O 0 0.003678942332044244
mutation O 1 0.9999840259552002
screening O 0 0.04940452799201012
in O 0 0.0012683359673246741
the O 0 0.0016975307371467352
two O 0 0.0019945893436670303
genes O 0 0.208053857088089
has O 0 0.004263385199010372
been O 0 0.005481244996190071
hampered O 1 0.9916451573371887
by O 0 0.00213135895319283
the O 0 0.0020282105542719364
lack O 0 0.008853085339069366
of O 0 0.0018924545729532838
genomic O 1 0.8673699498176575
structure O 0 0.007155481725931168
information O 0 0.0016117463819682598
. O 0 0.004014668986201286

We O 0 0.0025931624695658684
report O 0 0.002561606466770172
here O 0 0.0013675946975126863
the O 0 0.001698712701909244
complete O 0 0.00664497958496213
characterization O 0 0.01937352679669857
of O 0 0.0010309007484465837
the O 0 0.0028822056483477354
48 O 0 0.021147513762116432
exons O 0 0.3063732385635376
of O 0 0.001455420395359397
the O 0 0.005789392162114382
COL4A4 O 1 0.9999978542327881
gene O 1 0.9996161460876465
, O 0 0.0018451455980539322
a O 0 0.006015647202730179
comprehensive O 0 0.026544319465756416
gene O 1 0.9995009899139404
screen O 0 0.02455543540418148
, O 0 0.0010939175263047218
and O 0 0.0006800793344154954
the O 0 0.002168908016756177
subsequent O 0 0.01936567761003971
detection O 0 0.028916141018271446
of O 0 0.0013197308871895075
10 O 0 0.00514610018581152
novel O 0 0.028513239696621895
mutations O 1 0.9996169805526733
in O 0 0.0019801058806478977
eight O 0 0.010631369426846504
patients O 1 1.0
diagnosed O 1 1.0
with O 0 0.03250851482152939
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.010516376234591007

Furthermore O 0 0.028927765786647797
, O 0 0.0015383119462057948
we O 0 0.0014847676502540708
identified O 0 0.009725778363645077
a O 0 0.007467058952897787
glycine O 1 0.6889544725418091
to O 0 0.003382630180567503
alanine O 0 0.16815799474716187
substitution O 0 0.04022864252328873
in O 0 0.0019772977102547884
the O 0 0.005031552165746689
collagenous O 1 0.9996635913848877
domain O 0 0.030236193910241127
that O 0 0.0016029028920456767
is O 0 0.0036108801141381264
apparently O 0 0.01962074264883995
silent O 0 0.04224121570587158
in O 0 0.0015686533879488707
the O 0 0.005762122571468353
heterozygous O 1 0.9999934434890747
carriers O 1 0.9167381525039673
, O 0 0.0019907543901354074
in O 0 0.0016761074075475335
11 O 0 0.00999224092811346
. O 0 0.004366070032119751

5 O 0 0.016900725662708282
% O 0 0.0034286929294466972
of O 0 0.0008926201844587922
all O 0 0.0013519837521016598
control O 0 0.025648515671491623
individuals O 0 0.0042726038955152035
, O 0 0.0010960014769807458
and O 0 0.0006555744912475348
in O 0 0.0010774831753224134
one O 0 0.0027987768407911062
control O 0 0.019351651892066002
individual O 0 0.006122981198132038
homozygous O 1 0.9993013143539429
for O 0 0.0017365638632327318
this O 0 0.0031922932248562574
glycine O 1 0.8546552658081055
substitution O 0 0.07103976607322693
. O 0 0.005879925563931465

There O 0 0.0044379644095897675
has O 0 0.0032227521296590567
been O 0 0.003171575954183936
no O 0 0.0017082187114283442
previous O 0 0.0037602318916469812
finding O 0 0.005099338945001364
of O 0 0.0014653332764282823
a O 0 0.011381500400602818
glycine O 1 0.9384309649467468
substitution O 0 0.047761544585227966
that O 0 0.0013467976823449135
is O 0 0.002523521427065134
not O 0 0.001398613560013473
associated O 0 0.004699633922427893
with O 0 0.0008508972241543233
any O 0 0.0025956244207918644
obvious O 0 0.059485502541065216
phenotype O 1 0.9999988079071045
in O 0 0.00555451912805438
homozygous O 1 0.9999722242355347
individuals O 0 0.006277923472225666
. O 0 0.004157280549407005

Founder O 1 0.9717311263084412
BRCA1 O 1 1.0
and O 0 0.010147687047719955
BRCA2 O 1 1.0
mutations O 1 0.9996442794799805
in O 0 0.0018515746342018247
French O 0 0.021443361416459084
Canadian O 1 0.992999792098999
breast B-Disease 1 1.0
and I-Disease 1 0.8305360674858093
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.015233376994729042
. O 0 0.004507635720074177

We O 0 0.0028002732433378696
have O 0 0.0014697718434035778
identified O 0 0.00864596851170063
four O 0 0.00382051058113575
mutations O 1 0.9993853569030762
in O 0 0.0008930030162446201
each O 0 0.000785193289630115
of O 0 0.0009960581082850695
the O 0 0.011708415113389492
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
- O 1 0.9732298851013184
susceptibility O 1 0.9999960660934448
genes O 1 0.986072301864624
, O 0 0.004822393413633108
BRCA1 O 1 1.0
and O 0 0.0064358701929450035
BRCA2 O 1 1.0
, O 0 0.0013714932138100266
in O 0 0.001121970941312611
French O 0 0.03997191786766052
Canadian O 1 0.9994344115257263
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.044344235211610794
breast B-Disease 1 1.0
/ I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.011758001521229744
from O 0 0.004075967241078615
Quebec O 1 0.9557449817657471
. O 0 0.0059180110692977905

To O 0 0.004342299420386553
identify O 0 0.01826929673552513
founder O 0 0.05444841831922531
effects O 0 0.1228785589337349
, O 0 0.0013260272098705173
we O 0 0.0011920178076252341
examined O 0 0.020293645560741425
independently O 0 0.01001841202378273
ascertained O 0 0.08597569912672043
French O 0 0.033601440489292145
Canadian O 1 0.9759123921394348
cancer B-Disease 1 1.0
families O 0 0.007265283726155758
for O 0 0.000823451264295727
the O 0 0.0015227831900119781
distribution O 0 0.004553847946226597
of O 0 0.0008252154220826924
these O 0 0.0008309894474223256
eight O 0 0.007966809906065464
mutations O 1 0.9999833106994629
. O 0 0.00557094719260931

Mutations O 1 0.9996793270111084
were O 0 0.002431674860417843
found O 0 0.003871857887133956
in O 0 0.001535368268378079
41 O 0 0.01704760268330574
of O 0 0.0019631334580481052
97 O 0 0.050196606665849686
families O 0 0.012085014954209328
. O 0 0.0055998568423092365

Six O 0 0.004930285271257162
of O 0 0.0014353831065818667
eight O 0 0.008590535260736942
mutations O 1 0.9998841285705566
were O 0 0.0025342816952615976
observed O 0 0.011406008154153824
at O 0 0.0035698050633072853
least O 0 0.008308224380016327
twice O 0 0.018160013481974602
. O 0 0.005557801574468613

The O 0 0.02011711150407791
BRCA1 O 1 1.0
C4446T O 1 0.9999847412109375
mutation O 1 0.9999854564666748
was O 0 0.005221086088567972
the O 0 0.0014470821479335427
most O 0 0.0028059978503733873
common O 0 0.02029123716056347
mutation O 1 0.9999991655349731
found O 0 0.005106654949486256
, O 0 0.0008714690338820219
followed O 0 0.004759774077683687
by O 0 0.0019493455765768886
the O 0 0.006785678677260876
BRCA2 O 1 1.0
8765delAG O 1 0.9999957084655762
mutation O 1 0.9999886751174927
. O 0 0.008134644478559494

Together O 0 0.005054904613643885
, O 0 0.00181539764162153
these O 0 0.0022193884942680597
mutations O 1 0.9998791217803955
were O 0 0.0018296786583960056
found O 0 0.003912101034075022
in O 0 0.0016606742283329368
28 O 0 0.008259110152721405
of O 0 0.0014209712389856577
41 O 0 0.022570574656128883
families O 0 0.006043058354407549
identified O 0 0.00816869456321001
to O 0 0.0008676580036990345
have O 0 0.0015601440099999309
a O 0 0.012415900826454163
mutation O 1 0.9999922513961792
. O 0 0.006658335216343403

The O 0 0.006272980943322182
odds O 0 0.029505599290132523
of O 0 0.0016108910785987973
detection O 0 0.027061354368925095
of O 0 0.0006778553943149745
any O 0 0.0007504355744458735
of O 0 0.0005325170932337642
the O 0 0.002252771984785795
four O 0 0.009342583827674389
BRCA1 O 1 1.0
mutations O 1 0.9999974966049194
was O 0 0.010593907907605171
18 O 0 0.008917209692299366
. O 0 0.004055866971611977

7x O 1 0.9982028007507324
greater O 0 0.011068730615079403
if O 0 0.0026917934883385897
one O 0 0.001848673913627863
or O 0 0.0017796708270907402
more O 0 0.0012333638733252883
cases O 0 0.009606567211449146
of O 0 0.014162415638566017
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.0021202194038778543
also O 0 0.0011339978082105517
present O 0 0.0013168336590752006
in O 0 0.0008417901117354631
the O 0 0.0027449135668575764
family O 0 0.015601548366248608
. O 0 0.004804006777703762

The O 0 0.0059431870467960835
odds O 0 0.030589396134018898
of O 0 0.0018263236852362752
detection O 0 0.02733682654798031
of O 0 0.0007150013698264956
any O 0 0.0008843020186759531
of O 0 0.0005389885045588017
the O 0 0.0020669724326580763
four O 0 0.00637722248211503
BRCA2 O 1 1.0
mutations O 1 0.9999954700469971
was O 0 0.009483635425567627
5 O 0 0.009387560188770294
. O 0 0.004301374778151512

3x O 1 0.9632089734077454
greater O 0 0.009875276125967503
if O 0 0.0027262787334620953
there O 0 0.0012286314740777016
were O 0 0.0009305811254307628
at O 0 0.002125748200342059
least O 0 0.004169763065874577
five O 0 0.0027018953114748
cases O 0 0.010154434479773045
of O 0 0.0066296812146902084
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.00200863229110837
the O 0 0.0029612320940941572
family O 0 0.01718863472342491
. O 0 0.005190571770071983

Interestingly O 0 0.07693658769130707
, O 0 0.001268838532269001
the O 0 0.0013004681095480919
presence O 0 0.0047487071715295315
of O 0 0.001428145100362599
a O 1 0.9402651786804199
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
case O 0 0.028222788125276566
< O 1 0.9966183304786682
36 O 0 0.01447096187621355
years O 0 0.002220454392954707
of O 0 0.0010899739572778344
age O 0 0.00918077677488327
was O 0 0.005400460213422775
strongly O 0 0.009927734732627869
predictive O 0 0.06496842950582504
of O 0 0.0009319987148046494
the O 0 0.0015454613603651524
presence O 0 0.004890633746981621
of O 0 0.0005675401189364493
any O 0 0.0008706921944394708
of O 0 0.0007410322432406247
the O 0 0.0023542093113064766
eight O 0 0.009108385071158409
mutations O 1 0.9999779462814331
screened O 0 0.10786957293748856
. O 0 0.005835440941154957

Carriers O 0 0.08103673905134201
of O 0 0.0012860811548307538
the O 0 0.002382650738582015
same O 0 0.009132827632129192
mutation O 1 0.9999991655349731
, O 0 0.0017508866731077433
from O 0 0.0013404798228293657
different O 0 0.000897211953997612
families O 0 0.004374589771032333
, O 0 0.0012738584773615003
shared O 0 0.006395643576979637
similar O 0 0.008755389600992203
haplotypes O 1 0.9981253743171692
, O 0 0.001894244342111051
indicating O 0 0.00910754594951868
that O 0 0.0008556923130527139
the O 0 0.0037398787681013346
mutant O 1 0.9999780654907227
alleles O 1 0.9999840259552002
were O 0 0.002300423104315996
likely O 0 0.006139092613011599
to O 0 0.0009183650836348534
be O 0 0.0013807627838104963
identical O 0 0.007022832985967398
by O 0 0.00303219654597342
descent O 0 0.03010164573788643
for O 0 0.001796434517018497
a O 0 0.011301257647573948
mutation O 1 0.9998961687088013
in O 0 0.0019854020792990923
the O 0 0.0030312426388263702
founder O 0 0.039114873856306076
population O 0 0.01025613583624363
. O 0 0.004500009585171938

The O 0 0.0037125032395124435
identification O 0 0.006768561899662018
of O 0 0.0012981334002688527
common O 0 0.12867672741413116
BRCA1 O 1 1.0
and O 0 0.008742312900722027
BRCA2 O 1 1.0
mutations O 1 0.9999723434448242
will O 0 0.001690197386778891
facilitate O 0 0.009926957078278065
carrier O 1 0.6215673089027405
detection O 0 0.032045163214206696
in O 0 0.0016045307274907827
French O 0 0.024483731016516685
Canadian O 1 0.9992889165878296
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.02304999716579914
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.01978452317416668
. O 0 0.004772406071424484

Are O 0 0.003530728630721569
Dp71 O 1 0.9985644221305847
and O 0 0.004444580525159836
Dp140 O 1 0.9999918937683105
brain O 1 0.999998927116394
dystrophin O 1 0.999992847442627
isoforms O 1 0.590056836605072
related O 0 0.006458739284425974
to O 0 0.0018282162491232157
cognitive B-Disease 1 0.9977510571479797
impairment I-Disease 1 0.9999984502792358
in O 0 0.009987040422856808
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.6050438284873962

Molecular O 0 0.05022270977497101
study O 0 0.005626264493912458
and O 0 0.002040605992078781
neuropsychological O 1 0.7903053760528564
analysis O 0 0.00448666512966156
were O 0 0.0012773519847542048
performed O 0 0.00658133951947093
concurrently O 0 0.0064825695008039474
on O 0 0.0018871946958824992
49 O 0 0.041570596396923065
patients O 1 0.9999910593032837
with O 0 0.01047738827764988
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.8739657998085022
DMD B-Disease 1 1.0
) O 0 0.004923519678413868
in O 0 0.001117847627028823
order O 0 0.0017037319485098124
to O 0 0.0010188553715124726
find O 0 0.004398701246827841
a O 0 0.00640692887827754
molecular O 0 0.02085586078464985
explanation O 0 0.006659477483481169
for O 0 0.0011198102729395032
the O 0 0.002736772643402219
cognitive B-Disease 1 0.9957457184791565
impairment I-Disease 1 0.9999970197677612
observed O 0 0.012684432789683342
in O 0 0.0017861095257103443
most O 0 0.013023891486227512
DMD B-Disease 1 1.0
patients O 1 0.999998927116394
. O 0 0.006519317626953125

Complete O 0 0.009564380161464214
analysis O 0 0.0033669567201286554
of O 0 0.0012196027673780918
the O 0 0.007586656138300896
dystrophin O 1 0.9999990463256836
gene O 1 0.9987885355949402
was O 0 0.009699647314846516
performed O 0 0.007758766412734985
to O 0 0.0012837318936362863
define O 0 0.005619637202471495
the O 0 0.0022048507817089558
localization O 0 0.047397445887327194
of O 0 0.0020693019032478333
deletions O 1 0.9847796559333801
and O 0 0.002059484366327524
duplications O 1 0.9895074963569641
in O 0 0.0013492093421518803
relation O 0 0.005132786463946104
to O 0 0.0008242264157161117
the O 0 0.0022927247919142246
different O 0 0.004495126660913229
DMD B-Disease 1 1.0
promoters O 1 0.9941692352294922
. O 0 0.0069000995717942715

Qualitative O 0 0.027235856279730797
analysis O 0 0.004095008131116629
of O 0 0.0011307552922517061
the O 0 0.005026723258197308
Dp71 O 1 0.9997857213020325
transcript O 0 0.04023716598749161
and O 0 0.0019011932890862226
testing O 0 0.012271322309970856
for O 0 0.0008774791494943202
the O 0 0.0012742533581331372
specific O 0 0.002540042856708169
first O 0 0.004746111575514078
exon O 1 0.997199296951294
of O 0 0.0036701352801173925
Dp140 O 1 0.998279333114624
were O 0 0.001778050442226231
also O 0 0.0014040451496839523
carried O 0 0.004852759186178446
out O 0 0.0032485302072018385
. O 0 0.003976163920015097

Neuropsychological O 1 0.6308931112289429
analysis O 0 0.012424341402947903
assessed O 0 0.03479241952300072
verbal O 0 0.04452263191342354
and O 0 0.0030105721671134233
visuospatial O 1 0.999873161315918
intelligence O 0 0.009053569287061691
, O 0 0.0022637664806097746
verbal O 0 0.06453020125627518
memory O 1 0.7290070056915283
, O 0 0.0013372029643505812
and O 0 0.0008864077390171587
reading O 0 0.005685464479029179
skills O 0 0.012843689881265163
. O 0 0.004608395509421825

Comparison O 0 0.019247163087129593
of O 0 0.0019842754118144512
molecular O 0 0.022627471014857292
and O 0 0.0020232361275702715
psychometric O 1 0.7939081192016602
findings O 0 0.011095371097326279
demonstrated O 0 0.010156399570405483
that O 0 0.0017649433575570583
deletions O 0 0.32004091143608093
and O 0 0.0022286761086434126
duplications O 1 0.9791960716247559
that O 0 0.0015061900485306978
were O 0 0.0018638561014086008
localized O 1 0.9528465867042542
in O 0 0.0013297757832333446
the O 0 0.004640332888811827
distal O 1 0.9999985694885254
part O 0 0.0049776434898376465
of O 0 0.001272162888199091
the O 0 0.0056033688597381115
gene O 1 0.9999618530273438
seemed O 0 0.013336273841559887
to O 0 0.00123602116946131
be O 0 0.0022418515291064978
preferentially O 0 0.19967041909694672
associated O 0 0.008305294439196587
with O 0 0.003077142173424363
cognitive B-Disease 1 0.9934722185134888
impairment I-Disease 1 0.9999655485153198
. O 0 0.007446927484124899

Two O 0 0.004951599985361099
altered O 0 0.056986622512340546
Dp71 O 1 0.9533706307411194
transcripts O 0 0.009929252788424492
and O 0 0.0010261792922392488
two O 0 0.0018292440799996257
deleted O 0 0.0737670436501503
Dp140 O 1 0.9870539307594299
DNA O 0 0.06417891383171082
sequences O 0 0.023736564442515373
were O 0 0.0011030833702534437
found O 0 0.0020249292720109224
in O 0 0.000884622277226299
four O 0 0.0036391853354871273
patients O 1 0.9999997615814209
with O 0 0.007542852312326431
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 0 0.008975448086857796

These O 0 0.00251601031050086
findings O 0 0.00797296967357397
suggest O 0 0.005319633055478334
that O 0 0.0009743037517182529
some O 0 0.0019531736616045237
sequences O 0 0.02259785681962967
located O 0 0.006635220255702734
in O 0 0.0015642896760255098
the O 0 0.005419908557087183
distal O 1 0.9999762773513794
part O 0 0.006805510260164738
of O 0 0.0013913644943386316
the O 0 0.004782865289598703
gene O 1 0.9998358488082886
and O 0 0.0012735921191051602
, O 0 0.0008786232210695744
in O 0 0.0009078860748559237
particular O 0 0.0037527887616306543
, O 0 0.00136618094984442
some O 0 0.005589373875409365
DMD B-Disease 1 1.0
isoforms O 1 0.9099188446998596
expressed O 0 0.006763562560081482
in O 0 0.001398758846335113
the O 0 0.006231653969734907
brain O 1 0.9999998807907104
may O 0 0.008080155588686466
be O 0 0.0011486969888210297
related O 0 0.003392925951629877
to O 0 0.0008869102457538247
the O 0 0.0037919473834335804
cognitive B-Disease 1 0.9980596899986267
impairment I-Disease 1 0.9999977350234985
associated O 0 0.014375105500221252
with O 0 0.006776961963623762
DMD B-Disease 1 1.0
. O 0 0.004442833364009857
. O 0 0.003988466691225767

I1307K O 1 0.9987911581993103
APC O 1 0.9999785423278809
and O 0 0.005606217309832573
hMLH1 O 1 0.9999810457229614
mutations O 1 0.9985498785972595
in O 0 0.0021927841007709503
a O 0 0.005892581772059202
non O 0 0.00993864331394434
- O 0 0.016624270007014275
Jewish O 0 0.009168353863060474
family O 0 0.008395365439355373
with O 0 0.0023301930632442236
hereditary B-Disease 1 1.0
non I-Disease 1 0.9321638941764832
- I-Disease 1 0.9999969005584717
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.009584276005625725

We O 0 0.0030353162437677383
describe O 0 0.0077133020386099815
a O 0 0.004202195908874273
French O 0 0.01533766370266676
Canadian O 0 0.06434781104326248
hereditary B-Disease 1 0.9999998807907104
non I-Disease 1 0.8874748945236206
- I-Disease 1 0.9999916553497314
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.03395850956439972
HNPCC B-Disease 1 1.0
) O 0 0.008550294674932957
kindred O 1 0.9999935626983643
which O 0 0.0019056721357628703
carries O 0 0.008458358235657215
a O 0 0.006038520019501448
novel O 0 0.03631414473056793
truncating O 1 0.999890923500061
mutation O 1 0.999983549118042
in O 0 0.005453961901366711
hMLH1 O 1 0.9996210336685181
. O 0 0.0061899335123598576

Interestingly O 0 0.07753886282444
, O 0 0.0018704044632613659
the O 0 0.005017097108066082
I1307K O 1 0.9999659061431885
APC O 1 0.9999990463256836
polymorphism O 1 0.9893925189971924
, O 0 0.001915190601721406
associated O 0 0.003949561156332493
with O 0 0.0005001162644475698
an O 0 0.0013814769918099046
increased O 0 0.015431969426572323
risk O 1 0.9998828172683716
of O 0 0.04620055854320526
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.0022959306370466948
is O 0 0.0020827436819672585
also O 0 0.0009598008473403752
present O 0 0.0015008263289928436
in O 0 0.0008873406331986189
this O 0 0.0019647504668682814
family O 0 0.012285738252103329
. O 0 0.004492294043302536

The O 0 0.010511226952075958
I1307K O 1 0.9998055100440979
polymorphism O 1 0.8889024257659912
has O 0 0.004483289085328579
previously O 0 0.0039444477297365665
only O 0 0.0015106193022802472
been O 0 0.0034891823306679726
identified O 0 0.007574788760393858
in O 0 0.0011044102720916271
individuals O 0 0.0024349610321223736
of O 0 0.0016266736201941967
self O 0 0.04535472393035889
- O 0 0.030602484941482544
reported O 0 0.028565268963575363
Ashkenazi O 1 0.9904302954673767
Jewish O 0 0.016043715178966522
origins O 0 0.03179237246513367
. O 0 0.004941282793879509

In O 0 0.004106877837330103
addition O 0 0.004381537903100252
, O 0 0.0009803692810237408
in O 0 0.0010883751092478633
this O 0 0.0019503980875015259
family O 0 0.013504080474376678
, O 0 0.0013679279945790768
there O 0 0.0016780075384303927
appears O 0 0.013307836838066578
to O 0 0.0009611588320694864
be O 0 0.0014888549922034144
no O 0 0.0019654601346701384
relationship O 0 0.0060651833191514015
between O 0 0.0015405913582071662
the O 0 0.004511017352342606
I1307K O 1 0.9999738931655884
polymorphism O 1 0.9792163968086243
and O 0 0.0011032673064619303
the O 0 0.0019518362823873758
presence O 0 0.009404630400240421
or O 0 0.003405764000490308
absence O 0 0.020549168810248375
of O 0 0.005458601750433445
cancer B-Disease 1 1.0
. O 0 0.003468306502327323
. O 0 0.004146880004554987

Identification O 0 0.01680171489715576
of O 0 0.0012896365951746702
a O 0 0.0061518666334450245
novel O 0 0.03191906213760376
mutation O 1 0.9998468160629272
of O 0 0.0016277318354696035
the O 0 0.004280431661754847
CPO O 1 0.9993025064468384
gene O 1 0.9193153977394104
in O 0 0.0017999284900724888
a O 0 0.005114607512950897
Japanese O 0 0.015719328075647354
hereditary B-Disease 1 0.9999997615814209
coproporphyria I-Disease 1 0.999984622001648
family O 0 0.028289182111620903
. O 0 0.005579874850809574

Hereditary B-Disease 1 0.9999994039535522
coproporphyria I-Disease 1 0.9999175071716309
( O 0 0.013763929717242718
HCP B-Disease 1 0.9999511241912842
) O 0 0.003277682000771165
is O 0 0.0023231394588947296
an O 0 0.005822409875690937
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.999995231628418
disease I-Disease 1 1.0
characterized O 1 0.9925211071968079
by O 0 0.002589626470580697
a O 0 0.014778274111449718
deficiency B-Disease 1 1.0
of I-Disease 0 0.004344897344708443
coproporphyrinogen I-Disease 1 0.9999961853027344
oxidase I-Disease 1 0.9999738931655884
( O 0 0.011511610820889473
CPO O 1 0.9958712458610535
) O 0 0.005093758925795555
caused O 1 0.9251561164855957
by O 0 0.002922746352851391
a O 0 0.010159689001739025
mutation O 1 0.9999196529388428
in O 0 0.002219652757048607
the O 0 0.004932262934744358
CPO O 1 0.9996073842048645
gene O 1 0.9985561966896057
. O 0 0.005921355448663235

Only O 0 0.006648074369877577
11 O 0 0.015213781967759132
mutations O 1 0.9944051504135132
of O 0 0.0012922491878271103
the O 0 0.004240988288074732
gene O 1 0.9998525381088257
have O 0 0.0020080190151929855
been O 0 0.0038641432765871286
reported O 0 0.011615326628088951
in O 0 0.004901745822280645
HCP B-Disease 1 0.9999988079071045
patients O 1 0.9999970197677612
. O 0 0.006037570536136627

We O 0 0.002741083735600114
report O 0 0.003741071093827486
another O 0 0.016105305403470993
mutation O 1 0.9999099969863892
in O 0 0.0020628964994102716
a O 0 0.006061712745577097
Japanese O 0 0.011877961456775665
family O 0 0.015824241563677788
. O 0 0.0062012565322220325

Polymerase O 1 0.9531928300857544
chain O 0 0.4832915663719177
reaction O 0 0.05133023113012314
- O 0 0.02536165527999401
single O 0 0.023106958717107773
strand O 0 0.14278410375118256
conformational O 1 0.6990586519241333
polymorphism O 0 0.16725113987922668
and O 0 0.001610604114830494
direct O 0 0.005630358587950468
sequence O 0 0.01685613952577114
analyses O 0 0.009274552576243877
demonstrated O 0 0.011748873628675938
a O 0 0.01067397091537714
C O 0 0.15647290647029877
to O 0 0.004921343177556992
T O 1 0.9662355780601501
substitution O 0 0.052315328270196915
in O 0 0.003856691299006343
exon O 1 0.9636995792388916
1 O 0 0.00956755131483078
of O 0 0.001085747848264873
the O 0 0.005344746168702841
CPO O 1 0.9995469450950623
gene O 1 0.9825195074081421
at O 0 0.0072426036931574345
nucleotide O 0 0.11192956566810608
position O 0 0.010493229143321514
85 O 0 0.030056288465857506
, O 0 0.001728933653794229
which O 0 0.001633336185477674
lies O 0 0.007909589447081089
in O 0 0.0010171225294470787
the O 0 0.0037296731024980545
putative O 1 0.9990528225898743
presequence O 1 0.9968751668930054
for O 0 0.002444388810545206
targeting O 0 0.01854206807911396
to O 0 0.0035318229347467422
mitochondria O 0 0.1451614797115326
. O 0 0.006280598696321249

This O 0 0.00973526295274496
mutation O 1 0.999561607837677
changes O 0 0.008304661139845848
the O 0 0.003237627912312746
codon O 0 0.17873018980026245
for O 0 0.002664460800588131
glutamine O 0 0.12268770486116409
to O 0 0.0021238583140075207
a O 0 0.00842262152582407
termination O 1 0.967492401599884
codon O 0 0.3008273243904114
at O 0 0.01053652074187994
amino O 0 0.07026271522045135
acid O 0 0.12449909746646881
position O 0 0.010207319632172585
29 O 0 0.021509630605578423
. O 0 0.005079863592982292

MaeI O 1 0.9940646290779114
restriction O 0 0.04659454897046089
analysis O 0 0.006020039319992065
showed O 0 0.0066572753712534904
two O 0 0.0012872240040451288
other O 0 0.0014175348915159702
carriers O 0 0.046985697001218796
in O 0 0.001579518080689013
the O 0 0.0032245710026472807
family O 0 0.015781493857502937
. O 0 0.005718772299587727

The O 0 0.010990026406943798
C O 1 0.9939910769462585
- O 0 0.4892052412033081
T O 1 0.9999721050262451
mutation O 1 0.9999734163284302
is O 0 0.004106231965124607
located O 0 0.0053380378521978855
within O 0 0.0017128509934991598
a O 0 0.004177333787083626
recently O 0 0.010593269020318985
proposed O 0 0.007550399284809828
putative O 0 0.12543676793575287
alternative O 0 0.013627134263515472
translation O 0 0.012881699949502945
initiation O 0 0.1022120788693428
codon O 1 0.6821804642677307
( O 0 0.016713861376047134
TIC O 1 0.9999812841415405
- O 0 0.03577234968543053
1 O 0 0.019666850566864014
) O 0 0.0033032181672751904
, O 0 0.001426716335117817
supporting O 0 0.010177696123719215
that O 0 0.003662130329757929
TIC O 1 0.9999959468841553
- O 0 0.03191288933157921
1 O 0 0.01071117538958788
is O 0 0.00227925437502563
the O 0 0.0025943072978407145
real O 0 0.018067631870508194
TIC O 1 0.9999927282333374
rather O 0 0.00703297508880496
than O 0 0.0075768036767840385
TIC O 1 0.9999982118606567
- O 0 0.03556450828909874
2 O 0 0.011698934249579906
. O 0 0.002191962441429496
. O 0 0.004566107410937548

Human B-Disease 0 0.016794171184301376
complement I-Disease 0 0.03399922326207161
factor I-Disease 1 0.8284490704536438
H I-Disease 1 0.9999990463256836
deficiency I-Disease 1 1.0
associated O 0 0.01944875158369541
with O 0 0.01717481017112732
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.011505719274282455

This O 0 0.003550827968865633
study O 0 0.003358585527166724
reports O 0 0.0030991502571851015
on O 0 0.0011137488763779402
six O 0 0.002822575159370899
cases O 0 0.008672614581882954
of O 0 0.0036950078792870045
deficiency B-Disease 1 1.0
in I-Disease 0 0.0016296205576509237
the I-Disease 0 0.002143183955922723
human I-Disease 0 0.007788768038153648
complement I-Disease 0 0.024978836998343468
regulatory I-Disease 0 0.0862746313214302
protein I-Disease 0 0.128644660115242
Factor I-Disease 1 0.943352460861206
H I-Disease 1 0.9999856948852539
( O 0 0.018668899312615395
FH O 1 0.9999985694885254
) O 0 0.003266693092882633
in O 0 0.0007362808100879192
the O 0 0.0011394498869776726
context O 0 0.0027055777609348297
of O 0 0.001204201951622963
an O 0 0.03800424188375473
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.010113537311553955

Five O 0 0.0047774119302630424
of O 0 0.0012004370801150799
the O 0 0.002533329650759697
cases O 0 0.007325264625251293
were O 0 0.0016247929306700826
observed O 0 0.006840274669229984
in O 0 0.0010393268894404173
children O 0 0.006645794492214918
presenting O 0 0.012774519622325897
with O 0 0.011199786327779293
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9315361380577087
HUS B-Disease 1 1.0
) O 0 0.00702293636277318
. O 0 0.004071945324540138

Two O 0 0.0016052747378125787
of O 0 0.0008106807945296168
the O 0 0.00205703591927886
children O 0 0.007935291156172752
exhibited O 0 0.030651209875941277
a O 0 0.022503850981593132
homozygous O 1 0.9999995231628418
deficiency O 1 1.0
characterized O 0 0.3529585599899292
by O 0 0.002165482845157385
the O 0 0.0017703325720503926
absence O 0 0.010437676683068275
of O 0 0.0008842486422508955
the O 0 0.0025447080843150616
150 O 0 0.016583453863859177
- O 0 0.038150250911712646
kD O 1 0.8724581003189087
form O 0 0.00826580636203289
of O 0 0.002509600715711713
Factor O 1 0.9836034774780273
H O 1 0.9999784231185913
and O 0 0.0011991884093731642
the O 0 0.0017166604520753026
presence O 0 0.007266147527843714
, O 0 0.0013145648408681154
upon O 0 0.005883148871362209
immunoblotting O 1 0.999890923500061
, O 0 0.000938130309805274
of O 0 0.000802196329459548
the O 0 0.002639870624989271
42 O 0 0.02582811564207077
- O 0 0.04081883281469345
kD O 1 0.990774929523468
Factor O 1 0.6185997128486633
H O 1 0.9995365142822266
- O 0 0.03235408663749695
like O 0 0.009680003859102726
protein O 0 0.06987809389829636
1 O 0 0.015890514478087425
( O 0 0.008338412269949913
FHL O 1 0.999985933303833
- O 0 0.035923127084970474
1 O 0 0.014730752445757389
) O 0 0.00241007748991251
and O 0 0.0008721996564418077
other O 0 0.0024262776132673025
FH O 1 0.9999997615814209
- O 0 0.04594076797366142
related O 0 0.020896360278129578
protein O 0 0.10650818049907684
( O 0 0.010616373270750046
FHR O 1 0.9999654293060303
) O 0 0.006270552985370159
bands O 0 0.023252513259649277
. O 0 0.0045181987807154655

Southern O 0 0.04053213447332382
blot O 1 0.9930025935173035
and O 0 0.00409880792722106
PCR O 0 0.16379979252815247
analysis O 0 0.003764891065657139
of O 0 0.0012115729041397572
DNA O 0 0.02036214806139469
of O 0 0.0010474998271092772
one O 0 0.00425537908449769
patient O 1 0.999976396560669
with O 0 0.006358552258461714
homozygous O 1 0.9999998807907104
deficiency O 1 1.0
ruled O 0 0.03119763173162937
out O 0 0.002407182939350605
the O 0 0.0017481594113633037
presence O 0 0.005195173434913158
of O 0 0.0008712884737178683
a O 0 0.004090095404535532
large O 0 0.006643541157245636
deletion O 1 0.9948516488075256
of O 0 0.0014312723651528358
the O 0 0.006223747972398996
FH O 1 1.0
gene O 1 0.9996762275695801
as O 0 0.002035202458500862
the O 0 0.002272455021739006
underlying O 0 0.03781905397772789
defect O 1 0.9995855689048767
for O 0 0.0023073095362633467
the O 0 0.008476048707962036
deficiency O 1 1.0
. O 0 0.007461095228791237

The O 0 0.003983293194323778
other O 0 0.0006876911502331495
four O 0 0.001890335464850068
children O 0 0.006266220007091761
presented O 0 0.004060673993080854
with O 0 0.0033623322378844023
heterozygous O 1 0.9999998807907104
deficiency O 1 1.0
and O 0 0.002320000436156988
exhibited O 0 0.01372525654733181
a O 0 0.007199075073003769
normal O 0 0.03391281142830849
immunoblotting O 1 0.9964560866355896
pattern O 0 0.028046047315001488
of O 0 0.0019155725603923202
proteins O 0 0.016581237316131592
of O 0 0.0016869506798684597
the O 0 0.007593358401209116
FH O 1 0.9999997615814209
family O 0 0.03079928457736969
. O 0 0.006257095839828253

Factor B-Disease 1 0.9955106973648071
H I-Disease 1 0.9999995231628418
deficiency I-Disease 1 1.0
is O 0 0.003249476896598935
the O 0 0.001973479287698865
only O 0 0.00365194003097713
complement B-Disease 1 0.9973955154418945
deficiency I-Disease 1 1.0
associated O 0 0.01811426877975464
with O 0 0.005336476024240255
HUS B-Disease 1 1.0
. O 0 0.0071266768500208855

These O 0 0.0017550672637298703
observations O 0 0.004997368901968002
suggest O 0 0.004809309728443623
a O 0 0.00425419956445694
role O 0 0.008164709433913231
for O 0 0.003729376010596752
FH O 1 0.9999991655349731
and O 0 0.0051142387092113495
/ O 1 0.8191950917243958
or O 0 0.010678623802959919
FH O 1 0.9999998807907104
receptors O 1 0.723143458366394
in O 0 0.001922793802805245
the O 0 0.0047081648372113705
pathogenesis O 1 0.9999935626983643
of O 0 0.013410968706011772
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 0 0.0059880102053284645
. O 0 0.0045991516672074795

Further O 0 0.004950731061398983
evidence O 0 0.0016042557545006275
for O 0 0.0008163109887391329
a O 0 0.003102649701759219
major O 0 0.007014452014118433
ancient O 0 0.0067023769952356815
mutation O 1 0.9999977350234985
underlying O 1 0.9994489550590515
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 0.013790732249617577
linkage O 0 0.4334585964679718
disequilibrium O 1 0.9747086763381958
studies O 0 0.006227026227861643
in O 0 0.0010818146402016282
the O 0 0.0021035370882600546
Japanese O 0 0.011274032294750214
population O 0 0.009355725720524788
. O 0 0.004457388538867235

The O 0 0.03262912854552269
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.16154365241527557
DM B-Disease 1 1.0
) O 0 0.015278737992048264
mutation O 1 0.9999868869781494
is O 0 0.004976339638233185
an O 0 0.004217866342514753
unstable O 1 0.9978204965591431
( O 0 0.011295409873127937
CTG O 1 0.9995765089988708
) O 0 0.007914799265563488
n O 0 0.03981906175613403
repeat O 0 0.05143681913614273
, O 0 0.0014422924723476171
present O 0 0.0018689095741137862
at O 0 0.002645340980961919
a O 0 0.004881985019892454
copy O 0 0.011949916370213032
number O 0 0.0016742987791076303
of O 0 0.0014161725994199514
5 O 0 0.012926367111504078
- O 0 0.024995986372232437
37 O 0 0.030596530064940453
repeats O 0 0.048339713364839554
on O 0 0.0031173534225672483
normal O 0 0.027069903910160065
chromosomes O 0 0.07965492457151413
but O 0 0.003113911487162113
amplified O 0 0.051743410527706146
to O 0 0.002104362938553095
50 O 0 0.00883136224001646
- O 0 0.02400246635079384
3000 O 0 0.1024404987692833
copies O 0 0.012703124433755875
on O 0 0.01004848349839449
DM B-Disease 1 0.9999998807907104
chromosomes O 0 0.35621678829193115
. O 0 0.00922500342130661

Previous O 0 0.009392376989126205
findings O 0 0.00862356647849083
in O 0 0.002446930855512619
Caucasian O 1 0.961905300617218
populations O 0 0.023507235571742058
of O 0 0.0016654767096042633
a O 0 0.022799167782068253
DM B-Disease 1 1.0
founder O 1 0.9981766939163208
chromosome O 1 0.9999876022338867
raise O 0 0.011458555236458778
a O 0 0.005588483531028032
question O 0 0.00458949152380228
about O 0 0.0017800786299631
the O 0 0.0027196139562875032
molecular O 0 0.023605095222592354
events O 0 0.004765067249536514
involved O 0 0.0051740496419370174
in O 0 0.0010494685266166925
the O 0 0.002677761949598789
expansion O 0 0.028323350474238396
mutation O 1 0.9999910593032837
. O 0 0.007499805185943842

To O 0 0.0030459652189165354
investigate O 0 0.010059242136776447
whether O 0 0.002928926842287183
a O 0 0.007382799405604601
founder O 0 0.06624544411897659
chromosome O 1 0.9996349811553955
for O 0 0.002194807166233659
the O 0 0.010686622001230717
DM B-Disease 1 1.0
mutation O 1 0.9999984502792358
exists O 0 0.010493793524801731
in O 0 0.0012166573433205485
the O 0 0.0021947319619357586
Japanese O 0 0.008972241543233395
population O 0 0.006344203371554613
, O 0 0.0013265357119962573
we O 0 0.0019368772627785802
genotyped O 1 0.9979216456413269
families O 0 0.008919600397348404
using O 0 0.0069150435738265514
polymorphic O 1 0.9993033409118652
markers O 0 0.04825755953788757
near O 0 0.012987538240849972
the O 0 0.003999845124781132
( O 0 0.008649487979710102
CTG O 1 0.9998370409011841
) O 0 0.006507133133709431
n O 0 0.0369190014898777
repeat O 0 0.058533940464258194
region O 0 0.01142751332372427
and O 0 0.0018108781659975648
constructed O 0 0.015928253531455994
haplotypes O 1 0.9966694712638855
. O 0 0.006858952809125185

Six O 0 0.0077256145887076855
different O 0 0.0022945101372897625
haplotypes O 1 0.8745868802070618
were O 0 0.0017879545921459794
found O 0 0.00427892804145813
and O 0 0.003595635062083602
DM B-Disease 1 1.0
alleles O 1 0.9999982118606567
were O 0 0.0030678296461701393
always O 0 0.010114378295838833
haplotype O 1 0.9976552724838257
A O 0 0.024210168048739433
. O 0 0.005857344716787338

To O 0 0.0030773309990763664
find O 0 0.005118146073073149
an O 0 0.0015885306056588888
origin O 0 0.0040314593352377415
of O 0 0.0010398587910458446
the O 0 0.003424459369853139
( O 0 0.00850070733577013
CTG O 1 0.9998937845230103
) O 0 0.006204207893460989
n O 0 0.04665035381913185
repeat O 0 0.2732503116130829
mutation O 1 0.999859094619751
and O 0 0.001290363841690123
to O 0 0.0009039344731718302
investigate O 0 0.007840347476303577
the O 0 0.0020080634858459234
mechanism O 0 0.012598186731338501
of O 0 0.0009678790811449289
the O 0 0.0027035700622946024
expansion O 0 0.02439907193183899
mutation O 1 0.999968409538269
in O 0 0.001785246771760285
the O 0 0.002470125211402774
Japanese O 0 0.008483638055622578
population O 0 0.005282044876366854
we O 0 0.0012172932038083673
have O 0 0.001071825623512268
studied O 0 0.004906513728201389
90 O 0 0.015186061151325703
Japanese O 0 0.03181622549891472
DM B-Disease 1 0.9999998807907104
families O 0 0.015571259893476963
comprising O 0 0.011963487602770329
190 O 0 0.05132804438471794
affected O 0 0.10040123760700226
and O 0 0.0024659575428813696
130 O 0 0.0344950333237648
unaffected O 1 0.9985039234161377
members O 0 0.0038858195766806602
. O 0 0.00506003899499774

The O 0 0.005111119709908962
results O 0 0.008093304932117462
suggest O 0 0.00530784809961915
that O 0 0.0007439296459779143
a O 0 0.0038955500349402428
few O 0 0.003304931102320552
common O 0 0.011249699629843235
ancestral O 0 0.14042609930038452
mutations O 1 0.9997723698616028
in O 0 0.0018877005204558372
both O 0 0.002388204447925091
Caucasian O 1 0.9989843964576721
and O 0 0.0014556323876604438
Japanese O 0 0.0100014116615057
populations O 0 0.02698419988155365
have O 0 0.0018403393914923072
originated O 0 0.012148668989539146
by O 0 0.0017977484967559576
expansion O 0 0.00521792471408844
of O 0 0.0009122281335294247
an O 0 0.0025815521366894245
ancestral O 0 0.05987151712179184
n O 0 0.04743377864360809
= O 0 0.04358411952853203
5 O 0 0.010880989022552967
repeat O 0 0.04448511824011803
to O 0 0.0030937804840505123
n O 0 0.040120214223861694
= O 0 0.03931358456611633
19 O 0 0.021664638072252274
- O 0 0.02476106584072113
37 O 0 0.02489541657269001
copies O 0 0.008218829520046711
. O 0 0.0047415574081242085

These O 0 0.0015572358388453722
data O 0 0.002063360996544361
support O 0 0.005284588783979416
multistep O 0 0.13468590378761292
models O 0 0.008616105653345585
of O 0 0.002613937482237816
triplet O 1 0.9997530579566956
repeat O 0 0.08907883614301682
expansion O 0 0.011100715026259422
that O 0 0.0009579663164913654
have O 0 0.001296171685680747
been O 0 0.0026116559747606516
proposed O 0 0.0036883819848299026
for O 0 0.0013186478754505515
both O 0 0.0045351386070251465
DM B-Disease 1 1.0
and O 0 0.007500961888581514
Friedreichs B-Disease 1 0.9999990463256836
ataxia I-Disease 1 1.0
. O 0 0.004280797205865383
. O 0 0.004768333863466978

The O 0 0.004863409325480461
molecular O 0 0.01802045851945877
basis O 0 0.002618368249386549
of O 0 0.006106665823608637
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.002473636996001005
the O 0 0.0024208305403590202
western O 0 0.006912651006132364
Cape O 1 0.9444565176963806
, O 0 0.0018476545810699463
South O 0 0.005564853083342314
Africa O 0 0.014892750419676304
. O 0 0.004800141789019108

Deficiency B-Disease 1 0.9999997615814209
of I-Disease 0 0.0023354559671133757
the I-Disease 0 0.0022645480930805206
sixth I-Disease 0 0.02517535351216793
component I-Disease 0 0.020314617082476616
of I-Disease 0 0.0015781117836013436
human I-Disease 0 0.009816757403314114
complement I-Disease 0 0.033014461398124695
( O 0 0.011213857680559158
C6 O 1 0.9999990463256836
) O 0 0.005080740433186293
has O 0 0.0031277062371373177
been O 0 0.0033871487248688936
reported O 0 0.008266600780189037
in O 0 0.0010172679321840405
a O 0 0.0034693118650466204
number O 0 0.001489225192926824
of O 0 0.0010512496810406446
families O 0 0.004936239682137966
from O 0 0.0019003114430233836
the O 0 0.0025229104794561863
western O 0 0.00737511133775115
Cape O 1 0.9645683765411377
, O 0 0.0017232937971130013
South O 0 0.005702280439436436
Africa O 0 0.015706583857536316
. O 0 0.0047893947921693325

Meningococcal B-Disease 1 1.0
disease I-Disease 1 1.0
is O 0 0.009634798392653465
endemic O 1 0.9997621178627014
in O 0 0.0013912831200286746
the O 0 0.0022104657255113125
Cape O 1 0.9741916060447693
and O 0 0.0010001783957704902
almost O 0 0.003515812335535884
all O 0 0.0012352896155789495
pedigrees O 0 0.06624160706996918
of O 0 0.0023131745401769876
total O 0 0.017652830109000206
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 0.01654641516506672
C6Q0 O 1 0.9999984502792358
) O 0 0.0030916135292500257
have O 0 0.0012233875459060073
been O 0 0.0032755781430751085
ascertained O 0 0.091291144490242
because O 0 0.004404240287840366
of O 0 0.0037907552905380726
recurrent O 1 1.0
disease O 1 1.0
. O 0 0.008030839264392853

We O 0 0.0037734038196504116
have O 0 0.0028964278753846884
sequenced O 0 0.09333126246929169
the O 0 0.0032130752224475145
expressed O 0 0.008837501518428326
exons O 0 0.11446516215801239
of O 0 0.0017436898779124022
the O 0 0.006846672389656305
C6 O 1 0.9999991655349731
gene O 1 0.994739830493927
from O 0 0.003429196309298277
selected O 0 0.005458964500576258
cases O 0 0.006555933505296707
and O 0 0.0006680812803097069
have O 0 0.0009362256969325244
found O 0 0.0025032723788172007
three O 0 0.0018847765168175101
molecular O 0 0.04038705304265022
defects O 1 0.9999744892120361
leading O 0 0.008234801702201366
to O 0 0.0014941386179998517
total O 0 0.013984084129333496
deficiency O 1 1.0
879delG O 1 0.9999902248382568
, O 0 0.0021092321258038282
which O 0 0.0012062489986419678
is O 0 0.001819815719500184
the O 0 0.0024031319189816713
common O 0 0.016767611727118492
defect O 1 0.9996792078018188
in O 0 0.0016572229797020555
the O 0 0.0028497602324932814
Cape O 1 0.5759153366088867
and O 0 0.0017779582412913442
hitherto O 0 0.21318484842777252
unreported O 0 0.04943438246846199
, O 0 0.0016678362153470516
and O 0 0.0018157700542360544
1195delC O 1 0.999882698059082
and O 0 0.003973860759288073
1936delG O 1 0.9999613761901855
, O 0 0.002054177690297365
which O 0 0.001370943384245038
have O 0 0.0015014237724244595
been O 0 0.00322083942592144
previously O 0 0.005527073051780462
reported O 0 0.009585728868842125
in O 0 0.0018429731717333198
African O 0 0.019340209662914276
- O 0 0.030518174171447754
Americans O 0 0.01350089255720377
. O 0 0.004894231911748648

We O 0 0.003713604062795639
also O 0 0.0015230762073770165
show O 0 0.003198950784280896
that O 0 0.0007641893462277949
the O 0 0.0025100901257246733
879delG O 1 0.9998965263366699
and O 0 0.004519706591963768
1195delC O 1 0.9999927282333374
defects O 1 0.999990701675415
are O 0 0.0012689752038568258
associated O 0 0.004438805393874645
with O 0 0.0017353392904624343
characteristic O 1 0.7846633195877075
C6 O 1 0.9999997615814209
/ O 1 0.9932788014411926
C7 O 1 0.9999984502792358
region O 0 0.023402012884616852
DNA O 0 0.0692385658621788
marker O 1 0.9678354263305664
haplotypes O 1 0.9986279010772705
, O 0 0.002169228158891201
although O 0 0.0032366877421736717
small O 0 0.0035679801367223263
variations O 0 0.010123088955879211
were O 0 0.0019010304240509868
observed O 0 0.01613946445286274
. O 0 0.004594278521835804

The O 0 0.012250885367393494
1936delG O 1 0.9997120499610901
defect O 1 0.9996635913848877
was O 0 0.010802365839481354
observed O 0 0.010494579561054707
only O 0 0.0016071345889940858
once O 0 0.005131184589117765
in O 0 0.0011528581380844116
the O 0 0.002930782735347748
Cape O 1 0.9825527667999268
, O 0 0.001408561714924872
but O 0 0.0012214849703013897
its O 0 0.002606647787615657
associated O 0 0.014436334371566772
haplotype O 1 0.9995527863502502
could O 0 0.003685974981635809
be O 0 0.0022278407122939825
deduced O 0 0.050641756504774094
. O 0 0.005296152085065842

The O 0 0.004279862158000469
data O 0 0.001967240124940872
from O 0 0.0017346660606563091
the O 0 0.0033201074693351984
haplotypes O 1 0.9987806677818298
indicate O 0 0.010344218462705612
that O 0 0.0008045216673053801
these O 0 0.0006165765225887299
three O 0 0.0023808402474969625
molecular O 0 0.04983491078019142
defects O 1 0.999739944934845
account O 0 0.0036985944025218487
for O 0 0.0013264971785247326
the O 0 0.0046129124239087105
defects O 1 0.9999895095825195
in O 0 0.0010940044885501266
all O 0 0.0005922031123191118
the O 0 0.0026922852266579866
38 O 0 0.039842091500759125
unrelated O 1 0.6770934462547302
C6Q0 O 1 0.9999938011169434
individuals O 0 0.00632314570248127
we O 0 0.0012378767132759094
have O 0 0.0012753582559525967
studied O 0 0.0038201601710170507
from O 0 0.0020095128566026688
the O 0 0.004018804524093866
Cape O 1 0.7754810452461243
. O 0 0.005993919912725687

We O 0 0.002992087509483099
have O 0 0.0013275569071993232
also O 0 0.0013030151603743434
observed O 0 0.00846068188548088
the O 0 0.003964988514780998
879delG O 1 0.9999667406082153
defect O 1 0.9997921586036682
in O 0 0.0011990400962531567
two O 0 0.0017214874969795346
Dutch O 1 0.9544385075569153
C6 B-Disease 1 0.9999998807907104
- I-Disease 1 0.8588738441467285
deficient I-Disease 1 0.9999988079071045
kindreds O 1 0.9998993873596191
, O 0 0.0014853383181616664
but O 0 0.0013479826739057899
the O 0 0.0034312859643250704
879delG O 1 0.9999837875366211
defect O 1 0.9995892643928528
in O 0 0.0019012023694813251
the O 0 0.0030419337563216686
Cape O 1 0.9988232254981995
probably O 0 0.013885888271033764
did O 0 0.0026422070804983377
not O 0 0.000977388583123684
come O 0 0.001885647652670741
from O 0 0.0014991030329838395
The O 0 0.0029284644406288862
Netherlands O 0 0.014928588643670082
. O 0 0.00228823977522552
. O 0 0.004465182311832905

Complement B-Disease 1 0.9443696737289429
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.004079488571733236
seven O 0 0.002918063197284937
further O 0 0.006317686289548874
molecular O 0 0.05421926826238632
defects O 1 0.9998977184295654
and O 0 0.0012326044961810112
their O 0 0.001531100831925869
associated O 0 0.013413739390671253
marker O 1 0.8358603119850159
haplotypes O 1 0.9888232350349426
. O 0 0.008773736655712128

Seven O 0 0.00547216460108757
further O 0 0.004745627753436565
molecular O 0 0.022927910089492798
bases O 0 0.007149771321564913
of O 0 0.006426089443266392
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.0027029633056372404
described O 0 0.013637733645737171
. O 0 0.004132282454520464

All O 0 0.0020395584870129824
these O 0 0.0007325211190618575
new O 0 0.0032779935281723738
molecular O 0 0.05779724195599556
defects O 1 0.9999035596847534
involve O 0 0.014266160316765308
single O 0 0.018231535330414772
- O 0 0.032125622034072876
nucleotide O 0 0.11721167713403702
events O 0 0.005447326693683863
, O 0 0.0023941234685480595
deletions O 1 0.9242646098136902
and O 0 0.0015964965568855405
substitutions O 0 0.025706887245178223
, O 0 0.0010249798651784658
some O 0 0.0007556655327789485
of O 0 0.0008934047073125839
which O 0 0.0031018059235066175
alter O 0 0.12783411145210266
splice O 1 0.980604887008667
sites O 0 0.00653732568025589
, O 0 0.0015832365024834871
and O 0 0.0013216760708019137
others O 0 0.007751508615911007
codons O 0 0.4880349636077881
. O 0 0.005194338038563728

They O 0 0.0025637454818934202
are O 0 0.0009164184448309243
distributed O 0 0.005913355387747288
along O 0 0.003903727512806654
the O 0 0.007762306835502386
C7 O 1 1.0
gene O 1 0.9997703433036804
, O 0 0.0020404993556439877
but O 0 0.0015409588813781738
predominantly O 0 0.007691744714975357
towards O 0 0.0038324594497680664
the O 0 0.0026903345715254545
3 O 0 0.01054085697978735
end O 0 0.011006270535290241
. O 0 0.004814358428120613

All O 0 0.0021404039580374956
were O 0 0.0011977951508015394
found O 0 0.00395342567935586
in O 0 0.0021354220807552338
compound O 0 0.04088612645864487
heterozygous O 1 0.9994001388549805
individuals O 0 0.009037801995873451
. O 0 0.004293643869459629

The O 0 0.0185255017131567
C6 O 1 0.9999827146530151
/ O 1 0.9757564067840576
C7 O 1 0.99996018409729
marker O 1 0.5468209981918335
haplotypes O 1 0.9839641451835632
associated O 0 0.009991755709052086
with O 0 0.0020141571294516325
most O 0 0.009462578222155571
C7 B-Disease 1 1.0
defects I-Disease 1 0.9999922513961792
are O 0 0.001953396713361144
tabulated O 0 0.01731807552278042
. O 0 0.0018773063784465194
. O 0 0.003941971343010664

A O 0 0.03666532412171364
genome O 0 0.13968639075756073
- O 0 0.020257756114006042
wide O 0 0.010323718190193176
search O 0 0.01072260644286871
for O 0 0.0043853879906237125
chromosomal O 1 0.9999629259109497
loci O 1 0.9993340373039246
linked O 0 0.056842461228370667
to O 0 0.0038531373720616102
mental O 1 0.9999784231185913
health O 1 0.9990673661231995
wellness O 1 0.9996565580368042
in O 0 0.0020897078793495893
relatives O 0 0.012130392715334892
at O 0 0.0035113964695483446
high O 0 0.009296586737036705
risk O 1 0.9994502663612366
for O 0 0.008534896187484264
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 0 0.00403986731544137
the O 0 0.0018116884166374803
Old O 0 0.01462116464972496
Order O 0 0.006296513136476278
Amish O 0 0.13547663390636444
. O 0 0.006532565224915743

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 0.01818634569644928
BPAD B-Disease 1 1.0
; O 0 0.015871193259954453
manic B-Disease 1 1.0
- I-Disease 1 0.9999960660934448
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 0.004492876119911671
is O 0 0.0036706565879285336
characterized O 0 0.06427518278360367
by O 0 0.0021788545418530703
episodes O 0 0.022875560447573662
of O 0 0.0033651329576969147
mania B-Disease 1 1.0
and O 0 0.004384852480143309
/ O 1 0.9912715554237366
or O 0 0.010609389282763004
hypomania B-Disease 1 0.9999998807907104
interspersed O 0 0.04315193369984627
with O 0 0.0017319757025688887
periods O 0 0.014238745905458927
of O 0 0.004164313897490501
depression B-Disease 1 1.0
. O 0 0.00807102583348751

Compelling O 0 0.015800384804606438
evidence O 0 0.003042608732357621
supports O 0 0.010141141712665558
a O 0 0.005187266506254673
significant O 0 0.009879225865006447
genetic O 0 0.06023634225130081
component O 0 0.01886165514588356
in O 0 0.0014324525836855173
the O 0 0.003986041061580181
susceptibility O 1 0.9999845027923584
to O 0 0.004061466548591852
develop O 0 0.03348987177014351
BPAD B-Disease 1 0.9999979734420776
. O 0 0.00885365903377533

To O 0 0.003575145034119487
date O 0 0.005553476512432098
, O 0 0.0014392724260687828
however O 0 0.002484818920493126
, O 0 0.0016364502953365445
linkage O 0 0.0665641501545906
studies O 0 0.003700791159644723
have O 0 0.0012255581095814705
attempted O 0 0.010689672082662582
only O 0 0.0013074931921437383
to O 0 0.0016142681706696749
identify O 0 0.027818528935313225
chromosomal O 1 0.9999884366989136
loci O 1 0.9993904829025269
that O 0 0.003003625897690654
cause O 1 0.962075412273407
or O 0 0.0021731259766966105
increase O 0 0.0038592717610299587
the O 0 0.002890324452891946
risk O 1 0.9040350317955017
of O 0 0.0021931116934865713
developing O 0 0.03359901160001755
BPAD B-Disease 1 0.999998927116394
. O 0 0.009082663804292679

To O 0 0.0025011138059198856
determine O 0 0.004670850001275539
whether O 0 0.00197122641839087
there O 0 0.001253745169378817
could O 0 0.0027902116999030113
be O 0 0.0032811418641358614
protective O 1 0.999234676361084
alleles O 1 0.9999866485595703
that O 0 0.0026221966836601496
prevent O 0 0.03324006125330925
or O 0 0.0034341569989919662
reduce O 0 0.015113413333892822
the O 0 0.003395248670130968
risk O 1 0.7591254115104675
of O 0 0.002281005261465907
developing O 0 0.040244270116090775
BPAD B-Disease 1 0.9999998807907104
, O 0 0.0020881134551018476
similar O 0 0.0034412567038089037
to O 0 0.0008187040220946074
what O 0 0.001373319886624813
is O 0 0.0019681353587657213
observed O 0 0.006095550954341888
in O 0 0.0011283260537311435
other O 0 0.0022182255052030087
genetic B-Disease 1 0.9999990463256836
disorders I-Disease 1 1.0
, O 0 0.001562359044328332
we O 0 0.0010408161906525493
used O 0 0.0031725529115647078
mental O 1 0.9999532699584961
health O 1 0.9985735416412354
wellness O 1 0.9999510049819946
( O 0 0.004351507872343063
absence O 0 0.012283013202250004
of O 0 0.001336192712187767
any O 0 0.0065546040423214436
psychiatric B-Disease 1 1.0
disorder I-Disease 1 1.0
) O 0 0.002967309905216098
as O 0 0.0014835118781775236
the O 0 0.0036584611516445875
phenotype O 1 0.9999996423721313
in O 0 0.001592339831404388
our O 0 0.004356283228844404
genome O 1 0.7766063809394836
- O 0 0.023752382025122643
wide O 0 0.017679549753665924
linkage O 0 0.14051559567451477
scan O 0 0.2056286633014679
of O 0 0.0011814214522019029
several O 0 0.001743065076880157
large O 0 0.006620778236538172
multigeneration O 1 0.9995423555374146
Old O 0 0.015439796261489391
Order O 0 0.0071212295442819595
Amish O 0 0.09099264442920685
pedigrees O 0 0.24137240648269653
exhibiting O 0 0.038564249873161316
an O 0 0.0032682132441550493
extremely O 0 0.018403327092528343
high O 0 0.013886895030736923
incidence O 1 0.9999744892120361
of O 0 0.005963488016277552
BPAD B-Disease 1 1.0
. O 0 0.007358041126281023

We O 0 0.0029884171672165394
have O 0 0.001517132157459855
found O 0 0.0033698459155857563
strong O 0 0.0030927632469683886
evidence O 0 0.0013055730378255248
for O 0 0.0010695888195186853
a O 0 0.007937843911349773
locus O 1 0.9998248219490051
on O 0 0.007404594216495752
chromosome O 1 0.9999072551727295
4p O 1 0.9998072981834412
at O 0 0.012765622697770596
D4S2949 O 1 0.9959911704063416
( O 0 0.0070053148083388805
maximum O 0 0.022977011278271675
GENEHUNTER O 1 0.9996634721755981
- O 0 0.031108226627111435
PLUS O 0 0.030176199972629547
nonparametric O 0 0.17966076731681824
linkage O 0 0.0971735492348671
score O 0 0.018277334049344063
= O 0 0.040856122970581055
4 O 0 0.011156321503221989
. O 0 0.003221825696527958
05 O 1 0.9853426218032837
, O 0 0.005576751194894314
P O 1 0.9819527268409729
= O 0 0.04525070637464523
5 O 0 0.009638438932597637
. O 0 0.00219449819996953
22 O 0 0.014533291570842266
x O 0 0.06275919824838638
10 O 0 0.008094851858913898
( O 0 0.006755408830940723
- O 0 0.025126691907644272
4 O 0 0.01702249050140381
) O 0 0.004135394003242254
; O 0 0.00512334518134594
SIBPAL O 1 0.9999319314956665
Pempirical O 1 0.9926207065582275
value O 0 0.015212418511509895
< O 1 0.9326726794242859
3 O 0 0.019284870475530624
x O 0 0.05989227443933487
10 O 0 0.008928734809160233
( O 0 0.006483083125203848
- O 0 0.024158108979463577
5 O 0 0.01546909287571907
) O 0 0.0036135725677013397
) O 0 0.001936121378093958
and O 0 0.0010753152891993523
suggestive O 0 0.03939705342054367
evidence O 0 0.001262534991838038
for O 0 0.0007765582413412631
a O 0 0.007417786866426468
locus O 1 0.9999810457229614
on O 0 0.007954752072691917
chromosome O 1 0.9999852180480957
4q O 1 0.9988003969192505
at O 0 0.012178124859929085
D4S397 O 1 0.9981266856193542
( O 0 0.005862725432962179
maximum O 0 0.023970937356352806
GENEHUNTER O 1 0.9996077418327332
- O 0 0.0335957407951355
PLUS O 0 0.03984517976641655
nonparametric O 0 0.20022009313106537
linkage O 0 0.10854560881853104
score O 0 0.022066988050937653
= O 0 0.043307315558195114
3 O 0 0.011841291561722755
. O 0 0.0024740572553128004
29 O 0 0.01754351705312729
, O 0 0.004643591120839119
P O 1 0.9833764433860779
= O 0 0.05087589472532272
2 O 0 0.01034294068813324
. O 0 0.002832188503816724
57 O 0 0.03398113697767258
x O 0 0.07153096795082092
10 O 0 0.009284056723117828
( O 0 0.006553324405103922
- O 0 0.020821280777454376
3 O 0 0.01616993173956871
) O 0 0.004445496015250683
; O 0 0.004724578466266394
SIBPAL O 1 0.9998279809951782
Pempirical O 1 0.9954003691673279
value O 0 0.014718195423483849
< O 0 0.48892223834991455
1 O 0 0.019409285858273506
x O 0 0.05797228962182999
10 O 0 0.0073808045126497746
( O 0 0.005939571186900139
- O 0 0.023569975048303604
3 O 0 0.014370052143931389
) O 0 0.0035309279337525368
) O 0 0.0015344906132668257
that O 0 0.0006082613253965974
are O 0 0.0007336913258768618
linked O 0 0.04922667518258095
to O 0 0.002930179238319397
mental O 1 0.9999604225158691
health O 1 0.9993515610694885
wellness O 1 0.9998563528060913
. O 0 0.005892520770430565

These O 0 0.0027065547183156013
findings O 0 0.006468749605119228
are O 0 0.0008134375093504786
consistent O 0 0.005713132210075855
with O 0 0.0007120006484910846
the O 0 0.0019563634414225817
hypothesis O 0 0.029723187908530235
that O 0 0.0010719472775235772
certain O 0 0.00487319054082036
alleles O 1 0.9999681711196899
could O 0 0.006293727084994316
prevent O 0 0.03018058091402054
or O 0 0.0034984713420271873
modify O 0 0.03063139133155346
the O 0 0.004636728670448065
clinical O 1 0.9913541674613953
manifestations O 1 0.7381303906440735
of O 0 0.004082267172634602
BPAD B-Disease 1 1.0
and O 0 0.002025858499109745
perhaps O 0 0.006998617202043533
other O 0 0.0015325286658480763
related O 0 0.02299060858786106
affective B-Disease 1 0.9999998807907104
disorders I-Disease 1 1.0
. O 0 0.007019163109362125

Segregation O 0 0.40767842531204224
distortion O 0 0.253540962934494
in O 0 0.014464803971350193
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.013915346935391426

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.1656274050474167
DM B-Disease 1 1.0
) O 0 0.004527365788817406
is O 0 0.0027000524569302797
an O 0 0.00619238568469882
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999992847442627
disease I-Disease 1 1.0
which O 0 0.002382354112342
, O 0 0.0006932660471647978
in O 0 0.0007824990898370743
the O 0 0.00260028219781816
typical O 0 0.09060549736022949
pedigree O 1 0.9944974780082703
, O 0 0.0014342005597427487
shows O 0 0.0038069162983447313
a O 0 0.0032523348927497864
three O 0 0.0020651165395975113
generation O 0 0.03858118876814842
anticipation O 0 0.07660268247127533
cascade O 1 0.9514231085777283
. O 0 0.007255616597831249

This O 0 0.0027477892581373453
results O 0 0.006327221170067787
in O 0 0.003814628114923835
infertility B-Disease 1 0.9999998807907104
and O 0 0.17973850667476654
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.0355885773897171
CDM B-Disease 1 0.9999878406524658
) O 0 0.0027603418566286564
with O 0 0.0008669833187013865
the O 0 0.0021678630728274584
disappearance O 0 0.07577969133853912
of O 0 0.004641612526029348
DM B-Disease 1 1.0
in O 0 0.002654500538483262
that O 0 0.0023303029593080282
pedigree O 1 0.8679887056350708
. O 0 0.006828195881098509

The O 0 0.0038554826751351357
concept O 0 0.005327050574123859
of O 0 0.002416402567178011
segregation O 1 0.8951905965805054
distortion O 1 0.59090256690979
, O 0 0.0018677846528589725
where O 0 0.002075544325634837
there O 0 0.0015679625794291496
is O 0 0.003292195266112685
preferential O 0 0.050789572298526764
transmission O 0 0.05382474884390831
of O 0 0.001161817112006247
the O 0 0.0021687287371605635
larger O 0 0.01241397112607956
allele O 1 0.9999246597290039
at O 0 0.006022753659635782
the O 0 0.010795134119689465
DM B-Disease 1 1.0
locus O 1 0.999998927116394
, O 0 0.002698531374335289
has O 0 0.002547478536143899
been O 0 0.0023458804935216904
put O 0 0.0035062478855252266
forward O 0 0.0032370213884860277
to O 0 0.0010784545447677374
explain O 0 0.006847995799034834
partially O 0 0.03155391663312912
the O 0 0.0027810679748654366
maintenance O 0 0.02865668386220932
of O 0 0.004600726068019867
DM B-Disease 1 1.0
in O 0 0.002064033877104521
the O 0 0.0023660326842218637
population O 0 0.010823083110153675
. O 0 0.005029733292758465

In O 0 0.0028437343426048756
a O 0 0.004811969120055437
survey O 0 0.009330755099654198
of O 0 0.004021779168397188
DM B-Disease 1 1.0
in O 0 0.003477179678156972
Northern O 0 0.01399995107203722
Ireland O 0 0.014323357492685318
, O 0 0.0024841567501425743
59 O 0 0.03330765664577484
pedigrees O 0 0.1605646312236786
were O 0 0.003181075444445014
ascertained O 0 0.21282628178596497
. O 0 0.006578508764505386

Sibships O 1 0.997115969657898
where O 0 0.0037144471425563097
the O 0 0.0020623893942683935
status O 0 0.005446786992251873
of O 0 0.0007973500760272145
all O 0 0.0006948164664208889
the O 0 0.0015533964615315199
members O 0 0.0021676188334822655
had O 0 0.004104501102119684
been O 0 0.003714232239872217
identified O 0 0.009656950831413269
were O 0 0.0014063119888305664
examined O 0 0.014954199083149433
to O 0 0.0010005024960264564
determine O 0 0.0033741132356226444
the O 0 0.0022519822232425213
transmission O 0 0.05252663046121597
of O 0 0.0020415440667420626
the O 0 0.008136906661093235
DM B-Disease 1 1.0
expansion O 0 0.022652845829725266
from O 0 0.005288177169859409
affected O 0 0.1302521526813507
parents O 0 0.011630021966993809
to O 0 0.0013032816350460052
their O 0 0.002919672755524516
offspring O 1 0.9196820855140686
. O 0 0.005671517923474312

Where O 0 0.005848507862538099
the O 0 0.0038528922013938427
transmitting O 1 0.6360530257225037
parent O 1 0.9688833951950073
was O 0 0.013989773578941822
male O 0 0.0321575291454792
, O 0 0.002927538938820362
58 O 0 0.03200365975499153
. O 0 0.004742023069411516

3 O 0 0.015576093457639217
% O 0 0.0028157748747617006
of O 0 0.0010348936775699258
the O 0 0.003806435503065586
offspring O 1 0.9650124311447144
were O 0 0.0029286290518939495
affected O 1 0.6076003313064575
, O 0 0.0011238674633204937
and O 0 0.0004975917981937528
in O 0 0.0007480557542294264
the O 0 0.0014361098874360323
case O 0 0.003882664954289794
of O 0 0.0008331651333719492
a O 0 0.005991303361952305
female O 0 0.02397766336798668
transmitting O 1 0.9810738563537598
parent O 1 0.9986690282821655
, O 0 0.0033480292186141014
68 O 0 0.03967335447669029
. O 0 0.005370899103581905

7 O 0 0.02241278439760208
% O 0 0.00456946762278676
were O 0 0.00274347560480237
affected O 0 0.044973812997341156
. O 0 0.005898870062083006

Studies O 0 0.008938094601035118
on O 0 0.004373536445200443
meiotic O 1 0.9984018206596375
drive O 0 0.03435970097780228
in O 0 0.007042748853564262
DM B-Disease 1 1.0
have O 0 0.003283029654994607
shown O 0 0.005813198629766703
increased O 0 0.009823963046073914
transmission O 0 0.040314268320798874
of O 0 0.0009370543994009495
the O 0 0.0021341312676668167
larger O 0 0.014214258641004562
allele O 1 0.9998456239700317
at O 0 0.006069439463317394
the O 0 0.010065805166959763
DM B-Disease 1 1.0
locus O 1 0.9999333620071411
in O 0 0.0048561105504632
non O 0 0.02053942158818245
- O 1 0.6219173669815063
DM O 1 1.0
heterozygotes O 1 0.9999021291732788
for O 0 0.007053551729768515
CTGn O 1 0.999373733997345
. O 0 0.006680713966488838

This O 0 0.003593779867514968
study O 0 0.0041513582691550255
provides O 0 0.003698913846164942
further O 0 0.0020066527649760246
evidence O 0 0.0014035130152478814
that O 0 0.001173144904896617
the O 0 0.0067266616970300674
DM B-Disease 1 1.0
expansion O 0 0.02661716192960739
tends O 0 0.025558801367878914
to O 0 0.0016703828005120158
be O 0 0.0034128970000892878
transmitted O 1 0.8107975721359253
preferentially O 0 0.15806704759597778
. O 0 0.006238781381398439

Diagnosis O 1 0.9999979734420776
of O 0 0.01012915838509798
hemochromatosis B-Disease 1 1.0
. O 0 0.009959627874195576

If O 0 0.015263098292052746
untreated O 1 0.9999974966049194
, O 0 0.008276469074189663
hemochromatosis B-Disease 1 1.0
can O 0 0.011911900714039803
cause O 1 0.9999712705612183
serious O 1 0.9999885559082031
illness O 1 1.0
and O 0 0.0016920253401622176
early B-Disease 0 0.00756049295887351
death I-Disease 1 0.9423173666000366
, O 0 0.0011887663276866078
but O 0 0.001674522995017469
the O 0 0.005941337440162897
disease O 1 1.0
is O 0 0.0025266450829803944
still O 0 0.0033402484841644764
substantially O 0 0.02639312855899334
under O 0 0.008624231442809105
- O 1 0.9990634322166443
diagnosed O 1 1.0
. O 0 0.00784445833414793

The O 0 0.0052712783217430115
cornerstone O 0 0.03636530041694641
of O 0 0.001957532251253724
screening O 0 0.15041062235832214
and O 0 0.001320003648288548
case O 0 0.007312429137527943
detection O 0 0.03077520802617073
is O 0 0.0016203360864892602
the O 0 0.001290639047510922
measurement O 0 0.01057662907987833
of O 0 0.0021607298403978348
serum O 1 0.9994156360626221
transferrin O 1 0.9989210367202759
saturation O 0 0.268197238445282
and O 0 0.001651593716815114
the O 0 0.005203274544328451
serum O 1 0.9981974959373474
ferritin O 1 0.9940176010131836
level O 0 0.014205588959157467
. O 0 0.006141446065157652

Once O 0 0.01706092618405819
the O 0 0.007704460062086582
diagnosis O 1 0.9999991655349731
is O 0 0.005186102818697691
suspected O 0 0.06302747130393982
, O 0 0.002019336912781
physicians O 0 0.36092907190322876
must O 0 0.0023166160099208355
use O 0 0.004317196551710367
serum O 1 0.9980114698410034
ferritin O 1 0.9922742247581482
levels O 0 0.019903745502233505
and O 0 0.00406743073835969
hepatic O 1 1.0
iron O 0 0.4722227454185486
stores O 0 0.01528820302337408
on O 0 0.007094157859683037
liver O 1 1.0
biopsy O 1 0.9999996423721313
specimens O 0 0.01829807460308075
to O 0 0.0017410947475582361
assess O 0 0.040051721036434174
patients O 1 0.9997735619544983
for O 0 0.0011042357655242085
the O 0 0.001816866104491055
presence O 0 0.0076356674544513226
of O 0 0.002306889509782195
iron B-Disease 1 0.9971575736999512
overload I-Disease 1 0.9998239874839783
. O 0 0.0077078258618712425

Liver O 1 1.0
biopsy O 1 0.9999997615814209
is O 0 0.00421656109392643
also O 0 0.0011816071346402168
used O 0 0.0009490190423093736
to O 0 0.0008401257218793035
establish O 0 0.003655283246189356
the O 0 0.0025746480096131563
presence O 0 0.00939378421753645
or O 0 0.003372817998751998
absence O 0 0.017611293122172356
of O 0 0.00413217069581151
cirrhosis B-Disease 1 1.0
, O 0 0.0019235957879573107
which O 0 0.001401693793013692
can O 0 0.0031598990317434072
affect O 0 0.03720914572477341
prognosis O 1 0.9999998807907104
and O 0 0.002288050251081586
management O 0 0.0160654466599226
. O 0 0.004507049452513456

A O 0 0.031235264614224434
DNA O 0 0.05509249493479729
- O 0 0.016108933836221695
based O 0 0.0027761103119701147
test O 0 0.007982970215380192
for O 0 0.001356610911898315
the O 0 0.007043039426207542
HFE O 1 0.9999996423721313
gene O 1 0.9966279864311218
is O 0 0.004250042140483856
commercially O 0 0.018446123227477074
available O 0 0.0022552860900759697
, O 0 0.0008394474280066788
but O 0 0.0008363683591596782
its O 0 0.0010543770622462034
place O 0 0.0018899848219007254
in O 0 0.0010250702034682035
the O 0 0.0035201769787818193
diagnosis O 1 0.9999998807907104
of O 0 0.0058177500031888485
hemochromatosis B-Disease 1 1.0
is O 0 0.00521314749494195
still O 0 0.003512841649353504
being O 0 0.006091528106480837
evaluated O 0 0.04653095826506615
. O 0 0.004591160453855991

Currently O 0 0.009151747450232506
, O 0 0.0012509084772318602
the O 0 0.0015760310925543308
most O 0 0.002198450267314911
useful O 0 0.0047377608716487885
role O 0 0.005228814203292131
for O 0 0.001088337623514235
this O 0 0.0014175449032336473
test O 0 0.009019136428833008
is O 0 0.0015783392591401935
in O 0 0.0007044908124953508
the O 0 0.002150328131392598
detection O 0 0.03878197818994522
of O 0 0.004465057514607906
hemochromatosis B-Disease 1 1.0
in O 0 0.0020928471349179745
the O 0 0.0025310800410807133
family O 0 0.009152650833129883
members O 0 0.0025230557657778263
of O 0 0.0024662006180733442
patients O 1 0.9999969005584717
with O 0 0.0014398755738511682
a O 0 0.004490464460104704
proven O 0 0.017204245552420616
case O 0 0.003596755675971508
of O 0 0.0012092695105820894
the O 0 0.008031231351196766
disease O 1 1.0
. O 0 0.006882183253765106

It O 0 0.002391376066952944
is O 0 0.001849888707511127
crucial O 0 0.007308147847652435
to O 0 0.003942413721233606
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 0 0.04223450645804405
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 0.9997947812080383
because O 0 0.01303454115986824
phlebotomy O 1 0.9999973773956299
therapy O 1 0.9999909400939941
can O 0 0.007423262111842632
avert O 1 0.9999969005584717
serious O 1 0.9999998807907104
chronic O 1 1.0
disease O 1 1.0
and O 0 0.0018888615304604173
can O 0 0.0018113211262971163
even O 0 0.0018407212337478995
lead O 0 0.005062094423919916
to O 0 0.0013900832273066044
normal O 0 0.017929572612047195
life O 0 0.010453359223902225
expectancy O 0 0.303665429353714
. O 0 0.0026467707939445972
. O 0 0.0039140949957072735

Prevalence O 1 0.9895584583282471
of O 0 0.00201135384850204
the O 0 0.004980773665010929
I1307K O 1 0.9999803304672241
APC B-Disease 1 0.9999997615814209
gene O 1 0.9998773336410522
variant O 1 0.9904326796531677
in O 0 0.002061271807178855
Israeli O 0 0.007096344605088234
Jews O 0 0.003339283401146531
of O 0 0.0009599142358638346
differing O 0 0.005439592059701681
ethnic O 0 0.004387303721159697
origin O 0 0.004705782979726791
and O 0 0.0016915776068344712
risk O 1 0.9999746084213257
for O 0 0.03444274887442589
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.009126589633524418

BACKGROUND O 0 0.03837773576378822
& O 0 0.034453291445970535
AIMS O 0 0.030430037528276443
Israeli O 0 0.011068464256823063
Jews O 0 0.004298665560781956
of O 0 0.001494850148446858
European O 0 0.0064355009235441685
birth O 1 0.9735455513000488
, O 0 0.002251744270324707
i O 0 0.00559590570628643
. O 0 0.0019780395086854696
e O 0 0.022701935842633247
. O 0 0.002235640538856387
, O 0 0.0022778473794460297
Ashkenazim O 1 0.9998301267623901
, O 0 0.0010069644777104259
have O 0 0.0008423657855018973
the O 0 0.0036629880778491497
highest O 1 0.9998878240585327
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 0.9999912977218628
of O 0 0.0017650165827944875
any O 0 0.0018121040193364024
Israeli O 0 0.00852558296173811
ethnic O 0 0.008222983218729496
group O 0 0.009808599017560482
. O 0 0.004837410524487495

The O 0 0.012074203230440617
I1307K O 1 0.9998705387115479
APC B-Disease 1 0.9999974966049194
gene O 1 0.9995891451835632
variant O 1 0.994024932384491
was O 0 0.006998845841735601
found O 0 0.004349537193775177
in O 0 0.001971497666090727
6 O 0 0.012653971090912819
. O 0 0.004092745017260313

1 O 0 0.019502738490700722
% O 0 0.0038257937412708998
of O 0 0.00128860620316118
American O 0 0.005874709691852331
Jews O 0 0.005621677730232477
, O 0 0.0013256616657599807
28 O 0 0.007605044636875391
% O 0 0.001987624680623412
of O 0 0.0011440569069236517
their O 0 0.008522843942046165
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 1 0.5753467679023743
, O 0 0.001161739113740623
but O 0 0.0010250795166939497
not O 0 0.0007955448818393052
in O 0 0.0012042071903124452
non O 0 0.009304415434598923
- O 0 0.01787492074072361
Jews O 0 0.0086891520768404
. O 0 0.004522426053881645

We O 0 0.003701927373185754
assessed O 0 0.023778056725859642
the O 0 0.0054618618451058865
I1307K O 1 0.9999624490737915
prevalence O 1 0.9999285936355591
in O 0 0.002031386364251375
Israeli O 0 0.006719131022691727
Jews O 0 0.00331760267727077
of O 0 0.0007794352131895721
differing O 0 0.004904784262180328
ethnic O 0 0.0041976189240813255
origin O 0 0.004621834494173527
and O 0 0.0015610548434779048
risk O 1 0.9999425411224365
for O 0 0.0419401153922081
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.008341199718415737

METHODS O 0 0.024233968928456306
DNA O 0 0.04413594305515289
samples O 0 0.014291239902377129
from O 0 0.0038298063445836306
500 O 0 0.024372126907110214
unrelated O 0 0.03326592966914177
Jews O 0 0.005138630513101816
of O 0 0.001253774855285883
European O 0 0.005692976526916027
or O 0 0.003828260349109769
non O 0 0.011422048322856426
- O 0 0.01411336101591587
European O 0 0.005146410316228867
origin O 0 0.006108263973146677
, O 0 0.0010380172170698643
with O 0 0.0009095905115827918
or O 0 0.0017549125477671623
without O 0 0.002080452861264348
a O 0 0.0037501438055187464
personal O 0 0.005520566366612911
and O 0 0.002174186985939741
/ O 1 0.7571020722389221
or O 0 0.0031797648407518864
family O 0 0.009224584326148033
history O 0 0.004005926661193371
of O 0 0.004320546053349972
neoplasia B-Disease 1 1.0
, O 0 0.0018325581913813949
were O 0 0.0012716364581137896
examined O 0 0.015374492853879929
for O 0 0.0010248051257804036
the O 0 0.0033474534284323454
I1307K O 1 0.9998636245727539
variant O 1 0.9969307780265808
by O 0 0.0022999439388513565
the O 0 0.0042257229797542095
allele O 1 0.9999724626541138
- O 0 0.025905203074216843
specific O 0 0.007754972204566002
oligonucleotide O 1 0.8232919573783875
( O 0 0.010885070078074932
ASO O 1 0.999984860420227
) O 0 0.004028209485113621
method O 0 0.010564734227955341
. O 0 0.0037800557911396027

RESULTS O 0 0.02080950140953064
In O 0 0.0021110435482114553
persons O 0 0.005741980858147144
at O 0 0.0031938853207975626
average O 0 0.013481623493134975
risk O 1 0.999586284160614
for O 0 0.023787619546055794
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.005542750004678965
I1307K O 1 0.9999237060546875
was O 0 0.00709873391315341
found O 0 0.003908415790647268
in O 0 0.001426000497303903
5 O 0 0.009577121585607529
. O 0 0.00406681839376688

0 O 0 0.05155310779809952
% O 0 0.00583100039511919
of O 0 0.001861628028564155
120 O 0 0.009589184075593948
European O 0 0.004340922459959984
and O 0 0.0016633064951747656
1 O 0 0.01290955487638712
. O 0 0.0046890489757061005

6 O 0 0.0254343394190073
% O 0 0.004425326827913523
of O 0 0.0019217528169974685
188 O 0 0.06599044799804688
non O 0 0.014130448922514915
- O 0 0.01787378266453743
European O 0 0.006196724250912666
Jews O 0 0.0097219692543149
( O 0 0.010237686336040497
P O 1 0.9909537434577942
= O 0 0.06492538005113602
0 O 0 0.03142772987484932
. O 0 0.003543378785252571
08 O 0 0.16968247294425964
) O 0 0.004634814336895943
. O 0 0.004077986814081669

It O 0 0.006650909781455994
occurred O 0 0.02579033374786377
in O 0 0.002509008627384901
15 O 0 0.009089550003409386
. O 0 0.0052377013489604

4 O 0 0.01872762106359005
% O 0 0.003192323725670576
of O 0 0.0015668381238356233
52 O 0 0.03286191076040268
Ashkenazi O 1 0.9986106157302856
Israelis O 0 0.024412889033555984
with O 0 0.006585989147424698
familial O 1 1.0
cancer B-Disease 1 1.0
( O 0 0.014557458460330963
P O 1 0.9993295669555664
= O 0 0.05988612025976181
0 O 0 0.03452521190047264
. O 0 0.004572010599076748
02 O 1 0.9995991587638855
) O 0 0.0031564917881041765
and O 0 0.0009930100059136748
was O 0 0.005105349235236645
not O 0 0.0022634861525148153
detected O 0 0.06141538545489311
in O 0 0.0028003051411360502
51 O 0 0.02914416417479515
non O 0 0.013434434309601784
- O 0 0.01691192388534546
European O 0 0.0044908844865858555
Jews O 0 0.005581115838140249
at O 0 0.006441608536988497
increased O 1 0.7843329310417175
cancer B-Disease 1 1.0
risk O 1 0.9985231757164001
. O 0 0.005909219849854708

Colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999994039535522
occurred O 0 0.07094209641218185
personally O 0 0.03392292559146881
or O 0 0.0024761457461863756
in O 0 0.0010117943165823817
the O 0 0.0016242129495367408
families O 0 0.004108387511223555
of O 0 0.0011879517696797848
13 O 0 0.005966289900243282
of O 0 0.0015681320801377296
20 O 0 0.01153910905122757
Ashkenazi O 1 0.9999310970306396
I1307K O 1 0.999990701675415
carriers O 1 0.9881320595741272
, O 0 0.002006570575758815
8 O 0 0.0064965495839715
of O 0 0.001185328932479024
whom O 0 0.006796204950660467
also O 0 0.001287834020331502
had O 0 0.0028708307072520256
a O 0 0.004141670651733875
personal O 0 0.005272640381008387
or O 0 0.0031743026338517666
family O 0 0.008999987505376339
history O 0 0.003699174150824547
of O 0 0.0033501209691166878
noncolonic O 1 0.9999992847442627
neoplasia B-Disease 1 0.9999991655349731
. O 0 0.008557363413274288

CONCLUSIONS O 0 0.020218754187226295
The O 0 0.008015822619199753
I1307K O 1 0.999956488609314
APC O 1 0.9999978542327881
variant O 1 0.9984689354896545
may O 0 0.006299891509115696
represent O 0 0.0031551022548228502
a O 0 0.011316528543829918
susceptibility O 1 0.9999942779541016
gene O 1 0.9997501969337463
for O 0 0.008750316686928272
colorectal B-Disease 1 1.0
, I-Disease 0 0.002125798724591732
or I-Disease 0 0.0020642783492803574
other I-Disease 0 0.0008831712184473872
, I-Disease 0 0.00366323534399271
cancers I-Disease 1 1.0
in O 0 0.003754648379981518
Ashkenazi O 1 0.9999579191207886
Jews O 0 0.00628568883985281
, O 0 0.0010604595299810171
and O 0 0.001017716247588396
partially O 0 0.07867216318845749
explains O 0 0.011410815641283989
the O 0 0.0018362287664785981
higher O 0 0.010615375824272633
incidence O 1 0.9999954700469971
of O 0 0.017415642738342285
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.0029406375251710415
European O 0 0.005102231167256832
Israelis O 0 0.02314385212957859
. O 0 0.005164378322660923

Systematic O 0 0.0429406575858593
analysis O 0 0.004262377507984638
of O 0 0.0027604063507169485
coproporphyrinogen O 1 0.9999895095825195
oxidase O 1 0.9999682903289795
gene O 1 0.9997710585594177
defects O 1 0.9997126460075378
in O 0 0.004956110380589962
hereditary B-Disease 1 0.9999997615814209
coproporphyria I-Disease 1 0.9999748468399048
and O 0 0.004993814043700695
mutation O 1 0.9999990463256836
update O 0 0.05287459120154381
. O 0 0.005029766820371151

Hereditary B-Disease 1 0.9999979734420776
coproporphyria I-Disease 1 0.9998741149902344
( O 0 0.012539398856461048
HC B-Disease 1 0.9999104738235474
) O 0 0.0033494997769594193
is O 0 0.0026171307545155287
an O 0 0.006043493282049894
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 0 0.010051238350570202
autosomal O 1 1.0
dominant O 1 0.9997926354408264
inheritance O 1 0.9999337196350098
caused O 1 0.9998937845230103
by O 0 0.005303150042891502
deficient B-Disease 1 0.9993977546691895
activity I-Disease 0 0.009702270850539207
of I-Disease 0 0.0026058556977659464
coproporphyrinogen I-Disease 1 0.9999769926071167
III I-Disease 1 0.9999170303344727
oxidase I-Disease 1 0.9997629523277283
( O 0 0.012769143097102642
CPO O 1 0.9864463806152344
) O 0 0.0056164986453950405
. O 0 0.004152027890086174

Clinical O 1 0.9782077670097351
manifestations O 0 0.1179564818739891
of O 0 0.0016759319696575403
the O 0 0.006524319760501385
disease O 1 1.0
are O 0 0.0016929262783378363
characterized O 1 0.8638084530830383
by O 0 0.005275605246424675
acute O 1 1.0
attacks O 0 0.08708587288856506
of O 0 0.005935313180088997
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 0.011828862130641937
precipitated O 1 0.9999967813491821
by O 0 0.005002189427614212
drugs O 0 0.23843364417552948
, O 0 0.002178061520680785
fasting O 1 0.9955409169197083
, O 0 0.0036605733912438154
cyclical O 1 0.999996542930603
hormonal O 1 0.9999953508377075
changes O 0 0.009848187677562237
, O 0 0.0023915362544357777
or O 0 0.012340329587459564
infectious B-Disease 1 1.0
diseases I-Disease 1 1.0
. O 0 0.00565308565273881

Skin O 1 1.0
photosensitivity O 1 0.9999997615814209
may O 0 0.014667120762169361
also O 0 0.0016857722075656056
be O 0 0.0013114080065861344
present O 0 0.0033082913141697645
. O 0 0.0049674417823553085

The O 0 0.004496759735047817
seven O 0 0.006511579733341932
exons O 1 0.6809746623039246
, O 0 0.002103691454976797
the O 0 0.005192111246287823
exon O 1 0.9999048709869385
/ O 1 0.8112033605575562
intron O 1 0.9934072494506836
boundaries O 0 0.00589211517944932
and O 0 0.0011368700070306659
part O 0 0.0033193265553563833
of O 0 0.0017097211675718427
3 O 0 0.014973999001085758
noncoding O 0 0.1804804503917694
sequence O 0 0.01590593531727791
of O 0 0.001354364794678986
the O 0 0.004683987237513065
CPO O 1 0.9992865920066833
gene O 1 0.9934480786323547
were O 0 0.0024428709875792265
systematically O 0 0.02574700303375721
analyzed O 0 0.012920539826154709
by O 0 0.002394129289314151
an O 0 0.00366296898573637
exon O 1 0.9990991353988647
- O 0 0.018748728558421135
by O 0 0.004835142288357019
- O 0 0.04252706840634346
exon O 1 0.9971086382865906
denaturing O 1 0.9926807284355164
gradient O 1 0.740796685218811
gel O 1 0.9685559868812561
electrophoresis O 1 0.7708808779716492
( O 0 0.014416836202144623
DGGE O 1 0.9998358488082886
) O 0 0.005251599941402674
strategy O 0 0.015973355621099472
followed O 0 0.007797251921147108
by O 0 0.002202398143708706
direct O 0 0.0064801909029483795
sequencing O 0 0.04018107429146767
in O 0 0.0015786910662427545
seven O 0 0.005522140301764011
unrelated O 0 0.07776211947202682
heterozygous O 1 0.9999868869781494
HC B-Disease 1 0.999992847442627
patients O 1 0.9999960660934448
from O 0 0.004557753447443247
France O 0 0.019365178421139717
, O 0 0.0027462048456072807
Holland O 0 0.14842496812343597
, O 0 0.0015253759920597076
and O 0 0.00127568026073277
Czech O 0 0.016466505825519562
Republic O 0 0.00967076513916254
. O 0 0.006167153362184763

Seven O 0 0.010611461475491524
novel O 0 0.04247317835688591
mutations O 1 0.9994660019874573
and O 0 0.0011229150695726275
two O 0 0.0012003163574263453
new O 0 0.004056429490447044
polymorphisms O 1 0.998096764087677
were O 0 0.004396200180053711
detected O 0 0.09253562241792679
. O 0 0.004945220425724983

Among O 0 0.007498044520616531
these O 0 0.0024713531602174044
mutations O 1 0.9996696710586548
two O 0 0.0020469091832637787
are O 0 0.002405713312327862
missense O 1 0.999937891960144
( O 0 0.012292897328734398
G197W O 1 0.9998894929885864
, O 0 0.005150604527443647
W427R O 1 0.9994588494300842
) O 0 0.00346803804859519
, O 0 0.0009373293141834438
two O 0 0.0009828152833506465
are O 0 0.0017552969511598349
nonsense O 0 0.2820683717727661
( O 0 0.008253178559243679
Q306X O 1 0.9999463558197021
, O 0 0.0054482207633554935
Q385X O 1 0.9996898174285889
) O 0 0.0040700179524719715
, O 0 0.0010610981844365597
two O 0 0.0008250193204730749
are O 0 0.0011231728130951524
small O 0 0.00794338807463646
deletions O 1 0.9820615649223328
( O 0 0.009542753919959068
662de14bp O 1 0.9998190999031067
; O 0 0.0064520263113081455
1168del3bp O 1 0.9982241988182068
removing O 0 0.038948144763708115
a O 0 0.009116681292653084
glycine O 0 0.32357969880104065
at O 0 0.004889320116490126
position O 0 0.009193681180477142
390 O 0 0.0889216884970665
) O 0 0.003219420788809657
, O 0 0.0008450562017969787
and O 0 0.000605170032940805
one O 0 0.0013997417408972979
is O 0 0.0019986871629953384
a O 0 0.008343491703271866
splicing O 1 0.8950043320655823
mutation O 1 0.9999414682388306
( O 0 0.011179126799106598
IVS1 O 1 0.9999806880950928
- O 0 0.06535309553146362
15c O 1 0.9941463470458984
- O 0 0.062249232083559036
- O 0 0.0643714964389801
> O 1 0.9976598024368286
g O 1 0.7835059762001038
) O 0 0.0029185751918703318
which O 0 0.0014815748436376452
creates O 0 0.01301917340606451
a O 0 0.0050733317621052265
new O 0 0.005857572890818119
acceptor O 1 0.9536859393119812
splice O 1 0.9843847751617432
site O 0 0.016788486391305923
. O 0 0.0055782669223845005

The O 0 0.006588492076843977
pathological O 1 0.8027393817901611
significance O 0 0.004555469378829002
of O 0 0.0006612790748476982
the O 0 0.001901003299281001
point O 0 0.009752356447279453
mutations O 1 0.9999983310699463
G197W O 1 0.99994957447052
, O 0 0.004302543122321367
W427R O 1 0.9999247789382935
, O 0 0.001269123749807477
and O 0 0.0006471095257438719
the O 0 0.0013290870701894164
in O 0 0.0017981765558943152
- O 0 0.02308342419564724
frame O 0 0.03996432572603226
deletion O 1 0.9990401864051819
390delGly O 1 0.9971055388450623
were O 0 0.002617108402773738
assessed O 0 0.018027378246188164
by O 0 0.0016300644492730498
their O 0 0.001310114748775959
respective O 0 0.006312874145805836
expression O 0 0.018964078277349472
in O 0 0.0012270461302250624
a O 0 0.00694648502394557
prokaryotic O 0 0.06110069900751114
system O 0 0.00965210422873497
using O 0 0.003460722276940942
site O 0 0.010129464790225029
- O 0 0.02121150866150856
directed O 0 0.01889945939183235
mutagenesis O 1 0.6694062352180481
. O 0 0.008477463386952877

These O 0 0.006380876526236534
mutations O 1 0.9992745518684387
resulted O 0 0.02233452908694744
in O 0 0.0012140012113377452
the O 0 0.0021626728121191263
absence O 0 0.021749554201960564
or O 0 0.0023887394927442074
a O 0 0.0056051756255328655
dramatic O 0 0.02273058146238327
decrease O 0 0.0309674683958292
of O 0 0.003285262966528535
CPO O 1 0.9990993738174438
activity O 0 0.017265141010284424
. O 0 0.005125406198203564

The O 0 0.004339051898568869
two O 0 0.003249726491048932
polymorphisms O 1 0.997734546661377
were O 0 0.003863993100821972
localized O 1 0.9849194288253784
in O 0 0.0035074311308562756
noncoding O 0 0.15957479178905487
part O 0 0.003966348245739937
of O 0 0.0012761360267177224
the O 0 0.005014582071453333
gene O 1 0.9998428821563721
1 O 0 0.015581370331346989
) O 0 0.003036478068679571
a O 0 0.01048703771084547
C O 1 0.7901474833488464
/ O 0 0.23258307576179504
G O 1 0.9798667430877686
polymorphism O 0 0.14863349497318268
in O 0 0.0020381887443363667
the O 0 0.004410252906382084
promotor O 1 0.9999200105667114
region O 0 0.014842445030808449
, O 0 0.00245082238689065
142 O 0 0.0578421875834465
bp O 0 0.0711975246667862
upstream O 0 0.03100276179611683
from O 0 0.0022302097640931606
the O 0 0.004005464259535074
transcriptional O 0 0.4242284893989563
initiation O 0 0.0923905223608017
site O 0 0.014877927489578724
( O 0 0.006715402472764254
- O 0 0.050425104796886444
142C O 1 0.9998400211334229
/ O 1 0.9792084097862244
G O 1 0.9990492463111877
) O 0 0.004461606033146381
, O 0 0.0013819574378430843
and O 0 0.0011816222686320543
2 O 0 0.008105501532554626
) O 0 0.0022305557504296303
a O 0 0.005910844542086124
6 O 0 0.014774978160858154
bp O 0 0.09956931322813034
deletion O 1 0.9986711740493774
polymorphism O 0 0.19122369587421417
in O 0 0.002016212325543165
the O 0 0.003025694051757455
3 O 0 0.015074377879500389
noncoding O 0 0.15844111144542694
part O 0 0.004497668705880642
of O 0 0.0012228412088006735
the O 0 0.005166284739971161
CPO O 1 0.9997044205665588
gene O 1 0.9946795105934143
, O 0 0.004447511397302151
574 O 1 0.9709047079086304
bp O 0 0.07077828049659729
downstream O 0 0.03534937649965286
of O 0 0.001070478348992765
the O 0 0.0018936924170702696
last O 0 0.005912817548960447
base O 0 0.006237060762941837
of O 0 0.0008979457779787481
the O 0 0.0025700293481349945
normal O 0 0.03161555528640747
termination O 1 0.9981281161308289
codon O 1 0.9111467003822327
( O 0 0.012890391983091831
+ O 0 0.12514205276966095
574 O 1 0.9719213247299194
delATTCTT O 1 0.9979494214057922
) O 0 0.00708429329097271
. O 0 0.004987474996596575

Five O 0 0.018232380971312523
intragenic O 1 0.9993270635604858
dimorphisms O 1 0.9994416832923889
are O 0 0.0019668354652822018
now O 0 0.0037644982803612947
well O 0 0.002873780904337764
characterized O 0 0.03231063485145569
and O 0 0.0008444641134701669
the O 0 0.0017192617524415255
high O 0 0.004671124275773764
degree O 0 0.004349812399595976
of O 0 0.002436358015984297
allelic O 1 0.999929666519165
heterogeneity O 1 0.9934749007225037
in O 0 0.004238351713865995
HC B-Disease 1 0.9998692274093628
is O 0 0.004354758653789759
demonstrated O 0 0.008445602841675282
with O 0 0.0009909585351124406
seven O 0 0.0028390688821673393
new O 0 0.0024427755270153284
different O 0 0.002000429667532444
mutations O 1 0.9990712404251099
making O 0 0.002655214164406061
a O 0 0.0034937183372676373
total O 0 0.0024397075176239014
of O 0 0.0015004104934632778
nineteen O 1 0.8992103934288025
CPO O 1 0.9999538660049438
gene B-Disease 1 0.999984860420227
defects I-Disease 1 0.9999960660934448
reported O 0 0.019602982327342033
so O 0 0.0040552737191319466
far O 0 0.004538968671113253
. O 0 0.002308996394276619
. O 0 0.004346798174083233

Coincidence O 0 0.032960813492536545
of O 0 0.0011364331003278494
two O 0 0.001289583626203239
novel O 0 0.02663949877023697
arylsulfatase O 1 0.9993380904197693
A O 0 0.02458277717232704
alleles O 1 0.9996352195739746
and O 0 0.004885183181613684
mutation O 1 0.9999959468841553
459 O 1 0.9985337257385254
+ O 0 0.22605563700199127
1G O 1 0.9999675750732422
> O 1 0.9722097516059875
A O 0 0.009256680496037006
within O 0 0.0021670497953891754
a O 0 0.005442980211228132
family O 0 0.012650641612708569
with O 0 0.005730284843593836
metachromatic B-Disease 1 0.9999995231628418
leukodystrophy I-Disease 1 0.9999998807907104
: O 0 0.008101685903966427
molecular O 0 0.018718820065259933
basis O 0 0.002119792392477393
of O 0 0.00285442010499537
phenotypic O 1 0.9999128580093384
heterogeneity O 1 0.9633382558822632
. O 0 0.006302020978182554

In O 0 0.0035859360359609127
a O 0 0.0071076517924666405
family O 0 0.011323550716042519
with O 0 0.001560647040605545
three O 0 0.002836537780240178
siblings O 1 0.9813077449798584
, O 0 0.001399954198859632
one O 0 0.00218155886977911
developed O 0 0.009552656672894955
classical O 0 0.005610563326627016
late O 0 0.03390514478087425
infantile O 1 1.0
metachromatic B-Disease 1 0.9999996423721313
leukodystrophy I-Disease 1 1.0
( O 0 0.02520313858985901
MLD B-Disease 1 0.9999998807907104
) O 0 0.0076924581080675125
, O 0 0.004114661365747452
fatal O 1 0.9999997615814209
at O 0 0.006103798747062683
age O 0 0.01237180083990097
5 O 0 0.007937685586512089
years O 0 0.0027236624155193567
, O 0 0.001181574072688818
with O 0 0.0026576409582048655
deficient O 1 0.9999648332595825
arylsulfatase O 1 0.9998677968978882
A O 0 0.03401225432753563
( O 0 0.012765524908900261
ARSA O 1 0.9999971389770508
) O 0 0.004547412972897291
activity O 0 0.00653010793030262
and O 0 0.0011665939819067717
increased O 0 0.02065565064549446
galactosylsulfatide O 1 0.9996210336685181
( O 0 0.015545559115707874
GS O 1 0.9999992847442627
) O 0 0.010421214625239372
excretion O 1 0.9943578839302063
. O 0 0.007497848942875862

The O 0 0.003325739176943898
two O 0 0.000995952752418816
other O 0 0.0012076854472979903
siblings O 1 0.992647647857666
, O 0 0.002097879536449909
apparently O 0 0.026283573359251022
healthy O 1 0.938767671585083
at O 0 0.004771487321704626
12 O 0 0.008292163722217083
( O 0 0.0050863842479884624
1 O 0 0.020562149584293365
/ O 0 0.1697143018245697
2 O 0 0.012058219872415066
) O 0 0.0026791756972670555
and O 0 0.001241504680365324
15 O 0 0.006760155316442251
years O 0 0.004169501829892397
, O 0 0.0015905973268672824
respectively O 0 0.006008577533066273
, O 0 0.0011123482836410403
and O 0 0.0008966163732111454
their O 0 0.0016388942021876574
father O 0 0.07969380915164948
, O 0 0.0019905222579836845
apparently O 0 0.03410353511571884
healthy O 1 0.8694823980331421
as O 0 0.0020988897886127234
well O 0 0.0013976303162053227
, O 0 0.001500604092143476
presented O 0 0.009247592650353909
ARSA O 1 0.9999970197677612
and O 0 0.005871388595551252
GS O 1 0.9999921321868896
values O 0 0.00606718473136425
within O 0 0.0016592754982411861
the O 0 0.00169743865262717
range O 0 0.004404949489980936
of O 0 0.0053185028955340385
MLD B-Disease 1 1.0
patients O 1 0.9999885559082031
. O 0 0.009250245057046413

Mutation O 1 0.9999364614486694
screening O 0 0.072830431163311
and O 0 0.0020097538363188505
sequence O 0 0.01582341082394123
analysis O 0 0.005046096630394459
disclosed O 0 0.017725562676787376
the O 0 0.002229125704616308
involvement O 0 0.012334647588431835
of O 0 0.000966262596193701
three O 0 0.0017283837078139186
different O 0 0.003673812374472618
ARSA O 1 0.9999994039535522
mutations O 1 0.9998471736907959
being O 0 0.005334848538041115
the O 0 0.0018870688509196043
molecular O 0 0.013161757960915565
basis O 0 0.0018740971572697163
of O 0 0.002321105683222413
intrafamilial O 1 0.9998728036880493
phenotypic O 1 0.9997932314872742
heterogeneity O 1 0.9348320364952087
. O 0 0.005759367253631353

The O 0 0.007143072783946991
late O 0 0.040644653141498566
infantile O 1 1.0
patient O 1 0.9999991655349731
inherited O 1 0.9999771118164062
from O 0 0.002698597963899374
his O 0 0.0036667140666395426
mother O 0 0.03624098375439644
the O 0 0.0031687505543231964
frequent O 0 0.03393377363681793
0 O 0 0.030944116413593292
- O 0 0.034530337899923325
type O 0 0.4342721998691559
mutation O 1 0.9999847412109375
459 O 1 0.998248815536499
+ O 0 0.3286230266094208
1G O 1 0.9999568462371826
> O 1 0.9498487114906311
A O 0 0.015042629092931747
, O 0 0.0012943809852004051
and O 0 0.0007040448836050928
from O 0 0.0016117945779114962
his O 0 0.0035280268639326096
father O 0 0.020594730973243713
a O 0 0.006545035634189844
novel O 0 0.01719982549548149
, O 0 0.0018520487938076258
single O 0 0.01958906464278698
basepair O 1 0.9984766840934753
microdeletion O 1 0.9450070261955261
of O 0 0.0033967073541134596
guanine O 0 0.09267646819353104
at O 0 0.008918579667806625
nucleotide O 0 0.1141016036272049
7 O 0 0.01434953510761261
in O 0 0.003988270182162523
exon O 1 0.9952313303947449
1 O 0 0.02581433765590191
( O 0 0.009121309965848923
7delG O 1 0.9996246099472046
) O 0 0.005473835859447718
. O 0 0.004087586421519518

The O 0 0.005066147539764643
two O 0 0.0038173396605998278
clinically O 1 0.9999406337738037
unaffected O 1 0.9996618032455444
siblings O 0 0.23225824534893036
carried O 0 0.007250497583299875
the O 0 0.004208050202578306
maternal O 1 0.9997664093971252
mutation O 1 0.9999773502349854
459 O 1 0.994455873966217
+ O 0 0.44893601536750793
1G O 1 0.9999758005142212
> O 1 0.9939595460891724
A O 0 0.012621620669960976
and O 0 0.000926863809581846
, O 0 0.0006420380668714643
on O 0 0.0009736253996379673
their O 0 0.0022992745507508516
paternal O 1 0.9999041557312012
allele O 1 0.9999759197235107
, O 0 0.002297770930454135
a O 0 0.0060719819739460945
novel O 0 0.024807050824165344
cytosine O 0 0.13041099905967712
to O 0 0.0036790857557207346
thymidine O 1 0.5067250728607178
transition O 0 0.023432452231645584
at O 0 0.007805046625435352
nucleotide O 0 0.18649470806121826
2435 O 1 0.9921999573707581
in O 0 0.006576038431376219
exon O 1 0.9947004318237305
8 O 0 0.015234866179525852
, O 0 0.0020512761548161507
resulting O 0 0.020711760967969894
in O 0 0.0016187008004635572
substitution O 0 0.03495228290557861
of O 0 0.0030158795416355133
alanine O 1 0.9828768372535706
464 O 1 0.9889689683914185
by O 0 0.008220062591135502
valine O 1 0.999782145023346
( O 0 0.012329566292464733
A464V O 1 0.9996263980865479
) O 0 0.005293393973261118
. O 0 0.003981004469096661

The O 0 0.0069916448555886745
fathers O 0 0.06566694378852844
genotype O 1 0.9999366998672485
thus O 0 0.009399459697306156
was O 0 0.01116096694022417
7delG O 1 0.9999043941497803
/ O 1 0.7853689789772034
A464V O 1 0.9980598092079163
. O 0 0.0064116655848920345

Mutation O 1 0.9999843835830688
A464V O 1 0.9995063543319702
was O 0 0.00867005717009306
not O 0 0.0012172582792118192
found O 0 0.0031875765416771173
in O 0 0.0014593751402571797
18 O 0 0.010420231148600578
unrelated O 1 0.9889427423477173
MLD B-Disease 1 1.0
patients O 1 0.9999991655349731
and O 0 0.0023261872120201588
50 O 0 0.008335419930517673
controls O 0 0.02742936834692955
. O 0 0.005673642735928297

A464V O 1 0.9982208609580994
, O 0 0.002584651578217745
although O 0 0.003322337754070759
clearly O 0 0.010085300542414188
modifying O 0 0.11238405108451843
ARSA O 1 0.9999916553497314
and O 0 0.006682701408863068
GS O 1 0.9999978542327881
levels O 0 0.02428315579891205
, O 0 0.002200139220803976
apparently O 0 0.019194865599274635
bears O 0 0.0190040934830904
little O 0 0.006977582350373268
significance O 0 0.004767171107232571
for O 0 0.0022443814668804407
clinical O 1 0.9264589548110962
manifestation O 1 0.9879944324493408
of O 0 0.004289942793548107
MLD B-Disease 1 1.0
, O 0 0.003301128977909684
mimicking O 1 0.6510736346244812
the O 0 0.003996896091848612
frequent O 0 0.41343069076538086
ARSA O 1 0.9999996423721313
pseudodeficiency O 1 0.9999743700027466
allele O 1 0.9998194575309753
. O 0 0.008454344235360622

Our O 0 0.00637796800583601
results O 0 0.006961082108318806
demonstrate O 0 0.0034933630377054214
that O 0 0.0005559434066526592
in O 0 0.0007979676593095064
certain O 0 0.0034977782052010298
genetic O 0 0.46957650780677795
conditions O 0 0.030975915491580963
MLD B-Disease 1 0.9999996423721313
- O 0 0.04272199422121048
like O 0 0.016930120065808296
ARSA O 1 0.9999984502792358
and O 0 0.006197846028953791
GS O 1 0.9999963045120239
values O 0 0.009188604541122913
need O 0 0.003772441064938903
not O 0 0.0009894580580294132
be O 0 0.0017097488744184375
paralleled O 0 0.07409453392028809
by O 0 0.009244496002793312
clinical O 1 0.9999929666519165
disease O 1 1.0
, O 0 0.0017227793578058481
a O 0 0.00383897521533072
finding O 0 0.005804490763694048
with O 0 0.001829286920838058
serious O 1 0.9989181756973267
diagnostic O 1 0.985101580619812
and O 0 0.0028929337859153748
prognostic O 1 0.9999871253967285
implications O 0 0.14687350392341614
. O 0 0.006305209826678038

Moreover O 0 0.024944636970758438
, O 0 0.0019320842111483216
further O 0 0.009802408516407013
ARSA O 1 0.9999966621398926
alleles O 1 0.9999873638153076
functionally O 1 0.9925974607467651
similar O 0 0.006519258953630924
to O 0 0.0028862275648862123
A464V O 1 0.9998056292533875
might O 0 0.010310899466276169
exist O 0 0.002705315826460719
which O 0 0.0011470873141661286
, O 0 0.0008035091450437903
together O 0 0.0011505980510264635
with O 0 0.0015783860580995679
0 O 0 0.03226986899971962
- O 0 0.03870974853634834
type O 1 0.9682589173316956
mutations O 1 0.9999803304672241
, O 0 0.0024023535661399364
may O 0 0.011729998514056206
cause O 1 0.9998329877853394
pathological O 1 0.9999561309814453
ARSA O 1 0.9999994039535522
and O 0 0.006601900327950716
GS O 1 0.9999996423721313
levels O 0 0.01849197782576084
, O 0 0.001323218923062086
but O 0 0.001291327178478241
not O 0 0.0019476439338177443
clinical O 1 0.9984074234962463
outbreak O 1 0.9999998807907104
of O 0 0.0023230938240885735
the O 0 0.014385830610990524
disease O 1 1.0
. O 0 0.003046512370929122
. O 0 0.004053425509482622

Human O 0 0.06444370746612549
MLH1 O 1 0.9999997615814209
deficiency O 1 1.0
predisposes O 1 0.9999969005584717
to O 0 0.00858589168637991
hematological B-Disease 1 0.9999995231628418
malignancy I-Disease 1 1.0
and O 0 0.009976908564567566
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9493260979652405
1 I-Disease 0 0.013864671811461449
. O 0 0.004239774774760008

Heterozygous O 1 0.9996272325515747
germ O 1 0.9840812683105469
- O 0 0.044162340462207794
line O 0 0.02035815641283989
mutations O 1 0.9969646334648132
in O 0 0.0012617793399840593
the O 0 0.002543581183999777
DNA O 0 0.05942528694868088
mismatch O 1 0.9994593262672424
repair O 1 0.9980779886245728
genes O 0 0.10495341569185257
lead O 0 0.009111772291362286
to O 0 0.0036476259119808674
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.008800912648439407

The O 0 0.021380357444286346
disease O 1 1.0
susceptibility O 1 0.999994158744812
of O 0 0.0015519127482548356
individuals O 0 0.0029674877878278494
who O 0 0.002870759693905711
constitutionally O 1 0.6055027842521667
lack O 0 0.0086751040071249
both O 0 0.0017176142428070307
wild O 0 0.02951055020093918
- O 0 0.06858003884553909
type O 1 0.9865264296531677
alleles O 1 0.9999673366546631
is O 0 0.005017513874918222
unknown O 0 0.017599187791347504
. O 0 0.003953089471906424

We O 0 0.0025036928709596395
have O 0 0.0012706781271845102
identified O 0 0.007907642982900143
three O 0 0.0015126445796340704
offspring O 0 0.06551769375801086
in O 0 0.0013809114461764693
a O 0 0.012656884267926216
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.11200641095638275
who O 0 0.005924679338932037
developed O 1 0.7085304856300354
hematological B-Disease 1 0.9999996423721313
malignancy I-Disease 1 1.0
at O 0 0.005468200892210007
a O 0 0.005058824550360441
very O 0 0.004495494067668915
early O 0 0.008156676776707172
age O 0 0.011893871240317822
, O 0 0.0010001398622989655
and O 0 0.0007990914746187627
at O 0 0.0024837811943143606
least O 0 0.003309854306280613
two O 0 0.0006433188682422042
of O 0 0.0007466954411938787
them O 0 0.0007972653838805854
displayed O 0 0.006434955634176731
signs O 0 0.01520347036421299
of O 0 0.0058044851757586
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9651628732681274
1 I-Disease 0 0.02092297188937664
( O 0 0.010893239639699459
NF1 B-Disease 1 0.9999979734420776
) O 0 0.006210511550307274
. O 0 0.0044958763755857944

DNA O 0 0.06276139616966248
sequence O 0 0.019735045731067657
analysis O 0 0.004092033952474594
and O 0 0.0028242156840860844
allele O 1 0.999964714050293
- O 0 0.023010415956377983
specific O 0 0.006197813898324966
amplification O 0 0.06920680403709412
in O 0 0.0015539252199232578
two O 0 0.0016426797956228256
siblings O 0 0.08006343990564346
revealed O 0 0.018516739830374718
a O 0 0.01416479330509901
homozygous O 1 0.9999198913574219
MLH1 O 1 0.9999988079071045
mutation O 1 0.999995231628418
( O 0 0.012011491693556309
C676T O 1 0.9991520643234253
- O 0 0.04880043864250183
- O 0 0.0711352750658989
> O 1 0.9987885355949402
Arg226Stop O 1 0.9996281862258911
) O 0 0.005900475662201643
. O 0 0.004941149149090052

Thus O 0 0.008885218761861324
, O 0 0.0016115001635625958
a O 0 0.010306929238140583
homozygous O 1 0.9999556541442871
germ O 1 0.9868562817573547
- O 0 0.03558550402522087
line O 0 0.025715278461575508
MLH1 O 1 0.9999995231628418
mutation O 1 0.9999852180480957
and O 0 0.0033278181217610836
consequent O 1 0.9999630451202393
mismatch O 1 0.9999978542327881
repair O 1 0.9999988079071045
deficiency O 1 1.0
results O 0 0.007538184989243746
in O 0 0.0013119445648044348
a O 0 0.012039675377309322
mutator O 1 0.9999983310699463
phenotype O 1 0.9999998807907104
characterized O 1 0.9933691620826721
by O 0 0.01108725555241108
leukemia B-Disease 1 1.0
and O 0 0.003824766958132386
/ O 1 0.9989359974861145
or O 0 0.09913405776023865
lymphoma B-Disease 1 1.0
associated O 0 0.020291674882173538
with O 0 0.006442664656788111
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9715819954872131
1 I-Disease 0 0.012925351038575172
. O 0 0.002144171390682459
. O 0 0.0038996224757283926

Missense O 1 0.9999377727508545
mutations O 1 0.998826801776886
in O 0 0.0017714300192892551
the O 0 0.0016193721676245332
most O 0 0.0017646115738898516
ancient O 0 0.003011136082932353
residues O 0 0.025617031380534172
of O 0 0.001168969552963972
the O 0 0.0054045566357672215
PAX6 O 1 0.9999985694885254
paired O 0 0.06790567934513092
domain O 0 0.03833223879337311
underlie O 1 0.7468879818916321
a O 0 0.006060189101845026
spectrum O 0 0.033330295234918594
of O 0 0.0030084731988608837
human O 1 0.9801301956176758
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 0.9999998807907104
. O 0 0.007874329574406147

Mutations O 1 0.983579695224762
of O 0 0.0014848228311166167
the O 0 0.002807829063385725
human O 0 0.018599823117256165
PAX6 O 1 0.9999998807907104
gene O 1 0.999932050704956
underlie O 1 0.9999890327453613
aniridia B-Disease 1 0.9999997615814209
( O 0 0.023622773587703705
congenital B-Disease 1 1.0
absence I-Disease 0 0.019438335672020912
of I-Disease 0 0.001318795490078628
the I-Disease 0 0.004189379513263702
iris I-Disease 1 0.9999988079071045
) O 0 0.003341715782880783
, O 0 0.0008910095784813166
a O 0 0.0045705088414251804
rare O 0 0.02777870185673237
dominant O 1 0.996507465839386
malformation B-Disease 1 1.0
of I-Disease 0 0.0020444567780941725
the I-Disease 0 0.005740873049944639
eye I-Disease 1 0.9999986886978149
. O 0 0.0054478091187775135

The O 0 0.0057488419115543365
spectrum O 0 0.0445101298391819
of O 0 0.005424809642136097
PAX6 O 1 0.9999997615814209
mutations O 1 0.9999885559082031
in O 0 0.009487698785960674
aniridia B-Disease 1 1.0
patients O 1 0.9999852180480957
is O 0 0.005359209608286619
highly O 0 0.013561977073550224
biased O 0 0.024118876084685326
, O 0 0.001437925617210567
with O 0 0.0016737275291234255
92 O 0 0.03995179384946823
% O 0 0.002810861449688673
of O 0 0.000770276936236769
all O 0 0.0013771632220596075
reported O 0 0.02367648482322693
mutations O 1 0.9999853372573853
leading O 0 0.013896462507545948
to O 0 0.004061059094965458
premature O 1 0.9803017973899841
truncation O 1 0.711724042892456
of O 0 0.0021383180283010006
the O 0 0.004845322109758854
protein O 0 0.0656527653336525
( O 0 0.004790192935615778
nonsense O 0 0.03531520068645477
, O 0 0.0023868721909821033
splicing O 0 0.13869908452033997
, O 0 0.003288554958999157
insertions O 1 0.9237719774246216
and O 0 0.0030684275552630424
deletions O 1 0.9788770079612732
) O 0 0.003554672235623002
and O 0 0.0012442131992429495
just O 0 0.0054845670238137245
2 O 0 0.008335734717547894
% O 0 0.003802149323746562
leading O 0 0.007097849156707525
to O 0 0.0014447062276303768
substitution O 0 0.025468355044722557
of O 0 0.0012850899947807193
one O 0 0.00437620934098959
amino O 0 0.0898478701710701
acid O 0 0.11837058514356613
by O 0 0.003704235190525651
another O 0 0.013549812138080597
( O 0 0.011525921523571014
missense O 1 0.9993390440940857
) O 0 0.006885351613163948
. O 0 0.004960307385772467

The O 0 0.004258539527654648
extraordinary O 0 0.012702994048595428
conservation O 0 0.011245403438806534
of O 0 0.001060126698575914
the O 0 0.006370934192091227
PAX6 O 1 0.9999971389770508
protein O 0 0.08791588991880417
at O 0 0.004402599297463894
the O 0 0.0034232076723128557
amino O 0 0.07031965255737305
acid O 0 0.09101860970258713
level O 0 0.006916776765137911
amongst O 0 0.01749255880713463
vertebrates O 1 0.6226733922958374
predicts O 0 0.03127143532037735
that O 0 0.002781734336167574
pathological O 1 0.9999390840530396
missense O 1 0.9999904632568359
mutations O 1 0.9999960660934448
should O 0 0.0022136042825877666
in O 0 0.0008440293022431433
fact O 0 0.0024525050539523363
be O 0 0.0016521093202754855
common O 0 0.0069066863507032394
even O 0 0.0026948752347379923
though O 0 0.0027464868035167456
they O 0 0.0008837887435220182
are O 0 0.0009007908520288765
hardly O 0 0.01901797391474247
ever O 0 0.008711281232535839
seen O 0 0.010010904632508755
in O 0 0.004710954613983631
aniridia B-Disease 1 0.9999998807907104
patients O 1 0.9999957084655762
. O 0 0.006630120798945427

This O 0 0.004034952726215124
indicates O 0 0.010274607688188553
that O 0 0.0009472187957726419
there O 0 0.001155436271801591
is O 0 0.001976783387362957
a O 0 0.008297944441437721
heavy O 0 0.05389761924743652
ascertainment O 1 0.9993294477462769
bias O 0 0.040805634111166
in O 0 0.001437602681107819
the O 0 0.0019114309689030051
selection O 0 0.006938638631254435
of O 0 0.002409004606306553
patients O 1 0.9999985694885254
for O 0 0.0053010801784694195
PAX6 O 1 1.0
mutation O 1 0.9999850988388062
analysis O 0 0.0054220883175730705
and O 0 0.000622403109446168
that O 0 0.0005736907478421926
the O 0 0.0019414859125390649
missing O 0 0.2746870517730713
PAX6 O 1 0.9999997615814209
missense O 1 0.9999845027923584
mutations O 1 0.999932050704956
frequently O 0 0.017162146046757698
may O 0 0.01291867345571518
underlie O 1 0.9989506006240845
phenotypes O 1 0.9989493489265442
distinct O 0 0.015607481822371483
from O 0 0.00457407720386982
textbook O 1 0.9184466004371643
aniridia B-Disease 1 0.9999744892120361
. O 0 0.00799628160893917

Here O 0 0.0029216252733021975
we O 0 0.0010676725069060922
present O 0 0.0017226769123226404
four O 0 0.0027555092237889767
novel O 0 0.04941800236701965
PAX6 O 1 0.9999997615814209
missense O 1 0.9999977350234985
mutations O 1 0.999961256980896
, O 0 0.001790606533177197
two O 0 0.0008304429356940091
in O 0 0.0014104718575254083
association O 0 0.009766673669219017
with O 0 0.0038945521228015423
atypical O 1 0.9999997615814209
phenotypes O 1 0.9999969005584717
ectopia B-Disease 1 0.9999580383300781
pupillae I-Disease 1 0.9995817542076111
( O 0 0.007235780358314514
displaced B-Disease 0 0.23670266568660736
pupils I-Disease 0 0.03592195734381676
) O 0 0.0043388004414737225
and O 0 0.005091656930744648
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9999998807907104
( O 0 0.008855788968503475
searching B-Disease 0 0.05089201405644417
gaze I-Disease 1 0.9910681843757629
) O 0 0.003225277876481414
, O 0 0.0009447090560570359
and O 0 0.0007253069779835641
two O 0 0.0008898485102690756
in O 0 0.0013649038737639785
association O 0 0.007895927876234055
with O 0 0.0014500265242531896
more O 0 0.0032665906473994255
recognizable O 1 0.9992730021476746
aniridia B-Disease 1 0.9999982118606567
phenotypes O 1 0.9996680021286011
. O 0 0.007274304516613483

Strikingly O 0 0.06108114495873451
, O 0 0.0013527056435123086
all O 0 0.0007732365047559142
four O 0 0.003986966796219349
mutations O 1 0.9999480247497559
are O 0 0.0010280923452228308
located O 0 0.004528621211647987
within O 0 0.0018379557877779007
the O 0 0.004998704418540001
PAX6 O 1 0.9999996423721313
paired O 0 0.1381271779537201
domain O 0 0.022421522065997124
and O 0 0.0015839934349060059
affect O 0 0.029212908819317818
amino O 0 0.07937917113304138
acids O 0 0.0496097207069397
which O 0 0.0015991543186828494
are O 0 0.0008272755076177418
highly O 0 0.009956243447959423
conserved O 0 0.022072216495871544
in O 0 0.0010793869150802493
all O 0 0.0011492136400192976
known O 0 0.012597136199474335
paired O 0 0.04945607855916023
domain O 0 0.04005265608429909
proteins O 0 0.029579365625977516
. O 0 0.004790479317307472

Our O 0 0.0061427392065525055
results O 0 0.00784085039049387
support O 0 0.0038672613445669413
the O 0 0.0029996205121278763
hypothesis O 0 0.030826635658740997
that O 0 0.000890752300620079
the O 0 0.0014507785672321916
under O 0 0.003449203446507454
- O 0 0.011872353963553905
representation O 0 0.005152618046849966
of O 0 0.0038740234449505806
missense O 1 0.9999912977218628
mutations O 1 0.999985933303833
is O 0 0.005733172874897718
caused O 1 0.9819319248199463
by O 0 0.0056256940588355064
ascertainment O 1 0.9999018907546997
bias O 0 0.057289596647024155
and O 0 0.0016326319891959429
suggest O 0 0.004643451888114214
that O 0 0.0006719623343087733
a O 0 0.004191910848021507
substantial O 0 0.012232559733092785
burden O 1 0.9613151550292969
of O 0 0.005544209387153387
PAX6 B-Disease 1 1.0
- I-Disease 1 0.9916540384292603
related I-Disease 1 0.5569072365760803
disease I-Disease 1 1.0
remains O 0 0.010835852473974228
to O 0 0.0013852028641849756
be O 0 0.0018090999219566584
uncovered O 0 0.022760819643735886
. O 0 0.0020482856780290604
. O 0 0.00380149157717824

The O 0 0.009841883555054665
chromosomal O 1 0.9981175661087036
order O 0 0.0036215046420693398
of O 0 0.0020419969223439693
genes O 0 0.2360730916261673
controlling O 0 0.14319981634616852
the O 0 0.0040822201408445835
major O 0 0.0334903821349144
histocompatibility O 1 0.9999997615814209
complex O 0 0.014158847741782665
, O 0 0.0027805096469819546
properdin O 1 0.9999498128890991
factor O 1 0.558536171913147
B O 1 0.997547447681427
, O 0 0.002095273695886135
and O 0 0.0032087289728224277
deficiency B-Disease 1 1.0
of I-Disease 0 0.0014119199477136135
the I-Disease 0 0.0018023117445409298
second I-Disease 0 0.007162503898143768
component I-Disease 0 0.02087324485182762
of I-Disease 0 0.0018426224123686552
complement I-Disease 0 0.028166409581899643
. O 0 0.004659484140574932

The O 0 0.004602762404829264
relationship O 0 0.006046969443559647
of O 0 0.0010567775461822748
the O 0 0.004217593930661678
genes O 0 0.3365879952907562
coding O 0 0.0985909029841423
for O 0 0.004853813908994198
HLA O 1 0.9999895095825195
to O 0 0.001806981978006661
those O 0 0.0017918129451572895
coding O 0 0.07662970572710037
for O 0 0.003591390559449792
properdin O 1 0.9995337724685669
Factor O 0 0.30596381425857544
B O 1 0.9905951023101807
allotypes O 1 0.9955162405967712
and O 0 0.002086913213133812
for O 0 0.003949625417590141
deficiency B-Disease 1 1.0
of I-Disease 0 0.0014627386117354035
the I-Disease 0 0.001820763573050499
second I-Disease 0 0.0075112273916602135
component I-Disease 0 0.02034265175461769
of I-Disease 0 0.0017774885054677725
complement I-Disease 0 0.036160193383693695
( O 0 0.012605573982000351
C2 O 1 0.9999998807907104
) O 0 0.004202333744615316
was O 0 0.004892250988632441
studied O 0 0.0026456897612661123
in O 0 0.0009147134842351079
families O 0 0.003850100329145789
of O 0 0.0027507722843438387
patients O 1 0.9999995231628418
with O 0 0.009119645692408085
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 0 0.007136876229196787

Patients O 1 0.9999282360076904
were O 0 0.002097875578328967
selected O 0 0.004135192837566137
because O 0 0.002869883319362998
they O 0 0.0007235952070914209
were O 0 0.001967255724593997
heterozygous O 1 0.999736487865448
or O 0 0.006573494058102369
homozygous O 1 0.9999520778656006
for O 0 0.011072139255702496
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.008705337531864643

12 O 0 0.014820902608335018
families O 0 0.006850197445601225
with O 0 0.0016120034269988537
15 O 0 0.010507473722100258
matings O 1 0.9467278718948364
informative O 0 0.02736956998705864
for O 0 0.008048046380281448
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 0.0034977265167981386
found O 0 0.007101493421941996
. O 0 0.004320353735238314

Of O 0 0.00598217872902751
57 O 0 0.04504524543881416
informative O 0 0.0469423346221447
meioses O 1 0.99817955493927
, O 0 0.002039327286183834
two O 0 0.0013475149171426892
crossovers O 0 0.0478537455201149
were O 0 0.0011947625316679478
noted O 0 0.0028928278479725122
between O 0 0.001972179627045989
the O 0 0.010727103799581528
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 1 0.999339759349823
and O 0 0.001847632578574121
the O 0 0.005327727645635605
HLA O 1 1.0
- O 1 0.7479802966117859
B O 1 0.9995965361595154
gene O 1 0.9993048906326294
, O 0 0.0014905545394867659
with O 0 0.0012053943937644362
a O 0 0.00772893475368619
recombinant O 0 0.11614375561475754
fraction O 0 0.028306452557444572
of O 0 0.0024707652628421783
0 O 0 0.02723591960966587
. O 0 0.004696844611316919

035 O 1 0.9945781230926514
. O 0 0.014909843914210796

A O 0 0.03828522562980652
lod O 1 0.7314795255661011
score O 0 0.006651564501225948
of O 0 0.001825160812586546
13 O 0 0.008427676744759083
was O 0 0.004721798934042454
calculated O 0 0.00773297343403101
for O 0 0.0016321330331265926
linkage O 0 0.06795070320367813
between O 0 0.012834636494517326
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 0.009777816943824291
HLA O 1 0.9999996423721313
- O 0 0.06917506456375122
B O 1 0.9578651189804077
at O 0 0.0038259809371083975
a O 0 0.004672687966376543
maximum O 0 0.012585446238517761
likelihood O 0 0.026624860242009163
value O 0 0.0022477658931165934
of O 0 0.0009115943103097379
the O 0 0.0032335417345166206
recombinant O 0 0.16706696152687073
fraction O 0 0.02651979960501194
of O 0 0.002848817501217127
0 O 0 0.027136709541082382
. O 0 0.005009272135794163

04 O 1 0.8660867810249329
. O 0 0.010865418240427971

18 O 0 0.017640331760048866
families O 0 0.00718857254832983
with O 0 0.001953414175659418
21 O 0 0.013946080580353737
informative O 0 0.029992273077368736
matings O 0 0.19292138516902924
for O 0 0.001654924126341939
both O 0 0.002880637301132083
properdin O 1 0.9994233846664429
Factor O 0 0.2530682384967804
B O 1 0.9972973465919495
allotype O 1 0.9994105100631714
and O 0 0.006804727017879486
HLA O 1 0.9999995231628418
- O 0 0.06691161543130875
B O 1 0.8315240740776062
were O 0 0.0028858326841145754
found O 0 0.007366348057985306
. O 0 0.005011534783989191

Of O 0 0.00409958278760314
72 O 0 0.04302739351987839
informative O 0 0.035257283598184586
meioses O 1 0.9973981380462646
, O 0 0.002270827302709222
three O 0 0.0032454885076731443
recombinants O 1 0.9966950416564941
were O 0 0.002296768594533205
found O 0 0.004465822596102953
, O 0 0.0013030326226726174
giving O 0 0.004672474693506956
a O 0 0.008007340133190155
recombinant O 0 0.16034357249736786
fraction O 0 0.030978035181760788
of O 0 0.0031134525779634714
0 O 0 0.02922576665878296
. O 0 0.004829788114875555

042 O 1 0.959775984287262
. O 0 0.010151337832212448

A O 0 0.03820740431547165
lod O 1 0.661291241645813
score O 0 0.0071157123893499374
of O 0 0.0014751035487279296
16 O 0 0.00792723149061203
between O 0 0.006809053011238575
HLA O 1 0.9999998807907104
- O 0 0.05272068455815315
B O 1 0.9211889505386353
and O 0 0.002366670873016119
Factor O 0 0.21306420862674713
B O 1 0.9970109462738037
allotypes O 1 0.9986572265625
was O 0 0.007052983622997999
calculated O 0 0.007934235967695713
at O 0 0.0029482163954526186
a O 0 0.005033733788877726
maximum O 0 0.01389237493276596
likelihood O 0 0.0322195328772068
value O 0 0.0029085970018059015
of O 0 0.0008824793621897697
the O 0 0.004027302842587233
recombinant O 0 0.14488396048545837
fraction O 0 0.028510374948382378
of O 0 0.002296554623171687
0 O 0 0.027660798281431198
. O 0 0.005456228274852037

04 O 1 0.9491954445838928
. O 0 0.010578670538961887

A O 0 0.027031591162085533
crossover O 0 0.07102154940366745
was O 0 0.007642943877726793
shown O 0 0.004981926642358303
to O 0 0.001030958374030888
have O 0 0.0018921815790235996
occurred O 0 0.016186030581593513
between O 0 0.002596509177237749
genes O 0 0.06681434065103531
for O 0 0.0020335237495601177
Factor O 0 0.21614262461662292
B O 1 0.9835935235023499
and O 0 0.006489511113613844
HLA O 1 0.9999998807907104
- O 0 0.07392624765634537
D O 1 0.9935892820358276
, O 0 0.0015904541360214353
in O 0 0.00125010940246284
which O 0 0.004749940242618322
HLA O 1 0.9999998807907104
- O 0 0.07546264678239822
D O 1 0.998407781124115
segregared O 1 0.9988767504692078
with O 0 0.008191307075321674
HLA O 1 0.9999983310699463
- O 0 0.030848613008856773
A O 0 0.016594719141721725
and O 0 0.0032421948853880167
B O 1 0.9808347821235657
. O 0 0.006099695339798927

These O 0 0.0030392217449843884
studies O 0 0.0037616898771375418
suggest O 0 0.003970264922827482
that O 0 0.0006718169897794724
the O 0 0.001755248405970633
genes O 0 0.0709686204791069
for O 0 0.0019681614357978106
Factor O 0 0.320548415184021
B O 1 0.9996492862701416
and O 0 0.008845122531056404
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.001817686134018004
located O 0 0.005966643337160349
outside O 0 0.0019203657284379005
those O 0 0.0012291832827031612
for O 0 0.0036282127257436514
HLA O 1 1.0
, O 0 0.0016258135437965393
that O 0 0.0006985325017012656
the O 0 0.001115597551688552
order O 0 0.0019353051902726293
of O 0 0.0017390067223459482
genese O 1 0.9998656511306763
is O 0 0.011050310917198658
HLA O 1 0.9999991655349731
- O 0 0.026263006031513214
A O 0 0.014542650431394577
, O 0 0.0027819392271339893
- O 0 0.03037228062748909
B O 1 0.996796190738678
, O 0 0.0035308946389704943
- O 0 0.031594812870025635
D O 1 0.9822355508804321
, O 0 0.002833978971466422
Factor O 0 0.08261415362358093
B O 1 0.9981302618980408
allotype O 1 0.9999488592147827
, O 0 0.012242997996509075
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 0.001766083063557744
that O 0 0.000705427024513483
the O 0 0.002474510343745351
genes O 0 0.2375737577676773
coding O 0 0.11337228119373322
for O 0 0.008573002181947231
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 0.00383597519248724
Factor O 1 0.9413384795188904
B O 1 0.9994331002235413
allotypes O 1 0.9988982677459717
are O 0 0.0016085206298157573
approximately O 0 0.006413138937205076
3 O 0 0.013361300341784954
- O 0 0.02434898354113102
- O 0 0.021706540137529373
5 O 0 0.013633024878799915
centimorgans O 1 0.8821059465408325
from O 0 0.0030458734836429358
the O 0 0.005854740738868713
HLA O 1 0.9999995231628418
- O 0 0.024363253265619278
A O 0 0.013579939492046833
and O 0 0.004779851995408535
HLA O 1 0.9999997615814209
- O 0 0.17984819412231445
B O 1 0.9993526339530945
loci O 1 0.9998286962509155
, O 0 0.0018165670335292816
and O 0 0.000616516568697989
that O 0 0.0007209465256892145
the O 0 0.0020194060634821653
apparent O 0 0.055870167911052704
lack O 0 0.007939741015434265
of O 0 0.002011081902310252
recombinants O 1 0.9982571005821228
between O 0 0.0018289558356627822
the O 0 0.002594050718471408
Factor O 1 0.9487643241882324
B O 1 0.9994885921478271
gene O 1 0.9983676075935364
and O 0 0.00978571455925703
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 1 0.9999769926071167
suggests O 0 0.012489600107073784
that O 0 0.0007074365857988596
these O 0 0.0005443987320177257
two O 0 0.0016288108890876174
genes O 1 0.7882524132728577
lie O 0 0.010005207732319832
in O 0 0.001297468552365899
close O 0 0.006307707633823156
proximity O 0 0.01655372604727745
to O 0 0.0013849058886989951
one O 0 0.0030486565083265305
another O 0 0.011447679251432419
. O 0 0.0053883204236626625

Distribution O 0 0.013102618046104908
of O 0 0.0022775549441576004
emerin O 1 0.9996209144592285
and O 0 0.003247953951358795
lamins O 1 0.998238205909729
in O 0 0.001797035918571055
the O 0 0.0037018675357103348
heart O 1 0.9999945163726807
and O 0 0.0014660052256658673
implications O 0 0.02265307866036892
for O 0 0.002907034708186984
Emery B-Disease 1 0.9999911785125732
- I-Disease 1 0.9985814094543457
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.010242817923426628

Emerin O 1 0.9758659601211548
is O 0 0.00451067928224802
a O 0 0.006105508655309677
nuclear O 0 0.006956211291253567
membrane O 0 0.07966498285531998
protein O 0 0.046993888914585114
which O 0 0.0017382776131853461
is O 0 0.0028159155044704676
missing O 0 0.019725829362869263
or O 0 0.0042818523943424225
defective O 1 0.999562680721283
in O 0 0.003287350060418248
Emery B-Disease 1 0.9999911785125732
- I-Disease 1 0.9984114170074463
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.06173139065504074
EDMD B-Disease 1 0.9999997615814209
) O 0 0.006995873991400003
. O 0 0.0049547962844371796

It O 0 0.003864855505526066
is O 0 0.002478903392329812
one O 0 0.0019884139765053988
member O 0 0.003291389672085643
of O 0 0.0010136212222278118
a O 0 0.005991425830870867
family O 0 0.01081510167568922
of O 0 0.0036879139952361584
lamina O 1 0.9999880790710449
- O 0 0.034648362547159195
associated O 0 0.01277452614158392
proteins O 0 0.016739528626203537
which O 0 0.0016460033366456628
includes O 0 0.004106924869120121
LAP1 O 1 0.9999954700469971
, O 0 0.004890271462500095
LAP2 O 1 0.9999572038650513
and O 0 0.00598999485373497
lamin O 1 0.9999761581420898
B O 1 0.9989392161369324
receptor O 1 0.9920584559440613
( O 0 0.017751799896359444
LBR O 1 0.9992478489875793
) O 0 0.00665291678160429
. O 0 0.005632312968373299

A O 0 0.01730080135166645
panel O 0 0.00797082856297493
of O 0 0.0022237191442400217
16 O 0 0.019866451621055603
monoclonal O 1 0.9997488856315613
antibodies O 1 0.9993100166320801
( O 0 0.01487469207495451
mAbs O 1 0.9969154596328735
) O 0 0.004113234579563141
has O 0 0.002539218869060278
been O 0 0.0033801121171563864
mapped O 0 0.021873509511351585
to O 0 0.0010029494296759367
six O 0 0.0021378949750214815
specific O 0 0.0025300292763859034
sites O 0 0.002577457344159484
throughout O 0 0.0028622401878237724
the O 0 0.003675270127132535
emerin O 1 0.999066174030304
molecule O 0 0.07608848065137863
using O 0 0.011033928021788597
phage O 1 0.9930389523506165
- O 0 0.031783901154994965
displayed O 0 0.015989119186997414
peptide O 0 0.1527518332004547
libraries O 0 0.008828951045870781
and O 0 0.0009619878837838769
has O 0 0.002069536130875349
been O 0 0.0024186703376471996
used O 0 0.0016762063605710864
to O 0 0.002622276311740279
localize O 1 0.9816857576370239
emerin O 1 0.9907293915748596
in O 0 0.003381230402737856
human O 0 0.009246277622878551
and O 0 0.0045774392783641815
rabbit O 1 0.9999996423721313
heart O 1 0.9999938011169434
. O 0 0.007323835510760546

Several O 0 0.010045574977993965
mAbs O 1 0.9443668723106384
against O 0 0.005384279415011406
different O 0 0.0033639962784945965
emerin O 1 0.9996063113212585
epitopes O 1 0.9981476068496704
did O 0 0.004896201658993959
not O 0 0.001893072621896863
recognize O 0 0.01897992007434368
intercalated O 1 0.8390229940414429
discs O 0 0.01913127489387989
in O 0 0.001519611687399447
the O 0 0.005114763043820858
heart O 1 0.9999960660934448
, O 0 0.0017596394754946232
though O 0 0.003866348648443818
they O 0 0.0018866072641685605
recognized O 0 0.020274892449378967
cardiomyocyte O 1 0.9998658895492554
nuclei O 0 0.05370018258690834
strongly O 0 0.008977322839200497
, O 0 0.001252594985999167
both O 0 0.0012331700418144464
at O 0 0.002191820414736867
the O 0 0.002742564771324396
rim O 0 0.031189344823360443
and O 0 0.0011394259054213762
in O 0 0.0022507451940327883
intranuclear O 1 0.9998935461044312
spots O 0 0.0516938790678978
or O 0 0.004753322806209326
channels O 0 0.018235642462968826
. O 0 0.00564988050609827

A O 0 0.04476084187626839
polyclonal O 1 0.9997653365135193
rabbit O 1 0.9999712705612183
antiserum O 1 0.9991000890731812
against O 0 0.015133952721953392
emerin O 1 0.99893718957901
did O 0 0.005723111797124147
recognize O 0 0.011727162636816502
both O 0 0.0015034767566248775
nuclear O 0 0.004906914662569761
membrane O 0 0.04794169217348099
and O 0 0.00293951528146863
intercalated O 1 0.9572751522064209
discs O 0 0.02987356297671795
but O 0 0.0022720331326127052
, O 0 0.001386187388561666
after O 0 0.010059716179966927
affinity O 0 0.04842280596494675
purification O 0 0.042218271642923355
against O 0 0.002971919486299157
a O 0 0.006805987562984228
pure O 0 0.023096643388271332
- O 0 0.03490485996007919
emerin O 1 0.9955955147743225
band O 0 0.020500700920820236
on O 0 0.0017596193356439471
a O 0 0.0054950532503426075
western O 0 0.009309998713433743
blot O 1 0.9994795918464661
, O 0 0.0018946968484669924
it O 0 0.002227806719020009
stained O 1 0.99226975440979
only O 0 0.0017604621825739741
the O 0 0.002105575054883957
nuclear O 0 0.0073190429247915745
membrane O 0 0.07184531539678574
. O 0 0.005349950399249792

These O 0 0.002146871527656913
results O 0 0.0054908497259020805
would O 0 0.0015523502370342612
not O 0 0.0008403994725085795
be O 0 0.0009906102204695344
expected O 0 0.0030484043527394533
if O 0 0.004331670235842466
immunostaining O 1 0.9950911998748779
at O 0 0.008055949583649635
intercalated O 0 0.4450666010379791
discs O 0 0.025377508252859116
were O 0 0.0015642250655218959
due O 0 0.0078174052760005
to O 0 0.0008806200348772109
a O 0 0.00358407711610198
product O 0 0.003911696840077639
of O 0 0.0008994927047751844
the O 0 0.004058703314512968
emerin O 1 0.9999951124191284
gene O 1 0.999940037727356
and O 0 0.0016839224845170975
, O 0 0.0015069941291585565
therefore O 0 0.0032355510629713535
, O 0 0.0011080960975959897
cast O 0 0.00398156838491559
some O 0 0.0009821951389312744
doubt O 0 0.00684528099372983
upon O 0 0.003052189014852047
the O 0 0.0019392716931179166
hypothesis O 0 0.04124313220381737
that O 0 0.004832747858017683
cardiac B-Disease 1 1.0
defects I-Disease 1 0.9999990463256836
in O 0 0.005332480650395155
EDMD B-Disease 1 0.9999996423721313
are O 0 0.0033813784830272198
caused O 1 0.9973579049110413
by O 0 0.0031188889406621456
absence O 0 0.013804826885461807
of O 0 0.0025226296856999397
emerin O 1 0.9997957348823547
from O 0 0.006339837331324816
intercalated O 1 0.9744591116905212
discs O 0 0.036092936992645264
. O 0 0.004324343055486679

Although O 0 0.01488497294485569
emerin O 1 0.9819585680961609
was O 0 0.007044453639537096
abundant O 0 0.006850407924503088
in O 0 0.00117115571629256
the O 0 0.003699704771861434
membranes O 0 0.1067790761590004
of O 0 0.004201168194413185
cardiomyocyte O 1 0.9999631643295288
nuclei O 0 0.04989507794380188
, O 0 0.001756675192154944
it O 0 0.001455670571886003
was O 0 0.005952546838670969
absent O 0 0.029505722224712372
from O 0 0.0020074655767530203
many O 0 0.0016890012193471193
non O 0 0.013611773028969765
- O 0 0.05076146498322487
myocyte O 1 0.9999145269393921
cells O 0 0.048626888543367386
in O 0 0.002018314553424716
the O 0 0.004484372679144144
heart O 1 0.9999979734420776
. O 0 0.005528672132641077

This O 0 0.0035169252660125494
distribution O 0 0.006570427678525448
of O 0 0.002552468329668045
emerin O 1 0.9996949434280396
was O 0 0.006274437997490168
similar O 0 0.0031416546553373337
to O 0 0.0006972163100726902
that O 0 0.0006065116613171995
of O 0 0.0016925320960581303
lamin O 1 0.9999819993972778
A O 0 0.013822617940604687
, O 0 0.0014585923636332154
a O 0 0.005676990374922752
candidate O 0 0.026256505399942398
gene O 1 0.9974072575569153
for O 0 0.0019069641130045056
an O 0 0.005193409044295549
autosomal O 1 0.9999998807907104
form O 0 0.010849866084754467
of O 0 0.0038055316545069218
EDMD B-Disease 1 1.0
. O 0 0.007624460384249687

In O 0 0.00408529257401824
contrast O 0 0.012720541097223759
, O 0 0.004484554752707481
lamin O 1 0.9999921321868896
B1 O 1 0.9999954700469971
was O 0 0.014045707881450653
absent O 0 0.04500524327158928
from O 0 0.005521623883396387
cardiomyocyte O 1 0.9998394250869751
nuclei O 0 0.037918753921985626
, O 0 0.001758542493917048
showing O 0 0.008561547845602036
that O 0 0.004392419941723347
lamin O 1 0.9999747276306152
B1 O 1 0.9999983310699463
is O 0 0.0031605632975697517
not O 0 0.0010026590898633003
essential O 0 0.0037741814740002155
for O 0 0.0011580310529097915
localization O 0 0.046637993305921555
of O 0 0.0017162903677672148
emerin O 1 0.9983831644058228
to O 0 0.0015643076039850712
the O 0 0.0029690389055758715
nuclear O 0 0.012638092041015625
lamina O 1 0.9974657297134399
. O 0 0.0078280596062541

Lamin O 1 0.9999617338180542
B1 O 1 0.9999921321868896
is O 0 0.004757637623697519
also O 0 0.0012060955632477999
almost O 0 0.005672088358551264
completely O 0 0.01741189695894718
absent O 0 0.05031994357705116
from O 0 0.007763129658997059
skeletal O 1 0.999995231628418
muscle O 1 0.9999910593032837
nuclei O 0 0.06309287995100021
. O 0 0.0066485716961324215

In O 0 0.009995708242058754
EDMD B-Disease 1 0.9999949932098389
, O 0 0.0015550910029560328
the O 0 0.0012269110884517431
additional O 0 0.002544037764891982
absence O 0 0.016079192981123924
of O 0 0.003916346933692694
lamin O 1 0.9999923706054688
B1 O 1 0.9999901056289673
from O 0 0.010452693328261375
heart O 1 0.9999929666519165
and O 0 0.005480547435581684
skeletal O 1 0.9999991655349731
muscle O 1 0.9999988079071045
nuclei O 0 0.041241902858018875
which O 0 0.0027942704036831856
already O 0 0.009852437302470207
lack O 0 0.022817708551883698
emerin O 1 0.9999338388442993
may O 0 0.009472468867897987
offer O 0 0.003246237989515066
an O 0 0.001538401236757636
alternative O 0 0.009597175754606724
explanation O 0 0.0064790211617946625
of O 0 0.0009822896681725979
why O 0 0.007855047471821308
these O 0 0.0022449935786426067
tissues O 1 0.9999780654907227
are O 0 0.0014837435446679592
particularly O 0 0.010952182114124298
affected O 1 0.8740923404693604
. O 0 0.0023956785444170237
. O 0 0.0036432251799851656

Genetic O 0 0.08294650167226791
mapping O 0 0.017300045117735863
of O 0 0.0011281503830105066
the O 0 0.003444918431341648
copper B-Disease 0 0.1441076695919037
toxicosis I-Disease 1 0.9999959468841553
locus O 1 0.9997840523719788
in O 0 0.006203511264175177
Bedlington O 1 0.9999403953552246
terriers O 1 0.9991921782493591
to O 0 0.007834198884665966
dog O 1 0.9998972415924072
chromosome O 1 0.9998475313186646
10 O 0 0.006785919889807701
, O 0 0.0010611122706905007
in O 0 0.0010035077575594187
a O 0 0.005099286325275898
region O 0 0.013417929410934448
syntenic O 1 0.9995909333229065
to O 0 0.00208850996568799
human O 0 0.015740133821964264
chromosome O 1 0.9997221827507019
region O 0 0.024349773302674294
2p13 O 1 0.9999524354934692
- O 0 0.08129646629095078
p16 O 1 0.9996908903121948
. O 0 0.00851330254226923

Abnormal O 1 0.999884843826294
hepatic B-Disease 1 0.9999998807907104
copper I-Disease 0 0.0695020779967308
accumulation I-Disease 0 0.06644799560308456
is O 0 0.002650504233315587
recognized O 0 0.005356622859835625
as O 0 0.0016289892373606563
an O 0 0.004756725858896971
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 0.0027705177199095488
man O 0 0.21124808490276337
, O 0 0.002391271060332656
mouse O 1 0.9999942779541016
, O 0 0.004010805394500494
rat O 1 0.9999924898147583
and O 0 0.0033835836220532656
dog O 1 0.9999314546585083
. O 0 0.005112603772431612

The O 0 0.006462525110691786
major O 0 0.015179408714175224
cause O 1 0.8938701152801514
of O 0 0.004361592698842287
hepatic B-Disease 1 1.0
copper I-Disease 0 0.06865691393613815
accumulation I-Disease 0 0.07153486460447311
in O 0 0.0016942241927608848
man O 0 0.009954617358744144
is O 0 0.0025899135507643223
a O 0 0.010518409311771393
dysfunctional O 1 0.9999915361404419
ATP7B O 1 0.9999988079071045
gene O 1 0.999800980091095
, O 0 0.004266512114554644
causing O 1 0.999991774559021
Wilson B-Disease 1 0.9999932050704956
disease I-Disease 1 1.0
( O 0 0.025054866448044777
WD B-Disease 1 0.9999998807907104
) O 0 0.006431663408875465
. O 0 0.003888587700203061

Mutations O 1 0.9993571639060974
in O 0 0.0021117939613759518
the O 0 0.005575606133788824
ATP7B O 1 0.9999983310699463
genes O 1 0.9782752990722656
have O 0 0.0018982610199600458
also O 0 0.001261276425793767
been O 0 0.002850257558748126
demonstrated O 0 0.009965934790670872
in O 0 0.0028430919628590345
mouse O 1 0.9997615218162537
and O 0 0.0041649979539215565
rat O 1 0.9999433755874634
. O 0 0.007429550867527723

The O 0 0.013666979968547821
ATP7B O 1 0.9999876022338867
gene O 1 0.9994089603424072
has O 0 0.005277109332382679
been O 0 0.0040405928157269955
excluded O 0 0.01228580716997385
in O 0 0.0009711398161016405
the O 0 0.00184324337169528
much O 0 0.006804301869124174
rarer O 1 0.9992650151252747
human O 0 0.016627846285700798
copper B-Disease 1 0.952502965927124
overload I-Disease 1 0.9999995231628418
disease O 1 1.0
non B-Disease 0 0.017900805920362473
- I-Disease 0 0.0249232929199934
Indian I-Disease 0 0.02108791097998619
childhood I-Disease 1 0.9999572038650513
cirrhosis I-Disease 1 1.0
, O 0 0.0038268696516752243
indicating O 0 0.03204808011651039
genetic O 0 0.4539169669151306
heterogeneity O 1 0.9284039735794067
. O 0 0.0062239873223006725

By O 0 0.004784565418958664
investigating O 0 0.011797571554780006
the O 0 0.003686363808810711
common O 0 0.06960662454366684
autosomal O 1 1.0
recessive O 1 1.0
copper B-Disease 1 0.9997827410697937
toxicosis I-Disease 1 1.0
( O 0 0.017560990527272224
CT B-Disease 1 0.9999992847442627
) O 0 0.0036907237954437733
in O 0 0.0029799500480294228
Bedlington O 1 0.9999984502792358
terriers O 1 0.9999815225601196
, O 0 0.0018823686987161636
we O 0 0.0009494120022282004
have O 0 0.0012165281223133206
identified O 0 0.007628894876688719
a O 0 0.003244800493121147
new O 0 0.004345603287220001
locus O 1 0.9999631643295288
involved O 0 0.011643080040812492
in O 0 0.004797661677002907
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.008099463768303394

We O 0 0.004002611618489027
examined O 0 0.019053440541028976
whether O 0 0.0033852756023406982
the O 0 0.00723107298836112
WD B-Disease 1 0.9999992847442627
gene O 1 0.9998964071273804
ATP7B O 1 0.9999527931213379
was O 0 0.00914693158119917
also O 0 0.0027344494592398405
causative O 1 0.9975088834762573
for O 0 0.004475572146475315
CT B-Disease 1 0.9999879598617554
by O 0 0.003094665938988328
investigating O 0 0.013376879505813122
the O 0 0.004375810734927654
chromosomal O 1 0.9999456405639648
co O 0 0.03754805028438568
- O 0 0.024810513481497765
localization O 0 0.061510857194662094
of O 0 0.0030582917388528585
ATP7B O 1 0.9999984502792358
and O 0 0.002852847333997488
C04107 O 1 0.9997194409370422
, O 0 0.0016797217540442944
using O 0 0.003933102823793888
fluorescence O 0 0.09720120579004288
in O 0 0.004414216615259647
situ O 1 0.8266934156417847
hybridization O 0 0.12669236958026886
( O 0 0.009371703490614891
FISH O 0 0.05099119246006012
) O 0 0.0038677442353218794
. O 0 0.004552710801362991

C04107 O 1 0.9968944787979126
is O 0 0.003369924146682024
an O 0 0.0021484557073563337
anonymous O 0 0.03304509073495865
microsatellite O 1 0.9912810921669006
marker O 0 0.1081034317612648
closely O 0 0.011830042116343975
linked O 0 0.04300185665488243
to O 0 0.006371670868247747
CT B-Disease 1 0.9999892711639404
. O 0 0.008059940300881863

However O 0 0.006990585941821337
, O 0 0.003947243560105562
BAC O 1 0.9999918937683105
clones O 1 0.9898577332496643
containing O 0 0.021747995167970657
ATP7B O 1 0.9999216794967651
and O 0 0.0033269436098635197
C04107 O 1 0.9931341409683228
mapped O 0 0.031062839552760124
to O 0 0.0014873764012008905
the O 0 0.005441721063107252
canine O 1 0.9999988079071045
chromosome O 1 0.9999613761901855
regions O 0 0.0242542065680027
CFA22q11 O 1 0.9997884631156921
and O 0 0.004163350909948349
CFA10q26 O 1 0.9999269247055054
, O 0 0.002114376286044717
respectively O 0 0.005678842309862375
, O 0 0.0013062434736639261
demonstrating O 0 0.009440306574106216
that O 0 0.004259278532117605
WD B-Disease 1 0.9999966621398926
cannot O 0 0.008583435788750648
be O 0 0.0031992383301258087
homologous O 0 0.13415290415287018
to O 0 0.005795307457447052
CT B-Disease 1 0.9999591112136841
. O 0 0.006944702938199043

The O 0 0.006246407516300678
copper O 0 0.03719240799546242
transport O 0 0.021236170083284378
genes O 1 0.8902574181556702
CTR1 O 1 0.9999784231185913
and O 0 0.003754425561055541
CTR2 O 1 0.9999905824661255
were O 0 0.0018000277923420072
also O 0 0.0016275024972856045
excluded O 0 0.018620537593960762
as O 0 0.002325545297935605
candidate O 0 0.02274295501410961
genes O 0 0.11200687289237976
for O 0 0.005217563360929489
CT B-Disease 1 0.9999992847442627
since O 0 0.008039196953177452
they O 0 0.0007826489745639265
both O 0 0.0011896889191120863
mapped O 0 0.026394695043563843
to O 0 0.004087873734533787
canine O 1 0.9999953508377075
chromosome O 1 0.9999634027481079
region O 0 0.030002670362591743
CFA11q22 O 1 0.9994913339614868
. O 0 0.007347050588577986

2 O 0 0.02920561656355858
- O 0 0.03416820988059044
22 O 0 0.01834990456700325
. O 0 0.005419242195785046

5 O 0 0.02462725155055523
. O 0 0.0067629762925207615

A O 0 0.023257192224264145
transcribed O 0 0.05479579046368599
sequence O 0 0.02391720935702324
identified O 0 0.009276090189814568
from O 0 0.0019424324855208397
the O 0 0.004106770735234022
C04107 O 1 0.9981613755226135
- O 0 0.029236944392323494
containing O 0 0.019732395187020302
BAC O 1 0.9999817609786987
was O 0 0.008123410865664482
found O 0 0.0035244596656411886
to O 0 0.0008832915918901563
be O 0 0.0020648471545428038
homologous O 0 0.10138241201639175
to O 0 0.001913295709528029
a O 0 0.00900618638843298
gene O 1 0.9892538785934448
expressed O 0 0.0067512220703065395
from O 0 0.0029269447550177574
human O 0 0.019878767430782318
chromosome O 1 0.9999760389328003
2p13 O 1 0.9996694326400757
- O 0 0.07586991786956787
p16 O 1 0.9996659755706787
, O 0 0.002444016980007291
a O 0 0.005126744043081999
region O 0 0.00984019786119461
devoid O 0 0.028235599398612976
of O 0 0.0010328409262001514
any O 0 0.0030870346818119287
positional O 1 0.5977312922477722
candidate O 0 0.03730818256735802
genes O 0 0.19484636187553406
. O 0 0.005999727174639702

Molecular O 0 0.038726821541786194
analysis O 0 0.003865043167024851
of O 0 0.0011618995340541005
the O 0 0.006646219175308943
APC B-Disease 1 0.9999992847442627
gene O 1 0.9944477081298828
in O 0 0.003477172926068306
205 O 0 0.08361843228340149
families O 0 0.006977202836424112
: O 0 0.0035222931765019894
extended O 0 0.023786844685673714
genotype O 1 0.9999755620956421
- O 0 0.30058953166007996
phenotype O 1 0.9999988079071045
correlations O 0 0.06939738243818283
in O 0 0.0060554808005690575
FAP B-Disease 1 0.9999998807907104
and O 0 0.001697984174825251
evidence O 0 0.0010640621185302734
for O 0 0.0005808197893202305
the O 0 0.0016661667032167315
role O 0 0.006221894174814224
of O 0 0.003180714091286063
APC B-Disease 1 0.9999980926513672
amino O 0 0.10190101712942123
acid O 0 0.3512873649597168
changes O 0 0.011750922538340092
in O 0 0.012120882980525494
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 0.9999997615814209
. O 0 0.00912697333842516

BACKGROUND O 0 0.042171623557806015
/ O 0 0.052787307649850845
AIMS O 0 0.01928641088306904
The O 0 0.0022315853275358677
development O 0 0.0032808706164360046
of O 0 0.008598239161074162
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.0013466218952089548
a O 0 0.004669636953622103
variable O 0 0.03405354917049408
range O 0 0.0032017724588513374
of O 0 0.002025357447564602
extracolonic O 1 0.9999467134475708
manifestations O 1 0.9989424347877502
in O 0 0.007794168312102556
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.5284014940261841
FAP B-Disease 1 1.0
) O 0 0.004227775149047375
is O 0 0.0018145397771149874
the O 0 0.001317571266554296
result O 0 0.0042911735363304615
of O 0 0.0006926264613866806
the O 0 0.0023166551254689693
dominant O 1 0.9436789155006409
inheritance O 1 0.9951039552688599
of O 0 0.013643757440149784
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 0.03354150801897049
APC B-Disease 1 1.0
) O 0 0.01269120629876852
gene O 1 0.9999349117279053
mutations O 1 0.999693751335144
. O 0 0.00581106822937727

In O 0 0.0024514917749911547
this O 0 0.0016007754020392895
study O 0 0.0035934695042669773
, O 0 0.001529268454760313
direct O 0 0.012611676938831806
mutation O 1 0.9998162388801575
analysis O 0 0.003712048288434744
of O 0 0.0010590240126475692
the O 0 0.0062374151311814785
APC B-Disease 1 0.9999991655349731
gene O 1 0.9987792372703552
was O 0 0.006381501909345388
performed O 0 0.006593703292310238
to O 0 0.0012121241306886077
determine O 0 0.009916217066347599
genotype O 1 0.9999550580978394
- O 0 0.0874551311135292
phenotype O 1 0.9999892711639404
correlations O 0 0.046113140881061554
for O 0 0.001472018426284194
nine O 0 0.007724708411842585
extracolonic O 1 0.9999743700027466
manifestations O 1 0.9266416430473328
and O 0 0.0007973774918355048
to O 0 0.0007682618452236056
investigate O 0 0.009128379635512829
the O 0 0.0037360875867307186
incidence O 1 0.9999603033065796
of O 0 0.003865821287035942
APC B-Disease 1 1.0
mutations O 1 0.999976396560669
in O 0 0.002727581886574626
non O 0 0.020664190873503685
- O 1 0.9998654127120972
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.009707403369247913

METHODS O 0 0.01582137495279312
The O 0 0.009503786452114582
APC B-Disease 1 0.9999969005584717
gene O 1 0.9954019784927368
was O 0 0.009203090332448483
analysed O 0 0.027247492223978043
in O 0 0.0024127180222421885
190 O 0 0.03830984979867935
unrelated O 0 0.07829318940639496
FAP B-Disease 1 0.9999997615814209
and O 0 0.0018925446784123778
15 O 0 0.006122160237282515
non O 0 0.018788324669003487
- O 1 0.999843955039978
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999926090240479
using O 0 0.007588810287415981
denaturing O 1 0.9987906813621521
gradient O 1 0.7446731925010681
gel O 1 0.9666979908943176
electrophoresis O 0 0.14798131585121155
, O 0 0.0020598687697201967
the O 0 0.003375701140612364
protein O 0 0.08852227032184601
truncation O 1 0.9976905584335327
test O 0 0.013147445395588875
, O 0 0.0010155191412195563
and O 0 0.000836276332847774
direct O 0 0.007537743076682091
sequencing O 0 0.08474338799715042
. O 0 0.006605016533285379

RESULTS O 0 0.05347554385662079
Chain O 1 0.9549953937530518
terminating O 0 0.10608255118131638
signals O 0 0.015322024002671242
were O 0 0.001139001571573317
only O 0 0.001607428421266377
identified O 0 0.010374176315963268
in O 0 0.0034167724661529064
patients O 1 0.9999798536300659
belonging O 0 0.01605335995554924
to O 0 0.0017498101806268096
the O 0 0.007429986260831356
FAP B-Disease 1 0.9999998807907104
group O 0 0.01991667039692402
( O 0 0.009736090898513794
105 O 1 0.744024932384491
patients O 1 0.9999939203262329
) O 0 0.00578351691365242
. O 0 0.004992544185370207

Amino O 0 0.15486155450344086
acid O 0 0.139231339097023
changes O 0 0.007383725140243769
were O 0 0.0016104617388918996
identified O 0 0.009615766815841198
in O 0 0.0014337546890601516
four O 0 0.0048420606181025505
patients O 1 0.999995231628418
, O 0 0.0011729274410754442
three O 0 0.0009174773585982621
of O 0 0.0010981456143781543
whom O 0 0.008938267827033997
belonged O 0 0.012069057673215866
to O 0 0.000915641663596034
the O 0 0.0020319896284490824
non O 0 0.012914690189063549
- O 0 0.22762994468212128
FAP O 1 0.9999998807907104
group O 0 0.015726720914244652
of O 0 0.019580774009227753
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999998807907104
. O 0 0.005620861891657114

Genotype O 1 0.9999879598617554
- O 0 0.45074179768562317
phenotype O 1 0.9999737739562988
correlations O 0 0.08698678761720657
identified O 0 0.014685442671179771
significant O 0 0.005780904088169336
differences O 0 0.0035738118458539248
in O 0 0.0007598414085805416
the O 0 0.001292922766879201
nature O 0 0.0027052820660173893
of O 0 0.000910456757992506
certain O 0 0.006071482319384813
extracolonic O 1 0.999981164932251
manifestations O 1 0.9974601864814758
in O 0 0.007516547106206417
FAP B-Disease 1 1.0
patients O 1 0.9999908208847046
belonging O 0 0.01455317810177803
to O 0 0.0013207310112193227
three O 0 0.004125652834773064
mutation O 1 0.9999953508377075
subgroups O 0 0.13713552057743073
. O 0 0.005520801991224289

CONCLUSIONS O 0 0.02823813632130623
Extended O 0 0.04232356697320938
genotype O 1 0.9999902248382568
- O 0 0.428382933139801
phenotype O 1 0.9999972581863403
correlations O 0 0.05270782858133316
made O 0 0.0013785830233246088
in O 0 0.0009827918838709593
this O 0 0.0013594538904726505
study O 0 0.003927253186702728
may O 0 0.005638266447931528
have O 0 0.001041671261191368
the O 0 0.0013134479522705078
potential O 0 0.006279204972088337
to O 0 0.0009194537997245789
determine O 0 0.0029350286349654198
the O 0 0.0013493398437276483
most O 0 0.0020189848728477955
appropriate O 0 0.0049608186818659306
surveillance O 0 0.01734248735010624
and O 0 0.0033559815492480993
prophylactic O 1 0.9999927282333374
treatment O 1 0.9999576807022095
regimens O 1 0.999872088432312
for O 0 0.001903330790810287
those O 0 0.0027039791457355022
patients O 1 0.9999983310699463
with O 0 0.0033775672782212496
mutations O 1 0.9999845027923584
associated O 0 0.007881861180067062
with O 0 0.0015768102603033185
life O 0 0.011860953643918037
threatening O 1 0.9997360110282898
conditions O 0 0.016198188066482544
. O 0 0.004243069794028997

This O 0 0.00425540329888463
study O 0 0.0035421063657850027
also O 0 0.0012349289609119296
provided O 0 0.001995301339775324
evidence O 0 0.0016347363125532866
for O 0 0.000890685769263655
the O 0 0.003409013384953141
pathological O 1 0.9828494191169739
nature O 0 0.006010588724166155
of O 0 0.002053014701232314
amino O 0 0.09163541346788406
acid O 0 0.19008292257785797
changes O 0 0.0076759797520935535
in O 0 0.0039447639137506485
APC O 1 0.9999980926513672
associated O 0 0.00977668073028326
with O 0 0.001226001768372953
both O 0 0.0033529081847518682
FAP B-Disease 1 0.9999996423721313
and O 0 0.0023717042058706284
non O 0 0.025047555565834045
- O 1 0.9999831914901733
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999998807907104
. O 0 0.0026664927136152983
. O 0 0.0037752932403236628

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 0 0.08559168130159378
cancer B-Disease 1 1.0
risk O 1 0.9431869983673096
of O 0 0.0015233394224196672
the O 0 0.006747763138264418
APC O 1 0.9999997615814209
I1307K O 1 0.9999767541885376
polymorphism O 1 0.9900084733963013
. O 0 0.007302507758140564

Germ O 1 0.9884876608848572
- O 0 0.03603971749544144
line O 0 0.010394267737865448
and O 0 0.002407875144854188
somatic O 1 0.9833821654319763
truncating O 1 0.9992027878761292
mutations O 1 0.9974275231361389
of O 0 0.0019876097794622183
the O 0 0.006292611826211214
APC B-Disease 1 0.9999997615814209
gene O 1 0.9993880987167358
are O 0 0.0011644436744973063
thought O 0 0.005289335735142231
to O 0 0.0024301381781697273
initiate O 1 0.9991686344146729
colorectal B-Disease 1 1.0
tumor I-Disease 1 1.0
formation O 0 0.034479252994060516
in O 0 0.007516480516642332
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.009466109797358513
sporadic O 1 0.9999977350234985
colorectal O 1 1.0
carcinogenesis O 1 0.9999995231628418
, O 0 0.003563478821888566
respectively O 0 0.007510164752602577
. O 0 0.0037429321091622114

Recently O 0 0.025855258107185364
, O 0 0.0017338877078145742
an O 0 0.0038501315284520388
isoleucine O 1 0.9991175532341003
- O 0 0.0459032841026783
- O 0 0.05276002734899521
> O 1 0.9923209547996521
lysine O 1 0.990607500076294
polymorphism O 1 0.8102867007255554
at O 0 0.011859031394124031
codon O 1 0.9569713473320007
1307 O 1 0.9989504218101501
( O 0 0.013102173805236816
I1307K O 1 0.9895265102386475
) O 0 0.002119652461260557
of O 0 0.001117819338105619
the O 0 0.006778772454708815
APC B-Disease 1 0.9999998807907104
gene O 1 0.999539852142334
has O 0 0.00473541347309947
been O 0 0.003907185047864914
identified O 0 0.009981783106923103
in O 0 0.002069836715236306
6 O 0 0.012011333368718624
% O 0 0.005963442847132683
- O 0 0.020108820870518684
7 O 0 0.012195488438010216
% O 0 0.0030436054803431034
of O 0 0.0011528581380844116
the O 0 0.005324113182723522
Ashkenazi O 1 0.9992849230766296
Jewish O 0 0.01663580909371376
population O 0 0.0116273807361722
. O 0 0.005436639301478863

To O 0 0.0035842834040522575
assess O 0 0.01795051619410515
the O 0 0.0033333594910800457
risk O 0 0.13413293659687042
of O 0 0.0008848102879710495
this O 0 0.0016182330437004566
common O 0 0.017531782388687134
APC B-Disease 1 0.9999996423721313
allelic O 1 0.9999608993530273
variant O 1 0.9999209642410278
in O 0 0.012587437406182289
colorectal O 1 1.0
carcinogenesis O 1 0.9999984502792358
, O 0 0.002123287646099925
we O 0 0.0009825805900618434
have O 0 0.0012137861922383308
analyzed O 0 0.010055539198219776
a O 0 0.0037197964265942574
large O 0 0.005090055521577597
cohort O 0 0.1070244237780571
of O 0 0.003876644652336836
unselected O 1 0.967691957950592
Ashkenazi O 1 0.9940012097358704
Jewish O 0 0.012478900142014027
subjects O 0 0.009224205277860165
with O 0 0.006936752703040838
adenomatous B-Disease 1 1.0
polyps I-Disease 1 1.0
and O 0 0.0023041865788400173
. O 0 0.00245536002330482
or O 1 0.8441354632377625
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 0.001660586567595601
for O 0 0.0009403558215126395
the O 0 0.005165138281881809
APC O 1 0.9999997615814209
I1307K O 1 0.9999346733093262
polymorphism O 1 0.9904014468193054
. O 0 0.006455462891608477

The O 0 0.01837194338440895
APC O 1 0.9999979734420776
I1307K O 1 0.9999243021011353
allele O 1 0.9999085664749146
was O 0 0.012736544944345951
identified O 0 0.011543896980583668
in O 0 0.0022713111247867346
48 O 0 0.021963514387607574
( O 0 0.004723750986158848
10 O 0 0.005194360390305519
. O 0 0.0019504452357068658
1 O 0 0.011004801839590073
% O 0 0.0045038191601634026
) O 0 0.002530542900785804
of O 0 0.0032462459057569504
476 O 1 0.9997530579566956
patients O 1 0.9999959468841553
. O 0 0.00564153678715229

Compared O 0 0.018438369035720825
with O 0 0.0014515615766867995
the O 0 0.0027212079148739576
frequency O 0 0.029628653079271317
in O 0 0.001050436869263649
two O 0 0.00099710444919765
separate O 0 0.0036663482896983624
population O 0 0.008614836260676384
control O 0 0.020931998267769814
groups O 0 0.003349926322698593
, O 0 0.0014762100763618946
the O 0 0.005313457455486059
APC O 1 0.9999998807907104
I1307K O 1 0.999983549118042
allele O 1 0.9999603033065796
is O 0 0.005964426789432764
associated O 0 0.007384725380688906
with O 0 0.0009109335951507092
an O 0 0.0018248507985845208
estimated O 0 0.012291919440031052
relative O 0 0.02267918735742569
risk O 0 0.4793337285518646
of O 0 0.002035000827163458
1 O 0 0.013828243128955364
. O 0 0.004410081543028355

5 O 0 0.029481112957000732
- O 0 0.03184543177485466
1 O 0 0.019640380516648293
. O 0 0.005207141861319542

7 O 0 0.024645265191793442
for O 0 0.010956915095448494
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999998807907104
( O 0 0.007123974617570639
both O 0 0.004730112385004759
P O 1 0.9986019730567932
= O 0 0.048923078924417496
. O 0 0.004061572719365358
01 O 1 0.9999196529388428
) O 0 0.004312553908675909
. O 0 0.0041167461313307285

Furthermore O 0 0.027379371225833893
, O 0 0.001812752801924944
compared O 0 0.00909418985247612
with O 0 0.002260037465021014
noncarriers O 1 0.9998592138290405
, O 0 0.0056147039867937565
APC O 1 0.9999996423721313
I1307K O 1 0.9999724626541138
carriers O 1 0.8830230832099915
had O 0 0.004698231816291809
increased O 0 0.006711192429065704
numbers O 0 0.0029411199502646923
of O 0 0.002868447219952941
adenomas B-Disease 1 0.9999996423721313
and O 0 0.018803106620907784
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9999998807907104
per O 0 0.017656121402978897
patient O 1 0.9998981952667236
( O 0 0.013501368463039398
P O 1 0.9992607235908508
= O 0 0.05682928487658501
. O 0 0.004244034644216299
03 O 1 0.9981443881988525
) O 0 0.0035461040679365396
, O 0 0.0009237278718501329
as O 0 0.0010875074658542871
well O 0 0.0009791370248422027
as O 0 0.0015275852056220174
a O 0 0.006551909726113081
younger O 0 0.11805933713912964
age O 0 0.015277438797056675
at O 0 0.010395394638180733
diagnosis O 1 0.9999992847442627
. O 0 0.005860585719347

We O 0 0.0033263289369642735
conclude O 0 0.01089521311223507
that O 0 0.0011265374487265944
the O 0 0.005279871169477701
APC O 1 0.9999953508377075
I1307K O 1 0.9996496438980103
variant O 1 0.998009979724884
leads O 0 0.02333793044090271
to O 0 0.0029252709355205297
increased O 0 0.03308207169175148
adenoma B-Disease 1 1.0
formation O 0 0.0420982763171196
and O 0 0.0013131540035828948
directly O 0 0.005609301850199699
contributes O 0 0.03755701705813408
to O 0 0.0021365962456911802
3 O 0 0.009339939802885056
% O 0 0.005400503054261208
- O 0 0.016826309263706207
4 O 0 0.009278694167733192
% O 0 0.0022770697250962257
of O 0 0.0009372520726174116
all O 0 0.0018776049837470055
Ashkenazi O 1 0.9999760389328003
Jewish O 1 0.9983510971069336
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.009602035395801067

The O 0 0.004754004068672657
estimated O 0 0.013292073272168636
relative O 0 0.02015390433371067
risk O 1 0.9865124225616455
for O 0 0.0029636009130626917
carriers O 1 0.9857739210128784
may O 0 0.008302285335958004
justify O 0 0.016331609338521957
specific O 0 0.006399942561984062
clinical O 1 0.6953306198120117
screening O 0 0.039275191724300385
for O 0 0.0012393532088026404
the O 0 0.00264202943071723
360 O 0 0.03598972037434578
, O 0 0.002022868487983942
000 O 0 0.02537541277706623
Americans O 0 0.007511885836720467
expected O 0 0.0032877949997782707
to O 0 0.0017129569314420223
harbor O 0 0.045455627143383026
this O 0 0.003996812738478184
allele O 1 0.9999805688858032
, O 0 0.002047909889370203
and O 0 0.0017322609201073647
genetic O 0 0.3563518524169922
testing O 0 0.0157217625528574
in O 0 0.0008778758929111063
the O 0 0.001492629642598331
setting O 0 0.0040788608603179455
of O 0 0.0016755226533859968
long O 0 0.011160925962030888
- O 0 0.02113097533583641
term O 0 0.018400678411126137
- O 0 0.01974126137793064
outcome O 0 0.013398975133895874
studies O 0 0.0050698984414339066
may O 0 0.006485583260655403
impact O 0 0.016222897917032242
significantly O 0 0.040105730295181274
on O 0 0.014707655645906925
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 0.9997169375419617
in O 0 0.0016638102242723107
this O 0 0.00185026740655303
population O 0 0.008424808271229267
. O 0 0.0038233210798352957

Localization O 0 0.08900342136621475
of O 0 0.003389628604054451
human O 0 0.022872967645525932
BRCA1 O 1 1.0
and O 0 0.0021141315810382366
its O 0 0.00246151490136981
loss O 0 0.02388463355600834
in O 0 0.0013150714803487062
high O 0 0.006886955816298723
- O 0 0.016048399731516838
grade O 0 0.020355986431241035
, O 0 0.001568284467794001
non B-Disease 0 0.013486807234585285
- I-Disease 1 0.9970144033432007
inherited I-Disease 1 1.0
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.009248497895896435

Although O 0 0.004901048261672258
the O 0 0.0019599213264882565
link O 0 0.011759575456380844
between O 0 0.0016090439166873693
the O 0 0.007362771313637495
BRCA1 O 1 1.0
tumour B-Disease 1 1.0
- O 1 0.987762987613678
suppressor O 1 0.9999998807907104
gene O 1 0.999901294708252
and O 0 0.004144974052906036
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9808228611946106
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 0.004200432449579239
established O 0 0.0034823501482605934
, O 0 0.0007807182264514267
the O 0 0.0014190198853611946
role O 0 0.005872861482203007
, O 0 0.0010136960772797465
if O 0 0.001479367958381772
any O 0 0.0009280727244913578
, O 0 0.0007565471460111439
of O 0 0.0024833783973008394
BRCA1 O 1 1.0
in O 0 0.002821683883666992
non B-Disease 0 0.017666472122073174
- I-Disease 1 0.9984174966812134
familial I-Disease 1 1.0
cancers I-Disease 1 1.0
is O 0 0.0048582241870462894
unclear O 0 0.011948599480092525
. O 0 0.003979399800300598

BRCA1 O 1 1.0
mutations O 1 0.9998927116394043
are O 0 0.001841548248194158
rare O 0 0.012267461977899075
in O 0 0.0027593537233769894
sporadic B-Disease 1 0.9999408721923828
cancers I-Disease 1 1.0
, O 0 0.0014830606523901224
but O 0 0.001766305766068399
loss O 0 0.09355810284614563
of O 0 0.004559746477752924
BRCA1 O 1 1.0
resulting O 0 0.08656821399927139
from O 0 0.004066335503011942
reduced O 0 0.027229726314544678
expression O 0 0.022113433107733727
or O 0 0.0036548285279423
incorrect O 0 0.026768894866108894
subcellular O 0 0.12118837237358093
localization O 0 0.08636398613452911
is O 0 0.0038565064314752817
postulated O 0 0.05264558270573616
to O 0 0.000846880313474685
be O 0 0.0007061554933898151
important O 0 0.0011335150338709354
in O 0 0.001240928191691637
non B-Disease 0 0.013774139806628227
- I-Disease 1 0.9922163486480713
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9148562550544739
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.009325960651040077

Epigenetic O 1 0.9997702240943909
loss O 1 0.895091712474823
, O 0 0.0020775997545570135
however O 0 0.00270293140783906
, O 0 0.0011231866665184498
has O 0 0.0020773860160261393
not O 0 0.0010359431616961956
received O 0 0.00696782860904932
general O 0 0.005503591615706682
acceptance O 0 0.025757446885108948
due O 0 0.008655773475766182
to O 0 0.001297338167205453
controversy O 0 0.01721884496510029
regarding O 0 0.0030346785206347704
the O 0 0.002930158283561468
subcellular O 0 0.09347082674503326
localization O 0 0.07156746089458466
of O 0 0.007189089898020029
BRCA1 O 1 1.0
proteins O 0 0.04590531066060066
, O 0 0.0016153788892552257
reports O 0 0.003107883967459202
of O 0 0.0009361846023239195
which O 0 0.0017829937860369682
have O 0 0.0021309542935341597
ranged O 0 0.01810273714363575
from O 0 0.0021542708855122328
exclusively O 0 0.0056604607962071896
nuclear O 0 0.0031929989345371723
, O 0 0.0011174003593623638
to O 0 0.0018108332296833396
conditionally O 1 0.5111092329025269
nuclear O 0 0.003449296811595559
, O 0 0.000812457175925374
to O 0 0.0009668905986472964
the O 0 0.006125889718532562
ER O 1 0.9999984502792358
/ O 1 0.9335280060768127
golgi O 1 0.9980859756469727
, O 0 0.0016963343368843198
to O 0 0.002613148419186473
cytoplasmic O 1 0.9032259583473206
invaginations O 1 0.9844347834587097
into O 0 0.004481120500713587
the O 0 0.004057989921420813
nucleus O 0 0.0757674053311348
. O 0 0.006251008249819279

In O 0 0.00293070450425148
an O 0 0.0021598725579679012
attempt O 0 0.012152647599577904
to O 0 0.0015599398175254464
resolve O 0 0.014689906500279903
this O 0 0.001993985613808036
issue O 0 0.004205520264804363
, O 0 0.0008842000970616937
we O 0 0.0009409949416294694
have O 0 0.0018970725359395146
comprehensively O 0 0.2449255734682083
characterized O 0 0.13050241768360138
19 O 0 0.019836874678730965
anti O 0 0.21614207327365875
- O 1 0.9383169412612915
BRCA1 O 1 1.0
antibodies O 1 0.9977186918258667
. O 0 0.00705323088914156

These O 0 0.0043669817969202995
reagents O 0 0.054357532411813736
detect O 0 0.044588249176740646
a O 0 0.00880512222647667
220 O 0 0.035856835544109344
- O 0 0.048160258680582047
kD O 1 0.9803341031074524
protein O 0 0.1170663833618164
localized O 0 0.1566680520772934
in O 0 0.002440408570691943
discrete O 0 0.026843467727303505
nuclear O 0 0.006055027712136507
foci O 0 0.16957823932170868
in O 0 0.0015855544479563832
all O 0 0.0025572192389518023
epithelial O 1 0.9999818801879883
cell O 0 0.07846087217330933
lines O 0 0.010557888075709343
, O 0 0.0009458595886826515
including O 0 0.0008485200232826173
those O 0 0.0011144991731271148
derived O 0 0.012190698646008968
from O 0 0.009842747822403908
breast B-Disease 1 1.0
malignancies I-Disease 1 0.9999963045120239
. O 0 0.008536751382052898

Immunohistochemical O 1 0.9965097308158875
staining O 1 0.969167947769165
of O 0 0.004061250481754541
human O 0 0.03527017682790756
breast O 1 1.0
specimens O 0 0.019627578556537628
also O 0 0.002560320310294628
revealed O 0 0.03980710357427597
BRCA1 O 1 0.9999998807907104
nuclear O 0 0.011821729131042957
foci O 1 0.7971161603927612
in O 0 0.005379638634622097
benign O 1 0.9999998807907104
breast O 1 1.0
, O 0 0.01167727168649435
invasive B-Disease 1 1.0
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 0 0.002406379207968712
low B-Disease 0 0.0220964252948761
- I-Disease 0 0.04071904718875885
grade I-Disease 1 0.7752754092216492
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.010006628930568695

Conversely O 0 0.39346033334732056
, O 0 0.008406845852732658
BRCA1 O 1 1.0
expression O 0 0.04644155502319336
was O 0 0.008233912289142609
reduced O 0 0.027348069474101067
or O 0 0.004935631062835455
undetectable O 1 0.9731053709983826
in O 0 0.0014131319476291537
the O 0 0.0017999293049797416
majority O 0 0.005960565526038408
of O 0 0.0013054237933829427
high O 0 0.008700528182089329
- O 0 0.022673336789011955
grade O 0 0.03495456278324127
, O 0 0.008998950012028217
ductal B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 0.002726125530898571
suggesting O 0 0.008586459793150425
that O 0 0.0011196763953194022
absence O 0 0.014195222407579422
of O 0 0.004253207240253687
BRCA1 O 1 1.0
may O 0 0.011452476494014263
contribute O 0 0.007024366408586502
to O 0 0.0009837904945015907
the O 0 0.0033040298148989677
pathogenesis O 1 0.9999556541442871
of O 0 0.0016742398729547858
a O 0 0.003228960558772087
significant O 0 0.0047566150315105915
percentage O 0 0.006190023850649595
of O 0 0.00283878855407238
sporadic B-Disease 1 0.999995231628418
breast I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.0032609503250569105
. O 0 0.0038819238543510437

